| Cod |
Title+Abstracts |
| 1 |
ON DECEMBER 5, 2017, THE NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE HOSTED A PUBLIC WORKSHOP TITLED NUTRIGENOMICS AND THE FUTURE OF NUTRITION IN WASHINGTON, DC, TO REVIEW CURRENT KNOWLEDGE IN THE FIELD OF NUTRIGENOMICS AS IT RELATES TO NUTRITION |
| 2 |
"DRY MOUTH" AND "FLAMMER" SYNDROMES-NEGLECTED RISKS IN ADOLESCENTS AND NEW CONCEPTS BY PREDICTIVE, PREVENTIVE AND PERSONALISED APPROACH |
| 3 |
"EPIGENOME-WIDE METHYLATION PROFILE OF CHRONIC KIDNEY DISEASE-DERIVED ARTERIAL DNA UNCOVERS NOVEL PATHWAYS IN DISEASE-ASSOCIATED CARDIOVASCULAR PATHOLOGY |
| 4 |
"MIX OF MICS"- PHENOTYPIC AND BIOLOGICAL HETEROGENEITY OF "MULTIPOTENT" MUSCLE INTERSTITIAL CELLS (MICS) |
| 5 |
"THE MOTHERS HAVE EATEN UNRIPE GRAPES AND THE CHILDREN'S TEETH ARE SET ON EDGE": THE POTENTIAL INTER-GENERATIONAL EFFECTS OF THE HOLOCAUST ON CHRONIC MORBIDITY IN HOLOCAUST SURVIVORS' OFFSPRING |
| 6 |
'BIOLOGIC MEMORY' IN RESPONSE TO ACUTE KIDNEY INJURY: CYTORESISTANCE, TOLL-LIKE RECEPTOR HYPER-RESPONSIVENESS AND THE ONSET OF PROGRESSIVE RENAL DISEASE |
| 7 |
'BIOLOGIZING' PSYCHOPATHY: ETHICAL, LEGAL, AND RESEARCH IMPLICATIONS AT THE INTERFACE OF EPIGENETICS AND CHRONIC ANTISOCIAL CONDUCT |
| 8 |
'OMIC' GENETIC TECHNOLOGIES FOR HERBAL MEDICINES IN PSYCHIATRY |
| 9 |
'TRAINED IMMUNITY': CONSEQUENCES FOR LYMPHOID MALIGNANCIES |
| 10 |
14-3-3 LIGAND PREVENTS NUCLEAR IMPORT OF C-ABL PROTEIN IN CHRONIC MYELOID LEUKEMIA |
| 11 |
15Q12 VARIANTS, SPUTUM GENE PROMOTER HYPERMETHYLATION, AND LUNG CANCER RISK: A GWAS IN SMOKERS |
| 12 |
2017 CLINICAL TRIALS UPDATE IN NEW TREATMENTS OF BETA-THALASSEMIA |
| 13 |
360-DEGREE PERSPECTIVES ON OBESITY |
| 14 |
3RD COLLEGE OF PAEDIATRICS AND CHILD HEALTH LECTURE--THE PAST, THE PRESENT AND THE SHAPE OF THINGS TO COME |
| 15 |
450K-ARRAY ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS REVEALS GLOBAL DNA METHYLATION TO BE RELATIVELY STABLE OVER TIME AND SIMILAR IN RESTING AND PROLIFERATIVE COMPARTMENTS |
| 16 |
4CRNA NEAT1 SPONGE ADSORPTION OF MIR-378 MODULATES ACTIVITY OF LIPOPOLYSACCHARIDE-TREATED ARTICULAR CHONDROCYTES AND INFLUENCES THE PATHOLOGICAL DEVELOPMENT OF OSTEOARTHRITIS |
| 17 |
5' FLANKING REGION OF VAR GENES NUCLEATE HISTONE MODIFICATION PATTERNS LINKED TO PHENOTYPIC INHERITANCE OF VIRULENCE TRAITS IN MALARIA PARASITES |
| 18 |
5-AZACYTIDINE MODULATES CPG METHYLATION LEVELS OF EZH2 AND NOTCH1 IN MYELODYSPLASTIC SYNDROMES |
| 19 |
5-AZACYTYDINE AND RESVERATROL REVERSE SENESCENCE AND AGEING OF ADIPOSE STEM CELLS VIA MODULATION OF MITOCHONDRIAL DYNAMICS AND AUTOPHAGY |
| 20 |
5-HYDROXYMETHYLATION-ASSOCIATED EPIGENETIC MODIFIERS OF ALZHEIMER'S DISEASE MODULATE TAU-INDUCED NEUROTOXICITY |
| 21 |
5-HYDROXYMETHYLCYTOSINE (5HMC) AND TEN-ELEVEN TRANSLOCATION 1-3 (TET1-3) PROTEINS IN THE DORSAL ROOT GANGLIA OF MOUSE: EXPRESSION AND DYNAMIC REGULATION IN NEUROPATHIC PAIN |
| 22 |
5-HYDROXYMETHYLCYTOSINE AS A CLINICAL BIOMARKER: FLUORESCENCE-BASED ASSAY FOR HIGH-THROUGHPUT EPIGENETIC QUANTIFICATION IN HUMAN TISSUES |
| 23 |
60 YEARS OF NEUROENDOCRINOLOGY: REDEFINING NEUROENDOCRINOLOGY: STRESS, SEX AND COGNITIVE AND EMOTIONAL REGULATION |
| 24 |
8-OXOGUANINE DNA GLYCOSYLASE-1-DRIVEN DNA BASE EXCISION REPAIR: ROLE IN ASTHMA PATHOGENESIS |
| 25 |
A 3' TRNA-DERIVED FRAGMENT PRODUCED BY TRNA(LEUAAG) AND TRNA(LEUTAG) IS ASSOCIATED WITH POOR PROGNOSIS IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY OF CLASSICAL PROGNOSTIC FACTORS |
| 26 |
A 6-ALKYLSALICYLATE HISTONE ACETYLTRANSFERASE INHIBITOR INHIBITS HISTONE ACETYLATION AND PRO-INFLAMMATORY GENE EXPRESSION IN MURINE PRECISION-CUT LUNG SLICES |
| 27 |
A B-CELL EPIGENETIC SIGNATURE DEFINES THREE BIOLOGIC SUBGROUPS OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH CLINICAL IMPACT |
| 28 |
A BIOMIMETIC NATURAL SCIENCES APPROACH TO UNDERSTANDING THE MECHANISMS OF AGEING IN BURDEN OF LIFESTYLE DISEASES |
| 29 |
A BIOPSYCHOSOCIAL OVERVIEW OF THE OPIOID CRISIS: CONSIDERING NUTRITION AND GASTROINTESTINAL HEALTH |
| 30 |
A BRIEF LOOK AT HASHIMOTO'S DISEASE, ADRENAL INCIDENTALOMAS, OBESITY AND INSULIN RESISTANCE-COULD ENDOCRINE DISRUPTORS BE THE OTHER SIDE OF THE SAME COIN? HASHIMOTO'S DISEASE (HD) IS THE MOST COMMON CAUSE OF HYPOTHYROIDISM IN DEVELOPED COUNTRIES |
| 31 |
A CASE OF INFECTION-ASSOCIATED ANTIPROTEINASE-3-NEGATIVE CYTOPLASMIC ANTINEUTROPHIL CYTOPLASMIC ANTIBODY PAUCI-IMMUNE FOCAL NECROTIZING GLOMERULONEPHRITIS |
| 32 |
A CASE OF TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE WITH ASXL1 MUTATION |
| 33 |
A CASE STUDY OF CHIROPRACTIC MANAGEMENT OF PREGNANCY-RELATED HEARTBURN WITH POSTULATED FETAL EPIGENOME IMPLICATIONS |
| 34 |
A CHILD'S NUTRITION AND EPIGENETICS |
| 35 |
A CHROMATIN ACTIVITY-BASED CHEMOPROTEOMIC APPROACH REVEALS A TRANSCRIPTIONAL REPRESSOME FOR GENE-SPECIFIC SILENCING |
| 36 |
A CHROMATIN ASSAY FOR HUMAN BRAIN TISSUE |
| 37 |
A CHROMATIN REMODELING CHECKPOINT OF DIET-INDUCED MACROPHAGE ACTIVATION IN ADIPOSE TISSUE |
| 38 |
A COMMON ROLE FOR PSYCHOTROPIC MEDICATIONS: MEMORY IMPAIRMENT |
| 39 |
A COMPARISON OF EPIGENETIC MITOTIC-LIKE CLOCKS FOR CANCER RISK PREDICTION |
| 40 |
A COMPARISON OF HERPES SIMPLEX VIRUS TYPE 1 AND VARICELLA-ZOSTER VIRUS LATENCY AND REACTIVATION |
| 41 |
A COMPARISON OF NEUROIMAGING ABNORMALITIES IN MULTIPLE SCLEROSIS, MAJOR DEPRESSION AND CHRONIC FATIGUE SYNDROME (MYALGIC ENCEPHALOMYELITIS): IS THERE A COMMON CAUSE? THERE IS COPIOUS EVIDENCE OF ABNORMALITIES IN RESTING-STATE FUNCTIONAL NETWORK CONNECTIVITY STATES, GREY AND WHITE MATTER PATHOLOGY AND IMPAIRED CEREBRAL PERFUSION IN PATIENTS AFFORDED A DIAGNOSIS OF MULTIPLE SCLEROSIS, MAJOR DEPRESSION OR CHRONIC FATIGUE SYNDROME (CFS) (MYALGIC ENCEPHALOMYELITIS) |
| 42 |
A COMPREHENSIVE GENOME-WIDE PROFILING COMPARISON BETWEEN HBV AND HCV INFECTED HEPATOCELLULAR CARCINOMA |
| 43 |
A COMPREHENSIVE REVIEW OF THE GENETIC AND EPIGENETIC CONTRIBUTIONS TO THE DEVELOPMENT OF FIBROMYALGIA |
| 44 |
A COMPREHENSIVE REVIEW ON HIGH -FAT DIET-INDUCED DIABETES MELLITUS: AN EPIGENETIC VIEW |
| 45 |
A COMPREHENSIVE REVIEW ON RNA INTERFERENCE-MEDIATED TARGETING OF INTERLEUKINS AND ITS POTENTIAL THERAPEUTIC IMPLICATIONS IN COLON CANCER |
| 46 |
A CONCEPTUAL FRAMEWORK FOR THE DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE |
| 47 |
A CONCEPTUAL MODEL OF BIOPSYCHOSOCIAL MECHANISMS OF TRANSITION FROM ACUTE TO CHRONIC POSTSURGICAL PAIN IN CHILDREN AND ADOLESCENTS |
| 48 |
A CRUCIAL ROLE FOR MATERNAL DIETARY METHYL DONOR INTAKE IN EPIGENETIC PROGRAMMING AND FETAL GROWTH OUTCOMES |
| 49 |
A CURRENT GENETIC AND EPIGENETIC VIEW ON HUMAN AGING MECHANISMS |
| 50 |
A DEEP LEARNING MODEL FOR EARLY RISK PREDICTION OF HEART FAILURE WITH PRESERVED EJECTION FRACTION BY DNA METHYLATION PROFILES COMBINED WITH CLINICAL FEATURES |
| 51 |
A DISTINCT EPIGENETIC PROFILE DISTINGUISHES STENOTIC FROM NON-INFLAMED FIBROBLASTS IN THE ILEAL MUCOSA OF CROHN'S DISEASE PATIENTS |
| 52 |
A DNA METHYLATION BASED MEASURE OUTPERFORMS CIRCULATING CRP AS A MARKER OF CHRONIC INFLAMMATION AND PARTLY REFLECTS THE MONOCYTIC RESPONSE TO LONG-TERM INFLAMMATORY EXPOSURE: A CANADIAN LONGITUDINAL STUDY ON AGING ANALYSIS |
| 53 |
A DNA METHYLATION NETWORK INTERACTION MEASURE, AND DETECTION OF NETWORK ONCOMARKERS |
| 54 |
A DRY IMMERSION MODEL OF MICROGRAVITY MODULATES PLATELET PHENOTYPE, MIRNA SIGNATURE, AND CIRCULATING PLASMA PROTEIN BIOMARKER PROFILE |
| 55 |
A GAIN-OF-FUNCTION SODIUM CHANNEL BETA2-SUBUNIT MUTATION IN PAINFUL DIABETIC NEUROPATHY |
| 56 |
A GENOME-WIDE ASSOCIATION META-ANALYSIS OF CIRCULATING SEX HORMONE-BINDING GLOBULIN REVEALS MULTIPLE LOCI IMPLICATED IN SEX STEROID HORMONE REGULATION |
| 57 |
A GENOME-WIDE ASSOCIATION STUDY OF QUANTITATIVE COMPUTED TOMOGRAPHIC EMPHYSEMA IN KOREAN POPULATIONS |
| 58 |
A GENOME-WIDE SCAN TO LOCATE REGIONS ASSOCIATED WITH FAMILIAL VESICOURETERAL REFLUX |
| 59 |
A GENOME-WIDE SCREEN IDENTIFIES FREQUENTLY METHYLATED GENES IN HAEMATOLOGICAL AND EPITHELIAL CANCERS |
| 60 |
A GENOME-WIDE SCREEN REVEALS MICRORNAS IN PERIPHERAL SENSORY NEURONS DRIVING PAINFUL DIABETIC NEUROPATHY |
| 61 |
A HEALTH SURVEILLANCE SOFTWARE FRAMEWORK TO DELIVER INFORMATION ON PREVENTIVE HEALTHCARE STRATEGIES |
| 62 |
A HIGH DEFINITION PICTURE OF SOMATIC MUTATIONS IN CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NATURAL KILLER CELLS |
| 63 |
A HIGH METHYLATION LEVEL OF A NOVEL -284 BP CPG ISLAND IN THE RAMP1 GENE PROMOTER IS POTENTIALLY ASSOCIATED WITH MIGRAINE IN WOMEN |
| 64 |
A HIGH-THROUGHPUT SCREENING ASSAY FOR SILENCING ESTABLISHED HIV-1 MACROPHAGE INFECTION IDENTIFIES NUCLEOSIDE ANALOGS THAT PERTURB H3K9ME3 ON PROVIRAL GENOMES |
| 65 |
A JOURNEY FROM MICROENVIRONMENT TO MACROENVIRONMENT: THE ROLE OF METAFLAMMATION AND EPIGENETIC CHANGES IN CARDIORENAL DISEASE |
| 66 |
A KEY ROLE FOR EZH2 IN EPIGENETIC SILENCING OF HOX GENES IN MANTLE CELL LYMPHOMA |
| 67 |
A LONGITUDINAL STUDY OF THE ASSOCIATIONS OF BDNF GENOTYPE AND METHYLATION WITH POSTSTROKE ANXIETY |
| 68 |
A MECHANISTIC MODEL FOR YOGA AS A PREVENTIVE AND THERAPEUTIC MODALITY |
| 69 |
A MEDIAL PREFRONTAL CORTEX-NUCLEUS ACUMENS CORTICOTROPIN-RELEASING FACTOR CIRCUITRY FOR NEUROPATHIC PAIN-INCREASED SUSCEPTIBILITY TO OPIOID REWARD |
| 70 |
A METHOD TO DETECT DIFFERENTIALLY METHYLATED LOCI WITH NEXT-GENERATION SEQUENCING |
| 71 |
A MITOCHONDRIAL STAT3-METHIONINE METABOLISM AXIS PROMOTES ILC2-DRIVEN ALLERGIC LUNG INFLAMMATION |
| 72 |
A MOLECULAR SIGNATURE FOR DELAYED GRAFT FUNCTION |
| 73 |
A MULTI-GENERATIONAL STUDY ON LOW-DOSE BPA EXPOSURE IN WISTAR RATS: EFFECTS ON MATERNAL BEHAVIOR, FLAVOR INTAKE AND DEVELOPMENT |
| 74 |
A MULTIDISCIPLINARY APPROACH AND CURRENT PERSPECTIVE OF NONALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW |
| 75 |
A MURINE CELL LINE BASED MODEL OF CHRONIC CDK9 INHIBITION TO STUDY WIDESPREAD NON-GENETIC TRANSCRIPTIONAL ELONGATION DEFECTS (TEDEFF) IN CANCERS |
| 76 |
A NEW ASPECT OF CHRONIC PAIN AS A LIFESTYLE-RELATED DISEASE |
| 77 |
A NEW ERA OF LOW-DOSE RADIATION EPIDEMIOLOGY |
| 78 |
A NEW MECHANISTIC APPROACH FOR THE TREATMENT OF CHRONIC NEUROPATHIC PAIN WITH NITROUS OXIDE INTEGRATED FROM A SYSTEMS BIOLOGY NARRATIVE REVIEW |
| 79 |
A NEW PROSPECT FOR THE TREATMENT OF NEPHROTIC SYNDROME BASED ON NETWORK PHARMACOLOGY ANALYSIS |
| 80 |
A NEW ROLE FOR THE P2Y-LIKE GPR17 RECEPTOR IN THE MODULATION OF MULTIPOTENCY OF OLIGODENDROCYTE PRECURSOR CELLS IN VITRO |
| 81 |
A NEW TYPE OF DENTAL ANOMALY: MOLAR-INCISOR MALFORMATION (MIM) |
| 82 |
A NON-GENETIC BASIS FOR CANCER PROGRESSION AND METASTASIS: SELF-ORGANIZING ATTRACTORS IN CELL REGULATORY NETWORKS |
| 83 |
A NOVEL EPIGENETIC MARKER, TEN-ELEVEN TRANSLOCATION FAMILY MEMBER 2 (TET2), IS IDENTIFIED IN THE INTRACTABLE EPILEPTIC BRAIN AND REGULATES ATP BINDING CASSETTE SUBFAMILY B MEMBER 1 (ABCB1) IN THE BLOOD-BRAIN BARRIER |
| 84 |
A NOVEL EPIGENETIC MECHANISM OF FXR INHIBITING GLP-1 SECRETION VIA MIR-33 AND ITS DOWNSTREAM TARGETS |
| 85 |
A NOVEL INDOLE COMPOUND MA-35 ATTENUATES RENAL FIBROSIS BY INHIBITING BOTH TNF-ALPHA AND TGF-BETA(1) PATHWAYS |
| 86 |
A PATERNAL HYPERCALORIC DIET AFFECTS THE METABOLISM AND FERTILITY OF F1 AND F2 WISTAR RAT GENERATIONS |
| 87 |
A PHASE 1 STUDY OF AZACITIDINE WITH HIGH-DOSE CYTARABINE AND MITOXANTRONE IN HIGH-RISK ACUTE MYELOID LEUKEMIA |
| 88 |
A PHASE I BIOLOGICAL STUDY OF MG98, AN OLIGODEOXYNUCLEOTIDE ANTISENSE TO DNA METHYLTRANSFERASE 1, IN PATIENTS WITH HIGH-RISK MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA |
| 89 |
A PILOT INVESTIGATION OF DIFFERENTIAL HYDROXYMETHYLATION LEVELS IN PATIENT-DERIVED NEURAL STEM CELLS IMPLICATES ALTERED CORTICAL DEVELOPMENT IN BIPOLAR DISORDER |
| 90 |
A PILOT REVERSE VIRTUAL SCREENING STUDY SUGGESTS TOXIC EXPOSURES CAUSED LONG-TERM EPIGENETIC CHANGES IN GULF WAR ILLNESS |
| 91 |
A PILOT STUDY EXAMINING THE RELATIONSHIP BETWEEN CHRONIC HEROIN USE AND TELOMERE LENGTH AMONG INDIVIDUALS OF AFRICAN ANCESTRY |
| 92 |
A PILOT STUDY INVESTIGATING THE ROLE OF GENDER IN THE INTERGENERATIONAL RELATIONSHIPS BETWEEN GENE EXPRESSION, CHRONIC PAIN, AND ADVERSE CHILDHOOD EXPERIENCES IN A CLINICAL SAMPLE OF YOUTH WITH CHRONIC PAIN |
| 93 |
A PILOT STUDY OF PERIPHERAL BLOOD DNA METHYLATION MODELS AS PREDICTORS OF KNEE OSTEOARTHRITIS RADIOGRAPHIC PROGRESSION: DATA FROM THE OSTEOARTHRITIS INITIATIVE (OAI) |
| 94 |
A PLEIOTROPIC ROLE OF THE HEPATITIS B VIRUS CORE PROTEIN IN HEPATOCARCINOGENESIS |
| 95 |
A POSSIBLE ROLE FOR EPIGENETIC FEEDBACK REGULATION IN THE DYNAMICS OF THE EPITHELIAL-MESENCHYMAL TRANSITION (EMT) |
| 96 |
A PRIMER ON METABOLIC MEMORY: WHY EXISTING DIABESITY TREATMENTS FAIL |
| 97 |
A PRIMER ON THE EPIGENETICS OF KIDNEY FIBROSIS |
| 98 |
A PROOF-OF-CONCEPT FOR EPIGENETIC THERAPY OF TISSUE FIBROSIS: INHIBITION OF LIVER FIBROSIS PROGRESSION BY 3-DEAZANEPLANOCIN A |
| 99 |
A PUTATIVE "HEPITYPE" IN THE ATM GENE ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA RISK |
| 100 |
A QUINAZOLINE-BASED HDAC INHIBITOR AFFECTS GENE EXPRESSION PATHWAYS INVOLVED IN CHOLESTEROL BIOSYNTHESIS AND MEVALONATE IN PROSTATE CANCER CELLS |
| 101 |
A RAT METHYL-SEQ PLATFORM TO IDENTIFY EPIGENETIC CHANGES ASSOCIATED WITH STRESS EXPOSURE |
| 102 |
A REGULATORY ROLE FOR CHD2 IN MYELOPOIESIS |
| 103 |
A REHABILOMICS FRAMEWORK FOR PERSONALIZED AND TRANSLATIONAL REHABILITATION RESEARCH AND CARE FOR INDIVIDUALS WITH DISABILITIES: PERSPECTIVES AND CONSIDERATIONS FOR SPINAL CORD INJURY |
| 104 |
A REVIEW OF CYTOKINE-BASED PATHOPHYSIOLOGY OF LONG COVID SYMPTOMS |
| 105 |
A REVIEW OF MICROBIOTA AND IRRITABLE BOWEL SYNDROME: FUTURE IN THERAPIES |
| 106 |
A REVIEW OF MOLECULAR EVENTS OF CADMIUM-INDUCED CARCINOGENESIS |
| 107 |
A REVIEW OF PRE-CLINICAL MODELS FOR GULF WAR ILLNESS |
| 108 |
A REVIEW OF THE PROTECTIVE EFFECT OF MELATONIN IN PESTICIDE-INDUCED TOXICITY |
| 109 |
A REVIEW ON THE THERAPEUTIC ROLE OF TKIS IN CASE OF CML IN COMBINATION WITH EPIGENETIC DRUGS |
| 110 |
A ROLE FOR ACTIVITY-DEPENDENT EPIGENETICS IN THE DEVELOPMENT AND TREATMENT OF MAJOR DEPRESSIVE DISORDER |
| 111 |
A ROLE FOR G-PROTEIN COUPLED ESTROGEN RECEPTOR (GPER) IN ESTROGEN-INDUCED CARCINOGENESIS: DYSREGULATED GLANDULAR HOMEOSTASIS, SURVIVAL AND METASTASIS |
| 112 |
A ROLE FOR GLOBAL DNA METHYLATION LEVEL AND IL2 EXPRESSION IN THE TRANSITION FROM ACUTE TO CHRONIC LOW BACK PAIN |
| 113 |
A SELECTIVE HDAC 1/2 INHIBITOR MODULATES CHROMATIN AND GENE EXPRESSION IN BRAIN AND ALTERS MOUSE BEHAVIOR IN TWO MOOD-RELATED TESTS |
| 114 |
A SOCIO-BIOLOGICAL EXPLANATION FOR SOCIAL DISPARITIES IN NON-COMMUNICABLE CHRONIC DISEASES: THE PRODUCT OF HISTORY? THIS STUDY PLACES SOCIAL DISPARITIES IN THE MAJOR NON-COMMUNICABLE CHRONIC DISEASES WITHIN THEIR GLOBAL ECONOMIC AND HISTORICAL CONTEXTS |
| 115 |
A STEM CELL AGING FRAMEWORK, FROM MECHANISMS TO INTERVENTIONS |
| 116 |
A STUDY OF DNA METHYLATION OF BLADDER CANCER BIOMARKERS IN THE URINE OF PATIENTS WITH NEUROGENIC LOWER URINARY TRACT DYSFUNCTION |
| 117 |
A STUDY ON NUTRITIONAL STATUS AND TOOTH CROWN SIZE AMONG 6-9-YEAR-OLD CHILDREN: AN OBSERVATIONAL CROSS-SECTIONAL STUDY |
| 118 |
A SUBSET OF METHYLATED CPG SITES DIFFERENTIATE PSORIATIC FROM NORMAL SKIN |
| 119 |
A SYSTEMATIC EXAMINATION OF BRAIN VOLUMETRIC ABNORMALITIES IN RECENT-ONSET SCHIZOPHRENIA USING VOXEL-BASED, SURFACE-BASED AND REGION-OF-INTEREST-BASED MORPHOMETRIC ANALYSES |
| 120 |
A SYSTEMATIC REVIEW OF CHILDHOOD MALTREATMENT AND DNA METHYLATION: CANDIDATE GENE AND EPIGENOME-WIDE APPROACHES |
| 121 |
A SYSTEMATIC REVIEW OF TRANSCRIPTIONAL DYSREGULATION IN HUNTINGTON'S DISEASE STUDIED BY RNA SEQUENCING |
| 122 |
A SYSTEMATIC REVIEW ON FLUORIDE-INDUCED EPIGENETIC TOXICITY IN MAMMALS |
| 123 |
A SYSTEMATIC REVIEW, META-ANALYSIS, AND NETWORK ANALYSIS OF DIAGNOSTIC MICRORNAS IN GLAUCOMA |
| 124 |
A SYSTEMS APPROACH DELIVERS A FUNCTIONAL MICRORNA CATALOG AND EXPANDED TARGETS FOR SEIZURE SUPPRESSION IN TEMPORAL LOBE EPILEPSY |
| 125 |
A SYSTEMS BIOLOGY OVERVIEW ON HUMAN DIABETIC NEPHROPATHY: FROM GENETIC SUSCEPTIBILITY TO POST-TRANSCRIPTIONAL AND POST-TRANSLATIONAL MODIFICATIONS |
| 126 |
A TOXICOGENOMICS APPROACH TO IDENTIFY NEW PLAUSIBLE EPIGENETIC MECHANISMS OF OCHRATOXIN A CARCINOGENICITY IN RAT |
| 127 |
A TRANSCRIPTIONAL PERSPECTIVE ON HUMAN MACROPHAGE BIOLOGY |
| 128 |
A UNIFYING MECHANISM OF KETOGENIC DIET ACTION: THE MULTIPLE ROLES OF NICOTINAMIDE ADENINE DINUCLEOTIDE |
| 129 |
A UNIQUE VIRULENCE GENE OCCUPIES A PRINCIPAL POSITION IN IMMUNE EVASION BY THE MALARIA PARASITE PLASMODIUM FALCIPARUM |
| 130 |
A-TO-I EDITING OF MIR-200B-3P IN AIRWAY CELLS IS ASSOCIATED WITH MODERATE-TO-SEVERE ASTHMA |
| 131 |
A2B ADENOSINE SIGNALING REPRESSES CIITA TRANSCRIPTION VIA AN EPIGENETIC MECHANISM IN VASCULAR SMOOTH MUSCLE CELLS |
| 132 |
AACR WHITE PAPER: SHAPING THE FUTURE OF CANCER PREVENTION - A ROADMAP FOR ADVANCING SCIENCE AND PUBLIC HEALTH |
| 133 |
AAV-MEDIATED EXPRESSION OF SECRETED AND TRANSMEMBRANE ALPHAKLOTHO ISOFORMS RESCUES RELEVANT AGING HALLMARKS IN SENESCENT SAMP8 MICE |
| 134 |
ABCB1 REGULATION THROUGH LRPPRC IS INFLUENCED BY THE METHYLATION STATUS OF THE GC -100 BOX IN ITS PROMOTER |
| 135 |
ABERRANT CPG METHYLATION MEDIATES ABNORMAL TRANSCRIPTION OF MAO-A INDUCED BY ACUTE AND CHRONIC L-3,4-DIHYDROXYPHENYLALANINE ADMINISTRATION IN SH-SY5Y NEURONAL CELLS |
| 136 |
ABERRANT DNA HYPERMETHYLATION PATTERNS LEAD TO TRANSCRIPTIONAL SILENCING OF TUMOR SUPPRESSOR GENES IN UVB-EXPOSED SKIN AND UVB-INDUCED SKIN TUMORS OF MICE |
| 137 |
ABERRANT DNA METHYLATION AND EXPRESSION OF SPDEF AND FOXA2 IN AIRWAY EPITHELIUM OF PATIENTS WITH COPD |
| 138 |
ABERRANT DNA METHYLATION AT HOXA4 AND HOXA5 GENES ARE ASSOCIATED WITH RESISTANCE TO IMATINIB MESYLATE AMONG CHRONIC MYELOID LEUKEMIA PATIENTS |
| 139 |
ABERRANT DNA METHYLATION IS ASSOCIATED WITH DISEASE PROGRESSION, RESISTANCE TO IMATINIB AND SHORTENED SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA |
| 140 |
ABERRANT DNA METHYLATION MEDIATES THE TRANSGENERATIONAL RISK OF METABOLIC AND CHRONIC DISEASE DUE TO MATERNAL OBESITY AND OVERNUTRITION |
| 141 |
ABERRANT DNA METHYLATION OF MTOR PATHWAY GENES PROMOTES INFLAMMATORY ACTIVATION OF IMMUNE CELLS IN DIABETIC KIDNEY DISEASE |
| 142 |
ABERRANT DNA METHYLATION OF PHOSPHODIESTERASE [CORRECTED] 4D ALTERS AIRWAY SMOOTH MUSCLE CELL PHENOTYPES |
| 143 |
ABERRANT DNA METHYLATION OF TWO TUMOR SUPPRESSOR GENES, P14(ARF) AND P15(INK4B), AFTER CHRONIC OCCUPATIONAL EXPOSURE TO LOW LEVEL OF BENZENE |
| 144 |
ABERRANT DNA METHYLATION PROFILE OF CHRONIC AND TRANSFORMED CLASSIC PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS |
| 145 |
ABERRANT DNA METHYLATION STATUS AND MRNA EXPRESSION LEVEL OF SMG1 GENE IN CHRONIC MYELOID LEUKEMIA: A CASE-CONTROL STUDY |
| 146 |
ABERRANT ENDOMETRIAL DNA METHYLOME AND ASSOCIATED GENE EXPRESSION IN WOMEN WITH ENDOMETRIOSIS |
| 147 |
ABERRANT EPIGENETIC GENE REGULATION IN LYMPHOID MALIGNANCIES |
| 148 |
ABERRANT FLUID SHEAR STRESS CONTRIBUTES TO ARTICULAR CARTILAGE PATHOGENESIS VIA EPIGENETIC REGULATION OF ZBTB20 BY H3K4ME3 |
| 149 |
ABERRANT HYDROXYMETHYLATION IN PROMOTER CPG REGIONS OF GENES RELATED TO THE CELL CYCLE AND APOPTOSIS CHARACTERIZES ADVANCED CHRONIC MYELOID LEUKEMIA DISEASE, POOR IMATINIB RESPONDENTS AND POOR SURVIVAL |
| 150 |
ABERRANT HYPOMETHYLATION OF THE CANCER-TESTIS ANTIGEN PRAME CORRELATES WITH PRAME EXPRESSION IN ACUTE MYELOID LEUKEMIA |
| 151 |
ABERRANT METHYLATION AND IMPAIRED EXPRESSION OF THE P15(INK4B) CELL CYCLE REGULATORY GENE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) |
| 152 |
ABERRANT METHYLATION OF DAPK IN LONG-STANDING ULCERATIVE COLITIS AND ULCERATIVE COLITIS-ASSOCIATED CARCINOMA |
| 153 |
ABERRANT METHYLATION OF MULTIPLE TUMOR SUPPRESSOR GENES IN AGING LIVER, CHRONIC HEPATITIS, AND HEPATOCELLULAR CARCINOMA |
| 154 |
ABERRANT METHYLATION OF NUCLEOTIDE EXCISION REPAIR GENES IS ASSOCIATED WITH CHRONIC ARSENIC POISONING |
| 155 |
ABERRANT METHYLATION OF POLO-LIKE KINASE CPG ISLANDS IN PLK4 HETEROZYGOUS MICE |
| 156 |
ABERRANT METHYLATION OF THE DEATH-ASSOCIATED PROTEIN KINASE 1 (DAPK1) CPG ISLAND IN CHRONIC MYELOID LEUKEMIA |
| 157 |
ABERRANT METHYLATION OF TUMOUR SUPPRESSOR GENE ADAM12 IN CHRONIC LYMPOCYTIC LEUKEMIA PATIENTS: APPLICATION OF METHYLATION SPECIFIC-PCR TECHNIQUE |
| 158 |
ABERRANT P16 PROMOTER METHYLATION AMONG GREEK LUNG CANCER PATIENTS AND SMOKERS: CORRELATION WITH SMOKING |
| 159 |
ABERRANT PROMOTER HYPERMETHYLATION OF MULTIPLE GENES IN GALLBLADDER CARCINOMA AND CHRONIC CHOLECYSTITIS |
| 160 |
ABERRANT PROMOTER HYPOMETHYLATION IN CLL: DOES IT MATTER FOR DISEASE DEVELOPMENT? OVER THE LAST 30 YEARS, STUDIES OF ABERRANT DNA METHYLATION IN HEMATOLOGIC MALIGNANCIES HAVE BEEN DOMINATED BY THE PRIMARY FOCUS OF UNDERSTANDING PROMOTER HYPERMETHYLATION |
| 161 |
ABHD4-REGULATING RNA PANEL: NOVEL BIOMARKERS IN ACUTE CORONARY SYNDROME DIAGNOSIS |
| 162 |
ABL1 METHYLATION IN PH-POSITIVE ALL IS EXCLUSIVELY ASSOCIATED WITH THE P210 FORM OF BCR-ABL |
| 163 |
ABL1 METHYLATION IS A DISTINCT MOLECULAR EVENT ASSOCIATED WITH CLONAL EVOLUTION OF CHRONIC MYELOID LEUKEMIA |
| 164 |
ABNORMAL HISTONE METHYLATION IS RESPONSIBLE FOR INCREASED VASCULAR ENDOTHELIAL GROWTH FACTOR 165A SECRETION FROM AIRWAY SMOOTH MUSCLE CELLS IN ASTHMA |
| 165 |
ABNORMAL HOMOCYSTEINE METABOLISM: AN INSIGHT OF ALZHEIMER'S DISEASE FROM DNA METHYLATION |
| 166 |
ABNORMAL OVARIAN DNA METHYLATION PROGRAMMING DURING GONAD MATURATION IN WILD CONTAMINATED FISH |
| 167 |
ABNORMAL PLACENTATION ASSOCIATED WITH INFERTILITY AS A MARKER OF OVERALL HEALTH |
| 168 |
ABNORMAL TRANSMETHYLATION/TRANSSULFURATION METABOLISM AND DNA HYPOMETHYLATION AMONG PARENTS OF CHILDREN WITH AUTISM |
| 169 |
ABNORMALITIES OF AMPK ACTIVATION AND GLUCOSE UPTAKE IN CULTURED SKELETAL MUSCLE CELLS FROM INDIVIDUALS WITH CHRONIC FATIGUE SYNDROME |
| 170 |
ABNORMALITIES OF THE TYPE I INTERFERON SIGNALING PATHWAY IN LUPUS AUTOIMMUNITY |
| 171 |
ABROGATION OF HISTONE DEACETYLASES (HDACS) DECREASES SURVIVAL OF CHRONIC MYELOID LEUKEMIA CELLS: NEW INSIGHT INTO ATTENUATING EFFECTS OF THE PI3K/C-MYC AXIS ON PANOBINOSTAT CYTOTOXICITY |
| 172 |
ABSENCE OF HDAC3 BY MATRIX STIFFNESS PROMOTES CHROMATIN REMODELING AND FIBROBLAST ACTIVATION IN IDIOPATHIC PULMONARY FIBROSIS |
| 173 |
ACCELERATED AGING IN BIPOLAR DISORDERS: AN EXPLORATORY STUDY OF SIX EPIGENETIC CLOCKS |
| 174 |
ACCELERATED AGING IN PERINATALLY HIV-INFECTED CHILDREN: CLINICAL MANIFESTATIONS AND PATHOGENETIC MECHANISMS |
| 175 |
ACCELERATED AGING WITH HIV BEGINS AT THE TIME OF INITIAL HIV INFECTION |
| 176 |
ACCELERATED DNA METHYLATION AGE AND MEDICATION USE AMONG AFRICAN AMERICANS |
| 177 |
ACCELERATED EPIGENETIC AGING AND INFLAMMATORY/IMMUNOLOGICAL PROFILE (IPAGE) IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
| 178 |
ACCELERATED EPIGENETIC AGING AS A RISK FACTOR FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND DECREASED LUNG FUNCTION IN TWO PROSPECTIVE COHORT STUDIES |
| 179 |
ACCELERATED EPIGENETIC AGING IN DOWN SYNDROME |
| 180 |
ACCELERATED EPIGENETIC AGING IN OLDER ADULTS WITH HIV DISEASE: ASSOCIATIONS WITH SEROSTATUS, HIV CLINICAL FACTORS, AND HEALTH LITERACY |
| 181 |
ACCELERATED EPIGENETIC AGING MEDIATES THE ASSOCIATION BETWEEN VITAMIN D LEVELS AND KNEE PAIN IN COMMUNITY-DWELLING INDIVIDUALS |
| 182 |
ACCELERATED LUNG AGING AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 183 |
ACCELERATED VASCULAR AGING IN CHRONIC KIDNEY DISEASE: THE POTENTIAL FOR NOVEL THERAPIES |
| 184 |
ACCOUNTING FOR TRANSGENERATIONAL EFFECTS OF TOXICANT EXPOSURE IN POPULATION MODELS ALTERS THE PREDICTED LONG-TERM POPULATION STATUS |
| 185 |
ACCUMULATION OF ABERRANT CPG HYPERMETHYLATION BY HELICOBACTER PYLORI INFECTION PROMOTES DEVELOPMENT AND PROGRESSION OF GASTRIC MALT LYMPHOMA |
| 186 |
ACCUMULATION OF GENETIC AND EPIGENETIC ALTERATIONS IN NORMAL CELLS AND CANCER RISK |
| 187 |
ACE2 EXPRESSION IS INCREASED IN THE LUNGS OF PATIENTS WITH COMORBIDITIES ASSOCIATED WITH SEVERE COVID-19 |
| 188 |
ACETYL TRANSFERASE EP300 DEFICIENCY LEADS TO CHRONIC REPLICATION STRESS MEDIATED BY DEFECTIVE FORK PROTECTION AT STALLED REPLICATION FORKS |
| 189 |
ACETYL-L-CARNITINE IN CHRONIC PAIN: A NARRATIVE REVIEW |
| 190 |
ACETYL-L-CARNITINE IN PAINFUL PERIPHERAL NEUROPATHY: A SYSTEMATIC REVIEW |
| 191 |
ACETYL-L-CARNITINE: FROM A BIOLOGICAL CURIOSITY TO A DRUG FOR THE PERIPHERAL NERVOUS SYSTEM AND BEYOND |
| 192 |
ACETYLATED H4K16 BY MYST1 PROTECTS UROTSA CELLS FROM ARSENIC TOXICITY AND IS DECREASED FOLLOWING CHRONIC ARSENIC EXPOSURE |
| 193 |
ACETYLATION-MEDIATED EPIGENETIC REGULATION OF GLUCOCORTICOID RECEPTOR ACTIVITY: CIRCADIAN RHYTHM-ASSOCIATED ALTERATIONS OF GLUCOCORTICOID ACTIONS IN TARGET TISSUES |
| 194 |
ACETYLSHIKONIN SUPPRESSES INVASION OF PORPHYROMONAS GINGIVALIS?INFECTED YD10B ORAL CANCER CELLS BY MODULATING THE INTERLEUKIN-8/MATRIX METALLOPROTEINASE AXIS |
| 195 |
ACF CHROMATIN-REMODELING COMPLEX MEDIATES STRESS-INDUCED DEPRESSIVE-LIKE BEHAVIOR |
| 196 |
ACID REFLUX AND OESOPHAGEAL CANCER |
| 197 |
ACINAR ATP8B1/LPC PATHWAY PROMOTES MACROPHAGE EFFEROCYTOSIS AND CLEARANCE OF INFLAMMATION DURING CHRONIC PANCREATITIS DEVELOPMENT |
| 198 |
ACQUIRED TRANSCRIPTIONAL PROGRAMMING IN FUNCTIONAL AND EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS |
| 199 |
ACTIVATED HISTONE ACETYLTRANSFERASE P300/CBP-RELATED SIGNALLING PATHWAYS MEDIATE UP-REGULATION OF NADPH OXIDASE, INFLAMMATION, AND FIBROSIS IN DIABETIC KIDNEY |
| 200 |
ACTIVATED PROTEIN C BASED THERAPEUTIC STRATEGIES IN CHRONIC DISEASES |
| 201 |
ACTIVATING TRANSCRIPTION FACTOR 3 PROTECTS AGAINST PRESSURE-OVERLOAD HEART FAILURE VIA THE AUTOPHAGY MOLECULE BECLIN-1 PATHWAY |
| 202 |
ACTIVATION INDUCED CYTIDINE DEAMINASE: AN OLD FRIEND WITH NEW FACES |
| 203 |
ACTIVATION OF EPIGENETIC REGULATOR KDM6B BY SALMONELLA TYPHIMURIUM ENABLES CHRONIC INFECTIONS |
| 204 |
ACTIVATION OF HDAC4 AND GR SIGNALING CONTRIBUTES TO STRESS-INDUCED HYPERALGESIA IN THE MEDIAL PREFRONTAL CORTEX OF RATS |
| 205 |
ACTIVATION OF HLA-G EXPRESSION BY 5-AZA-2 - DEOXYCYTIDINE IN MALIGNANT HEMATOPOETIC CELLS ISOLATED FROM LEUKEMIA PATIENTS |
| 206 |
ACTIVATION OF NOTCH AND MYC SIGNALING VIA B-CELL-RESTRICTED DEPLETION OF DNMT3A GENERATES A CONSISTENT MURINE MODEL OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| 207 |
ACTIVATION OF THE TYPE I INTERFERON PATHWAY IN PRIMARY SJOGREN'S SYNDROME |
| 208 |
ACTIVATION-INDUCED CYTIDINE DEAMINASE (AID) LINKING IMMUNITY, CHRONIC INFLAMMATION, AND CANCER |
| 209 |
ACTIVATION-INDUCED CYTIDINE DEAMINASE: IN SICKNESS AND IN HEALTH |
| 210 |
ACTIVE DNA DEMETHYLATION IN POST-MITOTIC NEURONS: A REASON FOR OPTIMISM |
| 211 |
ACTIVITY-DEPENDENT A-TO-I RNA EDITING IN RAT CORTICAL NEURONS |
| 212 |
ACUPUNCTURE ALLEVIATES CHRONIC PAIN AND COMORBID CONDITIONS IN A MOUSE MODEL OF NEUROPATHIC PAIN: THE INVOLVEMENT OF DNA METHYLATION IN THE PREFRONTAL CORTEX |
| 213 |
ACUTE AND CHRONIC ELECTROCONVULSIVE SEIZURES (ECS) DIFFERENTIALLY REGULATE THE EXPRESSION OF EPIGENETIC MACHINERY IN THE ADULT RAT HIPPOCAMPUS |
| 214 |
ACUTE AND CHRONIC MOLECULAR SIGNATURES AND ASSOCIATED SYMPTOMS OF BLAST EXPOSURE IN MILITARY BREACHERS |
| 215 |
ACUTE AND LONG-TERM NUTRIENT-LED MODIFICATIONS OF GENE EXPRESSION: POTENTIAL ROLE OF SIRT1 AS A CENTRAL CO-ORDINATOR OF SHORT AND LONGER-TERM PROGRAMMING OF TISSUE FUNCTION |
| 216 |
ACUTE BETA-ADRENERGIC ACTIVATION TRIGGERS NUCLEAR IMPORT OF HISTONE DEACETYLASE 5 AND DELAYS G(Q)-INDUCED TRANSCRIPTIONAL ACTIVATION |
| 217 |
ACUTE EXERCISE INCREASES THE EXPRESSION OF KIR2DS4 BY PROMOTER DEMETHYLATION IN NK CELLS |
| 218 |
ACUTE HYPOXIA AND CHRONIC ISCHEMIA INDUCE DIFFERENTIAL TOTAL CHANGES IN PLACENTAL EPIGENETIC MODIFICATIONS |
| 219 |
ACUTE IMMOBILIZATION STRESS FOLLOWING CONTEXTUAL FEAR CONDITIONING REDUCES FEAR MEMORY: TIMING IS ESSENTIAL |
| 220 |
ACUTE KIDNEY DISEASE: AN OVERVIEW OF THE EPIDEMIOLOGY, PATHOPHYSIOLOGY, AND MANAGEMENT |
| 221 |
ACUTE KIDNEY INJURY TO CHRONIC KIDNEY DISEASE TRANSITION |
| 222 |
ACUTE LIVER STEATOSIS TRANSLATIONALLY CONTROLS THE EPIGENETIC REGULATOR MIER1 TO PROMOTE LIVER REGENERATION IN A STUDY WITH MALE MICE |
| 223 |
ACUTE PSYCHOSOCIAL STRESS-MEDIATED CHANGES IN THE EXPRESSION AND METHYLATION OF PERFORIN IN CHRONIC FATIGUE SYNDROME |
| 224 |
ACUTE SKELETAL MUSCLE CONTRACTIONS ORCHESTRATE SIGNALING MECHANISMS TO TRIGGER NUCLEAR NFATC1 SHUTTLING AND EPIGENETIC HISTONE MODIFICATIONS |
| 225 |
ACUTE STRESS-INDUCED EPIGENETIC MODULATIONS AND THEIR POTENTIAL PROTECTIVE ROLE TOWARD DEPRESSION |
| 226 |
ACUTE TRANSCRIPTOMIC AND EPIGENETIC ALTERATIONS AT T12 AFTER RAT T10 SPINAL CORD CONTUSIVE INJURY |
| 227 |
ADAPTATION OF AN OUTBREAKING INSECT DEFOLIATOR TO CHRONIC NUTRITIONAL STRESS |
| 228 |
ADAPTATION OF THE HUMAN POPULATION TO THE ENVIRONMENT: CURRENT KNOWLEDGE, CLUES FROM CZECH CYTOGENETIC AND "OMICS" BIOMONITORING STUDIES AND POSSIBLE MECHANISMS |
| 229 |
ADAPTATION OR PATHOLOGY? THE ROLE OF PRENATAL STRESSOR TYPE AND INTENSITY IN THE DEVELOPMENTAL PROGRAMING OF ADULT PHENOTYPE |
| 230 |
ADAPTIVE AND INNATE CYTOTOXIC EFFECTORS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) SUBJECTS WITH STABLE DISEASE |
| 231 |
ADAPTIVE CARDIORESPIRATORY CHANGES TO CHRONIC CONTINUOUS AND INTERMITTENT HYPOXIA |
| 232 |
ADAPTIVE PLASTICITY IN THE RETINA: PROTECTION AGAINST ACUTE INJURY AND NEURODEGENERATIVE DISEASE BY CONDITIONING STIMULI |
| 233 |
ADAPTIVE T CELL TUNING IN IMMUNE REGULATION AND IMMUNOTHERAPY OF AUTOIMMUNE DISEASES(?) |
| 234 |
ADDICTION OF CANCER STEM CELLS TO MUC1-C IN TRIPLE-NEGATIVE BREAST CANCER PROGRESSION |
| 235 |
ADDING FUEL TO THE FIRE: THE IMPACT OF STRESS ON THE AGEING BRAIN |
| 236 |
ADENOMYOSIS: MECHANISMS AND PATHOGENESIS |
| 237 |
ADENOSINE AUGMENTATION EVOKED BY AN ENT1 INHIBITOR IMPROVES MEMORY IMPAIRMENT AND NEURONAL PLASTICITY IN THE APP/PS1 MOUSE MODEL OF ALZHEIMER'S DISEASE |
| 238 |
ADENOSINE KINASE: A KEY REGULATOR OF PURINERGIC PHYSIOLOGY |
| 239 |
ADENOSINERGIC SIGNALING IN EPILEPSY |
| 240 |
ADIPOCYTE EXPRESSION OF SLC19A1 LINKS DNA HYPERMETHYLATION TO ADIPOSE TISSUE INFLAMMATION AND INSULIN RESISTANCE |
| 241 |
ADIPOCYTE, IMMUNE CELLS, AND MIRNA CROSSTALK: A NOVEL REGULATOR OF METABOLIC DYSFUNCTION AND OBESITY |
| 242 |
ADOLESCENT CANNABINOID EXPOSURE MODULATES THE VULNERABILITY TO COCAINE-INDUCED CONDITIONED PLACE PREFERENCE AND DNMT3A EXPRESSION IN THE PREFRONTAL CORTEX IN SWISS MICE |
| 243 |
ADOLESCENT CHRONIC INTERMITTENT TOLUENE INHALATION DYNAMICALLY REGULATES THE TRANSCRIPTOME AND NEURONAL METHYLOME WITHIN THE RAT MEDIAL PREFRONTAL CORTEX |
| 244 |
ADOLESCENT IDIOPATHIC SCOLIOSIS (AIS), ENVIRONMENT, EXPOSOME AND EPIGENETICS: A MOLECULAR PERSPECTIVE OF POSTNATAL NORMAL SPINAL GROWTH AND THE ETIOPATHOGENESIS OF AIS WITH CONSIDERATION OF A NETWORK APPROACH AND POSSIBLE IMPLICATIONS FOR MEDICAL THERAPY |
| 245 |
ADRENERGIC REPRESSION OF THE EPIGENETIC READER MECP2 FACILITATES CARDIAC ADAPTATION IN CHRONIC HEART FAILURE |
| 246 |
ADULT STEM CELL THERAPY FOR CARDIAC REPAIR IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION LEADING TO ISCHEMIC HEART FAILURE: AN OVERVIEW OF EVIDENCE FROM THE RECENT CLINICAL TRIALS |
| 247 |
ADULTHOOD ASTHMA AS A CONSEQUENCE OF CHILDHOOD ADVERSITY: A SYSTEMATIC REVIEW OF EPIGENETICALLY AFFECTED GENES |
| 248 |
ADVANCE IN STRESS FOR DEPRESSIVE DISORDER |
| 249 |
ADVANCED AGING PHENOTYPE IS REVEALED BY EPIGENETIC MODIFICATIONS IN RAT LIVER AFTER IN UTERO MALNUTRITION |
| 250 |
ADVANCED GLYCATION END PRODUCTS (AGES): BIOCHEMISTRY, SIGNALING, ANALYTICAL METHODS, AND EPIGENETIC EFFECTS |
| 251 |
ADVANCED THERAPEUTIC MODALITIES IN HEPATOCELLULAR CARCINOMA: NOVEL INSIGHTS |
| 252 |
ADVANCEMENTS IN THE UNDERLYING PATHOGENESIS OF SCHIZOPHRENIA: IMPLICATIONS OF DNA METHYLATION IN GLIAL CELLS |
| 253 |
ADVANCES AND PERSPECTIVES FROM GENETIC RESEARCH: DEVELOPMENT OF BIOLOGICAL MARKERS IN ALZHEIMER'S DISEASE |
| 254 |
ADVANCES IN ASTHMA 2015: ACROSS THE LIFESPAN |
| 255 |
ADVANCES IN MYELOFIBROSIS: A CLINICAL CASE APPROACH |
| 256 |
ADVANCES IN NUTRITIONAL EPIGENETICS-A FRESH PERSPECTIVE FOR AN OLD IDEA |
| 257 |
ADVANCES IN ONCOANAESTHESIA AND CANCER PAIN |
| 258 |
ADVANCES IN PATHOGENESIS AND NANOPARTICLES (NPS)-MEDIATED TREATMENT OF PSORIASIS |
| 259 |
ADVANCES IN PCOS PATHOGENESIS AND PROGRESSION-MITOCHONDRIAL MUTATIONS AND DYSFUNCTION |
| 260 |
ADVANCES IN RESEARCH INTO GAMETE AND EMBRYO-FETAL ORIGINS OF ADULT DISEASES |
| 261 |
ADVANCES IN TARGET THERAPY FOR LUNG CANCER |
| 262 |
ADVANCES IN THE POTENTIAL BIOMARKERS OF EPILEPSY |
| 263 |
ADVANCES WITH LONG NON-CODING RNAS IN DIABETIC PERIPHERAL NEUROPATHY |
| 264 |
ADVANCING ASTHMA CARE: THE GLASS IS ONLY HALF FULL! OVER THE PAST 20 YEARS, THERE HAS BEEN A CONCERTED EFFORT IN THE UNITED STATES TO REDUCE MORBIDITY RELATED TO CHRONIC DISEASE, INCLUDING ASTHMA |
| 265 |
ADVERSE EFFECTS OF RECREATIONAL AND MEDICAL CANNABIS |
| 266 |
ADVERSE OUTCOME PATHWAYS FOR IONIZING RADIATION AND BREAST CANCER INVOLVE DIRECT AND INDIRECT DNA DAMAGE, OXIDATIVE STRESS, INFLAMMATION, GENOMIC INSTABILITY, AND INTERACTION WITH HORMONAL REGULATION OF THE BREAST |
| 267 |
AFFECTIVE AND COGNITIVE BEHAVIOR IN THE ALPHA-GALACTOSIDASE A DEFICIENT MOUSE MODEL OF FABRY DISEASE |
| 268 |
AFLATOXIN B1 INDUCES PERSISTENT EPIGENOMIC EFFECTS IN PRIMARY HUMAN HEPATOCYTES ASSOCIATED WITH HEPATOCELLULAR CARCINOMA |
| 269 |
AGE AND PERIODONTAL HEALTH - IMMUNOLOGICAL VIEW |
| 270 |
AGE AND SUN EXPOSURE-RELATED WIDESPREAD GENOMIC BLOCKS OF HYPOMETHYLATION IN NONMALIGNANT SKIN |
| 271 |
AGE-ASSOCIATED EPIGENETIC MODIFICATIONS IN HUMAN DNA INCREASE ITS IMMUNOGENICITY |
| 272 |
AGE-DEPENDENT DECREASE IN THE INDUCTION OF REGULATORY T CELLS IS ASSOCIATED WITH DECREASED EXPRESSION OF RALDH2 IN MESENTERIC LYMPH NODE DENDRITIC CELLS |
| 273 |
AGE-INDUCED SUPPRESSION OF EZH2 MEDIATES INJURY OF PODOCYTES BY REDUCING H3K27ME3 |
| 274 |
AGE-RELATED CHANGES IN DNA METHYLATION AFFECT RENAL HISTOLOGY AND POST-TRANSPLANT FIBROSIS |
| 275 |
AGE-RELATED CLONAL HAEMOPOIESIS IS ASSOCIATED WITH INCREASED EPIGENETIC AGE |
| 276 |
AGE-RELATED DIFFERENCES IN MONOCYTE DNA METHYLATION AND IMMUNE FUNCTION IN HEALTHY KENYAN ADULTS AND CHILDREN |
| 277 |
AGE-RELATED EPIGENOME-WIDE DNA METHYLATION AND HYDROXYMETHYLATION IN LONGITUDINAL MOUSE BLOOD |
| 278 |
AGE-RELATED INFLAMMATION: THE CONTRIBUTION OF DIFFERENT ORGANS, TISSUES AND SYSTEMS |
| 279 |
AGE-RELATED MACULAR DEGENERATION: FROM EPIGENETICS TO THERAPEUTIC IMPLICATIONS |
| 280 |
AGE-RELATED MIRNAS DYSREGULATION AND ABNORMAL BACE1 EXPRESSION FOLLOWING PB EXPOSURE IN ADOLESCENT MICE |
| 281 |
AGEING - OXIDATIVE STRESS, PTMS AND DISEASE |
| 282 |
AGEING AND LOW-LEVEL CHRONIC INFLAMMATION: THE ROLE OF THE BIOLOGICAL CLOCK |
| 283 |
AGEING IS ASSOCIATED WITH MOLECULAR SIGNATURES OF INFLAMMATION AND TYPE 2 DIABETES IN RAT PANCREATIC ISLETS |
| 284 |
AGEING WITH HIV: CHALLENGES AND BIOMARKERS |
| 285 |
AGING AND AGING-RELATED DISEASES: FROM MOLECULAR MECHANISMS TO INTERVENTIONS AND TREATMENTS |
| 286 |
AGING AND ALCOHOL INTERACT TO ALTER HEPATIC DNA HYDROXYMETHYLATION |
| 287 |
AGING AND CHRONIC SUN EXPOSURE CAUSE DISTINCT EPIGENETIC CHANGES IN HUMAN SKIN |
| 288 |
AGING AND INDUCED SENESCENCE AS FACTORS IN THE PATHOGENESIS OF LUNG EMPHYSEMA |
| 289 |
AGING AND INTERSTITIAL LUNG DISEASES: UNRAVELING AN OLD FORGOTTEN PLAYER IN THE PATHOGENESIS OF LUNG FIBROSIS |
| 290 |
AGING AND PULMONARY FIBROSIS |
| 291 |
AGING AND STRESS: PAST HYPOTHESES, PRESENT APPROACHES AND PERSPECTIVES |
| 292 |
AGING AND SUSCEPTIBILITY TO PULMONARY DISEASE |
| 293 |
AGING HALLMARKS AND THE ROLE OF OXIDATIVE STRESS |
| 294 |
AGING INCREASES VULNERABILITY TO STRESS-INDUCED DEPRESSION VIA UPREGULATION OF NADPH OXIDASE IN MICE |
| 295 |
AGING INDUCES B CELL DEFECTS AND DECREASED ANTIBODY RESPONSES TO INFLUENZA INFECTION AND VACCINATION |
| 296 |
AGING, CELL SENESCENCE, THE PATHOGENESIS AND TARGETED THERAPIES OF OSTEOARTHRITIS |
| 297 |
AIM2 AND PSORIASIS |
| 298 |
AIR POLLUTION AND AIRWAY DISEASE |
| 299 |
AIR POLLUTION AND DNA METHYLATION: EFFECTS OF EXPOSURE IN HUMANS |
| 300 |
AIR POLLUTION AND INDOOR SETTINGS |
| 301 |
AIR POLLUTION ASSOCIATED EPIGENETIC MODIFICATIONS: TRANSGENERATIONAL INHERITANCE AND UNDERLYING MOLECULAR MECHANISMS |
| 302 |
AIR POLLUTION EXPOSURE AND AUTO-INFLAMMATORY AND AUTOIMMUNE DISEASES OF THE MUSCULOSKELETAL SYSTEM: A REVIEW OF EPIDEMIOLOGIC AND MECHANISTIC EVIDENCE |
| 303 |
AIR POLLUTION STRESS AND THE AGING PHENOTYPE: THE TELOMERE CONNECTION |
| 304 |
AIRWAY AGING AND METHYLATION DISRUPTIONS IN HIV-ASSOCIATED CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 305 |
AIRWAY WALL REMODELING IN CHILDHOOD ASTHMA-A PERSONALIZED PERSPECTIVE FROM CELL TYPE-SPECIFIC BIOLOGY |
| 306 |
AKT TARGETING AS A STRATEGY TO BOOST CHEMOTHERAPY EFFICACY IN NON-SMALL CELL LUNG CANCER THROUGH METABOLISM SUPPRESSION |
| 307 |
ALBUMINURIA DOWNREGULATION OF THE ANTI-AGING FACTOR KLOTHO: THE MISSING LINK POTENTIALLY EXPLAINING THE ASSOCIATION OF PATHOLOGICAL ALBUMINURIA WITH PREMATURE DEATH |
| 308 |
ALCOHOL AND DNA METHYLATION: AN EPIGENOME-WIDE ASSOCIATION STUDY IN BLOOD AND NORMAL BREAST TISSUE |
| 309 |
ALCOHOL AND HEPATOCELLULAR CARCINOMA: ADDING FUEL TO THE FLAME |
| 310 |
ALCOHOL AND NMDA RECEPTOR: CURRENT RESEARCH AND FUTURE DIRECTION |
| 311 |
ALCOHOL AND THE METHYLOME: DESIGN AND ANALYSIS CONSIDERATIONS FOR RESEARCH USING HUMAN SAMPLES |
| 312 |
ALCOHOL FEEDING IN MICE PROMOTES COLONIC HYPERPERMEABILITY AND CHANGES IN COLONIC ORGANOID STEM CELL FATE |
| 313 |
ALCOHOL METABOLISM AND EPIGENETICS CHANGES |
| 314 |
ALCOHOL USE DISORDER IS ASSOCIATED WITH UPREGULATION OF MICRORNA-34A AND MICRORNA-34C IN HIPPOCAMPAL POSTMORTEM TISSUE |
| 315 |
ALCOHOL, DNA METHYLATION, AND CANCER |
| 316 |
ALCOHOL-ASSOCIATED FOLATE DISTURBANCES RESULT IN ALTERED METHYLATION OF FOLATE-REGULATING GENES |
| 317 |
ALCOHOL-INDUCED DEVELOPMENTAL ORIGINS OF ADULT-ONSET DISEASES |
| 318 |
ALCOHOL-INDUCED EPIGENETIC CHANGES IN CANCER |
| 319 |
ALCOHOLIC LIVER DISEASE |
| 320 |
ALCOHOLIC LIVER DISEASE: PATHOGENESIS AND NEW THERAPEUTIC TARGETS |
| 321 |
ALCOHOLIC-RELATED LIVER DISEASE: PATHOGENESIS, MANAGEMENT AND FUTURE THERAPEUTIC DEVELOPMENTS |
| 322 |
ALKALINE PHOSPHATASE: AN OLD FRIEND AS TREATMENT TARGET FOR CARDIOVASCULAR AND MINERAL BONE DISORDERS IN CHRONIC KIDNEY DISEASE |
| 323 |
ALKBH4 STABILIZATION IS REQUIRED FOR ARSENIC-INDUCED 6MA DNA METHYLATION INHIBITION, KERATINOCYTE MALIGNANT TRANSFORMATION, AND TUMORIGENICITY |
| 324 |
ALL DISEASE BEGINS IN THE (LEAKY) GUT: ROLE OF ZONULIN-MEDIATED GUT PERMEABILITY IN THE PATHOGENESIS OF SOME CHRONIC INFLAMMATORY DISEASES |
| 325 |
ALLELE-SPECIFIC DNA METHYLATION LEVEL OF FKBP5 IS ASSOCIATED WITH POST-TRAUMATIC STRESS DISORDER |
| 326 |
ALLELIC SILENCING AT THE TUMOR-SUPPRESSOR LOCUS 13Q14 |
| 327 |
ALLERGIC INFLAMMATORY MEMORY IN HUMAN RESPIRATORY EPITHELIAL PROGENITOR CELLS |
| 328 |
ALPHA-KETOGLUTARIC ACID AMELIORATES INTERVERTEBRAL DISC DEGENERATION BY BLOCKING THE IL-6/JAK2/STAT3 PATHWAY |
| 329 |
ALPHA-OXOGLUTARATE INHIBITS THE PROLIFERATION OF IMMORTALIZED NORMAL BLADDER EPITHELIAL CELLS VIA AN EPIGENETIC SWITCH INVOLVING ARID1A |
| 330 |
ALPHA-SYNUCLEIN AND MECHANISMS OF EPIGENETIC REGULATION |
| 331 |
ALTERATION IN MITOCHONDRIAL DYNAMICS PROMOTES THE PROINFLAMMATORY RESPONSE OF MICROGLIA AND IS INVOLVED IN CEREBELLAR DYSFUNCTION OF YOUNG AND AGED MICE FOLLOWING LPS EXPOSURE |
| 332 |
ALTERATION OF EPIGENETIC PROFILE IN HUMAN HEPATOCELLULAR CARCINOMA AND ITS CLINICAL IMPLICATIONS |
| 333 |
ALTERATION OF PTGS2 PROMOTER METHYLATION IN CHRONIC PERIODONTITIS |
| 334 |
ALTERATIONS IN DEOXYRIBONUCLEIC ACID (DNA) METHYLATION PATTERNS OF CALCA, TIMP3, MMP2, AND IGF2R ARE ASSOCIATED WITH CHRONIC CYSTITIS IN A CYCLOPHOSPHAMIDE-INDUCED MOUSE MODEL |
| 335 |
ALTERATIONS IN DNA METHYLATION ASSOCIATE WITH FATTY LIVER AND METABOLIC ABNORMALITIES IN A MULTI-ETHNIC COHORT OF PRE-TEENAGE CHILDREN |
| 336 |
ALTERATIONS IN DNA METHYLATION STATUS ASSOCIATED WITH GULF WAR ILLNESS |
| 337 |
ALTERATIONS IN DNA METHYLATION/DEMETHYLATION INTERMEDIATES PREDICT CLINICAL OUTCOME IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 338 |
ALTERATIONS IN GENE EXPRESSION DUE TO CHRONIC LEAD EXPOSURE INDUCE BEHAVIORAL CHANGES |
| 339 |
ALTERATIONS IN HOMOCYSTEINE METABOLISM AMONG ALCOHOL DEPENDENT PATIENTS--CLINICAL, PATHOBIOCHEMICAL AND GENETIC ASPECTS |
| 340 |
ALTERATIONS IN LOCAL CHROMATIN ENVIRONMENT ARE INVOLVED IN SILENCING AND ACTIVATION OF SUBTELOMERIC VAR GENES IN PLASMODIUM FALCIPARUM |
| 341 |
ALTERATIONS IN SPERM-INHERITED NONCODING RNAS ASSOCIATE WITH LATE-TERM FETAL GROWTH RESTRICTION INDUCED BY PRECONCEPTION PATERNAL ALCOHOL USE |
| 342 |
ALTERATIONS OF DNA METHYLATION ASSOCIATED WITH ABNORMALITIES OF DNA METHYLTRANSFERASES IN HUMAN CANCERS DURING TRANSITION FROM A PRECANCEROUS TO A MALIGNANT STATE |
| 343 |
ALTERATIONS OF THE LUNG METHYLOME IN ALLERGIC AIRWAY HYPER-RESPONSIVENESS |
| 344 |
ALTERED BDNF METHYLATION IN PATIENTS WITH CHRONIC MUSCULOSKELETAL PAIN AND HIGH BIOPSYCHOSOCIAL COMPLEXITY |
| 345 |
ALTERED BRAIN EXPRESSION OF DNA METHYLATION AND HYDROXYMETHYLATION EPIGENETIC ENZYMES IN A RAT MODEL OF NEUROPATHIC PAIN |
| 346 |
ALTERED CARBON DIOXIDE METABOLISM AND CREATINE ABNORMALITIES IN RETT SYNDROME |
| 347 |
ALTERED DNA METHYLATION IN KIDNEY DISEASE: USEFUL MARKERS AND THERAPEUTIC TARGETS |
| 348 |
ALTERED DNA METHYLATION IS ASSOCIATED WITH ABERRANT GENE EXPRESSION IN PARENCHYMAL BUT NOT AIRWAY FIBROBLASTS ISOLATED FROM INDIVIDUALS WITH COPD |
| 349 |
ALTERED DNA METHYLATION PROFILES IN SF3B1 MUTATED CLL PATIENTS |
| 350 |
ALTERED DYNAMICS OF LIPID METABOLISM IN MUSCLE CELLS FROM PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHY IS AMELIORATED BY 6 MONTHS OF TRAINING |
| 351 |
ALTERED ENDOTHELIAL DYSFUNCTION-RELATED MIRS IN PLASMA FROM ME/CFS PATIENTS |
| 352 |
ALTERED GENE EXPRESSION OF VEGF, IGFS AND H19 LNCRNA AND EPIGENETIC PROFILE OF H19-DMR REGION IN ENDOMETRIAL TISSUES OF WOMEN WITH ENDOMETRIOSIS |
| 353 |
ALTERED LEVELS OF IMMUNE-REGULATORY MICRORNAS IN PLASMA SAMPLES OF PATIENTS WITH LUPUS NEPHRITIS |
| 354 |
ALTERED LONG NON-CODING RNAS EXPRESSION IN NORMAL AND DISEASED PRIMARY HUMAN AIRWAY EPITHELIAL CELLS EXPOSED TO DIESEL EXHAUST PARTICLES |
| 355 |
ALTERED MITOCHONDRIAL DNA METHYLATION AND MITOCHONDRIAL DNA COPY NUMBER IN AN APP/PS1 TRANSGENIC MOUSE MODEL OF ALZHEIMER DISEASE |
| 356 |
ALTERING A HISTONE H3K4 METHYLATION PATHWAY IN GLOMERULAR PODOCYTES PROMOTES A CHRONIC DISEASE PHENOTYPE |
| 357 |
ALTERNATIVE MODELS FOR TRANSGENERATIONAL EPIGENETIC INHERITANCE: MOLECULAR PSYCHIATRY BEYOND MICE AND MAN |
| 358 |
ALTERNATIVE SPLICING IN CHRONIC MYELOID LEUKEMIA (CML): A NOVEL THERAPEUTIC TARGET? ALTHOUGH THE IMATINIB BASED THERAPY OF CHRONIC MYELOID LEUKEMIA (CML) REPRESENTS A TRIUMPH OF MEDICINE, NOT ALL PATIENTS WITH CML BENEFIT FROM THIS DRUG DUE TO THE DEVELOPMENT OF RESISTANCE AND INTOLERANCE |
| 359 |
ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS |
| 360 |
AMBIENT AIR POLLUTION AND BIOMARKERS OF HEALTH EFFECT |
| 361 |
AMBIENT AIR POLLUTION AND THROMBOSIS |
| 362 |
AMBIENT AIR POLLUTION IMPAIRS REGULATORY T-CELL FUNCTION IN ASTHMA |
| 363 |
AMBIENT AIR POLLUTION: HEALTH HAZARDS TO CHILDREN |
| 364 |
AMELIORATION OF UREMIC TOXIN INDOXYL SULFATE-INDUCED OSTEOBLASTIC CALCIFICATION BY SET DOMAIN CONTAINING LYSINE METHYLTRANSFERASE 7/9 PROTEIN |
| 365 |
AMILORIDE MODULATION OF CARBON DIOXIDE HYPERSENSITIVITY AND THERMAL NOCICEPTIVE HYPERSENSITIVITY INDUCED BY INTERFERENCE WITH EARLY MATERNAL ENVIRONMENT |
| 366 |
AMINO ACID-INDUCED GENE EXPRESSION PROFILING IN CLONAL BETA-CELL LINE INS-1E CELLS |
| 367 |
AMPLIFIED PAIN SYNDROMES IN CHILDREN: TREATMENT AND NEW INSIGHTS INTO DISEASE PATHOGENESIS |
| 368 |
AMYLOID BETA-MEDIATED EPIGENETIC ALTERATION OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3 CONTROLS CELL SURVIVAL IN ALZHEIMER'S DISEASE |
| 369 |
AN ANDROGEN-DEPENDENT SEXUAL DIMORPHISM VISIBLE AT PUBERTY IN THE RAT HYPOTHALAMUS |
| 370 |
AN APICOMPLEXAN BROMODOMAIN PROTEIN, TGBDP1, ASSOCIATES WITH DIVERSE EPIGENETIC FACTORS TO REGULATE ESSENTIAL TRANSCRIPTIONAL PROCESSES IN TOXOPLASMA GONDII |
| 371 |
AN ATLAS OF THE AGING LUNG MAPPED BY SINGLE CELL TRANSCRIPTOMICS AND DEEP TISSUE PROTEOMICS |
| 372 |
AN EMERGING EPIDEMIC OF NONCOMMUNICABLE DISEASES IN DEVELOPING POPULATIONS DUE TO A TRIPLE EVOLUTIONARY MISMATCH |
| 373 |
AN EMERGING ROLE OF NEUTROPHILS AND NETOSIS IN CHRONIC INFLAMMATION AND FIBROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND ANCA-ASSOCIATED VASCULITIDES (AAV): IMPLICATIONS FOR THE PATHOGENESIS AND TREATMENT |
| 374 |
AN ENDOSIRNA-BASED REPRESSION MECHANISM COUNTERACTS TRANSPOSON ACTIVATION DURING GLOBAL DNA DEMETHYLATION IN EMBRYONIC STEM CELLS |
| 375 |
AN ENERGETIC VIEW OF STRESS: FOCUS ON MITOCHONDRIA |
| 376 |
AN EPI(C)GENETIC WAR: PATHOGENS, CANCER AND HUMAN GENOME |
| 377 |
AN EPIGENETIC HYPOTHESIS FOR THE GENOMIC MEMORY OF PAIN |
| 378 |
AN EPIGENETIC MAP OF AGE-ASSOCIATED AUTOSOMAL LOCI IN NORTHERN EUROPEAN FAMILIES AT HIGH RISK FOR THE METABOLIC SYNDROME |
| 379 |
AN EPIGENETIC MECHANISM FOR HIGH, SYNERGISTIC EXPRESSION OF INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) BY COMBINED TREATMENT WITH ZEBULARINE AND IFN-GAMMA: POTENTIAL THERAPEUTIC USE IN AUTOIMMUNE DISEASES |
| 380 |
AN EPIGENETIC PERSPECTIVE ON LIFESTYLE MEDICINE FOR DEPRESSION: IMPLICATIONS FOR PRIMARY CARE PRACTICE |
| 381 |
AN EPIGENOME-WIDE ASSOCIATION STUDY OF EARLY-ONSET MAJOR DEPRESSION IN MONOZYGOTIC TWINS |
| 382 |
AN EPIGENOME-WIDE STUDY OF BODY MASS INDEX AND DNA METHYLATION IN BLOOD USING PARTICIPANTS FROM THE SISTER STUDY COHORT |
| 383 |
AN EPIGENOME-WIDE STUDY OF DNA METHYLATION PROFILES AND LUNG FUNCTION AMONG AMERICAN INDIANS IN THE STRONG HEART STUDY |
| 384 |
AN EVOLUTIONARY PERSPECTIVE ON CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 385 |
AN IMMORTALIZED CELL LINE DERIVED FROM RENAL ERYTHROPOIETIN-PRODUCING (REP) CELLS DEMONSTRATES THEIR POTENTIAL TO TRANSFORM INTO MYOFIBROBLASTS |
| 386 |
AN IN VIVO IMMUNOHISTOCHEMICAL STUDY ON MACROH2A |
| 387 |
AN INDIVIDUALITY OF RESPONSE TO CANNABINOIDS: CHALLENGES IN SAFETY AND EFFICACY OF CANNABIS PRODUCTS |
| 388 |
AN INTEGRATED ANALYSIS OF SOCS1 DOWN-REGULATION IN HBV INFECTION-RELATED HEPATOCELLULAR CARCINOMA |
| 389 |
AN INTEGRATIVE HYPOTHESIS LINKING CANCER, DIABETES AND ATHEROSCLEROSIS: THE ROLE OF MUTATIONS AND EPIGENETIC CHANGES |
| 390 |
AN INTEGRATIVE MODEL OF PATHWAY CONVERGENCE IN GENETICALLY HETEROGENEOUS BLAST CRISIS CHRONIC MYELOID LEUKEMIA |
| 391 |
AN INTRODUCTION TO THE MATHEMATICAL MODELING IN THE STUDY OF CANCER SYSTEMS BIOLOGY |
| 392 |
AN ORALLY BIOAVAILABLE CHEMICAL PROBE OF THE LYSINE METHYLTRANSFERASES EZH2 AND EZH1 |
| 393 |
AN OVERVIEW OF EPIGENETICS IN NURSING |
| 394 |
AN UPDATE IN EPIGENETICS IN METABOLIC-ASSOCIATED FATTY LIVER DISEASE |
| 395 |
AN UPDATE ON EPIGENETIC REGULATION IN AUTOIMMUNE DISEASES |
| 396 |
AN UPDATE ON EPIGENETICS AND CHILDHOOD RESPIRATORY DISEASES |
| 397 |
AN UPDATE ON FETAL ALCOHOL SYNDROME-PATHOGENESIS, RISKS, AND TREATMENT |
| 398 |
AN UPDATE ON GENETIC SUSCEPTIBILITY IN LUPUS NEPHRITIS |
| 399 |
ANABOLIC STEROIDS-DRIVEN REGULATION OF PORCINE OVARIAN PUTATIVE STEM CELLS FAVORS THE ONSET OF THEIR NEOPLASTIC TRANSFORMATION |
| 400 |
ANALGESIA INDUCED BY THE EPIGENETIC DRUG, L-ACETYLCARNITINE, OUTLASTS THE END OF TREATMENT IN MOUSE MODELS OF CHRONIC INFLAMMATORY AND NEUROPATHIC PAIN |
| 401 |
ANALYSIS OF ABERRANT METHYLATION ON PROMOTER SEQUENCES OF TUMOR SUPPRESSOR GENES AND TOTAL DNA IN SPUTUM SAMPLES: A PROMISING TOOL FOR EARLY DETECTION OF COPD AND LUNG CANCER IN SMOKERS |
| 402 |
ANALYSIS OF APOPTOSOME DYSREGULATION IN PANCREATIC CANCER AND OF ITS ROLE IN CHEMORESISTANCE |
| 403 |
ANALYSIS OF EPIGENETIC AGE ACCELERATION AND HEALTHY LONGEVITY AMONG OLDER US WOMEN |
| 404 |
ANALYSIS OF EPIGENETIC AGE PREDICTORS IN PAIN-RELATED CONDITIONS |
| 405 |
ANALYSIS OF EPIGENETIC MECHANISMS REGULATING OPIOID RECEPTOR GENE TRANSCRIPTION |
| 406 |
ANALYSIS OF FIVE CHRONIC INFLAMMATORY DISEASES IDENTIFIES 27 NEW ASSOCIATIONS AND HIGHLIGHTS DISEASE-SPECIFIC PATTERNS AT SHARED LOCI |
| 407 |
ANALYSIS OF FOXP3+ REGULATORY T CELLS THAT DISPLAY APPARENT VIRAL ANTIGEN SPECIFICITY DURING CHRONIC HEPATITIS C VIRUS INFECTION |
| 408 |
ANALYSIS OF GENE EXPRESSION AND METHYLATION DATASETS IDENTIFIED ADAMTS9, FKBP5, AND PFKBF3 AS BIOMARKERS FOR OSTEOARTHRITIS |
| 409 |
ANALYSIS OF GENES ENCODING EPIGENETIC REGULATORS IN MYELOPROLIFERATIVE NEOPLASMS: COEXISTENCE OF A NOVEL SETBP1 MUTATION IN A PATIENT WITH A P |
| 410 |
ANALYSIS OF GENETICS AND DNA METHYLATION IN OSTEOARTHRITIS: WHAT HAVE WE LEARNT ABOUT THE DISEASE? OSTEOARTHRITIS (OA) IS A CHRONIC MUSCULOSKELETAL DISEASE CHARACTERISED BY THE DESTRUCTION OF ARTICULAR CARTILAGE, SYNOVIAL INFLAMMATION AND BONE REMODELLING |
| 411 |
ANALYSIS OF GENOME-WIDE DNA METHYLATION PATTERNS IN OBESITY |
| 412 |
ANALYSIS OF LONG NON-CODING RNA (LNCRNA) EXPRESSION IN HEPATITIS B PATIENTS |
| 413 |
ANALYSIS OF MIRNAS PROFILES IN SERUM OF PATIENTS WITH STEATOSIS AND STEATOHEPATITIS |
| 414 |
ANALYSIS OF PROMOTER METHYLATION IN STOOL: A NOVEL METHOD FOR THE DETECTION OF COLORECTAL CANCER |
| 415 |
ANALYSIS OF RETROTRANSPOSON SUBFAMILY DNA METHYLATION REVEALS NOVEL EARLY EPIGENETIC CHANGES IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 416 |
ANALYSIS OF THE DYNAMIC ABERRANT LANDSCAPE OF DNA METHYLATION AND GENE EXPRESSION DURING ARSENIC-INDUCED CELL TRANSFORMATION |
| 417 |
ANATOMIC SITE-SPECIFIC PATTERNS OF GENE COPY NUMBER GAINS IN SKIN, MUCOSAL, AND UVEAL MELANOMAS DETECTED BY FLUORESCENCE IN SITU HYBRIDIZATION |
| 418 |
ANCESTRAL EXPOSURE TO STRESS EPIGENETICALLY PROGRAMS PRETERM BIRTH RISK AND ADVERSE MATERNAL AND NEWBORN OUTCOMES |
| 419 |
ANDROGEN AXIS IN PROSTATE CANCER |
| 420 |
ANDROGEN-MEDIATED PERTURBATION OF THE HEPATIC CIRCADIAN SYSTEM THROUGH EPIGENETIC MODULATION PROMOTES NAFLD IN PCOS MICE |
| 421 |
ANIMAL MODELS IN EPIGENETIC RESEARCH: INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE CONSIDERATIONS ACROSS THE LIFESPAN |
| 422 |
ANNEXIN-A1 DEFICIENCY ATTENUATES STRESS-INDUCED TUMOR GROWTH VIA FATTY ACID METABOLISM IN MICE: AN INTEGRATED MULTIPLE OMICS ANALYSIS ON THE STRESS- MICROBIOME-METABOLITE-EPIGENETIC-ONCOLOGY (SMMEO) AXIS |
| 423 |
ANRIL REGULATES MULTIPLE MOLECULES OF PATHOGENETIC SIGNIFICANCE IN DIABETIC NEPHROPATHY |
| 424 |
ANTHOCYANINS: FROM MECHANISMS OF REGULATION IN PLANTS TO HEALTH BENEFITS IN FOODS |
| 425 |
ANTI-CANCER THERAPY IS ASSOCIATED WITH LONG-TERM EPIGENOMIC CHANGES IN CHILDHOOD CANCER SURVIVORS |
| 426 |
ANTI-DIABETIC FUNCTIONS OF SOY ISOFLAVONE GENISTEIN: MECHANISMS UNDERLYING ITS EFFECTS ON PANCREATIC BETA-CELL FUNCTION |
| 427 |
ANTI-HEPATITIS B VIRUS ACTIVITY OF FOOD NUTRIENTS AND POTENTIAL MECHANISMS OF ACTION |
| 428 |
ANTI-INFLAMMATORY ACTIVITY OF MIODESIN: MODULATION OF INFLAMMATORY MARKERS AND EPIGENETIC EVIDENCE |
| 429 |
ANTI-INFLAMMATORY TOPICAL MEDICATION - NEW DEVELOPMENTS IN THE TREATMENT OF ATOPIC DERMATITIS |
| 430 |
ANTICIPATION IN FAMILIES WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER LYMPHOPROLIFERATIVE DISORDERS |
| 431 |
ANTIDEPRESSANT ADMINISTRATION MODULATES STRESS-INDUCED DNA METHYLATION AND DNA METHYLTRANSFERASE EXPRESSION IN RAT PREFRONTAL CORTEX AND HIPPOCAMPUS |
| 432 |
ANTIDEPRESSANT TREATMENT IS ASSOCIATED WITH EPIGENETIC ALTERATIONS IN THE PROMOTER OF P11 IN A GENETIC MODEL OF DEPRESSION |
| 433 |
ANTIDEPRESSANT TREATMENT IS ASSOCIATED WITH EPIGENETIC ALTERATIONS OF HOMER1 PROMOTER IN A MOUSE MODEL OF CHRONIC DEPRESSION |
| 434 |
ANTIDEPRESSANT-LIKE EFFECT OF SODIUM BUTYRATE IS ASSOCIATED WITH AN INCREASE IN TET1 AND IN 5-HYDROXYMETHYLATION LEVELS IN THE BDNF GENE |
| 435 |
ANTIDEPRESSANT-LIKE EFFECTS OF COMBINED FLUOXETINE AND ZINC TREATMENT IN MICE EXPOSED TO CHRONIC RESTRAINT STRESS ARE RELATED TO MODULATION OF HISTONE DEACETYLASE |
| 436 |
ANTIFRAGILITY AND ANTIINFLAMMAGING: CAN THEY PLAY A ROLE FOR A HEALTHY LONGEVITY? ONE OF THE MOST EXCITING CHALLENGES OF THE RESEARCH ON AGING IS TO EXPLAIN HOW THE ENVIRONMENTAL FACTORS INTERACT WITH THE GENETIC BACKGROUND TO MODULATE THE CHANCES TO REACH THE EXTREME LIMIT OF HUMAN LIFE IN HEALTHY CONDITIONS |
| 437 |
ANTIGEN RECEPTOR STEREOTYPY IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 438 |
ANTIGEN-DRIVEN EGR2 EXPRESSION IS REQUIRED FOR EXHAUSTED CD8(+) T CELL STABILITY AND MAINTENANCE |
| 439 |
ANTILEUKEMIC ACTIVITY OF VALPROIC ACID IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS DEFINED BY MICROARRAY ANALYSIS |
| 440 |
ANTIOXIDATIVE EFFECTS OF RHODIOLA GENUS: PHYTOCHEMISTRY AND PHARMACOLOGICAL MECHANISMS AGAINST THE DISEASES |
| 441 |
ANTISENSE-INDUCED DOWNREGULATION OF MAJOR CIRCADIAN GENES MODULATES THE EXPRESSION OF HISTONE DEACETYLASE-2 (HDAC-2) AND CREB-BINDING PROTEIN (CBP) IN THE MEDIAL SHELL REGION OF NUCLEUS ACCUMBENS OF MICE EXPOSED TO CHRONIC EXCESSIVE ALCOHOL CONSUMPTION |
| 442 |
ANTIVIRAL THERAPIES FOR HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA |
| 443 |
AORTA MACROPHAGE INFLAMMATORY AND EPIGENETIC CHANGES IN A MURINE MODEL OF OBSTRUCTIVE SLEEP APNEA: POTENTIAL ROLE OF CD36 |
| 444 |
AORTIC AND CAROTID ARTERIAL STIFFNESS AND EPIGENETIC REGULATOR GENE EXPRESSION CHANGES PRECEDE BLOOD PRESSURE RISE IN STROKE-PRONE DAHL SALT-SENSITIVE HYPERTENSIVE RATS |
| 445 |
APABETALONE (RVX-208) REDUCES VASCULAR INFLAMMATION IN VITRO AND IN CVD PATIENTS BY A BET-DEPENDENT EPIGENETIC MECHANISM |
| 446 |
APABETALONE DOWNREGULATES FIBROTIC, INFLAMMATORY AND CALCIFIC PROCESSES IN RENAL MESANGIAL CELLS AND PATIENTS WITH RENAL IMPAIRMENT |
| 447 |
APABETALONE LOWERS SERUM ALKALINE PHOSPHATASE AND IMPROVES CARDIOVASCULAR RISK IN PATIENTS WITH CARDIOVASCULAR DISEASE |
| 448 |
APABETALONE MEDIATED EPIGENETIC MODULATION IS ASSOCIATED WITH FAVORABLE KIDNEY FUNCTION AND ALKALINE PHOSPHATASE PROFILE IN PATIENTS WITH CHRONIC KIDNEY DISEASE |
| 449 |
APOCYNIN PREVENTS ANXIETY-LIKE BEHAVIOR AND HISTONE DEACETYLASES OVEREXPRESSION INDUCED BY SUB-CHRONIC STRESS IN MICE |
| 450 |
APOPTOSIS AND AGING: INCREASED RESISTANCE TO APOPTOSIS ENHANCES THE AGING PROCESS |
| 451 |
APPLICATION OF ATAC-SEQ IN TUMOR-SPECIFIC T CELL EXHAUSTION |
| 452 |
APPLICATION OF THE KEY CHARACTERISTICS OF CARCINOGENS TO PER AND POLYFLUOROALKYL SUBSTANCES |
| 453 |
APPLICATIONS OF CRISPR SYSTEMS IN RESPIRATORY HEALTH: ENTERING A NEW 'RED PEN' ERA IN GENOME EDITING |
| 454 |
APPLICATIONS OF INDUCED PLURIPOTENT STEM CELL TECHNOLOGIES IN SPINAL CORD INJURY |
| 455 |
APPLICATIONS OF YOGA IN ORAL ONCOLOGY: A SYSTEMATIC SCOPING REVIEW |
| 456 |
APPLYING A LIFE COURSE BIOLOGICAL AGE FRAMEWORK TO IMPROVING THE CARE OF INDIVIDUALS WITH ADULT CANCERS: REVIEW AND RESEARCH RECOMMENDATIONS |
| 457 |
APPLYING A MULTISCALE SYSTEMS BIOLOGY APPROACH TO STUDY THE EFFECT OF CHRONIC LOW-DOSE EXPOSURE TO URANIUM IN RAT KIDNEYS |
| 458 |
APPLYING MINIMALLY INVASIVE BIOMARKERS OF CHRONIC STRESS ACROSS COMPLEX ECOLOGICAL CONTEXTS |
| 459 |
APPLYING SINGLE-CELL TECHNOLOGIES TO CLINICAL PATHOLOGY: PROGRESS IN NEPHROPATHOLOGY |
| 460 |
ARACHIDONIC ACID 15-LIPOXYGENASE: EFFECTS OF ITS EXPRESSION, METABOLITES, AND GENETIC AND EPIGENETIC VARIATIONS ON AIRWAY INFLAMMATION |
| 461 |
ARCHITECTS OF PITUITARY TUMOUR GROWTH |
| 462 |
ARE ALTERATIONS IN DNA METHYLATION RELATED TO CKD DEVELOPMENT? THE MODIFICATIONS IN GENOMIC DNA METHYLATION ARE INVOLVED IN THE REGULATION OF NORMAL AND PATHOLOGICAL CELLULAR PROCESSES |
| 463 |
ARE EPIGENETIC FACTORS IMPLICATED IN CHRONIC WIDESPREAD PAIN? BACKGROUND: CHRONIC WIDESPREAD MUSCULOSKELETAL PAIN (CWP) IS THE CARDINAL SYMPTOM OF FIBROMYALGIA AND AFFECTS ABOUT 12% OF THE GENERAL POPULATION |
| 464 |
ARE HEIGHT AND LEG LENGTH UNIVERSAL MARKERS OF CHILDHOOD CONDITIONS? THE GUANGZHOU BIOBANK COHORT STUDY |
| 465 |
ARE TARGETED THERAPIES FOR DIABETIC CARDIOMYOPATHY ON THE HORIZON? DIABETES INCREASES THE RISK OF HEART FAILURE APPROXIMATELY 2 |
| 466 |
ARE THE HEALTHY VULNERABLE? CYTOMEGALOVIRUS SEROPOSITIVITY IN HEALTHY ADULTS IS ASSOCIATED WITH ACCELERATED EPIGENETIC AGE AND IMMUNE DYSREGULATION |
| 467 |
ARE WE FINALLY GETTING PERSONAL? MOVING TOWARDS A PERSONALIZED APPROACH IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 468 |
ARGININE METHYLTRANSFERASES MEDIATE AN EPIGENETIC OVARIAN RESPONSE TO ENDOMETRIOSIS |
| 469 |
ARID1A LOSS DRIVES NONALCOHOLIC STEATOHEPATITIS IN MICE THROUGH EPIGENETIC DYSREGULATION OF HEPATIC LIPOGENESIS AND FATTY ACID OXIDATION |
| 470 |
ARID1B, A MOLECULAR SUPPRESSOR OF ERYTHROPOIESIS, IS ESSENTIAL FOR THE PREVENTION OF MONGE'S DISEASE |
| 471 |
ARISTOLOCHIC ACID CONTAINING HERBS INDUCE GENDER-RELATED ONCOLOGICAL DIFFERENCES IN UPPER TRACT UROTHELIAL CARCINOMA PATIENTS |
| 472 |
ARRAY COMPARATIVE GENOMIC HYBRIDIZATION AND SEQUENCING OF 23 GENES IN 80 PATIENTS WITH MYELOFIBROSIS AT CHRONIC OR ACUTE PHASE |
| 473 |
ARSENIC AND URINARY BLADDER CELL PROLIFERATION |
| 474 |
ARSENIC BIOTRANSFORMATION AS A CANCER PROMOTING FACTOR BY INDUCING DNA DAMAGE AND DISRUPTION OF REPAIR MECHANISMS |
| 475 |
ARSENIC EXPOSURE AND HUMAN BLOOD DNA METHYLATION AND HYDROXYMETHYLATION PROFILES IN TWO DIVERSE POPULATIONS FROM BANGLADESH AND SPAIN |
| 476 |
ARSENIC INDUCES FIBROGENIC CHANGES IN HUMAN KIDNEY EPITHELIAL CELLS POTENTIALLY THROUGH EPIGENETIC ALTERATIONS IN DNA METHYLATION |
| 477 |
ARSENIC PROJECTS IN SE ASIA |
| 478 |
ARSENIC TOXICOLOGY: TRANSLATING BETWEEN EXPERIMENTAL MODELS AND HUMAN PATHOLOGY |
| 479 |
ARSENIC TRIOXIDE INHIBITS DNA METHYLTRANSFERASE AND RESTORES TMS1 GENE EXPRESSION IN K562 CELLS |
| 480 |
ARSENIC-INDUCED CARCINOGENESIS: THE IMPACT OF MIRNA DYSREGULATION |
| 481 |
ARSENIC-INDUCED SUMOYLATION OF MUS81 IS INVOLVED IN REGULATING GENOMIC STABILITY |
| 482 |
ARSENITE BINDS TO THE ZINC FINGER MOTIF OF TIP60 HISTONE ACETYLTRANSFERASE AND INDUCES ITS DEGRADATION VIA THE 26S PROTEASOME |
| 483 |
ART AND HEALTH: CLINICAL OUTCOMES AND INSIGHTS ON MOLECULAR MECHANISMS FROM RODENT STUDIES |
| 484 |
ARTICULAR CARTILAGE CHANGES IN MATURING ATHLETES: NEW TARGETS FOR JOINT REJUVENATION |
| 485 |
ARTIFICIAL AIRWAYS FOR THE STUDY OF RESPIRATORY DISEASE |
| 486 |
ASENAPINE TRANSDERMAL PATCH FOR THE MANAGEMENT OF SCHIZOPHRENIA |
| 487 |
ASPIRIN PROTECTS HUMAN CORONARY ARTERY ENDOTHELIAL CELLS AGAINST ATHEROGENIC ELECTRONEGATIVE LDL VIA AN EPIGENETIC MECHANISM: A NOVEL CYTOPROTECTIVE ROLE OF ASPIRIN IN ACUTE MYOCARDIAL INFARCTION |
| 488 |
ASSESSING DIAGNOSTIC VALUE OF MICRORNAS FROM PERIPHERAL BLOOD MONONUCLEAR CELLS AND EXTRACELLULAR VESICLES IN MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME |
| 489 |
ASSESSING POTENTIAL MECHANISMS OF ARSENIC-INDUCED SKIN LESIONS AND CANCERS: HUMAN AND IN VITRO EVIDENCE |
| 490 |
ASSESSING THE IMPACT OF ARSENIC METABOLISM EFFICIENCY ON DNA METHYLATION USING MENDELIAN RANDOMIZATION |
| 491 |
ASSESSING THE IMPACT OF POLYETHYLENE NANO/MICROPLASTIC EXPOSURE ON HUMAN VAGINAL KERATINOCYTES |
| 492 |
ASSESSMENT OF HIV-1 INTEGRATION IN TISSUES AND SUBSETS ACROSS INFECTION STAGES |
| 493 |
ASSESSMENT OF P53 AND ATM FUNCTIONALITY IN CHRONIC LYMPHOCYTIC LEUKEMIA BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION |
| 494 |
ASSESSMENT OF PROMOTER METHYLATION IDENTIFIES PTCH AS A PUTATIVE TUMOR-SUPPRESSOR GENE IN HUMAN CLL |
| 495 |
ASSESSMENT OF THE HEALTH EFFECTS OF TRICHLOROETHYLENE |
| 496 |
ASSESSMENT OF THE IMPACT OF HIV INFECTION AND ANTI-RETROVIRAL TREATMENT ON THE CARDIOMETABOLIC HEALTH OF PREGNANT MOTHERS AND THEIR OFFSPRING (ARTMOMSBABES) |
| 497 |
ASSOCIATION BETWEEN BMI AND DNA METHYLATION IN BLOOD OR NORMAL ADULT BREAST TISSUE: A SYSTEMATIC REVIEW |
| 498 |
ASSOCIATION BETWEEN DIABETES AND CANCER |
| 499 |
ASSOCIATION BETWEEN HMLH1 HYPERMETHYLATION AND JC VIRUS (JCV) INFECTION IN HUMAN COLORECTAL CANCER (CRC) |
| 500 |
ASSOCIATION BETWEEN NEUROPATHIC PAIN CHARACTERISTICS AND DNA METHYLATION OF TRANSIENT RECEPTOR POTENTIAL ANKYRIN 1 IN HUMAN PERIPHERAL BLOOD |
| 501 |
ASSOCIATION OF ACCELEROMETER-MEASURED PHYSICAL ACTIVITY AND SEDENTARY TIME WITH EPIGENETIC MARKERS OF AGING |
| 502 |
ASSOCIATION OF ARSENIC EXPOSURE WITH WHOLE BLOOD DNA METHYLATION: AN EPIGENOME-WIDE STUDY OF BANGLADESHI ADULTS |
| 503 |
ASSOCIATION OF CHEMOKINE GENE VARIANTS WITH END STAGE RENAL DISEASE IN NORTH INDIAN POPULATION |
| 504 |
ASSOCIATION OF CIGARETTE SMOKING AND CRP LEVELS WITH DNA METHYLATION IN ALPHA-1 ANTITRYPSIN DEFICIENCY |
| 505 |
ASSOCIATION OF DNA METHYLTRANSFERASE 3B PROMOTOR POLYMORPHISM WITH CHILDHOOD CHRONIC IMMUNE THROMBOCYTOPENIA |
| 506 |
ASSOCIATION OF ENDOMETRIOSIS WITH CARDIOVASCULAR DISEASE: GENETIC ASPECTS (REVIEW) |
| 507 |
ASSOCIATION OF INCREASED DNA METHYLTRANSFERASE EXPRESSION WITH CARCINOGENESIS AND POOR PROGNOSIS IN PANCREATIC DUCTAL ADENOCARCINOMA |
| 508 |
ASSOCIATION OF LOW-DOSE EXPOSURE TO PERSISTENT ORGANIC POLLUTANTS WITH E-CADHERIN PROMOTER METHYLATION IN HEALTHY KOREANS |
| 509 |
ASSOCIATION OF NUTRACEUTICAL SUPPLEMENTS WITH LONGER TELOMERE LENGTH |
| 510 |
ASSOCIATION OF RASGRF1 METHYLATION WITH EPILEPTIC SEIZURES |
| 511 |
ASSOCIATION OF RASSF1A HYPERMETHYLATION WITH RISK OF HBV/HCV-INDUCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS |
| 512 |
ASSOCIATION OF SAT-A AND ALU METHYLATION STATUS WITH HCV-INDUCED CHRONIC LIVER DISEASE AND HEPATOCELLULAR CARCINOMA |
| 513 |
ASSOCIATION OF SEROTONIN TRANSPORTER GENE ALUJB METHYLATION WITH MAJOR DEPRESSION, AMYGDALA RESPONSIVENESS, 5-HTTLPR/RS25531 POLYMORPHISM, AND STRESS |
| 514 |
ASSOCIATION OF SHMT1, MAZ, ERG, AND L3MBTL3 GENE POLYMORPHISMS WITH SUSCEPTIBILITY TO MULTIPLE SCLEROSIS |
| 515 |
ASSOCIATION OF SOCS1 (- 820) (RS33977706) GENE POLYMORPHISM WITH CHRONIC PERIODONTITIS: A CASE-CONTROL STUDY IN BRAZILIANS |
| 516 |
ASSOCIATION OF THE CPG METHYLATION PATTERN OF THE PROXIMAL INSULIN GENE PROMOTER WITH TYPE 1 DIABETES |
| 517 |
ASSOCIATION STUDY OF FOXO3A SINGLE-NUCLEOTIDE POLYMORPHISM AND BRONCHIAL ASTHMA IN EGYPTIAN CHILDREN |
| 518 |
ASSOCIATIONS BETWEEN ANTIBIOTIC EXPOSURE DURING PREGNANCY, BIRTH WEIGHT AND ABERRANT METHYLATION AT IMPRINTED GENES AMONG OFFSPRING |
| 519 |
ASSOCIATIONS BETWEEN GENETIC AND EPIGENETIC VARIATIONS IN CYTOKINE GENES AND MILD PERSISTENT BREAST PAIN IN WOMEN FOLLOWING BREAST CANCER SURGERY |
| 520 |
ASSOCIATIONS BETWEEN MATERNAL PRENATAL STRESS, METHYLATION CHANGES IN IGF1 AND IGF2, AND BIRTH WEIGHT |
| 521 |
ASSOCIATIONS BETWEEN MATERNAL PSYCHOSOCIAL STRESS, DNA METHYLATION, AND NEWBORN BIRTH WEIGHT IDENTIFIED BY INVESTIGATING METHYLATION AT INDIVIDUAL, REGIONAL, AND GENOME LEVELS |
| 522 |
ASSOCIATIONS BETWEEN NEIGHBORHOOD SOCIOECONOMIC DEPRIVATION, IFNGAMMA, AND HIGH-DENSITY LIPOPROTEIN PARTICLE SIZE: DATA FROM THE WASHINGTON, D |
| 523 |
ASSOCIATIONS BETWEEN PERIODONTITIS AND SYSTEMIC INFLAMMATORY DISEASES: RESPONSE TO TREATMENT |
| 524 |
ASSOCIATIONS OF BDNF GENOTYPE AND PROMOTER METHYLATION WITH ACUTE AND LONG-TERM STROKE OUTCOMES IN AN EAST ASIAN COHORT |
| 525 |
ASSOCIATIONS OF BODY COMPOSITION AND PHYSICAL ACTIVITY LEVEL WITH MULTIPLE MEASURES OF EPIGENETIC AGE ACCELERATION |
| 526 |
ASSOCIATIONS OF HELICOBACTER PYLORI INFECTION AND CHRONIC ATROPHIC GASTRITIS WITH ACCELERATED EPIGENETIC AGEING IN OLDER ADULTS |
| 527 |
ASTHMA AND THE MISSING HERITABILITY PROBLEM: NECESSITY FOR MULTIOMICS APPROACHES IN DETERMINING ACCURATE RISK PROFILES |
| 528 |
ASTHMA EPIGENETICS |
| 529 |
ASTHMA IN URBAN CHILDREN: EPIDEMIOLOGY, ENVIRONMENTAL RISK FACTORS, AND THE PUBLIC HEALTH DOMAIN |
| 530 |
ASTHMA |
| 531 |
ASTROCYTE REACTIVITY FOLLOWING BLAST EXPOSURE INVOLVES ABERRANT HISTONE ACETYLATION |
| 532 |
ASTROCYTIC C-JUN N-TERMINAL KINASE-HISTONE DEACETYLASE-2 CASCADE CONTRIBUTES TO GLUTAMATE TRANSPORTER-1 DECREASE AND MECHANICAL ALLODYNIA FOLLOWING PERIPHERAL NERVE INJURY IN RATS |
| 533 |
ASTROCYTIC TRANSCRIPTION FACTOR REST UPREGULATES GLUTAMATE TRANSPORTER EAAT2, PROTECTING DOPAMINERGIC NEURONS FROM MANGANESE-INDUCED EXCITOTOXICITY |
| 534 |
ASTROGLIA IN THE VULNERABILITY TO AND MAINTENANCE OF STRESS-MEDIATED NEUROPATHOLOGY AND DEPRESSION |
| 535 |
ASXL1 MUTATION CORRECTION BY CRISPR/CAS9 RESTORES GENE FUNCTION IN LEUKEMIA CELLS AND INCREASES SURVIVAL IN MOUSE XENOGRAFTS |
| 536 |
ASXL1 MUTATIONS PREDICT INFERIOR MOLECULAR RESPONSE TO NILOTINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA |
| 537 |
ASYMPTOMATIC HYPERURICEMIA: IS IT REALLY ASYMPTOMATIC? PURPOSE OF REVIEW: HYPERURICEMIA IS HIGHLY PREVALENT, AFFECTING APPROXIMATELY 38 MILLION INDIVIDUALS IN THE UNITED STATES |
| 538 |
ATHEROSCLEROSIS AND EPIGENETIC MODIFICATIONS IN CHRONIC KIDNEY DISEASE |
| 539 |
ATHEROSCLEROSIS IS AN EPIGENETIC DISEASE |
| 540 |
ATMOSPHERIC FINE PARTICULATE MATTER AND EPITHELIAL MESENCHYMAL TRANSITION IN PULMONARY CELLS: STATE OF THE ART AND CRITICAL REVIEW OF THE IN VITRO STUDIES |
| 541 |
ATOPIC DERMATITIS: THE FATE OF THE FAT |
| 542 |
ATP-CITRATE LYASE IS AN EPIGENETIC REGULATOR TO PROMOTE OBESITY-RELATED KIDNEY INJURY |
| 543 |
ATRIAL FIBRILLATION IS ASSOCIATED WITH HYPERMETHYLATION IN HUMAN LEFT ATRIUM, AND TREATMENT WITH DECITABINE REDUCES ATRIAL TACHYARRHYTHMIAS IN SPONTANEOUSLY HYPERTENSIVE RATS |
| 544 |
ATTAINMENT OF THERMOREGULATION AS AFFECTED BY ENVIRONMENTAL FACTORS |
| 545 |
ATTENUATED EPIGENETIC SUPPRESSION OF MUSCLE STEM CELL NECROPTOSIS IS REQUIRED FOR EFFICIENT REGENERATION OF DYSTROPHIC MUSCLES |
| 546 |
ATTENUATED EXPRESSION OF SLCO2A1 CAUSED BY DNA METHYLATION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE |
| 547 |
ATTENUATED TLR4/MAPK SIGNALING IN MONOCYTES FROM PATIENTS WITH CRMO RESULTS IN IMPAIRED IL-10 EXPRESSION |
| 548 |
AUTISM SPECTRUM DISORDER AT THE CROSSROAD BETWEEN GENES AND ENVIRONMENT: CONTRIBUTIONS, CONVERGENCES, AND INTERACTIONS IN ASD DEVELOPMENTAL PATHOPHYSIOLOGY |
| 549 |
AUTOANTIGENS: NOVEL FORMS AND PRESENTATION TO THE IMMUNE SYSTEM |
| 550 |
AUTOIMMUNE POLYENDOCRINOPATHY-CANDIDIASIS-ECTODERMAL DYSTROPHY IN TWO SIBLINGS: SAME MUTATIONS BUT VERY DIFFERENT PHENOTYPES |
| 551 |
AUTOIMMUNITY AS AN ETIOLOGICAL FACTOR OF CANCER: THE TRANSFORMATIVE POTENTIAL OF CHRONIC TYPE 2 INFLAMMATION |
| 552 |
AUTOINFLAMMATION IN SYNDROMIC HIDRADENITIS SUPPURATIVA: THE ROLE OF AIM2 |
| 553 |
AUTOINFLAMMATORY RETINOPATHY IN CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR (CINCA) SYNDROME |
| 554 |
AUTOPHAGY IN HUMAN HEALTH AND DISEASE: NOVEL THERAPEUTIC OPPORTUNITIES |
| 555 |
AXIAL SPONDYLOARTHRITIS: RESHAPE THE FUTURE-FROM THE "2022 GISEA INTERNATIONAL SYMPOSIUM" |
| 556 |
AZACYTIDINE TREATMENT INHIBITS THE PROGRESSION OF HERPES STROMAL KERATITIS BY ENHANCING REGULATORY T CELL FUNCTION |
| 557 |
B-CELL ANTIGEN RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA: THERAPEUTIC TARGETS AND TRANSLATIONAL OPPORTUNITIES |
| 558 |
B-VITAMIN DEPENDENT METHIONINE METABOLISM AND ALCOHOLIC LIVER DISEASE |
| 559 |
BACH2 ENFORCES THE TRANSCRIPTIONAL AND EPIGENETIC PROGRAMS OF STEM-LIKE CD8(+) T CELLS |
| 560 |
BACK TO THE FUTURE: EPIGENETIC CLOCK PLASTICITY TOWARDS HEALTHY AGING |
| 561 |
BARIATRIC SURGERY-INDUCED WEIGHT LOSS AND ASSOCIATED GENOME-WIDE DNA-METHYLATION ALTERATIONS IN OBESE INDIVIDUALS |
| 562 |
BARRETT ESOPHAGUS: HISTORY, DEFINITION AND ETIOPATHOGENY |
| 563 |
BARRETT'S ESOPHAGUS: CAN BIOMARKERS PREDICT PROGRESSION TO MALIGNANCY? BARRETT'S ESOPHAGUS (BE) IS ONE OF THE MOST COMMON PREMALIGNANT LESIONS AND CAN PROGRESS TO ESOPHAGEAL ADENOCARCINOMA |
| 564 |
BASAL CELL CARCINOMAS OF THE SCALP AFTER RADIOTHERAPY FOR TINEA CAPITIS IN CHILDHOOD: A GENETIC AND EPIGENETIC STUDY WITH COMPARISON WITH BASAL CELL CARCINOMAS EVOLVING IN CHRONICALLY SUN-EXPOSED AREAS |
| 565 |
BASAL INSTINCT: PERSISTENCE OF BARRIER DYSFUNCTION |
| 566 |
BASES FOR THE ADEQUATE DEVELOPMENT OF NUTRITIONAL RECOMMENDATIONS FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
| 567 |
BASIC PROPERTIES AND MOLECULAR MECHANISMS OF EXOGENOUS CHEMICAL CARCINOGENS |
| 568 |
BATF REGULATES PROGENITOR TO CYTOLYTIC EFFECTOR CD8(+) T CELL TRANSITION DURING CHRONIC VIRAL INFECTION |
| 569 |
BCOR AND BCORL1 MUTATIONS IN MYELODYSPLASTIC SYNDROMES AND RELATED DISORDERS |
| 570 |
BCR-ABL INDEPENDENT MECHANISMS OF RESISTANCE IN CHRONIC MYELOID LEUKEMIA |
| 571 |
BCR-ABL INDUCES AUTOCRINE IGF-1 SIGNALING |
| 572 |
BCR-ABL1 KINASE-DEPENDENT ALTERATION OF MRNA METABOLISM: POTENTIAL ALTERNATIVES FOR THERAPEUTIC INTERVENTION |
| 573 |
BCR-ABL1-INDUCED DOWNREGULATION OF WASP IN CHRONIC MYELOID LEUKEMIA INVOLVES EPIGENETIC MODIFICATION AND CONTRIBUTES TO MALIGNANCY |
| 574 |
BCR/ABL INCREASES EZH2 LEVELS WHICH REGULATES XIAP EXPRESSION VIA MIRNA-219 IN CHRONIC MYELOID LEUKEMIA CELLS |
| 575 |
BDNF METHYLATION AND MATERNAL BRAIN ACTIVITY IN A VIOLENCE-RELATED SAMPLE |
| 576 |
BDNF METHYLATION AND SUICIDAL IDEATION IN PATIENTS WITH ACUTE CORONARY SYNDROME |
| 577 |
BDNF PROMOTER METHYLATION AND GENETIC VARIATION IN LATE-LIFE DEPRESSION |
| 578 |
BEHAVIOR, BDNF AND EPIGENETIC MECHANISMS IN RESPONSE TO SOCIAL ISOLATION AND SOCIAL SUPPORT IN MIDDLE AGED RATS EXPOSED TO CHRONIC STRESS |
| 579 |
BEHAVIORAL AND MOLECULAR NEUROEPIGENETIC ALTERATIONS IN PRENATALLY STRESSED MICE: RELEVANCE FOR THE STUDY OF CHROMATIN REMODELING PROPERTIES OF ANTIPSYCHOTIC DRUGS |
| 580 |
BEHAVIORAL AND NEUROBIOLOGICAL EFFECTS OF PRENATAL STRESS EXPOSURE IN MALE AND FEMALE APPSWE/PS1DE9 MICE |
| 581 |
BEHAVIORAL AND NEUROCHEMICAL CHARACTERIZATION OF TRKB-DEPENDENT MECHANISMS OF AGOMELATINE IN GLUCOCORTICOID RECEPTOR-IMPAIRED MICE |
| 582 |
BEHAVIORAL AND PHYSIOLOGICAL EFFECTS OF ACUTE AND CHRONIC KAVA EXPOSURE IN ADULT ZEBRAFISH |
| 583 |
BEHAVIORAL DIFFERENCES OF MALE WISTAR RATS FROM DIFFERENT VENDORS IN VULNERABILITY AND RESILIENCE TO CHRONIC MILD STRESS ARE REFLECTED IN EPIGENETIC REGULATION AND EXPRESSION OF P11 |
| 584 |
BEHAVIORAL NEUROADAPTATION TO ALCOHOL: FROM GLUCOCORTICOIDS TO HISTONE ACETYLATION |
| 585 |
BEHAVIORAL PERINATOLOGY: BIOBEHAVIORAL PROCESSES IN HUMAN FETAL DEVELOPMENT |
| 586 |
BEHAVIOURAL AND EPIGENETIC EFFECTS OF PATERNAL EXPOSURE TO CANNABINOIDS DURING ADOLESCENCE ON OFFSPRING VULNERABILITY TO STRESS |
| 587 |
BENEFIT OF APABETALONE ON PLASMA PROTEINS IN RENAL DISEASE |
| 588 |
BENZENE EXPOSURE IS ASSOCIATED WITH EPIGENETIC CHANGES (REVIEW) |
| 589 |
BET BROMODOMAIN INHIBITORS SUPPRESS INFLAMMATORY ACTIVATION OF GINGIVAL FIBROBLASTS AND EPITHELIAL CELLS FROM PERIODONTITIS PATIENTS |
| 590 |
BET BROMODOMAIN PROTEIN INHIBITION REVERSES CHIMERIC ANTIGEN RECEPTOR EXTINCTION AND REINVIGORATES EXHAUSTED T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 591 |
BET BROMODOMAIN PROTEINS AND EPIGENETIC REGULATION OF INFLAMMATION: IMPLICATIONS FOR TYPE 2 DIABETES AND BREAST CANCER |
| 592 |
BET BROMODOMAIN PROTEINS REGULATE TRANSCRIPTIONAL REPROGRAMMING IN GENETIC DILATED CARDIOMYOPATHY |
| 593 |
BET PROTEIN INHIBITION REGULATES CYTOKINE PRODUCTION AND PROMOTES NEUROPROTECTION AFTER SPINAL CORD INJURY |
| 594 |
BET PROTEIN INHIBITOR JQ1 MODULATES MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS INDUCED BY CHRONIC KIDNEY DISEASE |
| 595 |
BET PROTEINS REGULATE EXPRESSION OF OSR1 IN EARLY KIDNEY DEVELOPMENT |
| 596 |
BET PROTEINS: AN APPROACH TO FUTURE THERAPIES IN TRANSPLANTATION |
| 597 |
BET-BROMODOMAIN AND EZH2 INHIBITOR-TREATED CHRONIC GVHD MICE HAVE BLUNTED GERMINAL CENTERS WITH DISTINCT TRANSCRIPTOMES |
| 598 |
BETA-ADRENERGIC SIGNALING PROMOTES TUMOR ANGIOGENESIS AND PROSTATE CANCER PROGRESSION THROUGH HDAC2-MEDIATED SUPPRESSION OF THROMBOSPONDIN-1 |
| 599 |
BETA-CELL DIFFERENTIATION STATUS IN TYPE 2 DIABETES |
| 600 |
BETA-DEFENSINS AND ANALOGS IN HELICOBACTER PYLORI INFECTIONS: MRNA EXPRESSION LEVELS, DNA METHYLATION, AND ANTIBACTERIAL ACTIVITY |
| 601 |
BETA-GLUCAN "TRAINED IMMUNITY" IMMUNOMODULATORY PROPERTIES POTENTIATE TISSUE WOUND MANAGEMENT AND ACCELERATE FITNESS RECOVER |
| 602 |
BETTER UNDERSTANDING OF CHILDHOOD ASTHMA, TOWARDS PRIMARY PREVENTION - ARE WE THERE YET? CONSIDERATION OF PERTINENT LITERATURE |
| 603 |
BETULINIC ACID INHIBITS ENDOMETRIOSIS THROUGH SUPPRESSION OF ESTROGEN RECEPTOR BETA SIGNALING PATHWAY |
| 604 |
BEYOND BROODING ON ONCOMETABOLIC HAVOC IN IDH-MUTANT GLIOMAS AND AML: CURRENT AND FUTURE THERAPEUTIC STRATEGIES |
| 605 |
BEYOND ENDOMETRIOSIS GENOME-WIDE ASSOCIATION STUDY: FROM GENOMICS TO PHENOMICS TO THE PATIENT |
| 606 |
BEYOND GENETICS--THE EMERGING ROLE OF EPIGENETIC CHANGES IN HEMATOPOIETIC MALIGNANCIES |
| 607 |
BEYOND GENETICS: EPIGENETIC CODE IN CHRONIC KIDNEY DISEASE |
| 608 |
BEYOND HOMEOSTASIS: UNDERSTANDING THE IMPACT OF PSYCHOSOCIAL FACTORS ON APPETITE USING NONHUMAN PRIMATE MODELS |
| 609 |
BEYOND MOR: CAN INDUCTION OF DOPAMINE HOMEOSTASIS ALONG WITH ELECTROTHERAPY ATTENUATE THE OPIOID CRISIS? ONE IMPORTANT AREA FOR CONSIDERATION ESPECIALLY IN TERMS OF COMBATING THE ONGOING NEVER ENDING OPIOID CRISIS, RELATES TO NOVEL NEWER ASSESSMENTS FOR ALL ADDICTIVE BEHAVIORS BOTH SUBSTANCE AND NON-SUBSTANCE BEHAVIORS (RDS) |
| 610 |
BEYOND THE GENOME: EPIGENETIC MECHANISMS IN LUNG REMODELING |
| 611 |
BIDIRECTIONAL RESCUE OF EXTREME GENETIC PREDISPOSITIONS TO ANXIETY: IMPACT OF CRH RECEPTOR 1 AS EPIGENETIC PLASTICITY GENE IN THE AMYGDALA |
| 612 |
BINDING OF TFIIIC TO SINE ELEMENTS CONTROLS THE RELOCATION OF ACTIVITY-DEPENDENT NEURONAL GENES TO TRANSCRIPTION FACTORIES |
| 613 |
BINGE ALCOHOL ALTERS PNPLA3 LEVELS IN LIVER THROUGH EPIGENETIC MECHANISM INVOLVING HISTONE H3 ACETYLATION |
| 614 |
BINGE ALCOHOL-INDUCED MICROVESICULAR LIVER STEATOSIS AND INJURY ARE ASSOCIATED WITH DOWN-REGULATION OF HEPATIC HDAC 1, 7, 9, 10, 11 AND UP-REGULATION OF HDAC 3 |
| 615 |
BIOACTIVE COMPONENTS AND POSSIBLE ACTIVITIES OF MEDICINAL MUSHROOMS IN ALLEVIATING THE PATHOGENESIS OF NONALCOHOLIC FATTY LIVER DISEASE (REVIEW) |
| 616 |
BIOACTIVE COMPOUNDS IN OXIDATIVE STRESS-MEDIATED DISEASES: TARGETING THE NRF2/ARE SIGNALING PATHWAY AND EPIGENETIC REGULATION |
| 617 |
BIOACTIVE FOOD COMPOUNDS, EPIGENETICS AND CHRONIC DISEASE PREVENTION: FOCUS ON EARLY-LIFE INTERVENTIONS WITH POLYPHENOLS |
| 618 |
BIOBEHAVIORAL MECHANISMS ASSOCIATED WITH NONHEALING WOUNDS AND PSYCHONEUROLOGIC SYMPTOMS (PAIN, COGNITIVE DYSFUNCTION, FATIGUE, DEPRESSION, AND ANXIETY) IN OLDER INDIVIDUALS WITH CHRONIC VENOUS LEG ULCERS |
| 619 |
BIOCHEMICAL ASPECTS AND THERAPEUTIC MECHANISMS OF CANNABIDIOL IN EPILEPSY |
| 620 |
BIOCHEMISTRY AND MOLECULAR BIOLOGY OF GELATINASE B OR MATRIX METALLOPROTEINASE-9 (MMP-9): THE NEXT DECADE |
| 621 |
BIOENERGETIC EVOLUTION EXPLAINS PREVALENCE OF LOW NEPHRON NUMBER AT BIRTH: RISK FACTOR FOR CKD |
| 622 |
BIOETHICS IN HUMAN EMBRYOLOGY: THE DOUBLE-EDGED SWORD OF EMBRYO RESEARCH |
| 623 |
BIOINFORMATICS FOR CANCER MANAGEMENT IN THE POST-GENOME ERA |
| 624 |
BIOLOGICAL AGE ACCELERATION AND MOTORIC COGNITIVE RISK SYNDROME |
| 625 |
BIOLOGICAL AGE AND ENVIRONMENTAL RISK FACTORS FOR DEMENTIA AND STROKE: MOLECULAR MECHANISMS |
| 626 |
BIOLOGICAL AGING MODULATES CELL MIGRATION VIA LAMIN A/C-DEPENDENT NUCLEAR MOTION |
| 627 |
BIOLOGICAL AGING PROCESSES UNDERLYING COGNITIVE DECLINE AND NEURODEGENERATIVE DISEASE |
| 628 |
BIOLOGICAL AND CLINICAL INSIGHT FROM ANALYSIS OF THE TUMOR B-CELL RECEPTOR STRUCTURE AND FUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 629 |
BIOLOGICAL AND GENETIC MECHANISMS OF COPD, ITS DIAGNOSIS, TREATMENT, AND RELATIONSHIP WITH LUNG CANCER |
| 630 |
BIOLOGICAL AND MECHANICAL FACTORS AND EPIGENETIC REGULATION INVOLVED IN TENDON HEALING |
| 631 |
BIOLOGICAL AND SYNTHETIC TARGET DMARDS IN PSORIATIC ARTHRITIS |
| 632 |
BIOLOGICAL CORRELATES OF EARLY LIFE STRESSFUL EVENTS IN MAJOR DEPRESSIVE DISORDER |
| 633 |
BIOLOGICAL EFFECTS AND EPIDEMIOLOGICAL CONSEQUENCES OF ARSENIC EXPOSURE, AND REAGENTS THAT CAN AMELIORATE ARSENIC DAMAGE IN VIVO |
| 634 |
BIOLOGICAL EMBEDDING OF EARLY-LIFE ADVERSITY AND A SCOPING REVIEW OF THE EVIDENCE FOR INTERGENERATIONAL EPIGENETIC TRANSMISSION OF STRESS AND TRAUMA IN HUMANS |
| 635 |
BIOLOGICAL FUNCTION OF LONG NON-CODING RNA (LNCRNA) XIST |
| 636 |
BIOLOGICAL SUBSTRATES OF ADDICTION |
| 637 |
BIOLOGY OF PREMATURE AGEING IN SURVIVORS OF CANCER |
| 638 |
BIOMARKERS ASSOCIATED WITH MIGRAINE AND THEIR POTENTIAL ROLE IN MIGRAINE MANAGEMENT |
| 639 |
BIOMARKERS FOR MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS): A SYSTEMATIC REVIEW |
| 640 |
BIOMARKERS OF AGING IN FRAILTY AND AGE-ASSOCIATED DISORDERS: STATE OF THE ART AND FUTURE PERSPECTIVE |
| 641 |
BIOMARKERS OF MAJOR DEPRESSIVE DISORDER: KNOWING IS HALF THE BATTLE |
| 642 |
BIOMARKERS OF PARTICULATE MATTER EXPOSURE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A SYSTEMATIC REVIEW |
| 643 |
BIOME DEPLETION IN CONJUNCTION WITH EVOLUTIONARY MISMATCHES COULD PLAY A ROLE IN THE ETIOLOGY OF NEUROFIBROMATOSIS 1 |
| 644 |
BIOPHARMACEUTICAL MONOTARGETING VERSUS 'UNIVERSAL TARGETING' OF LATE-ONSET ALZHEIMER'S DISEASE USING MIXTURES OF PLEIOTROPIC NATURAL COMPOUNDS |
| 645 |
BIRTH DEFECTS IN GAZA: PREVALENCE, TYPES, FAMILIARITY AND CORRELATION WITH ENVIRONMENTAL FACTORS |
| 646 |
BIRTH MODE AND INFECTIOUS MORBIDITY RISKS IN QOM CHILDREN OF ARGENTINA |
| 647 |
BIRTH ORDER PATTERN IN THE INHERITANCE OF CHRONIC LYMPHOCYTIC LEUKAEMIA AND RELATED LYMPHOPROLIFERATIVE DISEASE |
| 648 |
BIRTH WEIGHT AND MATERNAL ENERGY STATUS DURING PREGNANCY AS PREDICTORS OF EPIGENETIC AGE ACCELERATION IN YOUNG ADULTS FROM METROPOLITAN CEBU, PHILIPPINES |
| 649 |
BIRTHWEIGHT, MATERNAL WEIGHT TRAJECTORIES AND GLOBAL DNA METHYLATION OF LINE-1 REPETITIVE ELEMENTS |
| 650 |
BISPHENOL A AND HUMAN CHRONIC DISEASES: CURRENT EVIDENCES, POSSIBLE MECHANISMS, AND FUTURE PERSPECTIVES |
| 651 |
BISPHENOL A AND PHTHALATES MODULATE PERITONEAL MACROPHAGE FUNCTION IN FEMALE MICE INVOLVING SYMD2-H3K36 DIMETHYLATION |
| 652 |
BISPHENOL A AS EPIGENETIC MODULATOR: SETTING THE STAGE FOR CARCINOGENESIS? BACKGROUND: BISPHENOL A (BPA) IS ONE OF THE MOST WIDELY PRODUCED CHEMICALS WORLDWIDE AND IS OFTEN USED IN THE PRODUCTION OF FOOD AND BEVERAGE CONTAINERS |
| 653 |
BISPHENOL A, HYPERTENSION, AND CARDIOVASCULAR DISEASES: EPIDEMIOLOGICAL, LABORATORY, AND CLINICAL TRIAL EVIDENCE |
| 654 |
BISPHENOL S INDUCED EPIGENETIC AND TRANSCRIPTIONAL CHANGES IN HUMAN BREAST CANCER CELL LINE MCF-7 |
| 655 |
BLOCKADE OF IMMUNE-CHECKPOINT B7-H4 AND LYSINE DEMETHYLASE 5B IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA CONFERS PROTECTIVE IMMUNITY AGAINST P |
| 656 |
BLOCKADE OF THE IL-1R1/TLR4 PATHWAY MEDIATES DISEASE-MODIFICATION THERAPEUTIC EFFECTS IN A MODEL OF ACQUIRED EPILEPSY |
| 657 |
BLOCKING THE SPINAL FBXO3/CARM1/K(+) CHANNEL EPIGENETIC SILENCING PATHWAY AS A STRATEGY FOR NEUROPATHIC PAIN RELIEF |
| 658 |
BLOOD DNA METHYLATION PREDICTS DIABETIC KIDNEY DISEASE PROGRESSION IN HIGH FAT DIET-FED MICE |
| 659 |
BLOOD GLOBAL DNA METHYLATION IS DECREASED IN NON-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS |
| 660 |
BLOOD LEVELS OF T-CELL RECEPTOR EXCISION CIRCLES (TRECS) PROVIDE AN INDEX OF EXPOSURE TO TRAUMATIC STRESS IN MICE AND HUMANS |
| 661 |
BLOOD MIR-144-3P: A NOVEL DIAGNOSTIC AND THERAPEUTIC TOOL FOR DEPRESSION |
| 662 |
BLOOD MONOCYTE TRANSCRIPTOME AND EPIGENOME ANALYSES REVEAL LOCI ASSOCIATED WITH HUMAN ATHEROSCLEROSIS |
| 663 |
BLOOD ORANGE JUICE INTAKE MODULATES PLASMA AND PBMC MICRORNA EXPRESSION IN OVERWEIGHT AND INSULIN-RESISTANT WOMEN: IMPACT ON MAPK AND NFKAPPAB SIGNALING PATHWAYS |
| 664 |
BLOOD REFLUX-INDUCED EPIGENETIC FACTORS HDACS AND DNMTS ARE ASSOCIATED WITH THE DEVELOPMENT OF HUMAN CHRONIC VENOUS DISEASE |
| 665 |
BLOOD TRANSCRIPTOMICS OF DRUG-NAIVE SPORADIC PARKINSON'S DISEASE PATIENTS |
| 666 |
BLOOD-BASED DNA METHYLATION BIOMARKERS FOR TYPE 2 DIABETES: POTENTIAL FOR CLINICAL APPLICATIONS |
| 667 |
BLOOD-BASED EPIGENOME-WIDE ANALYSES OF 19 COMMON DISEASE STATES: A LONGITUDINAL, POPULATION-BASED LINKED COHORT STUDY OF 18,413 SCOTTISH INDIVIDUALS |
| 668 |
BNDF METHYLATION IN MOTHERS AND NEWBORNS IS ASSOCIATED WITH MATERNAL EXPOSURE TO WAR TRAUMA |
| 669 |
BONE MARROW STROMAL CELL ANTIGEN-1 (CD157) REGULATED BY SPHINGOSINE KINASE 2 MEDIATES KIDNEY FIBROSIS |
| 670 |
BONE-METABOLISM-RELATED SERUM MICRORNAS TO DIAGNOSE OSTEOPOROSIS IN MIDDLE-AGED AND ELDERLY WOMEN |
| 671 |
BOTHROPS MOOJENI L-AMINO ACID OXIDASE INDUCES APOPTOSIS AND EPIGENETIC MODULATION ON BCR-ABL(+) CELLS |
| 672 |
BRAF, KRAS AND HELICOBACTER PYLORI EPIGENETIC CHANGES-ASSOCIATED CHRONIC GASTRITIS IN EGYPTIAN PATIENTS WITH AND WITHOUT GASTRIC CANCER |
| 673 |
BRAHMA-RELATED GENE 1 (BRG1) EPIGENETICALLY REGULATES CAM ACTIVATION DURING HYPOXIC PULMONARY HYPERTENSION |
| 674 |
BRAHMA-RELATED GENE 1 BRIDGES EPIGENETIC REGULATION OF PROINFLAMMATORY CYTOKINE PRODUCTION TO STEATOHEPATITIS IN MICE |
| 675 |
BRAIN AGE AND OTHER BODILY 'AGES': IMPLICATIONS FOR NEUROPSYCHIATRY |
| 676 |
BRAIN AGING: A IANUS-FACED PLAYER BETWEEN HEALTH AND NEURODEGENERATION |
| 677 |
BRAIN CIRCUITS AT RISK IN PSYCHIATRIC DISEASES AND PHARMACOLOGICAL PATHWAYS |
| 678 |
BRAIN DEVELOPMENT UNDER STRESS: HYPOTHESES OF GLUCOCORTICOID ACTIONS REVISITED |
| 679 |
BRAIN FOODS - THE ROLE OF DIET IN BRAIN PERFORMANCE AND HEALTH |
| 680 |
BRAIN INJURY IN CHRONICALLY VENTILATED PRETERM NEONATES: COLLATERAL DAMAGE RELATED TO VENTILATION STRATEGY |
| 681 |
BRAIN LIPOTOXICITY OF PHYTANIC ACID AND VERY LONG-CHAIN FATTY ACIDS |
| 682 |
BRAIN ON STRESS: HOW THE SOCIAL ENVIRONMENT GETS UNDER THE SKIN |
| 683 |
BRAIN PLASTICITY AND COGNITIVE FUNCTIONS AFTER ETHANOL CONSUMPTION IN C57BL/6J MICE |
| 684 |
BRAIN STAT5 MODULATES LONG-TERM METABOLIC AND EPIGENETIC CHANGES INDUCED BY PREGNANCY AND LACTATION IN FEMALE MICE |
| 685 |
BRAIN-DERIVED NEUROTROPHIC FACTOR INVOLVED EPIGENETIC REPRESSION OF UGT2B7 IN COLORECTAL CARCINOMA: A MECHANISM TO ALTER MORPHINE GLUCURONIDATION IN TUMOR |
| 686 |
BRAIN-SPECIFIC GENES CONTRIBUTE TO CHRONIC BUT NOT TO ACUTE BACK PAIN |
| 687 |
BRAINSTEM BRAIN-DERIVED NEUROTROPHIC FACTOR SIGNALING IS REQUIRED FOR HISTONE DEACETYLASE INHIBITOR-INDUCED PAIN RELIEF |
| 688 |
BRASSICA-DERIVED PLANT BIOACTIVES AS MODULATORS OF CHEMOPREVENTIVE AND INFLAMMATORY SIGNALING PATHWAYS |
| 689 |
BRD4 AS A THERAPEUTIC TARGET IN PULMONARY DISEASES |
| 690 |
BRD4 DEGRADATION BLOCKS EXPRESSION OF MYC AND MULTIPLE FORMS OF STEM CELL RESISTANCE IN PH(+) CHRONIC MYELOID LEUKEMIA |
| 691 |
BRD4 PROFILING IDENTIFIES CRITICAL CHRONIC LYMPHOCYTIC LEUKEMIA ONCOGENIC CIRCUITS AND REVEALS SENSITIVITY TO PLX51107, A NOVEL STRUCTURALLY DISTINCT BET INHIBITOR |
| 692 |
BRD4 PROMOTES HEPATIC STELLATE CELLS ACTIVATION AND HEPATIC FIBROSIS VIA MEDIATING P300/H3K27AC/PLK1 AXIS |
| 693 |
BREAKING BOUNDARIES: PAN BETI DISRUPT 3D CHROMATIN STRUCTURE, BD2-SELECTIVE BETI ARE STRICTLY EPIGENETIC TRANSCRIPTIONAL REGULATORS |
| 694 |
BREAST MILK MESENCHYMAL STEM CELLS AND/OR DERIVED EXOSOMES MITIGATED ADENINE-INDUCED NEPHROPATHY VIA MODULATING RENAL AUTOPHAGY AND FIBROTIC SIGNALING PATHWAYS AND THEIR EPIGENETIC REGULATIONS |
| 695 |
BRG1 IN THE NUCLEUS ACCUMBENS REGULATES COCAINE-SEEKING BEHAVIOR |
| 696 |
BROMATE-INDUCED CHANGES IN P21 DNA METHYLATION AND HISTONE ACETYLATION IN RENAL CELLS |
| 697 |
BROMODOMAIN AND EXTRATERMINAL PROTEINS AS NOVEL EPIGENETIC TARGETS FOR RENAL DISEASES |
| 698 |
BROMODOMAIN CONTAINING PROTEIN 4 (BRD4) REGULATES EXPRESSION OF ITS INTERACTING COACTIVATORS IN THE INNATE RESPONSE TO RESPIRATORY SYNCYTIAL VIRUS |
| 699 |
BROMODOMAIN PROTEIN 4 IS A KEY MOLECULAR DRIVER OF TGFBETA1-INDUCED HEPATIC STELLATE CELL ACTIVATION |
| 700 |
BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4): A KEY PLAYER IN INFLAMMATORY BOWEL DISEASE AND POTENTIAL TO INSPIRE EPIGENETIC THERAPEUTICS |
| 701 |
BROWN FAT DNMT3B DEFICIENCY AMELIORATES OBESITY IN FEMALE MICE |
| 702 |
BROWN RICE-SPECIFIC GAMMA-ORYZANOL AS A PROMISING PROPHYLACTIC AVENUE TO PROTECT AGAINST DIABETES MELLITUS AND OBESITY IN HUMANS |
| 703 |
BTLA EXPRESSION IN CLL: EPIGENETIC REGULATION AND IMPACT ON CLL B CELL PROLIFERATION AND ABILITY TO IL-4 PRODUCTION |
| 704 |
BUILDING RESILIENCE AGAINST THE SEQUELAE OF ADVERSE CHILDHOOD EXPERIENCES: RISE UP, CHANGE YOUR LIFE, AND REFORM HEALTH CARE |
| 705 |
BUILDING RISK-ON-A-CHIP MODELS TO IMPROVE BREAST CANCER RISK ASSESSMENT AND PREVENTION |
| 706 |
BUTYRATE AND DIETARY SOLUBLE FIBER IMPROVE NEUROINFLAMMATION ASSOCIATED WITH AGING IN MICE |
| 707 |
BY WHAT MOLECULAR MECHANISMS DO SOCIAL DETERMINANTS IMPACT CARDIOMETABOLIC RISK? WHILE IT IS WELL KNOWN FROM NUMEROUS EPIDEMIOLOGIC INVESTIGATIONS THAT SOCIAL DETERMINANTS (SOCIOECONOMIC, ENVIRONMENTAL, AND PSYCHOSOCIAL FACTORS EXPOSED TO OVER THE LIFE-COURSE) CAN DRAMATICALLY IMPACT CARDIOVASCULAR HEALTH, THE MOLECULAR MECHANISMS BY WHICH SOCIAL DETERMINANTS LEAD TO POOR CARDIOMETABOLIC OUTCOMES ARE NOT WELL UNDERSTOOD |
| 708 |
BYSTANDER EFFECTS IN RADIATION-INDUCED GENOMIC INSTABILITY |
| 709 |
C-MYC ONCOPROTEIN DICTATES TRANSCRIPTIONAL PROFILES OF ATP-BINDING CASSETTE TRANSPORTER GENES IN CHRONIC MYELOGENOUS LEUKEMIA CD34+ HEMATOPOIETIC PROGENITOR CELLS |
| 710 |
C-TERMINAL DOMAIN SMALL PHOSPHATASE 1 (CTDSP1) REGULATES GROWTH FACTOR EXPRESSION AND AXONAL REGENERATION IN PERIPHERAL NERVE TISSUE |
| 711 |
C |
| 712 |
CADMIUM AND ITS EPIGENETIC EFFECTS |
| 713 |
CADMIUM EXPOSURE AND AGE-ASSOCIATED DNA METHYLATION CHANGES IN NON-SMOKING WOMEN FROM NORTHERN THAILAND |
| 714 |
CADMIUM IS A MUTAGEN THAT ACTS BY INHIBITING MISMATCH REPAIR |
| 715 |
CAFFEINE INTAKE EXERTS DUAL GENOME-WIDE EFFECTS ON HIPPOCAMPAL METABOLISM AND LEARNING-DEPENDENT TRANSCRIPTION |
| 716 |
CALCIFIC AORTIC VALVE DISEASE-NATURAL HISTORY AND FUTURE THERAPEUTIC STRATEGIES |
| 717 |
CALCITONIN GENE-RELATED PEPTIDE REGULATES SPINAL MICROGLIAL ACTIVATION THROUGH THE HISTONE H3 LYSINE 27 TRIMETHYLATION VIA ENHANCER OF ZESTE HOMOLOG-2 IN RATS WITH NEUROPATHIC PAIN |
| 718 |
CALCIUM-DEPENDENT INTRACELLULAR SIGNAL PATHWAYS IN PRIMARY CULTURED ADIPOCYTES AND ANK3 GENE VARIATION IN PATIENTS WITH BIPOLAR DISORDER AND HEALTHY CONTROLS |
| 719 |
CALORIE RESTRICTION-REGULATED MOLECULAR PATHWAYS AND ITS IMPACT ON VARIOUS AGE GROUPS: AN OVERVIEW |
| 720 |
CALPAIN-14 AND ITS ASSOCIATION WITH EOSINOPHILIC ESOPHAGITIS |
| 721 |
CAN ASSISTED REPRODUCTIVE TECHNOLOGIES CAUSE ADULT-ONSET DISEASE? EVIDENCE FROM HUMAN AND MOUSE |
| 722 |
CAN CANNABIDIOL AFFECT THE EFFICACY OF CHEMOTHERAPY AND EPIGENETIC TREATMENTS IN CANCER? THE SUCCESS OF CANNABINOIDS WITH CHRONIC NEUROPATHIC PAIN AND ANXIETY HAS BEEN DEMONSTRATED IN A MULTITUDE OF STUDIES |
| 723 |
CAN EPIGENETIC AND INFLAMMATORY BIOMARKERS IDENTIFY CLINICALLY AGGRESSIVE PROSTATE CANCER? PROSTATE CANCER (PCA) IS A HIGHLY PREVALENT MALIGNANCY AND CONSTITUTES A MAJOR CAUSE OF CANCER-RELATED MORBIDITY AND MORTALITY |
| 724 |
CAN GENETICS GUIDE EXERCISE PRESCRIPTIONS IN OSTEOARTHRITIS? OSTEOARTHRITIS (OA) IS THE MOST COMMON FORM OF ARTHRITIS AND HAS A MULTIFACTORIAL ETIOLOGY |
| 725 |
CAN THE BLOOD TRYPTASE BE AN INDICATOR OF THE SEVERITY OF ATOPIC DERMATITIS? ATOPIC DERMATITIS (AD - ATOPIC ECZEMA) IS A CHRONIC INFLAMMATORY DERMATOSIS RESULTING FROM COMPLEX GENETIC, EPIGENETIC AND ENVIRONMENTAL INTERACTIONS WITH AN OVERLAPPING DEFECT IN THE EPIDERMAL BARRIER |
| 726 |
CAN TYPE 1 DIABETES BE AN UNEXPECTED COMPLICATION OF OBESITY? TYPE 1 DIABETES (T1D) IS ONE OF THE MOST COMMON CHRONIC AUTOIMMUNE DISEASES, CHARACTERIZED BY ABSOLUTE INSULIN DEFICIENCY CAUSED VIA INFLAMMATORY DESTRUCTION OF THE PANCREATIC BETA-CELL |
| 727 |
CAN VITAMINS, AS EPIGENETIC MODIFIERS, ENHANCE IMMUNITY IN COVID-19 PATIENTS WITH NON-COMMUNICABLE DISEASE? PURPOSE OF REVIEW: THE HIGHLY INFECTIOUS TRANSMISSIBLE DISEASE, THE NOVEL SARS-COV-2, CAUSING THE CORONAVIRUS DISEASE (COVID-19), HAS A MEDIAN INCUBATION TIME OF 5 TO 15 DAYS |
| 728 |
CAN WE IDENTIFY PATIENTS WITH HIGH RISK OF OSTEOARTHRITIS PROGRESSION WHO WILL RESPOND TO TREATMENT? A FOCUS ON BIOMARKERS AND FRAILTY |
| 729 |
CANCER ANGIOGENESIS INDUCED BY KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS IS MEDIATED BY EZH2 |
| 730 |
CANCER CELLS RESISTANT TO IMMUNE CHECKPOINT BLOCKADE ACQUIRE INTERFERON-ASSOCIATED EPIGENETIC MEMORY TO SUSTAIN T CELL DYSFUNCTION |
| 731 |
CANCER CHEMOPREVENTION: CLASSIC AND EPIGENETIC MECHANISMS INHIBITING TUMORIGENESIS |
| 732 |
CANCER DRUG RESISTANCE: THE CENTRAL ROLE OF THE KARYOTYPE |
| 733 |
CANCER EPIGENETICS: LINKING BASIC BIOLOGY TO CLINICAL MEDICINE |
| 734 |
CANCER HEALTHCARE DISPARITIES AMONG AFRICAN AMERICANS IN THE UNITED STATES |
| 735 |
CANCER STEM CELLS INDUCED BY CHRONIC STIMULATION WITH PROSTAGLANDIN E2 EXHIBITED CONSTITUTIVELY ACTIVATED PI3K AXIS |
| 736 |
CANCER STEM CELLS--NEW APPROACH TO CANCEROGENENSIS AND TREATMENT |
| 737 |
CANCER STEM CELLS |
| 738 |
CANCER SUSCEPTIBILITY: EPIGENETIC MANIFESTATION OF ENVIRONMENTAL EXPOSURES |
| 739 |
CANCER TREATMENT-INDUCED ACCELERATED AGING IN CANCER SURVIVORS: BIOLOGY AND ASSESSMENT |
| 740 |
CANCER/TESTIS ANTIGENS: EXPRESSION, REGULATION, TUMOR INVASION, AND USE IN IMMUNOTHERAPY OF CANCERS |
| 741 |
CANDIDATE GENES OF WALDENSTROM'S MACROGLOBULINEMIA: CURRENT EVIDENCE AND RESEARCH |
| 742 |
CANNABINOID CB2 RECEPTORS ARE UPREGULATED VIA BIVALENT HISTONE MODIFICATIONS AND CONTROL PRIMARY AFFERENT INPUT TO THE SPINAL CORD IN NEUROPATHIC PAIN |
| 743 |
CANNABINOID TYPE 2 RECEPTOR SYSTEM MODULATES PACLITAXEL-INDUCED MICROGLIAL DYSREGULATION AND CENTRAL SENSITIZATION IN RATS |
| 744 |
CANNABINOID WIN55,212-2 REPROGRAMS MONOCYTES AND MACROPHAGES TO INHIBIT LPS-INDUCED INFLAMMATION |
| 745 |
CANNABIS ALTERS EPIGENETIC INTEGRITY AND ENDOCANNABINOID SIGNALLING IN THE HUMAN FOLLICULAR NICHE |
| 746 |
CANNABIS TERATOLOGY EXPLAINS CURRENT PATTERNS OF COLORADAN CONGENITAL DEFECTS: THE CONTRIBUTION OF INCREASED CANNABINOID EXPOSURE TO RISING TERATOLOGICAL TRENDS |
| 747 |
CANNABIS-INDUCED HYPODOPAMINERGIC ANHEDONIA AND COGNITIVE DECLINE IN HUMANS: EMBRACING PUTATIVE INDUCTION OF DOPAMINE HOMEOSTASIS |
| 748 |
CAPITAL EM, CYRILLICSMALL O, CYRILLICLECULAR MECHANISMS OF INITIATION OF CARCINOGENESIS IN THE TESTIS |
| 749 |
CARDIAC EPIGENETIC CHANGES IN VEGF SIGNALING GENES ASSOCIATE WITH MYOCARDIAL MICROVASCULAR RAREFACTION IN EXPERIMENTAL CHRONIC KIDNEY DISEASE |
| 750 |
CARDIAC INVOLVEMENT IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES |
| 751 |
CARDIOMETABOLIC EFFECTS OF POSTNATAL HIGH-FAT DIET CONSUMPTION IN OFFSPRING EXPOSED TO MATERNAL PROTEIN RESTRICTION IN UTERO |
| 752 |
CARDIOMETABOLIC RISK FACTORS AND BENIGN GYNECOLOGIC DISORDERS |
| 753 |
CARDIORENAL SYNDROME: LONG ROAD BETWEEN KIDNEY AND HEART |
| 754 |
CARDIOVASCULAR ADAPTATIONS TO PARTICLE INHALATION EXPOSURE: MOLECULAR MECHANISMS OF THE TOXICOLOGY |
| 755 |
CARDIOVASCULAR RISK IN FATTY LIVER DISEASE: THE LIVER-HEART AXIS-LITERATURE REVIEW |
| 756 |
CARM1 REGULATES SENESCENCE DURING AIRWAY EPITHELIAL CELL INJURY IN COPD PATHOGENESIS |
| 757 |
CARTILAGE REPAIR BY MESENCHYMAL STEM CELLS: CLINICAL TRIAL UPDATE AND PERSPECTIVES |
| 758 |
CAS9-TARGETED NANOPORE SEQUENCING REVEALS EPIGENETIC HETEROGENEITY AFTER DE NOVO ASSEMBLY OF NATIVE FULL-LENGTH HEPATITIS B VIRUS GENOMES |
| 759 |
CASE REPORT OF CUTANEOUS SQUAMOUS CELL CARCINOMA AT THE WRIST JOINT AND THE PUBLIC HEALTH CRISIS OF ARSENICOSIS |
| 760 |
CASZ1: CURRENT IMPLICATIONS IN CARDIOVASCULAR DISEASES AND CANCERS |
| 761 |
CATEGORIZING THE CHARACTERISTICS OF HUMAN CARCINOGENS: A NEED FOR SPECIFICITY |
| 762 |
CAUSAL ROLE OF HELICOBACTER PYLORI INFECTION AND ERADICATION THERAPY IN GASTRIC CARCINOGENESIS |
| 763 |
CAUSES OF PULMONARY FIBROSIS IN THE ELDERLY |
| 764 |
CBP/P300 ACTIVATION PROMOTES AXON GROWTH, SPROUTING, AND SYNAPTIC PLASTICITY IN CHRONIC EXPERIMENTAL SPINAL CORD INJURY WITH SEVERE DISABILITY |
| 765 |
CC-486 MAINTENANCE AFTER STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROMES |
| 766 |
CCL5 SUPPRESSES KLOTHO EXPRESSION VIA P-STAT3/DNA METHYLTRANSFERASE1-MEDIATED PROMOTER HYPERMETHYLATION |
| 767 |
CD24 MEDIATES GASTRIC CARCINOGENESIS AND PROMOTES GASTRIC CANCER PROGRESSION VIA STAT3 ACTIVATION |
| 768 |
CD47 (CLUSTER OF DIFFERENTIATION 47) |
| 769 |
CD8 T CELL EXHAUSTION DURING CHRONIC VIRAL INFECTION AND CANCER |
| 770 |
CD8(+) T CELL DYSFUNCTION BY TOX INTOXICATION: A PROTUMORIGENIC EVENT IN THE TUMOR MICROENVIRONMENT |
| 771 |
CD8(+) T CELL EXHAUSTION |
| 772 |
CDYL DEFICIENCY BRAKES NEURONAL EXCITABILITY AND NOCICEPTION THROUGH PROMOTING KCNB1 TRANSCRIPTION IN PERIPHERAL SENSORY NEURONS |
| 773 |
CELL AND MOLECULAR MECHANISMS BEHIND DIET-INDUCED HYPOTHALAMIC INFLAMMATION AND OBESITY |
| 774 |
CELL TYPE-SPECIFIC MECHANISM OF SETD1A HETEROZYGOSITY IN SCHIZOPHRENIA PATHOGENESIS |
| 775 |
CELL TYPE-SPECIFIC WHOLE-GENOME LANDSCAPE OF DELTAFOSB BINDING IN THE NUCLEUS ACCUMBENS AFTER CHRONIC COCAINE EXPOSURE |
| 776 |
CELL- AND TISSUE-SPECIFIC EPIGENETIC CHANGES ASSOCIATED WITH CHRONIC INFLAMMATION IN INSULIN RESISTANCE AND TYPE 2 DIABETES MELLITUS |
| 777 |
CELL-FREE CIRCULATING EPIGENOMIC SIGNATURES: NON-INVASIVE BIOMARKER FOR CARDIOVASCULAR AND OTHER AGE-RELATED CHRONIC DISEASES |
| 778 |
CELL-FREE DNA METHYLATION: THE NEW FRONTIERS OF PANCREATIC CANCER BIOMARKERS' DISCOVERY |
| 779 |
CELL-FREE DNA PROMOTER HYPERMETHYLATION AS A DIAGNOSTIC MARKER FOR PANCREATIC DUCTAL ADENOCARCINOMA - AN EXTERNAL VALIDATION STUDY |
| 780 |
CELL-FREE DNA PROMOTER HYPERMETHYLATION IN PLASMA AS A DIAGNOSTIC MARKER FOR PANCREATIC ADENOCARCINOMA |
| 781 |
CELL-FREE FILTRATES (CFF) AS VECTORS OF A TRANSMISSIBLE PATHOLOGIC TISSUE MEMORY CODE: A HYPOTHETICAL AND NARRATIVE REVIEW |
| 782 |
CELL-FREE MICRORNA-148A IS ASSOCIATED WITH RENAL ALLOGRAFT DYSFUNCTION: IMPLICATION FOR BIOMARKER DISCOVERY |
| 783 |
CELL-SPECIFIC EPIGENETIC DRIVERS OF PATHOGENESIS IN RHEUMATOID ARTHRITIS |
| 784 |
CELL-SPECIFIC EXON METHYLATION AND CTCF BINDING IN NEURONS REGULATE CALCIUM ION CHANNEL SPLICING AND FUNCTION |
| 785 |
CELL-TYPE SPECIFIC EWAS IDENTIFIES GENES INVOLVED IN HIV PATHOGENESIS AND ONCOGENESIS AMONG PEOPLE WITH HIV INFECTION |
| 786 |
CELL-TYPE-SPECIFIC EPIGENETIC EDITING AT THE FOSB GENE CONTROLS SUSCEPTIBILITY TO SOCIAL DEFEAT STRESS |
| 787 |
CELLS OF ADULT T-CELL LEUKEMIA EVADE HTLV-1 TAX/NF-KAPPAB HYPERACTIVATION-INDUCED SENESCENCE |
| 788 |
CELLULAR ALLOSTATIC LOAD IS LINKED TO INCREASED ENERGY EXPENDITURE AND ACCELERATED BIOLOGICAL AGING |
| 789 |
CELLULAR AND MOLECULAR MECHANISMS DRIVING NEUROPATHIC PAIN: RECENT ADVANCEMENTS AND CHALLENGES |
| 790 |
CELLULAR AND MOLECULAR MECHANISMS OF CD8(+) T CELL DIFFERENTIATION, DYSFUNCTION AND EXHAUSTION |
| 791 |
CELLULAR AND MOLECULAR NETWORKS IN CHRONIC MYELOID LEUKEMIA: THE LEUKEMIC STEM, PROGENITOR AND STROMAL CELL INTERPLAY |
| 792 |
CELLULAR MECHANISMS PROMOTING CACHEXIA AND HOW THEY ARE OPPOSED BY SIRTUINS (1) |
| 793 |
CELLULAR RE- AND DE-PROGRAMMING BY MICROENVIRONMENTAL MEMORY: WHY SHORT TGF-BETA1 PULSES CAN HAVE LONG EFFECTS |
| 794 |
CELLULAR REPROGRAMMING IN BASIC AND APPLIED BIOMEDICINE: THE DAWN OF REGENERATIVE MEDICINE |
| 795 |
CELLULAR RESILIENCE |
| 796 |
CELLULAR SENESCENCE IN CANCER: FROM MECHANISMS TO DETECTION |
| 797 |
CELLULAR SENESCENCE IN OSTEOARTHRITIS PATHOLOGY |
| 798 |
CELLULAR SENESCENCE, SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE, AND CHRONIC KIDNEY DISEASE |
| 799 |
CELLULAR SIGNALING AND POTENTIAL NEW TREATMENT TARGETS IN DIABETIC RETINOPATHY |
| 800 |
CELLULAR, MOLECULAR, AND EPIGENETIC MECHANISMS IN NON-ASSOCIATIVE CONDITIONING: IMPLICATIONS FOR PAIN AND MEMORY |
| 801 |
CENTRAL AND PERIPHERAL IMMUNE DYSREGULATION IN POSTTRAUMATIC STRESS DISORDER: CONVERGENT MULTI-OMICS EVIDENCE |
| 802 |
CENTRAL AND PERIPHERAL STRESS-INDUCED EPIGENETIC MECHANISMS OF RESILIENCE |
| 803 |
CENTRAL CONTROL OF VISCERAL PAIN AND URINARY TRACT FUNCTION |
| 804 |
CENTRAL ENDOTHELIN-1 CONFERS ANALGESIA BY TRIGGERING SPINAL NEURONAL HISTONE DEACETYLASE 5 (HDAC5) NUCLEAR EXCLUSION IN PERIPHERAL NEUROPATHIC PAIN IN MICE |
| 805 |
CHALLENGES AND PERSPECTIVES OF THE DOUBLE BURDEN OF MALNUTRITION IN LATIN AMERICA |
| 806 |
CHALLENGES FOR MODELING AND INTERPRETING THE COMPLEX BIOLOGY OF SEVERE INJURY AND INFLAMMATION |
| 807 |
CHANGE IN MICRORNAS ASSOCIATED WITH NEURONAL ADAPTIVE RESPONSES IN THE NUCLEUS ACCUMBENS UNDER NEUROPATHIC PAIN |
| 808 |
CHANGED HISTONE ACETYLATION PATTERNS IN NORMAL-APPEARING WHITE MATTER AND EARLY MULTIPLE SCLEROSIS LESIONS |
| 809 |
CHANGES IN CLASS I AND IIB HDACS BY DELTA-OPIOID IN CHRONIC RAT GLAUCOMA MODEL |
| 810 |
CHANGES IN DNA METHYLATION IN APOE AND ACKR3 GENES IN MULTIPLE SCLEROSIS PATIENTS AND THE RELATIONSHIP WITH THEIR HEAVY METAL BLOOD LEVELS |
| 811 |
CHANGES IN DNA METHYLATION OF TANDEM DNA REPEATS ARE DIFFERENT FROM INTERSPERSED REPEATS IN CANCER |
| 812 |
CHANGES IN DNA METHYLATION PROFILES OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME PATIENTS REFLECT SYSTEMIC DYSFUNCTIONS |
| 813 |
CHANGES IN POLY(ADP-RIBOSYL)ATION PATTERNS IN WORKERS EXPOSED TO BTX |
| 814 |
CHANGES IN SMALL NONCODING RNA EXPRESSION DURING CHONDROCYTE SENESCENCE |
| 815 |
CHANGES IN THE EXPRESSION OF INFLAMMATORY AND EPIGENETIC-MODULATORY GENES AFTER AN INTENSIVE MEDITATION RETREAT |
| 816 |
CHARACTERISATION OF AN INFLAMMATION-RELATED EPIGENETIC SCORE AND ITS ASSOCIATION WITH COGNITIVE ABILITY |
| 817 |
CHARACTERISTIC PATTERNS OF ALTERED DNA METHYLATION PREDICT EMERGENCE OF HUMAN HEPATOCELLULAR CARCINOMA |
| 818 |
CHARACTERISTICS OF THE SPECTRUM OF PROLIFERATIVE LESIONS OBSERVED IN THE KIDNEY AND URINARY BLADDER OF FISCHER 344 RATS AND B6C3F1 MICE |
| 819 |
CHARACTERIZATION OF A KDM5 SMALL MOLECULE INHIBITOR WITH ANTIVIRAL ACTIVITY AGAINST HEPATITIS B VIRUS |
| 820 |
CHARACTERIZATION OF A PORTUGUESE FAMILY WITH CHARCOT-MARIE-TOOTH DISEASE TYPE 1E DUE TO A NOVEL POINT MUTATION IN THE PMP22 GENE |
| 821 |
CHARACTERIZATION OF ACETYLATION OF HISTONE H3 AT LYSINE 9 IN THE TRIGEMINAL GANGLION OF A RAT TRIGEMINAL NEURALGIA MODEL |
| 822 |
CHARACTERIZATION OF BLOOD SURROGATE IMMUNE-METHYLATION BIOMARKERS FOR IMMUNE CELL INFILTRATION IN CHRONIC INFLAMMAGING DISORDERS |
| 823 |
CHARACTERIZATION OF COMPREHENSIVE DYNAMIC EPIGENETIC CHANGES DURING HUMAN PRIMARY SJOGREN'S SYNDROME PROGRESSION |
| 824 |
CHARACTERIZATION OF COPY NUMBER ALTERATIONS IN A MOUSE MODEL OF FIBROSIS-ASSOCIATED HEPATOCELLULAR CARCINOMA REVEALS CONCORDANCE WITH HUMAN DISEASE |
| 825 |
CHARACTERIZATION OF FUNCTIONAL TRANSPOSABLE ELEMENT ENHANCERS IN ACUTE MYELOID LEUKEMIA |
| 826 |
CHARACTERIZATION OF K562 CELLS: UNCOVERING NOVEL CHROMOSOMES, ASSESSING TRANSFERRIN RECEPTOR EXPRESSION, AND PROBING PHARMACOLOGICAL THERAPIES |
| 827 |
CHARACTERIZATION OF LONG NON-CODING RNAS IN SYSTEMIC SCLEROSIS MONOCYTES: A POTENTIAL ROLE FOR PSMB8-AS1 IN ALTERED CYTOKINE SECRETION |
| 828 |
CHARACTERIZATION OF M (6) A MODIFIERS AND RNA MODIFICATIONS IN UTERINE FIBROIDS |
| 829 |
CHARACTERIZATION OF P190-BCR-ABL CHRONIC MYELOID LEUKEMIA REVEALS SPECIFIC SIGNALING PATHWAYS AND THERAPEUTIC TARGETS |
| 830 |
CHARACTERIZATION OF STRESS RESPONSE INVOLVED IN CHICKEN MYOPATHY |
| 831 |
CHARACTERIZATION OF TET AND IDH GENE EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA: COMPARISON WITH NORMAL B CELLS AND PROGNOSTIC SIGNIFICANCE |
| 832 |
CHARACTERIZING OPRM1 DNA METHYLATION IN PRESCRIPTION OPIOID USERS WITH CHRONIC MUSCULOSKELETAL PAIN |
| 833 |
CHARTING A SHARED EPIGENETIC PATHWAY TO CD8(+) T CELL DYSFUNCTION IN INFECTION AND CANCER |
| 834 |
CHEMICAL BIOLOGY OF LYSINE DEMETHYLASES |
| 835 |
CHEMICAL CARCINOGEN MECHANISMS OF ACTION AND IMPLICATIONS FOR TESTING METHODOLOGY |
| 836 |
CHEMICAL TOXICITY AND RADIOACTIVITY OF DEPLETED URANIUM: THE EVIDENCE FROM IN VIVO AND IN VITRO STUDIES |
| 837 |
CHEMICALLY INDUCED RENAL TUBULE TUMORS IN THE LABORATORY RAT AND MOUSE: REVIEW OF THE NCI/NTP DATABASE AND CATEGORIZATION OF RENAL CARCINOGENS BASED ON MECHANISTIC INFORMATION |
| 838 |
CHEMISTRY MEETS BIOLOGY IN COLITIS-ASSOCIATED CARCINOGENESIS |
| 839 |
CHEMO-ENZYMATIC FLUORESCENCE LABELING OF GENOMIC DNA FOR SIMULTANEOUS DETECTION OF GLOBAL 5-METHYLCYTOSINE AND 5-HYDROXYMETHYLCYTOSINE |
| 840 |
CHEMOENZYMATIC LABELING OF DNA METHYLATION PATTERNS FOR SINGLE-MOLECULE EPIGENETIC MAPPING |
| 841 |
CHEMOKINES FORM NANOPARTICLES WITH DNA AND CAN SUPERINDUCE TLR-DRIVEN IMMUNE INFLAMMATION |
| 842 |
CHEMOKINES IN CHRONIC PAIN: CELLULAR AND MOLECULAR MECHANISMS AND THERAPEUTIC POTENTIAL |
| 843 |
CHEMOSENSORY ABILITY AND SENSITIVITY IN HEALTH AND DISEASE: EPIGENETIC REGULATION AND COVID-19 |
| 844 |
CHILDHOOD ALLERGY DISEASE, EARLY DIAGNOSIS, AND THE POTENTIAL OF SALIVARY PROTEIN BIOMARKERS |
| 845 |
CHILDHOOD ATOPIC DERMATITIS: CURRENT DEVELOPMENTS, TREATMENT APPROACHES, AND FUTURE EXPECTATIONS |
| 846 |
CHILDHOOD EXPOSURE TO AMBIENT POLYCYCLIC AROMATIC HYDROCARBONS IS LINKED TO EPIGENETIC MODIFICATIONS AND IMPAIRED SYSTEMIC IMMUNITY IN T CELLS |
| 847 |
CHILDHOOD MALTREATMENT AND HEADACHE DISORDERS |
| 848 |
CHILDHOOD TRAUMA, THE STRESS RESPONSE AND METABOLIC SYNDROME: A FOCUS ON DNA METHYLATION |
| 849 |
CHILDHOOD TRAUMATIZATION IS ASSOCIATED WITH DIFFERENCES IN TRPA1 PROMOTER METHYLATION IN FEMALE PATIENTS WITH MULTISOMATOFORM DISORDER WITH PAIN AS THE LEADING BODILY SYMPTOM |
| 850 |
CHILDREN WITH CHRONIC IMMUNE THROMBOCYTOPENIA EXHIBIT HIGH EXPRESSION OF HUMAN ENDOGENOUS RETROVIRUSES TRIM28 AND SETDB1 |
| 851 |
CHIP-SEQ ANALYSIS OF HUMAN CHRONIC MYELOID LEUKEMIA CELLS |
| 852 |
CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC): A COMPREHENSIVE REVIEW |
| 853 |
CHOLINE, OTHER METHYL-DONORS AND EPIGENETICS |
| 854 |
CHONDROPROTECTIVE EFFECTS OF A HISTONE DEACETYLASE INHIBITOR, PANOBINOSTAT, ON PAIN BEHAVIOR AND CARTILAGE DEGRADATION IN ANTERIOR CRUCIATE LIGAMENT TRANSECTION-INDUCED EXPERIMENTAL OSTEOARTHRITIC RATS |
| 855 |
CHROMATIN ACCESSIBILITY LANDSCAPES OF IMMUNE CELLS IN RHEUMATOID ARTHRITIS NOMINATE MONOCYTES IN DISEASE PATHOGENESIS |
| 856 |
CHROMATIN ACCESSIBILITY MAPPING OF THE STRIATUM IDENTIFIES TYROSINE KINASE FYN AS A THERAPEUTIC TARGET FOR HEROIN USE DISORDER |
| 857 |
CHROMATIN ARCHITECTURE REVEALS CELL TYPE-SPECIFIC TARGET GENES FOR KIDNEY DISEASE RISK VARIANTS |
| 858 |
CHROMATIN DECONDENSATION AND T CELL HYPERRESPONSIVENESS IN DIABETES-ASSOCIATED HYPERGLYCEMIA |
| 859 |
CHROMATIN DYNAMICS IN KIDNEY DEVELOPMENT AND FUNCTION |
| 860 |
CHROMATIN MODIFICATIONS DURING REPAIR OF ENVIRONMENTAL EXPOSURE-INDUCED DNA DAMAGE: A POTENTIAL MECHANISM FOR STABLE EPIGENETIC ALTERATIONS |
| 861 |
CHROMATIN REMODELING FACTOR, INO80, INHIBITS PMAIP1 IN RENAL TUBULAR CELLS VIA EXCHANGE OF HISTONE VARIANT H2A |
| 862 |
CHROMATIN REMODELING IN MONOCYTE AND MACROPHAGE ACTIVATION |
| 863 |
CHROMODOMAIN Y-LIKE PROTEIN-MEDIATED HISTONE CROTONYLATION REGULATES STRESS-INDUCED DEPRESSIVE BEHAVIORS |
| 864 |
CHROMOSOMAL INSTABILITY IN ORAL SQUAMOUS CELL CARCINOMA |
| 865 |
CHRONIC ACRYLAMIDE EXPOSURE IN MALE MICE RESULTS IN ELEVATED DNA DAMAGE IN THE GERMLINE AND HERITABLE INDUCTION OF CYP2E1 IN THE TESTES |
| 866 |
CHRONIC ACTIVATION OF MUC1-C IN WOUND REPAIR PROMOTES PROGRESSION TO CANCER STEM CELLS |
| 867 |
CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION OF T/NK-CELL TYPE MIMICKING CLASSIC HODGKIN LYMPHOMA: CLINICOPATHOLOGIC AND GENETIC FEATURES OF 8 CASES SUPPORTING A VARIANT WITH "HODGKIN/REED-STERNBERG-LIKE" CELLS OF NK PHENOTYPE |
| 868 |
CHRONIC ADVANCED-GLYCATION END PRODUCTS TREATMENT INDUCES TXNIP EXPRESSION AND EPIGENETIC CHANGES IN GLOMERULAR PODOCYTES IN VIVO AND IN VITRO |
| 869 |
CHRONIC AGOMELATINE TREATMENT CORRECTS BEHAVIORAL, CELLULAR, AND BIOCHEMICAL ABNORMALITIES INDUCED BY PRENATAL STRESS IN RATS |
| 870 |
CHRONIC ALCOHOL BINGING INJURES THE LIVER AND OTHER ORGANS BY REDUCING NAD(+) LEVELS REQUIRED FOR SIRTUIN'S DEACETYLASE ACTIVITY |
| 871 |
CHRONIC ALCOHOL EXPOSURE AFFECTS PANCREATIC ACINAR MITOCHONDRIAL THIAMIN PYROPHOSPHATE UPTAKE: STUDIES WITH MOUSE 266-6 CELL LINE AND PRIMARY CELLS |
| 872 |
CHRONIC ALCOHOL EXPOSURE DIFFERENTIALLY ALTERS ONE-CARBON METABOLISM IN RAT LIVER AND BRAIN |
| 873 |
CHRONIC ALCOHOL EXPOSURE INHIBITS BIOTIN UPTAKE BY PANCREATIC ACINAR CELLS: POSSIBLE INVOLVEMENT OF EPIGENETIC MECHANISMS |
| 874 |
CHRONIC ALLERGY SIGNALING: IS IT ALL STRESSED-OUT MITOCHONDRIA? ALLERGIC DISEASES IN GENERAL, AND CHRONIC ALLERGIC INFLAMMATION IN PARTICULAR, ARE ON THE RISE IN THE UNITED STATES AND OTHER DEVELOPED COUNTRIES |
| 875 |
CHRONIC AND TRANSIENT HYPERGLYCEMIA INDUCES CHANGES IN THE EXPRESSION PATTERNS OF IL6 AND ADIPOQ GENES AND THEIR ASSOCIATED EPIGENETIC MODIFICATIONS IN DIFFERENTIATING HUMAN VISCERAL ADIPOCYTES |
| 876 |
CHRONIC ARSENIC INTOXICATION DIAGNOSTIC SCORE (CASIDS) |
| 877 |
CHRONIC BINGE ALCOHOL ADMINISTRATION DYSREGULATES GLOBAL REGULATORY GENE NETWORKS ASSOCIATED WITH SKELETAL MUSCLE WASTING IN SIMIAN IMMUNODEFICIENCY VIRUS-INFECTED MACAQUES |
| 878 |
CHRONIC CADMIUM EXPOSURE AGGRAVATES MALIGNANT PHENOTYPES OF NASOPHARYNGEAL CARCINOMA BY ACTIVATING THE WNT/BETA-CATENIN SIGNALING PATHWAY VIA HYPERMETHYLATION OF THE CASEIN KINASE 1ALPHA PROMOTER |
| 879 |
CHRONIC CHEMOGENETIC STIMULATION OF THE NUCLEUS ACCUMBENS PRODUCES LASTING REDUCTIONS IN BINGE DRINKING AND AMELIORATES ALCOHOL-RELATED MORPHOLOGICAL AND TRANSCRIPTIONAL CHANGES |
| 880 |
CHRONIC CIGARETTE SMOKE-INDUCED EPIGENOMIC CHANGES PRECEDE SENSITIZATION OF BRONCHIAL EPITHELIAL CELLS TO SINGLE-STEP TRANSFORMATION BY KRAS MUTATIONS |
| 881 |
CHRONIC CLOZAPINE TREATMENT RESTRAINS VIA HDAC2 THE PERFORMANCE OF MGLU2 RECEPTOR AGONISM IN A RODENT MODEL OF ANTIPSYCHOTIC ACTIVITY |
| 882 |
CHRONIC COCAINE-INDUCED H3 ACETYLATION AND TRANSCRIPTIONAL ACTIVATION OF CAMKIIALPHA IN THE NUCLEUS ACCUMBENS IS CRITICAL FOR MOTIVATION FOR DRUG REINFORCEMENT |
| 883 |
CHRONIC COCAINE-REGULATED EPIGENOMIC CHANGES IN MOUSE NUCLEUS ACCUMBENS |
| 884 |
CHRONIC COEXPOSURE TO ARSENIC AND ESTROGEN POTENTIATES GENOTOXIC ESTROGEN METABOLIC PATHWAY AND HYPERMETHYLATION OF DNA GLYCOSYLASE MBD4 IN HUMAN PROSTATE EPITHELIAL CELLS |
| 885 |
CHRONIC CONSTRICTION INJURY-INDUCED CHANGES IN CIRCULAR RNA EXPRESSION PROFILING OF THE DORSAL ROOT GANGLION IN A RAT MODEL OF NEUROPATHIC PAIN |
| 886 |
CHRONIC CORTICOSTERONE EXPOSURE INCREASES EXPRESSION AND DECREASES DEOXYRIBONUCLEIC ACID METHYLATION OF FKBP5 IN MICE |
| 887 |
CHRONIC CORTISOL EXPOSURE IN EARLY DEVELOPMENT LEADS TO NEUROENDOCRINE DYSREGULATION IN ADULTHOOD |
| 888 |
CHRONIC DELTA(8)-THC EXPOSURE DIFFERENTLY AFFECTS HISTONE MODIFICATIONS IN THE ADOLESCENT AND ADULT RAT BRAIN |
| 889 |
CHRONIC DIETARY ADMINISTRATION OF VALPROIC ACID PROTECTS NEURONS OF THE RAT NUCLEUS BASALIS MAGNOCELLULARIS FROM IBOTENIC ACID NEUROTOXICITY |
| 890 |
CHRONIC DIETARY EXPOSURE OF ROOSTERS TO A GLYPHOSATE-BASED HERBICIDE INCREASES SEMINAL PLASMA GLYPHOSATE AND AMPA CONCENTRATIONS, ALTERS SPERM PARAMETERS, AND INDUCES METABOLIC DISORDERS IN THE PROGENY |
| 891 |
CHRONIC EFFECTS OF CLOFIBRIC ACID IN ZEBRAFISH (DANIO RERIO): A MULTIGENERATIONAL STUDY |
| 892 |
CHRONIC ETHANOL EXPOSURE ALTERS DNA METHYLATION IN NEURAL STEM CELLS: ROLE OF MOUSE STRAIN AND SEX |
| 893 |
CHRONIC ETHANOL EXPOSURE AND WITHDRAWAL IMPAIR SYNAPTIC GABA(A) RECEPTOR-MEDIATED NEUROTRANSMISSION IN DEEP-LAYER PREFRONTAL CORTEX |
| 894 |
CHRONIC ETHANOL FEEDING ALTERS HEPATOCYTE MEMORY WHICH IS NOT ALTERED BY ACUTE FEEDING |
| 895 |
CHRONIC ETHANOL-MEDIATED HEPATOCYTE APOPTOSIS LINKS TO DECREASED TET1 AND 5-HYDROXYMETHYLCYTOSINE FORMATION |
| 896 |
CHRONIC EXERCISE MEDIATES EPIGENETIC SUPPRESSION OF L-TYPE CA2+ CHANNEL AND BKCA CHANNEL IN MESENTERIC ARTERIES OF HYPERTENSIVE RATS |
| 897 |
CHRONIC EXERCISE TRAINING ACTIVATES HISTONE TURNOVER IN MOUSE SKELETAL MUSCLE FIBERS |
| 898 |
CHRONIC EXPOSURE OF MICE TO BISPHENOL-A ALTERS UTERINE FIBROBLAST GROWTH FACTOR SIGNALING AND LEADS TO ABERRANT EPITHELIAL PROLIFERATION |
| 899 |
CHRONIC EXPOSURE TO A LOW CONCENTRATION OF BISPHENOL A DURING FOLLICLE CULTURE AFFECTS THE EPIGENETIC STATUS OF GERMINAL VESICLES AND METAPHASE II OOCYTES |
| 900 |
CHRONIC EXPOSURE TO ALCOHOL INHIBITS NEW MYELIN GENERATION IN ADULT MOUSE BRAIN |
| 901 |
CHRONIC EXPOSURE TO ANTHROPOGENIC AND CLIMATE RELATED STRESSORS ALTERS TRANSCRIPTIONAL RESPONSES IN THE LIVER OF ZEBRAFISH (DANIO RERIO) ACROSS MULTIPLE GENERATIONS |
| 902 |
CHRONIC EXPOSURE TO ARSENIC, ESTROGEN, AND THEIR COMBINATION CAUSES INCREASED GROWTH AND TRANSFORMATION IN HUMAN PROSTATE EPITHELIAL CELLS POTENTIALLY BY HYPERMETHYLATION-MEDIATED SILENCING OF MLH1 |
| 903 |
CHRONIC EXPOSURE TO BISPHENOL A RESULTED IN ALTERATIONS OF REPRODUCTIVE FUNCTIONS VIA IMMUNE DEFENSE, OXIDATIVE DAMAGE AND DISRUPTION DNA/HISTONE METHYLATION IN MALE RARE MINNOW GOBIOCYPRIS RARUS |
| 904 |
CHRONIC EXPOSURE TO CADMIUM INDUCES DIFFERENTIAL METHYLATION IN MICE SPERMATOZOA |
| 905 |
CHRONIC EXPOSURE TO CANNABINOIDS DURING ADOLESCENCE CAUSES LONG-LASTING BEHAVIORAL DEFICITS IN ADULT MICE |
| 906 |
CHRONIC EXPOSURE TO ENVIRONMENTAL LEVEL PHENANTHRENE INDUCES NON-OBESITY-DEPENDENT INSULIN RESISTANCE IN MALE MICE |
| 907 |
CHRONIC EXPOSURE TO ENVIRONMENTALLY RELEVANT CONCENTRATION OF FLUORIDE ALTERS OGG1 AND RAD51 EXPRESSIONS IN MICE: INVOLVEMENT OF EPIGENETIC REGULATION |
| 908 |
CHRONIC EXPOSURE TO ENVIRONMENTALLY RELEVANT CONCENTRATION OF FLUORIDE IMPAIRS OSTEOBLAST'S COLLAGEN SYNTHESIS AND MATRIX MINERALIZATION: INVOLVEMENT OF EPIGENETIC REGULATION IN SKELETAL FLUOROSIS |
| 909 |
CHRONIC EXPOSURE TO ETHANOL IN MALE MICE MAY BE ASSOCIATED WITH HEARING LOSS IN OFFSPRING |
| 910 |
CHRONIC EXPOSURE TO ETHANOL OF MALE MICE BEFORE MATING PRODUCES ATTENTION DEFICIT HYPERACTIVITY DISORDER-LIKE PHENOTYPE ALONG WITH EPIGENETIC DYSREGULATION OF DOPAMINE TRANSPORTER EXPRESSION IN MOUSE OFFSPRING |
| 911 |
CHRONIC EXPOSURE TO TNF REPROGRAMS CELL SIGNALING PATHWAYS IN FIBROBLAST-LIKE SYNOVIOCYTES BY ESTABLISHING LONG-TERM INFLAMMATORY MEMORY |
| 912 |
CHRONIC EXPOSURE TO WATER POLLUTANT TRICHLOROETHYLENE INCREASED EPIGENETIC DRIFT IN CD4(+) T CELLS |
| 913 |
CHRONIC FLT3-ITD SIGNALING IN ACUTE MYELOID LEUKEMIA IS CONNECTED TO A SPECIFIC CHROMATIN SIGNATURE |
| 914 |
CHRONIC HEAVY DRINKING DRIVES DISTINCT TRANSCRIPTIONAL AND EPIGENETIC CHANGES IN SPLENIC MACROPHAGES |
| 915 |
CHRONIC HEPATITIS B VIRUS AND HEPATITIS C VIRUS INFECTIONS AND CANCER: SYNERGY BETWEEN VIRAL AND HOST FACTORS |
| 916 |
CHRONIC HIGH GLUCOSE AND INSULIN STIMULATE BONE-MARROW STROMAL CELLS ADIPOGENIC DIFFERENTIATION IN YOUNG SPONTANEOUSLY HYPERTENSIVE RATS |
| 917 |
CHRONIC HIGH-FAT DIET DRIVES POSTNATAL EPIGENETIC REGULATION OF MU-OPIOID RECEPTOR IN THE BRAIN |
| 918 |
CHRONIC HYPERGRAVITY INDUCES A MODIFICATION OF HISTONE H3 LYSINE 27 TRIMETHYLATION AT TCRBETA LOCUS IN MURINE THYMOCYTES |
| 919 |
CHRONIC HYPOXIA DURING GESTATION CAUSES EPIGENETIC REPRESSION OF THE ESTROGEN RECEPTOR-ALPHA GENE IN OVINE UTERINE ARTERIES VIA HEIGHTENED PROMOTER METHYLATION |
| 920 |
CHRONIC HYPOXIA FACILITATES ALZHEIMER'S DISEASE THROUGH DEMETHYLATION OF GAMMA-SECRETASE BY DOWNREGULATING DNA METHYLTRANSFERASE 3B |
| 921 |
CHRONIC HYPOXIA-INDUCED CIRBP HYPERMETHYLATION ATTENUATES HYPOTHERMIC CARDIOPROTECTION VIA DOWN-REGULATION OF UBIQUINONE BIOSYNTHESIS |
| 922 |
CHRONIC IL-1BETA-INDUCED INFLAMMATION REGULATES EPITHELIAL-TO-MESENCHYMAL TRANSITION MEMORY PHENOTYPES VIA EPIGENETIC MODIFICATIONS IN NON-SMALL CELL LUNG CANCER |
| 923 |
CHRONIC INFECTION DRIVES DNMT3A-LOSS-OF-FUNCTION CLONAL HEMATOPOIESIS VIA IFNGAMMA SIGNALING |
| 924 |
CHRONIC INFLAMMATION AS A PROMOTOR OF MUTAGENESIS IN ESSENTIAL THROMBOCYTHEMIA, POLYCYTHEMIA VERA AND MYELOFIBROSIS |
| 925 |
CHRONIC INFLAMMATION INDUCES A NOVEL EPIGENETIC PROGRAM THAT IS CONSERVED IN INTESTINAL ADENOMAS AND IN COLORECTAL CANCER |
| 926 |
CHRONIC INFLAMMATION PATHWAY NF-KAPPAB COOPERATES WITH EPIGENETIC REPROGRAMMING TO DRIVE THE MALIGNANT PROGRESSION OF GLIOBLASTOMA |
| 927 |
CHRONIC INFLAMMATION, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, AND LUNG CANCER |
| 928 |
CHRONIC INFLAMMATION, THE TUMOR MICROENVIRONMENT AND CARCINOGENESIS |
| 929 |
CHRONIC INFLAMMATION: ACCELERATOR OF BIOLOGICAL AGING |
| 930 |
CHRONIC IRRADIATION OF HUMAN CELLS REDUCES HISTONE LEVELS AND DEREGULATES GENE EXPRESSION |
| 931 |
CHRONIC KIDNEY DISEASE IN CHILDREN AND THE ROLE OF EPIGENETICS: FUTURE THERAPEUTIC TRAJECTORIES |
| 932 |
CHRONIC KIDNEY DISEASE WITH UNKNOWN CAUSE ACROSS THE GLOBAL SPECTRUM |
| 933 |
CHRONIC KIDNEY DISEASE |
| 934 |
CHRONIC LOW DOSE IRRADIATION ALTERS HEPATIC TRANSCRIPTIONAL PROFILES, BUT NOT GLOBAL DNA METHYLATION IN MEDAKA (ORYZIAS LATIPES) |
| 935 |
CHRONIC LOW-DOSE EXPOSURE TO XENOESTROGEN AMBIENT AIR POLLUTANTS AND BREAST CANCER RISK: XENAIR PROTOCOL FOR A CASE-CONTROL STUDY NESTED WITHIN THE FRENCH E3N COHORT |
| 936 |
CHRONIC LOW-LEVEL PERFLUOROOCTANE SULFONATE (PFOS) EXPOSURE PROMOTES TESTICULAR STEROIDOGENESIS THROUGH ENHANCED HISTONE ACETYLATION |
| 937 |
CHRONIC LYMPHOCYTIC LEUKAEMIA GENOMICS AND THE PRECISION MEDICINE ERA |
| 938 |
CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RISK IS MEDIATED BY MULTIPLE ENHANCER VARIANTS WITHIN CLL RISK LOCI |
| 939 |
CHRONIC LYMPHOCYTIC LEUKEMIA AND 13Q14: MIRS AND MORE |
| 940 |
CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA: CROSSROADS OF GENETIC AND MICROENVIRONMENT INTERACTIONS |
| 941 |
CHRONIC LYMPHOCYTIC LEUKEMIA B-CELL NORMAL CELLULAR COUNTERPART: CLUES FROM A FUNCTIONAL PERSPECTIVE |
| 942 |
CHRONIC LYMPHOCYTIC LEUKEMIA PRESENCE IMPAIRS ANTIGEN-SPECIFIC CD8(+) T-CELL RESPONSES THROUGH EPIGENETIC REPROGRAMMING TOWARDS SHORT-LIVED EFFECTORS |
| 943 |
CHRONIC LYMPHOCYTIC LEUKEMIA |
| 944 |
CHRONIC LYMPHOCYTIC LEUKEMIA: FROM MOLECULAR PATHOGENESIS TO NOVEL THERAPEUTIC STRATEGIES |
| 945 |
CHRONIC LYMPHOCYTIC LEUKEMIA: MOLECULAR HETEROGENEITY REVEALED BY HIGH-THROUGHPUT GENOMICS |
| 946 |
CHRONIC MATERNAL PROTEIN DEPRIVATION IN MICE IS ASSOCIATED WITH OVEREXPRESSION OF THE COHESIN-MEDIATOR COMPLEX IN LIVER OF THEIR OFFSPRING |
| 947 |
CHRONIC MEHG EXPOSURE MODIFIES THE HISTONE H3K4ME3 EPIGENETIC LANDSCAPE IN CAENORHABDITIS ELEGANS |
| 948 |
CHRONIC METABOLIC DERANGEMENT-INDUCED COGNITIVE DEFICITS AND NEUROTOXICITY ARE ASSOCIATED WITH REST INACTIVATION |
| 949 |
CHRONIC METHAMPHETAMINE TREATMENT REDUCES THE EXPRESSION OF SYNAPTIC PLASTICITY GENES AND CHANGES THEIR DNA METHYLATION STATUS IN THE MOUSE BRAIN |
| 950 |
CHRONIC MILD STRESS EXACERBATES SEVERITY OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS IN ASSOCIATION WITH ALTERED NON-CODING RNA AND METABOLIC BIOMARKERS |
| 951 |
CHRONIC MILD STRESS MODIFIED EPIGENETIC MECHANISMS LEADING TO ACCELERATED SENESCENCE AND IMPAIRED COGNITIVE PERFORMANCE IN MICE |
| 952 |
CHRONIC MYELOID LEUKEMIA STEM CELL BIOLOGY |
| 953 |
CHRONIC MYELOID LEUKEMIA STEM CELLS |
| 954 |
CHRONIC MYELOID LEUKEMIA: CURRENT PERSPECTIVES |
| 955 |
CHRONIC MYELOID LEUKEMIA: MECHANISMS OF BLASTIC TRANSFORMATION |
| 956 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA STEM CELL TRANSCRIPTOMES ANTICIPATE DISEASE MORPHOLOGY AND OUTCOME |
| 957 |
CHRONIC MYELOMONOCYTIC LEUKAEMIA: A CONCISE CLINICAL AND PATHOPHYSIOLOGICAL REVIEW |
| 958 |
CHRONIC MYELOMONOCYTIC LEUKEMIA - A REVIEW |
| 959 |
CHRONIC MYELOMONOCYTIC LEUKEMIA AND ATYPICAL CHRONIC MYELOID LEUKEMIA: NOVEL PATHOGENETIC LESIONS |
| 960 |
CHRONIC MYELOMONOCYTIC LEUKEMIA: 2016 UPDATE ON DIAGNOSIS, RISK STRATIFICATION, AND MANAGEMENT |
| 961 |
CHRONIC MYELOMONOCYTIC LEUKEMIA: A GENETIC AND CLINICAL UPDATE |
| 962 |
CHRONIC MYELOMONOCYTIC LEUKEMIA: FOCUS ON CLINICAL PRACTICE |
| 963 |
CHRONIC MYELOMONOCYTIC LEUKEMIA: INSIGHTS INTO BIOLOGY, PROGNOSTIC FACTORS, AND TREATMENT |
| 964 |
CHRONIC MYELOPROLIFERATIVE DISEASES WITH AND WITHOUT THE PH CHROMOSOME: SOME UNRESOLVED ISSUES |
| 965 |
CHRONIC NEURODEGENERATIVE CONSEQUENCES OF TRAUMATIC BRAIN INJURY |
| 966 |
CHRONIC NEUROLOGICAL DISORDERS: GENETIC AND EPIGENETIC MARKERS FOR MONITORING OF PHARMACOTHERAPY |
| 967 |
CHRONIC NICOTINE EXPOSURE AUGMENTS RENAL OXIDATIVE STRESS AND INJURY THROUGH TRANSCRIPTIONAL ACTIVATION OF P66SHC |
| 968 |
CHRONIC NICOTINE EXPOSURE SYSTEMICALLY ALTERS MICRORNA EXPRESSION PROFILES DURING POST-EMBRYONIC STAGES IN CAENORHABDITIS ELEGANS |
| 969 |
CHRONIC NON-BACTERIAL OSTEOMYELITIS IS ASSOCIATED WITH IMPAIRED SP1 SIGNALING, REDUCED IL10 PROMOTER PHOSPHORYLATION, AND REDUCED MYELOID IL-10 EXPRESSION |
| 970 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND LUNG CANCER: COMMON PATHWAYS FOR PATHOGENESIS |
| 971 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE HALLMARKS OF AGING |
| 972 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS ASSOCIATED WITH EPIGENOME-WIDE DIFFERENTIAL METHYLATION IN BAL LUNG CELLS |
| 973 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN UPDATE ON NUCLEAR SIGNALING RELATED TO INFLAMMATION AND ANTI-INFLAMMATORY TREATMENT |
| 974 |
CHRONIC OCCUPATIONAL EXPOSURE ENDURED BY TOBACCO FARMERS FROM BRAZIL AND ASSOCIATION WITH DNA DAMAGE |
| 975 |
CHRONIC OCCUPATIONAL EXPOSURE TO ARSENIC INDUCES CARCINOGENIC GENE SIGNALING NETWORKS AND NEOPLASTIC TRANSFORMATION IN HUMAN LUNG EPITHELIAL CELLS |
| 976 |
CHRONIC OPIOID USE IS ASSOCIATED WITH INCREASED DNA METHYLATION CORRELATING WITH INCREASED CLINICAL PAIN |
| 977 |
CHRONIC ORAL EXPOSURE TO INORGANIC ARSENATE INTERFERES WITH METHYLATION STATUS OF P16INK4A AND RASSF1A AND INDUCES LUNG CANCER IN A/J MICE |
| 978 |
CHRONIC OXIDATIVE STRESS CAUSES ESTROGEN-INDEPENDENT AGGRESSIVE PHENOTYPE, AND EPIGENETIC INACTIVATION OF ESTROGEN RECEPTOR ALPHA IN MCF-7 BREAST CANCER CELLS |
| 979 |
CHRONIC OXIDATIVE STRESS INCREASES RESISTANCE TO DOXORUBICIN-INDUCED CYTOTOXICITY IN RENAL CARCINOMA CELLS POTENTIALLY THROUGH EPIGENETIC MECHANISM |
| 980 |
CHRONIC PAIN: EMERGING EVIDENCE FOR THE INVOLVEMENT OF EPIGENETICS |
| 981 |
CHRONIC PESTICIDE EXPOSURE IN FARM WORKERS IS ASSOCIATED WITH THE EPIGENETIC MODULATION OF HSA-MIR-199A-5P |
| 982 |
CHRONIC PRENATAL HYPOXIA INDUCES EPIGENETIC PROGRAMMING OF PKCEPSILON GENE REPRESSION IN RAT HEARTS |
| 983 |
CHRONIC PROSTATITIS AFFECTS MALE REPRODUCTIVE HEALTH AND IS ASSOCIATED WITH SYSTEMIC AND LOCAL EPIGENETIC INACTIVATION OF C-X-C MOTIF CHEMOKINE 12 RECEPTOR C-X-C CHEMOKINE RECEPTOR TYPE 4 |
| 984 |
CHRONIC PSYCHOLOGICAL STRESS ALTERS GENE EXPRESSION IN RAT COLON EPITHELIAL CELLS PROMOTING CHROMATIN REMODELING, BARRIER DYSFUNCTION AND INFLAMMATION |
| 985 |
CHRONIC RADIATION EXPOSURE AS AN ECOLOGICAL FACTOR: HYPERMETHYLATION AND GENETIC DIFFERENTIATION IN IRRADIATED SCOTS PINE POPULATIONS |
| 986 |
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS (CRMO) AND JUVENILE SPONDYLOARTHRITIS (JSPA): TO WHAT EXTENT ARE THEY RELATED? CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS (CRMO) IS AN AUTOINFLAMMATORY DISEASE OCCURRING MAINLY IN THE PEDIATRIC AGE GROUP (BEFORE 16 YEARS) AND GENERALLY PRESENTS AS A SEPARATE ENTITY |
| 987 |
CHRONIC SCHISTOSOMIASIS DURING PREGNANCY EPIGENETICALLY REPROGRAMS T-CELL DIFFERENTIATION IN OFFSPRING OF INFECTED MOTHERS |
| 988 |
CHRONIC SLEEP DISTURBANCES ALTERS SLEEP STRUCTURE AND TAU PHOSPHORYLATION IN ABETAPP/PS1 AD MICE AND THEIR WILD-TYPE LITTERMATES |
| 989 |
CHRONIC SOCIAL DEFEAT STRESS DIFFERENTIALLY REGULATES THE EXPRESSION OF BDNF TRANSCRIPTS AND EPIGENETIC MODIFYING ENZYMES IN SUSCEPTIBLE AND RESILIENT MICE |
| 990 |
CHRONIC SOCIAL STRESS INDUCES DNA METHYLATION CHANGES AT AN EVOLUTIONARY CONSERVED INTERGENIC REGION IN CHROMOSOME X |
| 991 |
CHRONIC STIMULATION DRIVES HUMAN NK CELL DYSFUNCTION AND EPIGENETIC REPROGRAMING |
| 992 |
CHRONIC STRESS AND ADIPOSE TISSUE IN THE ANOREXIC STATE: ENDOCRINE AND EPIGENETIC MECHANISMS |
| 993 |
CHRONIC STRESS INDUCES PERSISTENT CHANGES IN GLOBAL DNA METHYLATION AND GENE EXPRESSION IN THE MEDIAL PREFRONTAL CORTEX, ORBITOFRONTAL CORTEX, AND HIPPOCAMPUS |
| 994 |
CHRONIC STRESS INDUCES SEX-SPECIFIC ALTERATIONS IN METHYLATION AND EXPRESSION OF CORTICOTROPIN-RELEASING FACTOR GENE IN THE RAT |
| 995 |
CHRONIC STRESS LEADS TO EPIGENETIC DYSREGULATION IN THE NEUROPEPTIDE-Y AND CANNABINOID CB1 RECEPTOR GENES IN THE MOUSE CINGULATE CORTEX |
| 996 |
CHRONIC STRESS, EPIGENETICS, AND ADIPOSE TISSUE METABOLISM IN THE OBESE STATE |
| 997 |
CHRONIC STRESS-DRIVEN GLUCOCORTICOID RECEPTOR ACTIVATION PROGRAMS KEY CELL PHENOTYPES AND FUNCTIONAL EPIGENOMIC PATTERNS IN HUMAN FIBROBLASTS |
| 998 |
CHRONIC SUBCONVULSIVE ACTIVITY DURING EARLY POSTNATAL LIFE PRODUCES AUTISTIC BEHAVIOR IN THE ABSENCE OF NEUROTOXICITY IN THE JUVENILE WEANLING PERIOD |
| 999 |
CHRONIC SUN EXPOSURE IS ASSOCIATED WITH DISTINCT HISTONE ACETYLATION CHANGES IN HUMAN SKIN |
| 1000 |
CHRONIC T CELL RECEPTOR STIMULATION UNMASKS NK RECEPTOR SIGNALING IN PERIPHERAL T CELL LYMPHOMAS VIA EPIGENETIC REPROGRAMMING |
| 1001 |
CHRONIC TCDD EXPOSURE RESULTS IN THE DYSREGULATION OF GENE EXPRESSION IN SPLENIC B-LYMPHOCYTES AND IN THE IMPAIRMENTS IN T-CELL AND B-CELL DIFFERENTIATION IN MOUSE MODEL |
| 1002 |
CHRONIC TREATMENT OF NON-SMALL-CELL LUNG CANCER CELLS WITH GEFITINIB LEADS TO AN EPIGENETIC LOSS OF EPITHELIAL PROPERTIES ASSOCIATED WITH REDUCTIONS IN MICRORNA-155 AND -200C |
| 1003 |
CHRONIC TREATMENT WITH FLUOXETINE INDUCES SEX-DEPENDENT ANALGESIC EFFECTS AND MODULATES HDAC2 AND MGLU2 EXPRESSION IN FEMALE MICE |
| 1004 |
CHRONIC TREATMENT WITH HORMONAL CONTRACEPTIVES ALTERS HIPPOCAMPAL BDNF AND HISTONE H3 POST-TRANSLATIONAL MODIFICATIONS BUT NOT LEARNING AND MEMORY IN FEMALE RATS |
| 1005 |
CHRONIC VARIABLE PHYSICAL STRESS DURING THE PERIPUBERTAL-JUVENILE PERIOD CAUSES DIFFERENTIAL DEPRESSIVE AND ANXIOGENIC EFFECTS IN THE NOVELTY-SEEKING PHENOTYPE: FUNCTIONAL IMPLICATIONS FOR HIPPOCAMPAL AND AMYGDALAR BRAIN-DERIVED NEUROTROPHIC FACTOR AND THE MOSSY FIBRE PLASTICITY |
| 1006 |
CHRONIC VIRAL INFECTION AND PRIMARY CENTRAL NERVOUS SYSTEM MALIGNANCY |
| 1007 |
CHRONIC VIRUS INFECTION ENFORCES DEMETHYLATION OF THE LOCUS THAT ENCODES PD-1 IN ANTIGEN-SPECIFIC CD8(+) T CELLS |
| 1008 |
CHRONIC VOLUNTARY ALCOHOL CONSUMPTION ALTERS PROMOTER METHYLATION AND EXPRESSION OF FGF-2 AND FGFR1 |
| 1009 |
CHRONIC VOLUNTARY ETHANOL DRINKING IN CYNOMOLGUS MACAQUES ELICITS GENE EXPRESSION CHANGES IN PREFRONTAL CORTICAL AREA 46 |
| 1010 |
CHRONICALLY ELEVATED PROLIFERATION AS A RISK FACTOR FOR NEOPLASIA |
| 1011 |
CIGARETTE SMOKE CONDENSATE INDUCES DIFFERENTIAL EXPRESSION AND PROMOTER METHYLATION PROFILES OF CRITICAL GENES INVOLVED IN LUNG CANCER IN NL-20 LUNG CELLS IN VITRO: SHORT-TERM AND CHRONIC EXPOSURE |
| 1012 |
CIGARETTE SMOKE INDUCES DISTINCT HISTONE MODIFICATIONS IN LUNG CELLS: IMPLICATIONS FOR THE PATHOGENESIS OF COPD AND LUNG CANCER |
| 1013 |
CIGARETTE SMOKE-INDUCED INFLAMMATION: NLRP10-MEDIATED MECHANISMS |
| 1014 |
CIGARETTE SMOKING AND DNA METHYLATION |
| 1015 |
CIGARETTE SMOKING CAUSES EPIGENETIC CHANGES ASSOCIATED WITH CARDIORENAL FIBROSIS |
| 1016 |
CIITA EXPRESSION IS REGULATED BY HISTONE DEACETYLASE ENZYMES AND HAS A ROLE IN ALPHA-SYNUCLEIN PRE-FORMED FIBRIL-INDUCED ANTIGEN PRESENTATION IN MURINE MICROGLIAL CELL LINE |
| 1017 |
CIRCADIAN RHYTHMS IN LIVER PHYSIOLOGY AND LIVER DISEASES |
| 1018 |
CIRCFHIT MODULATES GABAERGIC SYNAPTIC TRANSMISSION VIA REGULATING THE PARENTAL GENE FHIT EXPRESSION IN THE SPINAL DORSAL HORN IN A RAT MODEL OF NEUROPATHIC PAIN |
| 1019 |
CIRCRNA-MIRNA CROSS-TALK IN THE TRANSITION FROM PAROXYSMAL TO PERMANENT ATRIAL FIBRILLATION |
| 1020 |
CIRCRNAS IN ATHEROSCLEROSIS, WITH SPECIAL EMPHASIS ON THE SPONGY EFFECT OF CIRCRNAS ON MIRNAS |
| 1021 |
CIRCULAR RNA AS AN EPIGENETIC REGULATOR IN CHRONIC LIVER DISEASES |
| 1022 |
CIRCULAR RNA HSA_CIRC_0098181 INHIBITS METASTASIS IN HEPATOCELLULAR CARCINOMA BY ACTIVATING THE HIPPO SIGNALING PATHWAY VIA INTERACTION WITH EEF2 |
| 1023 |
CIRCULATING MICRORNA PROFILES FOR PREMATURE CARDIOVASCULAR DEATH IN PATIENTS WITH KIDNEY FAILURE WITH REPLACEMENT THERAPY |
| 1024 |
CIRCULATING MICRORNAS 34A, 122, AND 192 ARE LINKED TO OBESITY-ASSOCIATED INFLAMMATION AND METABOLIC DISEASE IN PEDIATRIC PATIENTS |
| 1025 |
CIRCULATING MIRNAS ARE ASSOCIATED WITH INFLAMMATION BIOMARKERS IN CHILDREN WITH OVERWEIGHT AND OBESITY: RESULTS OF THE I |
| 1026 |
CIRCULATING MIRNAS EXPRESSION IN MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME |
| 1027 |
CIRCULATING MIRNAS IN SUCCESSFUL AND UNSUCCESSFUL AGING |
| 1028 |
CIRCULATING MIRNAS RELATED TO EPITHELIAL-MESENCHYMAL TRANSITIONS (EMT) AS THE NEW MOLECULAR MARKERS IN ENDOMETRIOSIS |
| 1029 |
CIRCULATING PLASMA MICRORNA IN PATIENTS WITH ACTIVE ACROMEGALY |
| 1030 |
CIRCULATING PLASMA MICRORNAS DYSREGULATION AND METABOLIC ENDOTOXEMIA INDUCED BY A HIGH-FAT HIGH-SATURATED DIET |
| 1031 |
CIRCULATING TUMOR DNA DETECTION AND ITS APPLICATION STATUS IN GASTRIC CANCER: A NARRATIVE REVIEW |
| 1032 |
CISPLATIN NEPHROTOXICITY: NEW INSIGHTS AND THERAPEUTIC IMPLICATIONS |
| 1033 |
CITRULLINATION OF AUTOANTIGENS IMPLICATES NETOSIS IN THE INDUCTION OF AUTOIMMUNITY |
| 1034 |
CKD IN ABORIGINAL AUSTRALIANS |
| 1035 |
CLASS I HISTONE DEACETYLASE INHIBITION IMPROVES PANCREATITIS OUTCOME BY LIMITING LEUKOCYTE RECRUITMENT AND ACINAR-TO-DUCTAL METAPLASIA |
| 1036 |
CLASS I HISTONE DEACETYLASES REGULATE P53/NF-KAPPAB CROSSTALK IN CANCER CELLS |
| 1037 |
CLASSIFICATION AND DIAGNOSIS OF TEMPOROMANDIBULAR DISORDERS AND TEMPOROMANDIBULAR DISORDER PAIN |
| 1038 |
CLINACANTHUS NUTANS EXTRACTS MODULATE EPIGENETIC LINK TO CYTOSOLIC PHOSPHOLIPASE A2 EXPRESSION IN SH-SY5Y CELLS AND PRIMARY CORTICAL NEURONS |
| 1039 |
CLINICAL AND BIOLOGICAL IMPLICATIONS OF DRIVER MUTATIONS IN MYELODYSPLASTIC SYNDROMES |
| 1040 |
CLINICAL AND GENETIC CHARACTERIZATION OF EPSTEIN-BARR VIRUS-ASSOCIATED T/NK-CELL LYMPHOPROLIFERATIVE DISEASES |
| 1041 |
CLINICAL AND MOLECULAR ASPECTS OF LEAD TOXICITY: AN UPDATE |
| 1042 |
CLINICAL AND MOLECULAR BASIS OF HEPATOCELLULAR CARCINOMA AFTER HEPATITIS C VIRUS ERADICATION |
| 1043 |
CLINICAL CHARACTERISTICS AND WHOLE EXOME/TRANSCRIPTOME SEQUENCING OF COEXISTING CHRONIC MYELOID LEUKEMIA AND MYELOFIBROSIS |
| 1044 |
CLINICAL CHARACTERISTICS OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ASSOCIATED WITH NON-HODGKIN B-CELL LYMPHOMA: A MULTICENTER RETROSPECTIVE STUDY |
| 1045 |
CLINICAL CORRELATION AMONG MALE INFERTILITY AND OVERALL MALE HEALTH: A SYSTEMATIC REVIEW OF THE LITERATURE |
| 1046 |
CLINICAL DEVELOPMENT OF DECITABINE AS A PROTOTYPE FOR AN EPIGENETIC DRUG PROGRAM |
| 1047 |
CLINICAL EFFECT AND BIOLOGICAL MECHANISM OF EXERCISE FOR RHEUMATOID ARTHRITIS: A MINI REVIEW |
| 1048 |
CLINICAL EPIGENETICS AND ACUTE/CHRONIC REJECTION IN SOLID ORGAN TRANSPLANTATION: AN UPDATE |
| 1049 |
CLINICAL EPIGENOMIC EXPLANATION OF THE EPIDEMIOLOGY OF CANNABINOID GENOTOXICITY MANIFESTING AS TRANSGENERATIONAL TERATOGENESIS, CANCEROGENESIS AND AGING ACCELERATION |
| 1050 |
CLINICAL FEATURES ASSOCIATED TO REFRACTORY OBSESSIVE-COMPULSIVE DISORDER |
| 1051 |
CLINICAL IMPLICATIONS OF EXOSOME-DERIVED NONCODING RNAS IN LIVER |
| 1052 |
CLINICAL IMPLICATIONS OF HEPATITIS B VIRUS RNA AND COVALENTLY CLOSED CIRCULAR DNA IN MONITORING PATIENTS WITH CHRONIC HEPATITIS B TODAY WITH A GAZE INTO THE FUTURE: THE FIELD IS UNPREPARED FOR A STERILIZING CURE |
| 1053 |
CLINICAL IMPLICATIONS OF INTERFERON-GAMMA GENETIC AND EPIGENETIC VARIANTS |
| 1054 |
CLINICAL IMPLICATIONS OF T CELL EXHAUSTION FOR CANCER IMMUNOTHERAPY |
| 1055 |
CLINICAL INTEGRATION OF GENOME DIAGNOSTICS FOR CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT |
| 1056 |
CLINICAL MANIFESTATIONS AND EPIGENETIC MECHANISMS OF GASTRIC MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA AND LONG-TERM FOLLOW-UP FOLLOWING HELICOBACTER PYLORI ERADICATION |
| 1057 |
CLINICAL MANIFESTATIONS AND EPIGENETIC REGULATION OF ORAL HERPESVIRUS INFECTIONS |
| 1058 |
CLINICAL MEASURES OF ALLOSTATIC LOAD IN CHILDREN AND ADOLESCENTS WITH FOOD ALLERGY, DEPRESSION, OR ANXIETY |
| 1059 |
CLINICAL PERSPECTIVES OF NON-CODING RNA IN ORAL INFLAMMATORY DISEASES AND NEUROPATHIC PAIN: A NARRATIVE REVIEW |
| 1060 |
CLINICAL RELEVANCE OF EPIGENETIC DYSREGULATION IN CHRONIC KIDNEY DISEASE-ASSOCIATED CARDIOVASCULAR DISEASE |
| 1061 |
CLINICAL REMISSION OF SIGHT-THREATENING NON-INFECTIOUS UVEITIS IS CHARACTERIZED BY AN UPREGULATION OF PERIPHERAL T-REGULATORY CELL POLARIZED TOWARDS T-BET AND TIGIT |
| 1062 |
CLINICAL SIGNIFICANCE OF DNA METHYLATION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: RESULTS FROM 3 UK CLINICAL TRIALS |
| 1063 |
CLINICAL SIGNIFICANCE OF MICRORNAS IN CHRONIC AND ACUTE HUMAN LEUKEMIA |
| 1064 |
CLINICAL SIGNIFICANCE OF PROMOTER METHYLATION STATUS OF TUMOR SUPPRESSOR GENES IN CIRCULATING DNA OF PANCREATIC CANCER PATIENTS |
| 1065 |
CLINICAL SIGNIFICANCE OF SERUM DRAM1 MRNA, ARSA MRNA, HSA-MIR-2053 AND LNCRNA-RP1-86D1 |
| 1066 |
CLINICAL USE OF AMINO ACIDS AS DIETARY SUPPLEMENT: PROS AND CONS |
| 1067 |
CLINICAL UTILITY OF PDSS2 EXPRESSION TO STRATIFY PATIENTS AT RISK FOR RECURRENCE OF HEPATOCELLULAR CARCINOMA |
| 1068 |
CLL INTRACLONAL FRACTIONS EXHIBIT ESTABLISHED AND RECENTLY ACQUIRED PATTERNS OF DNA METHYLATION |
| 1069 |
CLOFARABINE?PHYTOCHEMICAL COMBINATION EXPOSURES IN CML CELLS INHIBIT DNA METHYLATION MACHINERY, UPREGULATE TUMOR SUPPRESSOR GENES AND PROMOTE CASPASE?DEPENDENT APOPTOSIS |
| 1070 |
CLONAL ARCHITECTURE OF CHRONIC MYELOMONOCYTIC LEUKEMIAS |
| 1071 |
CLONAL DYNAMICS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1072 |
CLONAL EVOLUTION IN A CHRONIC NEUTROPHILIC LEUKEMIA PATIENT |
| 1073 |
CLONAL HAEMATOPOIESIS AND DYSREGULATION OF THE IMMUNE SYSTEM |
| 1074 |
CLONAL HAEMATOPOIESIS IN CHRONIC ISCHAEMIC HEART FAILURE: PROGNOSTIC ROLE OF CLONE SIZE FOR DNMT3A- AND TET2-DRIVER GENE MUTATIONS |
| 1075 |
CLONAL HEMATOPOIESIS DRIVEN BY DNMT3A AND TET2 MUTATIONS: ROLE IN MONOCYTE AND MACROPHAGE BIOLOGY AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE |
| 1076 |
CLONAL HEMATOPOIESIS IN MYELOPROLIFERATIVE NEOPLASMS CONFERS A PREDISPOSITION TO BOTH THROMBOSIS AND CANCER |
| 1077 |
CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP): LINKING SOMATIC MUTATIONS, HEMATOPOIESIS, CHRONIC INFLAMMATION AND CARDIOVASCULAR DISEASE |
| 1078 |
CLONAL NON-MALIGNANT HEMATOLOGICAL DISORDERS: UNRAVELING MOLECULAR PATHOGENIC MECHANISMS TO DEVELOP NOVEL TARGETED THERAPEUTICS |
| 1079 |
CLONAL XENOBIOTIC RESISTANCE DURING POLLUTION-INDUCED TOXIC INJURY AND HEPATOCELLULAR CARCINOGENESIS IN LIVER OF FEMALE FLOUNDER (PLATICHTHYS FLESUS (L |
| 1080 |
CLOSED COMPLETE GENOME SEQUENCES OF TWO NONTYPEABLE HAEMOPHILUS INFLUENZAE STRAINS CONTAINING NOVEL MODA ALLELES FROM THE SPUTUM OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 1081 |
CLUSTERED PROTOCADHERINS METHYLATION ALTERATIONS IN CANCER |
| 1082 |
CML - NOT ONLY BCR-ABL1 MATTERS |
| 1083 |
CNL AND ACML SHOULD BE CONSIDERED AS A SINGLE ENTITY BASED ON MOLECULAR PROFILES AND OUTCOMES |
| 1084 |
CO-OCCURRENCE OF PROTEIN CROTONYLATION AND 2-HYDROXYISOBUTYRYLATION IN THE PROTEOME OF END-STAGE RENAL DISEASE |
| 1085 |
COAGGREGATION OF ASTHMA AND TYPE 1 DIABETES IN CHILDREN: A NARRATIVE REVIEW |
| 1086 |
COCAINE ADMINISTRATION AND ITS WITHDRAWAL ENHANCE THE EXPRESSION OF GENES ENCODING HISTONE-MODIFYING ENZYMES AND HISTONE ACETYLATION IN THE RAT PREFRONTAL CORTEX |
| 1087 |
COCAINE ALTERS THE MOUSE TESTICULAR EPIGENOME WITH DIRECT IMPACT ON HISTONE ACETYLATION AND DNA METHYLATION MARKS |
| 1088 |
COCAINE DIRECTLY IMPAIRS MEMORY EXTINCTION AND ALTERS BRAIN DNA METHYLATION DYNAMICS IN HONEY BEES |
| 1089 |
COCAINE-RELATED DNA METHYLATION IN CAUDATE NEURONS ALTERS 3D CHROMATIN STRUCTURE OF THE IRXA GENE CLUSTER |
| 1090 |
COGNITIVE EFFECTS OF THE BET PROTEIN INHIBITOR APABETALONE: A PRESPECIFIED MONTREAL COGNITIVE ASSESSMENT ANALYSIS NESTED IN THE BETONMACE RANDOMIZED CONTROLLED TRIAL |
| 1091 |
COGNITIVE ENHANCERS AS A TREATMENT FOR HEROIN RELAPSE AND ADDICTION |
| 1092 |
COHESIN MUTATIONS IN MYELOID MALIGNANCIES |
| 1093 |
COHESIN RAD21 GENE PROMOTER METHYLATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1094 |
COHORT PROFILE: THE DUTCH FAMINE BIRTH COHORT (DFBC)- A PROSPECTIVE BIRTH COHORT STUDY IN THE NETHERLANDS |
| 1095 |
COHORT PROFILE: THE EWHA BIRTH AND GROWTH STUDY |
| 1096 |
COINCUBATION OF SPERM WITH EPIDIDYMAL EXTRACELLULAR VESICLE PREPARATIONS FROM CHRONIC INTERMITTENT ETHANOL-TREATED MICE IS SUFFICIENT TO IMPART ANXIETY-LIKE AND ETHANOL-INDUCED BEHAVIORS TO ADULT PROGENY |
| 1097 |
COLLABORATIVE MOLECULAR EPIDEMIOLOGY STUDY OF METABOLIC DYSREGULATION, DNA METHYLATION, AND BREAST CANCER RISK AMONG NIGERIAN WOMEN: MEND STUDY OBJECTIVES AND DESIGN |
| 1098 |
COLLATERAL DAMAGE: MATERNAL OBESITY DURING PREGNANCY CONTINUES TO RISE |
| 1099 |
COLONIC CARCINOGENESIS IN IBD: MOLECULAR EVENTS |
| 1100 |
COMBINATION OF MYELOPROLIFERATIVE NEOPLASM DRIVER GENE ACTIVATION WITH MUTATIONS OF SPLICE FACTOR OR EPIGENETIC MODIFIER GENES INCREASES RISK OF RAPID BLASTIC PROGRESSION |
| 1101 |
COMBINATION THERAPY USING LHRH AND SOMATOSTATIN ANALOGUES PLUS DEXAMETHASONE IN ANDROGEN ABLATION REFRACTORY PROSTATE CANCER PATIENTS WITH BONE INVOLVEMENT: A BENCH TO BEDSIDE APPROACH |
| 1102 |
COMBINED CHEMOSENSITIVITY AND CHROMATIN PROFILING PRIORITIZES DRUG COMBINATIONS IN CLL |
| 1103 |
COMBINED DUAL EFFECT OF MODULATION OF HUMAN NEUTROPHILS' OXIDATIVE BURST AND INHIBITION OF COLON CANCER CELLS PROLIFERATION BY HYDROXYCINNAMIC ACID DERIVATIVES |
| 1104 |
COMBINED EXPOSURE TO PROTONS AND (56)FE LEADS TO OVEREXPRESSION OF IL13 AND REACTIVATION OF REPETITIVE ELEMENTS IN THE MOUSE LUNG |
| 1105 |
COMBINED INHIBITION OF HISTONE DEACETYLASES AND BET FAMILY PROTEINS AS EPIGENETIC THERAPY FOR NERVE INJURY-INDUCED NEUROPATHIC PAIN |
| 1106 |
COMBINED TOXICITY OF ENDOCRINE-DISRUPTING CHEMICALS: A REVIEW |
| 1107 |
COMBINING CYTOGENETIC AND EPIGENETIC APPROACHES IN CHRONIC LYMPHOCYTIC LEUKEMIA IMPROVES PROGNOSIS PREDICTION FOR PATIENTS WITH ISOLATED 13Q DELETION |
| 1108 |
COMMENTARY ON SOME RECENT THESES RELEVANT TO COMBATING AGING: JUNE 2021 |
| 1109 |
COMMERCIAL PROCESSED SOY-BASED FOOD PRODUCT CONTAINS GLYCATED AND GLYCOXIDATED LUNASIN PROTEOFORMS |
| 1110 |
COMMON GENETIC POLYMORPHISMS INFLUENCE BLOOD BIOMARKER MEASUREMENTS IN COPD |
| 1111 |
COMMON MICRORNAS IN EPILEPSY AND MIGRAINE: THEIR POSSIBILITY AS CANDIDATES FOR BIOMARKERS AND THERAPEUTIC TARGETS DURING COMORBID ONSET OF BOTH CONDITIONS |
| 1112 |
COMMON PATHOGENETIC MECHANISMS UNDERLYING AGING AND TUMOR AND MEANS OF INTERVENTIONS |
| 1113 |
COMMON PATHWAYS IN IDIOPATHIC PULMONARY FIBROSIS AND CANCER |
| 1114 |
COMMONALITIES AND DISPARITIES BETWEEN ENDOMETRIOSIS AND CHRONIC ENDOMETRITIS: THERAPEUTIC POTENTIAL OF NOVEL ANTIBIOTIC TREATMENT STRATEGY AGAINST ECTOPIC ENDOMETRIUM |
| 1115 |
COMPARATIVE ANALYSIS OF EPIGENETIC VARIABILITY IN TWO PINE SPECIES EXPOSED TO CHRONIC RADIATION IN THE CHERNOBYL AND FUKUSHIMA AFFECTED ZONES |
| 1116 |
COMPARATIVE ANALYSIS OF NEUROECTODERMAL DIFFERENTIATION CAPACITY OF HUMAN BONE MARROW STROMAL CELLS USING VARIOUS CONVERSION PROTOCOLS |
| 1117 |
COMPARATIVE AND EXPERIMENTAL STUDIES ON THE GENES ALTERED BY CHRONIC HYPOXIA IN HUMAN BRAIN MICROENDOTHELIAL CELLS |
| 1118 |
COMPARATIVE GENOTYPING AND PHENOTYPING OF ASPERGILLUS FUMIGATUS ISOLATES FROM HUMANS, DOGS AND THE ENVIRONMENT |
| 1119 |
COMPARATIVE TRANSCRIPTOME AND METHYLOME ANALYSIS IN HUMAN SKELETAL MUSCLE ANABOLISM, HYPERTROPHY AND EPIGENETIC MEMORY |
| 1120 |
COMPARISON OF DIFFERENT HISTONE DEACETYLASE INHIBITORS IN ATTENUATING INFLAMMATORY PAIN IN RATS |
| 1121 |
COMPARISON OF EPIGENETIC PROFILES OF HUMAN ORAL EPITHELIAL CELLS FROM HIV-POSITIVE (ON HAART) AND HIV-NEGATIVE SUBJECTS |
| 1122 |
COMPARISON OF GENE EXPRESSION PROFILES IN CHROMATE TRANSFORMED BEAS-2B CELLS |
| 1123 |
COMPLEMENT COMPONENT C5A INDUCES ABERRANT EPIGENETIC MODIFICATIONS IN RENAL TUBULAR EPITHELIAL CELLS ACCELERATING SENESCENCE BY WNT4/BETACATENIN SIGNALING AFTER ISCHEMIA/REPERFUSION INJURY |
| 1124 |
COMPLETE GENOME SEQUENCE OF MORAXELLA CATARRHALIS STRAIN CCRI-195ME, ISOLATED FROM THE MIDDLE EAR |
| 1125 |
COMPLEX INHIBITION OF AUTOPHAGY BY MITOCHONDRIAL ALDEHYDE DEHYDROGENASE SHORTENS LIFESPAN AND EXACERBATES CARDIAC AGING |
| 1126 |
COMPLEX REGULATION OF THE REGULATOR OF SYNAPTIC PLASTICITY HISTONE DEACETYLASE 2 IN THE RODENT DORSAL HORN AFTER PERIPHERAL INJURY |
| 1127 |
COMPOUND COMBINATIONS TARGETING LONGEVITY: CHALLENGES AND PERSPECTIVES |
| 1128 |
COMPREHENSIVE ANALYSIS OF EPIGENETIC AND EPITRANSCRIPTOMIC GENES' EXPRESSION IN HUMAN NAFLD |
| 1129 |
COMPREHENSIVE ANALYSIS OF MRNA-LNCRNA CO-EXPRESSION PROFILES IN MOUSE BRAIN DURING INFECTION WITH TOXOPLASMA GONDII |
| 1130 |
COMPREHENSIVE ANALYSIS OF TRANSCRIPTOME-WIDE M(6)A METHYLOME IN THE LUNG TISSUES OF MICE WITH ACUTE PARTICULATE MATTER EXPOSURE |
| 1131 |
COMPREHENSIVE CIRCULAR RNA EXPRESSION PROFILING WITH ASSOCIATED CERNA NETWORK REVEALS THEIR THERAPEUTIC POTENTIAL IN CHOLESTEATOMA |
| 1132 |
COMPREHENSIVE DNA METHYLATION ANALYSIS USING A METHYL-CPG-BINDING DOMAIN CAPTURE-BASED METHOD IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS |
| 1133 |
COMPREHENSIVE EPIGENOMIC PROFILING OF HUMAN ALVEOLAR EPITHELIAL DIFFERENTIATION IDENTIFIES KEY EPIGENETIC STATES AND TRANSCRIPTION FACTOR CO-REGULATORY NETWORKS FOR MAINTENANCE OF DISTAL LUNG IDENTITY |
| 1134 |
COMPREHENSIVE GENETIC AND EPIGENETIC ANALYSIS OF OCCULT HEPATITIS B FROM LIVER TISSUE SAMPLES |
| 1135 |
COMPREHENSIVE MULTI-OMICS ANALYSIS REVEALS MITOCHONDRIAL STRESS AS A CENTRAL BIOLOGICAL HUB FOR SPACEFLIGHT IMPACT |
| 1136 |
COMPREHENSIVE OVERVIEW OF MICRORNA FUNCTION IN RHEUMATOID ARTHRITIS |
| 1137 |
COMPREHENSIVE PHENOTYPING IN INFLAMMATORY BOWEL DISEASE: SEARCH FOR BIOMARKER ALGORITHMS IN THE TRANSKINGDOM INTERACTIONS CONTEXT |
| 1138 |
COMPUTATIONAL METHODS FOR DETECTION OF DIFFERENTIALLY METHYLATED REGIONS USING KERNEL DISTANCE AND SCAN STATISTICS |
| 1139 |
COMPUTATIONAL METHODS FOR EPIGENETIC DRUG DISCOVERY: A FOCUS ON ACTIVITY LANDSCAPE MODELING |
| 1140 |
CONCENTRATION OF FOLIC ACID (FA) IN SERUM OF JAPANESE PREGNANT WOMEN |
| 1141 |
CONCERTED CELL AND IN VIVO SCREEN FOR PANCREATIC DUCTAL ADENOCARCINOMA (PDA) CHEMOTHERAPEUTICS |
| 1142 |
CONCISE REVIEW: CHRONIC MYELOID LEUKEMIA: STEM CELL NICHE AND RESPONSE TO PHARMACOLOGIC TREATMENT |
| 1143 |
CONCISE REVIEW: CLINICAL PROSPECTS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH REGENERATIVE APPROACHES |
| 1144 |
CONCOMITANT HETEROCHROMATINISATION AND DOWN-REGULATION OF GENE EXPRESSION UNVEILS EPIGENETIC SILENCING OF RELB IN AN AGGRESSIVE SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA IN MALES |
| 1145 |
CONCURRENT DIAGNOSIS OF ADENOMYOSIS AND CONGENITAL UTERINE ANOMALIES: A REVIEW |
| 1146 |
CONCURRENT EPIGENETIC SILENCING OF WNT/BETA-CATENIN PATHWAY INHIBITOR GENES IN B CELL CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 1147 |
CONDYLE MODELING STABILITY, CRANIOFACIAL ASYMMETRY AND ACTN3 GENOTYPES: CONTRIBUTION TO TMD PREVALENCE IN A COHORT OF DENTOFACIAL DEFORMITIES |
| 1148 |
CONGENITAL HYPOTHYROIDISM AND THYROID CANCER |
| 1149 |
CONNECTING THE IMMUNE SYSTEM, SYSTEMIC CHRONIC INFLAMMATION AND THE GUT MICROBIOME: THE ROLE OF SEX |
| 1150 |
CONNECTION BETWEEN INFLAMMATION AND CARCINOGENESIS IN GASTROINTESTINAL TRACT: FOCUS ON TGF-BETA SIGNALING |
| 1151 |
CONNECTIONS AMONG BIOLOGIC EMBEDDING OF CHILDHOOD ADVERSITY, ADULT CHRONIC ILLNESS, AND WOUND CARE: A REVIEW OF THE LITERATURE |
| 1152 |
CONSEQUENCES OF EARLY LIFE PROGRAMING BY GENETIC AND ENVIRONMENTAL INFLUENCES: A SYNTHESIS REGARDING PUBERTAL TIMING |
| 1153 |
CONSEQUENCES OF PATERNAL NUTRITION ON OFFSPRING HEALTH AND DISEASE |
| 1154 |
CONSERVED DNA METHYLATION PATTERNS IN HEALTHY BLOOD CELLS AND EXTENSIVE CHANGES IN LEUKEMIA MEASURED BY A NEW QUANTITATIVE TECHNIQUE |
| 1155 |
CONSIDERING MATERNAL DIETARY MODULATORS FOR EPIGENETIC REGULATION AND PROGRAMMING OF THE FETAL EPIGENOME |
| 1156 |
CONSIDERING THE USE OF THE TERMS STRAIN AND ADAPTATION IN PRION RESEARCH |
| 1157 |
CONTAMINANT METALS AS CARDIOVASCULAR RISK FACTORS: A SCIENTIFIC STATEMENT FROM THE AMERICAN HEART ASSOCIATION |
| 1158 |
CONTEXT-DEPENDENT EPIGENETIC REGULATION OF NUCLEAR FACTOR OF ACTIVATED T CELLS 1 IN PANCREATIC PLASTICITY |
| 1159 |
CONTEXTUAL MODIFIERS OF HEALTHSPAN, LIFESPAN, AND EPIGENOME IN MICE UNDER CHRONIC SOCIAL STRESS |
| 1160 |
CONTINUING WAR ON PAIN: A PERSONALIZED APPROACH TO THE THERAPY WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND OPIOIDS |
| 1161 |
CONTINUOUS DEVELOPMENTAL AND EARLY LIFE TRICHLOROETHYLENE EXPOSURE PROMOTED DNA METHYLATION ALTERATIONS IN POLYCOMB PROTEIN BINDING SITES IN EFFECTOR/MEMORY CD4(+) T CELLS |
| 1162 |
CONTRASTING EFFECTS OF ACUTE AND CHRONIC STRESS ON THE TRANSCRIPTOME, EPIGENOME, AND IMMUNE RESPONSE OF ATLANTIC SALMON |
| 1163 |
CONTRIBUTION OF AMYGDALA HISTONE ACETYLATION IN EARLY LIFE STRESS-INDUCED VISCERAL HYPERSENSITIVITY AND EMOTIONAL COMORBIDITY |
| 1164 |
CONTRIBUTION OF CHRONIC MYELOID LEUKAEMIA (CML) AS A DISEASE MODEL TO DEFINE AND STUDY CLONAL HETEROGENEITY |
| 1165 |
CONTRIBUTION OF DNA METHYLATION TO THE PATHOGENESIS OF SJOGREN'S SYNDROME: A REVIEW |
| 1166 |
CONTRIBUTION OF DNMT1 TO NEUROPATHIC PAIN GENESIS PARTIALLY THROUGH EPIGENETICALLY REPRESSING KCNA2 IN PRIMARY AFFERENT NEURONS |
| 1167 |
CONTRIBUTION OF DORSAL ROOT GANGLION OCTAMER TRANSCRIPTION FACTOR 1 TO NEUROPATHIC PAIN AFTER PERIPHERAL NERVE INJURY |
| 1168 |
CONTRIBUTION OF EPITHELIAL AND GUT MICROBIOME INFLAMMATORY BIOMARKERS TO THE IMPROVEMENT OF COLORECTAL CANCER PATIENTS' STRATIFICATION |
| 1169 |
CONTRIBUTION OF GENETIC, EPIGENETIC AND TRANSCRIPTOMIC DIFFERENCES TO TWIN DISCORDANCE IN MULTIPLE SCLEROSIS |
| 1170 |
CONTRIBUTION OF GENETICS AND EPIGENETICS TO PROGRESSION OF KIDNEY FIBROSIS |
| 1171 |
CONTRIBUTION OF MATURE HEPATOCYTES TO BILIARY REGENERATION IN RATS WITH ACUTE AND CHRONIC BILIARY INJURY |
| 1172 |
CONTRIBUTION OF THE ENVIRONMENT, EPIGENETIC MECHANISMS AND NON-CODING RNAS IN PSORIASIS |
| 1173 |
CONTRIBUTION OF TLR SIGNALING TO THE PATHOGENESIS OF COLITIS-ASSOCIATED CANCER IN INFLAMMATORY BOWEL DISEASE |
| 1174 |
CONTRIBUTION OF TRANSPOSABLE ELEMENTS TO TRANSGENERATIONAL EFFECTS OF CHRONIC RADIOACTIVE EXPOSURE OF NATURAL POPULATIONS OF DROSOPHILA MELANOGASTER LIVING FOR A LONG TIME IN THE ZONE OF THE CHERNOBYL NUCLEAR DISASTER |
| 1175 |
CONTRIBUTIONS OF AGE-RELATED THYMIC INVOLUTION TO IMMUNOSENESCENCE AND INFLAMMAGING |
| 1176 |
CONTROL OF APOBEC3B INDUCTION AND CCCDNA DECAY BY NF-KAPPAB AND MIR-138-5P |
| 1177 |
CONTROL OF BREATHING AND THE CIRCULATION IN HIGH-ALTITUDE MAMMALS AND BIRDS |
| 1178 |
CONTROL OF CCCDNA FUNCTION IN HEPATITIS B VIRUS INFECTION |
| 1179 |
CONVERGENCE AND DIVERGENCE IN THE ETIOLOGY OF MYELIN IMPAIRMENT IN PSYCHIATRIC DISORDERS AND DRUG ADDICTION |
| 1180 |
CONVERGENCE OF GENETIC, NUTRITIONAL AND INFLAMMATORY FACTORS IN GASTROINTESTINAL CANCERS |
| 1181 |
CONVERGENT ACTIONS OF STRESS AND STIMULANTS VIA EPIGENETIC REGULATION OF NEURAL CIRCUITRY |
| 1182 |
CONVERGING AND DIFFERENTIAL BRAIN PHOSPHOLIPID DYSREGULATION IN THE PATHOGENESIS OF REPETITIVE MILD TRAUMATIC BRAIN INJURY AND ALZHEIMER'S DISEASE |
| 1183 |
CONVERGING RELATIONSHIPS OF OBESITY AND HYPERURICEMIA WITH SPECIAL REFERENCE TO METABOLIC DISORDERS AND PLAUSIBLE THERAPEUTIC IMPLICATIONS |
| 1184 |
COOPERATIVE EPIGENETIC REMODELING BY TET2 LOSS AND NRAS MUTATION DRIVES MYELOID TRANSFORMATION AND MEK INHIBITOR SENSITIVITY |
| 1185 |
COORDINATED CHANGES IN AHRR METHYLATION IN LYMPHOBLASTS AND PULMONARY MACROPHAGES FROM SMOKERS |
| 1186 |
COORDINATED DYNAMIC GENE EXPRESSION CHANGES IN THE CENTRAL NUCLEUS OF THE AMYGDALA DURING ALCOHOL WITHDRAWAL |
| 1187 |
COPD GWAS VARIANT AT 19Q13 |
| 1188 |
COPD: A MULTIFACTORIAL SYSTEMIC DISEASE |
| 1189 |
CORRELATION BETWEEN GLOBAL METHYLATION LEVEL OF PERIPHERAL BLOOD LEUKOCYTES AND SERUM C REACTIVE PROTEIN LEVEL MODIFIED BY MTHFR POLYMORPHISM: A CROSS-SECTIONAL STUDY |
| 1190 |
CORRELATION BETWEEN HEPATIC HUMAN MALES ABSENT ON THE FIRST (HMOF) AND VIRAL PERSISTENCE IN CHRONIC HEPATITIS B PATIENTS |
| 1191 |
CORRELATION BETWEEN THE EPIGENETIC MODIFICATION OF HISTONE H3K9 ACETYLATION OF NR2B GENE PROMOTER IN RAT HIPPOCAMPUS AND ETHANOL WITHDRAWAL SYNDROME |
| 1192 |
CORRELATION OF CPG METHYLATION OF THE PDCD1 GENE WITH PD-1 EXPRESSION ON CD8(+) T CELLS AND MEDICAL LABORATORY INDICATORS IN CHRONIC HEPATITIS B INFECTION |
| 1193 |
CORRELATION OF CYP2R1 GENE PROMOTER METHYLATION WITH CIRCULATING VITAMIN D LEVELS AMONG HEALTHY ADULTS |
| 1194 |
CORRELATION OF EPIGENETIC CHANGE AND IDENTIFICATION OF RISK FACTORS FOR ORAL SUBMUCOUS FIBROSIS |
| 1195 |
CORRUPTED COORDINATION OF EPIGENETIC MODIFICATIONS LEADS TO DIVERGING CHROMATIN STATES AND TRANSCRIPTIONAL HETEROGENEITY IN CLL |
| 1196 |
CORRUPTION OF THE INTRA-GENE DNA METHYLATION ARCHITECTURE IS A HALLMARK OF CANCER |
| 1197 |
CORTICOSTERONE INDUCES DISCRETE EPIGENETIC SIGNATURES IN THE DORSAL AND VENTRAL HIPPOCAMPUS THAT DEPEND UPON SEX AND GENOTYPE: FOCUS ON METHYLATED NR3C1 GENE |
| 1198 |
CORTICOSTERONE-MEDIATED REGULATION AND FUNCTIONS OF MIR-218-5P IN RAT BRAIN |
| 1199 |
CORTICOTROPIN RELEASING FACTOR-BINDING PROTEIN (CRF-BP) AS A POTENTIAL NEW THERAPEUTIC TARGET IN ALZHEIMER'S DISEASE AND STRESS DISORDERS |
| 1200 |
CORTICOTROPIN RELEASING HORMONE AND IMAGING, RETHINKING THE STRESS AXIS |
| 1201 |
CORTICOTROPIN-RELEASING FACTOR RECEPTOR-1 MODULATES BIOMARKERS OF DNA OXIDATION IN ALZHEIMER'S DISEASE MICE |
| 1202 |
COULD DNA HYDROXYMETHYLATION BE CRUCIAL IN INFLUENCING STEROID HORMONE SIGNALING IN ENDOMETRIAL BIOLOGY AND ENDOMETRIOSIS? ENDOMETRIOSIS AFFECTS 10% OF REPRODUCTIVE-AGED WOMEN |
| 1203 |
COULD EPIGENETICS HELP EXPLAIN RACIAL DISPARITIES IN CHRONIC PAIN? AFRICAN AMERICANS DISPROPORTIONATELY SUFFER MORE SEVERE AND DEBILITATING MORBIDITY FROM CHRONIC PAIN THAN DO NON-HISPANIC WHITES |
| 1204 |
COULD TARGETING EPIGENETIC PROCESSES RELIEVE CHRONIC PAIN STATES? PURPOSE OF REVIEW: ABERRATIONS IN THE EPIGENETIC LANDSCAPE HAVE PREVIOUSLY BEEN ASSOCIATED WITH HUMAN DISEASES SUCH AS CANCER AND SCHIZOPHRENIA, AND DRUGS THAT TARGET EPIGENETIC PROCESSES ARE CURRENTLY USED AS THERAPEUTIC AGENTS |
| 1205 |
COULD THE INHIBITOR OF DNA BINDING 2 AND 4 PLAY A ROLE IN WHITE MATTER INJURY? WHITE MATTER INJURY (WMI) PREVENTS THE NORMAL DEVELOPMENT OF MYELINATION, LEADING TO CENTRAL NERVOUS SYSTEM MYELINATION DISORDERS AND THE PRODUCTION OF CHRONIC SEQUELAE ASSOCIATED WITH WMI, SUCH AS CHRONIC DYSKINESIA, COGNITIVE IMPAIRMENT AND CEREBRAL PALSY |
| 1206 |
COUNTERACTING AGED DNA METHYLATION STATES TO COMBAT AGEING AND AGE-RELATED DISEASES |
| 1207 |
COVID-19 AND CROSSTALK WITH THE HALLMARKS OF AGING |
| 1208 |
COVID-19 INFECTION AND RESPONSE TO VACCINATION IN CHRONIC KIDNEY DISEASE AND RENAL TRANSPLANTATION: A BRIEF PRESENTATION |
| 1209 |
COVID-19: A REVIEW ON SARS-COV-2 ORIGIN, EPIDEMIOLOGY, VIROLOGY, CLINICAL MANIFESTATIONS AND COMPLICATIONS WITH SPECIAL EMPHASIS ON ADVERSE OUTCOME IN BHOPAL GAS TRAGEDY SURVIVOR |
| 1210 |
COX2 ENHANCES NEOVASCULARIZATION OF INFLAMMATORY TENOCYTES THROUGH THE HIF-1ALPHA/VEGFA/PDGFB PATHWAY |
| 1211 |
CPG ISLAND METHYLATION AND EXPRESSION OF THE SECRETED FRIZZLED-RELATED PROTEIN GENE FAMILY IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1212 |
CPG ISLAND METHYLATION OF THE HTERT PROMOTER IS ASSOCIATED WITH LOWER TELOMERASE ACTIVITY IN B-CELL LYMPHOCYTIC LEUKEMIA |
| 1213 |
CPG ISLAND METHYLATION PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1214 |
CPG METHYLATION LEVELS IN HPA AXIS GENES PREDICT CHRONIC PAIN OUTCOMES FOLLOWING TRAUMA EXPOSURE |
| 1215 |
CPG PROMOTER METHYLATION STATUS IS NOT A PROGNOSTIC INDICATOR OF GENE EXPRESSION IN BERYLLIUM CHALLENGE |
| 1216 |
CRANIAL TREPHINATION AND INFECTIOUS DISEASE IN THE EASTERN MEDITERRANEAN: THE EVIDENCE FROM TWO ELITE BROTHERS FROM LATE BRONZE MEGIDDO, ISRAEL |
| 1217 |
CREG PROTECTS FROM MYOCARDIAL ISCHEMIA/REPERFUSION INJURY BY REGULATING MYOCARDIAL AUTOPHAGY AND APOPTOSIS |
| 1218 |
CRISPR INTERFERENCE OF A CLONALLY VARIANT GC-RICH NONCODING RNA FAMILY LEADS TO GENERAL REPRESSION OF VAR GENES IN PLASMODIUM FALCIPARUM |
| 1219 |
CRISPR/CAS9 GENOME EDITING REVEALS THAT THE INTRON IS NOT ESSENTIAL FOR VAR2CSA GENE ACTIVATION OR SILENCING IN PLASMODIUM FALCIPARUM |
| 1220 |
CRISPR/CAS9-BASED MUTAGENESIS OF HISTONE H3 |
| 1221 |
CRITICAL CONNECTIONS AMONG EMBEDDING OF CHILDHOOD ADVERSITY AND ADULT CHRONIC GASTROINTESTINAL AND GENITOURINARY DISORDERS: A REVIEW OF THE LITERATURE |
| 1222 |
CRITICAL MOMENTS IN PRESCHOOL OBESITY: THE CALL FOR NURSES AND COMMUNITIES TO ASSESS AND INTERVENE |
| 1223 |
CRITICAL REVIEW ON EMERGING HEALTH EFFECTS ASSOCIATED WITH THE INDOOR AIR QUALITY AND ITS SUSTAINABLE MANAGEMENT |
| 1224 |
CRITICAL ROLE OF ALL-TRANS RETINOIC ACID IN STABILIZING HUMAN NATURAL REGULATORY T CELLS UNDER INFLAMMATORY CONDITIONS |
| 1225 |
CRITICAL ROLE OF EPIGENETIC MODIFICATION IN THE PATHOGENESIS OF ATOPIC DERMATITIS |
| 1226 |
CRITICAL ROLE OF GUT MICROBIOTA AND EPIGENETIC FACTORS IN THE PATHOGENESIS OF BEHCET'S DISEASE |
| 1227 |
CRITICAL ROLE OF MICRORNAS IN CHRONIC LYMPHOCYTIC LEUKEMIA: OVEREXPRESSION OF THE ONCOGENE PLAG1 BY DEREGULATED MIRNAS |
| 1228 |
CRITICAL ROLE OF VGLL4 IN THE REGULATION OF CHRONIC NORMOBARIC HYPOXIA-INDUCED PULMONARY HYPERTENSION IN MICE |
| 1229 |
CRITICAL WINDOWS: EXPLORING THE ASSOCIATION BETWEEN PERINATAL TRAUMA, EPIGENETICS, AND CHRONIC PAIN |
| 1230 |
CROSS-TALK BETWEEN DNA METHYLATION AND ACTIVE HISTONE MODIFICATIONS REGULATES ABERRANT EXPRESSION OF ZAP70 IN CLL |
| 1231 |
CROSSTALK BETWEEN GLUCOSE METABOLISM, LACTATE PRODUCTION AND IMMUNE RESPONSE MODULATION |
| 1232 |
CROSSTALK BETWEEN INFLAMMATORY SIGNALING AND METHYLATION IN CANCER |
| 1233 |
CROSSTALK BETWEEN KIDNEY AND LIVER IN NON-ALCOHOLIC FATTY LIVER DISEASE: MECHANISMS AND THERAPEUTIC APPROACHES |
| 1234 |
CRYPTOTANSHINONE SUPPRESSES KEY ONCO-PROLIFERATIVE AND DRUG-RESISTANT PATHWAYS OF CHRONIC MYELOID LEUKEMIA BY TARGETING STAT5 AND STAT3 PHOSPHORYLATION |
| 1235 |
CUMULATIVE PROCEDURAL PAIN AND BRAIN DEVELOPMENT IN VERY PRETERM INFANTS: A SYSTEMATIC REVIEW OF CLINICAL AND PRECLINICAL STUDIES |
| 1236 |
CURCUMIN AMELIORATES NEPHROSCLEROSIS VIA SUPPRESSION OF HISTONE ACETYLATION INDEPENDENT OF HYPERTENSION |
| 1237 |
CURCUMIN AND COLORECTAL CANCER: AN UPDATE AND CURRENT PERSPECTIVE ON THIS NATURAL MEDICINE |
| 1238 |
CURCUMIN BLOCKS CHRONIC MORPHINE ANALGESIC TOLERANCE AND BRAIN-DERIVED NEUROTROPHIC FACTOR UPREGULATION |
| 1239 |
CURE AND LONG-TERM REMISSION STRATEGIES |
| 1240 |
CURRENT ADVANCES OF EPIGENETICS IN PERIODONTOLOGY FROM ENCODE PROJECT: A REVIEW AND FUTURE PERSPECTIVES |
| 1241 |
CURRENT AND FUTURE NUTRITIONAL STRATEGIES TO MODULATE INFLAMMATORY DYNAMICS IN METABOLIC DISORDERS |
| 1242 |
CURRENT AND NOVEL THERAPEUTIC APPROACHES IN MYELODYSPLASTIC SYNDROMES |
| 1243 |
CURRENT CONCEPTS IN CHRONIC INFLAMMATORY DISEASES: INTERACTIONS BETWEEN MICROBES, CELLULAR METABOLISM, AND INFLAMMATION |
| 1244 |
CURRENT CONCEPTS ON OXIDATIVE/CARBONYL STRESS, INFLAMMATION AND EPIGENETICS IN PATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 1245 |
CURRENT CONCEPTS ON THE ROLE OF INFLAMMATION IN COPD AND LUNG CANCER |
| 1246 |
CURRENT EPIGENETIC ASPECTS THE CLINICAL KIDNEY RESEARCHER SHOULD EMBRACE |
| 1247 |
CURRENT EVIDENCE FOR A ROLE OF EPIGENETIC MECHANISMS IN RESPONSE TO IONIZING RADIATION IN AN ECOTOXICOLOGICAL CONTEXT |
| 1248 |
CURRENT EVIDENCE FOR BIOLOGICAL BIOMARKERS AND MECHANISMS UNDERLYING ACUTE TO CHRONIC PAIN TRANSITION ACROSS THE PEDIATRIC AGE SPECTRUM |
| 1249 |
CURRENT KNOWLEDGE ON ENDOMETRIOSIS ETIOLOGY: A SYSTEMATIC REVIEW OF LITERATURE |
| 1250 |
CURRENT PERSPECTIVES ON MITOCHONDRIAL DYSFUNCTION IN MIGRAINE |
| 1251 |
CURRENT PERSPECTIVES ON ROLE OF CHROMATIN MODIFICATIONS AND DEACETYLASES IN LUNG INFLAMMATION IN COPD |
| 1252 |
CURRENT PERSPECTIVES ON THE NEUROBIOLOGY OF DRUG ADDICTION: A FOCUS ON GENETICS AND FACTORS REGULATING GENE EXPRESSION |
| 1253 |
CURRENT PROBLEMS AND FUTURE DIRECTIONS OF TRANSFUSION-INDUCED ALLOIMMUNIZATION: SUMMARY OF AN NHLBI WORKING GROUP |
| 1254 |
CURRENT PROGRESS ON THE MECHANISMS OF HYPERHOMOCYSTEINEMIA-INDUCED VASCULAR INJURY AND USE OF NATURAL POLYPHENOL COMPOUNDS |
| 1255 |
CURRENT STATUS OF NOVEL ANTIFIBROTIC THERAPIES IN PATIENTS WITH CHRONIC LIVER DISEASE |
| 1256 |
CURRENT STUDIES AND FUTURE DIRECTIONS FOR MEDULLOBLASTOMA: A REVIEW FROM THE PACIFIC PEDIATRIC NEURO-ONCOLOGY CONSORTIUM (PNOC) DISEASE WORKING GROUP |
| 1257 |
CURRENT TRENDS IN EPIGENETIC, CELLULAR AND MOLECULAR PATHWAYS IN MANAGEMENT OF RHEUMATOID ARTHRITIS |
| 1258 |
CURRENT UNDERSTANDING OF OSTEOARTHRITIS PATHOGENESIS AND RELEVANT NEW APPROACHES |
| 1259 |
CURRENT VIEWS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATHOGENESIS AND MANAGEMENT |
| 1260 |
CURRENT VIEWS ON THE INTERPLAY BETWEEN TYROSINE KINASES AND PHOSPHATASES IN CHRONIC MYELOID LEUKEMIA |
| 1261 |
CURRENT VIEWS ON THE PATHOGENESIS OF SJOGREN'S SYNDROME |
| 1262 |
CUTTING EDGE: PROLONGED EXPOSURE TO HIV REINFORCES A POISED EPIGENETIC PROGRAM FOR PD-1 EXPRESSION IN VIRUS-SPECIFIC CD8 T CELLS |
| 1263 |
CYCLIC VARIATIONS IN INCUBATION CONDITIONS INDUCE ADAPTIVE RESPONSES TO LATER HEAT EXPOSURE IN CHICKENS: A REVIEW |
| 1264 |
CYP2E1 EPIGENETIC REGULATION IN CHRONIC, LOW-LEVEL TOLUENE EXPOSURE: RELATIONSHIP WITH OXIDATIVE STRESS AND SMOKING HABIT |
| 1265 |
CYSTINURIA POORLY RESPONDING TO TREATMENT - THE RISK OF CHRONIC KIDNEY DISEASE |
| 1266 |
CYTOGENETIC AND MOLECULAR ABNORMALITIES IN CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 1267 |
CYTOMEGALOVIRUS INFECTION ACCELERATES EPIGENETIC AGING |
| 1268 |
CYTOPLASMATIC COMPARTMENTALIZATION BY BCR-ABL PROMOTES TET2 LOSS-OF-FUNCTION IN CHRONIC MYELOID LEUKEMIA |
| 1269 |
CYTOSINE METHYLATION CHANGES IN ENHANCER REGIONS OF CORE PRO-FIBROTIC GENES CHARACTERIZE KIDNEY FIBROSIS DEVELOPMENT |
| 1270 |
CYTOSINE METHYLATION IS A CONSERVED EPIGENETIC FEATURE FOUND THROUGHOUT THE PHYLUM PLATYHELMINTHES |
| 1271 |
CYTOSINE METHYLATION PREDICTS RENAL FUNCTION DECLINE IN AMERICAN INDIANS |
| 1272 |
CYTOTOXIC ACTIVITY OF VALPROIC ACID ON PRIMARY CHRONIC LYMPHOCYTIC LEUKEMIA CELLS |
| 1273 |
CYTOTOXIC PERIPHERAL T-CELL LYMPHOMAS AND EBV-POSITIVE T/NK-CELL LYMPHOPROLIFERATIVE DISEASES: EMERGING CONCEPTS, RECENT ADVANCES, AND THE PUTATIVE ROLE OF CLONAL HEMATOPOIESIS |
| 1274 |
DACH1 PROTECTS PODOCYTES FROM EXPERIMENTAL DIABETIC INJURY AND MODULATES PTIP-H3K4ME3 ACTIVITY |
| 1275 |
DAMAGE-ASSOCIATED MOLECULAR PATTERNS IN INFLAMMATORY BOWEL DISEASE: FROM BIOMARKERS TO THERAPEUTIC TARGETS |
| 1276 |
DAMPS, AGEING, AND CANCER: THE 'DAMP HYPOTHESIS' |
| 1277 |
DATA ON RNA-SEQ ANALYSIS OF DROSOPHILA MELANOGASTER DURING AGEING |
| 1278 |
DE NOVO EPIGENETIC PROGRAMS INHIBIT PD-1 BLOCKADE-MEDIATED T CELL REJUVENATION |
| 1279 |
DE NOVO MUTATIONS IDENTIFIED BY WHOLE-GENOME SEQUENCING IMPLICATE CHROMATIN MODIFICATIONS IN OBSESSIVE-COMPULSIVE DISORDER |
| 1280 |
DECIPHERING DNA METHYLATION SIGNATURES OF PANCREATIC CANCER AND PANCREATITIS |
| 1281 |
DECIPHERING NEURODEGENERATIVE DISEASES USING LONG-READ SEQUENCING |
| 1282 |
DECIPHERING THE ACTIVE CONSTITUENTS OF DABUSHEN DECOCTION OF AMELIORATING OSTEOARTHRITIS VIA PPARGAMMA PRESERVATION BY TARGETING DNMT1 |
| 1283 |
DECIPHERING THE EPIGENETIC CODE OF T LYMPHOCYTES |
| 1284 |
DECIPHERING THE MOLECULAR LANDSCAPE OF CUTANEOUS SQUAMOUS CELL CARCINOMA FOR BETTER DIAGNOSIS AND TREATMENT |
| 1285 |
DECIPHERING THE ROLE OF ABERRANT DNA METHYLATION IN NAFLD AND NASH |
| 1286 |
DECITABINE IN COMBINATION WITH DONOR LYMPHOCYTE INFUSIONS CAN INDUCE REMISSIONS IN RELAPSED MYELOID MALIGNANCIES WITH HIGHER LEUKEMIC BURDEN AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
| 1287 |
DECITABINE-INDUCED APOPTOSIS IS DERIVED BY PUMA AND NOXA INDUCTION IN CHRONIC MYELOID LEUKEMIA CELL LINE AS WELL AS IN PBL AND IS POTENTIATED BY SAHA |
| 1288 |
DECITABINE |
| 1289 |
DECODING THE FUNCTIONS OF POST-TRANSCRIPTIONAL REGULATORS IN THE DETERMINATION OF INFLAMMATORY STATES: FOCUS ON MACROPHAGE ACTIVATION |
| 1290 |
DECODING THE GENETIC AND EPIGENETIC BASIS OF ASTHMA |
| 1291 |
DECODING THE ROLE OF EPIGENETICS AND GENOMICS IN PAIN MANAGEMENT |
| 1292 |
DECREASED BLOOD PRESSURE IS RELATED TO CHANGES IN NF-KB PROMOTER METHYLATION LEVELS AFTER BARIATRIC SURGERY |
| 1293 |
DECREASED ERK AND JNK SIGNALING CONTRIBUTE TO GENE OVEREXPRESSION IN "SENESCENT" CD4+CD28- T CELLS THROUGH EPIGENETIC MECHANISMS |
| 1294 |
DECREASED EXPRESSION OF MIR-20A AND MIR-92A IN THE SERUM FROM SULFUR MUSTARD-EXPOSED PATIENTS DURING THE CHRONIC PHASE OF RESULTING ILLNESS |
| 1295 |
DECREASED GLOBAL DNA METHYLATION IN THE WHITE BLOOD CELLS OF HIGH FAT DIET FED VERVET MONKEYS (CHLOROCEBUS AETHIOPS) |
| 1296 |
DECREASED MIR-325-5P CONTRIBUTES TO VISCERAL HYPERSENSITIVITY THROUGH POST-TRANSCRIPTIONAL UPREGULATION OF CCL2 IN RAT DORSAL ROOT GANGLIA |
| 1297 |
DECREASED MRNA EXPRESSION LEVELS OF DNA METHYLTRANSFERASES TYPE 1 AND 3A IN SYSTEMIC LUPUS ERYTHEMATOSUS |
| 1298 |
DECREASED NUCLEAR RECEPTOR ACTIVITY AND EPIGENETIC MODULATION ASSOCIATES WITH DOWN-REGULATION OF HEPATIC DRUG-METABOLIZING ENZYMES IN CHRONIC KIDNEY DISEASE |
| 1299 |
DECREASED REELIN EXPRESSION IN THE LEFT PREFRONTAL CORTEX (BA9) IN CHRONIC SCHIZOPHRENIA PATIENTS |
| 1300 |
DEDIFFERENTIATION AND IN VIVO REPROGRAMMING OF COMMITTED CELLS IN WOUND REPAIR (REVIEW) |
| 1301 |
DEEP SEQUENCING REVEALS INCREASED DNA METHYLATION IN CHRONIC RAT EPILEPSY |
| 1302 |
DEFECTIVE FUNCTIONAL BETA-CELL MASS AND TYPE 2 DIABETES IN THE GOTO-KAKIZAKI RAT MODEL |
| 1303 |
DEFECTIVE TRAINED IMMUNITY IN PATIENTS WITH STAT-1-DEPENDENT CHRONIC MUCOCUTANEAOUS CANDIDIASIS |
| 1304 |
DEFECTS IN SPLICEOSOMAL MACHINERY: A NEW PATHWAY OF LEUKAEMOGENESIS |
| 1305 |
DEFICIENT H2A |
| 1306 |
DEFINING 'T CELL EXHAUSTION' |
| 1307 |
DEFINING A METHYLATION SIGNATURE ASSOCIATED WITH OPERATIONAL TOLERANCE IN KIDNEY TRANSPLANT RECIPIENTS |
| 1308 |
DEFINING A RESEARCH AGENDA TO ADDRESS THE CONVERGING EPIDEMICS OF TUBERCULOSIS AND DIABETES: PART 2: UNDERLYING BIOLOGIC MECHANISMS |
| 1309 |
DEFINING AND TARGETING PATTERNS OF T CELL DYSFUNCTION IN INBORN ERRORS OF IMMUNITY |
| 1310 |
DEFINING TRAINED IMMUNITY AND ITS ROLE IN HEALTH AND DISEASE |
| 1311 |
DEFINITIONS, BIOLOGY, AND CURRENT THERAPEUTIC LANDSCAPE OF MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS |
| 1312 |
DELETERIOUS EFFECTS OF CHRONIC FOLATE DEFICIENCY IN THE TS65DN MOUSE MODEL OF DOWN SYNDROME |
| 1313 |
DELETING DNMT3A IN CAR T CELLS PREVENTS EXHAUSTION AND ENHANCES ANTITUMOR ACTIVITY |
| 1314 |
DELINEATING CONDITIONS AND SUBTYPES IN CHRONIC PAIN USING NEUROIMAGING |
| 1315 |
DELTA FOSB MEDIATES EPIGENETIC DESENSITIZATION OF THE C-FOS GENE AFTER CHRONIC AMPHETAMINE EXPOSURE |
| 1316 |
DELTA9-TETRAHYDROCANNABINOL (DELTA9-THC) PROMOTES NEUROIMMUNE-MODULATORY MICRORNA PROFILE IN STRIATUM OF SIMIAN IMMUNODEFICIENCY VIRUS (SIV)-INFECTED MACAQUES |
| 1317 |
DELTAFOSB REGULATES GENE EXPRESSION AND COGNITIVE DYSFUNCTION IN A MOUSE MODEL OF ALZHEIMER'S DISEASE |
| 1318 |
DEMETHYLATION OF G-PROTEIN-COUPLED RECEPTOR 151 PROMOTER FACILITATES THE BINDING OF KRUPPEL-LIKE FACTOR 5 AND ENHANCES NEUROPATHIC PAIN AFTER NERVE INJURY IN MICE |
| 1319 |
DEMETHYLATION OF THE PD-1 PROMOTER IS IMPRINTED DURING THE EFFECTOR PHASE OF CD8 T CELL EXHAUSTION |
| 1320 |
DEMETHYLATION REGULATION OF BDNF GENE EXPRESSION IN DORSAL ROOT GANGLION NEURONS IS IMPLICATED IN OPIOID-INDUCED PAIN HYPERSENSITIVITY IN RATS |
| 1321 |
DEMONSTRATION AND CHARACTERIZATION OF MUTATIONS INDUCED BY HELICOBACTER PYLORI ORGANISMS IN GASTRIC EPITHELIAL CELLS |
| 1322 |
DEMONSTRATION OF THE USEFULNESS OF EPIGENETIC CANCER RISK PREDICTION BY A MULTICENTRE PROSPECTIVE COHORT STUDY |
| 1323 |
DENDRITIC CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS: FROM PATHOGENESIS TO THERAPEUTIC APPLICATIONS |
| 1324 |
DEOXYRIBONUCLEIC ACID (DNA) METHYLATION IN CHILDREN EXPOSED TO AIR POLLUTION: A POSSIBLE MECHANISM UNDERLYING RESPIRATORY HEALTH EFFECTS DEVELOPMENT |
| 1325 |
DEPLETED URANIUM INDUCES SEX- AND TISSUE-SPECIFIC METHYLATION PATTERNS IN ADULT ZEBRAFISH |
| 1326 |
DEPLETION OF NUCLEAR HISTONE H2A VARIANTS IS ASSOCIATED WITH CHRONIC DNA DAMAGE SIGNALING UPON DRUG-EVOKED SENESCENCE OF HUMAN SOMATIC CELLS |
| 1327 |
DEPRESSION AND ANTIDEPRESSANTS: INSIGHTS FROM KNOCKOUT OF DOPAMINE, SEROTONIN OR NORADRENALINE RE-UPTAKE TRANSPORTERS |
| 1328 |
DEPRESSION AND STRESS LEVELS INCREASE RISK OF LIVER CANCER THROUGH EPIGENETIC DOWNREGULATION OF HYPOCRETIN |
| 1329 |
DEPRESSION ASSOCIATED WITH DIABETES: FROM PATHOPHYSIOLOGY TO TREATMENT |
| 1330 |
DEPRESSIVE-LIKE BEHAVIORS ARE REGULATED BY NOX1/NADPH OXIDASE BY REDOX MODIFICATION OF NMDA RECEPTOR 1 |
| 1331 |
DEPRESSIVE-LIKE BEHAVIORS INDUCED BY CHRONIC SOCIAL DEFEAT STRESS ARE ASSOCIATED WITH HDAC7 REDUCTION IN THE NUCLEUS ACCUMBENS |
| 1332 |
DEPRESSIVE-LIKE PHENOTYPE INDUCED BY PRENATAL DEXAMETHASONE IN MICE IS REVERSED BY DESIPRAMINE |
| 1333 |
DEREGULATION AND EPIGENETIC MODIFICATION OF BCL2-FAMILY GENES CAUSE RESISTANCE TO VENETOCLAX IN HEMATOLOGIC MALIGNANCIES |
| 1334 |
DEREGULATION OF AIOLOS EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH EPIGENETIC MODIFICATIONS |
| 1335 |
DERMAL FIBROBLASTS CULTURED FROM DONORS WITH TYPE 2 DIABETES MELLITUS RETAIN AN EPIGENETIC MEMORY ASSOCIATED WITH POOR WOUND HEALING RESPONSES |
| 1336 |
DESCRIBING A TRANSCRIPTION FACTOR DEPENDENT REGULATION OF THE MICRORNA TRANSCRIPTOME |
| 1337 |
DESIGN AND MEASUREMENT IN A STUDY OF WAR EXPOSURE, HEALTH, AND AGING: PROTOCOL FOR THE VIETNAM HEALTH AND AGING STUDY |
| 1338 |
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF A PHENYL BUTYRIC ACID DERIVATIVE, N-(4-CHLOROPHENYL)-4-PHENYLBUTANAMIDE: A HDAC6 INHIBITOR WITH ANTI-PROLIFERATIVE ACTIVITY ON CERVIX CANCER AND LEUKEMIA CELLS |
| 1339 |
DESIGN, SYNTHESIS, BIOLOGICAL EVALUATION, AND STRUCTURAL CHARACTERIZATION OF POTENT HISTONE DEACETYLASE INHIBITORS BASED ON CYCLIC ALPHA/BETA-TETRAPEPTIDE ARCHITECTURES |
| 1340 |
DESIGNING SAFER DRUGS: (Q)SAR-BASED IDENTIFICATION OF MUTAGENS AND CARCINOGENS |
| 1341 |
DETANGLING THE INTERRELATIONS BETWEEN MAFLD, INSULIN RESISTANCE, AND KEY HORMONES |
| 1342 |
DETECTING ABNORMAL METHYLATION OF TUMOR SUPPRESSOR GENES GSTP1, P16, RIZ1, AND RASSF1A IN HEPATOCELLULAR CARCINOMA AND ITS CLINICAL SIGNIFICANCE |
| 1343 |
DETECTING CORD BLOOD CELL TYPE-SPECIFIC EPIGENETIC ASSOCIATIONS WITH GESTATIONAL DIABETES MELLITUS AND EARLY CHILDHOOD GROWTH |
| 1344 |
DETECTION OF BRAIN AMYLOID BETA DEPOSITION IN PATIENTS WITH NEUROPSYCHOLOGICAL IMPAIRMENT AFTER TRAUMATIC BRAIN INJURY: PET EVALUATION USING PITTSBURGH COMPOUND-B |
| 1345 |
DETECTION OF DIFFERENTIALLY METHYLATED REGIONS USING BAYES FACTOR FOR ORDINAL GROUP RESPONSES |
| 1346 |
DETECTION OF TRANSGENERATIONAL SPERMATOGENIC INHERITANCE OF ADULT MALE ACQUIRED CNS GENE EXPRESSION CHARACTERISTICS USING A DROSOPHILA SYSTEMS MODEL |
| 1347 |
DETECTION OF TYPE 2 DIABETES RELATED MODULES AND GENES BASED ON EPIGENETIC NETWORKS |
| 1348 |
DETERMINANTS OF FIBROSIS PROGRESSION AND REGRESSION IN NASH |
| 1349 |
DETERMINANTS OF INNATE IMMUNITY IN VISCERAL LEISHMANIASIS AND THEIR IMPLICATION IN VACCINE DEVELOPMENT |
| 1350 |
DETERMINANTS OF PULMONARY EMPHYSEMA SEVERITY IN TAIWANESE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: AN INTEGRATED EPIGENOMIC AND AIR POLLUTANT ANALYSIS |
| 1351 |
DETERMINATION OF SALIVA EPIGENETIC AGE IN INFANCY, AND ITS ASSOCIATION WITH PARENTAL SOCIO-ECONOMIC CHARACTERISTICS AND PREGNANCY OUTCOMES |
| 1352 |
DEVELOPMENT AND APPLICATION OF THE ADVERSE OUTCOME PATHWAY FRAMEWORK FOR UNDERSTANDING AND PREDICTING CHRONIC TOXICITY: I |
| 1353 |
DEVELOPMENT AND CHARACTERIZATION OF A HYDROGEN PEROXIDE-RESISTANT CHOLANGIOCYTE CELL LINE: A NOVEL MODEL OF OXIDATIVE STRESS-RELATED CHOLANGIOCARCINOMA GENESIS |
| 1354 |
DEVELOPMENT AND REGRESSION OF CIRRHOSIS |
| 1355 |
DEVELOPMENT AND VALIDATION OF A SIMPLE GENERAL POPULATION LUNG CANCER RISK MODEL INCLUDING AHRR-METHYLATION |
| 1356 |
DEVELOPMENT OF A DIETARY METHYL DONOR FOOD FREQUENCY QUESTIONNAIRE TO ASSESS FOLATE AND VITAMIN B(12) STATUS IN CHILDREN WITH CHRONIC HEPATITIS B VIRUS INFECTION |
| 1357 |
DEVELOPMENT OF INNATE IMMUNE MEMORY BY NON-IMMUNE CELLS DURING STAPHYLOCOCCUS AUREUS INFECTION DEPENDS ON REACTIVE OXYGEN SPECIES |
| 1358 |
DEVELOPMENT OF RATIOMETRIC ELECTROCHEMICAL MOLECULAR SWITCHES TO ASSAY ENDOGENOUS FORMALDEHYDE IN LIVE CELLS, WHOLE BLOOD AND CREATININE IN SALIVA |
| 1359 |
DEVELOPMENT REFRACTORINESS OF MLL-REARRANGED HUMAN B CELL ACUTE LEUKEMIAS TO REPROGRAMMING INTO PLURIPOTENCY |
| 1360 |
DEVELOPMENTAL ASPECTS OF A LIFE COURSE APPROACH TO HEALTHY AGEING |
| 1361 |
DEVELOPMENTAL CONSEQUENCES OF TRACE MINERAL DEFICIENCIES IN RODENTS: ACUTE AND LONG-TERM EFFECTS |
| 1362 |
DEVELOPMENTAL EPIGENETIC PROGRAMMING OF ADULT GERM CELL DEATH DISEASE: POLYCOMB PROTEIN EZH2-MIR-101 PATHWAY |
| 1363 |
DEVELOPMENTAL INFLUENCES ON MEDICALLY UNEXPLAINED SYMPTOMS |
| 1364 |
DEVELOPMENTAL NEUROENDOCRINOLOGY OF EARLY-LIFE STRESS: IMPACT ON CHILD DEVELOPMENT AND BEHAVIOR |
| 1365 |
DEVELOPMENTAL ORIGIN OF CHRONIC DISEASES: TOXICOLOGICAL IMPLICATION |
| 1366 |
DEVELOPMENTAL ORIGINS OF CHRONIC KIDNEY DISEASE: SHOULD WE FOCUS ON EARLY LIFE? CHRONIC KIDNEY DISEASE (CKD) IS BECOMING A GLOBAL BURDEN, DESPITE RECENT ADVANCES IN MANAGEMENT |
| 1367 |
DEVELOPMENTAL ORIGINS OF CHRONIC PHYSICAL AGGRESSION: A BIO-PSYCHO-SOCIAL MODEL FOR THE NEXT GENERATION OF PREVENTIVE INTERVENTIONS |
| 1368 |
DEVELOPMENTAL ORIGINS OF DISEASE AND DETERMINANTS OF CHROMATIN STRUCTURE: MATERNAL DIET MODIFIES THE PRIMATE FETAL EPIGENOME |
| 1369 |
DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD) |
| 1370 |
DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE THEORY IN CARDIOLOGY |
| 1371 |
DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE: NEW INSIGHTS |
| 1372 |
DEVELOPMENTAL ORIGINS OF METABOLIC DISEASES |
| 1373 |
DEVELOPMENTAL ORIGINS OF NONALCOHOLIC FATTY LIVER DISEASE |
| 1374 |
DEVELOPMENTAL PROGRAMMING OF ADULT DISEASE: REPROGRAMMING BY MELATONIN? ADULT-ONSET CHRONIC NON-COMMUNICABLE DISEASES (NCDS) CAN ORIGINATE FROM EARLY LIFE THROUGH SO-CALLED THE "DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE" (DOHAD) OR "DEVELOPMENTAL PROGRAMMING" |
| 1375 |
DEVELOPMENTAL PROGRAMMING OF ADULT HAEMATOPOIESIS SYSTEM |
| 1376 |
DEVELOPMENTAL PROGRAMMING OF BODY COMPOSITION: UPDATE ON EVIDENCE AND MECHANISMS |
| 1377 |
DEVELOPMENTAL PROGRAMMING: STATE-OF-THE-SCIENCE AND FUTURE DIRECTIONS-SUMMARY FROM A PENNINGTON BIOMEDICAL SYMPOSIUM |
| 1378 |
DEVELOPMENTAL PROGRAMS ARE KEPT ALIVE DURING ADULTHOOD BY STEM CELLS: THE AGING ASPECT |
| 1379 |
DEVELOPMENTAL RELATIONSHIPS OF FOUR EXHAUSTED CD8(+) T CELL SUBSETS REVEALS UNDERLYING TRANSCRIPTIONAL AND EPIGENETIC LANDSCAPE CONTROL MECHANISMS |
| 1380 |
DEVELOPMENTAL SUBTYPES ASSESSED BY DNA METHYLATION-IPLEX FORECAST THE NATURAL HISTORY OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1381 |
DI-(2-ETHYLHEXYL) PHTHALATE TRIGGERS DNA METHYLTRANSFERASE 1 EXPRESSION RESULTING IN ELEVATED CPG-METHYLATION AND ENRICHMENT OF MECP2 IN THE P21 PROMOTER IN VITRO |
| 1382 |
DIABETES ALTERS ACTIVATION AND REPRESSION OF PRO- AND ANTI-INFLAMMATORY SIGNALING PATHWAYS IN THE VASCULATURE |
| 1383 |
DIABETES AND ITS CARDIOVASCULAR COMPLICATIONS: POTENTIAL ROLE OF THE ACETYLTRANSFERASE P300 |
| 1384 |
DIABETES AND KIDNEY DISEASE: EMPHASIS ON TREATMENT WITH SGLT-2 INHIBITORS AND GLP-1 RECEPTOR AGONISTS |
| 1385 |
DIABETES IN CHILDHOOD CANCER SURVIVORS: EMERGING CONCEPTS IN PATHOPHYSIOLOGY AND FUTURE DIRECTIONS |
| 1386 |
DIABETES: AN UPDATE ON THE PANDEMIC AND POTENTIAL SOLUTIONS |
| 1387 |
DIABETIC GUT MICROBIOTA DYSBIOSIS AS AN INFLAMMAGING AND IMMUNOSENESCENCE CONDITION THAT FOSTERS PROGRESSION OF RETINOPATHY AND NEPHROPATHY |
| 1388 |
DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE: NON-INVASIVE ASSESSMENT OF CARDIOVASCULAR RISK |
| 1389 |
DIABETIC RETINOPATHY AND SYSTEMIC FACTORS |
| 1390 |
DIAGNOSING NOCIPLASTIC PAIN IN CANCER SURVIVORS: A MAJOR STEP FORWARD |
| 1391 |
DIAGNOSTIC APPROACH TO PATIENTS WITH LOW SERUM ALKALINE PHOSPHATASE |
| 1392 |
DIAGNOSTIC APPROACH TO PULMONARY HYPERTENSION IN PREMATURE NEONATES |
| 1393 |
DIAGNOSTIC VALUE OF THE HYPOMETHYLATION OF THE WISP1 PROMOTER IN PATIENTS WITH HEPATOCELLULAR CARCINOMA ASSOCIATED WITH HEPATITIS B VIRUS |
| 1394 |
DIET AND AGING |
| 1395 |
DIET AND MICROBIOME IN THE BEGINNING OF THE SEQUENCE OF GUT INFLAMMATION |
| 1396 |
DIET INDUCED EPIGENETIC CHANGES AND THEIR IMPLICATIONS FOR HEALTH |
| 1397 |
DIET PHYTOCHEMICALS AND CUTANEOUS CARCINOMA CHEMOPREVENTION: A REVIEW |
| 1398 |
DIET, GUT MICROBIOME AND EPIGENETICS: EMERGING LINKS WITH INFLAMMATORY BOWEL DISEASES AND PROSPECTS FOR MANAGEMENT AND PREVENTION |
| 1399 |
DIET-INDUCED OBESITY MODULATES EPIGENETIC RESPONSES TO IONIZING RADIATION IN MICE |
| 1400 |
DIET-REGULATING MICROBIOTA AND HOST IMMUNE SYSTEM IN LIVER DISEASE |
| 1401 |
DIETARY AND PHARMACOLOGICAL TREATMENT OF ABDOMINAL PAIN IN IBS |
| 1402 |
DIETARY ANTIOXIDANTS REMODEL DNA METHYLATION PATTERNS IN CHRONIC DISEASE |
| 1403 |
DIETARY APPROACHES TO WOMEN'S SEXUAL AND REPRODUCTIVE HEALTH |
| 1404 |
DIETARY COMPOSITION AND EFFECTS IN INFLAMMATORY BOWEL DISEASE |
| 1405 |
DIETARY FACTORS AND EPIGENETIC REGULATION FOR PROSTATE CANCER PREVENTION |
| 1406 |
DIETARY HISTONE DEACETYLASE INHIBITORS: FROM CELLS TO MICE TO MAN |
| 1407 |
DIETARY INFLUENCES ON MUTAGENESIS--WHERE IS THIS FIELD GOING? EARLY STUDIES ON DIETARY MUTAGENESIS WERE MOSTLY OBSERVATIONAL, WITH LARGE NUMBERS OF POTENTIAL DIETARY MUTAGENS BEING IDENTIFIED FROM EVERY CONCEIVABLE DIETARY SOURCE |
| 1408 |
DIETARY INTAKE IS ASSOCIATED WITH RESPIRATORY HEALTH OUTCOMES AND DNA METHYLATION IN CHILDREN WITH ASTHMA |
| 1409 |
DIETARY INTERVENTIONS AND NUTRITIONAL FACTORS IN THE PREVENTION OF PEDIATRIC ASTHMA |
| 1410 |
DIETARY INTERVENTIONS FOR AUTISM SPECTRUM DISORDER: AN UPDATED SYSTEMATIC REVIEW OF HUMAN STUDIES |
| 1411 |
DIETARY NATURAL PRODUCTS AS EPIGENETIC MODIFIERS IN AGING-ASSOCIATED INFLAMMATION AND DISEASE |
| 1412 |
DIETARY PATTERNS INFLUENCE TARGET GENE EXPRESSION THROUGH EMERGING EPIGENETIC MECHANISMS IN NONALCOHOLIC FATTY LIVER DISEASE |
| 1413 |
DIETARY PHYTOCHEMICALS AND CANCER CHEMOPREVENTION: A PERSPECTIVE ON OXIDATIVE STRESS, INFLAMMATION, AND EPIGENETICS |
| 1414 |
DIETARY PHYTOCHEMICALS IN NEUROIMMUNOAGING: A NEW THERAPEUTIC POSSIBILITY FOR HUMANS? ALTHOUGH SEVERAL EFFORTS HAVE BEEN MADE IN THE SEARCH FOR GENETIC AND EPIGENETIC PATTERNS LINKED TO DISEASES, A COMPREHENSIVE EXPLANATION OF THE MECHANISMS UNDERLYING PATHOLOGICAL PHENOTYPIC PLASTICITY IS STILL FAR FROM BEING CLARIFIED |
| 1415 |
DIETARY POLYPHENOLS AND THEIR RELATIONSHIP TO THE MODULATION OF NON-COMMUNICABLE CHRONIC DISEASES AND EPIGENETIC MECHANISMS: A MINI-REVIEW |
| 1416 |
DIETARY POLYPHENOLS REMODEL DNA METHYLATION PATTERNS OF NRF2 IN CHRONIC DISEASE |
| 1417 |
DIETARY TRENDS AND THE DECLINE IN MALE REPRODUCTIVE HEALTH |
| 1418 |
DIFFERENCES IN DNA METHYLATION REPROGRAMMING UNDERLIE THE SEXUAL DIMORPHISM OF BEHAVIORAL DISORDER CAUSED BY PRENATAL STRESS IN RATS |
| 1419 |
DIFFERENT CLINICAL FORMS OF HEREDITARY TYROSINEMIA (TYPE I) IN PATIENTS WITH IDENTICAL GENOTYPES |
| 1420 |
DIFFERENT PATTERNS OF ACETYLATION AND DIMETHYLATION OF HISTONE H3 BETWEEN YOUNG AND AGED CASES WITH CHRONIC TONSILLITIS: INFLUENCES OF INFLAMMATION AND AGING |
| 1421 |
DIFFERENTIAL BRAIN ADRA2A AND ADRA2C GENE EXPRESSION AND EPIGENETIC REGULATION IN SCHIZOPHRENIA |
| 1422 |
DIFFERENTIAL CPG DNA METHYLATION OF PERIPHERAL B CELLS, CD4(+) T CELLS, AND SALIVARY GLAND TISSUES IN IGG4-RELATED DISEASE |
| 1423 |
DIFFERENTIAL DNA METHYLATION IN MONOZYGOTIC TWINS DISCORDANT FOR FEMALE SEXUAL FUNCTIONING |
| 1424 |
DIFFERENTIAL DNA METHYLATION OF GENE PROMOTERS IN SMALL B-CELL LYMPHOMAS |
| 1425 |
DIFFERENTIAL DNA METHYLATION PROFILES OF CODING AND NON-CODING GENES DEFINE HIPPOCAMPAL SCLEROSIS IN HUMAN TEMPORAL LOBE EPILEPSY |
| 1426 |
DIFFERENTIAL EFFECTS OF BUTYRIC ACID ON MOUSE SKIN TUMORIGENESIS |
| 1427 |
DIFFERENTIAL EFFECTS OF CHRONIC IMMUNOSUPPRESSION ON BEHAVIORAL, EPIGENETIC, AND ALZHEIMER'S DISEASE-ASSOCIATED MARKERS IN 3XTG-AD MICE |
| 1428 |
DIFFERENTIAL EXPRESSION OF LONG NONCODING RNA IN HEPATOCELLULAR CARCINOMA ON TOP OF CHRONIC HCV AND HBV INFECTIONS |
| 1429 |
DIFFERENTIAL EXPRESSION OF MICRORNAS IN THE HIPPOCAMPI OF MALE AND FEMALE RODENTS AFTER CHRONIC ALCOHOL ADMINISTRATION |
| 1430 |
DIFFERENTIAL EXPRESSION OF SOX11 AND BDNF MRNA ISOFORMS IN THE INJURED AND REGENERATING NERVOUS SYSTEMS |
| 1431 |
DIFFERENTIAL FREQUENCIES OF P16(INK4A) PROMOTER HYPERMETHYLATION, P53 MUTATION, AND K-RAS MUTATION IN EXFOLIATIVE MATERIAL MARK THE DEVELOPMENT OF LUNG CANCER IN SYMPTOMATIC CHRONIC SMOKERS |
| 1432 |
DIFFERENTIAL GENE HYPERMETHYLATION IN GENITAL LICHEN SCLEROSUS AND CANCER: A COMPARATIVE STUDY |
| 1433 |
DIFFERENTIAL GENOME-WIDE ARRAY-BASED METHYLATION PROFILES IN PROGNOSTIC SUBSETS OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1434 |
DIFFERENTIAL METHYLATION AND EXPRESSION OF GENES IN THE HYPOXIA-INDUCIBLE FACTOR 1 SIGNALING PATHWAY ARE ASSOCIATED WITH PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY IN BREAST CANCER SURVIVORS AND WITH PRECLINICAL MODELS OF CHEMOTHERAPY-INDUCED NEUROPATHIC PAIN |
| 1435 |
DIFFERENTIAL METHYLATION LANDSCAPE OF PANCREATIC DUCTAL ADENOCARCINOMA AND ITS PRECANCEROUS LESIONS |
| 1436 |
DIFFERENTIAL METHYLATION OF THE TRPA1 PROMOTER IN PAIN SENSITIVITY |
| 1437 |
DIFFERENTIAL METHYLATION PATTERN OF XENOBIOTIC METABOLIZING GENES AND SUSCEPTIBILITY TO BALKAN ENDEMIC NEPHROPATHY, IN A COHORT OF ROMANIAN PATIENTS |
| 1438 |
DIFFERENTIAL METHYLATION TESTS OF REGULATORY REGIONS |
| 1439 |
DIFFERENTIAL PLACENTAL CPG METHYLATION IS ASSOCIATED WITH CHRONIC LUNG DISEASE OF PREMATURITY |
| 1440 |
DIFFERENTIAL REGULATION OF HUMAN 3BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2 FOR STEROID HORMONE BIOSYNTHESIS BY STARVATION AND CYCLIC AMP STIMULATION: STUDIES IN THE HUMAN ADRENAL NCI-H295R CELL MODEL |
| 1441 |
DIFFERENTIAL REGULATION OF K(CA) 2 |
| 1442 |
DIFFERENTIAL RESPONSE OF HUMAN HEPATOCYTE CHROMATIN TO HDAC INHIBITORS AS A FUNCTION OF MICROENVIRONMENTAL GLUCOSE LEVEL |
| 1443 |
DIFFERENTIAL RESPONSES OF HEALTHY AND CHRONIC OBSTRUCTIVE PULMONARY DISEASED HUMAN BRONCHIAL EPITHELIAL CELLS REPEATEDLY EXPOSED TO AIR POLLUTION-DERIVED PM(4) |
| 1444 |
DIFFERENTIALLY HYPOMETHYLATED CELL-FREE DNA AND CORONARY COLLATERAL CIRCULATION |
| 1445 |
DIFFUSE PEDIATRIC-TYPE HIGH-GRADE GLIOMA ARISING IN AN OVARIAN MATURE CYSTIC TERATOMA |
| 1446 |
DIGESTED CINNAMON (CINNAMOMUM VERUM J |
| 1447 |
DIOXIN AND ENDOMETRIOSIS: A NEW POSSIBLE RELATION BASED ON EPIGENETIC THEORY |
| 1448 |
DIPEPTIDYL PEPTIDASE-4 INHIBITION AND NARROW-BAND ULTRAVIOLET-B LIGHT IN PSORIASIS (DINUP): STUDY PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL |
| 1449 |
DIRECT LINEAGE REPROGRAMMING FOR INDUCED KERATINOCYTE STEM CELLS: A POTENTIAL APPROACH FOR SKIN REPAIR |
| 1450 |
DISAGREEMENT BETWEEN TWO COMMON BIOMARKERS OF GLOBAL DNA METHYLATION |
| 1451 |
DISALLOWED AND ALLOWED GENE EXPRESSION: TWO FACES OF MATURE ISLET BETA CELLS |
| 1452 |
DISCORDANT INTESTINAL MALROTATION IN ADULT MONOZYGOTIC TWINS DISCOVERED INCIDENTALLY DURING LAPAROSCOPIC GASTRIC BYPASS: A CASE REPORT AND REVIEW OF THE LITERATURE |
| 1453 |
DISCOVERING HOW ENVIRONMENTAL EXPOSURES ALTER GENES COULD LEAD TO NEW TREATMENTS FOR CHRONIC ILLNESSES |
| 1454 |
DISCOVERY OF CANDIDATE DNA METHYLATION CANCER DRIVER GENES |
| 1455 |
DISCOVERY OF THIENO[2,3-D]PYRIMIDINE-BASED HYDROXAMIC ACID DERIVATIVES AS BROMODOMAIN-CONTAINING PROTEIN 4/HISTONE DEACETYLASE DUAL INHIBITORS INDUCE AUTOPHAGIC CELL DEATH IN COLORECTAL CARCINOMA CELLS |
| 1456 |
DISCRIMINATING THE MOLECULAR BASIS OF HEPATOTOXICITY USING THE LARGE-SCALE CHARACTERISTIC MOLECULAR SIGNATURES OF TOXICANTS BY EXPRESSION PROFILING ANALYSIS |
| 1457 |
DISEASE PROGRESSION FROM CHRONIC HEPATITIS C TO CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IS ASSOCIATED WITH INCREASING DNA PROMOTER METHYLATION |
| 1458 |
DISORDER OF G2-M CHECKPOINT CONTROL IN ANILINE-INDUCED CELL PROLIFERATION IN RAT SPLEEN |
| 1459 |
DISORDERED APP METABOLISM AND NEUROVASCULATURE IN TRAUMA AND AGING: COMBINED RISKS FOR CHRONIC NEURODEGENERATIVE DISORDERS |
| 1460 |
DISORDERS OF CONSCIOUSNESS AND PHARMACEUTICALS THAT ACT ON OXYGEN BASED AMINO ACID AND MONOAMINE NEUROTRANSMITTER PATHWAYS OF THE BRAIN |
| 1461 |
DISRUPTION OF RCAN1 |
| 1462 |
DISRUPTION OF TET2 PROMOTES THE THERAPEUTIC EFFICACY OF CD19-TARGETED T CELLS |
| 1463 |
DISSECTING COMPLEX EPIGENETIC ALTERATIONS IN HUMAN LUPUS |
| 1464 |
DISSECTING THE HETEROGENEITY OF EXHAUSTED T CELLS AT THE MOLECULAR LEVEL |
| 1465 |
DISSECTING THE ROLE OF ABERRANT DNA METHYLATION IN HUMAN LEUKAEMIA |
| 1466 |
DISTINCT ACTIONS OF ANCESTRAL VINCLOZOLIN AND JUVENILE STRESS ON NEURAL GENE EXPRESSION IN THE MALE RAT |
| 1467 |
DISTINCT CLINICAL AND GENETIC FEATURES OF HEPATITIS B VIRUS-ASSOCIATED FOLLICULAR LYMPHOMA IN CHINESE PATIENTS |
| 1468 |
DISTINCT EPIGENETIC PROGRAMS REGULATE CARDIAC MYOCYTE DEVELOPMENT AND DISEASE IN THE HUMAN HEART IN VIVO |
| 1469 |
DISTINCT EVOLUTIONARY PATHS IN CHRONIC LYMPHOCYTIC LEUKEMIA DURING RESISTANCE TO THE GRAFT-VERSUS-LEUKEMIA EFFECT |
| 1470 |
DISTINCT GENE EXPRESSION PROFILES IN IMMORTALIZED HUMAN UROTHELIAL CELLS EXPOSED TO INORGANIC ARSENITE AND ITS METHYLATED TRIVALENT METABOLITES |
| 1471 |
DISTINCT GLOBAL DNA METHYLATION STATUS IN B-CELL LYMPHOMAS: IMMUNOHISTOCHEMICAL STUDY OF 5-METHYLCYTOSINE AND 5-HYDROXYMETHYLCYTOSINE |
| 1472 |
DISTINCT MECHANISMS REGULATE IL1B GENE TRANSCRIPTION IN LYMPHOID CD4 T CELLS AND MONOCYTES |
| 1473 |
DISTINCT PATTERNS OF GLOBAL PROMOTER METHYLATION IN EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1474 |
DISTINCT PATTERNS OF TRANSCRIPTIONAL AND EPIGENETIC ALTERATIONS CHARACTERIZE ACUTE AND CHRONIC KIDNEY INJURY |
| 1475 |
DISTRIBUTION OF H3K27ME3, H3K9ME3, AND H3K4ME3 ALONG AUTOPHAGY-RELATED GENES HIGHLY EXPRESSED IN STARVED ZEBRAFISH MYOTUBES |
| 1476 |
DIVERSE EPIGENETIC REGULATIONS OF MACROPHAGES IN ATHEROSCLEROSIS |
| 1477 |
DIVERSE PHENOTYPIC EXPRESSION OF NPHP4 MUTATIONS IN FOUR SIBLINGS |
| 1478 |
DIVERSE ROLES OF HEPATITIS B VIRUS IN LIVER CANCER |
| 1479 |
DIVERSE TARGETS OF THE TRANSCRIPTION FACTOR STAT3 CONTRIBUTE TO T CELL PATHOGENICITY AND HOMEOSTASIS |
| 1480 |
DIVERSITY OF DYSREGULATED LONG NON-CODING RNAS IN HBV-RELATED HEPATOCELLULAR CARCINOMA |
| 1481 |
DIVERSITY OF GENOME PROFILES IN MALIGNANT LYMPHOMA |
| 1482 |
DIVERSITY, MECHANISMS, AND SIGNIFICANCE OF MACROPHAGE PLASTICITY |
| 1483 |
DKK1 IS EPIGENETICALLY DOWNREGULATED BY PROMOTER METHYLATION AND INHIBITS BILE ACID-INDUCED GASTRIC INTESTINAL METAPLASIA |
| 1484 |
DLEU2: A MEANINGFUL LONG NONCODING RNA IN ONCOGENESIS |
| 1485 |
DMRFUSION: A DIFFERENTIALLY METHYLATED REGION DETECTION TOOL BASED ON THE RANKED FUSION METHOD |
| 1486 |
DNA CYTOSINE HYDROXYMETHYLATION LEVELS ARE DISTINCT AMONG NON-OVERLAPPING CLASSES OF PERIPHERAL BLOOD LEUKOCYTES |
| 1487 |
DNA DAMAGE AND EPIGENETIC CHANGES IN KIDNEY DISEASES - FOCUSED ON TRANSCRIPTION FACTORS IN PODOCYTES |
| 1488 |
DNA DAMAGE RECOGNITION IN THE RAT ZYGOTE FOLLOWING CHRONIC PATERNAL CYCLOPHOSPHAMIDE EXPOSURE |
| 1489 |
DNA DAMAGE SIGNALLING GUARDS AGAINST ACTIVATED ONCOGENES AND TUMOUR PROGRESSION |
| 1490 |
DNA DIRECTED PRO-DOPAMINE REGULATION COUPLING SUBLUXATION REPAIR, H-WAVE((R)) AND OTHER NEUROBIOLOGICALLY BASED MODALITIES TO ADDRESS COMPLEXITIES OF CHRONIC PAIN IN A FEMALE DIAGNOSED WITH REWARD DEFICIENCY SYNDROME (RDS): EMERGENCE OF INDUCTION OF "DOPAMINE HOMEOSTASIS" IN THE FACE OF THE OPIOID CRISIS |
| 1491 |
DNA HYDROXYMETHYLATION AT THE INTERFACE OF THE ENVIRONMENT AND NONALCOHOLIC FATTY LIVER DISEASE |
| 1492 |
DNA HYDROXYMETHYLATION BY TEN-ELEVEN TRANSLOCATION METHYLCYTOSINE DIOXYGENASE 1 AND 3 REGULATES NOCICEPTIVE SENSITIZATION IN A CHRONIC INFLAMMATORY PAIN MODEL |
| 1493 |
DNA HYPERMETHYLATION AND DNA HYPOMETHYLATION IS PRESENT AT DIFFERENT LOCI IN CHRONIC KIDNEY DISEASE |
| 1494 |
DNA HYPERMETHYLATION IN HYPERHOMOCYSTEINEMIA CONTRIBUTES TO ABNORMAL EXTRACELLULAR MATRIX METABOLISM IN THE KIDNEY |
| 1495 |
DNA HYPERMETHYLATION OF CELL CYCLE (P15 AND P16) AND APOPTOTIC (P14, P53, DAPK AND TMS1) GENES IN PERIPHERAL BLOOD OF LEUKEMIA PATIENTS |
| 1496 |
DNA IS HYPOMETHYLATED IN CIRCADIAN MANIFESTATIONS OF BRUXISM |
| 1497 |
DNA METHYLATION AGE IS ACCELERATED IN ALCOHOL DEPENDENCE |
| 1498 |
DNA METHYLATION ALTERATIONS CAUSED BY LEISHMANIA INFECTION MAY GENERATE A MICROENVIRONMENT PRONE TO TUMOUR DEVELOPMENT |
| 1499 |
DNA METHYLATION ANALYSIS IN NONALCOHOLIC FATTY LIVER DISEASE SUGGESTS DISTINCT DISEASE-SPECIFIC AND REMODELING SIGNATURES AFTER BARIATRIC SURGERY |
| 1500 |
DNA METHYLATION ANALYSIS OF CD4+ T CELLS IN PATIENTS WITH PSORIASIS |
| 1501 |
DNA METHYLATION ANALYSIS OF HUMAN TISSUE-SPECIFIC CONNEXIN GENES |
| 1502 |
DNA METHYLATION AND EPIGENETIC EVENTS UNDERLYING RENAL CELL CARCINOMAS |
| 1503 |
DNA METHYLATION AND GENE EXPRESSION DIFFERENCES IN CHILDREN CONCEIVED IN VITRO OR IN VIVO |
| 1504 |
DNA METHYLATION AND HISTONE DEACETYLATION REGULATING INSULIN SENSITIVITY DUE TO CHRONIC COLD EXPOSURE |
| 1505 |
DNA METHYLATION AND HISTONE MODIFICATION IN HYPERTENSION |
| 1506 |
DNA METHYLATION AND IMMUNE CELL MARKERS DEMONSTRATE EVIDENCE OF ACCELERATED AGING IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS OR HEPATITIS C VIRUS, WITH OR WITHOUT HUMAN IMMUNODEFICIENCT VIRUS CO-INFECTION |
| 1507 |
DNA METHYLATION AND INTRA-CLONAL HETEROGENEITY: THE CHRONIC MYELOID LEUKEMIA MODEL |
| 1508 |
DNA METHYLATION AND MRNA AND MICRORNA EXPRESSION OF SLE CD4+ T CELLS CORRELATE WITH DISEASE PHENOTYPE |
| 1509 |
DNA METHYLATION AND NON-CODING RNAS DURING TISSUE-INJURY ASSOCIATED PAIN |
| 1510 |
DNA METHYLATION AND NONCODING RNA IN OA: RECENT FINDINGS AND METHODOLOGICAL ADVANCES |
| 1511 |
DNA METHYLATION AND POTENTIAL MULTIGENERATIONAL EPIGENETIC EFFECTS LINKED TO URANIUM CHRONIC LOW-DOSE EXPOSURE IN GONADS OF MALES AND FEMALES RATS |
| 1512 |
DNA METHYLATION AND PROTEIN MARKERS OF CHRONIC INFLAMMATION AND THEIR ASSOCIATIONS WITH BRAIN AND COGNITIVE AGING |
| 1513 |
DNA METHYLATION AND PSYCHOTHERAPY RESPONSE IN TRAUMA-EXPOSED MEN WITH APPETITIVE AGGRESSION |
| 1514 |
DNA METHYLATION AND THE EPIGENETIC CLOCK IN RELATION TO PHYSICAL FRAILTY IN OLDER PEOPLE: THE LOTHIAN BIRTH COHORT 1936 |
| 1515 |
DNA METHYLATION AND THE POTENTIAL ROLE OF DEMETHYLATING AGENTS IN PREVENTION OF PROGRESSIVE CHRONIC KIDNEY DISEASE |
| 1516 |
DNA METHYLATION AS A BIOMARKER OF AGING IN EPIDEMIOLOGIC STUDIES |
| 1517 |
DNA METHYLATION AS A MEDIATOR OF ASSOCIATIONS BETWEEN THE ENVIRONMENT AND CHRONIC DISEASES: A SCOPING REVIEW ON APPLICATION OF MEDIATION ANALYSIS |
| 1518 |
DNA METHYLATION AS AN EPIGENETIC MECHANISM IN THE DEVELOPMENT OF MULTIPLE SCLEROSIS |
| 1519 |
DNA METHYLATION AT ATP11A CG11702988 IS A BIOMARKER OF LUNG DISEASE SEVERITY IN CYSTIC FIBROSIS: A LONGITUDINAL STUDY |
| 1520 |
DNA METHYLATION AT DIFFERENTIALLY METHYLATED REGIONS OF IMPRINTED GENES IS RESISTANT TO DEVELOPMENTAL PROGRAMMING BY MATERNAL NUTRITION |
| 1521 |
DNA METHYLATION AT IMPRINT REGULATORY REGIONS IN PRETERM BIRTH AND INFECTION |
| 1522 |
DNA METHYLATION CHANGE PROFILING OF COLORECTAL DISEASE: SCREENING TOWARDS CLINICAL USE |
| 1523 |
DNA METHYLATION CHANGES AND INFLAMMAGING IN AGING-ASSOCIATED DISEASES |
| 1524 |
DNA METHYLATION CHANGES IN CYSTIC FIBROSIS: CAUSE OR CONSEQUENCE? TWIN AND SIBLING STUDIES HAVE SHOWN THAT LUNG DISEASE SEVERITY IS VARIABLE AMONG CYSTIC FIBROSIS (CF) PATIENTS AND AFFECTED TO THE SAME EXTENT BY GENETIC AND NONHERITABLE FACTORS |
| 1525 |
DNA METHYLATION CHANGES IN GENES INVOLVED IN INFLAMMATION AND DEPRESSION IN FIBROMYALGIA: A PILOT STUDY |
| 1526 |
DNA METHYLATION CHANGES IN GLIAL CELLS OF THE NORMAL-APPEARING WHITE MATTER IN MULTIPLE SCLEROSIS PATIENTS |
| 1527 |
DNA METHYLATION CHANGES IN LUNG IMMUNE CELLS ARE ASSOCIATED WITH GRANULOMATOUS LUNG DISEASE |
| 1528 |
DNA METHYLATION CHANGES IN REGIONAL LUNG MACROPHAGES ARE ASSOCIATED WITH METABOLIC DIFFERENCES |
| 1529 |
DNA METHYLATION CHANGES IN WHOLE BLOOD AND CD16+ NEUTROPHILS IN RESPONSE TO CHRONIC FOLIC ACID SUPPLEMENTATION IN WOMEN OF CHILDBEARING AGE |
| 1530 |
DNA METHYLATION CHANGES INDUCED BY PRENATAL TOXIC METAL EXPOSURE: AN OVERVIEW OF EPIDEMIOLOGICAL EVIDENCE |
| 1531 |
DNA METHYLATION DURING DEPLETED URANIUM-INDUCED LEUKEMIA |
| 1532 |
DNA METHYLATION DYNAMICS AND COCAINE IN THE BRAIN: PROGRESS AND PROSPECTS |
| 1533 |
DNA METHYLATION DYNAMICS DURING B CELL MATURATION UNDERLIE A CONTINUUM OF DISEASE PHENOTYPES IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1534 |
DNA METHYLATION DYNAMICS IN A COASTAL FOUNDATION SEAGRASS SPECIES UNDER ABIOTIC STRESSORS |
| 1535 |
DNA METHYLATION DYSFUNCTION IN CHRONIC KIDNEY DISEASE |
| 1536 |
DNA METHYLATION ENZYMES IN THE KIDNEYS OF MALE AND FEMALE BTBR OB/OB MICE |
| 1537 |
DNA METHYLATION IN ADOLESCENTS WITH ANXIETY DISORDER: A LONGITUDINAL STUDY |
| 1538 |
DNA METHYLATION IN ANIMAL MODELS OF PSYCHOSIS |
| 1539 |
DNA METHYLATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 1540 |
DNA METHYLATION IN GASTRIC CANCER, RELATED TO HELICOBACTER PYLORI AND EPSTEIN-BARR VIRUS |
| 1541 |
DNA METHYLATION IN GENES OF LONGEVITY-REGULATING PATHWAYS: ASSOCIATION WITH OBESITY AND METABOLIC COMPLICATIONS |
| 1542 |
DNA METHYLATION IN HAEMATOLOGICAL MALIGNANCIES: THE ROLE OF DECITABINE |
| 1543 |
DNA METHYLATION IN HEPATOCELLULAR CARCINOMA |
| 1544 |
DNA METHYLATION IN HUMAN GASTRIC EPITHELIAL CELLS DEFINES REGIONAL IDENTITY WITHOUT RESTRICTING LINEAGE PLASTICITY |
| 1545 |
DNA METHYLATION IN LIVER TUMORIGENESIS IN FISH FROM THE ENVIRONMENT |
| 1546 |
DNA METHYLATION IN NASAL EPITHELIUM: STRENGTHS AND LIMITATIONS OF AN EMERGENT BIOMARKER FOR CHILDHOOD ASTHMA |
| 1547 |
DNA METHYLATION IN OSTEOARTHRITIS |
| 1548 |
DNA METHYLATION IN THE DEVELOPING HIPPOCAMPUS AND AMYGDALA OF ANXIETY-PRONE VERSUS RISK-TAKING RATS |
| 1549 |
DNA METHYLATION IN THE HUMAN CEREBRAL CORTEX IS DYNAMICALLY REGULATED THROUGHOUT THE LIFE SPAN AND INVOLVES DIFFERENTIATED NEURONS |
| 1550 |
DNA METHYLATION IS ASSOCIATED WITH AIRFLOW OBSTRUCTION IN PATIENTS LIVING WITH HIV |
| 1551 |
DNA METHYLATION IS GLOBALLY DISRUPTED AND ASSOCIATED WITH EXPRESSION CHANGES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE SMALL AIRWAYS |
| 1552 |
DNA METHYLATION IS PREDICTIVE OF MORTALITY IN CURRENT AND FORMER SMOKERS |
| 1553 |
DNA METHYLATION LEVELS ASSOCIATED WITH RACE AND CHILDHOOD ASTHMA SEVERITY |
| 1554 |
DNA METHYLATION LEVELS OF RELN PROMOTER REGION IN ULTRA-HIGH RISK, FIRST EPISODE AND CHRONIC SCHIZOPHRENIA COHORTS OF SCHIZOPHRENIA |
| 1555 |
DNA METHYLATION MAPPING IDENTIFIES GENE REGULATORY EFFECTS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 1556 |
DNA METHYLATION MODIFICATIONS ASSOCIATED WITH CHRONIC FATIGUE SYNDROME |
| 1557 |
DNA METHYLATION MODIFICATIONS INDUCED BY HEXAVALENT CHROMIUM |
| 1558 |
DNA METHYLATION MODULATES AGING PROCESS IN ADIPOCYTES |
| 1559 |
DNA METHYLATION MODULATES NOCICEPTIVE SENSITIZATION AFTER INCISION |
| 1560 |
DNA METHYLATION OF ALZHEIMER DISEASE AND TAUOPATHY-RELATED GENES IN POSTMORTEM BRAIN |
| 1561 |
DNA METHYLATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH DIFFERENTIAL RESPONSE TO CHEMOTHERAPY |
| 1562 |
DNA METHYLATION OF ENHANCER ELEMENTS IN MYELOID NEOPLASMS: THINK OUTSIDE THE PROMOTERS? GENE REGULATION THROUGH DNA METHYLATION IS A WELL DESCRIBED PHENOMENON THAT HAS A PROMINENT ROLE IN PHYSIOLOGICAL AND PATHOLOGICAL CELL-STATES |
| 1563 |
DNA METHYLATION OF METHYLATION COMPLEX GENES IN RELATION TO STRESS AND GENOME-WIDE METHYLATION IN MOTHER-NEWBORN DYADS |
| 1564 |
DNA METHYLATION OF PROXIMAL PLAT PROMOTER IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS |
| 1565 |
DNA METHYLATION OF T LYMPHOCYTES AS A THERAPEUTIC TARGET: IMPLICATIONS FOR RHEUMATOID ARTHRITIS ETIOLOGY |
| 1566 |
DNA METHYLATION OF TH1/TH2 CYTOKINE GENES AFFECTS SENSITIZATION AND PROGRESS OF EXPERIMENTAL ASTHMA |
| 1567 |
DNA METHYLATION OF THE KLF14 GENE REGION IN WHOLE BLOOD CELLS PROVIDES PREDICTION FOR THE CHRONIC INFLAMMATION IN THE ADIPOSE TISSUE |
| 1568 |
DNA METHYLATION OF TUMOR-SUPPRESSOR MIRNA GENES IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1569 |
DNA METHYLATION OF TXNIP INDEPENDENTLY ASSOCIATED WITH INFLAMMATION AND DIABETES MELLITUS IN TWINS |
| 1570 |
DNA METHYLATION PATTERNS IN CD4(+) T-CELLS SEPARATE PSORIASIS PATIENTS FROM HEALTHY CONTROLS, AND SKIN PSORIASIS FROM PSORIATIC ARTHRITIS |
| 1571 |
DNA METHYLATION PATTERNS IN CD8(+) T CELLS DISCERN PSORIASIS FROM PSORIATIC ARTHRITIS AND CORRELATE WITH CUTANEOUS DISEASE ACTIVITY |
| 1572 |
DNA METHYLATION PATTERNS IN JUVENILE SYSTEMIC SCLEROSIS AND LOCALIZED SCLERODERMA |
| 1573 |
DNA METHYLATION PATTERNS IN NEWBORNS EXPOSED TO TOBACCO IN UTERO |
| 1574 |
DNA METHYLATION PATTERNS OF CHRONIC EXPLOSIVE BREACHING IN U |
| 1575 |
DNA METHYLATION PATTERNS OF GENES RELATED TO IMMUNE RESPONSE IN THE DIFFERENT CLINICAL FORMS OF ORAL LICHEN PLANUS |
| 1576 |
DNA METHYLATION PROFILE ASSOCIATED WITH RAPID DECLINE IN KIDNEY FUNCTION: FINDINGS FROM THE CRIC STUDY |
| 1577 |
DNA METHYLATION PROFILE IN CHRONIC MYELOMONOCYTIC LEUKEMIA ASSOCIATES WITH DISTINCT CLINICAL, BIOLOGICAL AND GENETIC FEATURES |
| 1578 |
DNA METHYLATION PROFILE OF A RURAL COHORT EXPOSED TO EARLY-ADVERSITY AND MALNUTRITION: AN EXPLORATORY ANALYSIS |
| 1579 |
DNA METHYLATION PROFILE OF LIVER OF MICE CONCEIVED BY IN VITRO FERTILIZATION |
| 1580 |
DNA METHYLATION PROFILES ARE ASSOCIATED WITH COMPLEX REGIONAL PAIN SYNDROME AFTER TRAUMATIC INJURY |
| 1581 |
DNA METHYLATION PROFILES IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH CHEMOIMMUNOTHERAPY |
| 1582 |
DNA METHYLATION PROFILES IN PRECANCEROUS TISSUE AND CANCERS: CARCINOGENETIC RISK ESTIMATION AND PROGNOSTICATION BASED ON DNA METHYLATION STATUS |
| 1583 |
DNA METHYLATION PROFILES OF BLOOD CELLS ARE DISTINCT BETWEEN EARLY-ONSET OBESE AND CONTROL INDIVIDUALS |
| 1584 |
DNA METHYLATION PROFILES OF SELECTED PRO-INFLAMMATORY CYTOKINES IN ALZHEIMER DISEASE |
| 1585 |
DNA METHYLATION PROFILING IDENTIFIES EPIGENETIC DIFFERENCES BETWEEN DIABETES PATIENTS WITH ESRD AND DIABETES PATIENTS WITHOUT NEPHROPATHY |
| 1586 |
DNA METHYLATION PROFILING IDENTIFIES EPIGENETIC DIFFERENCES BETWEEN EARLY VERSUS LATE STAGES OF DIABETIC CHRONIC KIDNEY DISEASE |
| 1587 |
DNA METHYLATION PROFILING IDENTIFIES NOVEL MARKERS OF PROGRESSION IN HEPATITIS B-RELATED CHRONIC LIVER DISEASE |
| 1588 |
DNA METHYLATION PROFILING IMPLICATES EXPOSURE TO PCBS IN THE PATHOGENESIS OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1589 |
DNA METHYLATION PROFILING IN A CIGARETTE SMOKE-EXPOSED MOUSE MODEL OF AIRWAY INFLAMMATION |
| 1590 |
DNA METHYLATION PROFILING IN HUMAN LUNG TISSUE IDENTIFIES GENES ASSOCIATED WITH COPD |
| 1591 |
DNA METHYLATION PROFILING IN PERIPHERAL LUNG TISSUES OF SMOKERS AND PATIENTS WITH COPD |
| 1592 |
DNA METHYLATION PROFILING OF GENOMIC DNA ISOLATED FROM URINE IN DIABETIC CHRONIC KIDNEY DISEASE: A PILOT STUDY |
| 1593 |
DNA METHYLATION PROFILING REVEALS A PATHOLOGICAL SIGNATURE THAT CONTRIBUTES TO TRANSCRIPTIONAL DEFECTS OF CD34(+) CD15(-) CELLS IN EARLY CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA |
| 1594 |
DNA METHYLATION PROFILING REVEALS DIFFERENCES IN THE 3 HUMAN MONOCYTE SUBSETS AND IDENTIFIES UREMIA TO INDUCE DNA METHYLATION CHANGES DURING DIFFERENTIATION |
| 1595 |
DNA METHYLATION PROVIDES INSIGHT INTO INTERGENERATIONAL RISK FOR PRETERM BIRTH IN AFRICAN AMERICANS |
| 1596 |
DNA METHYLATION REDUCES THE YES-ASSOCIATED PROTEIN 1/WW DOMAIN CONTAINING TRANSCRIPTION REGULATOR 1 PATHWAY AND PREVENTS PATHOLOGIC REMODELING DURING BLADDER OBSTRUCTION BY LIMITING EXPRESSION OF BDNF |
| 1597 |
DNA METHYLATION REGULATED GENE EXPRESSION IN ORGAN FIBROSIS |
| 1598 |
DNA METHYLATION SIGNATURE IN MONONUCLEAR CELLS AND PROINFLAMMATORY CYTOKINES MAY DEFINE MOLECULAR SUBTYPES IN SPORADIC MENIERE DISEASE |
| 1599 |
DNA METHYLATION SIGNATURE OF CHILDHOOD CHRONIC PHYSICAL AGGRESSION IN T CELLS OF BOTH MEN AND WOMEN |
| 1600 |
DNA METHYLATION SIGNATURES OF ALZHEIMER'S DISEASE NEUROPATHOLOGY IN THE CORTEX ARE PRIMARILY DRIVEN BY VARIATION IN NON-NEURONAL CELL-TYPES |
| 1601 |
DNA METHYLATION SIGNATURES OF FUNCTIONAL SOMATIC SYNDROMES: SYSTEMATIC REVIEW |
| 1602 |
DNA METHYLATION SIGNATURES OF PULMONARY ARTERIAL SMOOTH MUSCLE CELLS IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION |
| 1603 |
DNA METHYLATION STUDIES IN SALIVA OF PATIENTS WITH SJOGREN'S SYNDROME |
| 1604 |
DNA METHYLATION SUSTAINS "INFLAMED" MEMORY OF PERIPHERAL IMMUNE CELLS AGGRAVATING KIDNEY INFLAMMATORY RESPONSE IN CHRONIC KIDNEY DISEASE |
| 1605 |
DNA METHYLATION YIELDS EPIGENETIC CLUES INTO THE DIABETIC NEPHROPATHY OF PIMA INDIANS |
| 1606 |
DNA METHYLATION, BACTERIA AND AIRWAY INFLAMMATION: LATEST INSIGHTS |
| 1607 |
DNA METHYLATION, COLON CANCER AND MEDITERRANEAN DIET: RESULTS FROM THE EPIC-ITALY COHORT |
| 1608 |
DNA METHYLATION-GOVERNED GENE EXPRESSION IN AUTOIMMUNE ARTHRITIS |
| 1609 |
DNA METHYLATION-INDEPENDENT GROWTH RESTRICTION AND ALTERED DEVELOPMENTAL PROGRAMMING IN A MOUSE MODEL OF PRECONCEPTION MALE ALCOHOL EXPOSURE |
| 1610 |
DNA METHYLATION/DEMETHYLATION NETWORK EXPRESSION IN PSYCHOTIC PATIENTS WITH A HISTORY OF ALCOHOL ABUSE |
| 1611 |
DNA METHYLATION: A NEW PLAYER IN MULTIPLE SCLEROSIS |
| 1612 |
DNA METHYLATION: A TARGET IN NEUROPATHIC PAIN |
| 1613 |
DNA METHYLTRANSFERASE 1 MEDIATED ABERRANT METHYLATION AND SILENCING OF SHP-1 GENE IN CHRONIC MYELOGENOUS LEUKEMIA CELLS |
| 1614 |
DNA METHYLTRANSFERASE 3A IS INVOLVED IN THE SUSTAINED EFFECTS OF CHRONIC STRESS ON SYNAPTIC FUNCTIONS AND BEHAVIORS |
| 1615 |
DNA METHYLTRANSFERASE 3B PLAYS A PROTECTIVE ROLE AGAINST HEPATOCARCINOGENESIS CAUSED BY CHRONIC INFLAMMATION VIA MAINTAINING MITOCHONDRIAL HOMEOSTASIS |
| 1616 |
DNA METHYLTRANSFERASE AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES |
| 1617 |
DNA METHYLTRANSFERASE EXPRESSION AND DNA METHYLATION IN HUMAN HEPATOCELLULAR CARCINOMA AND THEIR CLINICOPATHOLOGICAL CORRELATION |
| 1618 |
DNA METHYLTRANSFERASE INHIBITORS INCREASE NOD-LIKE RECEPTOR ACTIVITY AND EXPRESSION IN A MONOCYTIC CELL LINE |
| 1619 |
DNA METHYLTRANSFERASE REGULATES NITRIC OXIDE HOMEOSTASIS AND VIRULENCE IN A CHRONICALLY ADAPTED PSEUDOMONAS AERUGINOSA STRAIN |
| 1620 |
DNA METHYLTRANSFERASE-MEDIATED TRANSCRIPTIONAL SILENCING IN MALIGNANT GLIOMA: A COMBINED WHOLE-GENOME MICROARRAY AND PROMOTER ARRAY ANALYSIS |
| 1621 |
DNA METHYLTRANSFERASES AS TARGETS FOR CANCER THERAPY |
| 1622 |
DNA METHYLTRANSFERASES IN MALAR MELASMA AND THEIR MODIFICATION BY SUNSCREEN IN COMBINATION WITH 4% NIACINAMIDE, 0 |
| 1623 |
DNA MODIFICATIONS IN MODELS OF ALCOHOL USE DISORDERS |
| 1624 |
DNA-METHYLOME-BASED TUMOR HYPOXIA CLASSIFIER IDENTIFIES HPV-NEGATIVE HEAD AND NECK CANCER PATIENTS AT RISK FOR LOCOREGIONAL RECURRENCE AFTER PRIMARY RADIOCHEMOTHERAPY |
| 1625 |
DNAM-BASED SIGNATURES OF ACCELERATED AGING AND MORTALITY IN BLOOD ARE ASSOCIATED WITH LOW RENAL FUNCTION |
| 1626 |
DNMT1 MEDIATES CHRONIC PAIN-RELATED DEPRESSION BY INHIBITING GABAERGIC NEURONAL ACTIVATION IN THE CENTRAL AMYGDALA |
| 1627 |
DNMT1 MODULATION IN CHRONIC HEPATITIS B PATIENTS AND HYPOTHETIC INFLUENCE ON MITOCHONDRIAL DNA METHYLATION STATUS DURING LONG-TERM NUCLEO(T)SIDE ANALOGS THERAPY |
| 1628 |
DNMT3A AND TET2 DOMINATE CLONAL HEMATOPOIESIS AND DEMONSTRATE BENIGN PHENOTYPES AND DIFFERENT GENETIC PREDISPOSITIONS |
| 1629 |
DNMT3A ARG882 MUTATION DRIVES CHRONIC MYELOMONOCYTIC LEUKEMIA THROUGH DISTURBING GENE EXPRESSION/DNA METHYLATION IN HEMATOPOIETIC CELLS |
| 1630 |
DNMT3A CONTRIBUTES TO THE DEVELOPMENT AND MAINTENANCE OF BONE CANCER PAIN BY SILENCING KV1 |
| 1631 |
DNMT3A METHYLATION IN NEUROPATHIC PAIN |
| 1632 |
DNMTS ARE INVOLVED IN TGF-BETA1-INDUCED EPITHELIAL-MESENCHYMAL TRANSITIONS IN AIRWAY EPITHELIAL CELLS |
| 1633 |
DO EPIGENETIC EVENTS TAKE PLACE IN THE VASTUS LATERALIS OF PATIENTS WITH MILD CHRONIC OBSTRUCTIVE PULMONARY DISEASE? MUSCLE DYSFUNCTION IS A MAJOR COMORBIDITY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) |
| 1634 |
DOCOSAHEXAENOIC ACID ALTERS LIPID METABOLISM PROCESSES VIA H3K9AC EPIGENETIC MODIFICATION IN DAIRY GOAT |
| 1635 |
DOES A SINGLE BOUT OF EXERCISE IMPACTS BDNF, OXIDATIVE STRESS AND EPIGENETIC MARKERS IN SPINAL CORD INJURY PATIENTS? OUR AIM WAS TO EVALUATE THE IMPACT OF A SINGLE BOUT OF EXERCISE, CONSISTING OF A GAIT TRAINING SESSION WITH BODY WEIGHT SUPPORT (BWS), ON HISTONE ACETYLATION STATUS (GLOBAL HISTONE H4 AND H3 ACETYLATION LEVELS), BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) LEVELS, AND OXIDATIVE STRESS MARKERS IN PERIPHERAL BLOOD OF INDIVIDUALS WITH CHRONIC SPINAL CORD INJURY (SCI) |
| 1636 |
DOES AGEING AFFECT ZINC HOMEOSTASIS AND DIETARY REQUIREMENTS? DIETARY INTAKES OF ZINC ARE LOWER IN THE ELDERLY BECAUSE OF REDUCED ENERGY REQUIREMENTS, AND IT IS NOT CLEAR WHETHER AGEING IMPACTS ON ADAPTIVE HOMEOSTATIC MECHANISMS, NAMELY ABSORPTIVE EFFICIENCY AND ENDOGENOUS LOSSES IN THE GI TRACT |
| 1637 |
DOES DYSREGULATION OF KEY EPIGENETIC AND BIOCHEMICAL PATHWAYS OCCUR IN POSTULATED VASOACTIVE NEUROPEPTIDE AUTOIMMUNE DISORDERS? AUTOIMMUNE DYSFUNCTION OF CERTAIN VASOACTIVE NEUROPEPTIDES (VNS) HAS BEEN POSTULATED AS A CONTRIBUTING CAUSE OF SUDDEN INFANT DEATH SYNDROME (SIDS), CHRONIC FATIGUE SYNDROME (CFS), GULF WAR SYNDROME (GWS) AND OTHER FATIGUE-RELATED DISORDERS |
| 1638 |
DOES EARLY WEANING SHAPE FUTURE ENDOCRINE AND METABOLIC DISORDERS? LESSONS FROM ANIMAL MODELS |
| 1639 |
DOES EPIGENETIC 'MEMORY' OF EARLY-LIFE STRESS PREDISPOSE TO CHRONIC PAIN IN LATER LIFE? A POTENTIAL ROLE FOR THE STRESS REGULATOR FKBP5 |
| 1640 |
DOES EPIGENETICS PLAY A ROLE IN HUMAN ASTHMA? ASTHMA AND OTHER ALLERGIC DISEASES ARE AMONG THE MOST PREVALENT CHRONIC NON-COMMUNICABLE DISEASES OF CHILDHOOD |
| 1641 |
DOES GUT-BREAST MICROBIOTA AXIS ORCHESTRATES CANCER PROGRESSION? BREAST CANCER, EVEN TODAY, CAN CAUSE DEATH |
| 1642 |
DOES INFLAMMATION AFFECT OUTCOMES IN DIALYSIS PATIENTS? CHRONIC, LOW-GRADE INFLAMMATION IS A COMMON COMORBID CONDITION IN CHRONIC KIDNEY DISEASE (CKD), AND PARTICULARLY IN CHRONIC DIALYSIS PATIENTS |
| 1643 |
DOES RHEUMATOID ARTHRITIS REPRESENT AN ADAPTIVE, THRIFTY CONDITION? THE PRESENT ARTICLE PRESENTS EPIDEMIOLOGICAL, AND COMPARATIVE EVIDENCE SUPPORTING THE HYPOTHESIS THAT RHEUMATOID ARTHRITIS (RA) MAY REPRESENT A THRIFTY ADAPTATION SELECTED TO COMPEL ANIMALS TO MINIMIZE VOLUNTARY ENERGY EXPENDITURE |
| 1644 |
DOES THE ENVIRONMENT AFFECT MENOPAUSE? A REVIEW OF THE EFFECTS OF ENDOCRINE DISRUPTING CHEMICALS ON MENOPAUSE |
| 1645 |
DOES THE EPIGENETIC CLOCK GRIMAGE PREDICT MORTALITY INDEPENDENT OF GENETIC INFLUENCES: AN 18 YEAR FOLLOW-UP STUDY IN OLDER FEMALE TWIN PAIRS |
| 1646 |
DOES THE HEPATITIS B ANTIGEN HBX PROMOTE THE APPEARANCE OF LIVER CANCER STEM CELLS? HEPATITIS B VIRUS (HBV) IS A MAJOR ETIOLOGIC AGENT OF CHRONIC LIVER DISEASE AND HEPATOCELLULAR CARCINOMA (HCC) |
| 1647 |
DOES THE STRESS OF LABORATORY LIFE AND EXPERIMENTATION ON ANIMALS ADVERSELY AFFECT RESEARCH DATA? A CRITICAL REVIEW |
| 1648 |
DOES THE UREMIC MILIEU AFFECT THE EPIGENOTYPE? EPIGENETICS IS A DISCIPLINE THAT FOR MANY YEARS HAS LANGUISHED IN THE SHADOW OF ITS GENOMIC BIG BROTHER |
| 1649 |
DOG LEUKOCYTE ANTIGEN (DLA) CLASS II GENOTYPES ASSOCIATED WITH CHRONIC ENTEROPATHY IN FRENCH BULLDOGS AND MINIATURE DACHSHUNDS |
| 1650 |
DOMAIN-SELECTIVE TARGETING OF BET PROTEINS IN CANCER AND IMMUNOLOGICAL DISEASES |
| 1651 |
DOPAMINE AND GLUCOSE, OBESITY, AND REWARD DEFICIENCY SYNDROME |
| 1652 |
DOPAMINE SIGNALING LEADS TO LOSS OF POLYCOMB REPRESSION AND ABERRANT GENE ACTIVATION IN EXPERIMENTAL PARKINSONISM |
| 1653 |
DOPAMINE TRANSPORTER KNOCKOUT RATS DISPLAY EPIGENETIC ALTERATIONS IN RESPONSE TO COCAINE EXPOSURE |
| 1654 |
DORSAL ROOT GANGLIA COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 CONTRIBUTES TO PERIPHERAL NERVE INJURY-INDUCED PAIN HYPERSENSITIVITIES |
| 1655 |
DOSE-DEPENDENCE, SEX- AND TISSUE-SPECIFICITY, AND PERSISTENCE OF RADIATION-INDUCED GENOMIC DNA METHYLATION CHANGES |
| 1656 |
DOUBLE STRAND BREAKS CAN INITIATE GENE SILENCING AND SIRT1-DEPENDENT ONSET OF DNA METHYLATION IN AN EXOGENOUS PROMOTER CPG ISLAND |
| 1657 |
DOWN-EXPRESSION OF MIR-152 LEAD TO IMPAIRED ANTI-TUMOR EFFECT OF NK VIA UPREGULATION OF HLA-G |
| 1658 |
DOWN-REGULATION OF A PRO-APOPTOTIC PATHWAY REGULATED BY PCAF/ADA3 IN EARLY STAGE GASTRIC CANCER |
| 1659 |
DOWN-REGULATION OF CANDIDATE TUMOR SUPPRESSOR GENES WITHIN CHROMOSOME BAND 13Q14 |
| 1660 |
DOWN-REGULATION OF HEMATOPOIESIS MASTER REGULATOR PU |
| 1661 |
DOWN-REGULATION OF REDUCED FOLATE CARRIER GENE (RFC1) EXPRESSION AFTER EXPOSURE TO METHOTREXATE IN ZR-75-1 BREAST CANCER CELLS |
| 1662 |
DOWNREGULATION OF DEATH-ASSOCIATED PROTEIN KINASE 1 (DAPK1) IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1663 |
DOWNREGULATION OF DNA METHYLTRANSFERASE-3A AMELIORATES THE OSTEOGENIC DIFFERENTIATION ABILITY OF ADIPOSE-DERIVED STEM CELLS IN DIABETIC OSTEOPOROSIS VIA WNT/BETA-CATENIN SIGNALING PATHWAY |
| 1664 |
DOWNREGULATION OF GADD45BETA EXPRESSION BY HEPATITIS C VIRUS LEADS TO DEFECTIVE CELL CYCLE ARREST |
| 1665 |
DOWNREGULATION OF KIDNEY PROTECTIVE FACTORS BY INFLAMMATION: ROLE OF TRANSCRIPTION FACTORS AND EPIGENETIC MECHANISMS |
| 1666 |
DOWNREGULATION OF MICRORNA-145A-5P PROMOTES STEATOSIS-TO-NASH PROGRESSION THROUGH UPREGULATION OF NR4A2 |
| 1667 |
DOWNREGULATION OF PCAF BY MIR-181A/B PROVIDES FEEDBACK REGULATION TO TNF-ALPHA-INDUCED TRANSCRIPTION OF PROINFLAMMATORY GENES IN LIVER EPITHELIAL CELLS |
| 1668 |
DOWNREGULATION OF SOCS1 INCREASES INTERFERON-INDUCED ISGYLATION DURING DIFFERENTIATION OF INDUCED-PLURIPOTENT STEM CELLS TO HEPATOCYTES |
| 1669 |
DOWNREGULATION OF THE HISTONE METHYLTRANSFERASE SETD2 PROMOTES IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKAEMIA CELLS |
| 1670 |
DRAWING A LINE BETWEEN HISTONE DEMETHYLASE KDM5A AND KDM5B: THEIR ROLES IN DEVELOPMENT AND TUMORIGENESIS |
| 1671 |
DRD2 METHYLATION IS ASSOCIATED WITH EXECUTIVE CONTROL NETWORK CONNECTIVITY AND SEVERITY OF ALCOHOL PROBLEMS AMONG A SAMPLE OF POLYSUBSTANCE USERS |
| 1672 |
DRD4 METHYLATION AS A POTENTIAL BIOMARKER FOR PHYSICAL AGGRESSION: AN EPIGENOME-WIDE, CROSS-TISSUE INVESTIGATION |
| 1673 |
DRIVER GENE MUTATIONS AND EPIGENETICS IN COLORECTAL CANCER |
| 1674 |
DRIVER MUTATIONS IN LEUKEMIA PROMOTE DISEASE PATHOGENESIS THROUGH A COMBINATION OF CELL-AUTONOMOUS AND NICHE MODULATION |
| 1675 |
DRP1-MEDIATED MITOCHONDRIAL FISSION PROMOTES RENAL FIBROBLAST ACTIVATION AND FIBROGENESIS |
| 1676 |
DRUG ADDICTION: FROM BENCH TO BEDSIDE |
| 1677 |
DRUG ADDICTION: HYPERKATIFEIA/NEGATIVE REINFORCEMENT AS A FRAMEWORK FOR MEDICATIONS DEVELOPMENT |
| 1678 |
DRUG REPURPOSING AT THE INTERFACE OF MELANOMA IMMUNOTHERAPY AND AUTOIMMUNE DISEASE |
| 1679 |
DRUG RESISTANCE IN GIARDIA DUODENALIS |
| 1680 |
DRUG TARGET IDENTIFICATION AND DRUG REPURPOSING IN PSORIASIS THROUGH SYSTEMS BIOLOGY APPROACH, DNN-BASED DTI MODEL AND GENOME-WIDE MICROARRAY DATA |
| 1681 |
DRUG-INDUCED LIVER INJURY: MECHANISMS, TYPES AND BIOMARKERS |
| 1682 |
DRUG-MICROENVIRONMENT PERTURBATIONS REVEAL RESISTANCE MECHANISMS AND PROGNOSTIC SUBGROUPS IN CLL |
| 1683 |
DRUG-RESISTANT EPILEPSY: DRUG TARGET HYPOTHESIS AND BEYOND THE RECEPTORS |
| 1684 |
DRUG-TOLERANT CANCER CELLS SHOW REDUCED TUMOR-INITIATING CAPACITY: DEPLETION OF CD44 CELLS AND EVIDENCE FOR EPIGENETIC MECHANISMS |
| 1685 |
DRUGGABLE BIOCHEMICAL PATHWAYS AND POTENTIAL THERAPEUTIC ALTERNATIVES TO TARGET LEUKEMIC STEM CELLS AND ELIMINATE THE RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA |
| 1686 |
DRUGGING THE PAIN EPIGENOME |
| 1687 |
DRUGS OF ABUSE: EPIGENETIC MECHANISMS IN TOXICITY AND ADDICTION |
| 1688 |
DUAL BET/HDAC INHIBITION TO RELIEVE NEUROPATHIC PAIN: RECENT ADVANCES, PERSPECTIVES, AND FUTURE OPPORTUNITIES |
| 1689 |
DUAL HDAC/BRD4 INHIBITORS RELIEVES NEUROPATHIC PAIN BY ATTENUATING INFLAMMATORY RESPONSE IN MICROGLIA AFTER SPARED NERVE INJURY |
| 1690 |
DUAL ROLES OF CHROMATIN REMODELING PROTEIN BRG1 IN ANGIOTENSIN II-INDUCED ENDOTHELIAL-MESENCHYMAL TRANSITION |
| 1691 |
DUCTAL CELLS OF MINOR SALIVARY GLANDS IN SJOGREN'S SYNDROME EXPRESS LINE-1 ORF2P AND APOBEC3B |
| 1692 |
DURATION OF EXPOSURE TO EPIDURAL ANESTHESIA AT DELIVERY, DNA METHYLATION IN UMBILICAL CORD BLOOD AND THEIR ASSOCIATION WITH OFFSPRING ASTHMA IN NON-HISPANIC BLACK WOMEN |
| 1693 |
DUSP4 DEFICIENCY CAUSED BY PROMOTER HYPERMETHYLATION DRIVES JNK SIGNALING AND TUMOR CELL SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA |
| 1694 |
DUST MITE ALLERGEN-SPECIFIC IMMUNOTHERAPY INCREASES IL4 DNA METHYLATION AND INDUCES DER P-SPECIFIC T CELL TOLERANCE IN CHILDREN WITH ALLERGIC ASTHMA |
| 1695 |
DYNAMIC ASSOCIATION OF P300 WITH THE PROMOTER OF THE G PROTEIN-COUPLED RAT DELTA OPIOID RECEPTOR GENE DURING NGF-INDUCED NEURONAL DIFFERENTIATION |
| 1696 |
DYNAMIC DNA METHYLATION CHANGES IN EARLY VERSUS LATE ADULTHOOD SUGGEST NONDETERMINISTIC EFFECTS OF CHILDHOOD ADVERSITY: A META-ANALYSIS |
| 1697 |
DYNAMIC DNA METHYLATION CONTROLS GLUTAMATE RECEPTOR TRAFFICKING AND SYNAPTIC SCALING |
| 1698 |
DYNAMIC EFFECTS OF EARLY ADOLESCENT STRESS ON DEPRESSIVE-LIKE BEHAVIORS AND EXPRESSION OF CYTOKINES AND JMJD3 IN THE PREFRONTAL CORTEX AND HIPPOCAMPUS OF RATS |
| 1699 |
DYNAMIC EPIGENETIC CHANGES DURING A RELAPSE AND RECOVERY CYCLE IN MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME |
| 1700 |
DYNAMIC EXPRESSION OF ZNF382 AND ITS TUMOR-SUPPRESSOR ROLE IN HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOGENESIS |
| 1701 |
DYNAMIC IMMUNE/INFLAMMATION PRECISION MEDICINE: THE GOOD AND THE BAD INFLAMMATION IN INFECTION AND CANCER |
| 1702 |
DYNAMIC SELF-GUIDING ANALYSIS OF ALZHEIMER'S DISEASE |
| 1703 |
DYNAMICS AND EPIGENETIC SIGNATURE OF REGULATORY T-CELLS FOLLOWING ANTIRETROVIRAL THERAPY INITIATION IN ACUTE HIV INFECTION |
| 1704 |
DYNAMICS OF MINIMAL RESIDUAL DISEASE IN NEUROBLASTOMA PATIENTS |
| 1705 |
DYNAMICS OF SMOKING-INDUCED GENOME-WIDE METHYLATION CHANGES WITH TIME SINCE SMOKING CESSATION |
| 1706 |
DYNORPHIN/KOP AND NOCICEPTIN/NOP GENE EXPRESSION AND EPIGENETIC CHANGES BY COCAINE IN RAT STRIATUM AND NUCLEUS ACCUMBENS |
| 1707 |
DYSBIOTIC 1-CARBON METABOLISM IN CARDIAC MUSCLE REMODELING |
| 1708 |
DYSFUNCTION OF ENDOTHELIAL PROGENITOR CELLS FROM SMOKERS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS DUE TO INCREASED DNA DAMAGE AND SENESCENCE |
| 1709 |
DYSFUNCTIONAL ERG SIGNALING DRIVES PULMONARY VASCULAR AGING AND PERSISTENT FIBROSIS |
| 1710 |
DYSFUNCTIONAL IMMUNOMETABOLIC EFFECTS OF VITAMIN D DEFICIENCY, INCREASED CARDIOMETABOLIC RISK |
| 1711 |
DYSFUNCTIONAL STATE OF T CELLS OR EXHAUSTION DURING CHRONIC VIRAL INFECTIONS AND COVID-19: A REVIEW |
| 1712 |
DYSFUNCTIONAL VASCULAR ENDOTHELIUM AS A DRIVER OF ATHEROSCLEROSIS: EMERGING INSIGHTS INTO PATHOGENESIS AND TREATMENT |
| 1713 |
DYSFUNCTIONAL WOUND HEALING IN DIABETIC FOOT ULCERS: NEW CROSSROADS |
| 1714 |
DYSLEXIA AS AN ADAPTATION TO CORTICO-LIMBIC STRESS SYSTEM REACTIVITY |
| 1715 |
DYSLIPIDEMIC DIET-INDUCED MONOCYTE "PRIMING" AND DYSFUNCTION IN NON-HUMAN PRIMATES IS TRIGGERED BY ELEVATED PLASMA CHOLESTEROL AND ACCOMPANIED BY ALTERED HISTONE ACETYLATION |
| 1716 |
DYSREGULATED CD4+ T CELLS AND MICRORNAS IN MYOCARDITIS |
| 1717 |
DYSREGULATED IMMUNE SYSTEM NETWORKS IN WAR VETERANS WITH PTSD IS AN OUTCOME OF ALTERED MIRNA EXPRESSION AND DNA METHYLATION |
| 1718 |
DYSREGULATED LONG NON-CODING RNAS IN THE TEMPORAL LOBE EPILEPSY MOUSE MODEL |
| 1719 |
DYSREGULATED MICRORNAS IN THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS: A COMPREHENSIVE REVIEW |
| 1720 |
DYSREGULATED N6-METHYLADENOSINE (M(6)A) PROCESSING IN HEPATOCELLULAR CARCINOMA |
| 1721 |
DYSREGULATION OF AUTOPHAGY ACTS AS A PATHOGENIC MECHANISM OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) INDUCED BY COMMON ENVIRONMENTAL POLLUTANTS |
| 1722 |
DYSREGULATION OF BRAIN DOPAMINE SYSTEMS IN MAJOR DEPRESSIVE DISORDER |
| 1723 |
DYSREGULATION OF C-X-C MOTIF LIGAND 10 DURING AGING AND ASSOCIATION WITH COGNITIVE PERFORMANCE |
| 1724 |
DYSREGULATION OF EPIGENETIC RELATED GENES IN DIABETIC TRIGGER FINGER PATIENTS; PRELIMINARY ANALYSIS OF PATIENT-DERIVED SAMPLES |
| 1725 |
DYSREGULATION OF INFLAMMATION, OXIDATIVE STRESS, AND GLUCOSE METABOLISM-RELATED GENES AND MIRNAS IN VISCERAL ADIPOSE TISSUE OF WOMEN WITH TYPE 2 DIABETES MELLITUS |
| 1726 |
DYSREGULATION OF LNCRNAS IN RHEUMATOID ARTHRITIS: BIOMARKERS, PATHOGENESIS AND POTENTIAL THERAPEUTIC TARGETS |
| 1727 |
DYSREGULATION OF LONG NON-CODING RNAS IN MOUSE MODELS OF LOCALIZATION-RELATED EPILEPSY |
| 1728 |
DYSREGULATION OF MICRORNAS IN HYPERTROPHY AND OSSIFICATION OF LIGAMENTUM FLAVUM: NEW ADVANCES, CHALLENGES, AND POTENTIAL DIRECTIONS |
| 1729 |
DYSREGULATION OF MIR-155 EXPRESSION IN PROFESSIONAL MIXED MARTIAL ARTS (MMA) FIGHTERS |
| 1730 |
DYSREGULATION OF STEM CELL SIGNALING NETWORK DUE TO GERMLINE MUTATION, SNP, HELICOBACTER PYLORI INFECTION, EPIGENETIC CHANGE AND GENETIC ALTERATION IN GASTRIC CANCER |
| 1731 |
DYSREGULATION OF THE HISTONE DEMETHYLASE KDM6B IN ALCOHOL DEPENDENCE IS ASSOCIATED WITH EPIGENETIC REGULATION OF INFLAMMATORY SIGNALING PATHWAYS |
| 1732 |
DYSTONIA AND LEVODOPA-INDUCED DYSKINESIAS IN PARKINSON'S DISEASE: IS THERE A CONNECTION? DYSTONIA AND LEVODOPA-INDUCED DYSKINESIA (LID) ARE BOTH HYPERKINETIC MOVEMENT DISORDERS |
| 1733 |
E-CADHERIN GENE RE-EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS BY HDAC INHIBITORS |
| 1734 |
EAAT2 AS A RESEARCH TARGET IN BIPOLAR DISORDER AND UNIPOLAR DEPRESSION: A SYSTEMATIC REVIEW |
| 1735 |
EARLY AND SUSTAINED EXPANSION OF ADAPTIVE NATURAL KILLER CELLS FOLLOWING HAPLOIDENTICAL TRANSPLANTATION AND CTLA4IG-PRIMED DONOR LYMPHOCYTE INFUSIONS DISSOCIATE GRAFT-VERSUS-LEUKEMIA AND GRAFT-VERSUS-HOST EFFECTS |
| 1736 |
EARLY DETECTION AND PREVENTION OF SCHIZOPHRENIC PSYCHOSIS-A REVIEW |
| 1737 |
EARLY DETECTION OF ACCELERATED AGING AND CELLULAR DECLINE (AACD): A CONSENSUS STATEMENT |
| 1738 |
EARLY DEVELOPMENTAL CONDITIONING OF LATER HEALTH AND DISEASE: PHYSIOLOGY OR PATHOPHYSIOLOGY? EXTENSIVE EXPERIMENTAL ANIMAL STUDIES AND EPIDEMIOLOGICAL OBSERVATIONS HAVE SHOWN THAT ENVIRONMENTAL INFLUENCES DURING EARLY DEVELOPMENT AFFECT THE RISK OF LATER PATHOPHYSIOLOGICAL PROCESSES ASSOCIATED WITH CHRONIC, ESPECIALLY NONCOMMUNICABLE, DISEASE (NCD) |
| 1739 |
EARLY DNA METHYLATION CHANGES IN CHILDREN DEVELOPING BETA CELL AUTOIMMUNITY AT A YOUNG AGE |
| 1740 |
EARLY ENRICHED ENVIRONMENT PREVENTS EPIGENETIC P11 GENE CHANGES INDUCED BY ADULTHOOD STRESS IN MICE |
| 1741 |
EARLY EPIGENETIC DOWNREGULATION OF MICRORNA-192 EXPRESSION PROMOTES PANCREATIC CANCER PROGRESSION |
| 1742 |
EARLY EPIGENETIC DOWNREGULATION OF WNK2 KINASE DURING PANCREATIC DUCTAL ADENOCARCINOMA DEVELOPMENT |
| 1743 |
EARLY EPIGENOMIC AND TRANSCRIPTIONAL CHANGES REVEAL ELK-1 TRANSCRIPTION FACTOR AS A THERAPEUTIC TARGET IN HUNTINGTON'S DISEASE |
| 1744 |
EARLY LIFE ADVERSE ENVIRONMENTAL EXPOSURES INCREASE THE RISK OF UTERINE FIBROID DEVELOPMENT: ROLE OF EPIGENETIC REGULATION |
| 1745 |
EARLY LIFE ADVERSITY AS A RISK FACTOR FOR FIBROMYALGIA IN LATER LIFE |
| 1746 |
EARLY LIFE ADVERSITY, PUBERTAL TIMING, AND EPIGENETIC AGE ACCELERATION IN ADULTHOOD |
| 1747 |
EARLY LIFE ADVERSITY: EPIGENETIC REGULATION UNDERLYING DRUG ADDICTION SUSCEPTIBILITY |
| 1748 |
EARLY LIFE EVENTS AND THEIR CONSEQUENCES FOR LATER DISEASE: A LIFE HISTORY AND EVOLUTIONARY PERSPECTIVE |
| 1749 |
EARLY LIFE INTERVENTIONS CAN SHAPE AGING |
| 1750 |
EARLY LIFE STRESS AND PEDIATRIC POSTTRAUMATIC STRESS DISORDER |
| 1751 |
EARLY LIFE STRESS INCREASES STRESS VULNERABILITY THROUGH BDNF GENE EPIGENETIC CHANGES IN THE RAT HIPPOCAMPUS |
| 1752 |
EARLY LIFE STRESS RESTRICTS TRANSLATIONAL REACTIVITY IN CA3 NEURONS ASSOCIATED WITH ALTERED STRESS RESPONSES IN ADULTHOOD |
| 1753 |
EARLY LIFE STRESS TRIGGERS SUSTAINED CHANGES IN HISTONE DEACETYLASE EXPRESSION AND HISTONE H4 MODIFICATIONS THAT ALTER RESPONSIVENESS TO ADOLESCENT ANTIDEPRESSANT TREATMENT |
| 1754 |
EARLY LIFE STRESS, THE DEVELOPMENT OF AGGRESSION AND NEUROENDOCRINE AND NEUROBIOLOGICAL CORRELATES: WHAT CAN WE LEARN FROM ANIMAL MODELS? EARLY LIFE STRESS (CHILD AND ADOLESCENT ABUSE, NEGLECT AND TRAUMA) INDUCES ROBUST ALTERATIONS IN EMOTIONAL AND SOCIAL FUNCTIONING RESULTING IN ENHANCED RISK FOR THE DEVELOPMENT OF PSYCHOPATHOLOGIES SUCH AS MOOD AND AGGRESSIVE DISORDERS |
| 1755 |
EARLY NUTRITION AND LATER OUTCOMES IN PRETERM INFANTS |
| 1756 |
EARLY ONSET OF SENESCENCE AND IMBALANCED EPIDERMAL HOMEOSTASIS ACROSS THE DECADES IN PHOTOEXPOSED HUMAN SKIN: FINGERPRINTS OF INFLAMMAGING |
| 1757 |
EARLY ORIGINS OF ASTHMA (AND ALLERGY) |
| 1758 |
EARLY ORIGINS OF HEART DISEASE: LOW BIRTH WEIGHT AND THE ROLE OF THE INSULIN-LIKE GROWTH FACTOR SYSTEM IN CARDIAC HYPERTROPHY |
| 1759 |
EARLY PRECURSOR T CELLS ESTABLISH AND PROPAGATE T CELL EXHAUSTION IN CHRONIC INFECTION |
| 1760 |
EARLY PREDICTORS OF ASTHMA AND ALLERGY IN CHILDREN: THE ROLE OF EPIGENETICS |
| 1761 |
EARLY STRESS EVOKES AGE-DEPENDENT BIPHASIC CHANGES IN HIPPOCAMPAL NEUROGENESIS, BDNF EXPRESSION, AND COGNITION |
| 1762 |
EARLY TRANSCRIPTIONAL ALTERATION OF HISTONE DEACETYLASES IN A MURINE MODEL OF DOXORUBICIN-INDUCED CARDIOMYOPATHY |
| 1763 |
EARLY TRANSCRIPTIONAL AND EPIGENETIC DIVERGENCE OF CD8+ T CELLS RESPONDING TO ACUTE VERSUS CHRONIC INFECTION |
| 1764 |
EARLY-IMMEDIATE GENE EGR1 IS ASSOCIATED WITH TGFBETA1 REGULATION OF EPIGENETIC READER BROMODOMAIN-CONTAINING PROTEIN 4 VIA THE CANONICAL SMAD3 SIGNALING IN HEPATIC STELLATE CELLS IN VITRO AND IN VIVO |
| 1765 |
EARLY-LIFE ADVERSITY-INDUCED LONG-TERM EPIGENETIC PROGRAMMING ASSOCIATED WITH EARLY ONSET OF CHRONIC PHYSICAL AGGRESSION: STUDIES IN HUMANS AND ANIMALS |
| 1766 |
EARLY-LIFE EXPERIENCES AND THE DEVELOPMENT OF ADULT DISEASES WITH A FOCUS ON MENTAL ILLNESS: THE HUMAN BIRTH THEORY |
| 1767 |
EARLY-LIFE EXPOSURE TO ENDOCRINE DISRUPTING CHEMICALS AND LATER-LIFE HEALTH OUTCOMES: AN EPIGENETIC BRIDGE? A GROWING BODY OF EVIDENCE DEMONSTRATES THAT ADVERSE EVENTS EARLY IN DEVELOPMENT, AND PARTICULARLY DURING INTRAUTERINE LIFE, MAY PROGRAM RISKS FOR DISEASES IN ADULT LIFE |
| 1768 |
EARLY-LIFE LEAD EXPOSURE RESULTS IN DOSE- AND SEX-SPECIFIC EFFECTS ON WEIGHT AND EPIGENETIC GENE REGULATION IN WEANLING MICE |
| 1769 |
EARLY-LIFE NUTRITIONAL PROGRAMMING OF LONGEVITY |
| 1770 |
EARLY-LIFE ORIGIN OF ADULT INSOMNIA: DOES PRENATAL-EARLY-LIFE STRESS PLAY A ROLE? INSOMNIA IS VERY COMMON IN THE ADULT POPULATION AND IT INCLUDES A WIDE SPECTRUM OF SEQUELAE, THAT IS, NEUROENDOCRINE AND CARDIOVASCULAR ALTERATIONS AS WELL AS PSYCHIATRIC AND NEURODEGENERATIVE DISORDERS |
| 1771 |
EARLY-LIFE ORIGIN OF INTESTINAL INFLAMMATORY DISORDERS |
| 1772 |
EARLY-LIFE SOCIOECONOMIC DISADVANTAGE, NOT CURRENT, PREDICTS ACCELERATED EPIGENETIC AGING OF MONOCYTES |
| 1773 |
EARLY-LIFE STRESS-INDUCED VISCERAL HYPERSENSITIVITY AND ANXIETY BEHAVIOR IS REVERSED BY HISTONE DEACETYLASE INHIBITION |
| 1774 |
EARLY-LIFE STRESS: FROM NEUROENDOCRINE MECHANISMS TO STRESS-RELATED DISORDERS |
| 1775 |
EBV IN T-/NK-CELL TUMORIGENESIS |
| 1776 |
ECONOMIC HARDSHIP AND BIOLOGICAL WEATHERING: THE EPIGENETICS OF AGING IN A U |
| 1777 |
EDIBLE BLUE-GREEN ALGAE REDUCE THE PRODUCTION OF PRO-INFLAMMATORY CYTOKINES BY INHIBITING NF-KAPPAB PATHWAY IN MACROPHAGES AND SPLENOCYTES |
| 1778 |
EDITOR'S HIGHLIGHT: THE ALTERED DNA METHYLOME OF CHRONIC DOXORUBICIN EXPOSURE IN SPRAGUE DAWLEY RATS |
| 1779 |
EDITORIAL: MATERNAL INFLAMMATION DURING PREGNANCY: A MODIFIABLE PATHWAY TOWARD IMPROVING OFFSPRING SOCIOEMOTIONAL OUTCOMES IN CHILDHOOD AND ADOLESCENCE |
| 1780 |
EDUCATION AND LIFESTYLE FACTORS ARE ASSOCIATED WITH DNA METHYLATION CLOCKS IN OLDER AFRICAN AMERICANS |
| 1781 |
EFFECT OF 1 YEAR B AND D VITAMIN SUPPLEMENTATION ON LINE-1 REPETITIVE ELEMENT METHYLATION IN OLDER SUBJECTS |
| 1782 |
EFFECT OF A 3-WEEK MULTIDISCIPLINARY BODY WEIGHT REDUCTION PROGRAM ON THE EPIGENETIC AGE ACCELERATION IN OBESE ADULTS |
| 1783 |
EFFECT OF AGOMELATINE ON MEMORY DEFICITS AND HIPPOCAMPAL GENE EXPRESSION INDUCED BY CHRONIC SOCIAL DEFEAT STRESS IN MICE |
| 1784 |
EFFECT OF ALCOHOL CONSUMPTION ON CPG METHYLATION IN THE DIFFERENTIALLY METHYLATED REGIONS OF H19 AND IG-DMR IN MALE GAMETES: IMPLICATIONS FOR FETAL ALCOHOL SPECTRUM DISORDERS |
| 1785 |
EFFECT OF APABETALONE ON CARDIOVASCULAR EVENTS IN DIABETES, CKD, AND RECENT ACUTE CORONARY SYNDROME: RESULTS FROM THE BETONMACE RANDOMIZED CONTROLLED TRIAL |
| 1786 |
EFFECT OF ARSENIC EXPOSURE ON NRF2-KEAP1 PATHWAY AND EPIGENETIC MODIFICATION |
| 1787 |
EFFECT OF CHRONIC ALCOHOL EXPOSURE ON GUT VITAMIN B7 UPTAKE: INVOLVEMENT OF EPIGENETIC MECHANISMS AND EFFECT OF ALCOHOL METABOLITES |
| 1788 |
EFFECT OF CHRONIC ETHANOL CONSUMPTION IN RHESUS MACAQUES ON THE NUCLEUS ACCUMBENS CORE TRANSCRIPTOME |
| 1789 |
EFFECT OF CHRONIC HEROIN AND COCAINE ADMINISTRATION ON GLOBAL DNA METHYLATION IN BRAIN AND LIVER |
| 1790 |
EFFECT OF CHRONIC MILD STRESS ON HIPPOCAMPAL TRANSCRIPTOME IN MICE SELECTED FOR HIGH AND LOW STRESS-INDUCED ANALGESIA AND DISPLAYING DIFFERENT EMOTIONAL BEHAVIORS |
| 1791 |
EFFECT OF CHRONIC RADIATION ON THE FLAX (LINUM USITATISSIMUM L |
| 1792 |
EFFECT OF CHRONIC WESTERN DIETS ON NON-ALCOHOLIC FATTY LIVER OF MALE MICE MODIFYING THE PPAR-GAMMA PATHWAY VIA MIR-27B-5P REGULATION |
| 1793 |
EFFECT OF COLD ATMOSPHERIC PLASMA ON EPIGENETIC CHANGES, DNA DAMAGE, AND POSSIBILITIES FOR ITS USE IN SYNERGISTIC CANCER THERAPY |
| 1794 |
EFFECT OF DIABETES STATUS AND HYPERGLYCEMIA ON GLOBAL DNA METHYLATION AND HYDROXYMETHYLATION |
| 1795 |
EFFECT OF DIFFERENT COMBINATION OF MATERNAL AND POSTNATAL DIET ON ADIPOSE TISSUE MORPHOLOGY IN MALE RAT OFFSPRING |
| 1796 |
EFFECT OF GERM-FREE STATUS ON TRANSCRIPTIONAL PROFILES IN THE NUCLEUS ACCUMBENS AND TRANSCRIPTOMIC RESPONSE TO CHRONIC MORPHINE |
| 1797 |
EFFECT OF HELICOBACTER PYLORI ERADICATION ON GASTRIC PRECANCEROUS LESIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS |
| 1798 |
EFFECT OF HELICOBACTER PYLORI INFECTION ON GATA-5 AND TFF1 REGULATION, COMPARISON BETWEEN PEDIATRIC AND ADULT PATIENTS |
| 1799 |
EFFECT OF HELICOBACTER PYLORI INFECTION ON THE COMPOSITION OF GASTRIC MICROBIOTA IN THE DEVELOPMENT OF GASTRIC CANCER |
| 1800 |
EFFECT OF HISTONE DEACETYLASE INHIBITOR ON ETHANOL WITHDRAWAL-INDUCED HYPERALGESIA IN RATS |
| 1801 |
EFFECT OF MATERNAL DIET ON THE EPIGENOME: IMPLICATIONS FOR HUMAN METABOLIC DISEASE |
| 1802 |
EFFECT OF PATERNAL DIET ON SPERMATOGENESIS AND OFFSPRING HEALTH: FOCUS ON EPIGENETICS AND INTERVENTIONS WITH FOOD BIOACTIVE COMPOUNDS |
| 1803 |
EFFECT OF PROLONGED EMOTIONAL AND PAIN STRESS ON THE CONTENT OF METHYLCYTOSINE-BINDING PROTEIN MECP2 IN NUCLEI OF HIPPOCAMPAL NEURONS IN RATS WITH DIFFERENT EXCITABILITY OF THE NERVOUS SYSTEM |
| 1804 |
EFFECT OF RAT PARENTAL MORPHINE EXPOSURE ON PASSIVE AVOIDANCE MEMORY AND MORPHINE CONDITIONED PLACE PREFERENCE IN MALE OFFSPRING |
| 1805 |
EFFECT OF SMOKING ON THE DNA METHYLATION PATTERN OF THE SOCS1 PROMOTER IN EPITHELIAL CELLS FROM THE SALIVA OF PATIENTS WITH CHRONIC PERIODONTITIS |
| 1806 |
EFFECT OF TRANSCRIPTION INHIBITION AND GENERATION OF SUPPRESSIVE VIRAL NON-CODING RNAS |
| 1807 |
EFFECTIVE MODULATION OF INFLAMMATION AND OXIDATIVE STRESS FOR ENHANCED REGENERATION OF INTERVERTEBRAL DISCS USING 3D POROUS HYBRID PROTEIN NANOSCAFFOLD |
| 1808 |
EFFECTS OF ADOLESCENT SOCIAL STRESS AND ANTIDEPRESSANT TREATMENT ON COGNITIVE INFLEXIBILITY AND BDNF EPIGENETIC MODIFICATIONS IN THE MPFC OF ADULT MICE |
| 1809 |
EFFECTS OF ANTIPSYCHOTIC DRUGS ON THE EPIGENETIC MODIFICATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR GENE EXPRESSION IN THE HIPPOCAMPI OF CHRONIC RESTRAINT STRESS RATS |
| 1810 |
EFFECTS OF ANTIPSYCHOTICS ON THE BDNF IN SCHIZOPHRENIA |
| 1811 |
EFFECTS OF ARSENIC TOXICITY BEYOND EPIGENETIC MODIFICATIONS |
| 1812 |
EFFECTS OF BIOLOGICAL THERAPIES ON MOLECULAR FEATURES OF RHEUMATOID ARTHRITIS |
| 1813 |
EFFECTS OF CAFFEIC ACID ON EPIGENETICS IN THE BRAIN OF RATS WITH CHRONIC UNPREDICTABLE MILD STRESS |
| 1814 |
EFFECTS OF CHRONIC COBALT AND CHROMIUM EXPOSURE AFTER METAL-ON-METAL HIP RESURFACING: AN EPIGENOME-WIDE ASSOCIATION PILOT STUDY |
| 1815 |
EFFECTS OF CHRONIC EXPOSURE TO ARSENIC AND ESTROGEN ON EPIGENETIC REGULATORY GENES EXPRESSION AND EPIGENETIC CODE IN HUMAN PROSTATE EPITHELIAL CELLS |
| 1816 |
EFFECTS OF CHRONIC EXPOSURE TO BENZOPHENONE AND DICLOFENAC ON DNA METHYLATION LEVELS AND REPRODUCTIVE SUCCESS IN A MARINE COPEPOD |
| 1817 |
EFFECTS OF CHRONIC METAL EXPOSURE ON WILD FISH POPULATIONS REVEALED BY HIGH-THROUGHPUT CDNA SEQUENCING |
| 1818 |
EFFECTS OF CHRONIC METHAMPHETAMINE EXPOSURE ON REWARDING BEHAVIOR AND NEURODEGENERATION MARKERS IN ADULT MICE |
| 1819 |
EFFECTS OF CHRONIC OCHRATOXIN A EXPOSURE ON P53 HETEROZYGOUS AND P53 HOMOZYGOUS MICE |
| 1820 |
EFFECTS OF CHRONIC RESTRAINT STRESS ON THE GLOBAL DNA METHYLATION PROFILE OF RAT LUNG CELLS: MODULATION BY PHYSICAL EXERCISE |
| 1821 |
EFFECTS OF CHRONIC SOCIAL DEFEAT ON BEHAVIORAL AND NEURAL CORRELATES OF SOCIALITY: VASOPRESSIN, OXYTOCIN AND THE VASOPRESSINERGIC V1B RECEPTOR |
| 1822 |
EFFECTS OF DIETARY OLEACEIN TREATMENT ON ENDOTHELIAL DYSFUNCTION AND LUPUS NEPHRITIS IN BALB/C PRISTANE-INDUCED MICE |
| 1823 |
EFFECTS OF EARLY-LIFE STRESS AND HDAC INHIBITION ON MATERNAL BEHAVIOR IN MICE |
| 1824 |
EFFECTS OF ENVIRONMENTAL CONDITIONS ON NEPHRON NUMBER: MODELING MATERNAL DISEASE AND EPIGENETIC REGULATION IN RENAL DEVELOPMENT |
| 1825 |
EFFECTS OF HIGH-DOSE BISPHENOL A ON THE MOUSE ORAL MUCOSA: A POSSIBLE LINK WITH ORAL CANCERS |
| 1826 |
EFFECTS OF HISTONE DEACETYLASE INHIBITOR ON EXTRACELLULAR MATRIX PRODUCTION IN HUMAN NASAL POLYP ORGAN CULTURES |
| 1827 |
EFFECTS OF HISTONE DEACETYLASE INHIBITORS ON THE DEVELOPMENT OF EPILEPSY AND PSYCHIATRIC COMORBIDITY IN WAG/RIJ RATS |
| 1828 |
EFFECTS OF INHALED TOBACCO SMOKE ON THE PULMONARY TUMOR MICROENVIRONMENT |
| 1829 |
EFFECTS OF INHIBITING ASTROCYTES AND BET/BRD4 CHROMATIN READER ON SPATIAL MEMORY AND SYNAPTIC PROTEINS IN RATS WITH ALZHEIMER'S DISEASE |
| 1830 |
EFFECTS OF LONG-TERM ASPIRIN USE ON MOLECULAR ALTERATIONS IN PRECANCEROUS GASTRIC MUCOSA IN PATIENTS WITH AND WITHOUT GASTRIC CANCER |
| 1831 |
EFFECTS OF MATERNAL SEPARATION AND ANTIDEPRESSANT DRUG ON EPIGENETIC REGULATION OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR EXON I PROMOTER IN THE ADULT RAT HIPPOCAMPUS |
| 1832 |
EFFECTS OF METABOLIC MEMORY ON INFLAMMATION AND FIBROSIS ASSOCIATED WITH DIABETIC KIDNEY DISEASE: AN EPIGENETIC PERSPECTIVE |
| 1833 |
EFFECTS OF METHYL DONOR DIETS ON INCISIONAL PAIN IN MICE |
| 1834 |
EFFECTS OF MINDFULNESS-BASED THERAPY ON CLINICAL SYMPTOMS AND DNA METHYLATION IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME AND HIGH METABOLIC RISK |
| 1835 |
EFFECTS OF NON-HUMAN SPECIES IRRADIATION AFTER THE CHERNOBYL NPP ACCIDENT |
| 1836 |
EFFECTS OF NUTRIENT AND BIOACTIVE FOOD COMPONENTS ON ALZHEIMER'S DISEASE AND EPIGENETIC |
| 1837 |
EFFECTS OF PALMITATE ON GENOME-WIDE MRNA EXPRESSION AND DNA METHYLATION PATTERNS IN HUMAN PANCREATIC ISLETS |
| 1838 |
EFFECTS OF POLYPHENOLS ON NCRNAS IN CANCER-AN UPDATE |
| 1839 |
EFFECTS OF PRENATAL NICOTINE EXPOSURE ON HEPATIC GLUCOSE AND LIPID METABOLISM IN OFFSPRING RATS AND ITS HEREDITABILITY |
| 1840 |
EFFECTS OF SELECTIVE INHIBITION OF PROSTAGLANDIN E2 RECEPTORS EP2 AND EP4 ON THE MIRNA PROFILE IN ENDOMETRIOSIS |
| 1841 |
EFFECTS OF SHORT CHAIN FATTY ACID PRODUCING BACTERIA ON EPIGENETIC REGULATION OF FFAR3 IN TYPE 2 DIABETES AND OBESITY |
| 1842 |
EFFECTS OF STRESS AND MINDFULNESS ON EPIGENETICS |
| 1843 |
EFFECTS OF TELOMERASE INHIBITOR ON EPIGENETIC CHROMATIN MODIFICATION ENZYMES IN MALIGNANCIES |
| 1844 |
EFFECTS OF THE LIFESTYLE HABITS IN BREAST CANCER TRANSCRIPTIONAL REGULATION |
| 1845 |
EFFECTS OF THE MEDITERRANEAN DIET DURING PREGNANCY ON THE ONSET OF ALLERGY IN AT RISK CHILDREN: A STUDY PROTOCOL OF A MULTI-CENTER, RANDOMIZED- CONTROLLED, PARALLEL GROUPS, PROSPECTIVE TRIAL (THE PREMEDI STUDY) |
| 1846 |
EFFECTS OF TWO TYPES OF ENERGY RESTRICTION ON METHYLATION LEVELS OF ADIPONECTIN RECEPTOR 1 AND LEPTIN RECEPTOR OVERLAPPING TRANSCRIPT IN A MOUSE MAMMARY TUMOUR VIRUS-TRANSFORMING GROWTH FACTOR-ALPHA BREAST CANCER MOUSE MODEL |
| 1847 |
EFFECTS OF VARIOUS ENVIRONMENTS ON EPIGENETIC SETTINGS AND CHROMOSOMAL DAMAGE |
| 1848 |
EFFECTS OF VENLAFAXINE ON THE EXPRESSION LEVEL AND METHYLATION STATUS OF GENES INVOLVED IN OXIDATIVE STRESS IN RATS EXPOSED TO A CHRONIC MILD STRESS |
| 1849 |
EIGHT WEEKS OF PHYSICAL TRAINING DECREASES 2 YEARS OF DNA METHYLATION AGE OF SEDENTARY WOMEN |
| 1850 |
ELECTROACUPUNCTURE AMELIORATES DEPRESSION-LIKE BEHAVIORS COMORBID TO CHRONIC NEUROPATHIC PAIN VIA TET1-MEDIATED RESTORATION OF ADULT NEUROGENESIS |
| 1851 |
ELECTROACUPUNCTURE INDUCES BILATERAL S1 AND ACC EPIGENETIC REGULATION OF GENES IN A MOUSE MODEL OF NEUROPATHIC PAIN |
| 1852 |
ELECTRONIC CIGARETTES: THEIR CONSTITUENTS AND POTENTIAL LINKS TO ASTHMA |
| 1853 |
ELEVATED METHIONINE FLUX DRIVES PYROPTOSIS EVASION IN PERSISTER CANCER CELLS |
| 1854 |
ELEVATED SEMINAL PLASMA ESTRADIOL AND EPIGENETIC INACTIVATION OF ESR1 AND ESR2 IS ASSOCIATED WITH CP/CPPS |
| 1855 |
ELEVATION IN S-ADENOSYLHOMOCYSTEINE AND DNA HYPOMETHYLATION: POTENTIAL EPIGENETIC MECHANISM FOR HOMOCYSTEINE-RELATED PATHOLOGY |
| 1856 |
ELEVATION OF N-ACETYLTRANSFERASE 10 IN HIPPOCAMPAL NEURONS MEDIATES DEPRESSION- AND ANXIETY-LIKE BEHAVIORS |
| 1857 |
ELIMINATION OF PERSISTENT TOXICANTS FROM THE HUMAN BODY |
| 1858 |
ELUCIDATING POTENTIAL PROFIBROTIC MECHANISMS OF EMERGING BIOMARKERS FOR EARLY PROGNOSIS OF HEPATIC FIBROSIS |
| 1859 |
EMBEDDING THE COMMUNITY AND INDIVIDUALS IN DISEASE PREVENTION |
| 1860 |
EMBRYONIC PROGRAM ACTIVATED DURING BLAST CRISIS OF CHRONIC MYELOGENOUS LEUKEMIA (CML) IMPLICATES A TCF7L2 AND MYC COOPERATIVE CHROMATIN BINDING |
| 1861 |
EMERGENCE OF CANCER STEM CELLS IN HEPATOCELLULAR CARCINOMA |
| 1862 |
EMERGENCE OF FIBROBLASTS WITH A PROINFLAMMATORY EPIGENETICALLY ALTERED PHENOTYPE IN SEVERE HYPOXIC PULMONARY HYPERTENSION |
| 1863 |
EMERGENCE OF MUC1 IN MAMMALS FOR ADAPTATION OF BARRIER EPITHELIA |
| 1864 |
EMERGING AVENUES LINKING INFLAMMATION AND CANCER |
| 1865 |
EMERGING CONCEPTS ON THE ROLE OF EPIGENETICS IN THE RELATIONSHIPS BETWEEN NUTRITION AND HEALTH |
| 1866 |
EMERGING CROSSTALK BETWEEN LONG NON-CODING RNAS AND NRF2 SIGNALING |
| 1867 |
EMERGING GENE-EDITING MODALITIES FOR OSTEOARTHRITIS |
| 1868 |
EMERGING NEUROTOXIC MECHANISMS IN ENVIRONMENTAL FACTORS-INDUCED NEURODEGENERATION |
| 1869 |
EMERGING ROLE OF DREAM IN HEALTHY BRAIN AND NEUROLOGICAL DISEASES |
| 1870 |
EMERGING ROLE OF EPIGENETIC MECHANISMS IN ALCOHOL ADDICTION |
| 1871 |
EMERGING ROLE OF EPIGENETICS IN EXPLAINING RELATIONSHIP OF PERIODONTITIS AND CARDIOVASCULAR DISEASES |
| 1872 |
EMERGING ROLE OF LONG NON-CODING RNAS IN ENDOTHELIAL DYSFUNCTION AND THEIR MOLECULAR MECHANISMS |
| 1873 |
EMERGING ROLE OF MICRORNAS AND LONG NON-CODING RNAS IN SJOGREN'S SYNDROME |
| 1874 |
EMERGING ROLE OF NF-KAPPAB SIGNALING IN THE INDUCTION OF SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE (SASP) |
| 1875 |
EMERGING ROLE OF ONE-CARBON METABOLISM AND DNA METHYLATION ENRICHMENT ON DELTA-CONTAINING GABAA RECEPTOR EXPRESSION IN THE CEREBELLUM OF SUBJECTS WITH ALCOHOL USE DISORDERS (AUD) |
| 1876 |
EMERGING ROLES FOR EPIGENETIC PROGRAMMING IN THE CONTROL OF INFLAMMATORY SIGNALING INTEGRATION IN HEATH AND DISEASE |
| 1877 |
EMERGING ROLES OF EPIGENETIC MECHANISMS IN THE ENDURING EFFECTS OF EARLY-LIFE STRESS AND EXPERIENCE ON LEARNING AND MEMORY |
| 1878 |
EMERGING ROLES OF LONG NONCODING RNA IN CHONDROGENESIS, OSTEOGENESIS, AND OSTEOARTHRITIS |
| 1879 |
EMERGING ROLES OF NON-CODING RNAS IN PSORIASIS PATHOGENESIS |
| 1880 |
EMERGING STRATEGIES TO DISRUPT THE CENTRAL TGF-BETA AXIS IN KIDNEY FIBROSIS |
| 1881 |
EMERGING TREATMENTS FOR NEUROPATHIC PAIN |
| 1882 |
EMERGING TREATMENTS IN ACUTE MYELOID LEUKAEMIA |
| 1883 |
END-STAGE RENAL DISEASE, INFLAMMATION AND CARDIOVASCULAR OUTCOMES |
| 1884 |
ENDOCANNABINOID-EPIGENETIC CROSS-TALK: A BRIDGE TOWARD STRESS COPING |
| 1885 |
ENDOCRINE DISRUPTORS IN SOIL: EFFECTS OF BISPHENOL A ON GENE EXPRESSION OF THE EARTHWORM EISENIA FETIDA |
| 1886 |
ENDOGENOUS BIOLOGICAL DRIVERS IN DIABETIC LOWER LIMB WOUNDS RECURRENCE: HYPOTHETICAL REFLECTIONS |
| 1887 |
ENDOMETRIAL RECEPTIVITY IN WOMEN OF ADVANCED AGE: AN UNDERRATED FACTOR IN INFERTILITY |
| 1888 |
ENDOMETRIOSIS AND IN VITRO FERTILISATION |
| 1889 |
ENDOMETRIOSIS MALIGNANT TRANSFORMATION: EPIGENETICS AS A PROBABLE MECHANISM IN OVARIAN TUMORIGENESIS |
| 1890 |
ENDOMETRIOSIS-ASSOCIATED OVARIAN CARCINOMAS: INSIGHTS INTO PATHOGENESIS, DIAGNOSTICS, AND THERAPEUTIC TARGETS-A NARRATIVE REVIEW |
| 1891 |
ENDOMETRIOSIS |
| 1892 |
ENDOMETRIOSIS: EPIDEMIOLOGY, CLASSIFICATION, PATHOGENESIS, TREATMENT AND GENETICS (REVIEW OF LITERATURE) |
| 1893 |
ENDOMETRIOSIS: NEW PERSPECTIVE FOR THE DIAGNOSIS OF CERTAIN CYTOKINES IN WOMEN AND ADOLESCENT GIRLS, AS WELL AS THE PROGRESSION OF DISEASE OUTGROWTH: A SYSTEMATIC REVIEW |
| 1894 |
ENDOTHELIAL CELL SENESCENCE AND INFLAMMAGING: MICRORNAS AS BIOMARKERS AND INNOVATIVE THERAPEUTIC TOOLS |
| 1895 |
ENDOTHELIAL DYSFUNCTION IN INDIVIDUALS BORN AFTER FETAL GROWTH RESTRICTION: CARDIOVASCULAR AND RENAL CONSEQUENCES AND PREVENTIVE APPROACHES |
| 1896 |
ENDOTHELIAL-TO-MESENCHYMAL TRANSITION: AN UNDERAPPRECIATED MEDIATOR OF DIABETIC COMPLICATIONS |
| 1897 |
ENDOTHELIN-1 REGULATION IS ENTANGLED IN A COMPLEX WEB OF EPIGENETIC MECHANISMS IN DIABETES |
| 1898 |
ENDOTHELINS IN CARDIOVASCULAR BIOLOGY AND THERAPEUTICS |
| 1899 |
ENERGY BALANCE MODULATION IMPACTS EPIGENETIC REPROGRAMMING, ERALPHA AND ERBETA EXPRESSION, AND MAMMARY TUMOR DEVELOPMENT IN MMTV-NEU TRANSGENIC MICE |
| 1900 |
ENERGY SENSING PATHWAYS: BRIDGING TYPE 2 DIABETES AND COLORECTAL CANCER? THE RECENTLY RAPID INCREASE OF OBESITY AND TYPE 2 DIABETES MELLITUS HAS CAUSED GREAT BURDEN TO OUR SOCIETY |
| 1901 |
ENGRAFTMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA CELLS IN IMMUNOCOMPROMISED MICE SUPPORTS DISEASE DEPENDENCY ON CYTOKINES |
| 1902 |
ENHANCED EXPRESSION OF THE NUCLEAR ENVELOPE LAP2 TRANSCRIPTIONAL REPRESSORS IN NORMAL AND MALIGNANT ACTIVATED LYMPHOCYTES |
| 1903 |
ENHANCED NEUROINFLAMMATION MEDIATED BY DNA METHYLATION OF THE GLUCOCORTICOID RECEPTOR TRIGGERS COGNITIVE DYSFUNCTION AFTER SEVOFLURANE ANESTHESIA IN ADULT RATS SUBJECTED TO MATERNAL SEPARATION DURING THE NEONATAL PERIOD |
| 1904 |
ENHANCED RETINAL GANGLION CELL SURVIVAL IN GLAUCOMA BY HYPOXIC POSTCONDITIONING AFTER DISEASE ONSET |
| 1905 |
ENHANCER OF ZESTE HOMOLOG 2 CONTRIBUTES TO APOPTOSIS BY INACTIVATING JANUS KINASE 2/ SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION SIGNALING IN INFLAMMATORY BOWEL DISEASE |
| 1906 |
ENHANCER OF ZESTE HOMOLOG 2-CATALYSED H3K27 TRIMETHYLATION PLAYS A KEY ROLE IN ACUTE-ON-CHRONIC LIVER FAILURE VIA TNF-MEDIATED PATHWAY |
| 1907 |
ENRICHED ENVIRONMENT PRIORS TO TET1 HIPPOCAMPAL ADMINISTRATION FOR REGULATING PSYCHIATRIC BEHAVIORS VIA GLIAL REACTIVITY IN CHRONIC CEREBRAL HYPOPERFUSION MODELS |
| 1908 |
ENRICHMENT OF GENOMIC PATHWAYS BASED ON DIFFERENTIAL DNA METHYLATION ASSOCIATED WITH CHRONIC POSTSURGICAL PAIN AND ANXIETY IN CHILDREN: A PROSPECTIVE, PILOT STUDY |
| 1909 |
ENRICHMENT OF GENOMIC PATHWAYS BASED ON DIFFERENTIAL DNA METHYLATION PROFILES ASSOCIATED WITH CHRONIC MUSCULOSKELETAL PAIN IN OLDER ADULTS: AN EXPLORATORY STUDY |
| 1910 |
ENRICHMENT OF GENOMIC PATHWAYS BASED ON DIFFERENTIAL DNA METHYLATION PROFILES ASSOCIATED WITH KNEE OSTEOARTHRITIS PAIN |
| 1911 |
ENVIRONMENT IN CHILDREN'S HEALTH: A NEW CHALLENGE FOR RISK ASSESSMENT |
| 1912 |
ENVIRONMENT, DIET AND CPG ISLAND METHYLATION: EPIGENETIC SIGNALS IN GASTROINTESTINAL NEOPLASIA |
| 1913 |
ENVIRONMENTAL AND GENETIC CONTRIBUTIONS TO DIABETES |
| 1914 |
ENVIRONMENTAL AND GENETIC RISK FACTORS FOR MS: AN INTEGRATED REVIEW |
| 1915 |
ENVIRONMENTAL AND OCCUPATIONAL EXPOSURE OF METALS AND FEMALE REPRODUCTIVE HEALTH |
| 1916 |
ENVIRONMENTAL AND OCCUPATIONAL EXPOSURE TO CHEMICALS AND TELOMERE LENGTH IN HUMAN STUDIES |
| 1917 |
ENVIRONMENTAL ARSENIC EXPOSURE: FROM GENETIC SUSCEPTIBILITY TO PATHOGENESIS |
| 1918 |
ENVIRONMENTAL CARCINOGENESIS AND TRANSGENERATIONAL TRANSMISSION OF CARCINOGENIC RISK: FROM GENETICS TO EPIGENETICS |
| 1919 |
ENVIRONMENTAL ENDOCRINE DISRUPTORS: NEW DIABETOGENS? THE PREVALENCE OF TYPE-2 DIABETES HAS DRAMATICALLY INCREASED WORLDWIDE DURING THE LAST FEW DECADES |
| 1920 |
ENVIRONMENTAL ENRICHMENT PREVENTS STRESS-INDUCED EPIGENETIC CHANGES IN THE EXPRESSION OF GLUCOCORTICOID RECEPTOR AND CORTICOTROPHIN RELEASING HORMONE IN THE CENTRAL NUCLEUS OF THE AMYGDALA TO INHIBIT VISCERAL HYPERSENSITIVITY |
| 1921 |
ENVIRONMENTAL EPIGENETIC INHERITANCE THROUGH GAMETES AND IMPLICATIONS FOR HUMAN REPRODUCTION |
| 1922 |
ENVIRONMENTAL EPIGENETIC INTERACTION OF GAMETES AND EARLY EMBRYOSDAGGER |
| 1923 |
ENVIRONMENTAL EPIGENETIC MODIFICATIONS AND REPROGRAMMING-RECALCITRANT GENES |
| 1924 |
ENVIRONMENTAL EPIGENETICS AND ITS IMPLICATION ON DISEASE RISK AND HEALTH OUTCOMES |
| 1925 |
ENVIRONMENTAL EPIGENETICS IN METAL EXPOSURE |
| 1926 |
ENVIRONMENTAL EPIGENETICS OF ASTHMA: AN UPDATE |
| 1927 |
ENVIRONMENTAL EPIGENOMICS AND DISEASE SUSCEPTIBILITY |
| 1928 |
ENVIRONMENTAL EXPOSURE MEASUREMENT IN CANCER EPIDEMIOLOGY |
| 1929 |
ENVIRONMENTAL EXPOSURE, DNA METHYLATION, AND GENE REGULATION: LESSONS FROM DIETHYLSTILBESTEROL-INDUCED CANCERS |
| 1930 |
ENVIRONMENTAL EXPOSURES AROUND CONCEPTION: DEVELOPMENTAL PATHWAYS LEADING TO LIFETIME DISEASE RISK |
| 1931 |
ENVIRONMENTAL EXPOSURES, THE EPIGENOME, AND AFRICAN AMERICAN WOMEN'S HEALTH |
| 1932 |
ENVIRONMENTAL EXPOSURES: AN UNDERRECOGNIZED CONTRIBUTION TO NONCOMMUNICABLE DISEASES |
| 1933 |
ENVIRONMENTAL FACTORS ASSOCIATED WITH TYPE 1 DIABETES |
| 1934 |
ENVIRONMENTAL ORIGINS OF HYPERTENSION: PHYLOGENY, ONTOGENY AND EPIGENETICS |
| 1935 |
ENVIRONMENTAL RISK FACTORS AND EPIGENETIC ALTERNATIONS IN PSORIASIS |
| 1936 |
ENVIRONMENTAL RISK FACTORS OF TYPE 2 DIABETES-AN EXPOSOME APPROACH |
| 1937 |
EOMES IS ESSENTIAL FOR ANTITUMOR ACTIVITY OF CD8(+) T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1938 |
EPIDEMIOLOGIC EVIDENCE FOR ASSOCIATION BETWEEN ADVERSE ENVIRONMENTAL EXPOSURES IN EARLY LIFE AND EPIGENETIC VARIATION: A POTENTIAL LINK TO DISEASE SUSCEPTIBILITY? A GROWING BODY OF EVIDENCE SUGGESTS THAT THE RISK OF DEVELOPMENT AND PROGRESSION OF A VARIETY OF HUMAN CHRONIC DISEASES DEPENDS ON EPIGENETIC MODIFICATIONS TRIGGERED BY ENVIRONMENTAL CUES DURING EARLY LIFE SENSITIVE STAGES |
| 1939 |
EPIDEMIOLOGY AND (PATHO)PHYSIOLOGY OF FOLIC ACID SUPPLEMENT USE IN OBESE WOMEN BEFORE AND DURING PREGNANCY |
| 1940 |
EPIDEMIOLOGY AND CARCINOGENESIS OF HEPATOCELLULAR CARCINOMA |
| 1941 |
EPIDEMIOLOGY AND POTENTIAL MECHANISMS OF TOBACCO SMOKING AND HEAVY ALCOHOL CONSUMPTION IN PANCREATIC CANCER |
| 1942 |
EPIDEMIOLOGY OF LIVER CANCER IN AFRICA: CURRENT AND FUTURE TRENDS |
| 1943 |
EPIDERMAL GROWTH FACTOR IN HEALING DIABETIC FOOT ULCERS: FROM GENE EXPRESSION TO TISSUE HEALING AND SYSTEMIC BIOMARKER CIRCULATION |
| 1944 |
EPIGALLOCATECHIN-3-GALLATE AND BIX-01294 HAVE DIFFERENT IMPACT ON EPIGENETICS AND SENESCENCE MODULATION IN ACUTE AND CHRONIC MYELOID LEUKEMIA CELLS |
| 1945 |
EPIGALLOCATECHIN-3-GALLATE, A HISTONE ACETYLTRANSFERASE INHIBITOR, INHIBITS EBV-INDUCED B LYMPHOCYTE TRANSFORMATION VIA SUPPRESSION OF RELA ACETYLATION |
| 1946 |
EPIGENETIC ABNORMALITIES ASSOCIATED WITH A CHROMOSOME 18(Q21-Q22) INVERSION AND A GILLES DE LA TOURETTE SYNDROME PHENOTYPE |
| 1947 |
EPIGENETIC ABNORMALITIES IN MYELOPROLIFERATIVE NEOPLASMS: A TARGET FOR NOVEL THERAPEUTIC STRATEGIES |
| 1948 |
EPIGENETIC ACQUISITION OF INDUCIBILITY OF TYPE III CYTOTOXICITY IN P |
| 1949 |
EPIGENETIC ACTIVATION OF ASCT2 IN THE HIPPOCAMPUS CONTRIBUTES TO DEPRESSION-LIKE BEHAVIOR BY REGULATING D-SERINE IN MICE |
| 1950 |
EPIGENETIC ACTIVATION OF TENSIN 4 PROMOTES GASTRIC CANCER PROGRESSION |
| 1951 |
EPIGENETIC ACTIVATION OF THE TUSC3 GENE AS A POTENTIAL THERAPY FOR XMEN DISEASE |
| 1952 |
EPIGENETIC AGE ACCELERATION AMONG SURVIVORS OF PEDIATRIC MEDULLOBLASTOMA AND PRIMITIVE NEUROECTODERMAL TUMOR |
| 1953 |
EPIGENETIC AGE ACCELERATION AND CHRONIC HEALTH CONDITIONS AMONG ADULT SURVIVORS OF CHILDHOOD CANCER |
| 1954 |
EPIGENETIC AGE ACCELERATION MEDIATES THE RELATIONSHIP BETWEEN NEIGHBORHOOD DEPRIVATION AND PAIN SEVERITY IN ADULTS WITH OR AT RISK FOR KNEE OSTEOARTHRITIS PAIN |
| 1955 |
EPIGENETIC AGE ACCELERATION PREDICTS CANCER, CARDIOVASCULAR, AND ALL-CAUSE MORTALITY IN A GERMAN CASE COHORT |
| 1956 |
EPIGENETIC AGE IN PERIPHERAL BLOOD AMONG CHILDREN, ADOLESCENT, AND ADULT SURVIVORS OF CHILDHOOD CANCER |
| 1957 |
EPIGENETIC AGE PREDICTORS IN COMMUNITY-DWELLING ADULTS WITH HIGH IMPACT KNEE PAIN |
| 1958 |
EPIGENETIC AGING AND COLORECTAL CANCER: STATE OF THE ART AND PERSPECTIVES FOR FUTURE RESEARCH |
| 1959 |
EPIGENETIC AGING AND HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH SEVERE APLASTIC ANEMIA |
| 1960 |
EPIGENETIC AGING IN CHILDREN FROM A SMALL-SCALE FARMING SOCIETY IN THE CONGO BASIN: ASSOCIATIONS WITH CHILD GROWTH AND FAMILY CONFLICT |
| 1961 |
EPIGENETIC AGING IS ACCELERATED IN ALCOHOL USE DISORDER AND REGULATED BY GENETIC VARIATION IN APOL2 |
| 1962 |
EPIGENETIC AGING IS ASSOCIATED WITH CLINICAL AND EXPERIMENTAL PAIN IN COMMUNITY-DWELLING OLDER ADULTS |
| 1963 |
EPIGENETIC AGING MEDIATES THE ASSOCIATION BETWEEN PAIN IMPACT AND BRAIN AGING IN MIDDLE TO OLDER AGE INDIVIDUALS WITH KNEE PAIN |
| 1964 |
EPIGENETIC AGING, KNEE PAIN AND PHYSICAL PERFORMANCE IN COMMUNITY-DWELLING MIDDLE-TO-OLDER AGE ADULTS |
| 1965 |
EPIGENETIC ALTERATION OF MITOCHONDRIAL BIOGENESIS REGULATORY GENES IN ARSENIC EXPOSED INDIVIDUALS (WITH AND WITHOUT SKIN LESIONS) AND IN SKIN CANCER TISSUES: A CASE CONTROL STUDY |
| 1966 |
EPIGENETIC ALTERATION OF PRKCDBP IN COLORECTAL CANCERS AND ITS IMPLICATION IN TUMOR CELL RESISTANCE TO TNFALPHA-INDUCED APOPTOSIS |
| 1967 |
EPIGENETIC ALTERATION OF THE DOPAMINE TRANSPORTER GENE IN ALCOHOL-DEPENDENT PATIENTS IS ASSOCIATED WITH AGE |
| 1968 |
EPIGENETIC ALTERATION OF THE SOCS1 GENE IN CHRONIC MYELOID LEUKAEMIA |
| 1969 |
EPIGENETIC ALTERATIONS AND AN INCREASED FREQUENCY OF MICRONUCLEI IN WOMEN WITH FIBROMYALGIA |
| 1970 |
EPIGENETIC ALTERATIONS AND OCCUPATIONAL EXPOSURE TO BENZENE, FIBERS, AND HEAVY METALS ASSOCIATED WITH TUMOR DEVELOPMENT (REVIEW) |
| 1971 |
EPIGENETIC ALTERATIONS ASSOCIATED WITH CHILDHOOD TRAUMA AND ADULT MENTAL HEALTH OUTCOMES: A SYSTEMATIC REVIEW |
| 1972 |
EPIGENETIC ALTERATIONS ASSOCIATED WITH CHOLANGIOCARCINOMA (REVIEW) |
| 1973 |
EPIGENETIC ALTERATIONS BY DNA METHYLATION IN HOUSE DUST MITE-INDUCED AIRWAY HYPERRESPONSIVENESS |
| 1974 |
EPIGENETIC ALTERATIONS CAUSED BY NUTRITIONAL STRESS DURING FETAL PROGRAMMING OF THE ENDOCRINE PANCREAS |
| 1975 |
EPIGENETIC ALTERATIONS FROM BARRETT'S ESOPHAGUS TO ESOPHAGEAL ADENOCARCINOMA |
| 1976 |
EPIGENETIC ALTERATIONS IN A MURINE MODEL FOR CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1977 |
EPIGENETIC ALTERATIONS IN ACUTE KIDNEY INJURY |
| 1978 |
EPIGENETIC ALTERATIONS IN CHOLANGIOCARCINOMA-SUSTAINED IL-6/STAT3 SIGNALING IN CHOLANGIO- CARCINOMA DUE TO SOCS3 EPIGENETIC SILENCING |
| 1979 |
EPIGENETIC ALTERATIONS IN CHRONIC DISEASE FOCUSING ON BEHCET'S DISEASE: REVIEW |
| 1980 |
EPIGENETIC ALTERATIONS IN CYTOCHROME P450 OXIDOREDUCTASE (POR) IN SPERM OF RATS EXPOSED TO TETRAHYDROCANNABINOL (THC) |
| 1981 |
EPIGENETIC ALTERATIONS IN DNA AND HISTONE MODIFICATIONS CAUSED BY DEPRESSION AND ANTIDEPRESSANT DRUGS: LESSONS FROM THE RODENT MODELS |
| 1982 |
EPIGENETIC ALTERATIONS IN PEDIATRIC SLEEP APNEA |
| 1983 |
EPIGENETIC ALTERATIONS IN PODOCYTES IN DIABETIC NEPHROPATHY |
| 1984 |
EPIGENETIC ALTERATIONS IN PRESCRIPTION OPIOID MISUSE: NEW STRATEGIES FOR PRECISION PAIN MANAGEMENT |
| 1985 |
EPIGENETIC ALTERATIONS IN PRIMARY SJOGREN'S SYNDROME - AN OVERVIEW |
| 1986 |
EPIGENETIC ALTERATIONS MAY REGULATE TEMPORARY REVERSAL OF CD4(+) T CELL ACTIVATION CAUSED BY TRICHLOROETHYLENE EXPOSURE |
| 1987 |
EPIGENETIC ALTERATIONS OF CXCL5 IN CR(VI)-INDUCED CARCINOGENESIS |
| 1988 |
EPIGENETIC ANALYSIS IN A MURINE GENETIC MODEL OF GULF WAR ILLNESS |
| 1989 |
EPIGENETIC ANALYSIS IN RHEUMATOID ARTHRITIS SYNOVIOCYTES |
| 1990 |
EPIGENETIC ANALYSIS OF PAGET'S DISEASE OF BONE IDENTIFIES DIFFERENTIALLY METHYLATED LOCI THAT PREDICT DISEASE STATUS |
| 1991 |
EPIGENETIC ANALYSIS OF THE IFNLAMBDA3 GENE IDENTIFIES A NOVEL MARKER FOR RESPONSE TO THERAPY IN HCV-INFECTED SUBJECTS |
| 1992 |
EPIGENETIC AND DEVELOPMENTAL INFLUENCES ON THE RISK OF OBESITY, DIABETES, AND METABOLIC SYNDROME |
| 1993 |
EPIGENETIC AND EPITRANSCRIPTOMIC MECHANISMS OF CHROMIUM CARCINOGENESIS |
| 1994 |
EPIGENETIC AND GENE EXPRESSION ALTERATIONS OF FOXP3 IN THE T CELLS OF EAE MOUSE MODEL OF MULTIPLE SCLEROSIS |
| 1995 |
EPIGENETIC AND GENETIC ALTERATIONS AND THEIR INFLUENCE ON GENE REGULATION IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 1996 |
EPIGENETIC AND GENETIC ALTERATIONS OF THE EDNRB GENE IN NASOPHARYNGEAL CARCINOMA |
| 1997 |
EPIGENETIC AND INFLAMMATORY EVENTS IN EXPERIMENTAL PERIODONTITIS FOLLOWING SYSTEMIC MICROBIAL CHALLENGE |
| 1998 |
EPIGENETIC AND MIRNA EXPRESSION CHANGES IN PEOPLE WITH PAIN: A SYSTEMATIC REVIEW |
| 1999 |
EPIGENETIC AND NEURONAL ACTIVITY MARKERS SUGGEST THE RECRUITMENT OF THE PREFRONTAL CORTEX AND HIPPOCAMPUS IN THE THREE-HIT MODEL OF DEPRESSION IN MALE PACAP HETEROZYGOUS MICE |
| 2000 |
EPIGENETIC AND NON-CODING REGULATION OF ALCOHOL ABUSE AND ADDICTION |
| 2001 |
EPIGENETIC AND NON-EPIGENETIC REGULATION OF KLOTHO IN KIDNEY DISEASE |
| 2002 |
EPIGENETIC AND POST-TRANSCRIPTIONAL REPRESSION SUPPORT METABOLIC SUPPRESSION IN CHRONICALLY HYPOXIC GOLDFISH |
| 2003 |
EPIGENETIC AND TRANSCRIPTIONAL CONTROL OF THE OPIOID PRODYNORPHINE GENE: IN-DEPTH ANALYSIS IN THE HUMAN BRAIN |
| 2004 |
EPIGENETIC ASPECTS OF MULTIPLE SCLEROSIS AND FUTURE THERAPEUTIC OPTIONS |
| 2005 |
EPIGENETIC ASSOCIATIONS WITH ESTIMATED GLOMERULAR FILTRATION RATE AMONG MEN WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION |
| 2006 |
EPIGENETIC AUGMENTATION OF THE MACROPHAGE INFLAMMATORY PROTEIN 2/C-X-C CHEMOKINE RECEPTOR TYPE 2 AXIS THROUGH HISTONE H3 ACETYLATION IN INJURED PERIPHERAL NERVES ELICITS NEUROPATHIC PAIN |
| 2007 |
EPIGENETIC BASIS FOR FETAL ORIGINS OF AGE-RELATED DISEASE |
| 2008 |
EPIGENETIC BASIS FOR MONOCYTE DYSFUNCTION IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS |
| 2009 |
EPIGENETIC BASIS OF DIABETIC VASCULOPATHY |
| 2010 |
EPIGENETIC BASIS OF LEAD-INDUCED NEUROLOGICAL DISORDERS |
| 2011 |
EPIGENETIC BASIS OF MENTAL ILLNESS |
| 2012 |
EPIGENETIC BASIS OF OPIATE SUPPRESSION OF BDNF GENE EXPRESSION IN THE VENTRAL TEGMENTAL AREA |
| 2013 |
EPIGENETIC BASIS OF THE DARK SIDE OF ALCOHOL ADDICTION |
| 2014 |
EPIGENETIC BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF LIVER DISEASE |
| 2015 |
EPIGENETIC BIOMARKERS IN ESOPHAGEAL CANCER |
| 2016 |
EPIGENETIC BIOMARKERS IN PROGRESSION FROM NON-DYSPLASTIC BARRETT'S OESOPHAGUS TO OESOPHAGEAL ADENOCARCINOMA: A SYSTEMATIC REVIEW PROTOCOL |
| 2017 |
EPIGENETIC BIOMARKERS IN RHEUMATOLOGY - THE FUTURE? EPIGENETIC CHANGES ARE STABLE MODIFICATIONS OF DNA OR HISTONES THAT PROFOUNDLY ALTER GENE EXPRESSION |
| 2018 |
EPIGENETIC CHANGE (GATA-4 GENE METHYLATION) IS ASSOCIATED WITH HEALTH STATUS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 2019 |
EPIGENETIC CHANGE IN E-CADHERIN AND COX-2 TO PREDICT CHRONIC PERIODONTITIS |
| 2020 |
EPIGENETIC CHANGES AND FUNCTIONS IN PNEUMOCONIOSIS |
| 2021 |
EPIGENETIC CHANGES ASSOCIATED WITH DIFFERENT TYPES OF STRESSORS AND SUICIDE |
| 2022 |
EPIGENETIC CHANGES ASSOCIATED WITH DISEASE PROGRESSION IN A MOUSE MODEL OF CHILDHOOD ALLERGIC ASTHMA |
| 2023 |
EPIGENETIC CHANGES BY DNA METHYLATION IN CHRONIC AND INTERMITTENT HYPOXIA |
| 2024 |
EPIGENETIC CHANGES CAUSED BY DIABETES AND THEIR POTENTIAL ROLE IN THE DEVELOPMENT OF PERIODONTITIS |
| 2025 |
EPIGENETIC CHANGES DURING DISEASE PROGRESSION IN A MURINE MODEL OF HUMAN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2026 |
EPIGENETIC CHANGES IN BONE MARROW PROGENITOR CELLS INFLUENCE THE INFLAMMATORY PHENOTYPE AND ALTER WOUND HEALING IN TYPE 2 DIABETES |
| 2027 |
EPIGENETIC CHANGES IN CHRONIC INFLAMMATORY DISEASES |
| 2028 |
EPIGENETIC CHANGES IN DIABETES |
| 2029 |
EPIGENETIC CHANGES IN HEADACHE |
| 2030 |
EPIGENETIC CHANGES IN INFLAMMATORY GENES AND THE PROTECTIVE EFFECT OF COOKED RHUBARB ON PANCREATIC TISSUE OF RATS WITH CHRONIC ALCOHOL EXPOSURE |
| 2031 |
EPIGENETIC CHANGES IN LYMPHOCYTES OF SOLVENT-EXPOSED INDIVIDUALS |
| 2032 |
EPIGENETIC CHANGES IN P21 EXPRESSION IN RENAL CELLS AFTER EXPOSURE TO BROMATE |
| 2033 |
EPIGENETIC CHANGES IN SOLID AND HEMATOPOIETIC TUMORS |
| 2034 |
EPIGENETIC CHANGES IN THE ACUTE KIDNEY INJURY-TO-CHRONIC KIDNEY DISEASE TRANSITION |
| 2035 |
EPIGENETIC CHANGES OF FKBP5 AS A LINK CONNECTING GENETIC AND ENVIRONMENTAL RISK FACTORS WITH STRUCTURAL AND FUNCTIONAL BRAIN CHANGES IN MAJOR DEPRESSION |
| 2036 |
EPIGENETIC CHANGES OF THE IMMUNE SYSTEM WITH ROLE IN TUMOR DEVELOPMENT |
| 2037 |
EPIGENETIC CHANGES OF TIMP-3, GSTP-1 AND 14-3-3 SIGMA GENES AS INDICATION OF STATUS OF CHRONIC INFLAMMATION AND CANCER |
| 2038 |
EPIGENETIC CHANGES PREDISPOSING TO TYPE 2 DIABETES IN INTRAUTERINE GROWTH RETARDATION |
| 2039 |
EPIGENETIC CHANGES UNDERLIE THE ASSOCIATION BETWEEN DIABETES MELLITUS AND ORAL DISEASES |
| 2040 |
EPIGENETIC CHANGES WITH DIETARY SOY IN CYNOMOLGUS MONKEYS |
| 2041 |
EPIGENETIC CHANGES WITHIN THE ANNULUS FIBROSUS BY DNA METHYLATION IN RAT INTERVERTEBRAL DISC DEGENERATION MODEL |
| 2042 |
EPIGENETIC CHARACTERISTICS IN INFLAMMATORY CANDIDATE GENES IN AGGRESSIVE PERIODONTITIS |
| 2043 |
EPIGENETIC CLOCK ANALYSIS IN LONG-TERM MEDITATORS |
| 2044 |
EPIGENETIC CLOCK ANALYSIS OF BLOOD SAMPLES IN DRUG-NAIVE FIRST-EPISODE SCHIZOPHRENIA PATIENTS |
| 2045 |
EPIGENETIC CLOCK ANALYSIS OF DIET, EXERCISE, EDUCATION, AND LIFESTYLE FACTORS |
| 2046 |
EPIGENETIC CLOCK INDICATES ACCELERATED AGING IN GLIAL CELLS OF PROGRESSIVE MULTIPLE SCLEROSIS PATIENTS |
| 2047 |
EPIGENETIC CLOCKS MAY COME OUT OF RHYTHM-IMPLICATIONS FOR THE ESTIMATION OF CHRONOLOGICAL AGE IN FORENSIC CASEWORK |
| 2048 |
EPIGENETIC CLUSTERING OF LUNG ADENOCARCINOMAS BASED ON DNA METHYLATION PROFILES IN ADJACENT LUNG TISSUE: ITS CORRELATION WITH SMOKING HISTORY AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 2049 |
EPIGENETIC CODE AND POTENTIAL EPIGENETIC-BASED THERAPIES AGAINST CHRONIC DISEASES IN DEVELOPMENTAL ORIGINS |
| 2050 |
EPIGENETIC COMPONENTS OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME UNCOVER POTENTIAL TRANSPOSABLE ELEMENT ACTIVATION |
| 2051 |
EPIGENETIC CONDITIONING INDUCES INTERGENERATIONAL RESILIENCE TO DEMENTIA IN A MOUSE MODEL OF VASCULAR COGNITIVE IMPAIRMENT |
| 2052 |
EPIGENETIC CONNECTION OF THE CALCITONIN GENE-RELATED PEPTIDE AND ITS POTENTIAL IN MIGRAINE |
| 2053 |
EPIGENETIC CONNECTIONS OF THE TRPA1 ION CHANNEL IN PAIN TRANSMISSION AND NEUROGENIC INFLAMMATION - A THERAPEUTIC PERSPECTIVE IN MIGRAINE? PERSISTENT REPROGRAMMING OF EPIGENETIC PATTERN LEADS TO CHANGES IN GENE EXPRESSION OBSERVED IN MANY NEUROLOGICAL DISORDERS |
| 2054 |
EPIGENETIC CONTRIBUTIONS IN THE DEVELOPMENT OF RHEUMATOID ARTHRITIS |
| 2055 |
EPIGENETIC CONTROL DURING LYMPHOID DEVELOPMENT AND IMMUNE RESPONSES: ABERRANT REGULATION, VIRUSES, AND CANCER |
| 2056 |
EPIGENETIC CONTROL OF CD8(+) T CELL DIFFERENTIATION |
| 2057 |
EPIGENETIC CONTROL OF EPILEPSY TARGET GENES CONTRIBUTES TO A CELLULAR MEMORY OF EPILEPTOGENESIS IN CULTURED RAT HIPPOCAMPAL NEURONS |
| 2058 |
EPIGENETIC CONTROL OF GENE EXPRESSION IN THE ALCOHOLIC BRAIN |
| 2059 |
EPIGENETIC CONTROL OF GENE EXPRESSION IN THE LUNG |
| 2060 |
EPIGENETIC CONTROL OF HAEMATOPOIETIC STEM CELL AGING AND ITS CLINICAL IMPLICATIONS |
| 2061 |
EPIGENETIC CONTROL OF HYPERSENSITIVITY IN CHRONIC INFLAMMATORY PAIN BY THE DE NOVO DNA METHYLTRANSFERASE DNMT3A2 |
| 2062 |
EPIGENETIC CONTROL OF HYPERTENSION BY DNA METHYLATION: A REAL POSSIBILITY |
| 2063 |
EPIGENETIC CONTROL OF IL-23 EXPRESSION IN KERATINOCYTES IS IMPORTANT FOR CHRONIC SKIN INFLAMMATION |
| 2064 |
EPIGENETIC CONTROL OF INFLAMMATION IN ATOPIC DERMATITIS |
| 2065 |
EPIGENETIC CONTROL OF INTESTINAL BARRIER FUNCTION AND INFLAMMATION IN ZEBRAFISH |
| 2066 |
EPIGENETIC CONTROL OF ION CHANNEL EXPRESSION AND CELL-SPECIFIC SPLICING IN NOCICEPTORS: CHRONIC PAIN MECHANISMS AND POTENTIAL THERAPEUTIC TARGETS |
| 2067 |
EPIGENETIC CONTROL OF MACROPHAGE SHAPE TRANSITION TOWARDS AN ATYPICAL ELONGATED PHENOTYPE BY HISTONE DEACETYLASE ACTIVITY |
| 2068 |
EPIGENETIC CONTROL OF MICROSOMAL PROSTAGLANDIN E SYNTHASE-1 BY HDAC-MEDIATED RECRUITMENT OF P300 |
| 2069 |
EPIGENETIC CONTROL OF SKELETAL MUSCLE REGENERATION: INTEGRATING GENETIC DETERMINANTS AND ENVIRONMENTAL CHANGES |
| 2070 |
EPIGENETIC CONTROL OF SKIN IMMUNITY |
| 2071 |
EPIGENETIC CONTROL OF THE E-CADHERIN GENE (CDH1) BY CPG METHYLATION IN COLECTOMY SAMPLES OF PATIENTS WITH ULCERATIVE COLITIS |
| 2072 |
EPIGENETIC CONVERSION OF HUMAN ADULT BONE MESODERMAL STROMAL CELLS INTO NEUROECTODERMAL CELL TYPES FOR REPLACEMENT THERAPY OF NEURODEGENERATIVE DISORDERS |
| 2073 |
EPIGENETIC CROSSTALK IN CHRONIC INFECTION WITH HIV-1 |
| 2074 |
EPIGENETIC DEREGULATION IN CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICAL AND BIOLOGICAL IMPACT |
| 2075 |
EPIGENETIC DIFFERENCES IN INFLAMMATION GENES OF MONOZYGOTIC TWINS ARE RELATED TO PARENT-CHILD EMOTIONAL AVAILABILITY AND HEALTH |
| 2076 |
EPIGENETIC DIFFERENCES OF CHRONIC HEPATITIS B IN DIFFERENT TCM SYNDROMES: PROTOCOL FOR A CASE-CONTROL, NON-INTERVENTIONAL, OBSERVATIONAL CLINICAL STUDY |
| 2077 |
EPIGENETIC DISRUPTION OF PLACENTAL GENES BY CHRONIC MATERNAL CAFETERIA DIET IN RATS |
| 2078 |
EPIGENETIC DIVERGENCE IN THE TRPA1 PROMOTER CORRELATES WITH PRESSURE PAIN THRESHOLDS IN HEALTHY INDIVIDUALS |
| 2079 |
EPIGENETIC DNA METHYLATION CHANGES ASSOCIATED WITH HEADACHE CHRONIFICATION: A RETROSPECTIVE CASE-CONTROL STUDY |
| 2080 |
EPIGENETIC DNA METHYLATION OF EBI3 MODULATES HUMAN INTERLEUKIN-35 FORMATION VIA NFKB SIGNALING: A PROMISING THERAPEUTIC OPTION IN ULCERATIVE COLITIS |
| 2081 |
EPIGENETIC DOWN-REGULATION OF BIM EXPRESSION IS ASSOCIATED WITH REDUCED OPTIMAL RESPONSES TO IMATINIB TREATMENT IN CHRONIC MYELOID LEUKAEMIA |
| 2082 |
EPIGENETIC DOWNREGULATION OF SFRP4 CONTRIBUTES TO EPIDERMAL HYPERPLASIA IN PSORIASIS |
| 2083 |
EPIGENETIC DRUGS: A LONGSTANDING STORY |
| 2084 |
EPIGENETIC DYSFUNCTION IN TURNER SYNDROME IMMUNE CELLS |
| 2085 |
EPIGENETIC DYSREGULATION IN CHRONIC MYELOID LEUKAEMIA: A MYRIAD OF MECHANISMS AND THERAPEUTIC OPTIONS |
| 2086 |
EPIGENETIC DYSREGULATION IN ENDOMETRIOSIS: IMPLICATIONS FOR PATHOPHYSIOLOGY AND THERAPEUTICS |
| 2087 |
EPIGENETIC DYSREGULATION OF ID4 PREDICTS DISEASE PROGRESSION AND TREATMENT OUTCOME IN MYELOID MALIGNANCIES |
| 2088 |
EPIGENETIC DYSREGULATION OF SECRETED FRIZZLED-RELATED PROTEINS IN MYELOPROLIFERATIVE NEOPLASMS COMPLEMENTS THE JAK2V617F-MUTATION |
| 2089 |
EPIGENETIC DYSREGULATION OF THE DOPAMINE SYSTEM IN DIET-INDUCED OBESITY |
| 2090 |
EPIGENETIC DYSREGULATION OF THE WNT SIGNALLING PATHWAY IN CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 2091 |
EPIGENETIC DYSREGULATION OF VIRULENCE GENE EXPRESSION IN SEVERE PLASMODIUM FALCIPARUM MALARIA |
| 2092 |
EPIGENETIC EFFECT OF CHRONIC STRESS ON DOPAMINE SIGNALING AND DEPRESSION |
| 2093 |
EPIGENETIC EFFECTS FOLLOWING ACUTE AND CHRONIC EXERCISE IN CARDIOVASCULAR DISEASE: A SYSTEMATIC REVIEW |
| 2094 |
EPIGENETIC EFFECTS MEDIATED BY ANTIEPILEPTIC DRUGS AND THEIR POTENTIAL APPLICATION |
| 2095 |
EPIGENETIC EFFECTS OF BENZENE IN HEMATOLOGIC NEOPLASMS: THE ALTERED GENE EXPRESSION |
| 2096 |
EPIGENETIC EFFECTS OF CHILDHOOD ADVERSITY IN THE BRAIN AND SUICIDE RISK |
| 2097 |
EPIGENETIC EFFECTS OF HERBAL MEDICINE |
| 2098 |
EPIGENETIC EFFECTS OF HUMAN BREAST MILK |
| 2099 |
EPIGENETIC EFFECTS OF LOW-LEVEL SODIUM ARSENITE EXPOSURE ON HUMAN LIVER HEPARG CELLS |
| 2100 |
EPIGENETIC EFFECTS OF NATURAL POLYPHENOLS: A FOCUS ON SIRT1-MEDIATED MECHANISMS |
| 2101 |
EPIGENETIC EFFECTS OF PRENATAL STRESS ON 11BETA-HYDROXYSTEROID DEHYDROGENASE-2 IN THE PLACENTA AND FETAL BRAIN |
| 2102 |
EPIGENETIC EFFECTS OF SELENIUM AND THEIR IMPLICATIONS FOR HEALTH |
| 2103 |
EPIGENETIC EPIDEMIOLOGY OF THE DEVELOPMENTAL ORIGINS HYPOTHESIS |
| 2104 |
EPIGENETIC EVENTS IN LIVER CANCER RESULTING FROM ALCOHOLIC LIVER DISEASE |
| 2105 |
EPIGENETIC EVIDENCE FOR INVOLVEMENT OF THE OXYTOCIN RECEPTOR GENE IN OBSESSIVE-COMPULSIVE DISORDER |
| 2106 |
EPIGENETIC EVOLUTION AND LINEAGE HISTORIES OF CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 2107 |
EPIGENETIC FACTORS IN SCHIZOPHRENIA: MECHANISMS AND EXPERIMENTAL APPROACHES |
| 2108 |
EPIGENETIC FACTORS RELATED TO LOW BACK PAIN: A SYSTEMATIC REVIEW OF THE CURRENT LITERATURE |
| 2109 |
EPIGENETIC FEATURES OF HIV-INDUCED T-CELL EXHAUSTION PERSIST DESPITE EARLY ANTIRETROVIRAL THERAPY |
| 2110 |
EPIGENETIC FINDINGS IN PERIODONTITIS IN UK TWINS: A CROSS-SECTIONAL STUDY |
| 2111 |
EPIGENETIC FUNCTION OF TET FAMILY, 5-METHYLCYTOSINE, AND 5-HYDROXYMETHYLCYTOSINE IN HEMATOLOGIC MALIGNANCIES |
| 2112 |
EPIGENETIC GENE SILENCING UNDERLIES C-FIBER DYSFUNCTIONS IN NEUROPATHIC PAIN |
| 2113 |
EPIGENETIC HALLMARKS OF AGE-RELATED MACULAR DEGENERATION ARE RECAPITULATED IN A PHOTOSENSITIVE MOUSE MODEL |
| 2114 |
EPIGENETIC HETEROCHROMATIN MARKERS DISTINGUISH TERMINALLY DIFFERENTIATED LEUKOCYTES FROM INCOMPLETELY DIFFERENTIATED LEUKEMIA CELLS IN HUMAN BLOOD |
| 2115 |
EPIGENETIC HETEROGENEITY IN HIV-1 LATENCY ESTABLISHMENT |
| 2116 |
EPIGENETIC HISTONE DEACETYLATION INHIBITION PREVENTS THE DEVELOPMENT AND PERSISTENCE OF TEMPORAL LOBE EPILEPSY |
| 2117 |
EPIGENETIC HISTONE METHYLATION MODULATES FIBROTIC GENE EXPRESSION |
| 2118 |
EPIGENETIC HISTONE METHYLATION OF PPARGAMMA AND CPT1A SIGNALING CONTRIBUTES TO BETAHISTINE PREVENTING OLANZAPINE-INDUCED DYSLIPIDEMIA |
| 2119 |
EPIGENETIC HISTONE MODIFICATION REGULATES DEVELOPMENTAL LEAD EXPOSURE INDUCED HYPERACTIVITY IN RATS |
| 2120 |
EPIGENETIC HISTONE MODIFICATIONS IN A CLINICALLY RELEVANT RAT MODEL OF CHRONIC ETHANOL-BINGE-MEDIATED LIVER INJURY |
| 2121 |
EPIGENETIC HISTONE MODIFICATIONS IN THE PATHOGENESIS OF DIABETIC KIDNEY DISEASE |
| 2122 |
EPIGENETIC IMPACT OF INFECTION ON CARCINOGENESIS: MECHANISMS AND APPLICATIONS |
| 2123 |
EPIGENETIC IMPACTS OF STRESS PRIMING OF THE NEUROINFLAMMATORY RESPONSE TO SARIN SURROGATE IN MICE: A MODEL OF GULF WAR ILLNESS |
| 2124 |
EPIGENETIC IMPLICATION OF GENE-ADJACENT RETROELEMENTS IN HELICOBACTER PYLORI-INFECTED ADULTS |
| 2125 |
EPIGENETIC INACTIVATION OF DLX4 IS ASSOCIATED WITH DISEASE PROGRESSION IN CHRONIC MYELOID LEUKEMIA |
| 2126 |
EPIGENETIC INACTIVATION OF MIR-34B/C IN ADDITION TO MIR-34A AND DAPK1 IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2127 |
EPIGENETIC INACTIVATION OF MIR-9 FAMILY MICRORNAS IN CHRONIC LYMPHOCYTIC LEUKEMIA--IMPLICATIONS ON CONSTITUTIVE ACTIVATION OF NFKAPPAB PATHWAY |
| 2128 |
EPIGENETIC INACTIVATION OF PLCD1 IN CHRONIC MYELOID LEUKEMIA |
| 2129 |
EPIGENETIC INACTIVATION OF SUPPRESSORS OF CYTOKINE SIGNALLING IN PHILADELPHIA-NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS |
| 2130 |
EPIGENETIC INACTIVATION OF THE AUTOPHAGY-LYSOSOMAL SYSTEM IN APPENDIX IN PARKINSON'S DISEASE |
| 2131 |
EPIGENETIC INACTIVATION OF THE HSA-MIR-203 IN HAEMATOLOGICAL MALIGNANCIES |
| 2132 |
EPIGENETIC INACTIVATION OF THE MIR-124-1 IN HAEMATOLOGICAL MALIGNANCIES |
| 2133 |
EPIGENETIC INACTIVATION OF THE MIR-34A IN HEMATOLOGICAL MALIGNANCIES |
| 2134 |
EPIGENETIC INACTIVATION OF THE MIR129-2 IN HEMATOLOGICAL MALIGNANCIES |
| 2135 |
EPIGENETIC INACTIVATION OF TUMOR SUPPRESSOR GENES IN SERUM OF PATIENTS WITH CUTANEOUS MELANOMA |
| 2136 |
EPIGENETIC INFLUENCES IN THE OBESITY/COLORECTAL CANCER AXIS: A NOVEL THERAGNOSTIC AVENUE |
| 2137 |
EPIGENETIC INHERITANCE AND EVOLUTION: A PATERNAL PERSPECTIVE ON DIETARY INFLUENCES |
| 2138 |
EPIGENETIC INHERITANCE OF FETAL GENES IN ALLERGIC ASTHMA |
| 2139 |
EPIGENETIC INSIGHTS INTO MULTIPLE SCLEROSIS DISEASE PROGRESSION |
| 2140 |
EPIGENETIC INTERACTIONS BETWEEN ALCOHOL AND CANNABINERGIC EFFECTS: FOCUS ON HISTONE MODIFICATION AND DNA METHYLATION |
| 2141 |
EPIGENETIC INTERVENTIONS FOR EPILEPTOGENESIS: A NEW FRONTIER FOR CURING EPILEPSY |
| 2142 |
EPIGENETIC INVESTIGATION OF VARIABLY X CHROMOSOME INACTIVATED GENES IN MONOZYGOTIC FEMALE TWINS DISCORDANT FOR PRIMARY BILIARY CIRRHOSIS |
| 2143 |
EPIGENETIC LANDSCAPE OF HIV-1 INFECTION IN PRIMARY HUMAN MACROPHAGE |
| 2144 |
EPIGENETIC LANDSCAPE OF STRESS SURFEIT DISORDERS: KEY ROLE FOR DNA METHYLATION DYNAMICS |
| 2145 |
EPIGENETIC MAINTENANCE OF ACQUIRED GENE EXPRESSION PROGRAMS DURING MEMORY CD8 T CELL HOMEOSTASIS |
| 2146 |
EPIGENETIC MANIPULATION RESTORES FUNCTIONS OF DEFECTIVE CD8(+) T CELLS FROM CHRONIC VIRAL INFECTION |
| 2147 |
EPIGENETIC MARKER OF TELOMERIC AGE IS ASSOCIATED WITH EXACERBATIONS AND HOSPITALIZATIONS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 2148 |
EPIGENETIC MARKERS OF RENAL FUNCTION IN AFRICAN AMERICANS |
| 2149 |
EPIGENETIC MARKERS TO PREDICT CONVERSION FROM GESTATIONAL DIABETES TO TYPE 2 DIABETES |
| 2150 |
EPIGENETIC MEASURES OF AGEING PREDICT THE PREVALENCE AND INCIDENCE OF LEADING CAUSES OF DEATH AND DISEASE BURDEN |
| 2151 |
EPIGENETIC MECHANISM IN SEARCH FOR THE PATHOMECHANISM OF DIABETIC NEUROPATHY DEVELOPMENT IN DIABETES MELLITUS TYPE 1 (T1DM) |
| 2152 |
EPIGENETIC MECHANISM OF 5-HT/NE/DA TRIPLE REUPTAKE INHIBITOR ON ADULT DEPRESSION SUSCEPTIBILITY IN EARLY STRESS MICE |
| 2153 |
EPIGENETIC MECHANISMS ACTIVATED BY CHILDHOOD ADVERSITY |
| 2154 |
EPIGENETIC MECHANISMS AND KIDNEY DISEASES |
| 2155 |
EPIGENETIC MECHANISMS AND METABOLIC REPROGRAMMING IN FIBROGENESIS: DUAL TARGETING OF G9A AND DNMT1 FOR THE INHIBITION OF LIVER FIBROSIS |
| 2156 |
EPIGENETIC MECHANISMS ARE INVOLVED IN THE REGULATION OF ETHANOL CONSUMPTION IN MICE |
| 2157 |
EPIGENETIC MECHANISMS ELICITED BY NUTRITION IN EARLY LIFE |
| 2158 |
EPIGENETIC MECHANISMS FOR NUTRITION DETERMINANTS OF LATER HEALTH OUTCOMES |
| 2159 |
EPIGENETIC MECHANISMS IMPACTED BY CHRONIC STRESS ACROSS THE RODENT LIFESPAN |
| 2160 |
EPIGENETIC MECHANISMS IN ASTHMA |
| 2161 |
EPIGENETIC MECHANISMS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 2162 |
EPIGENETIC MECHANISMS IN COPD: IMPLICATIONS FOR PATHOGENESIS AND DRUG DISCOVERY |
| 2163 |
EPIGENETIC MECHANISMS IN DIABETIC VASCULAR COMPLICATIONS |
| 2164 |
EPIGENETIC MECHANISMS IN HEPATIC STELLATE CELL ACTIVATION DURING LIVER FIBROSIS AND CARCINOGENESIS |
| 2165 |
EPIGENETIC MECHANISMS IN HEPATITIS B VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA |
| 2166 |
EPIGENETIC MECHANISMS IN HEPATOCELLULAR CARCINOMA: HOW ENVIRONMENTAL FACTORS INFLUENCE THE EPIGENOME |
| 2167 |
EPIGENETIC MECHANISMS IN IRRITABLE BOWEL SYNDROME |
| 2168 |
EPIGENETIC MECHANISMS IN MONOCYTES/MACROPHAGES REGULATE INFLAMMATION IN CARDIOMETABOLIC AND VASCULAR DISEASE |
| 2169 |
EPIGENETIC MECHANISMS IN PARENCHYMAL LUNG DISEASES: BYSTANDERS OR THERAPEUTIC TARGETS? EPIGENETIC RESPONSES DUE TO ENVIRONMENTAL CHANGES ALTER CHROMATIN STRUCTURE, WHICH IN TURN MODIFIES THE PHENOTYPE, GENE EXPRESSION PROFILE, AND ACTIVITY OF EACH CELL TYPE THAT HAS A ROLE IN THE PATHOPHYSIOLOGY OF A DISEASE |
| 2170 |
EPIGENETIC MECHANISMS IN RESPIRATORY MUSCLE DYSFUNCTION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 2171 |
EPIGENETIC MECHANISMS IN THE PATHOGENESIS OF DIABETIC FOOT ULCERS |
| 2172 |
EPIGENETIC MECHANISMS INVOLVED IN HCV-INDUCED HEPATOCELLULAR CARCINOMA (HCC) |
| 2173 |
EPIGENETIC MECHANISMS INVOLVED IN INTRAUTERINE GROWTH RESTRICTION AND ABERRANT KIDNEY DEVELOPMENT AND FUNCTION |
| 2174 |
EPIGENETIC MECHANISMS INVOLVED IN MODULATION OF INFLAMMATORY DISEASES |
| 2175 |
EPIGENETIC MECHANISMS OF ANGIOGENESIS IN THE ISCHEMIC HEART DISEASES WITH ACUPUNCTURE TREATMENT |
| 2176 |
EPIGENETIC MECHANISMS OF CHRONIC PAIN |
| 2177 |
EPIGENETIC MECHANISMS OF HYPERGLYCEMIC MEMORY |
| 2178 |
EPIGENETIC MECHANISMS OF MACROPHAGE ACTIVATION IN TYPE 2 DIABETES |
| 2179 |
EPIGENETIC MECHANISMS OF NEURAL PLASTICITY IN CHRONIC NEUROPATHIC PAIN |
| 2180 |
EPIGENETIC MECHANISMS OF PANCREATOBILIARY FIBROSIS |
| 2181 |
EPIGENETIC MECHANISMS REGULATE NADPH OXIDASE-4 EXPRESSION IN CELLULAR SENESCENCE |
| 2182 |
EPIGENETIC MECHANISMS REGULATING THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AND THEIR PROMISE FOR THERAPEUTICS |
| 2183 |
EPIGENETIC MECHANISMS RESPONSIBLE FOR THE TRANSGENERATIONAL INHERITANCE OF INTRAUTERINE GROWTH RESTRICTION PHENOTYPES |
| 2184 |
EPIGENETIC MECHANISMS THAT UNDERPIN METABOLIC AND CARDIOVASCULAR DISEASES |
| 2185 |
EPIGENETIC MECHANISMS UNDERLYING HIV-INFECTION INDUCED SUSCEPTIBILITY OF CD4+ T CELLS TO ENHANCED ACTIVATION-INDUCED FASL EXPRESSION AND CELL DEATH |
| 2186 |
EPIGENETIC MECHANISMS UNDERLYING PATHOBIOLOGY OF ALCOHOL USE DISORDER |
| 2187 |
EPIGENETIC MECHANISMS UNDERLYING STRESS-INDUCED VISCERAL PAIN: RESILIENCE VERSUS VULNERABILITY IN A TWO-HIT MODEL OF EARLY LIFE STRESS AND CHRONIC ADULT STRESS |
| 2188 |
EPIGENETIC MECHANISMS UNDERLYING THE BENEFITS OF FLAVONOIDS IN CARDIOVASCULAR HEALTH AND DISEASES: ARE LONG NON-CODING RNAS RISING STARS? CARDIOVASCULAR DISEASES (CVDS) RANK AS THE FIRST LEADING CAUSE OF DEATH GLOBALLY |
| 2189 |
EPIGENETIC MECHANISMS UNDERLYING THE THERAPEUTIC EFFECTS OF HDAC INHIBITORS IN CHRONIC MYELOID LEUKEMIA |
| 2190 |
EPIGENETIC MECHANISMS |
| 2191 |
EPIGENETIC MEMORY CONTRIBUTING TO THE PATHOGENESIS OF AKI-TO-CKD TRANSITION |
| 2192 |
EPIGENETIC METHODS AND TWIN STUDIES |
| 2193 |
EPIGENETIC MODIFICATION DRIVES ACUTE KIDNEY INJURY-TO-CHRONIC KIDNEY DISEASE PROGRESSION |
| 2194 |
EPIGENETIC MODIFICATION IN NEUROPATHIC PAIN |
| 2195 |
EPIGENETIC MODIFICATION MECHANISMS INVOLVED IN INFLAMMATION AND FIBROSIS IN RENAL PATHOLOGY |
| 2196 |
EPIGENETIC MODIFICATION MEDIATES THE INCREASE OF LAG-3(+) T CELLS IN CHRONIC OSTEOMYELITIS |
| 2197 |
EPIGENETIC MODIFICATION OF BDNF MEDIATES NEUROPATHIC PAIN VIA MIR-30A-3P/EP300 AXIS IN CCI RATS |
| 2198 |
EPIGENETIC MODIFICATION OF DRG NEURONAL GENE EXPRESSION SUBSEQUENT TO NERVE INJURY: ETIOLOGICAL CONTRIBUTION TO COMPLEX REGIONAL PAIN SYNDROMES (PART I) |
| 2199 |
EPIGENETIC MODIFICATION OF DRG NEURONAL GENE EXPRESSION SUBSEQUENT TO NERVE INJURY: ETIOLOGICAL CONTRIBUTION TO COMPLEX REGIONAL PAIN SYNDROMES (PART II) |
| 2200 |
EPIGENETIC MODIFICATION OF FOXP3 IN PATIENTS WITH CHRONIC HIV INFECTION |
| 2201 |
EPIGENETIC MODIFICATION OF GLUCOCORTICOID RECEPTOR PROMOTER I(7) IN MATERNALLY SEPARATED AND RESTRAINT-STRESSED RATS |
| 2202 |
EPIGENETIC MODIFICATION OF MIR-10A REGULATES RENAL DAMAGE BY TARGETING CREB1 IN TYPE 2 DIABETES MELLITUS |
| 2203 |
EPIGENETIC MODIFICATION OF SPINAL MIR-219 EXPRESSION REGULATES CHRONIC INFLAMMATION PAIN BY TARGETING CAMKIIGAMMA |
| 2204 |
EPIGENETIC MODIFICATION OF THE VON WILLEBRAND FACTOR PROMOTER DRIVES PLATELET AGGREGATION ON THE PULMONARY ENDOTHELIUM IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION |
| 2205 |
EPIGENETIC MODIFICATION OF THE X CHROMOSOME INFLUENCES SUSCEPTIBILITY TO POLYCYSTIC OVARY SYNDROME |
| 2206 |
EPIGENETIC MODIFICATIONS AND DIABETIC RETINOPATHY |
| 2207 |
EPIGENETIC MODIFICATIONS AND GLUCOCORTICOID SENSITIVITY IN MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) |
| 2208 |
EPIGENETIC MODIFICATIONS AND NON-CODING RNA IN DIABETES-MELLITUS-INDUCED CORONARY ARTERY DISEASE: PATHOPHYSIOLOGICAL LINK AND NEW THERAPEUTIC FRONTIERS |
| 2209 |
EPIGENETIC MODIFICATIONS AND OBSESSIVE-COMPULSIVE DISORDER: WHAT DO WE KNOW? OBSESSIVE-COMPULSIVE DISORDER (OCD) IS A CHRONIC, SEVERE DISABLING NEUROPSYCHIATRIC DISORDER WHOSE PATHOPHYSIOLOGY IS NOT YET WELL DEFINED |
| 2210 |
EPIGENETIC MODIFICATIONS AND POTENTIAL NEW TREATMENT TARGETS IN DIABETIC RETINOPATHY |
| 2211 |
EPIGENETIC MODIFICATIONS AND THE DEVELOPMENT OF KIDNEY GRAFT FIBROSIS |
| 2212 |
EPIGENETIC MODIFICATIONS AND THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): AN UPDATE REVIEW |
| 2213 |
EPIGENETIC MODIFICATIONS AS OUTCOMES OF EXERCISE INTERVENTIONS RELATED TO SPECIFIC METABOLIC ALTERATIONS: A SYSTEMATIC REVIEW |
| 2214 |
EPIGENETIC MODIFICATIONS ASSOCIATED TO NEUROINFLAMMATION AND NEUROPATHIC PAIN AFTER NEURAL TRAUMA |
| 2215 |
EPIGENETIC MODIFICATIONS FOLLOWING NOXIOUS STIMULI IN INFANTS |
| 2216 |
EPIGENETIC MODIFICATIONS IN CHRONIC MYELOID LEUKEMIA CELLS THROUGH RUXOLITINIB TREATMENT |
| 2217 |
EPIGENETIC MODIFICATIONS IN CHRONIC RHINOSINUSITIS WITH AND WITHOUT NASAL POLYPS |
| 2218 |
EPIGENETIC MODIFICATIONS IN FIBROTIC DISEASES: IMPLICATIONS FOR PATHOGENESIS AND PHARMACOLOGICAL TARGETS |
| 2219 |
EPIGENETIC MODIFICATIONS IN HEPATIC STELLATE CELLS CONTRIBUTE TO LIVER FIBROSIS |
| 2220 |
EPIGENETIC MODIFICATIONS IN NEUROPATHIC PAIN |
| 2221 |
EPIGENETIC MODIFICATIONS IN RHEUMATOID ARTHRITIS, A REVIEW |
| 2222 |
EPIGENETIC MODIFICATIONS IN SALIVARY GLANDS FROM PATIENTS WITH SJOGREN'S SYNDROME AFFECT CYTOKERATIN 19 EXPRESSION |
| 2223 |
EPIGENETIC MODIFICATIONS IN SPINAL LIGAMENT AGING |
| 2224 |
EPIGENETIC MODIFICATIONS IN THE PATHOGENESIS OF SYSTEMIC SCLEROSIS |
| 2225 |
EPIGENETIC MODIFICATIONS IN TUMOR-ASSOCIATED MACROPHAGES: A NEW PERSPECTIVE FOR AN OLD FOE |
| 2226 |
EPIGENETIC MODIFICATIONS INDUCED BY NUTRIENTS IN EARLY LIFE PHASES: GENDER DIFFERENCES IN METABOLIC ALTERATION IN ADULTHOOD |
| 2227 |
EPIGENETIC MODIFICATIONS OF CHRONIC HYPOXIA-MEDIATED NEURODEGENERATION IN ALZHEIMER'S DISEASE |
| 2228 |
EPIGENETIC MODIFICATIONS OF HISTONES IN PERIODONTAL DISEASE |
| 2229 |
EPIGENETIC MODIFICATIONS OF INFLAMMATION IN INTERVERTEBRAL DISC DEGENERATION |
| 2230 |
EPIGENETIC MODIFICATIONS OF KLOTHO EXPRESSION IN KIDNEY DISEASES |
| 2231 |
EPIGENETIC MODIFICATIONS OF MAJOR DEPRESSIVE DISORDER |
| 2232 |
EPIGENETIC MODIFICATIONS OF MIRNAS IN OSTEOARTHRITIS: A SYSTEMATIC REVIEW ON THEIR METHYLATION LEVELS AND EFFECTS ON CHONDROCYTES, EXTRACELLULAR MATRIX AND JOINT INFLAMMATION |
| 2233 |
EPIGENETIC MODIFICATIONS OF THE NUCLEAR FACTOR KAPPA B SIGNALLING PATHWAY AND ITS IMPACT ON INFLAMMATORY BOWEL DISEASE |
| 2234 |
EPIGENETIC MODIFICATIONS PRECEDE MOLECULAR ALTERATIONS AND DRIVE HUMAN HEPATOCARCINOGENESIS |
| 2235 |
EPIGENETIC MODIFICATIONS, ALCOHOLIC BRAIN AND POTENTIAL DRUG TARGETS |
| 2236 |
EPIGENETIC MODIFIERS AS POTENTIAL THERAPEUTIC TARGETS IN DIABETIC KIDNEY DISEASE |
| 2237 |
EPIGENETIC MODIFIERS IN MYELOID MALIGNANCIES: THE ROLE OF HISTONE DEACETYLASE INHIBITORS |
| 2238 |
EPIGENETIC MODULATION AS A THERAPEUTIC PROSPECT FOR TREATMENT OF AUTOIMMUNE RHEUMATIC DISEASES |
| 2239 |
EPIGENETIC MODULATION BY APABETALONE COUNTERS CYTOKINE-DRIVEN ACUTE PHASE RESPONSE IN VITRO, IN MICE AND IN PATIENTS WITH CARDIOVASCULAR DISEASE |
| 2240 |
EPIGENETIC MODULATION IN CHRONIC HEPATITIS B VIRUS INFECTION |
| 2241 |
EPIGENETIC MODULATION IN PERIODONTITIS: INTERACTION OF ADIPONECTIN AND JMJD3-IRF4 AXIS IN MACROPHAGES |
| 2242 |
EPIGENETIC MODULATION OF CD8(+) T CELL FUNCTION IN LENTIVIRUS INFECTIONS: A REVIEW |
| 2243 |
EPIGENETIC MODULATION OF CHRONIC ANXIETY AND PAIN BY HISTONE DEACETYLATION |
| 2244 |
EPIGENETIC MODULATION OF COLLAGEN 1A1: THERAPEUTIC IMPLICATIONS IN FIBROSIS AND ENDOMETRIOSIS |
| 2245 |
EPIGENETIC MODULATION OF GREMLIN-1/NOTCH PATHWAY IN EXPERIMENTAL CRESCENTIC IMMUNE-MEDIATED GLOMERULONEPHRITIS |
| 2246 |
EPIGENETIC MODULATION OF INFLAMMATION AND SYNAPTIC PLASTICITY PROMOTES RESILIENCE AGAINST STRESS IN MICE |
| 2247 |
EPIGENETIC MODULATION OF MACROPHAGE POLARIZATION PREVENTS LUMBAR DISC DEGENERATION |
| 2248 |
EPIGENETIC MODULATION OF MACROPHAGE POLARIZATION- PERSPECTIVES IN DIABETIC WOUNDS |
| 2249 |
EPIGENETIC MODULATION OF MGLU2 RECEPTORS BY HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF INFLAMMATORY PAIN |
| 2250 |
EPIGENETIC MODULATION OF OPIOID RECEPTORS BY DRUGS OF ABUSE |
| 2251 |
EPIGENETIC MODULATION OF VASOPRESSIN EXPRESSION IN HEALTH AND DISEASE |
| 2252 |
EPIGENETIC MODULATION OF VISCERAL NOCICEPTION |
| 2253 |
EPIGENETIC MODULATION OF WNT SIGNALING CONTRIBUTES TO NEUROPATHIC PAIN IN RATS |
| 2254 |
EPIGENETIC MODULATION: RESEARCH PROGRESS ON HISTONE ACETYLATION LEVELS IN MAJOR DEPRESSIVE DISORDERS |
| 2255 |
EPIGENETIC MODULATIONS IN EARLY ENDOTHELIAL CELLS AND DNA HYPERMETHYLATION IN HUMAN SKIN AFTER SULFUR MUSTARD EXPOSURE |
| 2256 |
EPIGENETIC PATHWAYS IN MACROPHAGES EMERGE AS NOVEL TARGETS IN ATHEROSCLEROSIS |
| 2257 |
EPIGENETIC PERSPECTIVES IN SYSTEMIC LUPUS ERYTHEMATOSUS: PATHOGENESIS, BIOMARKERS, AND THERAPEUTIC POTENTIALS |
| 2258 |
EPIGENETIC PRIMING IN CHRONIC LIVER DISEASE IMPACTS THE TRANSCRIPTIONAL AND GENETIC LANDSCAPES OF HEPATOCELLULAR CARCINOMA |
| 2259 |
EPIGENETIC PRIMING IN DRUG ADDICTION |
| 2260 |
EPIGENETIC PROCESSES DURING PREECLAMPSIA AND EFFECTS ON FETAL DEVELOPMENT AND CHRONIC HEALTH |
| 2261 |
EPIGENETIC PROFILE IN CHRONIC LYMPHOCYTIC LEUKEMIA USING METHYLATION-SPECIFIC MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION |
| 2262 |
EPIGENETIC PROFILING IN CHRONIC LYMPHOCYTIC LEUKEMIA REVEALS NOVEL METHYLATION TARGETS |
| 2263 |
EPIGENETIC PROGRAMMING AT THE MOGAT1 LOCUS MAY LINK NEONATAL OVERNUTRITION WITH LONG-TERM HEPATIC STEATOSIS AND INSULIN RESISTANCE |
| 2264 |
EPIGENETIC PROGRAMMING BY STRESS AND GLUCOCORTICOIDS ALONG THE HUMAN LIFESPAN |
| 2265 |
EPIGENETIC PROGRAMMING IN THE PREIMPLANTATION RAT EMBRYO IS DISRUPTED BY CHRONIC PATERNAL CYCLOPHOSPHAMIDE EXPOSURE |
| 2266 |
EPIGENETIC PROGRAMMING OF MU-OPIOID RECEPTOR GENE IN MOUSE BRAIN IS REGULATED BY MECP2 AND BRG1 CHROMATIN REMODELLING FACTOR |
| 2267 |
EPIGENETIC PROGRAMMING OF OBESITY AND DIABETES BY IN UTERO EXPOSURE TO GESTATIONAL DIABETES MELLITUS |
| 2268 |
EPIGENETIC PROGRAMMING OF T CELLS IMPACTS IMMUNE RECONSTITUTION IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS |
| 2269 |
EPIGENETIC PROGRAMMING OF THE NEUROENDOCRINE STRESS RESPONSE BY ADULT LIFE STRESS |
| 2270 |
EPIGENETIC QUANTIFICATION OF IMMUNOSENESCENT CD8(+) TEMRA CELLS IN HUMAN BLOOD |
| 2271 |
EPIGENETIC READER SP140 LOSS OF FUNCTION DRIVES CROHN'S DISEASE DUE TO UNCONTROLLED MACROPHAGE TOPOISOMERASES |
| 2272 |
EPIGENETIC REDUCTION OF MIR-214-3P UPREGULATES ASTROCYTIC COLONY-STIMULATING FACTOR-1 AND CONTRIBUTES TO NEUROPATHIC PAIN INDUCED BY NERVE INJURY |
| 2273 |
EPIGENETIC REGULATION ALTERS BIOFILM ARCHITECTURE AND COMPOSITION IN MULTIPLE CLINICAL ISOLATES OF NONTYPEABLE HAEMOPHILUS INFLUENZAE |
| 2274 |
EPIGENETIC REGULATION AND FETAL PROGRAMMING |
| 2275 |
EPIGENETIC REGULATION AND T-CELL RESPONSES IN ENDOMETRIOSIS - SOMETHING OTHER THAN AUTOIMMUNITY |
| 2276 |
EPIGENETIC REGULATION AS A PROMISING TOOL FOR TREATMENT OF ATHEROSCLEROSIS |
| 2277 |
EPIGENETIC REGULATION BY ASXL1 IN MYELOID MALIGNANCIES |
| 2278 |
EPIGENETIC REGULATION BY SUV4-20H1 IN CARDIOPULMONARY PROGENITOR CELLS IS REQUIRED TO PREVENT PULMONARY HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 2279 |
EPIGENETIC REGULATION IN ALLERGIC DISEASES AND RELATED STUDIES |
| 2280 |
EPIGENETIC REGULATION IN DRUG ADDICTION |
| 2281 |
EPIGENETIC REGULATION IN EARLY CHILDHOOD: A MINIATURIZED AND VALIDATED METHOD TO ASSESS HISTONE ACETYLATION |
| 2282 |
EPIGENETIC REGULATION IN EXPOSOME-INDUCED TUMORIGENESIS: EMERGING ROLES OF NCRNAS |
| 2283 |
EPIGENETIC REGULATION IN FIBROSIS PROGRESS |
| 2284 |
EPIGENETIC REGULATION IN INTERVERTEBRAL DISC DEGENERATION |
| 2285 |
EPIGENETIC REGULATION IN KIDNEY TOXICITY: INSIGHTS FROM CISPLATIN NEPHROTOXICITY |
| 2286 |
EPIGENETIC REGULATION IN KIDNEY TRANSPLANTATION |
| 2287 |
EPIGENETIC REGULATION IN LEAN NONALCOHOLIC FATTY LIVER DISEASE |
| 2288 |
EPIGENETIC REGULATION IN MAJOR DEPRESSION AND OTHER STRESS-RELATED DISORDERS: MOLECULAR MECHANISMS, CLINICAL RELEVANCE AND THERAPEUTIC POTENTIAL |
| 2289 |
EPIGENETIC REGULATION IN MONOCYTE/MACROPHAGE: A KEY PLAYER DURING ATHEROSCLEROSIS |
| 2290 |
EPIGENETIC REGULATION IN MURINE OFFSPRING AS A NOVEL MECHANISM FOR TRANSMATERNAL ASTHMA PROTECTION INDUCED BY MICROBES |
| 2291 |
EPIGENETIC REGULATION IN PATHOLOGY OF ATHEROSCLEROSIS: A NOVEL PERSPECTIVE |
| 2292 |
EPIGENETIC REGULATION IN SUBSTANCE USE DISORDERS |
| 2293 |
EPIGENETIC REGULATION IN THE ACUTE KIDNEY INJURY TO CHRONIC KIDNEY DISEASE TRANSITION |
| 2294 |
EPIGENETIC REGULATION IN THE PATHOGENESIS OF SJOGREN SYNDROME AND RHEUMATOID ARTHRITIS |
| 2295 |
EPIGENETIC REGULATION IN UTERINE FIBROIDS-THE ROLE OF TEN-ELEVEN TRANSLOCATION ENZYMES AND THEIR POTENTIAL THERAPEUTIC APPLICATION |
| 2296 |
EPIGENETIC REGULATION OF ABIOTIC STRESS MEMORY: MAINTAINING THE GOOD THINGS WHILE THEY LAST |
| 2297 |
EPIGENETIC REGULATION OF ACUTE INFLAMMATORY PAIN |
| 2298 |
EPIGENETIC REGULATION OF ADIPOGENESIS |
| 2299 |
EPIGENETIC REGULATION OF AIRWAY EPITHELIUM IMMUNE FUNCTIONS IN ASTHMA |
| 2300 |
EPIGENETIC REGULATION OF BDNF EXPRESSION IN THE PRIMARY SENSORY NEURONS AFTER PERIPHERAL NERVE INJURY: IMPLICATIONS IN THE DEVELOPMENT OF NEUROPATHIC PAIN |
| 2301 |
EPIGENETIC REGULATION OF BEIGE ADIPOCYTE FATE BY HISTONE METHYLATION |
| 2302 |
EPIGENETIC REGULATION OF CANCER STEM CELL MARKER CD133 BY TRANSFORMING GROWTH FACTOR-BETA |
| 2303 |
EPIGENETIC REGULATION OF CANNABINOID-MEDIATED ATTENUATION OF INFLAMMATION AND ITS IMPACT ON THE USE OF CANNABINOIDS TO TREAT AUTOIMMUNE DISEASES |
| 2304 |
EPIGENETIC REGULATION OF CATHEPSIN L EXPRESSION IN CHRONIC MYELOID LEUKAEMIA |
| 2305 |
EPIGENETIC REGULATION OF CC-CHEMOKINE LIGAND 2 IN NONRESOLVING INFLAMMATION |
| 2306 |
EPIGENETIC REGULATION OF CELL-FATE CHANGES THAT DETERMINE ADULT LIVER REGENERATION AFTER INJURY |
| 2307 |
EPIGENETIC REGULATION OF CELLULAR FUNCTIONS IN WOUND HEALING |
| 2308 |
EPIGENETIC REGULATION OF CHEMOKINE (CC-MOTIF) LIGAND 2 IN INFLAMMATORY DISEASES |
| 2309 |
EPIGENETIC REGULATION OF CHONDROCYTES AND SUBCHONDRAL BONE IN OSTEOARTHRITIS |
| 2310 |
EPIGENETIC REGULATION OF CHRONIC PAIN |
| 2311 |
EPIGENETIC REGULATION OF CYTOSOLIC PHOSPHOLIPASE A2 IN SH-SY5Y HUMAN NEUROBLASTOMA CELLS |
| 2312 |
EPIGENETIC REGULATION OF DENDRITIC CELL-DERIVED INTERLEUKIN-12 FACILITATES IMMUNOSUPPRESSION AFTER A SEVERE INNATE IMMUNE RESPONSE |
| 2313 |
EPIGENETIC REGULATION OF ENDOTHELIAL CELL FUNCTION BY NUCLEIC ACID METHYLATION IN CARDIAC HOMEOSTASIS AND DISEASE |
| 2314 |
EPIGENETIC REGULATION OF ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN CHRONIC HEART DISEASE |
| 2315 |
EPIGENETIC REGULATION OF FERROPTOSIS-ASSOCIATED GENES AND ITS IMPLICATION IN CANCER THERAPY |
| 2316 |
EPIGENETIC REGULATION OF FRUCTOSE-1,6-BISPHOSPHATASE 1 BY HOST TRANSCRIPTION FACTOR SPECKLED 110 KDA DURING HEPATITIS B VIRUS INFECTION |
| 2317 |
EPIGENETIC REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING AND ITS IMPLICATIONS IN PSYCHIATRIC DISORDERS |
| 2318 |
EPIGENETIC REGULATION OF GABAERGIC DIFFERENTIATION IN THE DEVELOPING BRAIN |
| 2319 |
EPIGENETIC REGULATION OF GABAERGIC NEUROTRANSMISSION AND NEUROSTEROID BIOSYNTHESIS IN ALCOHOL USE DISORDER |
| 2320 |
EPIGENETIC REGULATION OF GENE EXPRESSION AND M2 MACROPHAGE POLARIZATION AS NEW POTENTIAL OMEGA-3 POLYUNSATURATED FATTY ACID TARGETS IN COLON INFLAMMATION AND CANCER |
| 2321 |
EPIGENETIC REGULATION OF GENES THAT MODULATE CHRONIC STRESS-INDUCED VISCERAL PAIN IN THE PERIPHERAL NERVOUS SYSTEM |
| 2322 |
EPIGENETIC REGULATION OF HEPATIC STELLATE CELL ACTIVATION AND LIVER FIBROSIS |
| 2323 |
EPIGENETIC REGULATION OF HEPATIC STELLATE CELL ACTIVATION AND MACROPHAGE IN CHRONIC LIVER INFLAMMATION |
| 2324 |
EPIGENETIC REGULATION OF HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA: IMPLICATIONS FOR EPIGENETIC THERAPY AGAINST CHRONIC HEPATITIS B |
| 2325 |
EPIGENETIC REGULATION OF HIPPOCAMPAL FOSB EXPRESSION CONTROLS BEHAVIORAL RESPONSES TO COCAINE |
| 2326 |
EPIGENETIC REGULATION OF HOTAIR IN ADVANCED CHRONIC MYELOID LEUKEMIA |
| 2327 |
EPIGENETIC REGULATION OF HUMAN CANCER/TESTIS ANTIGEN GENE, HAGE, IN CHRONIC MYELOID LEUKEMIA |
| 2328 |
EPIGENETIC REGULATION OF IMMEDIATE-EARLY GENE NR4A2/NURR1 IN THE MEDIAL HABENULA DURING REINSTATEMENT OF COCAINE-ASSOCIATED BEHAVIOR |
| 2329 |
EPIGENETIC REGULATION OF IMMUNE CELL FUNCTIONS DURING POST-SEPTIC IMMUNOSUPPRESSION |
| 2330 |
EPIGENETIC REGULATION OF IMMUNE FUNCTION IN ASTHMA |
| 2331 |
EPIGENETIC REGULATION OF INFLAMMATION BY MICRORNAS IN POST-INFECTIOUS BRONCHIOLITIS OBLITERANS |
| 2332 |
EPIGENETIC REGULATION OF INFLAMMATION IN INSULIN RESISTANCE |
| 2333 |
EPIGENETIC REGULATION OF INFLAMMATION: THE METABOLOMICS CONNECTION |
| 2334 |
EPIGENETIC REGULATION OF INFLAMMATORY CYTOKINE-INDUCED EPITHELIAL-TO-MESENCHYMAL CELL TRANSITION AND CANCER STEM CELL GENERATION |
| 2335 |
EPIGENETIC REGULATION OF INFLAMMATORY CYTOKINES AND ASSOCIATED GENES IN HUMAN MALIGNANCIES |
| 2336 |
EPIGENETIC REGULATION OF INFLAMMATORY FACTORS IN ADIPOSE TISSUE |
| 2337 |
EPIGENETIC REGULATION OF INFLAMMATORY RESPONSES IN THE CONTEXT OF PHYSICAL ACTIVITY |
| 2338 |
EPIGENETIC REGULATION OF INFLAMMATORY SIGNALING AND INFLAMMATION-INDUCED CANCER |
| 2339 |
EPIGENETIC REGULATION OF KEAP1-NRF2 SIGNALING |
| 2340 |
EPIGENETIC REGULATION OF LEUKOCYTE INFLAMMATORY MEDIATOR PRODUCTION DICTATES STAPHYLOCOCCUS AUREUS CRANIOTOMY INFECTION OUTCOME |
| 2341 |
EPIGENETIC REGULATION OF LIVER FIBROSIS |
| 2342 |
EPIGENETIC REGULATION OF MACROPHAGE POLARIZATION AND FUNCTION |
| 2343 |
EPIGENETIC REGULATION OF MACROPHAGE POLARIZATION IN CARDIOVASCULAR DISEASES |
| 2344 |
EPIGENETIC REGULATION OF MACROPHAGES: FROM HOMEOSTASIS MAINTENANCE TO HOST DEFENSE |
| 2345 |
EPIGENETIC REGULATION OF MATRIX METALLOPROTEINASE-1 AND -3 EXPRESSION IN MYCOBACTERIUM TUBERCULOSIS INFECTION |
| 2346 |
EPIGENETIC REGULATION OF METABOLISM AND INFLAMMATION BY CALORIE RESTRICTION |
| 2347 |
EPIGENETIC REGULATION OF MIR-124 UNDER ETHANOL DEPENDENCE AND WITHDRAWAL |
| 2348 |
EPIGENETIC REGULATION OF MUSCLE PHENOTYPE AND ADAPTATION: A POTENTIAL ROLE IN COPD MUSCLE DYSFUNCTION |
| 2349 |
EPIGENETIC REGULATION OF MYOFIBROBLAST DIFFERENTIATION AND EXTRACELLULAR MATRIX PRODUCTION IN NASAL POLYP-DERIVED FIBROBLASTS |
| 2350 |
EPIGENETIC REGULATION OF NEUROINFLAMMATION IN PARKINSON'S DISEASE |
| 2351 |
EPIGENETIC REGULATION OF NEWBORNS' IMPRINTED GENES RELATED TO GESTATIONAL GROWTH: PATTERNING BY PARENTAL RACE/ETHNICITY AND MATERNAL SOCIOECONOMIC STATUS |
| 2352 |
EPIGENETIC REGULATION OF NRF2/KEAP1 BY PHYTOCHEMICALS |
| 2353 |
EPIGENETIC REGULATION OF OPIOID-INDUCED HYPERALGESIA, DEPENDENCE, AND TOLERANCE IN MICE |
| 2354 |
EPIGENETIC REGULATION OF PERSISTENT PAIN |
| 2355 |
EPIGENETIC REGULATION OF PRAME GENE IN CHRONIC MYELOID LEUKEMIA |
| 2356 |
EPIGENETIC REGULATION OF PULMONARY ARTERIAL HYPERTENSION-INDUCED VASCULAR AND RIGHT VENTRICULAR REMODELING: NEW OPPORTUNITIES? PULMONARY ARTERY HYPERTENSION (PAH) IS A RARE CHRONIC DISEASE WITH HIGH IMPACT ON PATIENTS' QUALITY OF LIFE AND CURRENTLY NO AVAILABLE CURE |
| 2357 |
EPIGENETIC REGULATION OF PULMONARY INFLAMMATION |
| 2358 |
EPIGENETIC REGULATION OF RAC1 INDUCES SYNAPTIC REMODELING IN STRESS DISORDERS AND DEPRESSION |
| 2359 |
EPIGENETIC REGULATION OF REDOX STATE MEDIATES PERSISTENT CARDIORESPIRATORY ABNORMALITIES AFTER LONG-TERM INTERMITTENT HYPOXIA |
| 2360 |
EPIGENETIC REGULATION OF SKELETAL MUSCLE METABOLISM |
| 2361 |
EPIGENETIC REGULATION OF SKELETAL TISSUE INTEGRITY AND OSTEOPOROSIS DEVELOPMENT |
| 2362 |
EPIGENETIC REGULATION OF SNAP25 PREVENTS PROGRESSIVE GLUTAMATE EXCITOTOXICTY IN HYPOXIC CA3 NEURONS |
| 2363 |
EPIGENETIC REGULATION OF SPINAL CORD GENE EXPRESSION CONTRIBUTES TO ENHANCED POSTOPERATIVE PAIN AND ANALGESIC TOLERANCE SUBSEQUENT TO CONTINUOUS OPIOID EXPOSURE |
| 2364 |
EPIGENETIC REGULATION OF SPINAL CORD GENE EXPRESSION CONTROLS OPIOID-INDUCED HYPERALGESIA |
| 2365 |
EPIGENETIC REGULATION OF SPINAL CXCR2 SIGNALING IN INCISIONAL HYPERSENSITIVITY IN MICE |
| 2366 |
EPIGENETIC REGULATION OF STEROIDOGENIC ENZYMES EXPRESSED IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM HEALTHY INDIVIDUALS AND FROM PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2367 |
EPIGENETIC REGULATION OF T CELL EXHAUSTION |
| 2368 |
EPIGENETIC REGULATION OF T HELPER CELLS AND INTESTINAL PATHOGENICITY |
| 2369 |
EPIGENETIC REGULATION OF T-HELPER CELL DIFFERENTIATION, MEMORY, AND PLASTICITY IN ALLERGIC ASTHMA |
| 2370 |
EPIGENETIC REGULATION OF THE ALTERNATIVELY ACTIVATED MACROPHAGE PHENOTYPE |
| 2371 |
EPIGENETIC REGULATION OF THE GLUCOCORTICOID RECEPTOR PROMOTER 1(7) IN ADULT RATS |
| 2372 |
EPIGENETIC REGULATION OF THE IL-13-INDUCED HUMAN EOTAXIN-3 GENE BY CREB-BINDING PROTEIN-MEDIATED HISTONE 3 ACETYLATION |
| 2373 |
EPIGENETIC REGULATION OF THE N-TERMINAL TRUNCATED ISOFORM OF MATRIX METALLOPROTEINASE-2 (NTT-MMP-2) AND ITS PRESENCE IN RENAL AND CARDIAC DISEASES |
| 2374 |
EPIGENETIC REGULATION OF TNFA EXPRESSION IN PERIODONTAL DISEASE |
| 2375 |
EPIGENETIC REGULATION OF TRANSCRIPTION FACTOR BINDING MOTIFS PROMOTES TH1 RESPONSE IN CHAGAS DISEASE CARDIOMYOPATHY |
| 2376 |
EPIGENETIC REGULATION OF TUMOR NECROSIS FACTOR ALPHA (TNFALPHA) RELEASE IN HUMAN MACROPHAGES BY HIV-1 SINGLE-STRANDED RNA (SSRNA) IS DEPENDENT ON TLR8 SIGNALING |
| 2377 |
EPIGENETIC REGULATION OF TUMOR SUPPRESSORS BY HELICOBACTER PYLORI ENHANCES EBV-INDUCED PROLIFERATION OF GASTRIC EPITHELIAL CELLS |
| 2378 |
EPIGENETIC REGULATION OF VASCULAR SMOOTH MUSCLE CELL PHENOTYPE SWITCHING IN ATHEROSCLEROTIC ARTERY REMODELING: A MINI-REVIEW |
| 2379 |
EPIGENETIC REGULATION OF WNT PATHWAY ANTAGONISTS IN HUMAN GLIOBLASTOMA MULTIFORME |
| 2380 |
EPIGENETIC REGULATION OF WNT SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2381 |
EPIGENETIC REGULATION OF WOUND HEALING AND FIBROSIS |
| 2382 |
EPIGENETIC REGULATIONS IN DIABETIC NEPHROPATHY |
| 2383 |
EPIGENETIC REGULATOR G9A PROVIDES GLUCOSE AS A SWEET KEY TO STRESS RESISTANCE |
| 2384 |
EPIGENETIC REGULATOR UHRF1 ORCHESTRATES PROINFLAMMATORY GENE EXPRESSION IN RHEUMATOID ARTHRITIS IN A SUPPRESSIVE MANNER |
| 2385 |
EPIGENETIC REGULATORS OF THE REVASCULARIZATION RESPONSE TO CHRONIC ARTERIAL OCCLUSION |
| 2386 |
EPIGENETIC REGULATORY MECHANISMS IN STRESS-INDUCED BEHAVIOR |
| 2387 |
EPIGENETIC REMODELING BY VITAMIN C POTENTIATES PLASMA CELL DIFFERENTIATION |
| 2388 |
EPIGENETIC REMODELLING LICENCES ADULT CHOLANGIOCYTES FOR ORGANOID FORMATION AND LIVER REGENERATION |
| 2389 |
EPIGENETIC REPOLARIZATION OF T LYMPHOCYTES FROM CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS USING 5-AZA-2'-DEOXYCYTIDINE |
| 2390 |
EPIGENETIC REPRESSION OF CCDC37 AND MAP1B LINKS CHRONIC OBSTRUCTIVE PULMONARY DISEASE TO LUNG CANCER |
| 2391 |
EPIGENETIC REPRESSION OF DNA MISMATCH REPAIR BY INFLAMMATION AND HYPOXIA IN INFLAMMATORY BOWEL DISEASE-ASSOCIATED COLORECTAL CANCER |
| 2392 |
EPIGENETIC REPRESSION OF INTERLEUKIN 2 EXPRESSION IN SENESCENT CD4+ T CELLS DURING CHRONIC HIV TYPE 1 INFECTION |
| 2393 |
EPIGENETIC REPROGRAMMING AND EMERGING EPIGENETIC THERAPIES IN CML |
| 2394 |
EPIGENETIC REPROGRAMMING IN LIVER FIBROSIS AND CANCER |
| 2395 |
EPIGENETIC REPROGRAMMING IN MIST1(-/-) MICE PREDICTS THE MOLECULAR RESPONSE TO CERULEIN-INDUCED PANCREATITIS |
| 2396 |
EPIGENETIC REPROGRAMMING IN PERIODONTAL DISEASE: DYNAMIC CROSSTALK WITH POTENTIAL IMPACT IN ONCOGENESIS |
| 2397 |
EPIGENETIC REPROGRAMMING OF AIRWAY MACROPHAGES PROMOTES POLARIZATION AND INFLAMMATION IN MUCO-OBSTRUCTIVE LUNG DISEASE |
| 2398 |
EPIGENETIC REPROGRAMMING OF CORTICAL NEURONS THROUGH ALTERATION OF DOPAMINERGIC CIRCUITS |
| 2399 |
EPIGENETIC REPROGRAMMING OF HOST GENES IN VIRAL AND MICROBIAL PATHOGENESIS |
| 2400 |
EPIGENETIC REPROGRAMMING OF IMMUNE CELLS IN WOMEN WITH PCOS IMPACT GENES CONTROLLING REPRODUCTIVE FUNCTION |
| 2401 |
EPIGENETIC REPROGRAMMING PROMOTES THE ANTIVIRAL ACTION OF IFNALPHA IN HBV-INFECTED CELLS |
| 2402 |
EPIGENETIC REPROGRAMMING SENSITIZES CML STEM CELLS TO COMBINED EZH2 AND TYROSINE KINASE INHIBITION |
| 2403 |
EPIGENETIC REPROGRAMMING: A POSSIBLE ETIOLOGICAL FACTOR IN BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS? PURPOSE: THE ETIOLOGY OF BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS IS POORLY UNDERSTOOD |
| 2404 |
EPIGENETIC RESEARCH IN MULTIPLE SCLEROSIS: PROGRESS, CHALLENGES, AND OPPORTUNITIES |
| 2405 |
EPIGENETIC RESPONSE IN MICE MASTITIS: ROLE OF HISTONE H3 ACETYLATION AND MICRORNA(S) IN THE REGULATION OF HOST INFLAMMATORY GENE EXPRESSION DURING STAPHYLOCOCCUS AUREUS INFECTION |
| 2406 |
EPIGENETIC RESPONSES TO RHINOVIRUS EXPOSURE IN AIRWAY EPITHELIAL CELLS ARE CORRELATED WITH KEY TRANSCRIPTIONAL PATHWAYS IN CHRONIC RHINOSINUSITIS |
| 2407 |
EPIGENETIC RESTORATION OF VOLTAGE-GATED POTASSIUM CHANNEL KV1 |
| 2408 |
EPIGENETIC REWIRING OF SKELETAL MUSCLE ENHANCERS AFTER EXERCISE TRAINING SUPPORTS A ROLE IN WHOLE-BODY FUNCTION AND HUMAN HEALTH |
| 2409 |
EPIGENETIC SCARRING OF EXHAUSTED T CELLS HINDERS MEMORY DIFFERENTIATION UPON ELIMINATING CHRONIC ANTIGENIC STIMULATION |
| 2410 |
EPIGENETIC SCARS OF CD8(+) T CELL EXHAUSTION PERSIST AFTER CURE OF CHRONIC INFECTION IN HUMANS |
| 2411 |
EPIGENETIC SCORES FOR THE CIRCULATING PROTEOME AS TOOLS FOR DISEASE PREDICTION |
| 2412 |
EPIGENETIC SIDE-EFFECTS OF COMMON PHARMACEUTICALS: A POTENTIAL NEW FIELD IN MEDICINE AND PHARMACOLOGY |
| 2413 |
EPIGENETIC SIGNALING AND RNA REGULATION IN CARDIOVASCULAR DISEASES |
| 2414 |
EPIGENETIC SIGNALING IN PSYCHIATRIC DISORDERS |
| 2415 |
EPIGENETIC SIGNALING IN PSYCHIATRIC DISORDERS: STRESS AND DEPRESSION |
| 2416 |
EPIGENETIC SIGNALING OF CANCER STEM CELLS DURING INFLAMMATION |
| 2417 |
EPIGENETIC SIGNATURE OF CHRONIC CEREBRAL HYPOPERFUSION AND BENEFICIAL EFFECTS OF S-ADENOSYLMETHIONINE IN RATS |
| 2418 |
EPIGENETIC SIGNATURE OF CHRONIC LOW BACK PAIN IN HUMAN T CELLS |
| 2419 |
EPIGENETIC SIGNATURE OF CHRONIC MATERNAL STRESS LOAD DURING PREGNANCY MIGHT BE A POTENTIAL BIOMARKER FOR SPONTANEOUS PRETERM BIRTH |
| 2420 |
EPIGENETIC SIGNATURE OF IMPAIRED FASTING GLUCOSE IN THE OLD ORDER AMISH |
| 2421 |
EPIGENETIC SIGNATURE OF PD-1+ TCF1+ CD8 T CELLS THAT ACT AS RESOURCE CELLS DURING CHRONIC VIRAL INFECTION AND RESPOND TO PD-1 BLOCKADE |
| 2422 |
EPIGENETIC SIGNATURES DISCRIMINATE PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE COLITIS FROM PATIENTS WITH ULCERATIVE COLITIS |
| 2423 |
EPIGENETIC SIGNATURES OF SMOKING IN FIVE BRAIN REGIONS |
| 2424 |
EPIGENETIC SIGNATURES UNDERLYING INFLAMMATION: AN INTERPLAY OF NUTRITION, PHYSICAL ACTIVITY, METABOLIC DISEASES, AND ENVIRONMENTAL FACTORS FOR PERSONALIZED NUTRITION |
| 2425 |
EPIGENETIC SILENCING OF IRF1 DYSREGULATES TYPE III INTERFERON RESPONSES TO RESPIRATORY VIRUS INFECTION IN EPITHELIAL TO MESENCHYMAL TRANSITION |
| 2426 |
EPIGENETIC SILENCING OF LONG NON-CODING RNA BM742401 IN MULTIPLE MYELOMA: IMPACT ON PROGNOSIS AND MYELOMA DISSEMINATION |
| 2427 |
EPIGENETIC SILENCING OF MICRORNA-125B-5P PROMOTES LIVER FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE VIA INTEGRIN ALPHA8-MEDIATED ACTIVATION OF RHOA SIGNALING PATHWAY |
| 2428 |
EPIGENETIC SILENCING OF MIR-124 PREVENTS SPERMINE OXIDASE REGULATION: IMPLICATIONS FOR HELICOBACTER PYLORI-INDUCED GASTRIC CANCER |
| 2429 |
EPIGENETIC SILENCING OF MIR-137 IS A FREQUENT EVENT IN GASTRIC CARCINOGENESIS |
| 2430 |
EPIGENETIC SILENCING OF MIR-210 INCREASES THE PROLIFERATION OF GASTRIC EPITHELIUM DURING CHRONIC HELICOBACTER PYLORI INFECTION |
| 2431 |
EPIGENETIC SILENCING OF MIR-26A1 IN CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA: IMPACT ON EZH2 EXPRESSION |
| 2432 |
EPIGENETIC SILENCING OF MIR-708 ENHANCES NF-KAPPAB SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2433 |
EPIGENETIC SILENCING OF NAD(P)H:QUINONE OXIDOREDUCTASE 1 BY HEPATITIS B VIRUS X PROTEIN INCREASES MITOCHONDRIAL INJURY AND CELLULAR SUSCEPTIBILITY TO OXIDATIVE STRESS IN HEPATOMA CELLS |
| 2434 |
EPIGENETIC SILENCING OF RIPK3 IN HEPATOCYTES PREVENTS MLKL-MEDIATED NECROPTOSIS FROM CONTRIBUTING TO LIVER PATHOLOGIES |
| 2435 |
EPIGENETIC SILENCING OF SFRP1 ACTIVATES THE CANONICAL WNT PATHWAY AND CONTRIBUTES TO INCREASED CELL GROWTH AND PROLIFERATION IN HEPATOCELLULAR CARCINOMA |
| 2436 |
EPIGENETIC SILENCING OF SOCS3 IDENTIFIES A SUBSET OF PROSTATE CANCER WITH AN AGGRESSIVE BEHAVIOR |
| 2437 |
EPIGENETIC SILENCING OF SONIC HEDGEHOG ELICITS ANTITUMOR IMMUNE RESPONSE AND SUPPRESSES TUMOR GROWTH BY INHIBITING THE HEDGEHOG SIGNALING PATHWAY IN METASTATIC SPINE TUMORS IN SPRAGUE-DAWLEY RATS |
| 2438 |
EPIGENETIC SILENCING OF THE CIRCADIAN CLOCK GENE CRY1 IS ASSOCIATED WITH AN INDOLENT CLINICAL COURSE IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2439 |
EPIGENETIC SILENCING OF THE MLH1 PROMOTER IN RELATION TO THE DEVELOPMENT OF GASTRIC CANCER AND ITS USE AS A BIOMARKER FOR PATIENTS WITH MICROSATELLITE INSTABILITY: A SYSTEMATIC ANALYSIS |
| 2440 |
EPIGENETIC SILENCING OF TUMOR SUPPRESSOR LONG NON-CODING RNA BM742401 IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2441 |
EPIGENETIC SILENCING OF TUMOR SUPPRESSOR MIR-3151 CONTRIBUTES TO CHINESE CHRONIC LYMPHOCYTIC LEUKEMIA BY CONSTITUTIVE ACTIVATION OF MADD/ERK AND PIK3R2/AKT SIGNALING PATHWAYS |
| 2442 |
EPIGENETIC STABILITY IN THE ADULT MOUSE CORTEX UNDER CONDITIONS OF PHARMACOLOGICALLY INDUCED HISTONE ACETYLATION |
| 2443 |
EPIGENETIC STABILITY OF EXHAUSTED T CELLS LIMITS DURABILITY OF REINVIGORATION BY PD-1 BLOCKADE |
| 2444 |
EPIGENETIC STATES OF NEPHRON PROGENITORS AND EPITHELIAL DIFFERENTIATION |
| 2445 |
EPIGENETIC STATUS OF GDNF IN THE VENTRAL STRIATUM DETERMINES SUSCEPTIBILITY AND ADAPTATION TO DAILY STRESSFUL EVENTS |
| 2446 |
EPIGENETIC STRATEGIES SYNERGIZE WITH PD-L1/PD-1 TARGETED CANCER IMMUNOTHERAPIES TO ENHANCE ANTITUMOR RESPONSES |
| 2447 |
EPIGENETIC STUDIES IN ALZHEIMER'S DISEASE: CURRENT FINDINGS, CAVEATS, AND CONSIDERATIONS FOR FUTURE STUDIES |
| 2448 |
EPIGENETIC SUPPRESSION OF GAD65 EXPRESSION MEDIATES PERSISTENT PAIN |
| 2449 |
EPIGENETIC SUPPRESSION OF HIPPOCAMPAL CALBINDIN-D28K BY DELTAFOSB DRIVES SEIZURE-RELATED COGNITIVE DEFICITS |
| 2450 |
EPIGENETIC SUPPRESSION OF LIVER X RECEPTOR BETA IN ANTERIOR CINGULATE CORTEX BY HDAC5 DRIVES CFA-INDUCED CHRONIC INFLAMMATORY PAIN |
| 2451 |
EPIGENETIC SUPPRESSION OF PGC1ALPHA (PPARGC1A) CAUSES COLLATERAL SENSITIVITY TO HMGCR-INHIBITORS WITHIN BRAF-TREATMENT RESISTANT MELANOMAS |
| 2452 |
EPIGENETIC SUPPRESSION OF POTASSIUM-CHLORIDE CO-TRANSPORTER 2 EXPRESSION IN INFLAMMATORY PAIN INDUCED BY COMPLETE FREUND'S ADJUVANT (CFA) |
| 2453 |
EPIGENETIC SUPPRESSION OF THE IMMUNOREGULATOR MZB1 IS ASSOCIATED WITH THE MALIGNANT PHENOTYPE OF GASTRIC CANCER |
| 2454 |
EPIGENETIC TARGETING OF HISTONE DEACETYLASES IN DIAGNOSTICS AND TREATMENT OF DEPRESSION |
| 2455 |
EPIGENETIC TARGETS FOR NOVEL THERAPIES OF LUNG DISEASES |
| 2456 |
EPIGENETIC TARGETS FOR REVERSING IMMUNE DEFECTS CAUSED BY ALCOHOL EXPOSURE |
| 2457 |
EPIGENETIC TARGETS FOR THERAPEUTIC APPROACHES IN COPD AND ASTHMA |
| 2458 |
EPIGENETIC TARGETS IN SYNOVIAL SARCOMA: A MINI-REVIEW |
| 2459 |
EPIGENETIC THERAPIES FOR NON-ONCOLOGY INDICATIONS |
| 2460 |
EPIGENETIC THERAPIES FOR OSTEOARTHRITIS |
| 2461 |
EPIGENETIC THERAPY AS A PUTATIVE MOLECULAR TARGET TO MODULATE B CELL BIOLOGY AND BEHAVIOR IN THE CONTEXT OF IMMUNOLOGICAL DISORDERS |
| 2462 |
EPIGENETIC THERAPY OF MYELODYSPLASTIC SYNDROMES CONNECTS TO CELLULAR DIFFERENTIATION INDEPENDENTLY OF ENDOGENOUS RETROELEMENT DEREPRESSION |
| 2463 |
EPIGENETIC THERAPY REPROGRAMS HEREDITARY DISEASE |
| 2464 |
EPIGENETIC THERAPY USING BELINOSTAT FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: A MULTICENTER PHASE I/II STUDY WITH BIOMARKER AND PHARMACOKINETIC ANALYSIS OF TUMORS FROM PATIENTS IN THE MAYO PHASE II CONSORTIUM AND THE CANCER THERAPEUTICS RESEARCH GROUP |
| 2465 |
EPIGENETIC THERAPY WITH HYDRALAZINE AND MAGNESIUM VALPROATE REVERSES IMATINIB RESISTANCE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA |
| 2466 |
EPIGENETIC THERAPY: NOVEL TRANSLATIONAL IMPLICATIONS FOR ARREST OF ENVIRONMENTAL DIOXIN-INDUCED DISEASE IN FEMALES |
| 2467 |
EPIGENETIC TOXICITY OF TRICHLOROETHYLENE: A SINGLE-MOLECULE PERSPECTIVE |
| 2468 |
EPIGENETIC TOXICOLOGY AS TOXICANT-INDUCED CHANGES IN INTRACELLULAR SIGNALLING LEADING TO ALTERED GAP JUNCTIONAL INTERCELLULAR COMMUNICATION |
| 2469 |
EPIGENETIC TRAJECTORIES OF THE PREMALIGNANT-TO-MALIGNANT TRANSITION OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2470 |
EPIGENETIC TRANSCRIPTIONAL ACTIVATION OF MONOCYTE CHEMOTACTIC PROTEIN 3 CONTRIBUTES TO LONG-LASTING NEUROPATHIC PAIN |
| 2471 |
EPIGENETIC TRANSGENERATIONAL INHERITANCE OF ALTERED STRESS RESPONSES |
| 2472 |
EPIGENETIC TRANSMISSION OF THE IMPACT OF EARLY STRESS ACROSS GENERATIONS |
| 2473 |
EPIGENETIC TREATMENTS OF ADULT RATS PROMOTE RECOVERY FROM VISUAL ACUITY DEFICITS INDUCED BY LONG-TERM MONOCULAR DEPRIVATION |
| 2474 |
EPIGENETIC UNDERPINNINGS OF INFLAMMATION: CONNECTING THE DOTS BETWEEN PULMONARY DISEASES, LUNG CANCER AND COVID-19 |
| 2475 |
EPIGENETIC UP-REGULATION OF ADAMTS4 IN SYMPATHETIC GANGLIA IS INVOLVED IN THE MAINTENANCE OF NEUROPATHIC PAIN FOLLOWING NERVE INJURY |
| 2476 |
EPIGENETIC UPREGULATION OF CCL2 AND CCL3 VIA HISTONE MODIFICATIONS IN INFILTRATING MACROPHAGES AFTER PERIPHERAL NERVE INJURY |
| 2477 |
EPIGENETIC UPREGULATION OF CDK5 IN THE DORSAL HORN CONTRIBUTES TO NEUROPATHIC PAIN IN RATS |
| 2478 |
EPIGENETIC UPREGULATION OF CXCL12 EXPRESSION CONTRIBUTES TO THE ACQUISITION AND MAINTENANCE OF MORPHINE-INDUCED CONDITIONED PLACE PREFERENCE |
| 2479 |
EPIGENETIC UPREGULATION OF CXCL12 EXPRESSION MEDIATES ANTITUBULIN CHEMOTHERAPEUTICS-INDUCED NEUROPATHIC PAIN |
| 2480 |
EPIGENETIC UPREGULATION OF LARGE-CONDUCTANCE CA2+-ACTIVATED K+ CHANNEL EXPRESSION IN UTERINE VASCULAR ADAPTATION TO PREGNANCY |
| 2481 |
EPIGENETIC UPREGULATION OF LNCRNAS AT 13Q14 |
| 2482 |
EPIGENETIC UPREGULATION OF METABOTROPIC GLUTAMATE RECEPTOR 2 IN THE SPINAL CORD ATTENUATES OESTROGEN-INDUCED VISCERAL HYPERSENSITIVITY |
| 2483 |
EPIGENETIC VARIATION AND HUMAN DISEASE |
| 2484 |
EPIGENETIC, TRANSCRIPTIONAL AND PHENOTYPIC RESPONSES IN TWO GENERATIONS OF DAPHNIA MAGNA EXPOSED TO THE DNA METHYLATION INHIBITOR 5-AZACYTIDINE |
| 2485 |
EPIGENETIC-BASED AGE ACCELERATION IN A REPRESENTATIVE SAMPLE OF OLDER AMERICANS: ASSOCIATIONS WITH AGING-RELATED MORBIDITY AND MORTALITY |
| 2486 |
EPIGENETIC-SENSITIVE CHALLENGES OF CARDIOHEPATIC INTERACTIONS: CLINICAL AND THERAPEUTIC IMPLICATIONS IN HEART FAILURE PATIENTS |
| 2487 |
EPIGENETIC: A MISSING PARADIGM IN CELLULAR AND MOLECULAR PATHWAYS OF SULFUR MUSTARD LUNG: A PROSPECTIVE AND COMPARATIVE STUDY |
| 2488 |
EPIGENETICALLY DYSREGULATED GENES AND PATHWAYS IMPLICATED IN THE PATHOGENESIS OF NON-SYNDROMIC HIGH MYOPIA |
| 2489 |
EPIGENETICALLY MODIFIED NUCLEOTIDES IN CHRONIC HEROIN AND COCAINE TREATED MICE |
| 2490 |
EPIGENETICALLY REGULATED INFLAMMATION IN VASCULAR SENESCENCE AND RENAL PROGRESSION OF CHRONIC KIDNEY DISEASE |
| 2491 |
EPIGENETICS AND CARDIOVASCULAR DISEASE IN DIABETES |
| 2492 |
EPIGENETICS AND CHILDHOOD ASTHMA: CURRENT EVIDENCE AND FUTURE RESEARCH DIRECTIONS |
| 2493 |
EPIGENETICS AND CHROMATIN REMODELING PLAY A ROLE IN LUNG DISEASE |
| 2494 |
EPIGENETICS AND CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2495 |
EPIGENETICS AND DOHAD: FROM BASICS TO BIRTH AND BEYOND |
| 2496 |
EPIGENETICS AND EARLY LIFE ORIGINS OF CHRONIC NONCOMMUNICABLE DISEASES |
| 2497 |
EPIGENETICS AND ENVIRONMENTAL LUNG DISEASE |
| 2498 |
EPIGENETICS AND EPILEPSY PREVENTION: THE THERAPEUTIC POTENTIAL OF ADENOSINE AND METABOLIC THERAPIES |
| 2499 |
EPIGENETICS AND EXERCISE |
| 2500 |
EPIGENETICS AND IMPRINTED GENES: INSIGHTS FROM THE IMPRINTED GNAS LOCUS |
| 2501 |
EPIGENETICS AND ITS ROLE IN PERIODONTAL DISEASES: A STATE-OF-THE-ART REVIEW |
| 2502 |
EPIGENETICS AND LIVER FIBROSIS |
| 2503 |
EPIGENETICS AND METABOLISM AT THE CROSSROADS OF STRESS-INDUCED PLASTICITY, STEMNESS AND THERAPEUTIC RESISTANCE IN CANCER |
| 2504 |
EPIGENETICS AND MODULATIONS OF EARLY FLAVOR EXPERIENCES: CAN METABOLOMICS CONTRIBUTE TO PREVENTION DURING WEANING? THE SIGNIFICANT INCREASE IN CHRONIC NON-COMMUNICABLE DISEASES HAS CHANGED THE GLOBAL EPIDEMIOLOGICAL LANDSCAPE |
| 2505 |
EPIGENETICS AND MUSCLE DYSFUNCTION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 2506 |
EPIGENETICS AND NUTRITION-RELATED EPIDEMICS OF METABOLIC DISEASES: CURRENT PERSPECTIVES AND CHALLENGES |
| 2507 |
EPIGENETICS AND OBESITY: THE DEVIL IS IN THE DETAILS |
| 2508 |
EPIGENETICS AND OSTEOARTHRITIS |
| 2509 |
EPIGENETICS AND PAIN: NEW INSIGHTS TO AN OLD PROBLEM |
| 2510 |
EPIGENETICS AND POSTSURGICAL PAIN: A SCOPING REVIEW |
| 2511 |
EPIGENETICS AND PREECLAMPSIA: PROGRAMMING OF FUTURE OUTCOMES |
| 2512 |
EPIGENETICS AND PRIMARY BILIARY CIRRHOSIS: A COMPREHENSIVE REVIEW AND IMPLICATIONS FOR AUTOIMMUNITY |
| 2513 |
EPIGENETICS AND PSYCHOSTIMULANT ADDICTION |
| 2514 |
EPIGENETICS AND SARCOIDOSIS |
| 2515 |
EPIGENETICS AND SJOGREN'S SYNDROME |
| 2516 |
EPIGENETICS AND SYSTEMIC LUPUS ERYTHEMATOSUS: UNMET NEEDS |
| 2517 |
EPIGENETICS AND THE BURDEN OF NONCOMMUNICABLE DISEASE: A PAUCITY OF RESEARCH IN AFRICA |
| 2518 |
EPIGENETICS AND THE EMBODIMENT OF RACE: DEVELOPMENTAL ORIGINS OF US RACIAL DISPARITIES IN CARDIOVASCULAR HEALTH |
| 2519 |
EPIGENETICS AND THE ENVIRONMENT IN AIRWAY DISEASE: ASTHMA AND ALLERGIC RHINITIS |
| 2520 |
EPIGENETICS AND THE GLUCOCORTICOID RECEPTOR: A REVIEW OF THE IMPLICATIONS IN DEPRESSION |
| 2521 |
EPIGENETICS AND THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH MODEL: BRIDGING NATURE, NURTURE, AND PATIENT-CENTERED POPULATION HEALTH |
| 2522 |
EPIGENETICS AND THE SOCIAL WORK IMPERATIVE |
| 2523 |
EPIGENETICS AND THE TRANSITION FROM ACUTE TO CHRONIC PAIN |
| 2524 |
EPIGENETICS AND THE UREMIC PHENOTYPE: A MATTER OF BALANCE |
| 2525 |
EPIGENETICS AND TRAINED IMMUNITY |
| 2526 |
EPIGENETICS APPLIED TO PSYCHIATRY: CLINICAL OPPORTUNITIES AND FUTURE CHALLENGES |
| 2527 |
EPIGENETICS APPROACHES TOWARD PRECISION MEDICINE FOR IDIOPATHIC PULMONARY FIBROSIS: FOCUS ON DNA METHYLATION |
| 2528 |
EPIGENETICS AS A KEY LINK BETWEEN PSYCHOSOCIAL STRESS AND AGING: CONCEPTS, EVIDENCE, MECHANISMS |
| 2529 |
EPIGENETICS CHANGES ASSOCIATED TO ENVIRONMENTAL TRIGGERS IN AUTOIMMUNITY |
| 2530 |
EPIGENETICS IN ALLERGIC DISEASES |
| 2531 |
EPIGENETICS IN ASTHMA |
| 2532 |
EPIGENETICS IN ATHEROSCLEROSIS AND INFLAMMATION |
| 2533 |
EPIGENETICS IN AUTOIMMUNE CONNECTIVE TISSUE DISEASES |
| 2534 |
EPIGENETICS IN BIPOLAR DISORDER: A CRITICAL REVIEW OF THE LITERATURE |
| 2535 |
EPIGENETICS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2536 |
EPIGENETICS IN EPILEPSY |
| 2537 |
EPIGENETICS IN HEART FAILURE PHENOTYPES |
| 2538 |
EPIGENETICS IN HEPATOCELLULAR CARCINOMA: AN UPDATE AND FUTURE THERAPY PERSPECTIVES |
| 2539 |
EPIGENETICS IN HYPERHOMOCYSTEINEMIC STATES |
| 2540 |
EPIGENETICS IN IDIOPATHIC PULMONARY FIBROSIS |
| 2541 |
EPIGENETICS IN KIDNEY DEVELOPMENT AND RENAL DISEASE |
| 2542 |
EPIGENETICS IN KIDNEY DISEASES |
| 2543 |
EPIGENETICS IN LIVER DISEASE |
| 2544 |
EPIGENETICS IN LIVER DISEASE: FROM BIOLOGY TO THERAPEUTICS |
| 2545 |
EPIGENETICS IN LIVER FIBROSIS: COULD HDACS BE A THERAPEUTIC TARGET? CHRONIC LIVER DISEASES (CLD) REPRESENT A WORLDWIDE HEALTH PROBLEM |
| 2546 |
EPIGENETICS IN MULTIPLE SCLEROSIS: MOLECULAR MECHANISMS AND DIETARY INTERVENTION |
| 2547 |
EPIGENETICS IN MYELOID MALIGNANCIES |
| 2548 |
EPIGENETICS IN MYELOPROLIFERATIVE NEOPLASMS |
| 2549 |
EPIGENETICS IN OBESITY AND DIABETES MELLITUS: NEW INSIGHTS |
| 2550 |
EPIGENETICS IN OSTEOARTHRITIS: POTENTIAL OF HDAC INHIBITORS AS THERAPEUTICS |
| 2551 |
EPIGENETICS IN PAIN AND ANALGESIA: AN IMMINENT RESEARCH FIELD |
| 2552 |
EPIGENETICS IN PRIMARY SJOGREN'S SYNDROME |
| 2553 |
EPIGENETICS IN PSORIASIS: PERSPECTIVE OF DNA METHYLATION |
| 2554 |
EPIGENETICS IN REACTIVE AND REPARATIVE CARDIAC FIBROGENESIS: THE PROMISE OF EPIGENETIC THERAPY |
| 2555 |
EPIGENETICS IN RENAL DISEASES |
| 2556 |
EPIGENETICS IN RHEUMATOID ARTHRITIS |
| 2557 |
EPIGENETICS IN RHEUMATOID ARTHRITIS; FIBROBLAST-LIKE SYNOVIOCYTES AS AN EMERGING PARADIGM IN THE PATHOGENESIS OF THE DISEASE |
| 2558 |
EPIGENETICS IN SUSCEPTIBILITY, PROGRESSION, AND DIAGNOSIS OF PERIODONTITIS |
| 2559 |
EPIGENETICS IN SYSTEMIC LUPUS ERYTHEMATOSUS: LEADING THE WAY FOR SPECIFIC THERAPEUTIC AGENTS |
| 2560 |
EPIGENETICS IN THE DEVELOPMENT, MODIFICATION, AND PREVENTION OF CARDIOVASCULAR DISEASE |
| 2561 |
EPIGENETICS IN THE PERIOPERATIVE PERIOD |
| 2562 |
EPIGENETICS IN THE PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE: INFLUENCE OF EXERCISE AND NUTRITION |
| 2563 |
EPIGENETICS IN TUBERCULOSIS: IMMUNOMODULATION OF HOST IMMUNE RESPONSE |
| 2564 |
EPIGENETICS INSIGHTS INTO CHRONIC PAIN: DNA HYPOMETHYLATION IN FIBROMYALGIA-A CONTROLLED PILOT-STUDY |
| 2565 |
EPIGENETICS INVOLVEMENT IN OXALIPLATIN-INDUCED POTASSIUM CHANNEL TRANSCRIPTIONAL DOWNREGULATION AND HYPERSENSITIVITY |
| 2566 |
EPIGENETICS MECHANISMS IN RENAL DEVELOPMENT |
| 2567 |
EPIGENETICS MODIFIERS: POTENTIAL HUB FOR UNDERSTANDING AND TREATING NEURODEVELOPMENTAL DISORDERS FROM HYPOXIC INJURY |
| 2568 |
EPIGENETICS OF ALCOHOL-RELATED LIVER DISEASES |
| 2569 |
EPIGENETICS OF ANKYLOSING SPONDYLITIS: RECENT DEVELOPMENTS |
| 2570 |
EPIGENETICS OF CHRONIC INFLAMMATORY DISEASES |
| 2571 |
EPIGENETICS OF CHRONIC PAIN AFTER THORACIC SURGERY |
| 2572 |
EPIGENETICS OF DEPRESSION |
| 2573 |
EPIGENETICS OF DRUG ABUSE: PREDISPOSITION OR RESPONSE |
| 2574 |
EPIGENETICS OF DRUG ADDICTION |
| 2575 |
EPIGENETICS OF ESTROGEN AND PROGESTERONE RECEPTORS IN ENDOMETRIOSIS |
| 2576 |
EPIGENETICS OF FEAR, ANXIETY AND STRESS - FOCUS ON HISTONE MODIFICATIONS |
| 2577 |
EPIGENETICS OF INFLAMMATION, MATERNAL INFECTION, AND NUTRITION |
| 2578 |
EPIGENETICS OF INFLAMMATORY BOWEL DISEASES |
| 2579 |
EPIGENETICS OF KIDNEY DISEASE |
| 2580 |
EPIGENETICS OF MICRO-OPIOID RECEPTORS: INTERSECTION WITH HIV-1 INFECTION OF THE CENTRAL NERVOUS SYSTEM |
| 2581 |
EPIGENETICS OF MUCUS HYPERSECRETION IN CHRONIC RESPIRATORY DISEASES |
| 2582 |
EPIGENETICS OF MYELODYSPLASTIC SYNDROMES |
| 2583 |
EPIGENETICS OF NICOTINE: ANOTHER NAIL IN THE COUGHING |
| 2584 |
EPIGENETICS OF OBESITY |
| 2585 |
EPIGENETICS OF OBSTRUCTIVE SLEEP APNEA SYNDROME: A SYSTEMATIC REVIEW |
| 2586 |
EPIGENETICS OF PAIN MEDIATORS |
| 2587 |
EPIGENETICS OF PARAOXONASES |
| 2588 |
EPIGENETICS OF PRIMARY BILIARY CHOLANGITIS |
| 2589 |
EPIGENETICS OF PROGRESSION OF CHRONIC KIDNEY DISEASE: FACT OR FANTASY? EPIGENETIC MODIFICATIONS ARE IMPORTANT IN THE NORMAL FUNCTIONING OF THE CELL, FROM REGULATING DYNAMIC EXPRESSION OF ESSENTIAL GENES AND ASSOCIATED PROTEINS TO REPRESSING THOSE THAT ARE UNNEEDED |
| 2590 |
EPIGENETICS OF PROTEASOME INHIBITION IN THE LIVER OF RATS FED ETHANOL CHRONICALLY |
| 2591 |
EPIGENETICS OF PSORIASIS |
| 2592 |
EPIGENETICS OF RENAL DEVELOPMENT AND DISEASE |
| 2593 |
EPIGENETICS OF RIBOSOMAL RNA GENES |
| 2594 |
EPIGENETICS OF SCHIZOPHRENIA |
| 2595 |
EPIGENETICS OF SPONDYLOARTHRITIS |
| 2596 |
EPIGENETICS OF STRESS ADAPTATIONS IN THE BRAIN |
| 2597 |
EPIGENETICS OF SUBCELLULAR STRUCTURE FUNCTIONING IN THE ORIGIN OF RISK OR RESILIENCE TO COMORBIDITY OF NEUROPSYCHIATRIC AND CARDIOMETABOLIC DISORDERS |
| 2598 |
EPIGENETICS OF THE DEPRESSED BRAIN: ROLE OF HISTONE ACETYLATION AND METHYLATION |
| 2599 |
EPIGENETICS OF THE VASCULAR ENDOTHELIUM |
| 2600 |
EPIGENETICS REGULATION DURING VIRUS-HOST INTERACTION AND THEIR EFFECTS ON THE VIRUS AND HOST CELL |
| 2601 |
EPIGENETICS, DNA ORGANIZATION, AND INFLAMMATORY BOWEL DISEASE |
| 2602 |
EPIGENETICS, ENDOMETRIOSIS AND SEX STEROID RECEPTORS: AN UPDATE ON THE EPIGENETIC REGULATORY MECHANISMS OF ESTROGEN AND PROGESTERONE RECEPTORS IN PATIENTS WITH ENDOMETRIOSIS |
| 2603 |
EPIGENETICS, ENVIRONMENT AND EPIDEMIOLOGY: AN INTERVIEW WITH KARL KELSEY |
| 2604 |
EPIGENETICS, PREGNANCY AND AUTOIMMUNE RHEUMATIC DISEASES |
| 2605 |
EPIGENETICS-A POTENTIAL MEDIATOR BETWEEN AIR POLLUTION AND PRETERM BIRTH |
| 2606 |
EPIGENETICS-BEYOND THE GENOME IN ALCOHOLISM |
| 2607 |
EPIGENETICS/EPIGENOMICS AND PREVENTION BY CURCUMIN OF EARLY STAGES OF INFLAMMATORY-DRIVEN COLON CANCER |
| 2608 |
EPIGENETICS: A KEY PARADIGM IN REPRODUCTIVE HEALTH |
| 2609 |
EPIGENETICS: A POTENTIAL KEY MECHANISM INVOLVED IN THE PATHOGENESIS OF CARDIORENAL SYNDROMES |
| 2610 |
EPIGENETICS: A POTENTIAL MECHANISM INVOLVED IN THE PATHOGENESIS OF VARIOUS ADVERSE CONSEQUENCES OF OBSTRUCTIVE SLEEP APNEA |
| 2611 |
EPIGENETICS: A PROMISING PARADIGM FOR BETTER UNDERSTANDING AND MANAGING PAIN |
| 2612 |
EPIGENETICS: DECIPHERING HOW ENVIRONMENTAL FACTORS MAY MODIFY AUTOIMMUNE TYPE 1 DIABETES |
| 2613 |
EPIGENETICS: DECIPHERING ITS ROLE IN DIABETES AND ITS CHRONIC COMPLICATIONS |
| 2614 |
EPIGENETICS: NEW QUESTIONS ON THE RESPONSE TO HYPOXIA |
| 2615 |
EPIGENETICS: TIME TO TRANSLATE INTO TRANSPLANTATION |
| 2616 |
EPIGENOME MODULATION INDUCED BY KETOGENIC DIETS |
| 2617 |
EPIGENOME TARGETING BY PROBIOTIC METABOLITES |
| 2618 |
EPIGENOME-MODIFYING TOOLS IN ASTHMA |
| 2619 |
EPIGENOME-WIDE ANALYSIS REVEALS FUNCTIONAL MODULATORS OF DRUG SENSITIVITY AND POST-TREATMENT SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 2620 |
EPIGENOME-WIDE ASSOCIATION DATA IMPLICATES DNA METHYLATION-MEDIATED GENETIC RISK IN PSORIASIS |
| 2621 |
EPIGENOME-WIDE ASSOCIATION STUDIES IDENTIFY DNA METHYLATION ASSOCIATED WITH KIDNEY FUNCTION |
| 2622 |
EPIGENOME-WIDE ASSOCIATION STUDIES IN ASTHMA: A SYSTEMATIC REVIEW |
| 2623 |
EPIGENOME-WIDE ASSOCIATION STUDIES OF THE FRACTIONAL EXHALED NITRIC OXIDE AND BRONCHODILATOR DRUG RESPONSE IN MODERATE-TO-SEVERE PEDIATRIC ASTHMA |
| 2624 |
EPIGENOME-WIDE ASSOCIATION STUDY (EWAS) OF BMI, BMI CHANGE AND WAIST CIRCUMFERENCE IN AFRICAN AMERICAN ADULTS IDENTIFIES MULTIPLE REPLICATED LOCI |
| 2625 |
EPIGENOME-WIDE ASSOCIATION STUDY AND MULTI-TISSUE REPLICATION OF INDIVIDUALS WITH ALCOHOL USE DISORDER: EVIDENCE FOR ABNORMAL GLUCOCORTICOID SIGNALING PATHWAY GENE REGULATION |
| 2626 |
EPIGENOME-WIDE ASSOCIATION STUDY IDENTIFIES DNA METHYLATION MARKERS FOR ASTHMA REMISSION IN WHOLE BLOOD AND NASAL EPITHELIUM |
| 2627 |
EPIGENOME-WIDE ASSOCIATION STUDY OF ADIPOSITY AND FUTURE RISK OF OBESITY-RELATED DISEASES |
| 2628 |
EPIGENOME-WIDE ASSOCIATION STUDY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND LUNG FUNCTION IN KOREANS |
| 2629 |
EPIGENOME-WIDE ASSOCIATION STUDY OF DIABETIC CHRONIC KIDNEY DISEASE PROGRESSION IN THE KOREAN POPULATION: THE KNOW-CKD STUDY |
| 2630 |
EPIGENOME-WIDE ASSOCIATION STUDY OF POSTTRAUMATIC STRESS DISORDER IDENTIFIES NOVEL LOCI IN U |
| 2631 |
EPIGENOME-WIDE ASSOCIATION STUDY OF WHOLE BLOOD GENE EXPRESSION IN FRAMINGHAM HEART STUDY PARTICIPANTS PROVIDES MOLECULAR INSIGHT INTO THE POTENTIAL ROLE OF CHRNA5 IN CIGARETTE SMOKING-RELATED LUNG DISEASES |
| 2632 |
EPIGENOME-WIDE DNA METHYLATION AND PESTICIDE USE IN THE AGRICULTURAL LUNG HEALTH STUDY |
| 2633 |
EPIGENOME-WIDE DNA METHYLATION PATTERNS ASSOCIATED WITH FATIGUE IN PRIMARY SJOGREN'S SYNDROME |
| 2634 |
EPIGENOME-WIDE DNA METHYLATION PROFILING OF CONDITIONED PAIN MODULATION IN INDIVIDUALS WITH NON-SPECIFIC CHRONIC LOW BACK PAIN |
| 2635 |
EPIGENOME-WIDE DNA METHYLATION REGULATES CARDINAL PATHOLOGICAL FEATURES OF PSORIASIS |
| 2636 |
EPIGENOME-WIDE EPIDEMIOLOGIC STUDIES OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION, TREATMENT, AND DISEASE PROGRESSION |
| 2637 |
EPIGENOME-WIDE STUDY IDENTIFIES EPIGENETIC OUTLIERS IN NORMAL MUCOSA OF PATIENTS WITH COLORECTAL CANCER |
| 2638 |
EPIGENOME: BIOSENSOR OF CUMULATIVE EXPOSURE TO CHEMICAL AND NONCHEMICAL STRESSORS RELATED TO ENVIRONMENTAL JUSTICE |
| 2639 |
EPIGENOMIC ANALYSIS DETECTS WIDESPREAD GENE-BODY DNA HYPOMETHYLATION IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2640 |
EPIGENOMIC AND TRANSCRIPTIONAL PROFILING IDENTIFIES IMPAIRED GLYOXYLATE DETOXIFICATION IN NAFLD AS A RISK FACTOR FOR HYPEROXALURIA |
| 2641 |
EPIGENOMIC AND TRANSCRIPTOMIC ANALYSES REVEAL DIFFERENCES BETWEEN LOW-GRADE INFLAMMATION AND SEVERE EXHAUSTION IN LPS-CHALLENGED MURINE MONOCYTES |
| 2642 |
EPIGENOMIC AND TRANSCRIPTOMIC ANALYSIS OF CHRONIC INFLAMMATORY DISEASES |
| 2643 |
EPIGENOMIC ASSOCIATION ANALYSIS IDENTIFIES SMOKING-RELATED DNA METHYLATION SITES IN AFRICAN AMERICANS |
| 2644 |
EPIGENOMIC DRIVERS OF IMMUNE DYSFUNCTION IN AGING |
| 2645 |
EPIGENOMIC INDICATORS OF AGE IN AFRICAN AMERICANS |
| 2646 |
EPIGENOMIC LINKS BETWEEN SOCIAL DETERMINANTS OF HEALTH AND SYMPTOMS: A SCOPING REVIEW |
| 2647 |
EPIGENOMIC PLASTICITY OF ARABIDOPSIS MSH1 MUTANTS UNDER PROLONGED COLD STRESS |
| 2648 |
EPIGENOMIC TARGETS FOR THE TREATMENT OF RESPIRATORY DISEASE |
| 2649 |
EPIGENOMIC, GENOMIC, AND TRANSCRIPTOMIC LANDSCAPE OF SCHWANNOMATOSIS |
| 2650 |
EPIGENOMIC-GUIDED MASS CYTOMETRY PROFILING REVEALS DISEASE-SPECIFIC FEATURES OF EXHAUSTED CD8 T CELLS |
| 2651 |
EPIGENOMICS AND TRANSCRIPTOMICS IN THE PREDICTION AND DIAGNOSIS OF CHILDHOOD ASTHMA: ARE WE THERE YET? ASTHMA IS THE MOST COMMON NON-COMMUNICABLE CHRONIC DISEASE OF CHILDHOOD |
| 2652 |
EPIGENOMICS OF LEUKEMIA: FROM MECHANISMS TO THERAPEUTIC APPLICATIONS |
| 2653 |
EPIGENOTYPING IN PERIPHERAL BLOOD CELL DNA AND BREAST CANCER RISK: A PROOF OF PRINCIPLE STUDY |
| 2654 |
EPILEPSY PROGRESSION IS ASSOCIATED WITH CUMULATIVE DNA METHYLATION CHANGES IN INFLAMMATORY GENES |
| 2655 |
EPIMUTAGENESIS: A PROSPECTIVE MECHANISM TO REMEDIATE ARSENIC-INDUCED TOXICITY |
| 2656 |
EPIMUTATION AND CANCER: A NEW CARCINOGENIC MECHANISM OF LYNCH SYNDROME (REVIEW) |
| 2657 |
EPITHELIAL DYSFUNCTION IN CHRONIC RESPIRATORY DISEASES, A SHARED ENDOTYPE? PURPOSE OF REVIEW: EPITHELIAL BARRIER DEFECTS ARE BEING APPRECIATED IN VARIOUS INFLAMMATORY DISORDERS; HOWEVER, CAUSAL UNDERLYING MECHANISMS ARE LACKING |
| 2658 |
EPITHELIAL METAPLASIA: ADULT STEM CELL REPROGRAMMING AND (PRE)NEOPLASTIC TRANSFORMATION MEDIATED BY INFLAMMATION? THROUGHOUT ADULT LIFE, NEW DEVELOPMENTAL COMMITMENT OF ADULT STEM CELLS CAUSES METAPLASTIC CONVERSIONS TO OCCUR FREQUENTLY IN SOME ORGANS |
| 2659 |
EPITHELIAL-TO-MESENCHYMAL TRANSITION IN THE CONTEXT OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION IN NON-SMALL-CELL LUNG CANCER |
| 2660 |
EPITHERAPY AND IMMUNE CHECKPOINT BLOCKADE: USING EPIGENETIC REINVIGORATION OF EXHAUSTED AND DYSFUNCTIONAL T CELLS TO REIMBURSE IMMUNOTHERAPY RESPONSE |
| 2661 |
EPSTEIN-BARR VIRUS AND GASTRIC CARCINOMA--VIRAL CARCINOGENESIS THROUGH EPIGENETIC MECHANISMS |
| 2662 |
EPSTEIN-BARR VIRUS AND MULTIPLE SCLEROSIS: A CONVOLUTED INTERACTION AND THE OPPORTUNITY TO UNRAVEL PREDICTIVE BIOMARKERS |
| 2663 |
EPSTEIN-BARR VIRUS PROMOTES B CELL LYMPHOMAS BY MANIPULATING THE HOST EPIGENETIC MACHINERY |
| 2664 |
ESTABLISHMENT AND VALIDATION OF EXHAUSTED CD8+ T CELL FEATURE AS A PROGNOSTIC MODEL OF HCC |
| 2665 |
ESTABLISHMENT OF A NOVEL MYELODYSPLASTIC SYNDROME (MDS) XENOTRANSPLANTATION MODEL |
| 2666 |
ESTABLISHMENT OF AN INTERMITTENT COLD STRESS MODEL USING TUPAIA BELANGERI AND EVALUATION OF COMPOUND C737 TARGETING NEURON-RESTRICTIVE SILENCER FACTOR |
| 2667 |
ESTROGEN AND SEROTONIN ENHANCE STRESS-INDUCED VISCERAL HYPERSENSITIVITY IN FEMALE RATS BY UP-REGULATING BRAIN-DERIVED NEUROTROPHIC FACTOR IN SPINAL CORD |
| 2668 |
ESTROGEN RECEPTORS AND ENDOMETRIOSIS |
| 2669 |
ESTROGEN- AND PROGESTERONE (P4)-MEDIATED EPIGENETIC MODIFICATIONS OF ENDOMETRIAL STROMAL CELLS (ENSCS) AND/OR MESENCHYMAL STEM/STROMAL CELLS (MSCS) IN THE ETIOPATHOGENESIS OF ENDOMETRIOSIS |
| 2670 |
ETHANOL ACTIONS ON THE VENTRAL TEGMENTAL AREA: NOVEL POTENTIAL TARGETS ON REWARD PATHWAY NEURONS |
| 2671 |
ETHANOL CONSUMPTION INDUCES NONSPECIFIC INFLAMMATION AND FUNCTIONAL DEFECTS IN ALVEOLAR MACROPHAGES |
| 2672 |
ETHANOL-INDUCED EPIGENETIC REGULATIONS AT THE BDNF GENE IN C57BL/6J MICE |
| 2673 |
ETHANOL-INDUCED MODULATION OF GPR55 EXPRESSION IN HUMAN MONOCYTE-DERIVED DENDRITIC CELLS IS ACCOMPANIED BY H4K12 ACETYLATION |
| 2674 |
ETHOSUXIMIDE REDUCES EPILEPTOGENESIS AND BEHAVIORAL COMORBIDITY IN THE GAERS MODEL OF GENETIC GENERALIZED EPILEPSY |
| 2675 |
ETIOPATHOGENESIS OF INFLAMMATORY BOWEL DISEASE: TODAY AND TOMORROW |
| 2676 |
ETIOPATHOGENESIS OF OVARIAN CANCER |
| 2677 |
EVALUATING THE CHALLENGES AND REPRODUCIBILITY OF STUDIES INVESTIGATING DNA METHYLATION SIGNATURES OF PSYCHOLOGICAL STRESS |
| 2678 |
EVALUATION OF A PROGNOSTIC EPIGENETIC CLASSIFICATION SYSTEM IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS |
| 2679 |
EVALUATION OF CIRCULATORY RNA-BASED BIOMARKER PANEL IN HEPATOCELLULAR CARCINOMA |
| 2680 |
EVALUATION OF EPIGENETIC (HDAC, DNMT) AND PAIN (GAD65, TGF) FACTORS FOLLOWING PHOTOBIOMODULATION THERAPY IN A NEUROPATHIC PAIN MODEL |
| 2681 |
EVALUATION OF MUSCLE-SPECIFIC AND METABOLISM REGULATING MICRORNAS IN A CHRONIC SWIMMING RAT MODEL |
| 2682 |
EVALUATION OF SERUM LINE-1 HYPOMETHYLATION AS A PROGNOSTIC MARKER FOR HEPATOCELLULAR CARCINOMA |
| 2683 |
EVALUATION OF THE IMPACT OF S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASE INHIBITOR, 3-DEAZANEPLANOCIN A, ON TISSUE INJURY AND COGNITIVE FUNCTION IN MICE |
| 2684 |
EVALUATION OF X CHROMOSOME INACTIVATION WITH RESPECT TO HLA GENETIC SUSCEPTIBILITY IN RHEUMATOID ARTHRITIS AND SYSTEMIC SCLEROSIS |
| 2685 |
EVIDENCE FOR EPIGENETIC REGULATION OF GENE EXPRESSION AND FUNCTION IN CHRONIC EXPERIMENTAL DIABETIC NEUROPATHY |
| 2686 |
EVIDENCE FOR THE INVOLVEMENT OF EPIGENETICS IN THE PROGRESSION OF RENAL FIBROGENESIS |
| 2687 |
EVIDENCE OF EPIGENETIC ALTERATIONS IN THROMBOSIS AND COAGULATION: A SYSTEMATIC REVIEW |
| 2688 |
EVIDENCE THAT METHYLATION OF HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA IN LIVER TISSUES OF PATIENTS WITH CHRONIC HEPATITIS B MODULATES HBV REPLICATION |
| 2689 |
EVOLUTION OF DNA METHYLATION IS LINKED TO GENETIC ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2690 |
EVOLUTION OF DOHAD: THE IMPACT OF ENVIRONMENTAL HEALTH SCIENCES |
| 2691 |
EVOLUTION OF HEPATIC FIBROSIS RESEARCH |
| 2692 |
EVOLUTION OF THE CONCEPTS OF ENDOMETROSIS, POST BREEDING ENDOMETRITIS, AND SUSCEPTIBILITY OF MARES |
| 2693 |
EVOLUTION, KIDNEY DEVELOPMENT, AND CHRONIC KIDNEY DISEASE |
| 2694 |
EVOLVING SPECTRUM OF DIABETIC WOUND: MECHANISTIC INSIGHTS AND THERAPEUTIC TARGETS |
| 2695 |
EVOLVING UNDERSTANDING OF THE CLL GENOME |
| 2696 |
EWING SARCOMA |
| 2697 |
EX VIVO MODELS OF CHRONIC GRANULOMATOUS DISEASE |
| 2698 |
EXAMINING MULTI- AND TRANSGENERATIONAL BEHAVIORAL AND MOLECULAR ALTERATIONS RESULTING FROM PARENTAL EXPOSURE TO AN ENVIRONMENTAL PCB AND PBDE MIXTURE |
| 2699 |
EXCESS BODY WEIGHT: NOVEL INSIGHTS INTO ITS ROLES IN OBESITY COMORBIDITIES |
| 2700 |
EXCESS IRON: CONSIDERATIONS RELATED TO DEVELOPMENT AND EARLY GROWTH |
| 2701 |
EXCESSIVE BRANCHED-CHAIN AMINO ACID ACCUMULATION RESTRICTS MESENCHYMAL STEM CELL-BASED THERAPY EFFICACY IN MYOCARDIAL INFARCTION |
| 2702 |
EXCITOTOXICITY AND OVERNUTRITION ADDITIVELY IMPAIR METABOLIC FUNCTION AND IDENTITY OF PANCREATIC BETA-CELLS |
| 2703 |
EXERCISE ADAPTATIONS: MOLECULAR MECHANISMS AND POTENTIAL TARGETS FOR THERAPEUTIC BENEFIT |
| 2704 |
EXERCISE AND COLORECTAL CANCER: PREVENTION AND MOLECULAR MECHANISMS |
| 2705 |
EXERCISE AND LOW-LEVEL GABA(A) RECEPTOR INHIBITION MODULATE LOCOMOTOR ACTIVITY AND THE EXPRESSION OF BDNF ACCOMPANIED BY CHANGES IN EPIGENETIC REGULATION IN THE HIPPOCAMPUS |
| 2706 |
EXERCISE ATTENUATES LOW BACK PAIN AND ALTERS EPIGENETIC REGULATION IN INTERVERTEBRAL DISCS IN A MOUSE MODEL |
| 2707 |
EXERCISE EFFECTS ON METHYLATION OF ASC GENE |
| 2708 |
EXERCISE IN NEUROMUSCULAR DISORDERS: A PROMISING INTERVENTION |
| 2709 |
EXERCISE INDUCES AGE-DEPENDENT CHANGES ON EPIGENETIC PARAMETERS IN RAT HIPPOCAMPUS: A PRELIMINARY STUDY |
| 2710 |
EXERCISE MITIGATES ALCOHOL INDUCED ENDOPLASMIC RETICULUM STRESS MEDIATED COGNITIVE IMPAIRMENT THROUGH ATF6-HERP SIGNALING |
| 2711 |
EXERCISE TRAINING ALTERS THE GENOMIC RESPONSE TO ACUTE EXERCISE IN HUMAN ADIPOSE TISSUE |
| 2712 |
EXERCISE TRAINING AND DNA METHYLATION IN HUMANS |
| 2713 |
EXERCISE TRAINING AND EPIGENETIC REGULATION: MULTILEVEL MODIFICATION AND REGULATION OF GENE EXPRESSION |
| 2714 |
EXERCISE-CONDITIONED PLASMA ATTENUATES NUCLEAR CONCENTRATIONS OF DNA METHYLTRANSFERASE 3B IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS |
| 2715 |
EXERCISE-INDUCED BIOCHEMICAL CHANGES AND THEIR POTENTIAL INFLUENCE ON CANCER: A SCIENTIFIC REVIEW |
| 2716 |
EXERCISE-MODULATED EPIGENETIC MARKERS AND INFLAMMATORY RESPONSE IN COPD INDIVIDUALS: A PILOT STUDY |
| 2717 |
EXERCISE: PUTTING ACTION INTO OUR EPIGENOME |
| 2718 |
EXHAUSTED T CELLS AND EPIGENETIC STATUS |
| 2719 |
EXOME SEQUENCING REVEALS DNMT3A AND ASXL1 VARIANTS ASSOCIATE WITH PROGRESSION OF CHRONIC MYELOID LEUKEMIA AFTER TYROSINE KINASE INHIBITOR THERAPY |
| 2720 |
EXOSOMAL MIRNAS IN HEPATITIS B VIRUS RELATED LIVER DISEASE: A NEW HOPE FOR BIOMARKER |
| 2721 |
EXOSOMAL NON CODING RNAS AS A NOVEL TARGET FOR DIABETES MELLITUS AND ITS COMPLICATIONS |
| 2722 |
EXOSOMES AS A NEW PAIN BIOMARKER OPPORTUNITY |
| 2723 |
EXOSOMES: NOMENCLATURE, ISOLATION, AND BIOLOGICAL ROLES IN LIVER DISEASES |
| 2724 |
EXPERIENCE-SENSITIVE EPIGENETIC MECHANISMS, DEVELOPMENTAL PLASTICITY, AND THE BIOLOGICAL EMBEDDING OF CHRONIC DISEASE RISK |
| 2725 |
EXPERIENCES OF TRAUMA AND DNA METHYLATION PROFILES AMONG AFRICAN AMERICAN MOTHERS AND CHILDREN |
| 2726 |
EXPERIMENTAL PHARMACOLOGICAL MANAGEMENT OF PSORIASIS |
| 2727 |
EXPLAINING THE BLACK-WHITE DISPARITY IN PRETERM BIRTH: A CONSENSUS STATEMENT FROM A MULTI-DISCIPLINARY SCIENTIFIC WORK GROUP CONVENED BY THE MARCH OF DIMES |
| 2728 |
EXPLORING EPIGENETIC AND MICRORNA APPROACHES FOR GAMMA-GLOBIN GENE REGULATION |
| 2729 |
EXPLORING EPIGENETIC DRUGS AS POTENTIAL INHIBITORS OF SARS-COV-2 MAIN PROTEASE: A DOCKING AND MD SIMULATION STUDY |
| 2730 |
EXPLORING THE BIOLOGICAL FUNCTION OF IMMUNE CELL-RELATED GENES IN HUMAN IMMUNODEFICIENCY VIRUS (HIV)-1 INFECTION BASED ON WEIGHTED GENE CO-EXPRESSION NETWORK ANALYSIS (WGCNA) |
| 2731 |
EXPLORING THE COMPLEX RELATIONSHIP BETWEEN MICROBIOTA AND SYSTEMIC LUPUS ERYTHEMATOSUS |
| 2732 |
EXPLORING THE EPIGENETIC REGULATED MODULATION OF FIBROBLAST GROWTH FACTOR 21 INVOLVEMENT IN HIGH-FAT DIET ASSOCIATED PARKINSON'S DISEASE IN RATS |
| 2733 |
EXPLORING THE POTENTIAL OF PHYTOCOMPOUNDS FOR TARGETING EPIGENETIC MECHANISMS IN RHEUMATOID ARTHRITIS: AN IN SILICO STUDY USING SIMILARITY INDEXING |
| 2734 |
EXPLORING THE RELATIONSHIP BETWEEN DNA METHYLATION AGE MEASURES AND PSYCHONEUROLOGICAL SYMPTOMS IN WOMEN WITH EARLY-STAGE BREAST CANCER |
| 2735 |
EXPLORING THE RELATIONSHIP BETWEEN EPIGENETIC DNA METHYLATION AND CARDIAC FIBROSIS THROUGH RAMAN MICROSPECTROSCOPY |
| 2736 |
EXPLORING THE TRANSCRIPTOME OF RESIDENT SPINAL MICROGLIA AFTER COLLAGEN ANTIBODY-INDUCED ARTHRITIS |
| 2737 |
EXPOSING A DEADLY ALLIANCE: NOVEL INSIGHTS INTO THE BIOLOGICAL LINKS BETWEEN COPD AND LUNG CANCER |
| 2738 |
EXPOSOMES TO EXOSOMES: EXOSOMES AS TOOLS TO STUDY EPIGENETIC ADAPTIVE MECHANISMS IN HIGH-ALTITUDE HUMANS |
| 2739 |
EXPOSURE TO AIR POLLUTION DISRUPTS CIRCADIAN RHYTHM THROUGH ALTERATIONS IN CHROMATIN DYNAMICS |
| 2740 |
EXPOSURE TO EARLY LIFE STRESS RESULTS IN EPIGENETIC CHANGES IN NEUROTROPHIC FACTOR GENE EXPRESSION IN A PARKINSONIAN RAT MODEL |
| 2741 |
EXPOSURE TO IONIZING RADIATION DISRUPTS NORMAL EPIGENETIC AGING IN JAPANESE MEDAKA |
| 2742 |
EXPOSURE TO THE PLASTICIZER, DI-(2-ETHYLHEXYL) PHTHALATE DURING JUVENILE PERIOD EXACERBATES AUTISM-LIKE BEHAVIOR IN ADULT BTBR T + TF/J MICE DUE TO DNA HYPOMETHYLATION AND ENHANCED INFLAMMATION IN BRAIN AND SYSTEMIC IMMUNE CELLS |
| 2743 |
EXPOSURE TO ULTRAFINE PARTICULATE MATTER INDUCES NF-KAPPABETA MEDIATED EPIGENETIC MODIFICATIONS |
| 2744 |
EXPOSURE TO VIOLENCE, CHRONIC STRESS, NASAL DNA METHYLATION, AND ATOPIC ASTHMA IN CHILDREN |
| 2745 |
EXPRESS: HISTONE HYPERACETYLATION MODULATES SPINAL TYPE II METABOTROPIC GLUTAMATE RECEPTOR ALLEVIATING STRESS-INDUCED VISCERAL HYPERSENSITIVITY IN FEMALE RATS |
| 2746 |
EXPRESSION ANALYSIS OF LONG NON-CODING RNAS AND THEIR TARGET GENES IN MULTIPLE SCLEROSIS PATIENTS |
| 2747 |
EXPRESSION ANALYSIS OF THE EPIGENETIC METHYLTRANSFERASES AND METHYL-CPG BINDING PROTEIN FAMILIES IN THE NORMAL B-CELL AND B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) |
| 2748 |
EXPRESSION AND FUNCTION OF EZH2 IN SYNOVIAL FIBROBLASTS: EPIGENETIC REPRESSION OF THE WNT INHIBITOR SFRP1 IN RHEUMATOID ARTHRITIS |
| 2749 |
EXPRESSION AND POLYMORPHISM OF MICRO-RNA ACCORDING TO BODY MASS INDEX AND BREAST CANCER PRESENTATION IN TUNISIAN PATIENTS |
| 2750 |
EXPRESSION LEVELS OF THE TYROSINE HYDROXYLASE GENE AND HISTONE MODIFICATIONS AROUND ITS PROMOTER IN THE LOCUS COERULEUS AND VENTRAL TEGMENTAL AREA OF RATS DURING FORCED ABSTINENCE FROM MORPHINE |
| 2751 |
EXPRESSION OF ACETYL-HISTONE H3 AND ACETYL-HISTONE H4 IN DORSAL ROOT GANGLION AND SPINAL DORSAL HORN IN RAT CHRONIC PAIN MODELS |
| 2752 |
EXPRESSION OF ANGIOGENIC FACTORS IN CHRONIC MYELOID LEUKAEMIA: ROLE OF THE BCR/ABL ONCOGENE, BIOCHEMICAL MECHANISMS, AND POTENTIAL CLINICAL IMPLICATIONS |
| 2753 |
EXPRESSION OF BCL2L12 IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: ASSOCIATION WITH CLINICAL AND MOLECULAR PROGNOSTIC MARKERS |
| 2754 |
EXPRESSION OF CAVEOLIN 1 IS ENHANCED BY DNA DEMETHYLATION DURING ADIPOCYTE DIFFERENTIATION |
| 2755 |
EXPRESSION OF CLASS II HISTONE DEACETYLASES IN TWO MOUSE MODELS OF TEMPORAL LOBE EPILEPSY |
| 2756 |
EXPRESSION OF DNA METHYLTRANSFERASES IN ADULT DORSAL ROOT GANGLIA IS CELL-TYPE SPECIFIC AND UP REGULATED IN A RODENT MODEL OF NEUROPATHIC PAIN |
| 2757 |
EXPRESSION OF EPIGENETIC MACHINERY GENES IS SENSITIVE TO MATERNAL OBESITY AND WEIGHT LOSS IN RELATION TO FETAL GROWTH IN MICE |
| 2758 |
EXPRESSION OF HORMONAL CARCINOGENESIS GENES AND RELATED REGULATORY MICRORNAS IN UTERUS AND OVARIES OF DDT-TREATED FEMALE RATS |
| 2759 |
EXPRESSION OF IL-17 AND ITS GENE PROMOTER METHYLATION STATUS ARE ASSOCIATED WITH THE PROGRESSION OF CHRONIC HEPATITIS B VIRUS INFECTION |
| 2760 |
EXPRESSION OF PD-L1, PD-L2, PD-1 AND CTLA4 IN MYELODYSPLASTIC SYNDROMES IS ENHANCED BY TREATMENT WITH HYPOMETHYLATING AGENTS |
| 2761 |
EXPRESSION OF TESTIS-SPECIFIC GENES, TEX101 AND ODF4, IN CHRONIC MYELOID LEUKEMIA AND EVALUATION OF TEX101 IMMUNOGENICITY |
| 2762 |
EXPRESSION OF TET2 ENZYME INDICATES ENHANCED EPIGENETIC MODIFICATION OF CELLS IN PERIODONTITIS |
| 2763 |
EXPRESSION OF THE LEUKEMIC PROGNOSTIC MARKER CD7 IS LINKED TO EPIGENETIC MODIFICATIONS IN CHRONIC MYELOID LEUKEMIA |
| 2764 |
EXPRESSION PATTERN, REGULATION, AND CLINICAL SIGNIFICANCE OF TOX IN BREAST CANCER |
| 2765 |
EXPRESSION, EPIGENETIC REGULATION, AND HUMORAL IMMUNOGENICITY OF CANCER-TESTIS ANTIGENS IN CHRONIC MYELOID LEUKEMIA |
| 2766 |
EXPRESSION, POLYMORPHISM AND METHYLATION PATTERN OF INTERLEUKIN-6 IN PERIODONTAL TISSUES |
| 2767 |
EXPRESSION, PROGNOSTIC VALUE, AND FUNCTIONAL MECHANISM OF THE KDM5 FAMILY IN PANCREATIC CANCER |
| 2768 |
EXPRESSIONS OF SERUM LNCRNAS IN DIABETIC RETINOPATHY - A POTENTIAL DIAGNOSTIC TOOL |
| 2769 |
EXTENDED DOSING WITH CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH MYELOID MALIGNANCIES |
| 2770 |
EXTENDING INJURY- AND DISEASE-RESISTANT CNS PHENOTYPES BY REPETITIVE EPIGENETIC CONDITIONING |
| 2771 |
EXTENSIVE PROMOTER DNA HYPERMETHYLATION AND HYPOMETHYLATION IS ASSOCIATED WITH ABERRANT MICRORNA EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2772 |
EXTRACELLULAR ATP AND NEURODEGENERATION |
| 2773 |
EXTRACELLULAR SIGNAL-REGULATED PROTEIN KINASES 1 AND 2 ACTIVATION BY ADDICTIVE DRUGS: A SIGNAL TOWARD PATHOLOGICAL ADAPTATION |
| 2774 |
EXTRACELLULAR SUPEROXIDE DISMUTASE (EC-SOD) REGULATES GENE METHYLATION AND CARDIAC FIBROSIS DURING CHRONIC HYPOXIC STRESS |
| 2775 |
EXTRACELLULAR VESICLES AND ASTHMA-MORE THAN JUST A CO-EXISTENCE |
| 2776 |
EXTRAUTERINE GROWTH RESTRICTION ON PULMONARY VASCULAR ENDOTHELIAL DYSFUNCTION IN ADULT MALE RATS: THE ROLE OF EPIGENETIC MECHANISMS |
| 2777 |
EXTREMELY LOW BIRTH WEIGHT AND ACCELERATED BIOLOGICAL AGING |
| 2778 |
EZH1 IS AN ANTIPSYCHOTIC-SENSITIVE EPIGENETIC MODULATOR OF SOCIAL AND MOTIVATIONAL BEHAVIOR THAT IS DYSREGULATED IN SCHIZOPHRENIA |
| 2779 |
EZH2 AND MATRIX CO-REGULATE PHENOTYPE AND KCNB2 EXPRESSION IN BLADDER SMOOTH MUSCLE CELLS |
| 2780 |
EZH2 DOWN-REGULATION EXACERBATES LIPID ACCUMULATION AND INFLAMMATION IN IN VITRO AND IN VIVO NAFLD |
| 2781 |
EZH2 IN MYELOID MALIGNANCIES |
| 2782 |
EZH2 INHIBITION CONFERS PIK3CA-DRIVEN LUNG TUMORS ENHANCED SENSITIVITY TO PI3K INHIBITION |
| 2783 |
EZH2 METHYLTRANSFERASE REGULATES NEUROINFLAMMATION AND NEUROPATHIC PAIN |
| 2784 |
EZH2 PROMOTES EXTRACELLULAR MATRIX DEGRADATION VIA NUCLEAR FACTOR-KAPPAB (NF-KAPPAB) AND P38 SIGNALING PATHWAYS IN PULPITIS |
| 2785 |
EZH2 REGULATES SPINAL NEUROINFLAMMATION IN RATS WITH NEUROPATHIC PAIN |
| 2786 |
EZH2 RESTRICTS THE SMOOTH MUSCLE LINEAGE DURING MOUSE LUNG MESOTHELIAL DEVELOPMENT |
| 2787 |
EZH2-MEDIATED EPIGENETIC MODIFICATION IS REQUIRED FOR ALLOGENEIC T CELL-INDUCED LUPUS DISEASE |
| 2788 |
FACTORS AFFECTING THE TRANSITION OF ACUTE KIDNEY INJURY TO CHRONIC KIDNEY DISEASE: POTENTIAL MECHANISMS AND FUTURE PERSPECTIVES |
| 2789 |
FACTORS INFLUENCING EPIGENETIC MECHANISMS: IS THERE A ROLE FOR BARIATRIC SURGERY? EPIGENETICS IS THE INTERACTION BETWEEN THE GENOME AND ENVIRONMENTAL STIMULI CAPABLE OF INFLUENCING GENE EXPRESSION DURING DEVELOPMENT AND AGING |
| 2790 |
FACTORS TO CONSIDER IN THE USE OF STEM CELLS FOR PHARMACEUTIC DRUG DEVELOPMENT AND FOR CHEMICAL SAFETY ASSESSMENT |
| 2791 |
FAT-FREE P300 IS GOOD FOR SCAR-FREE TISSUE REPAIR |
| 2792 |
FAT10 IS AN EPIGENETIC MARKER FOR LIVER PRENEOPLASIA IN A DRUG-PRIMED MOUSE MODEL OF TUMORIGENESIS |
| 2793 |
FATE-MAPPING OF GM-CSF EXPRESSION IDENTIFIES A DISCRETE SUBSET OF INFLAMMATION-DRIVING T HELPER CELLS REGULATED BY CYTOKINES IL-23 AND IL-1BETA |
| 2794 |
FATTY ACIDS, EPIGENETIC MECHANISMS AND CHRONIC DISEASES: A SYSTEMATIC REVIEW |
| 2795 |
FATTY LIVER AND CHRONIC KIDNEY DISEASE: NOVEL MECHANISTIC INSIGHTS AND THERAPEUTIC OPPORTUNITIES |
| 2796 |
FBW7 MEDIATES SENESCENCE AND PULMONARY FIBROSIS THROUGH TELOMERE UNCAPPING |
| 2797 |
FCER1G GENE HYPOMETHYLATION IN PATIENTS WITH RHEUMATOID ARTHRITIS |
| 2798 |
FDG-PET IMAGING REVEALS LOCAL BRAIN GLUCOSE UTILIZATION IS ALTERED BY CLASS I HISTONE DEACETYLASE INHIBITORS |
| 2799 |
FEED COMPOSITION DIFFERENCES RESULTING FROM ORGANIC AND CONVENTIONAL FARMING PRACTICES AFFECT PHYSIOLOGICAL PARAMETERS IN WISTAR RATS-RESULTS FROM A FACTORIAL, TWO-GENERATION DIETARY INTERVENTION TRIAL |
| 2800 |
FEEDBACK REGULATORS OF HYPOXIA-INDUCIBLE FACTORS AND THEIR ROLE IN CANCER BIOLOGY |
| 2801 |
FEMALE OBESITY: SHORT- AND LONG-TERM CONSEQUENCES ON THE OFFSPRING |
| 2802 |
FETAL AND INFANT ORIGINS OF ASTHMA |
| 2803 |
FETAL DEVELOPMENTAL PROGRAMING: INSIGHTS FROM HUMAN STUDIES AND EXPERIMENTAL MODELS |
| 2804 |
FETAL EPIGENETIC MECHANISMS AND INNATE IMMUNITY IN ASTHMA |
| 2805 |
FETAL MALNUTRITION AND LONG-TERM OUTCOMES |
| 2806 |
FETAL PROGRAMMING AND THE RISK OF NONCOMMUNICABLE DISEASE |
| 2807 |
FETAL PROGRAMMING OF CHRONIC KIDNEY DISEASE: THE ROLE OF MATERNAL SMOKING, MITOCHONDRIAL DYSFUNCTION, AND EPIGENETIC MODFIFICATION |
| 2808 |
FETAL PROGRAMMING OF HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS FUNCTION AND BEHAVIOR BY SYNTHETIC GLUCOCORTICOIDS |
| 2809 |
FGF1 AMELIORATES OBESITY-ASSOCIATED HEPATIC STEATOSIS BY REVERSING IGFBP2 HYPERMETHYLATION |
| 2810 |
FGF23 AND FETUIN-A INTERACTION IN THE LIVER AND IN THE CIRCULATION |
| 2811 |
FGFR2-RELATED PATHOGENESIS AND FGFR2-TARGETED THERAPEUTICS (REVIEW) |
| 2812 |
FIBROBLAST MEMORY IN DEVELOPMENT, HOMEOSTASIS AND DISEASE |
| 2813 |
FIBROBLAST REPROGRAMMING IN GASTROINTESTINAL CANCER |
| 2814 |
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA: MIDDLE-AGE ONSET OF HETEROTOPIC OSSIFICATION FROM A UNIQUE MISSENSE MUTATION (C |
| 2815 |
FIBROMYALGIA: GENETICS AND EPIGENETICS INSIGHTS MAY PROVIDE THE BASIS FOR THE DEVELOPMENT OF DIAGNOSTIC BIOMARKERS |
| 2816 |
FIBROMYALGIA: PATHOGENESIS, MECHANISMS, DIAGNOSIS AND TREATMENT OPTIONS UPDATE |
| 2817 |
FIBROSIS IN THE LIVER: ACUTE PROTECTION AND CHRONIC DISEASE |
| 2818 |
FIBROSIS UNDER ARREST |
| 2819 |
FILARIAL AND WOLBACHIA GENOMICS |
| 2820 |
FINE-MAPPING INFLAMMATORY BOWEL DISEASE LOCI TO SINGLE-VARIANT RESOLUTION |
| 2821 |
FINE-TUNING AUTOPHAGY: FROM TRANSCRIPTIONAL TO POSTTRANSLATIONAL REGULATION |
| 2822 |
FIRST-IN-HUMAN STUDY OF INHALED AZACITIDINE IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER |
| 2823 |
FLAVONOIDS AS EPIGENETIC MODULATORS FOR PROSTATE CANCER PREVENTION |
| 2824 |
FLAVONOIDS IN BONE EROSIVE DISEASES: PERSPECTIVES IN OSTEOPOROSIS TREATMENT |
| 2825 |
FLOW-DEPENDENT EPIGENETIC REGULATION OF IGFBP5 EXPRESSION BY H3K27ME3 CONTRIBUTES TO ENDOTHELIAL ANTI-INFLAMMATORY EFFECTS |
| 2826 |
FLUOXETINE EPIGENETICALLY ALTERS THE CAMKIIALPHA PROMOTER IN NUCLEUS ACCUMBENS TO REGULATE DELTAFOSB BINDING AND ANTIDEPRESSANT EFFECTS |
| 2827 |
FLUOXETINE INCREASES HIPPOCAMPAL NEUROGENESIS AND INDUCES EPIGENETIC FACTORS BUT DOES NOT IMPROVE FUNCTIONAL RECOVERY AFTER TRAUMATIC BRAIN INJURY |
| 2828 |
FLUOXETINE TREATMENT SUPPORTS PREDICTIVE VALIDITY OF THE THREE HIT MODEL OF DEPRESSION IN MALE PACAP HETEROZYGOUS MICE AND UNDERPINS THE IMPACT OF EARLY LIFE ADVERSITY ON THERAPEUTIC EFFICACY |
| 2829 |
FLUSHING OUT CARCINOID SYNDROME: BENEFICIAL EFFECT OF THE ANTICANCER EPIGENETIC AGENT RRX-001 IN A PATIENT WITH A TREATMENT-REFRACTORY NEUROENDOCRINE TUMOR |
| 2830 |
FOCAL 9P INSTABILITY IN HEMATOLOGIC NEOPLASIAS REVEALED BY COMPARATIVE GENOMIC HYBRIDIZATION AND SINGLE-NUCLEOTIDE POLYMORPHISM MICROARRAY ANALYSES |
| 2831 |
FOCUS ON T CELL EXHAUSTION: NEW ADVANCES IN TRADITIONAL CHINESE MEDICINE IN INFECTION AND CANCER |
| 2832 |
FOCUSING THE SPOTLIGHT ON THE ZEBRAFISH INTESTINE TO ILLUMINATE MECHANISMS OF COLORECTAL CANCER |
| 2833 |
FOLATE AND DNA METHYLATION: A REVIEW OF MOLECULAR MECHANISMS AND THE EVIDENCE FOR FOLATE'S ROLE |
| 2834 |
FOLIC ACID MODULATES MATRIX METALLOPROTEINASE-2 EXPRESSION, ALLEVIATES NEUROPATHIC PAIN, AND IMPROVES FUNCTIONAL RECOVERY IN SPINAL CORD-INJURED RATS |
| 2835 |
FOOD AS MEDICINE: TARGETING THE URAEMIC PHENOTYPE IN CHRONIC KIDNEY DISEASE |
| 2836 |
FOOD INTAKE IN EARLY LIFE AND EPIGENETIC MODIFICATIONS OF PRO-OPIOMELANOCORTIN EXPRESSION IN ARCUATE NUCLEUS |
| 2837 |
FORKHEAD O TRANSCRIPTION FACTOR 4 RESTRICTS HBV COVALENTLY CLOSED CIRCULAR DNA TRANSCRIPTION AND HBV REPLICATION THROUGH GENETIC DOWNREGULATION OF HEPATOCYTE NUCLEAR FACTOR 4 ALPHA AND EPIGENETIC SUPPRESSION OF COVALENTLY CLOSED CIRCULAR DNA VIA INTERACTING WITH PROMYELOCYTIC LEUKEMIA PROTEIN |
| 2838 |
FORMALDEHYDE CARCINOGENICITY RESEARCH: 30 YEARS AND COUNTING FOR MODE OF ACTION, EPIDEMIOLOGY, AND CANCER RISK ASSESSMENT |
| 2839 |
FOSB INDUCTION IN NUCLEUS ACCUMBENS BY COCAINE IS REGULATED BY E2F3A |
| 2840 |
FRAMEWORK ANALYSIS FOR THE CARCINOGENIC MODE OF ACTION OF NITROBENZENE |
| 2841 |
FREQUENCY OF THE DOPAMINE RECEPTOR D3 (RS6280) VS |
| 2842 |
FREQUENT CONCOMITANT EPIGENETIC SILENCING OF SOX1 AND SECRETED FRIZZLED-RELATED PROTEINS (SFRPS) IN HUMAN HEPATOCELLULAR CARCINOMA |
| 2843 |
FREQUENT CPG ISLAND METHYLATION IN PRECURSOR LESIONS AND EARLY GASTRIC ADENOCARCINOMAS |
| 2844 |
FREQUENT EPIGENETIC INACTIVATION OF SFRP GENES IN HEPATOCELLULAR CARCINOMA |
| 2845 |
FREQUENT EPIGENETIC INACTIVATION OF THE SLIT2 GENE IN CHRONIC AND ACUTE LYMPHOCYTIC LEUKEMIA |
| 2846 |
FREQUENT INVOLVEMENT OF CHROMATIN REMODELER ALTERATIONS IN GASTRIC FIELD CANCERIZATION |
| 2847 |
FREQUENT P15 PROMOTER METHYLATION IN TUMOR AND PERIPHERAL BLOOD FROM HEPATOCELLULAR CARCINOMA PATIENTS |
| 2848 |
FREQUENT SOMATIC MUTATIONS IN EPIGENETIC REGULATORS IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA |
| 2849 |
FROM AIR POLLUTION TO CARDIOVASCULAR DISEASES: THE EMERGING ROLE OF EPIGENETICS |
| 2850 |
FROM CHILD ABUSE TO DEVELOPING BORDERLINE PERSONALITY DISORDER INTO ADULTHOOD: EXPLORING THE NEUROMORPHOLOGICAL AND EPIGENETIC PATHWAY |
| 2851 |
FROM CIRRHOSIS TO HEPATOCELLULAR CARCINOMA: NEW MOLECULAR INSIGHTS ON INFLAMMATION AND CELLULAR SENESCENCE |
| 2852 |
FROM GASTRIC INFLAMMATION TO GASTRIC CANCER |
| 2853 |
FROM HELICOBACTER PYLORI INFECTION TO GASTRIC CANCER: CURRENT EVIDENCE ON THE IMMUNE RESPONSE |
| 2854 |
FROM HEPATITIS TO HEPATOCELLULAR CARCINOMA: A PROPOSED MODEL FOR CROSS-TALK BETWEEN INFLAMMATION AND EPIGENETIC MECHANISMS |
| 2855 |
FROM INFLAMMAGING TO HEALTHY AGING BY DIETARY LIFESTYLE CHOICES: IS EPIGENETICS THE KEY TO PERSONALIZED NUTRITION? THE PROGRESSIVELY OLDER POPULATION IN DEVELOPED COUNTRIES IS REFLECTED IN AN INCREASE IN THE NUMBER OF PEOPLE SUFFERING FROM AGE-RELATED CHRONIC INFLAMMATORY DISEASES SUCH AS METABOLIC SYNDROME, DIABETES, HEART AND LUNG DISEASES, CANCER, OSTEOPOROSIS, ARTHRITIS, AND DEMENTIA |
| 2856 |
FROM METHYLATION TO MYELINATION: EPIGENOMIC AND TRANSCRIPTOMIC PROFILING OF CHRONIC INACTIVE DEMYELINATED MULTIPLE SCLEROSIS LESIONS |
| 2857 |
FROM PATHOGENESIS TO TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 2858 |
FROM RILUZOLE TO DEXPRAMIPEXOLE VIA SUBSTITUTED-BENZOTHIAZOLE DERIVATIVES FOR AMYOTROPHIC LATERAL SCLEROSIS DISEASE TREATMENT: CASE STUDIES |
| 2859 |
FROM SMOKING TO COPD--CURRENT APPROACHES |
| 2860 |
FROM SOCIAL DETERMINANTS TO SOCIAL EPIGENETICS: HEALTH GEOGRAPHIES OF CHRONIC DISEASE |
| 2861 |
FROM TRAINED IMMUNITY IN ALLERGY TO TRAINED IMMUNITY-BASED ALLERGEN VACCINES |
| 2862 |
FRUCTOSE-MEDIATED EFFECTS ON GENE EXPRESSION AND EPIGENETIC MECHANISMS ASSOCIATED WITH NAFLD PATHOGENESIS |
| 2863 |
FUNCTION OF DNA METHYLTRANSFERASE 3A IN LEAD (PB(2+) )-INDUCED CYCLOOXYGENASE-2 GENE |
| 2864 |
FUNCTION OF PM2 |
| 2865 |
FUNCTIONAL ABDOMINAL PAIN DISORDERS IN CHILDREN |
| 2866 |
FUNCTIONAL ADULT ACETYLCHOLINE RECEPTOR DEVELOPS INDEPENDENTLY OF MOTOR INNERVATION IN SOL 8 MOUSE MUSCLE CELL LINE |
| 2867 |
FUNCTIONAL AND CANCER GENOMICS OF ASXL FAMILY MEMBERS |
| 2868 |
FUNCTIONAL CONSEQUENCES OF CALCIUM-DEPENDENT SYNAPSE-TO-NUCLEUS COMMUNICATION: FOCUS ON TRANSCRIPTION-DEPENDENT METABOLIC PLASTICITY |
| 2869 |
FUNCTIONAL FOODS AND HEALTH EFFECTS: A NUTRITIONAL BIOCHEMISTRY PERSPECTIVE |
| 2870 |
FUNCTIONAL GENE POLYMORPHISMS AND EXPRESSION ALTERATION OF SELECTED MICRORNAS AND THE RISK OF VARIOUS GASTRIC LESIONS IN HELICOBACTER PYLORI-RELATED GASTRIC DISEASES |
| 2871 |
FUNCTIONAL GENOMICS IN EXPERIMENTAL AND HUMAN TEMPORAL LOBE EPILEPSY: POWERFUL NEW TOOLS TO IDENTIFY MOLECULAR DISEASE MECHANISMS OF HIPPOCAMPAL DAMAGE |
| 2872 |
FUNCTIONAL GENOMICS OF SEROTONIN RECEPTOR 2A (HTR2A): INTERACTION OF POLYMORPHISM, METHYLATION, EXPRESSION AND DISEASE ASSOCIATION |
| 2873 |
FUNCTIONAL METHYLOME ANALYSIS OF HUMAN DIABETIC KIDNEY DISEASE |
| 2874 |
FUNCTIONAL NUTRITION AS INTEGRATED INTERVENTION FOR IN- AND OUTPATIENT WITH SCHIZOPHRENIA |
| 2875 |
FUNCTIONAL ROLE AND THERAPEUTIC TARGETING OF MICRORNAS IN INFLAMMATORY BOWEL DISEASE |
| 2876 |
FUNCTIONAL ROLES OF LONG NONCODING RNA MALAT1 IN GYNECOLOGIC CANCERS |
| 2877 |
FUNCTIONAL STATE OF NEUTROPHIC GRANULOCYTES' GENOME OF THE PERIPHERAL BLOOD IN PATIENTS WITH CHRONIC HEPATITIS C WITH CONCOMITANT DIABETES MELLITUS TYPE II |
| 2878 |
FUNCTIONAL T CELLS ARE CAPABLE OF SUPERNUMERARY CELL DIVISION AND LONGEVITY |
| 2879 |
FUNDAMENTALS TO THERAPEUTICS: EPIGENETIC MODULATION OF CD8(+) T CELL EXHAUSTION IN THE TUMOR MICROENVIRONMENT |
| 2880 |
FUSOBACTERIUM NUCLEATUM INFECTION IN COLORECTAL CANCER: LINKING INFLAMMATION, DNA MISMATCH REPAIR AND GENETIC AND EPIGENETIC ALTERATIONS |
| 2881 |
FUTURE PERSPECTIVES OF PERSONALIZED WEIGHT LOSS INTERVENTIONS BASED ON NUTRIGENETIC, EPIGENETIC, AND METAGENOMIC DATA |
| 2882 |
G-PROTEIN-COUPLED RECEPTOR GPR17 REGULATES OLIGODENDROCYTE DIFFERENTIATION IN RESPONSE TO LYSOLECITHIN-INDUCED DEMYELINATION |
| 2883 |
G9A INHIBITS CREB-TRIGGERED EXPRESSION OF MU OPIOID RECEPTOR IN PRIMARY SENSORY NEURONS FOLLOWING PERIPHERAL NERVE INJURY |
| 2884 |
G9A IS ESSENTIAL FOR EPIGENETIC SILENCING OF K(+) CHANNEL GENES IN ACUTE-TO-CHRONIC PAIN TRANSITION |
| 2885 |
G9A PARTICIPATES IN NERVE INJURY-INDUCED KCNA2 DOWNREGULATION IN PRIMARY SENSORY NEURONS |
| 2886 |
GABA-AALPHA5 MIGHT BE INVOLVED IN LEARNING-MEMORY DYSFUNCTION IN THE OFFSPRINGS OF CHRONIC ETHANOL-TREATED RATS VIA GABA-AALPHA5 HISTONE H3K9 ACETYLATION |
| 2887 |
GADD45A TRANSCRIPTIONAL INDUCTION ELICITED BY THE AURORA KINASE INHIBITOR MK-0457 IN BCR-ABL-EXPRESSING CELLS IS DRIVEN BY OCT-1 TRANSCRIPTION FACTOR |
| 2888 |
GAIN-OF-FUNCTION MUTATION OF GATA-2 IN ACUTE MYELOID TRANSFORMATION OF CHRONIC MYELOID LEUKEMIA |
| 2889 |
GAIN-OF-FUNCTION STAT1 MUTATIONS IMPAIR STAT3 ACTIVITY IN PATIENTS WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS (CMC) |
| 2890 |
GAP JUNCTIONAL INTERCELLULAR COMMUNICATION AS A BIOLOGICAL "ROSETTA STONE" IN UNDERSTANDING, IN A SYSTEMS BIOLOGICAL MANNER, STEM CELL BEHAVIOR, MECHANISMS OF EPIGENETIC TOXICOLOGY, CHEMOPREVENTION AND CHEMOTHERAPY |
| 2891 |
GARCINOL AND ITS ROLE IN CHRONIC DISEASES |
| 2892 |
GARDENIAE FRUCTUS ATTENUATES THIOACETAMIDE-INDUCED LIVER FIBROSIS IN MICE VIA BOTH AMPK/SIRT1/NF-KAPPAB PATHWAY AND NRF2 SIGNALING |
| 2893 |
GAS5 RS2067079 AND MIR-137 RS1625579 FUNCTIONAL SNPS AND RISK OF CHRONIC HEPATITIS B VIRUS INFECTION AMONG EGYPTIAN PATIENTS |
| 2894 |
GASTRIC CANCER AS A STEM-CELL DISEASE: DATA AND HYPOTHESES |
| 2895 |
GASTRIC CANCER DEVELOPMENT AFTER THE SUCCESSFUL ERADICATION OF HELICOBACTER PYLORI |
| 2896 |
GASTRIC ENTEROCHROMAFFIN-LIKE CELL HYPERPLASIA AND NEOPLASIA IN THE RAT: AN INDIRECT EFFECT OF THE HISTAMINE H2-RECEPTOR ANTAGONIST, BL-6341 |
| 2897 |
GASTRIC TUMOR MICROENVIRONMENT |
| 2898 |
GATA3-DEPENDENT EPIGENETIC UPREGULATION OF CCL21 IS INVOLVED IN THE DEVELOPMENT OF NEUROPATHIC PAIN INDUCED BY BORTEZOMIB |
| 2899 |
GC-MS-BASED URINARY ORGANIC ACID PROFILING REVEALS MULTIPLE DYSREGULATED METABOLIC PATHWAYS FOLLOWING EXPERIMENTAL ACUTE ALCOHOL CONSUMPTION |
| 2900 |
GENDER BIAS IN THERAPEUTIC EFFORT: FROM RESEARCH TO HEALTH CARE |
| 2901 |
GENDER DIFFERENCES IN GERM-CELL MUTAGENESIS AND GENETIC RISK |
| 2902 |
GENDER DIFFERENCES IN THE LIVERS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA AND CHRONIC HEPATITIS C INFECTION |
| 2903 |
GENDER-SPECIFIC METHYLATION DIFFERENCES IN RELATION TO PRENATAL EXPOSURE TO CIGARETTE SMOKE |
| 2904 |
GENE BODY METHYLATION FACILITATES THE TRANSCRIPTION OF CTSG VIA ANTISENSE LNCRNA AL136018 |
| 2905 |
GENE DYSREGULATION IN THE ADULT RAT PARAVENTRICULAR NUCLEUS AND AMYGDALA BY PRENATAL EXPOSURE TO DEXAMETHASONE |
| 2906 |
GENE EDITING FOR INFLAMMATORY DISORDERS |
| 2907 |
GENE EXPRESSION MODIFICATIONS IN THE LIVER CAUSED BY BINGE DRINKING AND S-ADENOSYLMETHIONINE FEEDING |
| 2908 |
GENE EXPRESSION PROFILE OF NORMAL BREAST TISSUE AND BODY MASS INDEX |
| 2909 |
GENE EXPRESSION PROFILING IN FIBROMYALGIA INDICATES AN AUTOIMMUNE ORIGIN OF THE DISEASE AND OPENS NEW AVENUES FOR TARGETED THERAPY |
| 2910 |
GENE EXPRESSION PROFILING OF EPIGENETIC CHROMATIN MODIFICATION ENZYMES AND HISTONE MARKS BY CIGARETTE SMOKE: IMPLICATIONS FOR COPD AND LUNG CANCER |
| 2911 |
GENE EXPRESSION PROFILING OF LOSS OF TET2 AND/OR JAK2V617F MUTANT HEMATOPOIETIC STEM CELLS FROM MOUSE MODELS OF MYELOPROLIFERATIVE NEOPLASMS |
| 2912 |
GENE REGULATION IN THE VASCULAR ENDOTHELIUM: WHY EPIGENETICS IS IMPORTANT FOR THE KIDNEY |
| 2913 |
GENE REGULATORY MECHANISMS UNDERLYING SEX DIFFERENCES IN BRAIN DEVELOPMENT AND PSYCHIATRIC DISEASE |
| 2914 |
GENE REGULATORY NETWORK UNDERLYING THE IMMORTALIZATION OF EPITHELIAL CELLS |
| 2915 |
GENE THERAPY FOR CHRONIC HBV-CAN WE ELIMINATE CCCDNA? CHRONIC INFECTION WITH THE HEPATITIS B VIRUS (HBV) IS A GLOBAL HEALTH CONCERN AND ACCOUNTS FOR APPROXIMATELY 1 MILLION DEATHS ANNUALLY |
| 2916 |
GENE VARIANTS AS DETERMINANTS OF LONGEVITY: FOCUS ON THE INFLAMMATORY FACTORS |
| 2917 |
GENE-ENVIRONMENT INTERACTIONS IN COMMON MENTAL DISORDERS: AN UPDATE AND STRATEGY FOR A GENOME-WIDE SEARCH |
| 2918 |
GENE-ENVIRONMENT INTERACTIONS IN MAJOR MENTAL DISORDERS IN THE CZECH REPUBLIC |
| 2919 |
GENE-GENE AND GENE-ENVIRONMENT INTERACTIONS DEFINING LIPID-RELATED TRAITS |
| 2920 |
GENE-SET ANALYSIS IS SEVERELY BIASED WHEN APPLIED TO GENOME-WIDE METHYLATION DATA |
| 2921 |
GENE-SPECIFIC DIFFERENTIAL DNA METHYLATION AND CHRONIC ARSENIC EXPOSURE IN AN EPIGENOME-WIDE ASSOCIATION STUDY OF ADULTS IN BANGLADESH |
| 2922 |
GENE-SPECIFIC DNA METHYLATION ASSOCIATION WITH SERUM LEVELS OF C-REACTIVE PROTEIN IN AFRICAN AMERICANS |
| 2923 |
GENE-SPECIFIC EPIGENETIC REGULATION IN SERIOUS INFECTIONS WITH SYSTEMIC INFLAMMATION |
| 2924 |
GENERAL ANESTHETIC NEUROTOXICITY IN THE YOUNG: MECHANISM AND PREVENTION |
| 2925 |
GENERATING LONG-LIVED CD8(+) T-CELL MEMORY: INSIGHTS FROM EPIGENETIC PROGRAMS |
| 2926 |
GENERATION OF AN EPIGENETIC SIGNATURE BY CHRONIC HYPOXIA IN PROSTATE CELLS |
| 2927 |
GENERATION OF HUMAN CORTICAL NEURONS FROM A NEW IMMORTAL FETAL NEURAL STEM CELL LINE |
| 2928 |
GENERATION OF IPSCS FROM CULTURED HUMAN MALIGNANT CELLS |
| 2929 |
GENES AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 2930 |
GENES AND DIET IN THE PREVENTION OF CHRONIC DISEASES IN FUTURE GENERATIONS |
| 2931 |
GENES AND ENVIRONMENTS, DEVELOPMENT AND TIME |
| 2932 |
GENES AND EPIGENETIC PROCESSES AS PROSPECTIVE PAIN TARGETS |
| 2933 |
GENESIS OF THE MYOFIBROBLAST IN LUNG INJURY AND FIBROSIS |
| 2934 |
GENETIC ADDICTION RISK SCORE (GARS) , A PREDICTOR OF VULNERABILITY TO OPIOID DEPENDENCE |
| 2935 |
GENETIC ALTERATION ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2936 |
GENETIC AND EPIGENETIC ABNORMALITIES IN PRIMARY SCLEROSING CHOLANGITIS-ASSOCIATED CHOLANGIOCARCINOMA |
| 2937 |
GENETIC AND EPIGENETIC ALTERATIONS DURING RENAL CARCINOGENESIS |
| 2938 |
GENETIC AND EPIGENETIC ALTERATIONS IN BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA |
| 2939 |
GENETIC AND EPIGENETIC ALTERATIONS IN HEPATITIS B VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA |
| 2940 |
GENETIC AND EPIGENETIC ALTERATIONS IN NORMAL AND SENSITIVE COPD-DISEASED HUMAN BRONCHIAL EPITHELIAL CELLS REPEATEDLY EXPOSED TO AIR POLLUTION-DERIVED PM(2 |
| 2941 |
GENETIC AND EPIGENETIC ALTERATIONS IN TOLL LIKE RECEPTOR 2 AND WOUND HEALING IMPAIRMENT IN TYPE 2 DIABETES PATIENTS |
| 2942 |
GENETIC AND EPIGENETIC ALTERATIONS OF LTF AT 3P21 |
| 2943 |
GENETIC AND EPIGENETIC ALTERATIONS OF TUMOR SUPPRESSOR AND TUMOR-RELATED GENES IN GASTRIC CANCER |
| 2944 |
GENETIC AND EPIGENETIC BASIS OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| 2945 |
GENETIC AND EPIGENETIC BASIS OF PSORIASIS PATHOGENESIS |
| 2946 |
GENETIC AND EPIGENETIC CHANGES IN THE EUTOPIC ENDOMETRIUM OF WOMEN WITH ENDOMETRIOSIS: ASSOCIATION WITH DECREASED ENDOMETRIAL ALPHAVBETA3 INTEGRIN EXPRESSION |
| 2947 |
GENETIC AND EPIGENETIC CHANGES INDUCED BY CHRONIC LOW DOSE EXPOSURE TO ARSENIC OF MOUSE TESTICULAR LEYDIG CELLS |
| 2948 |
GENETIC AND EPIGENETIC CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASE-ASSOCIATED COLORECTAL CANCER |
| 2949 |
GENETIC AND EPIGENETIC CONSEQUENCE OF EARLY-LIFE SOCIAL STRESS ON DEPRESSION: ROLE OF SEROTONIN-ASSOCIATED GENES |
| 2950 |
GENETIC AND EPIGENETIC DAMAGE INDUCED BY REACTIVE NITROGEN SPECIES: IMPLICATIONS IN CARCINOGENESIS |
| 2951 |
GENETIC AND EPIGENETIC EPIDEMIOLOGY OF CHRONIC WIDESPREAD PAIN |
| 2952 |
GENETIC AND EPIGENETIC ETIOLOGY OF INFLAMMATORY BOWEL DISEASE: AN UPDATE |
| 2953 |
GENETIC AND EPIGENETIC EVENTS IN DIABETIC WOUND HEALING |
| 2954 |
GENETIC AND EPIGENETIC FACTORS DETERMINING NAFLD RISK |
| 2955 |
GENETIC AND EPIGENETIC FACTORS INFLUENCING CHRONIC KIDNEY DISEASE |
| 2956 |
GENETIC AND EPIGENETIC FACTORS INTERACTING WITH CLONAL HEMATOPOIESIS RESULTING IN CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 2957 |
GENETIC AND EPIGENETIC IMPACT OF CHRONIC INFLAMMATION ON COLON MUCOSA CELLS |
| 2958 |
GENETIC AND EPIGENETIC INSIGHTS INTO FETAL ALCOHOL SPECTRUM DISORDERS |
| 2959 |
GENETIC AND EPIGENETIC INSTABILITY INDUCED BY BETEL QUID ASSOCIATED CHEMICALS |
| 2960 |
GENETIC AND EPIGENETIC MARKERS IN THE EVALUATION OF PANCREATIC MASSES |
| 2961 |
GENETIC AND EPIGENETIC MECHANISMS IN METAL CARCINOGENESIS AND COCARCINOGENESIS: NICKEL, ARSENIC, AND CHROMIUM |
| 2962 |
GENETIC AND EPIGENETIC MECHANISMS INFLUENCING ACUTE TO CHRONIC POSTSURGICAL PAIN TRANSITIONS IN PEDIATRICS: PRECLINICAL TO CLINICAL EVIDENCE |
| 2963 |
GENETIC AND EPIGENETIC MECHANISMS LINKING PAIN AND PSYCHIATRIC DISORDERS |
| 2964 |
GENETIC AND EPIGENETIC MECHANISMS UNDERLYING ARSENIC-ASSOCIATED DIABETES MELLITUS: A PERSPECTIVE OF THE CURRENT EVIDENCE |
| 2965 |
GENETIC AND EPIGENETIC MODIFICATIONS IN THE PATHOGENESIS OF DIABETIC RETINOPATHY: A MOLECULAR LINK TO REGULATE GENE EXPRESSION |
| 2966 |
GENETIC AND EPIGENETIC PROFILING OF CLL DISEASE PROGRESSION REVEALS LIMITED SOMATIC EVOLUTION AND SUGGESTS A RELATIONSHIP TO MEMORY-CELL DEVELOPMENT |
| 2967 |
GENETIC AND EPIGENETIC REGULATION OF CATECHOL-O-METHYLTRANSFERASE IN RELATION TO INFLAMMATION IN CHRONIC FATIGUE SYNDROME AND FIBROMYALGIA |
| 2968 |
GENETIC AND EPIGENETIC REGULATION OF PD-1 EXPRESSION |
| 2969 |
GENETIC AND EPIGENETIC REGULATION OF THE INNATE IMMUNE RESPONSE TO GOUT |
| 2970 |
GENETIC AND EPIGENETIC SIGNATURES IN HUMAN HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW |
| 2971 |
GENETIC AND EPIGENETIC SILENCING OF MICRORNA-203 ENHANCES ABL1 AND BCR-ABL1 ONCOGENE EXPRESSION |
| 2972 |
GENETIC AND EPIGENETIC STUDIES IN DIABETIC KIDNEY DISEASE |
| 2973 |
GENETIC AND EPIGENETIC STUDIES OF ATOPIC DERMATITIS |
| 2974 |
GENETIC AND METHYLATION STATUS OF CDKN2A (P14(ARF)/P16(INK4A)) AND TP53 GENES IN RECURRENT RESPIRATORY PAPILLOMATOSIS |
| 2975 |
GENETIC AND MOLECULAR ALTERATIONS ASSOCIATED WITH ORAL SQUAMOUS CELL CANCER (REVIEW) |
| 2976 |
GENETIC AND MOLECULAR BASIS OF DIABETIC FOOT ULCERS: CLINICAL REVIEW |
| 2977 |
GENETIC AND PHENOTYPIC CHARACTERIZATION OF IN-HOST DEVELOPED AZOLE-RESISTANT ASPERGILLUS FLAVUS ISOLATES |
| 2978 |
GENETIC ASSOCIATION AND EXPRESSION ANALYSES OF THE PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE (PIP5K1C) GENE IN ALCOHOL USE DISORDER-RELEVANCE FOR PAIN SIGNALING AND ALCOHOL USE |
| 2979 |
GENETIC BACKGROUND OF JUVENILE IDIOPATHIC ARTHRITIS |
| 2980 |
GENETIC BASIS OF HEPATITIS VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA: LINKAGE BETWEEN INFECTION, INFLAMMATION, AND TUMORIGENESIS |
| 2981 |
GENETIC COMPLEXITY OF CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 2982 |
GENETIC CONSIDERATIONS IN PEDIATRIC CHRONIC KIDNEY DISEASE |
| 2983 |
GENETIC DETERMINANTS OF CANCER COAGULOPATHY, ANGIOGENESIS AND DISEASE PROGRESSION |
| 2984 |
GENETIC DETERMINANTS OF POOR RESPONSE TO TREATMENT IN SEVERE ASTHMA |
| 2985 |
GENETIC DIVERSITY FOR NITROGEN USE EFFICIENCY IN ARABIDOPSIS THALIANA |
| 2986 |
GENETIC ENGINEERING TO ENHANCE CROP-BASED PHYTONUTRIENTS (NUTRACEUTICALS) TO ALLEVIATE DIET-RELATED DISEASES |
| 2987 |
GENETIC EPIDEMIOLOGY IN KIDNEY DISEASE |
| 2988 |
GENETIC FACTORS AND SYSTEMIC SCLEROSIS |
| 2989 |
GENETIC FACTORS INVOLVED IN THE CO?OCCURRENCE OF ENDOMETRIOSIS WITH ANKYLOSING SPONDYLITIS (REVIEW) |
| 2990 |
GENETIC FACTORS PREDISPOSING TO SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS |
| 2991 |
GENETIC INSTABILITY IN INHERITED AND SPORADIC LEUKEMIAS |
| 2992 |
GENETIC LANDSCAPE AND DEREGULATED PATHWAYS IN B-CELL LYMPHOID MALIGNANCIES |
| 2993 |
GENETIC PAIN LOSS DISORDERS |
| 2994 |
GENETIC PATHOGENESIS OF INFLAMMATION-ASSOCIATED CANCERS IN DIGESTIVE ORGANS |
| 2995 |
GENETIC POLYMORPHISMS IN FOLATE PATHWAY ENZYMES, DRD4 AND GSTM1 ARE RELATED TO TEMPOROMANDIBULAR DISORDER |
| 2996 |
GENETIC PROFILE AND MICROSATELLITE INSTABILITY IN A CASE OF SECONDARY ESOPHAGEAL SQUAMOUS CELL CARCINOMA 12 YEARS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR APLASTIC ANEMIA |
| 2997 |
GENETIC VARIANTS IN DNMT1 AND THE RISK OF CARDIAC AUTONOMIC NEUROPATHY IN WOMEN WITH TYPE 1 DIABETES |
| 2998 |
GENETIC VARIANTS IN TELOMERASE REVERSE TRANSCRIPTASE CONTRIBUTE TO SOLAR LENTIGINES |
| 2999 |
GENETIC VARIATION, STRESS, AND PHYSIOLOGICAL STRESS RESPONSE IN ADULTS WITH FOOD ALLERGY OR CELIAC DISEASE |
| 3000 |
GENETIC VARIATIONS IN UCA1, A LNCRNA FUNCTIONING AS A MIRNA SPONGE, DETERMINE ENDOMETRIOSIS DEVELOPMENT AND THE POTENTIAL ASSOCIATED INFERTILITY VIA REGULATING LIPOGENESIS |
| 3001 |
GENETIC, EPIGENETIC AND ENVIRONMENTAL IMPACT ON SEX DIFFERENCES IN SOCIAL BEHAVIOR |
| 3002 |
GENETIC, EPIGENETIC AND POSTTRANSCRIPTIONAL MECHANISMS FOR TREATMENT OF MAJOR DEPRESSION: THE 5-HT1A RECEPTOR GENE AS A PARADIGM |
| 3003 |
GENETIC, EPIGENETIC AND STEM CELL ALTERATIONS IN ENDOMETRIOSIS: NEW INSIGHTS AND POTENTIAL THERAPEUTIC PERSPECTIVES |
| 3004 |
GENETIC, EPIGENETIC, AND MECHANISTIC STUDIES OF TEMPOROMANDIBULAR DISORDERS AND OVERLAPPING PAIN CONDITIONS |
| 3005 |
GENETIC, EPIGENETIC, AND STEROIDOGENIC MODULATION MECHANISMS IN ENDOMETRIOSIS |
| 3006 |
GENETIC, GENOMIC AND EPIGENOMIC STUDIES OF BALKAN ENDEMIC NEPHROPATHY (BEN) |
| 3007 |
GENETIC, IMMUNOLOGIC, AND ENVIRONMENTAL BASIS OF SARCOIDOSIS |
| 3008 |
GENETIC-EPIGENETIC INTERACTION MODULATES MU-OPIOID RECEPTOR REGULATION |
| 3009 |
GENETICS AND EPIGENETICS IN NEOPLASMS WITH PLASMACYTOID DENDRITIC CELLS |
| 3010 |
GENETICS AND EPIGENETICS IN PERIOPERATIVE MEDICINE |
| 3011 |
GENETICS AND EPIGENETICS IN THE FIBROGENIC EVOLUTION OF CHRONIC LIVER DISEASES |
| 3012 |
GENETICS AND EPIGENETICS IN THE PATHOGENESIS OF PRIMARY BILIARY CHOLANGITIS |
| 3013 |
GENETICS AND EPIGENETICS OF CHRONIC ALLOGRAFT DYSFUNCTION IN KIDNEY TRANSPLANTS |
| 3014 |
GENETICS AND EPIGENETICS OF CHRONIC RHINOSINUSITIS |
| 3015 |
GENETICS AND EPIGENETICS OF CLL |
| 3016 |
GENETICS AND EPIGENETICS OF IBD |
| 3017 |
GENETICS AND EPIGENETICS OF INFLAMMATORY BOWEL DISEASE |
| 3018 |
GENETICS AND EPIGENETICS OF LIVER CANCER |
| 3019 |
GENETICS AND EPIGENETICS OF NASAL POLYPOSIS: A SYSTEMATIC REVIEW |
| 3020 |
GENETICS AND EPIGENETICS OF OSTEOARTHRITIS |
| 3021 |
GENETICS AND EPIGENETICS OF PRIMARY SJOGREN SYNDROME: IMPLICATIONS FOR FUTURE THERAPIES |
| 3022 |
GENETICS AND EPIGENETICS PURPOSE IN NONALCOHOLIC FATTY LIVER DISEASE |
| 3023 |
GENETICS AND IMMUNODYSFUNCTION UNDERLYING BEHCET'S DISEASE AND IMMUNOMODULANT TREATMENT APPROACHES |
| 3024 |
GENETICS AND PATHOGENESIS OF DIFFUSE LARGE B-CELL LYMPHOMA |
| 3025 |
GENETICS AND PATHOPHYSIOLOGY OF GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND ITS MAIN AUTOANTIGEN PROTEINASE 3 |
| 3026 |
GENETICS OF BEHCET'S DISEASE: FUNCTIONAL GENETIC ANALYSIS AND ESTIMATING DISEASE HERITABILITY |
| 3027 |
GENETICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 3028 |
GENETICS OF COMPLEX AIRWAY DISEASE |
| 3029 |
GENETICS OF INFLAMMATORY BOWEL DISEASES: A COMPARISON BETWEEN WESTERN AND EASTERN PERSPECTIVES |
| 3030 |
GENETICS OF OPISTHORCHIS VIVERRINI-RELATED CHOLANGIOCARCINOMA |
| 3031 |
GENETICS OF RHEUMATOID ARTHRITIS |
| 3032 |
GENETICS OF TINNITUS: AN EMERGING AREA FOR MOLECULAR DIAGNOSIS AND DRUG DEVELOPMENT |
| 3033 |
GENETICS, EPIGENETICS, AND GENDER IMPACT IN AXIAL-SPONDYLOARTHRITIS SUSCEPTIBILITY: AN UPDATE ON GENETIC POLYMORPHISMS AND THEIR SEX RELATED ASSOCIATIONS |
| 3034 |
GENETICS/EPIGENETICS/ALLERGY: THE GUN IS LOADED |
| 3035 |
GENETICS/GENOMICS IN CHRONIC KIDNEY DISEASE--TOWARDS PERSONALIZED MEDICINE? THE PROGRESSION RATE OF CHRONIC KIDNEY DISEASE (CKD) TO ITS TERMINAL STAGE, END-STAGE RENAL DISEASE (ESRD), AND THE DEVELOPMENT AND SEVERITY OF VARIOUS COMPLICATIONS, ARE AT LEAST INDIRECTLY INFLUENCED BY GENETIC--AND EPIGENETIC--FACTORS |
| 3036 |
GENISTEIN AMELIORATES RENAL FIBROSIS THROUGH REGULATION SNAIL VIA M6A RNA DEMETHYLASE ALKBH5 |
| 3037 |
GENOME AND METHYLOME VARIATION IN HELICOBACTER PYLORI WITH A CAG PATHOGENICITY ISLAND DURING EARLY STAGES OF HUMAN INFECTION |
| 3038 |
GENOME ENGINEERING FOR OSTEOARTHRITIS: FROM DESIGNER CELLS TO DISEASE-MODIFYING DRUGS |
| 3039 |
GENOME ENGINEERING FOR PERSONALIZED ARTHRITIS THERAPEUTICS |
| 3040 |
GENOME HYPERMETHYLATION IN PINUS SILVESTRIS OF CHERNOBYL--A MECHANISM FOR RADIATION ADAPTATION? ADAPTATION IS A COMPLEX PROCESS BY WHICH POPULATIONS OF ORGANISMS RESPOND TO LONG-TERM ENVIRONMENTAL STRESSES BY PERMANENT GENETIC CHANGE |
| 3041 |
GENOME-EPIGENOME INTERACTIONS ASSOCIATED WITH MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME |
| 3042 |
GENOME-WIDE ALTERATION OF HISTONE METHYLATION PROFILES ASSOCIATED WITH COGNITIVE CHANGES IN RESPONSE TO DEVELOPMENTAL ARSENIC EXPOSURE IN MICE |
| 3043 |
GENOME-WIDE ANALYSIS IDENTIFIES NR4A1 AS A KEY MEDIATOR OF T CELL DYSFUNCTION |
| 3044 |
GENOME-WIDE ANALYSIS OF 5-HMC IN THE PERIPHERAL BLOOD OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS USING AN HMEDIP-CHIP |
| 3045 |
GENOME-WIDE ANALYSIS OF ABERRANT METHYLATION OF ENHANCER DNA IN HUMAN OSTEOARTHRITIS |
| 3046 |
GENOME-WIDE ANALYSIS OF DNA METHYLATION IDENTIFIES S100A13 AS AN EPIGENETIC BIOMARKER IN INDIVIDUALS WITH CHRONIC (>/= 30 YEARS) TYPE 2 DIABETES WITHOUT DIABETIC RETINOPATHY |
| 3047 |
GENOME-WIDE ANALYSIS OF DNA METHYLATION IN ENDOMETRIOSIS USING ILLUMINA HUMAN METHYLATION 450 K BEADCHIPS |
| 3048 |
GENOME-WIDE ANALYSIS REVEALED THAT DZNEP REDUCES TUBULOINTERSTITIAL FIBROSIS VIA DOWN-REGULATION OF PRO-FIBROTIC GENES |
| 3049 |
GENOME-WIDE ANALYSIS REVEALS ZINC TRANSPORTER ZIP9 REGULATED BY DNA METHYLATION PROMOTES RADIATION-INDUCED SKIN FIBROSIS VIA THE TGF-BETA SIGNALING PATHWAY |
| 3050 |
GENOME-WIDE ASSOCIATION ANALYSES FOR LUNG FUNCTION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IDENTIFY NEW LOCI AND POTENTIAL DRUGGABLE TARGETS |
| 3051 |
GENOME-WIDE ASSOCIATION ANALYSIS OF EOSINOPHILIC ESOPHAGITIS PROVIDES INSIGHT INTO THE TISSUE SPECIFICITY OF THIS ALLERGIC DISEASE |
| 3052 |
GENOME-WIDE ASSOCIATION ANALYSIS OF PAIN SEVERITY IN DYSMENORRHEA IDENTIFIES ASSOCIATION AT CHROMOSOME 1P13 |
| 3053 |
GENOME-WIDE ASSOCIATION STUDIES IDENTIFY NOVEL GENETIC LOCI FOR EPIGENETIC AGE ACCELERATION AMONG SURVIVORS OF CHILDHOOD CANCER |
| 3054 |
GENOME-WIDE CRISPR SCREENS OF T CELL EXHAUSTION IDENTIFY CHROMATIN REMODELING FACTORS THAT LIMIT T CELL PERSISTENCE |
| 3055 |
GENOME-WIDE DNA HYPERMETHYLATION OPPOSES HEALING IN PATIENTS WITH CHRONIC WOUNDS BY IMPAIRING EPITHELIAL-MESENCHYMAL TRANSITION |
| 3056 |
GENOME-WIDE DNA METHYLATION ANALYSIS IMPLICATES ENRICHMENT OF INTERFERON PATHWAY IN AFRICAN AMERICAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND EUROPEAN AMERICANS WITH LUPUS NEPHRITIS |
| 3057 |
GENOME-WIDE DNA METHYLATION ANALYSIS IN ANKYLOSING SPONDYLITIS IDENTIFIES HLA-B*27 DEPENDENT AND INDEPENDENT DNA METHYLATION CHANGES IN WHOLE BLOOD |
| 3058 |
GENOME-WIDE DNA METHYLATION ANALYSIS IN RENAL ISCHEMIA REPERFUSION INJURY |
| 3059 |
GENOME-WIDE DNA METHYLATION ANALYSIS OF ASTRAGALUS AND DANSHEN ON THE INTERVENTION OF MYOFIBROBLAST ACTIVATION IN IDIOPATHIC PULMONARY FIBROSIS |
| 3060 |
GENOME-WIDE DNA METHYLATION ANALYSIS OF MAMMARY GLAND TISSUES FROM CHINESE HOLSTEIN COWS WITH STAPHYLOCOCCUS AUREUS INDUCED MASTITIS |
| 3061 |
GENOME-WIDE DNA METHYLATION ANALYSIS PREDICTS AN EPIGENETIC SWITCH FOR GATA FACTOR EXPRESSION IN ENDOMETRIOSIS |
| 3062 |
GENOME-WIDE DNA METHYLATION ANALYSIS REVEALS NOVEL EPIGENETIC CHANGES IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3063 |
GENOME-WIDE DNA METHYLATION AND LONG-TERM AMBIENT AIR POLLUTION EXPOSURE IN KOREAN ADULTS |
| 3064 |
GENOME-WIDE DNA METHYLATION ENCODES CARDIAC TRANSCRIPTIONAL REPROGRAMMING IN HUMAN ISCHEMIC HEART FAILURE |
| 3065 |
GENOME-WIDE DNA METHYLATION PATTERNS IN CD4+ T CELLS FROM CHINESE HAN PATIENTS WITH RHEUMATOID ARTHRITIS |
| 3066 |
GENOME-WIDE DNA METHYLATION PATTERNS IN CD4+ T CELLS FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 3067 |
GENOME-WIDE DNA METHYLATION PROFILES IN PRECANCEROUS CONDITIONS AND CANCERS |
| 3068 |
GENOME-WIDE DNA METHYLATION PROFILING IDENTIFIES DIFFERENTIAL METHYLATION IN UNINVOLVED PSORIATIC EPIDERMIS |
| 3069 |
GENOME-WIDE DNA METHYLATION PROFILING IDENTIFIES EPIGENETIC CHANGES IN CD4+ AND CD14+ CELLS OF MULTIPLE SCLEROSIS PATIENTS |
| 3070 |
GENOME-WIDE DNA METHYLATION PROFILING IN CD8 T-CELLS AND GAMMA DELTA T-CELLS OF ASIAN INDIAN PATIENTS WITH TAKAYASU ARTERITIS |
| 3071 |
GENOME-WIDE DNA METHYLATION PROFILING INTEGRATED WITH GENE EXPRESSION PROFILING IDENTIFIES PAX9 AS A NOVEL PROGNOSTIC MARKER IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3072 |
GENOME-WIDE DNA METHYLATION REPROGRAMMING IN RESPONSE TO INORGANIC ARSENIC LINKS INHIBITION OF CTCF BINDING, DNMT EXPRESSION AND CELLULAR TRANSFORMATION |
| 3073 |
GENOME-WIDE DNA METHYLATION STATUS OF MONGOLIANS EXHIBITS SIGNS OF CELLULAR STRESS RESPONSE RELATED TO THEIR NOMADIC LIFESTYLE |
| 3074 |
GENOME-WIDE DNA METHYLOME AND TRANSCRIPTOME CHANGES INDUCED BY INORGANIC NANOPARTICLES IN HUMAN KIDNEY CELLS AFTER CHRONIC EXPOSURE |
| 3075 |
GENOME-WIDE EPIGENETIC STUDY OF CHRONIC RHINOSINUSITIS TISSUES REVEALS DYSREGULATED INFLAMMATORY, IMMUNOLOGIC AND REMODELING PATHWAYS |
| 3076 |
GENOME-WIDE EPIGENOMIC ANALYSES IN PATIENTS WITH NOCICEPTIVE AND NEUROPATHIC CHRONIC PAIN SUBTYPES REVEALS ALTERATIONS IN METHYLATION OF GENES INVOLVED IN THE NEURO-MUSCULOSKELETAL SYSTEM |
| 3077 |
GENOME-WIDE METHYL-SEQ ANALYSIS OF BLOOD-BRAIN TARGETS OF GLUCOCORTICOID EXPOSURE |
| 3078 |
GENOME-WIDE METHYLATION ANALYSIS OF A LARGE POPULATION SAMPLE SHOWS NEUROLOGICAL PATHWAYS INVOLVEMENT IN CHRONIC WIDESPREAD MUSCULOSKELETAL PAIN |
| 3079 |
GENOME-WIDE METHYLATION AND EXPRESSION ANALYSES REVEAL THE EPIGENETIC LANDSCAPE OF IMMUNE-RELATED DISEASES FOR TOBACCO SMOKING |
| 3080 |
GENOME-WIDE METHYLATION IN ALCOHOL USE DISORDER SUBJECTS: IMPLICATIONS FOR AN EPIGENETIC REGULATION OF THE CORTICO-LIMBIC GLUCOCORTICOID RECEPTORS (NR3C1) |
| 3081 |
GENOME-WIDE PROMOTER DNA METHYLATION PROFILING OF HEPATOCELLULAR CARCINOMAS ARISING EITHER SPONTANEOUSLY OR DUE TO CHRONIC EXPOSURE TO GINKGO BILOBA EXTRACT (GBE) IN B6C3F1/N MICE |
| 3082 |
GENOME-WIDE REDISTRIBUTION OF MECP2 IN DORSAL ROOT GANGLIA AFTER PERIPHERAL NERVE INJURY |
| 3083 |
GENOME-WIDE SCREEN OF DNA METHYLATION CHANGES INDUCED BY LOW DOSE X-RAY RADIATION IN MICE |
| 3084 |
GENOME-WIDE SCREEN OF DNA METHYLATION IDENTIFIES NOVEL MARKERS IN CHILDHOOD OBESITY |
| 3085 |
GENOME-WIDE SCREEN OF OVARY-SPECIFIC DNA METHYLATION IN POLYCYSTIC OVARY SYNDROME |
| 3086 |
GENOME-WIDE TRANSCRIPTOMICS OF THE AMYGDALA REVEALS SIMILAR OLIGODENDROCYTE-RELATED RESPONSES TO ACUTE AND CHRONIC ALCOHOL DRINKING IN FEMALE MICE |
| 3087 |
GENOME?WIDE EXPRESSION AND METHYLATION ANALYSES REVEAL ABERRANT CELL ADHESION SIGNALING IN TYROSINE KINASE INHIBITOR?RESISTANT CML CELLS |
| 3088 |
GENOMEWIDE HISTONE H3 LYSINE 9 ACETYLATION PROFILING IN CD4+ T CELLS REVEALED ENDOPLASMIC RETICULUM STRESS DEFICIENCY IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE |
| 3089 |
GENOMIC AND EPIGENOMIC ALTERATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3090 |
GENOMIC AND EPIGENOMIC EVALUATION OF ELECTRICALLY INDUCED EXERCISE IN PEOPLE WITH SPINAL CORD INJURY: APPLICATION TO PRECISION REHABILITATION |
| 3091 |
GENOMIC AND EPIGENOMIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3092 |
GENOMIC AND EPIGENOMIC MECHANISMS OF GLUCOCORTICOIDS IN THE BRAIN |
| 3093 |
GENOMIC AND EPIGENOMIC RESPONSES TO CHRONIC STRESS INVOLVE MIRNA-MEDIATED PROGRAMMING |
| 3094 |
GENOMIC AND PERSONALIZED MEDICINE APPROACHES FOR SUBSTANCE USE DISORDERS (SUDS) LOOKING AT GENOME-WIDE ASSOCIATION STUDIES |
| 3095 |
GENOMIC APPROACHES IN THE SEARCH FOR MOLECULAR BIOMARKERS IN CHRONIC KIDNEY DISEASE |
| 3096 |
GENOMIC CHARACTERIZATION REVEALS NOVEL MECHANISMS UNDERLYING THE VALOSIN-CONTAINING PROTEIN-MEDIATED CARDIAC PROTECTION AGAINST HEART FAILURE |
| 3097 |
GENOMIC DEREGULATION OF PRMT5 SUPPORTS GROWTH AND STRESS TOLERANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3098 |
GENOMIC DISRUPTION OF THE HISTONE METHYLTRANSFERASE SETD2 IN CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 3099 |
GENOMIC DNA METHYLATION SIGNATURES IN DIFFERENT TISSUES AFTER AMBIENT AIR PARTICULATE MATTER EXPOSURE |
| 3100 |
GENOMIC IMPACT OF CIGARETTE SMOKE, WITH APPLICATION TO THREE SMOKING-RELATED DISEASES |
| 3101 |
GENOMIC IMPRINTING: SENSING THE ENVIRONMENT AND DRIVING THE FETAL GROWTH |
| 3102 |
GENOMIC INSTABILITIES, CELLULAR SENESCENCE, AND AGING: IN VITRO, IN VIVO AND AGING-LIKE HUMAN SYNDROMES |
| 3103 |
GENOMIC LANDSCAPE OF HCC |
| 3104 |
GENOMIC, EPIGENOMIC, TRANSCRIPTOMIC, PROTEOMIC AND METABOLOMIC APPROACHES IN ATOPIC DERMATITIS |
| 3105 |
GENOMICS AND PROTEOMICS IN LIVER FIBROSIS AND CIRRHOSIS |
| 3106 |
GENOMICS AND THE RESPIRATORY EFFECTS OF AIR POLLUTION EXPOSURE |
| 3107 |
GENOMICS OF CHRONIC NEUTROPHILIC LEUKEMIA |
| 3108 |
GENOMICS OF PAIN IN OSTEOARTHRITIS |
| 3109 |
GENOTOXIC AND EPIGENETIC EFFECTS OF DIURON IN THE PACIFIC OYSTER: IN VITRO EVIDENCE OF INTERACTION BETWEEN DNA DAMAGE AND DNA METHYLATION |
| 3110 |
GENOTYPE- OR PHENOTYPE-TARGETING ANTICANCER THERAPIES? LESSONS FROM TUMOR EVOLUTIONARY BIOLOGY |
| 3111 |
GENOTYPE-PHENOTYPE INTERACTIONS IN THE MYELOPROLIFERATIVE NEOPLASMS |
| 3112 |
GEOEPIDEMIOLOGY AND (EPI-)GENETICS IN PRIMARY BILIARY CHOLANGITIS |
| 3113 |
GERMINAL EPIMUTATION OF FRAGILE HISTIDINE TRIAD (FHIT) GENE IS ASSOCIATED WITH PROGRESSION TO ACUTE AND CHRONIC ADULT T-CELL LEUKEMIA DISEASES |
| 3114 |
GERMLINE ALLELE-SPECIFIC EXPRESSION OF DAPK1 IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3115 |
GEROMETABOLITES: THE PSEUDOHYPOXIC AGING SIDE OF CANCER ONCOMETABOLITES |
| 3116 |
GEROSCIENCE: ADDRESSING THE MISMATCH BETWEEN ITS EXCITING RESEARCH OPPORTUNITIES, ITS ECONOMIC IMPERATIVE AND ITS CURRENT FUNDING CRISIS |
| 3117 |
GESTATIONAL DIABETES MELLITUS EPIGENETICALLY AFFECTS GENES PREDOMINANTLY INVOLVED IN METABOLIC DISEASES |
| 3118 |
GESTATIONAL DIABETES MELLITUS: GENETIC FACTORS, EPIGENETIC ALTERATIONS, AND MICROBIAL COMPOSITION |
| 3119 |
GESTATIONAL EXPOSURE TO PARTICULATE AIR POLLUTION EXACERBATES THE GROWTH PHENOTYPES INDUCED BY PRECONCEPTION PATERNAL ALCOHOL USE: A MULTIPLEX MODEL OF EXPOSURE |
| 3120 |
GESTATIONAL HYPOXIA AND BLOOD-BRAIN BARRIER PERMEABILITY: EARLY ORIGINS OF CEREBROVASCULAR DYSFUNCTION INDUCED BY EPIGENETIC MECHANISMS |
| 3121 |
GESTATIONAL INTERMITTENT HYPOXIA INDUCES ENDOTHELIAL DYSFUNCTION, REDUCES PERIVASCULAR ADIPONECTIN AND CAUSES EPIGENETIC CHANGES IN ADULT MALE OFFSPRING |
| 3122 |
GESTATIONAL VALPROIC ACID EXPOSURE INDUCES EPIGENETIC MODIFICATIONS IN MURINE DECIDUA |
| 3123 |
GETTING AN INSIGHT INTO THE COMPLEXITY OF MAJOR CHRONIC INFLAMMATORY AND DEGENERATIVE DISEASES: A POTENTIAL NEW SYSTEMIC APPROACH TO THEIR TREATMENT |
| 3124 |
GHRELIN TREATMENT IMPROVES PHYSICAL DECLINE IN SARCOPENIA MODEL MICE THROUGH MUSCULAR ENHANCEMENT AND MITOCHONDRIAL ACTIVATION |
| 3125 |
GHSR DNA HYPERMETHYLATION IS A COMMON EPIGENETIC ALTERATION OF HIGH DIAGNOSTIC VALUE IN A BROAD SPECTRUM OF CANCERS |
| 3126 |
GINSENOSIDE REDUCES COGNITIVE IMPAIRMENT DURING CHRONIC CEREBRAL HYPOPERFUSION THROUGH BRAIN-DERIVED NEUROTROPHIC FACTOR REGULATED BY EPIGENETIC MODULATION |
| 3127 |
GINSENOSIDE RG1 REDUCED MICROGLIAL ACTIVATION AND MITOCHONDRIAL DYSFUNCTION TO ALLEVIATE DEPRESSION-LIKE BEHAVIOUR VIA THE GAS5/EZH2/SOCS3/NRF2 AXIS |
| 3128 |
GIPC-REGULATED IGFBP-3 PROMOTES HSC MIGRATION IN VITRO AND PORTAL HYPERTENSION IN VIVO THROUGH A BETA1-INTEGRIN PATHWAY |
| 3129 |
GIVINOSTAT: AN EMERGING TREATMENT FOR POLYCYTHEMIA VERA |
| 3130 |
GLAST BUT NOT LEAST--DISTRIBUTION, FUNCTION, GENETICS AND EPIGENETICS OF L-GLUTAMATE TRANSPORT IN BRAIN--FOCUS ON GLAST/EAAT1 |
| 3131 |
GLOBAL AND SPECIFIC HISTONE ACETYLATION PATTERN IN PATIENTS WITH BALKAN ENDEMIC NEPHROPATHY, A WORLDWIDE DISEASE |
| 3132 |
GLOBAL DISTRIBUTION OF DNA HYDROXYMETHYLATION AND DNA METHYLATION IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3133 |
GLOBAL DNA HYPOMETHYLATION AND ITS CORRELATION TO THE BETAINE LEVEL IN PERIPHERAL BLOOD OF PATIENTS WITH SCHIZOPHRENIA |
| 3134 |
GLOBAL DNA HYPOMETHYLATION IS AN EARLY EVENT IN HELICOBACTER PYLORI-RELATED GASTRIC CARCINOGENESIS |
| 3135 |
GLOBAL DNA METHYLATION AND HYDROXYMETHYLATION LEVELS IN PBMCS ARE ALTERED IN RRMS PATIENTS TREATED WITH IFN-BETA AND GA-A PRELIMINARY STUDY |
| 3136 |
GLOBAL DNA METHYLATION LEVELS IN WHITE BLOOD CELLS OF PATIENTS WITH CHRONIC HEROIN USE DISORDER |
| 3137 |
GLOBAL DNA METHYLATION PROFILING OF MANGANESE-EXPOSED HUMAN NEUROBLASTOMA SH-SY5Y CELLS REVEALS EPIGENETIC ALTERATIONS IN PARKINSON'S DISEASE-ASSOCIATED GENES |
| 3138 |
GLOBAL DNA METHYLATION PROFILING REVEALS NEW INSIGHTS INTO EPIGENETICALLY DEREGULATED PROTEIN CODING AND LONG NONCODING RNAS IN CLL |
| 3139 |
GLOBAL ENDOMETRIAL DNA METHYLATION ANALYSIS REVEALS INSIGHTS INTO MQTL REGULATION AND ASSOCIATED ENDOMETRIOSIS DISEASE RISK AND ENDOMETRIAL FUNCTION |
| 3140 |
GLOBAL EPIGENETIC SCREENING TECHNOLOGIES: A NOVEL TOOL TO ADDRESS CANCER HEALTH DISPARITIES IN HIGH-RISK POPULATION GROUPS |
| 3141 |
GLOBAL GENE EXPRESSION AND CHROMATIN ACCESSIBILITY OF THE PERIPHERAL NERVOUS SYSTEM IN ANIMAL MODELS OF PERSISTENT PAIN |
| 3142 |
GLOBAL METHYLATION PROFILES IN BUCCAL CELLS OF LONG-TERM SMOKERS AND MOIST SNUFF CONSUMERS |
| 3143 |
GLOBAL MIRNA/PROTEOMIC ANALYSES IDENTIFY MIRNAS AT 14Q32 AND 3P21, WHICH CONTRIBUTE TO FEATURES OF CHRONIC IRON-EXPOSED FALLOPIAN TUBE EPITHELIAL CELLS |
| 3144 |
GLOBAL ORAL HEALTH INEQUALITIES: TASK GROUP--PERIODONTAL DISEASE |
| 3145 |
GLOBAL POPULATION VARIATION IN PLACENTAL SIZE AND STRUCTURE: EVIDENCE FROM CEBU, PHILIPPINES |
| 3146 |
GLOBAL RESEARCH TRENDS ON EPIGENETICS AND NEUROPATHIC PAIN: A BIBLIOMETRIC ANALYSIS |
| 3147 |
GLP OVEREXPRESSION IS ASSOCIATED WITH POOR PROGNOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND ITS INHIBITION INDUCES LEUKEMIC CELL DEATH |
| 3148 |
GLUCOCORTICOID INDUCED LOSS OF OESTROGEN RECEPTOR ALPHA GENE METHYLATION AND RESTORATION OF SENSITIVITY TO FULVESTRANT IN TRIPLE NEGATIVE BREAST CANCER |
| 3149 |
GLUCOCORTICOID-INDUCED FINGERPRINTS ON VISCERAL ADIPOSE TISSUE TRANSCRIPTOME AND EPIGENOME |
| 3150 |
GLUCOCORTICOIDS AND AGGRESSION: A TRIPARTITE INTERACTION |
| 3151 |
GLUCOCORTICOIDS, EPIGENETIC CONTROL AND STRESS RESILIENCE |
| 3152 |
GLUCOSE VARIABILITY: HOW DOES IT WORK? A GROWING BODY OF EVIDENCE POINTS TO THE ROLE OF GLUCOSE VARIABILITY (GV) IN THE DEVELOPMENT OF THE MICROVASCULAR AND MACROVASCULAR COMPLICATIONS OF DIABETES |
| 3153 |
GLUCOSE-INDUCED EXPRESSION OF THE HOMEOTIC TRANSCRIPTION FACTOR PREP1 IS ASSOCIATED WITH HISTONE POST-TRANSLATIONAL MODIFICATIONS IN SKELETAL MUSCLE |
| 3154 |
GLUN2B/CAMKII MEDIATES CFA-INDUCED HYPERALGESIA VIA HDAC4-MODIFIED SPINAL COX2 TRANSCRIPTION |
| 3155 |
GLUTAMINE METABOLISM IN ADIPOCYTES: A BONA FIDE EPIGENETIC MODULATOR OF INFLAMMATION |
| 3156 |
GLYCEMIC MEMORIES AND THE EPIGENETIC COMPONENT OF DIABETIC NEPHROPATHY |
| 3157 |
GLYCEMIC MEMORY |
| 3158 |
GLYCOGEN SYNTHASE KINASE 3BETA MISSPLICING CONTRIBUTES TO LEUKEMIA STEM CELL GENERATION |
| 3159 |
GLYPHOSATE PRIMES MAMMARY CELLS FOR TUMORIGENESIS BY REPROGRAMMING THE EPIGENOME IN A TET3-DEPENDENT MANNER |
| 3160 |
GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS: PATHOPHYSIOLOGY-BASED REVIEW ON CURRENT APPROACHES AND FUTURE DIRECTIONS |
| 3161 |
GRAINYHEAD-LIKE 2 (GRHL2) INHIBITS KERATINOCYTE DIFFERENTIATION THROUGH EPIGENETIC MECHANISM |
| 3162 |
GREATER STRESS AND TRAUMA MEDIATE RACE-RELATED DIFFERENCES IN EPIGENETIC AGE BETWEEN BLACK AND WHITE YOUNG ADULTS IN A COMMUNITY SAMPLE |
| 3163 |
GREEN TEA CATECHIN EXTRACT IN INTERVENTION OF CHRONIC BREAST CELL CARCINOGENESIS INDUCED BY ENVIRONMENTAL CARCINOGENS |
| 3164 |
GREEN TEA PREVENTS NAFLD BY MODULATION OF MIR-34A AND MIR-194 EXPRESSION IN A HIGH-FAT DIET MOUSE MODEL |
| 3165 |
GRIK1-AS1 DEFICIENCY ACCELERATES ENDOMETRIOSIS PROGRESSION BY BOOSTING DNMT1-DEPENDENT SFRP1 PROMOTER METHYLATION IN ENDOMETRIAL STROMAL CELLS |
| 3166 |
GROCERY DELIVERY TO SUPPORT HEALTHY WEIGHT GAIN AMONG PREGNANT YOUNG WOMEN WITH LOW INCOME: PROTOCOL FOR A RANDOMIZED CONTROLLED TRIAL |
| 3167 |
GROUP 1 METABOTROPIC GLUTAMATE RECEPTOR EXPRESSION DEFINES A T CELL MEMORY POPULATION DURING CHRONIC TOXOPLASMA INFECTION THAT ENHANCES IFN-GAMMA AND PERFORIN PRODUCTION IN THE CNS |
| 3168 |
GTPASE REGULATOR ASSOCIATED WITH THE FOCAL ADHESION KINASE (GRAF) TRANSCRIPT WAS DOWN-REGULATED IN PATIENTS WITH MYELOID MALIGNANCIES |
| 3169 |
GUIDE FOR CURRENT NUTRIGENETIC, NUTRIGENOMIC, AND NUTRIEPIGENETIC APPROACHES FOR PRECISION NUTRITION INVOLVING THE PREVENTION AND MANAGEMENT OF CHRONIC DISEASES ASSOCIATED WITH OBESITY |
| 3170 |
GUT INFLAMMATION AND TUMORIGENESIS: EVERY SITE HAS A DIFFERENT TALE TO TELL |
| 3171 |
GUT MICROBIAL GABAERGIC SIGNALING IMPROVES STRESS-ASSOCIATED INNATE IMMUNITY TO RESPIRATORY VIRAL INFECTION |
| 3172 |
GUT MICROBIOTA AND RISK OF DEVELOPING CELIAC DISEASE |
| 3173 |
GUT MICROBIOTA-MICRORNA INTERACTIONS IN ANKYLOSING SPONDYLITIS |
| 3174 |
H19 LNCRNA IDENTIFIED AS A MASTER REGULATOR OF GENES THAT DRIVE UTERINE LEIOMYOMAS |
| 3175 |
H2AX PHOSPHORYLATION REGULATED BY P38 IS INVOLVED IN BIM EXPRESSION AND APOPTOSIS IN CHRONIC MYELOGENOUS LEUKEMIA CELLS INDUCED BY IMATINIB |
| 3176 |
H3 |
| 3177 |
H3K9ME2 REGULATION OF BDNF EXPRESSION IN THE HIPPOCAMPUS AND MEDIAL PREFRONTAL CORTEX IS INVOLVED IN THE DEPRESSIVE-LIKE PHENOTYPE INDUCED BY MATERNAL SEPARATION IN MALE RATS |
| 3178 |
HAEMATOLOGIC MALIGNANCIES WITH UNFAVOURABLE GENE MUTATIONS BENEFIT FROM DONOR LYMPHOCYTE INFUSION WITH/WITHOUT DECITABINE FOR PROPHYLAXIS OF RELAPSE AFTER ALLOGENEIC HSCT: A PILOT STUDY |
| 3179 |
HAIR CORTISOL AS A HYPOTHALAMIC-PITUITARY-ADRENAL AXIS BIOMARKER IN PREGNANT WOMEN WITH ASTHMA: A RETROSPECTIVE OBSERVATIONAL STUDY |
| 3180 |
HALLMARKS OF AGING IN MACROPHAGES: CONSEQUENCES TO SKIN INFLAMMAGING |
| 3181 |
HALLMARKS OF AGING: AN EXPANDING UNIVERSE |
| 3182 |
HALLMARKS OF CD8(+) T CELL DYSFUNCTION ARE ESTABLISHED WITHIN HOURS OF TUMOR ANTIGEN ENCOUNTER BEFORE CELL DIVISION |
| 3183 |
HALLMARKS OF T CELL AGING |
| 3184 |
HARNESSING METABOLISM OF HEPATIC MACROPHAGES TO AID LIVER REGENERATION |
| 3185 |
HBC BINDS TO THE CPG ISLANDS OF HBV CCCDNA AND PROMOTES AN EPIGENETIC PERMISSIVE STATE |
| 3186 |
HBV COVALENTLY CLOSED CIRCULAR DNA MINICHROMOSOMES IN DISTINCT EPIGENETIC TRANSCRIPTIONAL STATES DIFFER IN THEIR VULNERABILITY TO DAMAGE |
| 3187 |
HBV INDUCED HEPATOCELLULAR CARCINOMA AND RELATED POTENTIAL IMMUNOTHERAPY |
| 3188 |
HBV-SPECIFIC CD8+ T-CELL TOLERANCE IN THE LIVER |
| 3189 |
HBX RELIEVES CHROMATIN-MEDIATED TRANSCRIPTIONAL REPRESSION OF HEPATITIS B VIRAL CCCDNA INVOLVING SETDB1 HISTONE METHYLTRANSFERASE |
| 3190 |
HCV-INDUCED EPIGENETIC CHANGES ASSOCIATED WITH LIVER CANCER RISK PERSIST AFTER SUSTAINED VIROLOGIC RESPONSE |
| 3191 |
HDAC AND HAT INHIBITORS DIFFERENTLY AFFECT ANALGESIA MEDIATED BY GROUP II METABOTROPIC GLUTAMATE RECEPTORS |
| 3192 |
HDAC INHIBITION COUNTERACTS METASTATIC RE-ACTIVATION OF PROSTATE CANCER CELLS INDUCED BY CHRONIC MTOR SUPPRESSION |
| 3193 |
HDAC INHIBITION REGULATES OXIDATIVE STRESS IN CD4(+)THELPER CELLS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND NON-SMALL CELL LUNG CANCER PATIENTS VIA MITOCHONDRIAL TRANSCRIPTION FACTOR A (MTTFA) MODULATING NF-KAPPAB/HIF1ALPHA AXIS |
| 3194 |
HDAC INHIBITORS ATTENUATE THE DEVELOPMENT OF HYPERSENSITIVITY IN MODELS OF NEUROPATHIC PAIN |
| 3195 |
HDAC INHIBITORS AUGMENTED CELL MIGRATION AND METASTASIS THROUGH INDUCTION OF PKCS LEADING TO IDENTIFICATION OF LOW TOXICITY MODALITIES FOR COMBINATION CANCER THERAPY |
| 3196 |
HDAC INHIBITORS RESTORE C-FIBRE SENSITIVITY IN EXPERIMENTAL NEUROPATHIC PAIN MODEL |
| 3197 |
HDAC INHIBITORS: TARGETS FOR TUMOR THERAPY, IMMUNE MODULATION AND LUNG DISEASES |
| 3198 |
HDAC-LINKED "PROLIFERATIVE" MIRNA EXPRESSION PATTERN IN PANCREATIC NEUROENDOCRINE TUMORS |
| 3199 |
HDAC1 INTERACTS WITH THE P50 NF-?B SUBUNIT VIA ITS NUCLEAR LOCALIZATION SEQUENCE TO CONSTRAIN INFLAMMATORY GENE EXPRESSION |
| 3200 |
HDAC1 REGULATES DIFFERENTIATION OF BIPOTENT LIVER PROGENITOR CELLS DURING REGENERATION VIA SOX9B AND CDK8 |
| 3201 |
HDAC2 IN PRIMARY SENSORY NEURONS CONSTITUTIVELY RESTRAINS CHRONIC PAIN BY REPRESSING ALPHA2DELTA-1 EXPRESSION AND ASSOCIATED NMDA RECEPTOR ACTIVITY |
| 3202 |
HDAC2 REGULATES ATYPICAL ANTIPSYCHOTIC RESPONSES THROUGH THE MODULATION OF MGLU2 PROMOTER ACTIVITY |
| 3203 |
HDAC3 ACTIVITY WITHIN THE NUCLEUS ACCUMBENS REGULATES COCAINE-INDUCED PLASTICITY AND BEHAVIOR IN A CELL-TYPE-SPECIFIC MANNER |
| 3204 |
HDAC3 REGULATES GINGIVAL FIBROBLAST INFLAMMATORY RESPONSES IN PERIODONTITIS |
| 3205 |
HDAC8, A POTENTIAL THERAPEUTIC TARGET, REGULATES PROLIFERATION AND DIFFERENTIATION OF BONE MARROW STROMAL CELLS IN FIBROUS DYSPLASIA |
| 3206 |
HDAC9 IS AN EPIGENETIC REPRESSOR OF KIDNEY ANGIOTENSINOGEN ESTABLISHING A SEX DIFFERENCE |
| 3207 |
HDACI: CELLULAR EFFECTS, OPPORTUNITIES FOR RESTORATIVE DENTISTRY |
| 3208 |
HEAD CIRCUMFERENCE AS AN EPIGENETIC RISK FACTOR FOR MATERNAL NUTRITION |
| 3209 |
HEALTH DISPARITIES IN SYSTEMIC LUPUS ERYTHEMATOSUS |
| 3210 |
HEALTH EFFECTS ASSOCIATED WITH PRE- AND PERINATAL EXPOSURE TO ARSENIC |
| 3211 |
HEALTH EFFECTS OF EXPOSURE TO DIESEL EXHAUST PARTICLES |
| 3212 |
HEALTH PROMOTING EFFECTS OF BRASSICA-DERIVED PHYTOCHEMICALS: FROM CHEMOPREVENTIVE AND ANTI-INFLAMMATORY ACTIVITIES TO EPIGENETIC REGULATION |
| 3213 |
HEART RHYTHM GENOMIC FABRIC IN HYPOXIA |
| 3214 |
HEAT STRESS-INDUCED LIFE SPAN EXTENSION IN YEAST |
| 3215 |
HEAVY CHRONIC INTERMITTENT ETHANOL EXPOSURE ALTERS SMALL NONCODING RNAS IN MOUSE SPERM AND EPIDIDYMOSOMES |
| 3216 |
HEDGEHOG SIGNALING PATHWAY AND GASTROINTESTINAL STEM CELL SIGNALING NETWORK (REVIEW) |
| 3217 |
HEDGEHOG/GLI AND PI3K SIGNALING IN THE INITIATION AND MAINTENANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3218 |
HELICOBACTER INFECTION IS REQUIRED FOR INFLAMMATION AND COLON CANCER IN SMAD3-DEFICIENT MICE |
| 3219 |
HELICOBACTER PYLORI AND GASTRIC CANCER |
| 3220 |
HELICOBACTER PYLORI AND MICRORNAS: RELATION WITH INNATE IMMUNITY AND PROGRESSION OF PRENEOPLASTIC CONDITIONS |
| 3221 |
HELICOBACTER PYLORI AND THE MOLECULAR PATHOGENESIS OF INTESTINAL-TYPE GASTRIC CARCINOMA |
| 3222 |
HELICOBACTER PYLORI ASSOCIATED CHRONIC GASTRITIS, CLINICAL SYNDROMES, PRECANCEROUS LESIONS, AND PATHOGENESIS OF GASTRIC CANCER DEVELOPMENT |
| 3223 |
HELICOBACTER PYLORI INFECTION AND AUTOIMMUNE DISEASES; IS THERE AN ASSOCIATION WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS, AUTOIMMUNE ATROPHY GASTRITIS AND AUTOIMMUNE PANCREATITIS? A SYSTEMATIC REVIEW AND META-ANALYSIS STUDY |
| 3224 |
HELICOBACTER PYLORI INFECTION AND STEM CELLS AT THE ORIGIN OF GASTRIC CANCER |
| 3225 |
HELICOBACTER PYLORI INFECTION INTRODUCES DNA DOUBLE-STRAND BREAKS IN HOST CELLS |
| 3226 |
HELICOBACTER PYLORI INFECTION, ONCOGENIC PATHWAYS AND EPIGENETIC MECHANISMS IN GASTRIC CARCINOGENESIS |
| 3227 |
HELICOBACTER PYLORI INFECTION-INDUCED H3SER10 PHOSPHORYLATION IN STEPWISE GASTRIC CARCINOGENESIS AND ITS CLINICAL IMPLICATIONS |
| 3228 |
HELICOBACTER PYLORI-INDUCED CHRONIC GASTRITIS AND ASSESSING RISKS FOR GASTRIC CANCER |
| 3229 |
HELICOBACTER PYLORI-INDUCED GASTRIC INFLAMMATION AND GASTRIC CANCER |
| 3230 |
HELICOBACTER PYLORI-INDUCED INFLAMMATION AND EPIGENETIC CHANGES DURING GASTRIC CARCINOGENESIS |
| 3231 |
HELICOBACTER PYLORI-INDUCED MODULATION OF THE PROMOTER METHYLATION OF WNT ANTAGONIST GENES IN GASTRIC CARCINOGENESIS |
| 3232 |
HELICOBACTER PYLORI-INDUCED SIGNALING PATHWAYS CONTRIBUTE TO INTESTINAL METAPLASIA AND GASTRIC CARCINOGENESIS |
| 3233 |
HELICOBACTER, INFLAMMATION, AND GASTRIC CANCER |
| 3234 |
HEMATOPOIETIC AND CHRONIC MYELOID LEUKEMIA STEM CELLS: MULTI-STABILITY VERSUS LINEAGE RESTRICTION |
| 3235 |
HEMIN AVAILABILITY INDUCES COORDINATED DNA METHYLATION AND GENE EXPRESSION CHANGES IN PORPHYROMONAS GINGIVALIS |
| 3236 |
HEN EGG LYSOZYME ALLEVIATES STATIC MECHANICAL PAIN VIA NRF1-PARKIN-TACAN SIGNALING AXIS IN SENSORY NEURONS |
| 3237 |
HEPATIC COX-2 EXPRESSION PROTECTS MICE FROM AN ALCOHOL-HIGH FAT DIET-INDUCED METABOLIC DISORDER BY INVOLVING PROTEIN ACETYLATION RELATED ENERGY METABOLISM |
| 3238 |
HEPATIC EPIGENETIC REPROGRAMMING AFTER LIVER RESECTION IN OFFSPRING ALLEVIATES THE EFFECTS OF MATERNAL OBESITY |
| 3239 |
HEPATIC INACTIVATION OF THE TYPE 2 DEIODINASE CONFERS RESISTANCE TO ALCOHOLIC LIVER STEATOSIS |
| 3240 |
HEPATIC LIPID ACCUMULATION ALTERS GLOBAL HISTONE H3 LYSINE 9 AND 4 TRIMETHYLATION IN THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA NETWORK |
| 3241 |
HEPATIC MICRORNA MODULATION MIGHT BE AN EARLY EVENT TO NON-ALCOHOLIC FATTY LIVER DISEASE DEVELOPMENT DRIVEN BY HIGH-FAT DIET IN MALE MICE |
| 3242 |
HEPATIC NCOR1 DELETION EXACERBATES ALCOHOL-INDUCED LIVER INJURY IN MICE BY PROMOTING CCL2-MEDIATED MONOCYTE-DERIVED MACROPHAGE INFILTRATION |
| 3243 |
HEPATIC STEATOSIS IN HEPATITIS C IS A STORAGE DISEASE DUE TO HCV INTERACTION WITH MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) |
| 3244 |
HEPATIC STELLATE CELLS AND EXTRACELLULAR MATRIX IN HEPATOCELLULAR CARCINOMA: MORE COMPLICATED THAN EVER |
| 3245 |
HEPATIC STELLATE CELLS AS KEY TARGET IN LIVER FIBROSIS |
| 3246 |
HEPATITIS B VIRUS (HBV) INDUCES THE EXPRESSION OF INTERLEUKIN-8 THAT IN TURN REDUCES HBV SENSITIVITY TO INTERFERON-ALPHA |
| 3247 |
HEPATITIS B VIRUS BASAL CORE PROMOTER MUTATIONS SHOW LOWER REPLICATION FITNESS ASSOCIATED WITH CCCDNA ACETYLATION STATUS |
| 3248 |
HEPATITIS B VIRUS GENOME ASYMMETRY IN HEPATOCELLULAR CARCINOMA |
| 3249 |
HEPATITIS B VIRUS HIJACKS CTHRC1 TO EVADE HOST IMMUNITY AND MAINTAIN REPLICATION |
| 3250 |
HEPATITIS B VIRUS INFECTION, MICRORNAS AND LIVER DISEASE |
| 3251 |
HEPATITIS B VIRUS INFECTION: AN INSIGHT INTO THE CLINICAL CONNECTION AND MOLECULAR INTERACTION BETWEEN HEPATITIS B VIRUS AND HOST EXTRAHEPATIC CANCER RISK |
| 3252 |
HEPATITIS B VIRUS SUPPRESSES COMPLEMENT C9 SYNTHESIS BY LIMITING THE AVAILABILITY OF TRANSCRIPTION FACTOR USF-1 AND INHIBITS FORMATION OF MEMBRANE ATTACK COMPLEX: IMPLICATIONS IN DISEASE PATHOGENESIS |
| 3253 |
HEPATITIS B VIRUS X PROTEIN ACCELERATES THE DEVELOPMENT OF HEPATOMA |
| 3254 |
HEPATITIS B VIRUS X PROTEIN AND HEPATOCARCINOGENESIS |
| 3255 |
HEPATITIS B VIRUS X PROTEIN MEDIATED EPIGENETIC ALTERATIONS IN THE PATHOGENESIS OF HEPATOCELLULAR CARCINOMA |
| 3256 |
HEPATITIS B VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA AND HEPATIC CANCER STEM CELLS |
| 3257 |
HEPATITIS B X ANTIGEN (HBX) IS AN IMPORTANT THERAPEUTIC TARGET IN THE PATHOGENESIS OF HEPATOCELLULAR CARCINOMA |
| 3258 |
HEPATITIS C AND INTERFERON INDUCED THYROIDITIS |
| 3259 |
HEPATITIS C VIRUS AND HEPATOCELLULAR CARCINOMA: WHEN THE HOST LOSES ITS GRIP |
| 3260 |
HEPATITIS C VIRUS LEAVES AN EPIGENETIC SIGNATURE POST CURE OF INFECTION BY DIRECT-ACTING ANTIVIRALS |
| 3261 |
HEPATITIS C VIRUS-INDUCED UP-REGULATION OF PROTEIN PHOSPHATASE 2A INHIBITS HISTONE MODIFICATION AND DNA DAMAGE REPAIR |
| 3262 |
HEPATITIS D AND HEPATOCELLULAR CARCINOMA |
| 3263 |
HEPATITIS VIRUS AND HEPATOCELLULAR CARCINOMA: RECENT ADVANCES |
| 3264 |
HEPATITIS VIRUS INFECTION AFFECTS DNA METHYLATION IN MICE WITH HUMANIZED LIVERS |
| 3265 |
HEPATOCARCINOMA: GENETIC AND EPIGENETIC FEATURES |
| 3266 |
HEPATOCELLULAR CANCER AND GUT MICROBIOME: TIME TO UNTIE GORDIAN'S KNOT |
| 3267 |
HEPATOCELLULAR CARCINOMA AND POSSIBLE CHEMICAL AND BIOLOGICAL CAUSES: A REVIEW |
| 3268 |
HEPATOCELLULAR CARCINOMA IMMUNOTHERAPY AND THE POTENTIAL INFLUENCE OF GUT MICROBIOME |
| 3269 |
HEPATOCELLULAR CARCINOMA IN ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE-ONE OF A KIND OR TWO DIFFERENT ENEMIES? HEPATOCELLULAR CANCER (HCC) IS A CANCER WITH AN OVERALL POOR PROGNOSIS AND AN ALARMING GLOBALLY RISING INCIDENCE |
| 3270 |
HEPATOCELLULAR CARCINOMA IN THE CONTEXT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH): RECENT ADVANCES IN THE PATHOGENIC MECHANISMS |
| 3271 |
HEPATOCELLULAR CARCINOMA RISK AFTER VIRAL RESPONSE IN HEPATITIS C VIRUS-ADVANCED FIBROSIS: WHO TO SCREEN AND FOR HOW LONG? HEPATITIS C VIRUS (HCV) CHRONIC INFECTION IS ASSOCIATED WITH FIBROSIS PROGRESSION, END-STAGE LIVER COMPLICATIONS AND HCC |
| 3272 |
HEPATOCELLULAR CARCINOMA: AN UPDATE |
| 3273 |
HEPATOCELLULAR CARCINOMA: MOLECULAR PATHWAYS AND NEW THERAPEUTIC TARGETS |
| 3274 |
HEPATOCELLULAR CARCINOMA: THE VIRUS OR THE LIVER? HEPATOCELLULAR CARCINOMA (HCC) REPRESENTS A MAJOR PUBLIC HEALTH PROBLEM BEING ONE OF THE MOST COMMON CAUSES OF CANCER-RELATED DEATHS WORLDWIDE |
| 3275 |
HEPATOCELLULAR CARCINOMA: THERAPEUTIC ADVANCES IN SIGNALING, EPIGENETIC AND IMMUNE TARGETS |
| 3276 |
HEPATOCYTE GROWTH CONTROL BY SOCS1 AND SOCS3 |
| 3277 |
HEPATOCYTE PLOIDY AND PATHOLOGICAL MUTATIONS IN HEPATOCELLULAR CARCINOMA: IMPACT ON ONCOGENESIS AND THERAPEUTICS |
| 3278 |
HEPATOEPIGENETIC ALTERATIONS IN VIRAL AND NONVIRAL-INDUCED HEPATOCELLULAR CARCINOMA |
| 3279 |
HERITABLE ALTERATION IN DNA METHYLATION INDUCED BY NITROGEN-DEFICIENCY STRESS ACCOMPANIES ENHANCED TOLERANCE BY PROGENIES TO THE STRESS IN RICE (ORYZA SATIVA L |
| 3280 |
HERPES ZOSTER OPHTHALMICUS FOLLOWING ONABOTULINUMTOXINA ADMINISTRATION FOR CHRONIC MIGRAINE: A CASE REPORT AND LITERATURE REVIEW |
| 3281 |
HETEROGENEOUS TFH CELL POPULATIONS THAT DEVELOP DURING ENTERIC HELMINTH INFECTION PREDICT THE QUALITY OF TYPE 2 PROTECTIVE RESPONSE |
| 3282 |
HETEROGENIC ENDOTHELIAL RESPONSES TO INFLAMMATION: ROLE FOR DIFFERENTIAL N-GLYCOSYLATION AND VASCULAR BED OF ORIGIN |
| 3283 |
HIDDEN ROLE OF GUT MICROBIOME DYSBIOSIS IN SCHIZOPHRENIA: ANTIPSYCHOTICS OR PSYCHOBIOTICS AS THERAPEUTICS? SCHIZOPHRENIA IS A CHRONIC, HETEROGENEOUS NEURODEVELOPMENTAL DISORDER THAT HAS COMPLEX SYMPTOMS AND UNCERTAIN ETIOLOGY |
| 3284 |
HIDRADENITIS SUPPURATIVA PRESENTS A METHYLOME DYSREGULATION CAPABLE TO EXPLAIN THE PRO-INFLAMMATORY MICROENVIRONMENT: ARE THESE DNA METHYLATIONS POTENTIAL THERAPEUTIC TARGETS? BACKGROUND: HIDRADENITIS SUPPURATIVA (HS) IS A CHRONIC, SYSTEMIC, INFLAMMATORY SKIN CONDITION WITH ELUSIVE PATHOGENESIS THAT AFFECTS THERAPEUTIC INTERVENTION DIRECTLY |
| 3285 |
HIDRADENITIS SUPPURATIVA: A PERSPECTIVE ON GENETIC FACTORS INVOLVED IN THE DISEASE |
| 3286 |
HIDRADENITIS SUPPURATIVA: DETANGLING PHENOTYPES AND IDENTIFYING COMMON DENOMINATORS |
| 3287 |
HIERARCHICAL AND CYBERNETIC NATURE OF BIOLOGIC SYSTEMS AND THEIR RELEVANCE TO HOMEOSTATIC ADAPTATION TO LOW-LEVEL EXPOSURES TO OXIDATIVE STRESS-INDUCING AGENTS |
| 3288 |
HIERARCHICAL TRANSCRIPTIONAL NETWORK GOVERNING HETEROGENEOUS T CELL EXHAUSTION AND ITS IMPLICATIONS FOR IMMUNE CHECKPOINT BLOCKADE |
| 3289 |
HIF-1ALPHA MEDIATES TUMOR HYPOXIA TO CONFER A PERPETUAL MESENCHYMAL PHENOTYPE FOR MALIGNANT PROGRESSION |
| 3290 |
HIGH CORTISOL IN 5-YEAR-OLD CHILDREN CAUSES LOSS OF DNA METHYLATION IN SINE RETROTRANSPOSONS: A POSSIBLE ROLE FOR ZNF263 IN STRESS-RELATED DISEASES |
| 3291 |
HIGH DIETARY SALT INTAKE IS ASSOCIATED WITH HISTONE METHYLATION IN SALT-SENSITIVE INDIVIDUALS |
| 3292 |
HIGH FAT DIET AND EXERCISE LEAD TO A DISRUPTED AND PATHOGENIC DNA METHYLOME IN MOUSE LIVER |
| 3293 |
HIGH FAT DIET-TRIGGERED NON-ALCOHOLIC FATTY LIVER DISEASE: A REVIEW OF PROPOSED MECHANISMS |
| 3294 |
HIGH INCIDENCE OF MGMT AND RARBETA PROMOTER METHYLATION IN PRIMARY GLIOBLASTOMAS: ASSOCIATION WITH HISTOPATHOLOGICAL CHARACTERISTICS, INFLAMMATORY MEDIATORS AND CLINICAL OUTCOME |
| 3295 |
HIGH PHOSPHATE-INDUCED DOWNREGULATION OF PPARGAMMA CONTRIBUTES TO CKD-ASSOCIATED VASCULAR CALCIFICATION |
| 3296 |
HIGH RESOLUTION INTEGRATIVE ANALYSIS REVEALS WIDESPREAD GENETIC AND EPIGENETIC CHANGES AFTER CHRONIC IN-VITRO ACID AND BILE EXPOSURE IN BARRETT'S EPITHELIUM CELLS |
| 3297 |
HIGH SODIUM INTAKE DURING POSTNATAL PHASES INDUCES AN INCREASE IN ARTERIAL BLOOD PRESSURE IN ADULT RATS |
| 3298 |
HIGH-DEFINITION CPG METHYLATION OF NOVEL GENES IN GASTRIC CARCINOGENESIS IDENTIFIED BY NEXT-GENERATION SEQUENCING |
| 3299 |
HIGH-FAT DIET RELATED LUNG FIBROSIS-EPIGENETIC REGULATION MATTERS |
| 3300 |
HIGH-FAT DIET REPROGRAMS THE EPIGENOME OF RAT SPERMATOZOA AND TRANSGENERATIONALLY AFFECTS METABOLISM OF THE OFFSPRING |
| 3301 |
HIGH-FAT OR ETHINYL-OESTRADIOL INTAKE DURING PREGNANCY INCREASES MAMMARY CANCER RISK IN SEVERAL GENERATIONS OF OFFSPRING |
| 3302 |
HIGH-FAT, SUCROSE AND SALT-RICH DIET DURING RAT SPERMATOGENESIS LEAD TO THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN THE FEMALE OFFSPRING OF THE F2 GENERATION |
| 3303 |
HIGH-FREQUENCY P16(INK) (4A) PROMOTER METHYLATION IS ASSOCIATED WITH HISTONE METHYLTRANSFERASE SETDB1 EXPRESSION IN SPORADIC CUTANEOUS MELANOMA |
| 3304 |
HIGH-GLUCOSE CONCENTRATIONS CHANGE DNA METHYLATION LEVELS IN HUMAN IVM OOCYTES |
| 3305 |
HIGH-LEVEL EXPRESSION OF BCL3 DIFFERENTIATES T(2;5)(P23;Q35)-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA FROM HODGKIN DISEASE |
| 3306 |
HIGH-PHOSPHATE-INDUCED CALCIFICATION IS RELATED TO SM22ALPHA PROMOTER METHYLATION IN VASCULAR SMOOTH MUSCLE CELLS |
| 3307 |
HIGH-RESOLUTION GENOMIC PROFILING OF LIVER CANCER LINKS ETIOLOGY WITH MUTATION AND EPIGENETIC SIGNATURES |
| 3308 |
HIGH-RESOLUTION TRANSCRIPTOMIC AND EPIGENETIC PROFILING IDENTIFIES NOVEL REGULATORS OF COPD |
| 3309 |
HIGHER GENE EXPRESSION VARIABILITY IN THE MORE AGGRESSIVE SUBTYPE OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3310 |
HIGHER ORDER GENES INTERACTION IN DNA REPAIR AND CYTOKINE GENES POLYMORPHISM AND RISK TO LUNG CANCER IN NORTH INDIANS |
| 3311 |
HIGHLIGHTING THE TRAJECTORY FROM INTRAUTERINE GROWTH RESTRICTION TO FUTURE OBESITY |
| 3312 |
HIPPOCAMPAL AND BEHAVIORAL DYSFUNCTIONS IN A MOUSE MODEL OF ENVIRONMENTAL STRESS: NORMALIZATION BY AGOMELATINE |
| 3313 |
HIPPOCAMPAL BDNF IN PHYSIOLOGICAL CONDITIONS AND SOCIAL ISOLATION |
| 3314 |
HIPPOCAMPAL CANNABINOID 1 RECEPTORS ARE MODULATED FOLLOWING COCAINE SELF-ADMINISTRATION IN MALE RATS |
| 3315 |
HIPPOCAMPAL MU OPIOID RECEPTORS ARE MODULATED FOLLOWING COCAINE SELF-ADMINISTRATION IN RAT |
| 3316 |
HISTIOCYTIC SARCOMA AS A SECONDARY MALIGNANCY: PATHOBIOLOGY, DIAGNOSIS, AND TREATMENT |
| 3317 |
HISTOLOGICAL TRANSFORMATION TO SIGNET-RING CELL CARCINOMA IN A PATIENT WITH CLINICALLY AGGRESSIVE POORLY DIFFERENTIATED ADENOCARCINOMA OF THE ASCENDING COLON AFTER RESPONSE TO CHEMOTHERAPY PLUS CETUXIMAB: A CASE REPORT |
| 3318 |
HISTONE ACETYLATION AND EXPRESSION OF MONO-AMINERGIC TRANSMITTERS SYNTHETASES INVOLVED IN CUS-INDUCED DEPRESSIVE RATS |
| 3319 |
HISTONE ACETYLATION AND HISTONE DEACETYLATION IN NEUROPATHIC PAIN: AN UNRESOLVED PUZZLE? CHRONIC PAIN IS BROADLY CLASSIFIED INTO SOMATIC, VISCERAL OR NEUROPATHIC PAIN DEPENDING UPON THE LOCATION AND EXTENT OF PAIN PERCEPTION |
| 3320 |
HISTONE ACETYLATION IN MICROGLIA CONTRIBUTES TO EXERCISE-INDUCED HYPOALGESIA IN NEUROPATHIC PAIN MODEL MICE |
| 3321 |
HISTONE ACETYLATION OF THE HTR3A GENE IN THE PREFRONTAL CORTEX OF WISTAR RATS REGULATES ETHANOL-SEEKING BEHAVIOR |
| 3322 |
HISTONE ACETYLTRANSFERASE P300 INDUCES DE NOVO SUPER-ENHANCERS TO DRIVE CELLULAR SENESCENCE |
| 3323 |
HISTONE DEACETYLASE 1 (HDAC1): A KEY PLAYER OF T CELL-MEDIATED ARTHRITIS |
| 3324 |
HISTONE DEACETYLASE 2 IS INVOLVED IN MICRO?OPIOID RECEPTOR SUPPRESSION IN THE SPINAL DORSAL HORN IN A RAT MODEL OF CHRONIC PANCREATITIS PAIN |
| 3325 |
HISTONE DEACETYLASE 2-MEDIATED EPIGENETIC REGULATION IS INVOLVED IN THE EARLY ISOFLURANE EXPOSURE-RELATED INCREASE IN SUSCEPTIBILITY TO ANXIETY-LIKE BEHAVIOUR EVOKED BY CHRONIC VARIABLE STRESS IN MICE |
| 3326 |
HISTONE DEACETYLASE 3 (HDAC3) AS AN IMPORTANT EPIGENETIC REGULATOR OF KIDNEY DISEASES |
| 3327 |
HISTONE DEACETYLASE 4 PROMOTES CHOLESTATIC LIVER INJURY IN THE ABSENCE OF PROHIBITIN-1 |
| 3328 |
HISTONE DEACETYLASE 5 MODULATES THE EFFECTS OF SOCIAL ADVERSITY IN EARLY LIFE ON COCAINE-INDUCED BEHAVIOR |
| 3329 |
HISTONE DEACETYLASE 6-MEDIATED SELECTIVE AUTOPHAGY REGULATES COPD-ASSOCIATED CILIA DYSFUNCTION |
| 3330 |
HISTONE DEACETYLASE INHIBITOR GIVINOSTAT ALLEVIATES LIVER FIBROSIS BY REGULATING HEPATIC STELLATE CELL ACTIVATION |
| 3331 |
HISTONE DEACETYLASE INHIBITOR SUBERANILOHYDROXAMIC ACID TREATMENT REVERSES HYPOSENSITIVITY TO GAMMA-AMINOBUTYRIC ACID IN THE VENTRAL TEGMENTAL AREA DURING ETHANOL WITHDRAWAL |
| 3332 |
HISTONE DEACETYLASE INHIBITOR-INDUCED EMERGENCE OF SYNAPTIC DELTA-OPIOID RECEPTORS AND BEHAVIORAL ANTINOCICEPTION IN PERSISTENT NEUROPATHIC PAIN |
| 3333 |
HISTONE DEACETYLASE INHIBITORS AND DIABETIC KIDNEY DISEASE |
| 3334 |
HISTONE DEACETYLASE INHIBITORS COUNTERACT CGRP SIGNALING AND PRONOCICEPTIVE SENSITIZATION IN A RAT MODEL OF MEDICATION OVERUSE HEADACHE |
| 3335 |
HISTONE DEACETYLASE INHIBITORS FOR CARDIOVASCULAR CONDITIONS AND HEALTHY LONGEVITY |
| 3336 |
HISTONE DEACETYLASE INHIBITORS INDUCE PROTEOLYSIS OF ACTIVATED CDC42-ASSOCIATED KINASE-1 IN LEUKEMIC CELLS |
| 3337 |
HISTONE DEACETYLASE INHIBITORS PREVENT PERSISTENT HYPERSENSITIVITY IN AN OROFACIAL NEUROPATHIC PAIN MODEL |
| 3338 |
HISTONE DEACETYLASE INHIBITORS: THE EPIGENETIC THERAPEUTICS THAT REPRESS HYPOXIA-INDUCIBLE FACTORS |
| 3339 |
HISTONE DEACETYLASE ISOFORMS DIFFERENTIALLY MODULATE INFLAMMATORY AND AUTOANTIBODY RESPONSES IN A MOUSE MODEL OF MYASTHENIA GRAVIS |
| 3340 |
HISTONE DEACETYLASE MEDIATED TRANSCRIPTIONAL ACTIVATION REDUCES PROVIRAL LOADS IN HTLV-1 ASSOCIATED MYELOPATHY/TROPICAL SPASTIC PARAPARESIS PATIENTS |
| 3341 |
HISTONE DEACETYLASE-2 IS INVOLVED IN STRESS-INDUCED COGNITIVE IMPAIRMENT VIA HISTONE DEACETYLATION AND PI3K/AKT SIGNALING PATHWAY MODIFICATION |
| 3342 |
HISTONE DEACETYLASE9 REPRESENTS THE EPIGENETIC PROMOTION OF M1 MACROPHAGE POLARIZATION AND INFLAMMATORY RESPONSE VIA TLR4 REGULATION |
| 3343 |
HISTONE DEACETYLASES (HDAC) IN PHYSIOLOGICAL AND PATHOLOGICAL BONE REMODELLING |
| 3344 |
HISTONE DEACETYLASES (HDACS) AND ATHEROSCLEROSIS: A MECHANISTIC AND PHARMACOLOGICAL REVIEW |
| 3345 |
HISTONE DEACETYLASES AS EPIGENETIC TARGETS FOR TREATING PARKINSON'S DISEASE |
| 3346 |
HISTONE DEACETYLASES MEDIATE GABA(A) RECEPTOR EXPRESSION, PHYSIOLOGY, AND BEHAVIORAL MALADAPTATIONS IN RAT MODELS OF ALCOHOL DEPENDENCE |
| 3347 |
HISTONE DEACETYLASES MEDIATE THE SILENCING OF MIR-15A, MIR-16, AND MIR-29B IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3348 |
HISTONE DEACETYLASES MEET MICRORNA-ASSOCIATED MMP-9 EXPRESSION REGULATION IN GLUCOCORTICOID-SENSITIVE AND -RESISTANT CELL LINES |
| 3349 |
HISTONE DEACETYLASES TAKE CENTER STAGE ON REGULATION OF PODOCYTE FUNCTION |
| 3350 |
HISTONE DEACETYLATION MEETS MIRNA: EPIGENETICS AND POST-TRANSCRIPTIONAL REGULATION IN CANCER AND CHRONIC DISEASES |
| 3351 |
HISTONE DEMETHYLASE JARID1B REGULATES PROLIFERATION AND MIGRATION OF PULMONARY ARTERIAL SMOOTH MUSCLE CELLS IN MICE WITH CHRONIC HYPOXIA-INDUCED PULMONARY HYPERTENSION VIA NUCLEAR FACTOR-KAPPA B (NFKB) |
| 3352 |
HISTONE DEMETHYLASE RBP2 MEDIATES THE BLAST CRISIS OF CHRONIC MYELOID LEUKEMIA THROUGH AN RBP2/PTEN/BCR-ABL CASCADE |
| 3353 |
HISTONE DEMETHYLASES REGULATE ADIPOCYTE THERMOGENESIS |
| 3354 |
HISTONE DEMETHYLATION PROFILES IN NONALCOHOLIC FATTY LIVER DISEASE AND PROGNOSTIC VALUES IN HEPATOCELLULAR CARCINOMA: A BIOINFORMATIC ANALYSIS |
| 3355 |
HISTONE EXTRACTION FROM HUMAN ARTICULAR CARTILAGE FOR THE STUDY OF EPIGENETIC REGULATION IN OSTEOARTHRITIS |
| 3356 |
HISTONE H3 LYSINE 27 ACETYLATION PROFILE UNDERGOES TWO GLOBAL SHIFTS IN UNDERNOURISHED CHILDREN AND SUGGESTS ALTERED ONE-CARBON METABOLISM |
| 3357 |
HISTONE H3 LYSINE 9 DI-METHYLATION AS AN EPIGENETIC SIGNATURE OF THE INTERFERON RESPONSE |
| 3358 |
HISTONE H3K9 METHYLATION REGULATES CHRONIC STRESS AND IL-6-INDUCED COLON EPITHELIAL PERMEABILITY AND VISCERAL PAIN |
| 3359 |
HISTONE H4 LYSINE 16 ACETYLATION CONTROLS CENTRAL CARBON METABOLISM AND DIET-INDUCED OBESITY IN MICE |
| 3360 |
HISTONE H4K20 TRIMETHYLATION IS DECREASED IN MURINE MODELS OF HEART DISEASE |
| 3361 |
HISTONE LYSINE DEMETHYLASE JMJD2D/KDM4D AND FAMILY MEMBERS MEDIATE EFFECTS OF CHRONIC SOCIAL DEFEAT STRESS ON MOUSE HIPPOCAMPAL NEUROGENESIS AND MOOD DISORDERS |
| 3362 |
HISTONE LYSINE DEMETHYLASE KDM5B MAINTAINS CHRONIC MYELOID LEUKEMIA VIA MULTIPLE EPIGENETIC ACTIONS |
| 3363 |
HISTONE LYSINE DEMETHYLASES OF JMJD2 OR KDM4 FAMILY ARE IMPORTANT EPIGENETIC REGULATORS IN REWARD CIRCUITRY IN THE ETIOPATHOLOGY OF DEPRESSION |
| 3364 |
HISTONE METHYLATION BY THE KLEEFSTRA SYNDROME PROTEIN EHMT1 MEDIATES HOMEOSTATIC SYNAPTIC SCALING |
| 3365 |
HISTONE METHYLATION IN PRE-CANCEROUS LIVER DISEASES AND HEPATOCELLULAR CARCINOMA: RECENT OVERVIEW |
| 3366 |
HISTONE METHYLATION RELATED THERAPEUTIC CHALLENGE IN CARDIOVASCULAR DISEASES |
| 3367 |
HISTONE METHYLTRANSFERASE EZH2: A POTENTIAL THERAPEUTIC TARGET FOR KIDNEY DISEASES |
| 3368 |
HISTONE METHYLTRANSFERASE G9A DIMINISHES EXPRESSION OF CANNABINOID CB(1) RECEPTORS IN PRIMARY SENSORY NEURONS IN NEUROPATHIC PAIN |
| 3369 |
HISTONE METHYLTRANSFERASES AS THERAPEUTIC TARGETS FOR KIDNEY DISEASES |
| 3370 |
HISTONE MODIFICATION OF NEDD4 UBIQUITIN LIGASE CONTROLS THE LOSS OF AMPA RECEPTORS AND COGNITIVE IMPAIRMENT INDUCED BY REPEATED STRESS |
| 3371 |
HISTONE MODIFICATION OF PAIN-RELATED GENE EXPRESSION IN SPINAL CORD NEURONS UNDER A PERSISTENT POSTSURGICAL PAIN-LIKE STATE BY ELECTROCAUTERY |
| 3372 |
HISTONE MODIFICATIONS OF THE CRHR1 GENE IN A RAT MODEL OF DEPRESSION FOLLOWING CHRONIC STRESS |
| 3373 |
HISTONE MODULATION BLOCKS TREG-INDUCED FOXP3 BINDING TO THE IL-2 PROMOTER OF VIRUS-SPECIFIC CD8(+) T CELLS FROM FELINE IMMUNODEFICIENCY VIRUS-INFECTED CATS |
| 3374 |
HISTONE POST-TRANSLATIONAL MODIFICATIONS AS POTENTIAL THERAPEUTIC TARGETS FOR PAIN MANAGEMENT |
| 3375 |
HISTONE POSTTRANSLATIONAL MODIFICATIONS PREDICT SPECIFIC ALTERNATIVE EXON SUBTYPES IN MAMMALIAN BRAIN |
| 3376 |
HISTONE-MEDIATED EPIGENETICS IN ADDICTION |
| 3377 |
HISTORICAL APPROACH AND EVOLUTION OF THE STRESS CONCEPT: A PERSONAL ACCOUNT |
| 3378 |
HIV INDUCED NITRIC OXIDE AND LIPID PEROXIDATION, INFLUENCES NEONATAL BIRTHWEIGHT IN A SOUTH AFRICAN POPULATION |
| 3379 |
HIV LATENCY AND THE NONCODING RNA THERAPEUTIC LANDSCAPE |
| 3380 |
HIV-1 INFECTION OF GENETICALLY ENGINEERED IPSC-DERIVED CENTRAL NERVOUS SYSTEM-ENGRAFTED MICROGLIA IN A HUMANIZED MOUSE MODEL |
| 3381 |
HLA AND AUTOIMMUNE DISEASES: TYPE 1 DIABETES (T1D) AS AN EXAMPLE |
| 3382 |
HMDB AND 5-AZADC COMBINATION REVERSES TUMOR SUPPRESSOR CCAAT/ENHANCER-BINDING PROTEIN DELTA TO STRENGTHEN THE DEATH OF LIVER CANCER CELLS |
| 3383 |
HNF1B NEPHROPATHY HAS A SLOW-PROGRESSIVE PHENOTYPE IN CHILDHOOD-WITH THE EXCEPTION OF VERY EARLY ONSET CASES: RESULTS OF THE GERMAN MULTICENTER HNF1B CHILDHOOD REGISTRY |
| 3384 |
HOFBAUER CELLS: THEIR ROLE IN HEALTHY AND COMPLICATED PREGNANCY |
| 3385 |
HOMEOSTATIC IMBALANCE AND COLON CANCER: THE DYNAMIC EPIGENETIC INTERPLAY OF INFLAMMATION, ENVIRONMENTAL TOXINS, AND CHEMOPREVENTIVE PLANT COMPOUNDS |
| 3386 |
HOMEOSTATIC TISSUE RESPONSES IN SKIN BIOPSIES FROM NOMID PATIENTS WITH CONSTITUTIVE OVERPRODUCTION OF IL-1BETA |
| 3387 |
HOMOCYSTEINE ASSOCIATED GENOMIC DNA HYPERMETHYLATION IN PATIENTS WITH CHRONIC ALCOHOLISM |
| 3388 |
HOMOCYSTEINE INDUCES PODOCYTE APOPTOSIS BY REGULATING MIR-1929-5P EXPRESSION THROUGH C-MYC, DNMT1 AND EZH2 |
| 3389 |
HOMOCYSTEINE SUPPRESSES THE EXPRESSION OF THE COLLAGEN CROSS-LINKER LYSYL OXIDASE INVOLVING IL-6, FLI1, AND EPIGENETIC DNA METHYLATION |
| 3390 |
HOPX PLAYS A CRITICAL ROLE IN ANTIRETROVIRAL DRUGS INDUCED EPIGENETIC MODIFICATION AND CARDIAC HYPERTROPHY |
| 3391 |
HORMETIC ASSOCIATION BETWEEN PERCEIVED STRESS AND HUMAN EPIGENETIC AGING BASED ON RESILIENCE CAPACITY |
| 3392 |
HOST AND VIRAL GENETIC VARIATION IN HBV-RELATED HEPATOCELLULAR CARCINOMA |
| 3393 |
HOST DETERMINANTS OF PRION STRAIN DIVERSITY INDEPENDENT OF PRION PROTEIN GENOTYPE |
| 3394 |
HOST EPIGENETIC ALTERATIONS AND HEPATITIS B VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA |
| 3395 |
HOST GENETIC FACTORS PREDISPOSING TO HIV-ASSOCIATED NEUROCOGNITIVE DISORDER |
| 3396 |
HOST SHP1 PHOSPHATASE ANTAGONIZES HELICOBACTER PYLORI CAGA AND CAN BE DOWNREGULATED BY EPSTEIN-BARR VIRUS |
| 3397 |
HOW ADVANCED ARE WE ON THE CONSEQUENCES OF ORAL EXPOSURE TO FOOD CONTAMINANTS ON THE OCCURRENCE OF CHRONIC NON COMMUNICABLE DISEASES? THE DEVELOPMENT OF AN INDIVIDUAL DURING FETAL LIFE AND CHILDHOOD IS CHARACTERIZED BY RAPID GROWTH AS WELL AS GRADUAL MATURATION OF ORGANS AND SYSTEMS |
| 3398 |
HOW ALCOHOL DRINKING AFFECTS OUR GENES: AN EPIGENETIC POINT OF VIEW |
| 3399 |
HOW CAN GENETICS AND EPIGENETICS HELP THE NEPHROLOGIST IMPROVE THE DIAGNOSIS AND TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS? DISCOVERY OF NOVEL IMPROVED TOOLS FOR DIAGNOSIS, PREVENTION AND THERAPY OF CHRONIC KIDNEY DISEASE (CKD) IS AN IMPORTANT TASK FOR THE NEPHROLOGY COMMUNITY AND IT IS LIKELY THAT SCIENTIFIC BREAKTHROUGHS, TO A LARGE EXTENT, WILL BE BASED ON GENOMICS |
| 3400 |
HOW CAN PRECISION MEDICINE BE APPLIED TO TEMPOROMANDIBULAR DISORDERS AND ITS COMORBIDITIES? THE EIGHTH SCIENTIFIC MEETING OF THE TMJ ASSOCIATION, LTD |
| 3401 |
HOW DID HEPATITIS B VIRUS EFFECT THE HOST GENOME IN THE LAST DECADE? THE PRINCIPAL REASON OF CHRONIC LIVER DISEASE, CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IS CHRONIC VIRAL HEPATITIS ALL OVER THE WORLD |
| 3402 |
HOW DOES AGE DETERMINE THE DEVELOPMENT OF HUMAN IMMUNE-MEDIATED ARTHRITIS? DOES AGE SUBSTANTIALLY AFFECT THE EMERGENCE OF HUMAN IMMUNE-MEDIATED ARTHRITIS? CHILDREN DO NOT USUALLY DEVELOP IMMUNE-MEDIATED ARTICULAR INFLAMMATION DURING THEIR FIRST YEAR OF LIFE |
| 3403 |
HOW EPIGENETIC MODIFICATIONS DRIVE THE EXPRESSION AND MEDIATE THE ACTION OF PGC-1ALPHA IN THE REGULATION OF METABOLISM |
| 3404 |
HOW EPIGENETICS IMPACTS ON HUMAN DISEASES |
| 3405 |
HOW STRESS GETS UNDER THE SKIN: EARLY LIFE ADVERSITY AND GLUCOCORTICOID RECEPTOR EPIGENETIC REGULATION |
| 3406 |
HOW THE IMMUNE SYSTEM RESPONDS TO ALLERGY IMMUNOTHERAPY |
| 3407 |
HOW WELL DO WE UNDERSTAND THE LONG-TERM HEALTH IMPLICATIONS OF CHILDHOOD BULLYING? ONCE DISMISSED AS AN INNOCUOUS EXPERIENCE OF CHILDHOOD, BULLYING IS NOW RECOGNIZED AS HAVING SIGNIFICANT PSYCHOLOGICAL EFFECTS, PARTICULARLY WITH CHRONIC EXPOSURE |
| 3408 |
HOW WESTERN DIET AND LIFESTYLE DRIVE THE PANDEMIC OF OBESITY AND CIVILIZATION DISEASES |
| 3409 |
HOXA4 GENE PROMOTER HYPERMETHYLATION AS AN EPIGENETIC MECHANISM MEDIATING RESISTANCE TO IMATINIB MESYLATE IN CHRONIC MYELOID LEUKEMIA PATIENTS |
| 3410 |
HOXA5 UNDERGOES DYNAMIC DNA METHYLATION AND TRANSCRIPTIONAL REPRESSION IN THE ADIPOSE TISSUE OF MICE EXPOSED TO HIGH-FAT DIET |
| 3411 |
HP1GAMMA PREVENTS ACTIVATION OF THE CGAS/STING PATHWAY BY PRESERVING NUCLEAR ENVELOPE AND GENOMIC INTEGRITY IN COLON ADENOCARCINOMA CELLS |
| 3412 |
HPA AXIS REGULATION AND EPIGENETIC PROGRAMMING OF IMMUNE-RELATED GENES IN CHRONICALLY STRESSED AND NON-STRESSED MID-LIFE WOMEN |
| 3413 |
HSA-MIR-29C AND HSA-MIR-135B DIFFERENTIAL EXPRESSION AS POTENTIAL BIOMARKER OF GASTRIC CARCINOGENESIS |
| 3414 |
HSD11B2, RUNX3, AND LINE-1 METHYLATION IN PLACENTAL DNA OF HYPERTENSIVE DISORDERS OF PREGNANCY PATIENTS |
| 3415 |
HSP90 INHIBITION INCREASES SOCS3 TRANSCRIPT AND REGULATES MIGRATION AND CELL DEATH IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3416 |
HTR1A, HTR1B, HTR2A, HTR2C AND HTR6 GENE POLYMORPHISMS AND EXTRAPYRAMIDAL SIDE EFFECTS IN HALOPERIDOL-TREATED PATIENTS WITH SCHIZOPHRENIA |
| 3417 |
HUMAN AND HELICOBACTER PYLORI INTERACTIONS DETERMINE THE OUTCOME OF GASTRIC DISEASES |
| 3418 |
HUMAN HEALTH CONSEQUENCES OF ENVIRONMENTALLY-MODULATED GENE EXPRESSION: POTENTIAL ROLES OF ELF-EMF INDUCED EPIGENETIC VERSUS MUTAGENIC MECHANISMS OF DISEASE |
| 3419 |
HUMAN LINE-1 RETROTRANSPOSONS: IMPACTS ON THE GENOME AND REGULATION BY HOST FACTORS |
| 3420 |
HUMAN LUNG DNA METHYLATION QUANTITATIVE TRAIT LOCI COLOCALIZE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE GENOME-WIDE ASSOCIATION LOCI |
| 3421 |
HUMAN MATTERS IN ASTHMA: CONSIDERING THE MICROBIOME IN PULMONARY HEALTH |
| 3422 |
HUMAN MONOCYTE-TO-MACROPHAGE DIFFERENTIATION INVOLVES HIGHLY LOCALIZED GAIN AND LOSS OF DNA METHYLATION AT TRANSCRIPTION FACTOR BINDING SITES |
| 3423 |
HUMAN PRIMARY AIRWAY EPITHELIAL CELLS ISOLATED FROM ACTIVE SMOKERS HAVE EPIGENETICALLY IMPAIRED ANTIVIRAL RESPONSES |
| 3424 |
HUMAN STEM CELLS ISOLATED FROM ADULT SKELETAL MUSCLE DIFFERENTIATE INTO NEURAL PHENOTYPES |
| 3425 |
HUMAN SYMPATHETIC NERVE BIOLOGY: PARALLEL INFLUENCES OF STRESS AND EPIGENETICS IN ESSENTIAL HYPERTENSION AND PANIC DISORDER |
| 3426 |
HUMAN UMBILICAL ARTERY ENDOTHELIAL CELLS FROM LARGE-FOR-GESTATIONAL-AGE NEWBORN HAVE INCREASED ANTIOXIDANT EFFICIENCY AND GENE EXPRESSION |
| 3427 |
HUMAN VARIATION IN RESPONSE TO FOOD AND NUTRIENTS |
| 3428 |
HUMANS AT HIGH ALTITUDE: HYPOXIA AND FETAL GROWTH |
| 3429 |
HUNGRY IN THE WOMB: WHAT ARE THE CONSEQUENCES? LESSONS FROM THE DUTCH FAMINE |
| 3430 |
HYALURONAN AS TUNABLE DRUG DELIVERY SYSTEM |
| 3431 |
HYDROGEN SULFIDE ALLEVIATES HYPERTENSIVE KIDNEY DYSFUNCTION THROUGH AN EPIGENETIC MECHANISM |
| 3432 |
HYDROGEN SULFIDE BIOSYNTHESIS IS IMPAIRED IN THE OSTEOARTHRITIC JOINT |
| 3433 |
HYDROXYMETHYLATION OF MICRORNA-365-3P REGULATES NOCICEPTIVE BEHAVIORS VIA KCNH2 |
| 3434 |
HYPER-METHYLATED HUB GENES OF T-CELL RECEPTOR SIGNALING PREDICT A POOR CLINICAL OUTCOME IN LUNG ADENOCARCINOMA |
| 3435 |
HYPERGLYCEMIA AND VASCULAR METABOLIC MEMORY: TRUTH OR FICTION? PREVENTION OF LONG-TERM COMPLICATIONS REMAINS THE MAIN CHALLENGE IN THE TREATMENT OF DIABETES |
| 3436 |
HYPERGLYCEMIC MEMORY OF INNATE IMMUNE CELLS PROMOTES IN VITRO PROINFLAMMATORY RESPONSES OF HUMAN MONOCYTES AND MURINE MACROPHAGES |
| 3437 |
HYPERGLYCEMIC MICROENVIRONMENT COMPROMISES THE HOMEOSTASIS OF COMMUNICATION BETWEEN THE BONE-BRAIN AXIS BY THE EPIGENETIC REPRESSION OF THE OSTEOCALCIN RECEPTOR, GPR158 IN THE HIPPOCAMPUS |
| 3438 |
HYPERHOMOCYSTEINEMIA IN UREMIA--A RED FLAG IN A DISRUPTED CIRCUIT |
| 3439 |
HYPERMETHYLATION AND LOSS OF EXPRESSION OF GLUTATHIONE PEROXIDASE-3 IN BARRETT'S TUMORIGENESIS |
| 3440 |
HYPERMETHYLATION AND LOW TRANSCRIPTION OF TLR2 GENE IN CHRONIC PERIODONTITIS |
| 3441 |
HYPERMETHYLATION IN GENE PROMOTERS ARE INDUCED BY CHRONIC EXPOSURE TO BENZENE, TOLUENE, ETHYLBENZENE AND XYLENES |
| 3442 |
HYPERMETHYLATION IN THE PROMOTER OF THE MTHFR GENE IS ASSOCIATED WITH DIABETIC COMPLICATIONS AND BIOCHEMICAL INDICATORS |
| 3443 |
HYPERMETHYLATION IN THE PROMOTER REGION OF THE ADRA1A GENE IS ASSOCIATED WITH OPIOID USE DISORDER IN HAN CHINESE |
| 3444 |
HYPERMETHYLATION OF E-CADHERIN IN LEUKEMIA |
| 3445 |
HYPERMETHYLATION OF ITGA4, TFPI2 AND VIMENTIN PROMOTERS IS INCREASED IN INFLAMED COLON TISSUE: PUTATIVE RISK MARKERS FOR COLITIS-ASSOCIATED CANCER |
| 3446 |
HYPERMETHYLATION OF MIR21 IN CD4+ T CELLS FROM PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS ASSOCIATES WITH LOWER MIRNA-21 LEVELS AND CONCOMITANT UP-REGULATION OF ITS TARGET GENES |
| 3447 |
HYPERMETHYLATION OF MITOCHONDRIAL TRANSCRIPTION FACTOR A INDUCED BY CIGARETTE SMOKE IS ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 3448 |
HYPERMETHYLATION OF THE N-MYC DOWNSTREAM-REGULATED GENE 2 PROMOTER IN PERIPHERAL BLOOD MONONUCLEAR CELLS IS ASSOCIATED WITH LIVER FIBROSIS IN CHRONIC HEPATITIS B |
| 3449 |
HYPERMETHYLATION OF THE NRF2 PROMOTER INDUCES FERROPTOSIS BY INHIBITING THE NRF2-GPX4 AXIS IN COPD |
| 3450 |
HYPERMETHYLATION OF THE TSPOAP1-AS1 PROMOTER MAY BE ASSOCIATED WITH OBESITY IN OVERWEIGHT/OBESE KOREAN SUBJECTS |
| 3451 |
HYPERMETHYLATIONS OF RASAL1 AND KLOTHO IS ASSOCIATED WITH RENAL DYSFUNCTION IN A CHINESE POPULATION ENVIRONMENTALLY EXPOSED TO CADMIUM |
| 3452 |
HYPERTENSIVE DISORDERS OF PREGNANCY SHARE COMMON CFDNA METHYLATION PROFILES |
| 3453 |
HYPOMETHYLATED UBIQUITIN-CONJUGATING ENZYME2 Q1 (UBE2Q1) GENE PROMOTER IN THE SERUM IS A PROMISING BIOMARKER FOR HEPATITIS B VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA |
| 3454 |
HYPOMETHYLATION AT THE REGULATORY T CELL-SPECIFIC DEMETHYLATED REGION IN CD25HI T CELLS IS DECOUPLED FROM FOXP3 EXPRESSION AT THE INFLAMED SITE IN CHILDHOOD ARTHRITIS |
| 3455 |
HYPOMETHYLATION COORDINATES ANTAGONISTICALLY WITH HYPERMETHYLATION IN CANCER DEVELOPMENT: A CASE STUDY OF LEUKEMIA |
| 3456 |
HYPOMETHYLATION OF IL1RN AND NFKB1 GENES IS LINKED TO THE DYSBALANCE IN IL1BETA/IL-1RA AXIS IN FEMALE PATIENTS WITH TYPE 2 DIABETES MELLITUS |
| 3457 |
HYPOMETHYLATION OF INTERLEUKIN-6 (IL-6) GENE INCREASES THE RISK OF ESSENTIAL HYPERTENSION: A MATCHED CASE-CONTROL STUDY |
| 3458 |
HYPOMETHYLATION OF LINE-1 REPEAT ELEMENTS AND GLOBAL LOSS OF DNA HYDROXYMETHYLATION IN VAPERS AND SMOKERS |
| 3459 |
HYPOMETHYLATION OF NERVE GROWTH FACTOR (NGF) PROMOTES BINDING OF C/EBPALPHA AND CONTRIBUTES TO INFLAMMATORY HYPERALGESIA IN RATS |
| 3460 |
HYPOMETHYLATION OF THE IL8 PROMOTER IN NASAL EPITHELIAL CELLS OF PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS |
| 3461 |
HYPOMETHYLATION-MEDIATED H19 OVEREXPRESSION INCREASES THE RISK OF DISEASE EVOLUTION THROUGH THE ASSOCIATION WITH BCR-ABL TRANSCRIPT IN CHRONIC MYELOID LEUKEMIA |
| 3462 |
HYPOTHALAMIC NR3C1 DNA METHYLATION IN RATS EXPOSED TO PRENATAL STRESS |
| 3463 |
HYPOTHALAMIC-PITUITARY-ADRENAL AND HYPOTHALAMIC-PITUITARY-GONADAL AXES: SEX DIFFERENCES IN REGULATION OF STRESS RESPONSIVITY |
| 3464 |
HYPOTHESIS |
| 3465 |
HYPOTHESIS: REGULATION OF NEUROPLASTICITY MAY INVOLVE I-MOTIF AND G-QUADRUPLEX DNA FORMATION MODULATED BY EPIGENETIC MECHANISMS |
| 3466 |
HYPOXIA AS A KEY PLAYER IN THE AKI-TO-CKD TRANSITION |
| 3467 |
HYPOXIA, HIF, AND ASSOCIATED SIGNALING NETWORKS IN CHRONIC KIDNEY DISEASE |
| 3468 |
HYPOXIA-INDUCED DNA HYPERMETHYLATION IN HUMAN PULMONARY FIBROBLASTS IS ASSOCIATED WITH THY-1 PROMOTER METHYLATION AND THE DEVELOPMENT OF A PRO-FIBROTIC PHENOTYPE |
| 3469 |
HYPOXIA-INDUCIBLE HISTONE LYSINE DEMETHYLASES: IMPACT ON THE AGING PROCESS AND AGE-RELATED DISEASES |
| 3470 |
HYPOXIA-INDUCIBLE KDM3A ADDICTION IN MULTIPLE MYELOMA |
| 3471 |
IDENTIFICATION AND CHARACTERIZATIONS OF NOVEL, SELECTIVE HISTONE METHYLTRANSFERASE SET7 INHIBITORS BY SCAFFOLD HOPPING- AND 2D-MOLECULAR FINGERPRINT-BASED SIMILARITY SEARCH |
| 3472 |
IDENTIFICATION AND MANAGEMENT OF PAIN MEDICATION ABUSE AND MISUSE: CURRENT STATE AND FUTURE DIRECTIONS |
| 3473 |
IDENTIFICATION OF A NOVEL, METHYLATION-DEPENDENT, RUNX2 REGULATORY REGION ASSOCIATED WITH OSTEOARTHRITIS RISK |
| 3474 |
IDENTIFICATION OF A RICE METALLOCHAPERONE FOR CADMIUM TOLERANCE BY AN EPIGENETIC MECHANISM AND POTENTIAL USE FOR CLEAN UP IN WETLAND |
| 3475 |
IDENTIFICATION OF A STAT5 TARGET GENE, DPF3, PROVIDES NOVEL INSIGHTS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3476 |
IDENTIFICATION OF A TRANSMEMBRANE PROTEIN INVOLVED IN SHEAR STRESS SIGNALING AND HEPATOCARCINOGENESIS AFTER A SUSTAINED VIROLOGICAL RESPONSE TO HEPATITIS C VIRUS |
| 3477 |
IDENTIFICATION OF ABNORMALLY METHYLATED DIFFERENTIALLY EXPRESSED GENES IN CHRONIC PERIODONTITIS BY INTEGRATED BIOINFORMATICS ANALYSIS |
| 3478 |
IDENTIFICATION OF ADPKD-RELATED GENES AND PATHWAYS IN CELLS OVEREXPRESSING PKD2 |
| 3479 |
IDENTIFICATION OF BIOACTIVE METABOLITES AND EVALUATION OF IN VITRO ANTI-INFLAMMATORY AND IN VIVO ANTINOCICEPTIVE AND ANTIARTHRITIC ACTIVITIES OF ENDOPHYTE FUNGI ISOLATED FROM ELAEOCARPUS FLORIBUNDUS BLUME |
| 3480 |
IDENTIFICATION OF BIOMARKERS AND GENETIC APPROACHES TOWARD CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 3481 |
IDENTIFICATION OF CANDIDATE GENES AND GENE NETWORKS SPECIFICALLY ASSOCIATED WITH ANALGESIC TOLERANCE TO MORPHINE |
| 3482 |
IDENTIFICATION OF CDC5L AS BRIDGE GENE BETWEEN CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND LUNG ADENOCARCINOMA |
| 3483 |
IDENTIFICATION OF CERNA NETWORK TO EXPLAIN THE MECHANISM OF COGNITIVE DYSFUNCTIONS INDUCED BY PS NPS IN MICE |
| 3484 |
IDENTIFICATION OF CHROMATIN REMODELING GENES ARID4A AND ARID4B AS LEUKEMIA SUPPRESSOR GENES |
| 3485 |
IDENTIFICATION OF CIRCULAR RNAS EXPRESSION PATTERN IN CAPRINE FETAL FIBROBLAST CELLS EXPOSED TO A CHRONIC NON-CYTOTOXIC DOSE OF GRAPHENE OXIDE-SILVER NANOPARTICLE NANOCOMPOSITES |
| 3486 |
IDENTIFICATION OF COMMON MICRORNA BETWEEN COPD AND NON-SMALL CELL LUNG CANCER THROUGH PATHWAY ENRICHMENT ANALYSIS |
| 3487 |
IDENTIFICATION OF DIFFERENTIALLY METHYLATED SITES WITH WEAK METHYLATION EFFECTS |
| 3488 |
IDENTIFICATION OF DNA METHYLATION ASSOCIATED ENRICHMENT PATHWAYS IN ADULTS WITH NON-SPECIFIC CHRONIC LOW BACK PAIN |
| 3489 |
IDENTIFICATION OF EPIGENETIC INTERACTIONS BETWEEN MICRORNA-30C-5P AND DNA METHYLTRANSFERASES IN NEUROPATHIC PAIN |
| 3490 |
IDENTIFICATION OF EPIGENETIC MEMORY CANDIDATES ASSOCIATED WITH GESTATIONAL AGE AT BIRTH THROUGH ANALYSIS OF METHYLOME AND TRANSCRIPTIONAL DATA |
| 3491 |
IDENTIFICATION OF EXPRESSED MIRNAS IN HUMAN RHEUMATOID ARTHRITIS USING COMPUTATIONAL APPROACH - DISCOVERY OF A NEW MIR-7167 FROM HUMAN |
| 3492 |
IDENTIFICATION OF HISTONE DEACETYLASE 10 (HDAC10) INHIBITORS THAT MODULATE AUTOPHAGY IN TRANSFORMED CELLS |
| 3493 |
IDENTIFICATION OF KEY GENES, PATHWAYS, AND MIRNA/MRNA REGULATORY NETWORKS OF CUMS-INDUCED DEPRESSION IN NUCLEUS ACCUMBENS BY INTEGRATED BIOINFORMATICS ANALYSIS |
| 3494 |
IDENTIFICATION OF MICRORNAS WITH DYSREGULATED EXPRESSION IN STATUS EPILEPTICUS INDUCED EPILEPTOGENESIS |
| 3495 |
IDENTIFICATION OF MIRNAS POTENTIALLY INVOLVED IN BRONCHIOLITIS OBLITERANS SYNDROME: A COMPUTATIONAL STUDY |
| 3496 |
IDENTIFICATION OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME-ASSOCIATED DNA METHYLATION PATTERNS |
| 3497 |
IDENTIFICATION OF NOVEL EPIGENETIC ABNORMALITIES AS SPUTUM BIOMARKERS FOR LUNG CANCER RISK AMONG SMOKERS AND COPD PATIENTS |
| 3498 |
IDENTIFICATION OF NOVEL HYPOMORPHIC AND NULL MUTATIONS IN KLF1 DERIVED FROM A GENETIC SCREEN FOR MODIFIERS OF ALPHA-GLOBIN TRANSGENE VARIEGATION |
| 3499 |
IDENTIFICATION OF NOVEL TRANSCRIPTIONAL REGULATORS INVOLVED IN MACROPHAGE DIFFERENTIATION AND ACTIVATION IN U937 CELLS |
| 3500 |
IDENTIFICATION OF NOVEL, CLONALLY STABLE, SOMATIC MUTATIONS TARGETING TRANSCRIPTION FACTORS PAX5 AND NKX2-3, THE EPIGENETIC REGULATOR LRIF1, AND BRAF IN A CASE OF ATYPICAL B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA HARBORING A T(14;18)(Q32;Q21) |
| 3501 |
IDENTIFICATION OF POTENTIAL BIOMARKERS FOR SYSTEMIC LUPUS ERYTHEMATOSUS BY INTEGRATED ANALYSIS OF GENE EXPRESSION AND METHYLATION DATA |
| 3502 |
IDENTIFICATION OF POTENTIAL BIOMARKERS OF CHRONIC KIDNEY DISEASE IN INDIVIDUALS WITH DIABETES: PROTOCOL FOR A CROSS-SECTIONAL OBSERVATIONAL STUDY |
| 3503 |
IDENTIFICATION OF POTENTIAL DIFFERENTIALLY METHYLATED GENE-RELATED BIOMARKERS IN ENDOMETRIOSIS |
| 3504 |
IDENTIFICATION OF POTENTIALLY FUNCTIONAL CIRCRNAS AND PREDICTION OF CIRCRNA-MIRNA-MRNA REGULATORY NETWORK IN PERIODONTITIS: BRIDGING THE GAP BETWEEN BIOINFORMATICS AND CLINICAL NEEDS |
| 3505 |
IDENTIFICATION OF SEX-SPECIFIC DNA METHYLATION CHANGES DRIVEN BY SPECIFIC CHEMICALS IN CORD BLOOD IN A FAROESE BIRTH COHORT |
| 3506 |
IDENTIFICATION OF SPINAL CORD MICRORNA AND GENE SIGNATURES IN A MODEL OF CHRONIC STRESS-INDUCED VISCERAL HYPERALGESIA IN RAT |
| 3507 |
IDENTIFICATION OF TARGET GENES AT JUVENILE IDIOPATHIC ARTHRITIS GWAS LOCI IN HUMAN NEUTROPHILS |
| 3508 |
IDENTIFYING A PANEL OF GENES/PROTEINS/MIRNAS MODULATED BY ARSENICALS IN BLADDER, PROSTATE, KIDNEY CANCERS |
| 3509 |
IDENTIFYING MECHANISMS OF ENDOMETRIOSIS-ASSOCIATED REDUCED FECUNDITY IN A RAT MODEL: NOVEL INSIGHTS TOWARD UNDERSTANDING HUMAN INFERTILITY |
| 3510 |
IDENTIFYING NOVEL B-CELL TARGETS FOR CHRONIC INFLAMMATORY AUTOIMMUNE DISEASE BY SCREENING OF CHEMICAL PROBES IN A PATIENT-DERIVED CELL ASSAY |
| 3511 |
IDIOPATHIC ENVIRONMENTAL INTOLERANCES (IEI): FROM MOLECULAR EPIDEMIOLOGY TO MOLECULAR MEDICINE |
| 3512 |
IDIOPATHIC PULMONARY FIBROSIS |
| 3513 |
IDIOPATHIC PULMONARY FIBROSIS: PATHOGENESIS AND MANAGEMENT |
| 3514 |
IDIOPATHIC PULMONARY FIBROSIS: PATHOGENESIS AND THERAPEUTIC APPROACHES |
| 3515 |
IDO AND KYNURENINE METABOLITES IN PERIPHERAL AND CNS DISORDERS |
| 3516 |
IDO1 AND INFLAMMATORY NEOVASCULARIZATION: BRINGING NEW BLOOD TO TUMOR-PROMOTING INFLAMMATION |
| 3517 |
IFNG/IFNG-AS1 EXPRESSION LEVEL BALANCE: IMPLICATIONS FOR AUTISM SPECTRUM DISORDER |
| 3518 |
IGE SENSITIZATION PROFILES DIFFER BETWEEN ADULT PATIENTS WITH SEVERE AND MODERATE ATOPIC DERMATITIS |
| 3519 |
IGF-1 SIGNALING IN NEONATAL HYPOXIA-INDUCED PULMONARY HYPERTENSION: ROLE OF EPIGENETIC REGULATION |
| 3520 |
IGLV3-21R110 IDENTIFIES AN AGGRESSIVE BIOLOGICAL SUBTYPE OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH INTERMEDIATE EPIGENETICS |
| 3521 |
IKAROS: FROM CHROMATIN ORGANIZATION TO TRANSCRIPTIONAL ELONGATION CONTROL |
| 3522 |
IL-10 PRODUCTION BY CLL CELLS IS ENHANCED IN THE ANERGIC IGHV MUTATED SUBSET AND ASSOCIATES WITH REDUCED DNA METHYLATION OF THE IL10 LOCUS |
| 3523 |
IL-10-PRODUCING B CELLS ARE CHARACTERIZED BY A SPECIFIC METHYLATION SIGNATURE |
| 3524 |
IL-13 REGULATES HUMAN NASAL EPITHELIAL CELL DIFFERENTIATION VIA H3K4ME3 MODIFICATION |
| 3525 |
IL-1BETA, IL-8, AND MATRIX METALLOPROTEINASES-1, -2, AND -10 ARE ENRICHED UPON MONOCYTE-BREAST CANCER CELL COCULTIVATION IN A MATRIGEL-BASED THREE-DIMENSIONAL SYSTEM |
| 3526 |
IL-6 AND SIL-6R INDUCES STAT3-DEPENDENT DIFFERENTIATION OF HUMAN VSMCS INTO OSTEOBLAST-LIKE CELLS THROUGH JMJD2B-MEDIATED HISTONE DEMETHYLATION OF RUNX2 |
| 3527 |
IL-6 ENHANCES THE NUCLEAR TRANSLOCATION OF DNA CYTOSINE-5-METHYLTRANSFERASE 1 (DNMT1) VIA PHOSPHORYLATION OF THE NUCLEAR LOCALIZATION SEQUENCE BY THE AKT KINASE |
| 3528 |
IL36G GENETIC VARIANT IS INDEPENDENTLY ASSOCIATED WITH SUSCEPTIBILITY, SEVERITY AND JOINT INVOLVEMENT IN PSORIASIS |
| 3529 |
ILLUMINATING THE LIVE-CELL DYNAMICS OF HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA USING THE CRISPR-TAG SYSTEM |
| 3530 |
IMATINIB (ST1571) PROVIDES ONLY LIMITED SELECTIVITY FOR CML CELLS AND TREATMENT MIGHT BE COMPLICATED BY SILENT BCR-ABL GENES |
| 3531 |
IMATINIB CAUSES EPIGENETIC ALTERATIONS OF PTEN GENE VIA UPREGULATION OF DNA METHYLTRANSFERASES AND POLYCOMB GROUP PROTEINS |
| 3532 |
IMATINIB INDEPENDENT ABERRANT METHYLATION OF NOV/CCN3 IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS: A MECHANISM UPSTREAM OF BCR-ABL1 FUNCTION? BACKGROUND: THE NOV GENE PRODUCT, CCN3, HAS BEEN REPORTED IN A DIVERSE RANGE OF TUMORS TO SERVE AS A NEGATIVE GROWTH REGULATOR, WHILE ACTING AS A TUMOR SUPPRESSOR IN CHRONIC MYELOGENOUS LEUKEMIA (CML) |
| 3533 |
IMATINIB TREATMENTS HAVE LONG-TERM IMPACT ON PLACENTATION AND EMBRYO SURVIVAL |
| 3534 |
IMMEDIATE-EARLY GENES MODULATION BY ANTIPSYCHOTICS: TRANSLATIONAL IMPLICATIONS FOR A PUTATIVE GATEWAY TO DRUG-INDUCED LONG-TERM BRAIN CHANGES |
| 3535 |
IMMUNE AND GENETIC MECHANISMS IN COPD: POSSIBLE TARGETS FOR THERAPEUTIC INTERVENTIONS |
| 3536 |
IMMUNE CHROMATIN READER SP140 REGULATES MICROBIOTA AND RISK FOR INFLAMMATORY BOWEL DISEASE |
| 3537 |
IMMUNE DYSREGULATION IN KABUKI SYNDROME: A CASE REPORT OF EVANS SYNDROME AND HYPOGAMMAGLOBULINEMIA |
| 3538 |
IMMUNE REGULATION IN CHRONIC HEPATITIS C VIRUS INFECTION |
| 3539 |
IMMUNE SENESCENCE, EPIGENETICS AND AUTOIMMUNITY |
| 3540 |
IMMUNE-DERIVED CYTOKINES IN THE NERVOUS SYSTEM: EPIGENETIC INSTRUCTIVE SIGNALS OR NEUROPATHOGENIC MEDIATORS? THE INVESTIGATION OF THE EFFECTS OF INFLAMMATORY CYTOKINES (IC) ON THE GROWTH AND DIFFERENTIATION OF NEURAL CELLS HAS PROVIDED NEW INSIGHTS ON THE ROLE OF SUCH SOLUBLE MEDIATORS IN NERVOUS SYSTEM DEVELOPMENT AND/OR PLASTIC REMODELING AS WELL AS IN THE PATHOGENESIS OF INFLAMMATORY NEURODEGENERATIVE DISORDERS, WHICH ARE CHARACTERIZED BY CHRONIC IC DYSREGULATION IN THE CENTRAL NERVOUS SYSTEM (CNS) |
| 3541 |
IMMUNOEPIGENETIC REGULATION OF INFLAMMATORY BOWEL DISEASE: CURRENT INSIGHTS INTO NOVEL EPIGENETIC MODULATIONS OF THE SYSTEMIC IMMUNE RESPONSE |
| 3542 |
IMMUNOHISTOCHEMICAL ANALYSIS OF HISTONE H3 ACETYLATION IN THE TRIGEMINAL ROOT ENTRY ZONE IN AN ANIMAL MODEL OF TRIGEMINAL NEURALGIA |
| 3543 |
IMMUNOLOGY, GENETICS AND MICROBIOTA IN THE COPD PATHOPHYSIOLOGY: POTENTIAL SCOPE FOR PATIENT STRATIFICATION |
| 3544 |
IMMUNOMETABOLIC CONTROL OF TRAINED IMMUNITY |
| 3545 |
IMMUNOMETABOLISM IN THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS |
| 3546 |
IMMUNOMODULATORY DIET IN PEDIATRIC AGE |
| 3547 |
IMMUNOMODULATORY ROLE OF NUTRIENTS: HOW CAN PULMONARY DYSFUNCTIONS IMPROVE? NUTRITION IS AN IMPORTANT TOOL THAT CAN BE USED TO MODULATE THE IMMUNE RESPONSE DURING INFECTIOUS DISEASES |
| 3548 |
IMMUNOPATHOGENESIS OF BEHCET DISEASE |
| 3549 |
IMMUNOSENESCENCE AND MULTIPLE SCLEROSIS |
| 3550 |
IMMUNOSENESCENCE IN ATHEROSCLEROSIS: A ROLE FOR CHRONIC VIRAL INFECTIONS |
| 3551 |
IMMUNOSENESCENCE: MOLECULAR MECHANISMS AND DISEASES |
| 3552 |
IMMUNOSUPPRESSION BY CHRONIC EXPOSURE TO N-NITROSODIMETHYLAMINE (NDMA) IN MICE |
| 3553 |
IMMUNOTOLERANCE OF DAIRY HEIFERS IN RESPONSE TO REPEATED EXPOSURE TO BACTERIAL LIPOPOLYSACCHARIDE ENDOTOXIN |
| 3554 |
IMPACT OF ADVANCED GLYCATION END PRODUCTS (AGES) AND ITS RECEPTOR (RAGE) ON CANCER METABOLIC SIGNALING PATHWAYS AND ITS PROGRESSION |
| 3555 |
IMPACT OF AGE, ANTIRETROVIRAL THERAPY, AND CANCER ON EPIGENETIC AGING IN PEOPLE LIVING WITH HIV |
| 3556 |
IMPACT OF ALCOHOL CONSUMPTION ON MALE FERTILITY POTENTIAL: A NARRATIVE REVIEW |
| 3557 |
IMPACT OF BMI AND WAIST CIRCUMFERENCE ON EPIGENOME-WIDE DNA METHYLATION AND IDENTIFICATION OF EPIGENETIC BIOMARKERS IN BLOOD: AN EWAS IN MULTI-ETHNIC ASIAN INDIVIDUALS |
| 3558 |
IMPACT OF CHRONIC BENZENE POISONING ON ABERRANT MITOCHONDRIAL DNA METHYLATION: A PROSPECTIVE OBSERVATIONAL STUDY |
| 3559 |
IMPACT OF CHRONIC CONDITIONS AND DEMENTIA IN RURAL WEST TEXAS: A HEALTHY AGING STUDY |
| 3560 |
IMPACT OF CLINICAL, CYTOGENETIC, AND MOLECULAR PROFILES ON LONG-TERM SURVIVAL AFTER TRANSPLANTATION IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 3561 |
IMPACT OF EPIGENETIC ALTERATIONS IN THE DEVELOPMENT OF ORAL DISEASES |
| 3562 |
IMPACT OF FMR1 PREMUTATION ON NEUROBEHAVIOR AND BIOENERGETICS IN YOUNG MONOZYGOTIC TWINS |
| 3563 |
IMPACT OF FRAILTY IN ELDERLY PATIENTS WITH MODERATE TO SEVERE ASTHMA |
| 3564 |
IMPACT OF GENETIC AND ENVIRONMENTAL FACTORS ON AUTOIMMUNE HEPATITIS |
| 3565 |
IMPACT OF GENETIC POLYMORPHISMS AND BIOMARKERS ON THE EFFECTIVENESS AND TOXICITY OF TREATMENT OF CHRONIC MYELOID LEUKEMIA AND ACUTE MYELOID LEUKEMIA |
| 3566 |
IMPACT OF HEAVY METALS ON THE FEMALE REPRODUCTIVE SYSTEM |
| 3567 |
IMPACT OF HEPATITIS VIRUS AND AGING ON DNA METHYLATION IN HUMAN HEPATOCARCINOGENESIS |
| 3568 |
IMPACT OF INFLAMMATION ON EPIGENETIC DNA METHYLATION - A NOVEL RISK FACTOR FOR CARDIOVASCULAR DISEASE? OBJECTIVE: THE LIFESPAN OF DIALYSIS PATIENTS IS AS SHORT AS IN PATIENTS WITH METASTATIC CANCER DISEASE, MAINLY DUE TO CARDIOVASCULAR DISEASE (CVD) |
| 3569 |
IMPACT OF INTRA-UTERINE LIFE ON FUTURE HEALTH |
| 3570 |
IMPACT OF JUVENILE HORMONE ANALOGUE INSECTICIDES ON THE WATER FLEA MOINA MACROCOPA: GROWTH, REPRODUCTION AND TRANSGENERATIONAL EFFECT |
| 3571 |
IMPACT OF LOCAL ANESTHETICS ON EPIGENETICS IN CANCER |
| 3572 |
IMPACT OF MATERNAL DIABETES ON EPIGENETIC MODIFICATIONS LEADING TO DISEASES IN THE OFFSPRING |
| 3573 |
IMPACT OF MATERNAL UNDERNUTRITION ON DIABETES AND CARDIOVASCULAR DISEASE RISK IN ADULT OFFSPRING |
| 3574 |
IMPACT OF METHIONINE SYNTHASE REDUCTASE POLYMORPHISMS IN CHRONIC MYELOID LEUKEMIA PATIENTS |
| 3575 |
IMPACT OF MOLECULAR PROFILING ON THE MANAGEMENT OF PATIENTS WITH MYELOFIBROSIS |
| 3576 |
IMPACT OF NUTRITION ON POLLUTANT TOXICITY: AN UPDATE WITH NEW INSIGHTS INTO EPIGENETIC REGULATION |
| 3577 |
IMPACT OF NUTRITION ON TELOMERE HEALTH: SYSTEMATIC REVIEW OF OBSERVATIONAL COHORT STUDIES AND RANDOMIZED CLINICAL TRIALS |
| 3578 |
IMPACT OF PARENTAL OVER- AND UNDERWEIGHT ON THE HEALTH OF OFFSPRING |
| 3579 |
IMPACT OF PATERNAL EDUCATION ON EPIGENETIC AGEING IN ADOLESCENCE AND MID-ADULTHOOD: A MULTI-COHORT STUDY IN THE USA AND MEXICO |
| 3580 |
IMPACT OF PERINATAL ENVIRONMENTAL TOBACCO SMOKE ON THE DEVELOPMENT OF CHILDHOOD ALLERGIC DISEASES |
| 3581 |
IMPACT OF PHYSICAL ACTIVITY AND EXERCISE ON THE EPIGENOME IN SKELETAL MUSCLE AND EFFECTS ON SYSTEMIC METABOLISM |
| 3582 |
IMPACT OF PRENATAL AND EARLY LIFE ENVIRONMENTAL EXPOSURES ON NORMAL HUMAN DEVELOPMENT |
| 3583 |
IMPACT OF SHORT- AND LONG-TERM ELECTRICALLY INDUCED MUSCLE EXERCISE ON GENE SIGNALING PATHWAYS, GENE EXPRESSION, AND PGC1A METHYLATION IN MEN WITH SPINAL CORD INJURY |
| 3584 |
IMPACT OF SOCIAL DEFEAT STRESS ON DNA METHYLATION IN DRD2, NR3C1, AND STMN1 IN WILD-TYPE AND STMN1 KNOCK-OUT MICE |
| 3585 |
IMPACT OF THE EXPOSOME ON THE EPIGENOME IN INFLAMMATORY BOWEL DISEASE PATIENTS AND ANIMAL MODELS |
| 3586 |
IMPACT OF THE POLYCARBONATE STRIPPERS USED IN ASSISTED REPRODUCTION TECHNIQUES ON EMBRYONIC DEVELOPMENT |
| 3587 |
IMPACT OF TLR4 ON BEHAVIORAL AND COGNITIVE DYSFUNCTIONS ASSOCIATED WITH ALCOHOL-INDUCED NEUROINFLAMMATORY DAMAGE |
| 3588 |
IMPACT OF TP53 GENE PROMOTER METHYLATION ON CHRONIC LYMPHOCYTIC LEUKEMIA PATHOGENESIS AND PROGRESSION |
| 3589 |
IMPACTS OF ECCENTRIC RESISTANCE EXERCISE ON DNA METHYLATION OF CANDIDATE GENES FOR INFLAMMATORY CYTOKINES IN SKELETAL MUSCLE AND LEUKOCYTES OF HEALTHY MALES |
| 3590 |
IMPAIRED LATENT INHIBITION IN GDNF-DEFICIENT MICE EXPOSED TO CHRONIC STRESS |
| 3591 |
IMPAIRED ONE CARBON METABOLISM AND DNA METHYLATION IN ALCOHOL TOXICITY |
| 3592 |
IMPAIRED VASCULAR FUNCTION CONTRIBUTES TO EXERCISE INTOLERANCE IN CHRONIC KIDNEY DISEASE |
| 3593 |
IMPLICATION OF THE MEDITERRANEAN DIET ON THE HUMAN EPIGENOME |
| 3594 |
IMPLICATIONS OF EARLY LIFE STRESS ON FETAL METABOLIC PROGRAMMING OF SCHIZOPHRENIA: A FOCUS ON EPIPHENOMENA UNDERLYING MORBIDITY AND EARLY MORTALITY |
| 3595 |
IMPLICATIONS OF MATERNAL CONDITIONS AND PREGNANCY COURSE ON OFFSPRING'S MEDICAL PROBLEMS IN ADULT LIFE |
| 3596 |
IMPLICATIONS OF SPHINGOLIPIDS ON AGING AND AGE-RELATED DISEASES |
| 3597 |
IMPLICATIONS OF VIRAL INFECTIONS AND ONCOGENESIS IN UTERINE CERVICAL CARCINOMA ETIOLOGY AND PATHOGENESIS |
| 3598 |
IMPLICATIONS ON HYPNOTHERAPY: NEUROPLASTICITY, EPIGENETICS AND PAIN |
| 3599 |
IMPORTANCE OF EPIGENETIC CHANGES IN CANCER ETIOLOGY, PATHOGENESIS, CLINICAL PROFILING, AND TREATMENT: WHAT CAN BE LEARNED FROM HEMATOLOGIC MALIGNANCIES? EPIGENETIC ALTERATIONS REPRESENT A KEY CANCER HALLMARK, EVEN IN HEMATOLOGIC MALIGNANCIES (HMS) OR BLOOD CANCERS, WHOSE CLINICAL FEATURES DISPLAY A HIGH INTER-INDIVIDUAL VARIABILITY |
| 3600 |
IMPORTANCE OF EPIGENETIC MECHANISMS IN VISCERAL PAIN INDUCED BY CHRONIC WATER AVOIDANCE STRESS |
| 3601 |
IMPORTANCE OF PROBIOTICS IN THE PREVENTION AND TREATMENT OF COLORECTAL CANCER |
| 3602 |
IMPRINTED GENES AND MULTIPLE SCLEROSIS: WHAT DO WE KNOW? MULTIPLE SCLEROSIS (MS) IS A CHRONIC AUTOIMMUNE NEURODEGENERATIVE DISEASE OF THE CENTRAL NERVOUS SYSTEM THAT ARISES FROM INTERPLAY BETWEEN NON-GENETIC AND GENETIC RISK FACTORS |
| 3603 |
IMPROPER PREANALYTICAL PROCESSES ON PERIPHERAL BLOOD COMPROMISE RNA QUALITY AND SKEW THE TRANSCRIPTIONAL READOUTS OF MRNA AND LNCRNA |
| 3604 |
IMPROVEMENT OF PHYSICAL DECLINE THROUGH COMBINED EFFECTS OF MUSCLE ENHANCEMENT AND MITOCHONDRIAL ACTIVATION BY A GASTRIC HORMONE GHRELIN IN MALE 5/6NX CKD MODEL MICE |
| 3605 |
IMPROVING PARP INHIBITOR EFFICACY IN HIGH-GRADE SEROUS OVARIAN CARCINOMA: A FOCUS ON THE IMMUNE SYSTEM |
| 3606 |
IMPROVING TREATMENT OF NEURODEVELOPMENTAL DISORDERS: RECOMMENDATIONS BASED ON PRECLINICAL STUDIES |
| 3607 |
IN DEFENSE OF THE SOMATIC MUTATION THEORY OF CANCER |
| 3608 |
IN SEARCH FOR GENES RELATED TO ATHEROSCLEROSIS AND DYSLIPIDEMIA USING ANIMAL MODELS |
| 3609 |
IN UTERO ARSENIC EXPOSURE AND EPIGENOME-WIDE ASSOCIATIONS IN PLACENTA, UMBILICAL ARTERY, AND HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS |
| 3610 |
IN UTERO EXPOSURE TO ENDOCRINE-DISRUPTING CHEMICALS, MATERNAL FACTORS AND ALTERATIONS IN THE EPIGENETIC LANDSCAPE UNDERLYING LATER-LIFE HEALTH EFFECTS |
| 3611 |
IN UTERO LIFE AND EPIGENETIC PREDISPOSITION FOR DISEASE |
| 3612 |
IN UTERO PARTICULATE MATTER EXPOSURE PRODUCES HEART FAILURE, ELECTRICAL REMODELING, AND EPIGENETIC CHANGES AT ADULTHOOD |
| 3613 |
IN UTERO PROGRAMMING AND EARLY DETECTION OF CARDIOVASCULAR DISEASE IN THE OFFSPRING OF MOTHERS WITH OBESITY |
| 3614 |
IN VITRO CELL TRANSFORMATION ASSAYS: A VALUABLE APPROACH FOR CARCINOGENIC POTENTIALITY ASSESSMENT OF NANOMATERIALS |
| 3615 |
IN VITRO FOLATE DEFICIENCY INDUCES DEOXYNUCLEOTIDE POOL IMBALANCE, APOPTOSIS, AND MUTAGENESIS IN CHINESE HAMSTER OVARY CELLS |
| 3616 |
IN VITRO MODELING OF CD8 T CELL EXHAUSTION ENABLES CRISPR SCREENING TO REVEAL A ROLE FOR BHLHE40 |
| 3617 |
IN VITRO MODELING OF CD8(+) T CELL EXHAUSTION ENABLES CRISPR SCREENING TO REVEAL A ROLE FOR BHLHE40 |
| 3618 |
IN VITRO MODELING OF THE NEUROBIOLOGICAL EFFECTS OF GLUCOCORTICOIDS: A REVIEW |
| 3619 |
IN VIVO ACUTE ON CHRONIC ETHANOL EFFECTS IN LIVER: A MOUSE MODEL EXHIBITING EXACERBATED INJURY, ALTERED METABOLIC AND EPIGENETIC RESPONSES |
| 3620 |
IN VIVO AND IN VITRO GENOTOXIC AND EPIGENETIC EFFECTS OF TWO TYPES OF COLA BEVERAGES AND CAFFEINE: A MULTIASSAY APPROACH |
| 3621 |
IN VIVO AND IN VITRO MODELS OF HEPATOCELLULAR CARCINOMA: CURRENT STRATEGIES FOR TRANSLATIONAL MODELING |
| 3622 |
IN VIVO ANTAGONISTIC ROLE OF THE HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 REGULATORY PROTEINS TAX AND HBZ |
| 3623 |
IN VIVO COMET ASSAY ON ISOLATED KIDNEY CELLS TO DISTINGUISH GENOTOXIC CARCINOGENS FROM EPIGENETIC CARCINOGENS OR CYTOTOXIC COMPOUNDS |
| 3624 |
IN VIVO FUNCTION OF FLOW-RESPONSIVE CIS-DNA ELEMENTS OF ENOS GENE: A ROLE FOR CHROMATIN-BASED MECHANISMS |
| 3625 |
IN VIVO GENOME AND METHYLOME ADAPTATION OF CAG-NEGATIVE HELICOBACTER PYLORI DURING EXPERIMENTAL HUMAN INFECTION |
| 3626 |
IN-SILICO DISCOVERY OF DUAL ACTIVE MOLECULE TO RESTORE SYNAPTIC WIRING AGAINST AUTISM SPECTRUM DISORDER VIA HDAC2 AND H3R INHIBITION |
| 3627 |
INACTIVATION OF LARS2, LOCATED AT THE COMMONLY DELETED REGION 3P21 |
| 3628 |
INACTIVATION OF NUCLEAR HISTONE DEACETYLASES BY EP300 DISRUPTS THE MICEE COMPLEX IN IDIOPATHIC PULMONARY FIBROSIS |
| 3629 |
INACTIVATION OF P15(INK4B) IN CHRONIC ARSENIC POISONING CASES |
| 3630 |
INCLUSION OF SOCIAL AND STRUCTURAL DETERMINANTS OF HEALTH TO ADVANCE UNDERSTANDING OF THEIR INFLUENCE ON THE BIOLOGY OF CHRONIC DISEASE |
| 3631 |
INCORPORATING BIOMARKERS IN COPD MANAGEMENT: THE RESEARCH KEEPS GOING |
| 3632 |
INCORPORATING TRANSGENERATIONAL EPIGENETIC INHERITANCE INTO ECOLOGICAL RISK ASSESSMENT FRAMEWORKS |
| 3633 |
INCREASE IN HDAC9 SUPPRESSES MYOBLAST DIFFERENTIATION VIA EPIGENETIC REGULATION OF AUTOPHAGY IN HYPOXIA |
| 3634 |
INCREASED CD4(+) T CELL LINEAGE COMMITMENT DETERMINED BY CPG METHYLATION CORRELATES WITH BETTER PROGNOSIS IN URINARY BLADDER CANCER PATIENTS |
| 3635 |
INCREASED DNA METHYLATION, CELLULAR SENESCENCE AND PREMATURE EPIGENETIC AGING IN GUINEA PIGS AND HUMANS WITH TUBERCULOSIS |
| 3636 |
INCREASED DNA METHYLTRANSFERASE ACTIVITY AND DNA METHYLATION FOLLOWING EPIDERMAL GROWTH FACTOR STIMULATION IN OVARIAN CANCER CELLS |
| 3637 |
INCREASED EPIGENETIC AGE ACCELERATION IN THE HIDRADENITIS SUPPURATIVA SKIN |
| 3638 |
INCREASED EXPRESSION OF BETA-DEFENSIN 1 (DEFB1) IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 3639 |
INCREASED EXPRESSION OF H19/MIR-675 IS ASSOCIATED WITH A LOW FAT-FREE MASS INDEX IN PATIENTS WITH COPD |
| 3640 |
INCREASED EXTRACELLULAR MATRIX PROTEIN PRODUCTION IN CHRONIC DIABETIC COMPLICATIONS: IMPLICATIONS OF NON-CODING RNAS |
| 3641 |
INCREASED GENE EXPRESSION OF HISTONE DEACETYLASES IN PATIENTS WITH PHILADELPHIA-NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS |
| 3642 |
INCREASED H3K4ME3 METHYLATION AND DECREASED MIR-7113-5P EXPRESSION LEAD TO ENHANCED WNT/BETA-CATENIN SIGNALING IN IMMUNE CELLS FROM PTSD PATIENTS LEADING TO INFLAMMATORY PHENOTYPE |
| 3643 |
INCREASED INFLAMMATORY RESPONSE IN AGED MICE IS ASSOCIATED WITH AGE-RELATED ZINC DEFICIENCY AND ZINC TRANSPORTER DYSREGULATION |
| 3644 |
INCREASED LEVELS OF ENDOGENOUS RETROVIRUSES TRIGGER FIBROINFLAMMATION AND PLAY A ROLE IN KIDNEY DISEASE DEVELOPMENT |
| 3645 |
INCREASED PRESENCE AND DIFFERENTIAL MOLECULAR IMPRINTING OF TRANSIT AMPLIFYING CELLS IN PSORIASIS |
| 3646 |
INCREASED PROTEIN EXPRESSION OF DNA METHYLTRANSFERASE (DNMT) 1 IS SIGNIFICANTLY CORRELATED WITH THE MALIGNANT POTENTIAL AND POOR PROGNOSIS OF HUMAN HEPATOCELLULAR CARCINOMAS |
| 3647 |
INCREASED REELIN PROMOTER METHYLATION IS ASSOCIATED WITH GRANULE CELL DISPERSION IN HUMAN TEMPORAL LOBE EPILEPSY |
| 3648 |
INCREASED RELATIVE ABUNDANCE OF RUMINOCCOCUS IS ASSOCIATED WITH REDUCED CARDIOVASCULAR RISK IN AN OBESE POPULATION |
| 3649 |
INCREASED STRESS AND ALTERED EXPRESSION OF HISTONE MODIFYING ENZYMES IN BRAIN ARE ASSOCIATED WITH ABERRANT BEHAVIOUR IN VITAMIN B12 DEFICIENT FEMALE MICE |
| 3650 |
INCREASED TRANSCRIPTION OF TSPO, HDAC2, AND HDAC6 IN THE AMYGDALA OF MALES WITH ALCOHOL USE DISORDER |
| 3651 |
INCREASING COMPLEXITY OF MOLECULAR LANDSCAPES IN HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS DURING DEVELOPMENT AND AGING |
| 3652 |
INDIVIDUAL DNA METHYLATION PATTERN SHIFTS IN NANOPARTICLES-EXPOSED WORKERS ANALYZED IN FOUR CONSECUTIVE YEARS |
| 3653 |
INDIVIDUAL EPIGENETIC VARIATION: WHEN, WHY, AND SO WHAT? EPIGENETICS PROVIDES A POTENTIAL EXPLANATION FOR HOW ENVIRONMENTAL FACTORS MODIFY THE RISK FOR COMMON DISEASES AMONG INDIVIDUALS |
| 3654 |
INDOXYL SULFATE ACCELERATES VASCULAR SMOOTH MUSCLE CELL CALCIFICATION VIA MICRORNA-29B DEPENDENT REGULATION OF WNT/BETA-CATENIN SIGNALING |
| 3655 |
INDOXYL SULFATE ENHANCE THE HYPERMETHYLATION OF KLOTHO AND PROMOTE THE PROCESS OF VASCULAR CALCIFICATION IN CHRONIC KIDNEY DISEASE |
| 3656 |
INDUCIBLE PRMT1 ABLATION IN ADULT VASCULAR SMOOTH MUSCLE LEADS TO CONTRACTILE DYSFUNCTION AND AORTIC DISSECTION |
| 3657 |
INDUCTION AND RECOVERY OF CPG SITE SPECIFIC METHYLATION CHANGES IN HUMAN BRONCHIAL CELLS AFTER LONG-TERM EXPOSURE TO CARBON NANOTUBES AND ASBESTOS |
| 3658 |
INDUCTION OF ABERRANT TRIMETHYLATION OF HISTONE H3 LYSINE 27 BY INFLAMMATION IN MOUSE COLONIC EPITHELIAL CELLS |
| 3659 |
INDUCTION OF EPIGENETIC ALTERATIONS BY CHRONIC INFLAMMATION AND ITS SIGNIFICANCE ON CARCINOGENESIS |
| 3660 |
INDUCTION OF HEPATIC DIFFERENTIATION OF MOUSE BONE MARROW STROMAL STEM CELLS BY THE HISTONE DEACETYLASE INHIBITOR VPA |
| 3661 |
INDUCTION OF INNATE IMMUNE MEMORY BY ENGINEERED NANOPARTICLES IN MONOCYTES/MACROPHAGES: FROM HYPOTHESIS TO REALITY |
| 3662 |
INDUCTION OF STABLE HUMAN FOXP3(+) TREGS BY A PARASITE-DERIVED TGF-BETA MIMIC |
| 3663 |
INDUCTION OF TET3-DEPENDENT EPIGENETIC REMODELING BY LOW-DOSE HYDRALAZINE ATTENUATES PROGRESSION OF CHRONIC KIDNEY DISEASE |
| 3664 |
INFANT NEUROBEHAVIORAL DEVELOPMENT |
| 3665 |
INFECTION AS A POTENTIAL COFACTOR IN THE GENETIC-EPIGENETIC PATHOPHYSIOLOGY OF ENDOMETRIOSIS: A SYSTEMATIC REVIEW |
| 3666 |
INFECTION, STEM CELLS AND CANCER SIGNALS |
| 3667 |
INFILTRATING MACROPHAGES INDUCE ERALPHA EXPRESSION THROUGH AN IL17A-MEDIATED EPIGENETIC MECHANISM TO SENSITIZE ENDOMETRIAL CANCER CELLS TO ESTROGEN |
| 3668 |
INFLAMMAGEING AND METAFLAMMATION: THE YIN AND YANG OF TYPE 2 DIABETES |
| 3669 |
INFLAMMAGING AND CANCER: A CHALLENGE FOR THE MEDITERRANEAN DIET |
| 3670 |
INFLAMMAGING AND COMPLEMENT SYSTEM: A LINK BETWEEN ACUTE KIDNEY INJURY AND CHRONIC GRAFT DAMAGE |
| 3671 |
INFLAMMATION AND CANCER |
| 3672 |
INFLAMMATION AND CANCER: AN ANCIENT LINK WITH NOVEL POTENTIALS |
| 3673 |
INFLAMMATION AND DE-DIFFERENTIATION IN PANCREATIC CARCINOGENESIS |
| 3674 |
INFLAMMATION AND DYSREGULATED FIBROBLAST PROLIFERATION--NEW MECHANISMS? IDIOPATHIC PULMONARY FIBROSIS (IPF) IS A DEVASTATING, AGE-RELATED LUNG DISEASE OF UNKNOWN CAUSE THAT HAS FEW TREATMENT OPTIONS |
| 3675 |
INFLAMMATION AND HISTONE MODIFICATION IN CHRONIC PAIN |
| 3676 |
INFLAMMATION AND NEUTROPHIL IMMUNOSENESCENCE IN HEALTH AND DISEASE: TARGETED TREATMENTS TO IMPROVE CLINICAL OUTCOMES IN THE ELDERLY |
| 3677 |
INFLAMMATION AND PYROPTOSIS MEDIATE MUSCLE EXPANSION IN AN INTERLEUKIN-1BETA (IL-1BETA)-DEPENDENT MANNER |
| 3678 |
INFLAMMATION AND REGENERATION IN THE DENTIN-PULP COMPLEX: A DOUBLE-EDGED SWORD |
| 3679 |
INFLAMMATION IN AGING: CAUSE, EFFECT, OR BOTH? AGING IS A PROGRESSIVE DEGENERATIVE PROCESS TIGHTLY INTEGRATED WITH INFLAMMATION |
| 3680 |
INFLAMMATION IN ALCOHOLIC LIVER DISEASE |
| 3681 |
INFLAMMATION, DNA METHYLATION AND COLITIS-ASSOCIATED CANCER |
| 3682 |
INFLAMMATION, FIBROSIS AND CANCER: MECHANISMS, THERAPEUTIC OPTIONS AND CHALLENGES |
| 3683 |
INFLAMMATION, MICROBIOTA, AND PROSTATE CANCER |
| 3684 |
INFLAMMATION, PHYSICAL ACTIVITY, AND CHRONIC DISEASE: AN EVOLUTIONARY PERSPECTIVE |
| 3685 |
INFLAMMATION-ASSOCIATED CANCER DEVELOPMENT IN DIGESTIVE ORGANS: MECHANISMS AND ROLES FOR GENETIC AND EPIGENETIC MODULATION |
| 3686 |
INFLAMMATION-RELATED ABERRANT PATTERNS OF DNA METHYLATION: DETECTION AND ROLE IN EPIGENETIC DEREGULATION OF CANCER CELL TRANSCRIPTOME |
| 3687 |
INFLAMMATION-RELATED GENES ARE ASSOCIATED WITH EPIGENETIC AGING IN HIV |
| 3688 |
INFLAMMATION: GEARING THE JOURNEY TO CANCER |
| 3689 |
INFLAMMATORY AUTO-IMMUNE DISEASES OF THE INTESTINE AND THEIR MANAGEMENT BY NATURAL BIOACTIVE COMPOUNDS |
| 3690 |
INFLAMMATORY BOWEL DISEASE: GENETICS, EPIGENETICS, AND PATHOGENESIS |
| 3691 |
INFLAMMATORY BOWEL DISEASES: AN UPDATED OVERVIEW ON THE HEAT SHOCK PROTEIN INVOLVEMENT |
| 3692 |
INFLAMMATORY BOWEL DISEASES: THE ROLE OF GUT MICROBIOTA |
| 3693 |
INFLAMMATORY CELLS CAN ALTER THE LEVELS OF H3K9AC AND GAMMAH2AX IN DYSPLASTIC CELLS AND FAVOR TUMOR PHENOTYPE |
| 3694 |
INFLAMMATORY COMPONENTS OF THE THYROID CANCER MICROENVIRONMENT: AN AVENUE FOR IDENTIFICATION OF NOVEL BIOMARKERS |
| 3695 |
INFLAMMATORY DISEASES AND GROWTH: EFFECTS ON THE GH-IGF AXIS AND ON GROWTH PLATE |
| 3696 |
INFLAMMATORY MACROPHAGE MEMORY IN NONSTEROIDAL ANTI-INFLAMMATORY DRUG-EXACERBATED RESPIRATORY DISEASE |
| 3697 |
INFLAMMATORY MARKERS IN CANCER: POTENTIAL RESOURCES |
| 3698 |
INFLAMMATORY MECHANISMS LINKING MATERNAL AND CHILDHOOD ASTHMA |
| 3699 |
INFLAMMATORY MEMORIES: IS EPIGENETICS THE MISSING LINK TO PERSISTENT STROMAL CELL ACTIVATION IN RHEUMATOID ARTHRITIS? RHEUMATOID ARTHRITIS (RA) IS A CHRONIC INFLAMMATORY DISEASE LEADING TO JOINT DESTRUCTION |
| 3700 |
INFLAMMATORY MEMORY AND TISSUE ADAPTATION IN SICKNESS AND IN HEALTH |
| 3701 |
INFLAMMATORY RESPONSE TO REGULATED CELL DEATH IN GOUT AND ITS FUNCTIONAL IMPLICATIONS |
| 3702 |
INFLAMMATORY SIGNALING PATHWAYS IN PRELEUKEMIC AND LEUKEMIC STEM CELLS |
| 3703 |
INFLAMMATORY SIGNALLING AS MEDIATOR OF EPIGENETIC MODULATION IN TISSUE-SPECIFIC CHRONIC INFLAMMATION |
| 3704 |
INFLUENCE OF CIGARETTE SMOKING ON ALS OUTCOME: A POPULATION-BASED STUDY |
| 3705 |
INFLUENCE OF EPIGENETICS ON PERIODONTITIS AND PERI-IMPLANTITIS PATHOGENESIS |
| 3706 |
INFLUENCE OF GENETICS ON DISEASE SUSCEPTIBILITY AND PROGRESSION |
| 3707 |
INFLUENCE OF MATERNAL OVERNUTRITION AND GESTATIONAL DIABETES ON THE PROGRAMMING OF METABOLIC HEALTH OUTCOMES IN THE OFFSPRING: EXPERIMENTAL EVIDENCE |
| 3708 |
INFLUENCE OF PHARMACOLOGICAL AND EPIGENETIC FACTORS TO SUPPRESS NEUROTROPHIC FACTORS AND ENHANCE NEURAL PLASTICITY IN STRESS AND MOOD DISORDERS |
| 3709 |
INFLUENCE OF VITAMIN D AND COTININE ON T-REGULATORY CELLS AND ASTHMA SEVERITY IN CHILDREN |
| 3710 |
INFLUENCES OF POLYCYCLIC AROMATIC HYDROCARBON ON THE EPIGENOME TOXICITY AND ITS APPLICABILITY IN HUMAN HEALTH RISK ASSESSMENT |
| 3711 |
INHALED DRUG DELIVERY FOR THE TARGETED TREATMENT OF ASTHMA |
| 3712 |
INHALED POLLUTANTS: THE MOLECULAR SCENE BEHIND RESPIRATORY AND SYSTEMIC DISEASES ASSOCIATED WITH ULTRAFINE PARTICULATE MATTER |
| 3713 |
INHERITANCE OF ACQUIRED BEHAVIOUR ADAPTATIONS AND BRAIN GENE EXPRESSION IN CHICKENS |
| 3714 |
INHERITANCE OF SOCIAL DOMINANCE IS ASSOCIATED WITH GLOBAL SPERM DNA METHYLATION IN INBRED MALE MICE |
| 3715 |
INHERITED EFFECTS OF LOW-DOSE EXPOSURE TO METHYLMERCURY IN NEURAL STEM CELLS |
| 3716 |
INHIBITING INFLAMMATION WITH MYELOID CELL-SPECIFIC NANOBIOLOGICS PROMOTES ORGAN TRANSPLANT ACCEPTANCE |
| 3717 |
INHIBITION OF 11BETA-HSD1 AMELIORATES COGNITION AND MOLECULAR DETRIMENTAL CHANGES AFTER CHRONIC MILD STRESS IN SAMP8 MICE |
| 3718 |
INHIBITION OF BCL6B PROMOTES GASTRIC CANCER BY AMPLIFYING INFLAMMATION IN MICE |
| 3719 |
INHIBITION OF BET PROTEINS REDUCES RIGHT VENTRICLE HYPERTROPHY AND PULMONARY HYPERTENSION RESULTING FROM COMBINED HYPOXIA AND PULMONARY INFLAMMATION |
| 3720 |
INHIBITION OF CLASS I HISTONE DEACETYLASES ABROGATES TUMOR GROWTH FACTOR BETA EXPRESSION AND DEVELOPMENT OF FIBROSIS DURING CHRONIC PANCREATITIS |
| 3721 |
INHIBITION OF CLASS II HISTONE DEACETYLASES IN THE SPINAL CORD ATTENUATES INFLAMMATORY HYPERALGESIA |
| 3722 |
INHIBITION OF DNA METHYLATION DURING CHRONIC OBSTRUCTIVE BLADDER DISEASE (COBD) IMPROVES FUNCTION, PATHOLOGY AND EXPRESSION |
| 3723 |
INHIBITION OF DNA METHYLTRANSFERASE OR HISTONE DEACETYLASE PROTECTS RETINAL PIGMENT EPITHELIAL CELLS FROM DNA DAMAGE INDUCED BY OXIDATIVE STRESS BY THE STIMULATION OF ANTIOXIDANT ENZYMES |
| 3724 |
INHIBITION OF EZH2 AMELIORATES CARTILAGE ENDPLATE DEGENERATION AND ATTENUATES THE PROGRESSION OF INTERVERTEBRAL DISC DEGENERATION VIA DEMETHYLATION OF SOX-9 |
| 3725 |
INHIBITION OF GLYCOGEN SYNTHASE KINASE-3 ACTIVITY LEADS TO EPIGENETIC SILENCING OF NUCLEAR FACTOR KAPPAB TARGET GENES AND INDUCTION OF APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS |
| 3726 |
INHIBITION OF HISTONE METHYLTRANSFERASE EZH2 SUPPRESSES ENDOMETRIOTIC VESICLE DEVELOPMENT IN A RAT MODEL OF ENDOMETRIOSIS |
| 3727 |
INHIBITION OF PANCREATIC ACINAR MITOCHONDRIAL THIAMIN PYROPHOSPHATE UPTAKE BY THE CIGARETTE SMOKE COMPONENT 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE |
| 3728 |
INHIBITION OF REPLICATION OF HEPATITIS B VIRUS USING TRANSCRIPTIONAL REPRESSORS THAT TARGET THE VIRAL DNA |
| 3729 |
INHIBITION OF TET1 PREVENTS THE DEVELOPMENT OF OSTEOARTHRITIS AND REVEALS THE 5HMC LANDSCAPE THAT ORCHESTRATES PATHOGENESIS |
| 3730 |
INHIBITION OF THE COREST REPRESSOR COMPLEX PROMOTES WOUND RE-EPITHELIALIZATION VIA REGULATION OF KERATINOCYTE MIGRATION |
| 3731 |
INNATE AND ADAPTIVE IMMUNE REGULATION DURING CHRONIC VIRAL INFECTIONS |
| 3732 |
INNATE IMMUNE MEMORY AND THE HOST RESPONSE TO INFECTION |
| 3733 |
INNATE IMMUNE MEMORY IN INFLAMMATORY ARTHRITIS |
| 3734 |
INNATE IMMUNE MEMORY IN MONOCYTES AND MACROPHAGES: THE POTENTIAL THERAPEUTIC STRATEGIES FOR ATHEROSCLEROSIS |
| 3735 |
INNATE IMMUNE MEMORY: IMPLICATIONS FOR DEVELOPMENT OF PEDIATRIC IMMUNOMODULATORY AGENTS AND ADJUVANTED VACCINES |
| 3736 |
INNATE IMMUNE TOLERANCE IN MICROGLIA DOES NOT IMPACT ON CENTRAL NERVOUS SYSTEM PRION DISEASE |
| 3737 |
INNATE IMMUNITY, EPIGENETICS AND AUTOIMMUNITY IN RHEUMATOID ARTHRITIS |
| 3738 |
INORGANIC ARSENIC-INDUCED CELLULAR TRANSFORMATION IS COUPLED WITH GENOME WIDE CHANGES IN CHROMATIN STRUCTURE, TRANSCRIPTOME AND SPLICING PATTERNS |
| 3739 |
INS AND OUTS OF CADMIUM-INDUCED CARCINOGENESIS: MECHANISM AND PREVENTION |
| 3740 |
INSIGHT INTO GENETIC PREDISPOSITION TO CHRONIC LYMPHOCYTIC LEUKEMIA FROM INTEGRATIVE EPIGENOMICS |
| 3741 |
INSIGHT INTO THE POTENTIAL MECHANISMS OF ENDOCRINE DISRUPTION BY DIETARY PHYTOESTROGENS IN THE CONTEXT OF THE ETIOPATHOGENESIS OF ENDOMETRIOSIS |
| 3742 |
INSIGHTS FOR HEPATITIS C VIRUS RELATED HEPATOCELLULAR CARCINOMA GENETIC BIOMARKERS: EARLY DIAGNOSIS AND THERAPEUTIC INTERVENTION |
| 3743 |
INSIGHTS FROM GENOMIC STUDIES ON THE ROLE OF SEX STEROIDS IN THE AETIOLOGY OF ENDOMETRIOSIS |
| 3744 |
INSIGHTS INTO THE CRYSTAL STRUCTURE OF BRD2-BD2 - PHENANTHRIDINONE COMPLEX AND THEORETICAL STUDIES ON PHENANTHRIDINONE ANALOGS |
| 3745 |
INSIGHTS INTO THE DIVERSE EFFECTS OF NITRIC OXIDE ON TUMOR BIOLOGY |
| 3746 |
INSIGHTS INTO THE EPIGENETICS OF CHRONIC RHINOSINUSITIS WITH AND WITHOUT NASAL POLYPS: A SYSTEMATIC REVIEW |
| 3747 |
INSIGHTS INTO THE MOLECULAR GENETICS OF MYELOPROLIFERATIVE NEOPLASMS |
| 3748 |
INSIGHTS INTO THE ROLE OF DNA METHYLATION AND PROTEIN MISFOLDING IN DIABETES MELLITUS |
| 3749 |
INSIGHTS INTO THE ROLE OF PLASMATIC AND EXOSOMAL MICRORNAS IN OXIDATIVE STRESS-RELATED METABOLIC DISEASES |
| 3750 |
INSULIN RESISTANCE IN POLYCYSTIC OVARY SYNDROME ACROSS VARIOUS TISSUES: AN UPDATED REVIEW OF PATHOGENESIS, EVALUATION, AND TREATMENT |
| 3751 |
INTAKE OF NATURAL COMPOUNDS AND CIRCULATING MICRORNA EXPRESSION LEVELS: THEIR RELATIONSHIP INVESTIGATED IN HEALTHY SUBJECTS WITH DIFFERENT DIETARY HABITS |
| 3752 |
INTEGRATED ANALYSIS OF CIRCRNAS AND MRNAS EXPRESSION PROFILE REVEALED THE INVOLVEMENT OF HSA_CIRC_0007919 IN THE PATHOGENESIS OF ULCERATIVE COLITIS |
| 3753 |
INTEGRATED ANALYSIS OF GENE EXPRESSION AND METHYLATION DATA TO IDENTIFY POTENTIAL BIOMARKERS RELATED TO ATHEROSCLEROSIS ONSET |
| 3754 |
INTEGRATED ANALYSIS OF OMICS DATA REVEAL AP-1 AS A POTENTIAL REGULATION HUB IN THE INFLAMMATION-INDUCED HYPERALGESIA RAT MODEL |
| 3755 |
INTEGRATED BIOINFORMATICS ANALYSIS UNCOVERS CHARACTERISTIC GENES AND MOLECULAR SUBTYPING SYSTEM FOR ENDOMETRIOSIS |
| 3756 |
INTEGRATED GENOMIC SEQUENCING IN MYELOID BLAST CRISIS CHRONIC MYELOID LEUKEMIA (MBC-CML), IDENTIFIED POTENTIALLY IMPORTANT FINDINGS IN THE CONTEXT OF LEUKEMOGENESIS MODEL |
| 3757 |
INTEGRATED MECHANISMS OF CAMKII-DEPENDENT VENTRICULAR REMODELING |
| 3758 |
INTEGRATED MRNA AND MICRORNA TRANSCRIPTOME PROFILING DURING DIFFERENTIATION OF HUMAN NASAL POLYP EPITHELIUM REVEALS AN ALTERED CILIOGENESIS |
| 3759 |
INTEGRATED SINGLE CELL ANALYSIS SHOWS CHRONIC ALCOHOL DRINKING DISRUPTS MONOCYTE DIFFERENTIATION IN THE BONE MARROW NICHE |
| 3760 |
INTEGRATED SINGLE CELL ANALYSIS SHOWS CHRONIC ALCOHOL DRINKING DISRUPTS MONOCYTE DIFFERENTIATION IN THE BONE MARROW |
| 3761 |
INTEGRATING GENETIC AND EPIGENETIC FACTORS IN CHRONIC MYELOID LEUKEMIA RISK ASSESSMENT: TOWARD GENE EXPRESSION-BASED BIOMARKERS |
| 3762 |
INTEGRATING THE TUMOR-SUPPRESSIVE ACTIVITY OF MASPIN WITH P53 IN RETUNING THE EPITHELIAL HOMEOSTASIS: A WORKING HYPOTHESIS AND APPLICABLE PROSPECTS |
| 3763 |
INTEGRATION OF NUTRIGENOMICS, MELATONIN, SEROTONIN AND INFLAMMATORY CYTOKINES IN THE PATHOPHYSIOLOGY OF PREGNANCY-SPECIFIC URINARY INCONTINENCE IN WOMEN WITH GESTATIONAL DIABETES MELLITUS |
| 3764 |
INTEGRATIVE ANALYSIS OF DNA METHYLATION AND GENE EXPRESSION DATA IDENTIFIES EPAS1 AS A KEY REGULATOR OF COPD |
| 3765 |
INTEGRATIVE ANALYSIS OF TRANSCRIPTOMIC AND PROTEOMIC PROFILING IN INFLAMMATORY BOWEL DISEASE COLON BIOPSIES |
| 3766 |
INTEGRATIVE EPIGENETIC PROFILING ANALYSIS IDENTIFIES DNA METHYLATION CHANGES ASSOCIATED WITH CHRONIC ALCOHOL CONSUMPTION |
| 3767 |
INTEGRATIVE EPIGENOMIC ANALYSIS IN DIFFERENTIATED HUMAN PRIMARY BRONCHIAL EPITHELIAL CELLS EXPOSED TO CIGARETTE SMOKE |
| 3768 |
INTEGRATIVE EPIGENOMICS IN CHRONIC LYMPHOCYTIC LEUKAEMIA: BIOLOGICAL INSIGHTS AND CLINICAL APPLICATIONS |
| 3769 |
INTEGRATIVE MEDICINE TO TACKLE THE PROBLEM OF CHRONIC DISEASES |
| 3770 |
INTEGRATIVE SMALL AND LONG RNA OMICS ANALYSIS OF HUMAN HEALING AND NONHEALING WOUNDS DISCOVERS COOPERATING MICRORNAS AS THERAPEUTIC TARGETS |
| 3771 |
INTER- AND TRANSGENERATIONAL EPIGENETIC INHERITANCE: EVIDENCE IN ASTHMA AND COPD? EVIDENCE IS NOW EMERGING THAT EARLY LIFE ENVIRONMENT CAN HAVE LIFELONG EFFECTS ON METABOLIC, CARDIOVASCULAR, AND PULMONARY FUNCTION IN OFFSPRING, A CONCEPT ALSO KNOWN AS FETAL OR DEVELOPMENTAL PROGRAMMING |
| 3772 |
INTERACTION BETWEEN MICRORNA AND DNA METHYLATION IN ATHEROSCLEROSIS |
| 3773 |
INTERACTION OF CERVICAL MICROBIOME WITH EPIGENOME OF EPITHELIAL CELLS: SIGNIFICANCE OF INFLAMMATION TO PRIMARY HEALTHCARE |
| 3774 |
INTERACTION OF GONADAL HORMONES, DOPAMINERGIC SYSTEM, AND EPIGENETIC REGULATION IN THE GENERATION OF SEX DIFFERENCES IN SUBSTANCE USE DISORDERS: A SYSTEMATIC REVIEW |
| 3775 |
INTERACTIONS BETWEEN ARSENIC-INDUCED TOXICITY AND NUTRITION IN EARLY LIFE |
| 3776 |
INTERACTIONS BETWEEN DYSLIPIDEMIA AND THE IMMUNE SYSTEM AND THEIR RELEVANCE AS PUTATIVE THERAPEUTIC TARGETS IN ATHEROSCLEROSIS |
| 3777 |
INTERACTOME OF OBESITY: OBESIDOME : GENETIC OBESITY, STRESS INDUCED OBESITY, PATHOGENIC OBESITY INTERACTION |
| 3778 |
INTERFERING WITH ALTERNATIVELY ACTIVATED MACROPHAGES BY CSF-1R INHIBITION EXERTS THERAPEUTIC CAPACITY ON ALLERGIC AIRWAY INFLAMMATION |
| 3779 |
INTERFERON ALPHA INDUCES MULTIPLE CELLULAR PROTEINS THAT COORDINATELY SUPPRESS HEPADNAVIRAL COVALENTLY CLOSED CIRCULAR DNA TRANSCRIPTION |
| 3780 |
INTERFERON DRIVES HCV SCARRING OF THE EPIGENOME AND CREATES TARGETABLE VULNERABILITIES FOLLOWING VIRAL CLEARANCE |
| 3781 |
INTERFERON SIGNATURE IN PATIENTS WITH STAT1 GAIN-OF-FUNCTION MUTATION IS EPIGENETICALLY DETERMINED |
| 3782 |
INTERFERON THERAPY OF CHRONIC HEPATITIS B |
| 3783 |
INTERFERON-GAMMA PROMOTER HYPOMETHYLATION AND INCREASED EXPRESSION IN CHRONIC PERIODONTITIS |
| 3784 |
INTERGENERATIONAL EFFECTS OF ALCOHOL: A REVIEW OF PATERNAL PRECONCEPTION ETHANOL EXPOSURE STUDIES AND EPIGENETIC MECHANISMS IN THE MALE GERMLINE |
| 3785 |
INTERGENERATIONAL EFFECTS OF PRE-PREGNANCY CHRONIC LIPOPOLYSACCHARIDE FROM PORPHYROMONAS GINGIVALIS ON THE LEARNING, MEMORY AND SEIZURE SUSCEPTIBILITY OF OFFSPRING |
| 3786 |
INTERGENERATIONAL INFLUENCES ON CHILD GROWTH AND UNDERNUTRITION |
| 3787 |
INTERGENERATIONAL METABOLIC SYNDROME AND NEURONAL NETWORK HYPEREXCITABILITY IN AUTISM |
| 3788 |
INTERLEUKIN 1 ALPHA (IL1A) POLYMORPHISMS AND RISK OF ENDOMETRIOSIS IN IRANIAN POPULATION: A CASE-CONTROL STUDY |
| 3789 |
INTERLEUKIN 17 CONTRIBUTES TO THE CHRONICITY OF INFLAMMATORY DISEASES SUCH AS RHEUMATOID ARTHRITIS |
| 3790 |
INTERLEUKIN 1BETA AND PROSTAGLANDIN E2 AFFECT EXPRESSION OF DNA METHYLATING AND DEMETHYLATING ENZYMES IN HUMAN GINGIVAL FIBROBLASTS |
| 3791 |
INTERLEUKIN 6 SUPPORTS THE MAINTENANCE OF P53 TUMOR SUPPRESSOR GENE PROMOTER METHYLATION |
| 3792 |
INTERLEUKIN-1BETA INCREASES THE RISK OF GASTRIC CANCER THROUGH INDUCTION OF ABERRANT DNA METHYLATION IN A MOUSE MODEL |
| 3793 |
INTERLEUKIN-22 IN ALCOHOLIC HEPATITIS AND BEYOND |
| 3794 |
INTERLEUKIN-33 MEDIATES BOTH IMMUNE-RELATED AND NON-IMMUNE-RELATED INHIBITORY EFFECTS AGAINST HEPATITIS B VIRUS |
| 3795 |
INTERLEUKIN-6 CONTRIBUTES TO GROWTH IN CHOLANGIOCARCINOMA CELLS BY ABERRANT PROMOTER METHYLATION AND GENE EXPRESSION |
| 3796 |
INTERLEUKIN-6 PROMOTES TUMORIGENESIS BY ALTERING DNA METHYLATION IN ORAL CANCER CELLS |
| 3797 |
INTERNATIONAL BREAST CANCER AND NUTRITION: A MODEL FOR RESEARCH, TRAINING AND POLICY IN DIET, EPIGENETICS, AND CHRONIC DISEASE PREVENTION |
| 3798 |
INTERPLAY BETWEEN ACTIVATION OF ENDOGENOUS RETROVIRUSES AND INFLAMMATION AS COMMON PATHOGENIC MECHANISM IN NEUROLOGICAL AND PSYCHIATRIC DISORDERS |
| 3799 |
INTERPLAY BETWEEN INFLAMMATION AND EPIGENETIC CHANGES IN CANCER |
| 3800 |
INTERPLAY OF INFLAMMATORY MEDIATORS WITH EPIGENETICS AND CARTILAGE MODIFICATIONS IN OSTEOARTHRITIS |
| 3801 |
INTERPLAY OF VITAMIN D AND SIRT1 IN TISSUE-SPECIFIC METABOLISM-POTENTIAL ROLES IN PREVENTION AND TREATMENT OF NON-COMMUNICABLE DISEASES INCLUDING CANCER |
| 3802 |
INTERSTITIAL LUNG DISEASE IN CONNECTIVE TISSUE DISEASE: A COMMON LESION WITH HETEROGENEOUS MECHANISMS AND TREATMENT CONSIDERATIONS |
| 3803 |
INTESTINAL METAPLASIA OF THE STOMACH |
| 3804 |
INTESTINAL MICROBIOTA, CHRONIC INFLAMMATION, AND COLORECTAL CANCER |
| 3805 |
INTESTINE-SPECIFIC HOMEOBOX (ISX) INDUCES INTESTINAL METAPLASIA AND CELL PROLIFERATION TO CONTRIBUTE TO GASTRIC CARCINOGENESIS |
| 3806 |
INTRACELLULAR INTERFERON SIGNALLING PATHWAYS AS POTENTIAL REGULATORS OF COVALENTLY CLOSED CIRCULAR DNA IN THE TREATMENT OF CHRONIC HEPATITIS B |
| 3807 |
INTRACELLULAR PROTONS ACCELERATE AGING AND SWITCH ON AGING HALLMARKS IN MICE |
| 3808 |
INTRANASAL ADMINISTRATION OF ACINETOBACTER LWOFFII IN A MURINE MODEL OF ASTHMA INDUCES IL-6-MEDIATED PROTECTION ASSOCIATED WITH CECAL MICROBIOTA CHANGES |
| 3809 |
INTRAPERITONEAL 5-AZACYTIDINE ALLEVIATES NERVE INJURY-INDUCED PAIN IN RATS BY MODULATING DNA METHYLATION |
| 3810 |
INTRATHECAL 5-AZACYTIDINE INHIBITS GLOBAL DNA METHYLATION AND METHYL- CPG-BINDING PROTEIN 2 EXPRESSION AND ALLEVIATES NEUROPATHIC PAIN IN RATS FOLLOWING CHRONIC CONSTRICTION INJURY |
| 3811 |
INTRATUMORAL HETEROGENEITY: CLONAL COOPERATION IN EPITHELIAL-TO-MESENCHYMAL TRANSITION AND METASTASIS |
| 3812 |
INTRAUTERINE ENDOGENOUS HIGH GLUCOCORTICOIDS PROGRAM OVARIAN DYSFUNCTION IN FEMALE OFFSPRING SECONDARY TO PRENATAL CAFFEINE EXPOSURE |
| 3813 |
INTRAUTERINE GROWTH RESTRICTION INHIBITS EXPRESSION OF EUKARYOTIC ELONGATION FACTOR 2 KINASE, A REGULATOR OF PROTEIN TRANSLATION |
| 3814 |
INTRAUTERINE HYPOXIA AND EPIGENETIC PROGRAMMING IN LUNG DEVELOPMENT AND DISEASE |
| 3815 |
INTRAUTERINE PROGRAMMING MECHANISM FOR HYPERCHOLESTEROLEMIA IN PRENATAL CAFFEINE-EXPOSED FEMALE ADULT RAT OFFSPRING |
| 3816 |
INTRAUTERINE PROGRAMMING OF CARTILAGINOUS 11BETA-HSD2 INDUCED BY CORTICOSTERONE AND CAFFEINE MEDIATED SUSCEPTIBILITY TO ADULT OSTEOARTHRITIS |
| 3817 |
INTRAUTERINE PROGRAMMING OF THE ENDOCRINE PANCREAS |
| 3818 |
INTRINSIC AND ENVIRONMENTAL BASIS OF AGING: A NARRATIVE REVIEW |
| 3819 |
INTRINSIC MUTAGENIC PROPERTIES OF 5-CHLOROCYTOSINE: A MECHANISTIC CONNECTION BETWEEN CHRONIC INFLAMMATION AND CANCER |
| 3820 |
INTRODUCTION TO PRECLINICAL EVIDENCE FROM ANIMAL MODELS OF ENDOMETRIOSIS |
| 3821 |
INTRODUCTION: FROM PATHOGENESIS TO THERAPY, DEEP ENDOMETRIOSIS REMAINS A SOURCE OF CONTROVERSY |
| 3822 |
INVESTIGATING EPIGENETIC EFFECTS OF ACTIVATION-INDUCED DEAMINASE IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3823 |
INVESTIGATING THE EFFECTS OF A SYNTHETIC CANNABINOID ON THE PATHOGENESIS OF LEUKEMIA AND LEUKEMIC STEM CELLS: A NEW THERAPEUTIC APPROACH |
| 3824 |
INVESTIGATING THE EPIGENETIC EFFECTS OF A PROTOTYPE SMOKE-DERIVED CARCINOGEN IN HUMAN CELLS |
| 3825 |
INVESTIGATION OF CTNNB1 GENE MUTATIONS AND EXPRESSION IN HEPATOCELLULAR CARCINOMA AND CIRRHOSIS IN ASSOCIATION WITH HEPATITIS B VIRUS INFECTION |
| 3826 |
INVESTIGATION OF EPIGENETICS IN KIDNEY CELL BIOLOGY |
| 3827 |
INVESTIGATION OF HETEROCHROMATIN PROTEIN 1 FUNCTION IN THE MALARIA PARASITE PLASMODIUM FALCIPARUM USING A CONDITIONAL DOMAIN DELETION AND SWAPPING APPROACH |
| 3828 |
INVOLVEMENT OF B-CELL CLL/LYMPHOMA 2 PROMOTER METHYLATION IN CIGARETTE SMOKE EXTRACT-INDUCED EMPHYSEMA |
| 3829 |
INVOLVEMENT OF EPIGENETICS IN OSTEOARTHRITIS |
| 3830 |
INVOLVEMENT OF HISTONE LYSINE CROTONYLATION IN THE REGULATION OF NERVE-INJURY-INDUCED NEUROPATHIC PAIN |
| 3831 |
INVOLVEMENT OF INFLAMMATORY CYTOKINES AND EPIGENETIC MODIFICATION OF THE MTTFA COMPLEX IN T-HELPER CELLS OF PATIENTS' SUFFERING FROM NON-SMALL CELL LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 3832 |
INVOLVEMENT OF SPINAL SIRT1 IN DEVELOPMENT OF CHRONIC CONSTRICTION INJURY INDUCED NEUROPATHIC PAIN IN RATS |
| 3833 |
INVOLVEMENT OF THE DYNORPHIN/KOR SYSTEM ON THE NOCICEPTIVE, EMOTIONAL AND COGNITIVE MANIFESTATIONS OF JOINT PAIN IN MICE |
| 3834 |
INVOLVEMENTS OF LONG NONCODING RNAS IN OBESITY-ASSOCIATED INFLAMMATORY DISEASES |
| 3835 |
IONISING RADIATION INDUCES PROMOTER DNA HYPOMETHYLATION AND PERTURBS TRANSCRIPTIONAL ACTIVITY OF GENES INVOLVED IN MORPHOGENESIS DURING GASTRULATION IN ZEBRAFISH |
| 3836 |
IONIZING RADIATION POTENTIATES HIGH-FAT DIET-INDUCED INSULIN RESISTANCE AND REPROGRAMS SKELETAL MUSCLE AND ADIPOSE PROGENITOR CELLS |
| 3837 |
IONIZING RADIATION-INDUCED OXIDATIVE STRESS, EPIGENETIC CHANGES AND GENOMIC INSTABILITY: THE PIVOTAL ROLE OF MITOCHONDRIA |
| 3838 |
IOX1 IMPEDES HOST INFLAMMATION IN IMIQUIMOD-TRIGGERED PSORIASIS |
| 3839 |
IPSC-DERIVED NEURAL PRECURSOR CELLS: POTENTIAL FOR CELL TRANSPLANTATION THERAPY IN SPINAL CORD INJURY |
| 3840 |
IRON DEFICIENCY REPROGRAMS PHOSPHORYLATION SIGNALING AND REDUCES O-GLCNAC PATHWAYS IN NEURONAL CELLS |
| 3841 |
IRON SUPPLEMENTATION REVERSES THE REDUCTION OF HYDROXYMETHYLCYTOSINE IN HEPATIC DNA ASSOCIATED WITH CHRONIC ALCOHOL CONSUMPTION IN RATS |
| 3842 |
IRON- AND 2-OXOGLUTARATE-DEPENDENT DIOXYGENASES: AN EMERGING GROUP OF MOLECULAR TARGETS FOR NICKEL TOXICITY AND CARCINOGENICITY |
| 3843 |
IRON-MEDIATED EPIGENETIC ACTIVATION OF NRF2 TARGETS |
| 3844 |
IRREVERSIBLE DOWN-REGULATION OF MIR-375 IN THE LIVERS OF FISCHER 344 RATS AFTER CHRONIC FURAN EXPOSURE |
| 3845 |
IS AGING A "RETRO"SPECTIVE EVENT? REACTIVATION OF ENDOGENOUS RETROVIRUSES (ERVS), THE RELICS OF ANCIENT INFECTIONS, HAS BEEN IMPLICATED IN A NUMBER OF DISEASE CONTEXTS |
| 3846 |
IS ATHEROSCLEROSIS A NEUROGENIC PHENOMENON? IDENTIFIED RISK FACTORS FOR ATHEROSCLEROSIS INCLUDE DIET, AGE, GENDER, FAMILY HISTORY, STRESS, LIFESTYLE, SMOKING, DIABETES, DYSLIPIDEMIAS, HYPERTENSION, AND HIV |
| 3847 |
IS CHRONIC LONG-TERM INHIBITION OF GASTRIC SECRETION REALLY DANGEROUS? POWERFUL GASTRIC SECRETION INHIBITORS PRODUCE CANCER IN THEIR TARGET ORGAN, THE STOMACH, IN EXPERIMENTAL ANIMALS |
| 3848 |
IS EPIGENETICS AN IMPORTANT LINK BETWEEN EARLY LIFE EVENTS AND ADULT DISEASE? BACKGROUND: EPIGENETIC MECHANISMS PROVIDE ONE POTENTIAL EXPLANATION FOR HOW ENVIRONMENTAL INFLUENCES IN EARLY LIFE CAUSE LONG-TERM CHANGES IN CHRONIC DISEASE SUSCEPTIBILITY |
| 3849 |
IS ERADICATION OF HELICOBACTER PYLORI THE FEASIBLE WAY TO PREVENT GASTRIC CANCER? NEW EVIDENCE AND PROGRESS, BUT STILL A LONG WAY TO GO |
| 3850 |
IS GENDER A FACTOR AFFECTING LONG-TERM HETEROTOPIC OSSIFICATION INCIDENCE AFTER SINGLE-LEVEL CERVICAL DISC ARTHROPLASTY? BACKGROUND: CERVICAL DISC DISEASES HAVE BEEN TREATED BY CERVICAL DISC ARTHROPLASTY (CDA) |
| 3851 |
IS IRRITABLE BOWEL SYNDROME OUT OF DATE AND MISLEADING AS A DIAGNOSIS? AIM: THIS STUDY AIMED AT ASSESSING THE EFFICACY OF TARGETED INTERVENTIONS ADDRESSING COMMON FOOD SENSITIVITIES AND LIFESTYLE FACTORS THAT COMMONLY CONTRIBUTE TO THE PRESENTATION OF GASTROINTESTINAL PROBLEMS IDENTIFIED AS IRRITABLE BOWEL SYNDROME (IBS) |
| 3852 |
IS MATERNAL MICROBIAL METABOLISM AN EARLY-LIFE DETERMINANT OF HEALTH? MOUNTING EVIDENCE SUGGESTS THAT ENVIRONMENTAL STRESS EXPERIENCED IN UTERO (FOR EXAMPLE, MATERNAL NUTRITIONAL DEFICITS) ESTABLISHES A PREDISPOSITION IN THE NEWBORN TO THE DEVELOPMENT OF CHRONIC DISEASES LATER IN LIFE |
| 3853 |
IS MIR-223 UPREGULATION IN INFLAMMATORY BOWEL DISEASES A PROTECTIVE RESPONSE? INFLAMMATORY BOWEL DISEASES (IBD) ARE CHARACTERIZED BY CHRONIC INFLAMMATION AND DAMAGE OF COLONOCYTES WITH ETIOLOGY OF GENETIC, EPIGENETIC AND ENVIRONMENTAL FACTORS |
| 3854 |
IS PTSD AN EVOLUTIONARY SURVIVAL ADAPTATION INITIATED BY UNRESTRAINED CYTOKINE SIGNALING AND MAINTAINED BY EPIGENETIC CHANGE? INTRODUCTION: TREATMENT OUTCOMES FOR PTSD WITH CURRENT PSYCHOLOGICAL THERAPIES ARE POOR, WITH VERY FEW PATIENTS ACHIEVING SUSTAINED SYMPTOM REMISSION |
| 3855 |
IS THERE ANY THERAPEUTIC VALUE FOR THE USE OF HISTONE DEACETYLASE INHIBITORS FOR CHRONIC PAIN? CHRONIC PAIN IS A COMPLEX CLINICAL CONDITION THAT REDUCES THE QUALITY OF LIFE FOR BILLIONS OF PEOPLE |
| 3856 |
ISCHAEMIA REPERFUSION INJURY: MECHANISMS OF PROGRESSION TO CHRONIC GRAFT DYSFUNCTION |
| 3857 |
ISCHEMIA- REPERFUSION INJURY AND ITS INFLUENCE ON THE EPIGENETIC MODIFICATION OF THE DONOR KIDNEY GENOME |
| 3858 |
ISCHEMIA-INDUCED DNA HYPERMETHYLATION DURING KIDNEY TRANSPLANT PREDICTS CHRONIC ALLOGRAFT INJURY |
| 3859 |
ISLET STRUCTURE AND FUNCTION IN THE GK RAT |
| 3860 |
ISOCHROMOSOME 13 IN A PATIENT WITH CHILDHOOD-ONSET SCHIZOPHRENIA, ADHD, AND MOTOR TIC DISORDER |
| 3861 |
ISOLATION OF HUMAN ANTIGEN-SPECIFIC REGULATORY T CELLS WITH HIGH SUPPRESSIVE FUNCTION |
| 3862 |
ISOPATHIC USE OF AUTO-SARCODE OF DNA AS ANTI-MIASMATIC HOMEOPATHIC MEDICINE AND MODULATOR OF GENE EXPRESSION? INTRODUCTION: IN ADDITION TO THE FOUR PILLARS OF HOMEOPATHY, VITALISM AND THE MIASMATIC THEORY ARE OFTEN USED TO EXPLAIN THE HEALTH-DISEASE PROCESS |
| 3863 |
IT'S WHAT AND WHEN YOU EAT: AN OVERVIEW OF TRANSCRIPTIONAL AND EPIGENETIC RESPONSES TO DIETARY PERTURBATIONS IN PANCREATIC ISLETS |
| 3864 |
JAK-STAT PATHWAY INHIBITION PARTIALLY RESTORES INTESTINAL HOMEOSTASIS IN HDAC1- AND HDAC2-INTESTINAL EPITHELIAL CELL-DEFICIENT MICE |
| 3865 |
JAK2 REGULATES MISMATCH REPAIR PROTEIN-MEDIATED EPIGENETIC ALTERATIONS IN RESPONSE TO OXIDATIVE DAMAGE |
| 3866 |
JHDM1D AND HDAC1-3 MRNA EXPRESSION LEVELS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 3867 |
JMJD3/H3K27ME3 EPIGENETIC MODIFICATION REGULATES TH17/TREG CELL DIFFERENTIATION IN ULCERATIVE COLITIS |
| 3868 |
JMJD6 EXERTS FUNCTION IN NEUROPATHIC PAIN BY REGULATING NF?KAPPAB FOLLOWING PERIPHERAL NERVE INJURY IN RATS |
| 3869 |
JNK1 REGULATES HISTONE ACETYLATION IN TRIGEMINAL NEURONS FOLLOWING CHEMICAL STIMULATION |
| 3870 |
JUNCTIONAL ZONE ENDOMETRIUM ALTERATIONS IN GYNECOLOGICAL AND OBSTETRICAL DISORDERS AND IMPACT ON DIAGNOSIS, PROGNOSIS AND TREATMENT |
| 3871 |
JUVENILE MYELOMONOCYTIC LEUKEMIA - A BONA FIDE RASOPATHY SYNDROME |
| 3872 |
JUVENILE MYELOMONOCYTIC LEUKEMIA-A COMPREHENSIVE REVIEW AND RECENT ADVANCES IN MANAGEMENT |
| 3873 |
K-RAS AND P16(INK4A)ALTERATIONS IN SPUTUM OF NSCLC PATIENTS AND IN HEAVY ASYMPTOMATIC CHRONIC SMOKERS |
| 3874 |
KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS IMMEDIATE EARLY PROTEINS TRIGGER FOXQ1 EXPRESSION IN ORAL EPITHELIAL CELLS, ENGAGING IN A NOVEL LYTIC CYCLE-SUSTAINING POSITIVE FEEDBACK LOOP |
| 3875 |
KDM2A DEFICIENCY IN MACROPHAGES ENHANCES THERMOGENESIS TO PROTECT MICE AGAINST HFD-INDUCED OBESITY BY ENHANCING H3K36ME2 AT THE PPARG LOCUS |
| 3876 |
KDM4A-MEDIATED HISTONE DEMETHYLATION OF SLC7A11 INHIBITS CELL FERROPTOSIS IN OSTEOSARCOMA |
| 3877 |
KDM6A PROMOTES IMATINIB RESISTANCE THROUGH YY1-MEDIATED TRANSCRIPTIONAL UPREGULATION OF TRKA INDEPENDENTLY OF ITS DEMETHYLASE ACTIVITY IN CHRONIC MYELOGENOUS LEUKEMIA |
| 3878 |
KDM6B OVEREXPRESSION ACTIVATES INNATE IMMUNE SIGNALING AND IMPAIRS HEMATOPOIESIS IN MICE |
| 3879 |
KERATIN 19-EXPRESSING HEPATOCELLULAR CARCINOMA AND SMALL-DUCT TYPE INTRAHEPATIC CHOLANGIOCARCINOMA SHOW A SIMILAR POSTOPERATIVE CLINICAL COURSE BUT HAVE DISTINCT GENETIC FEATURES |
| 3880 |
KETAMINE: REPURPOSING AND REDEFINING A MULTIFACETED DRUG |
| 3881 |
KETOGENIC DIETS AND THE NERVOUS SYSTEM: A SCOPING REVIEW OF NEUROLOGICAL OUTCOMES FROM NUTRITIONAL KETOSIS IN ANIMAL STUDIES |
| 3882 |
KETONE BODIES AS METABOLITES AND SIGNALLING MOLECULES AT THE CROSSROAD BETWEEN INFLAMMATION AND EPIGENETIC CONTROL OF CARDIOMETABOLIC DISORDERS |
| 3883 |
KEY CHARACTERISTICS OF CARCINOGENS AS A BASIS FOR ORGANIZING DATA ON MECHANISMS OF CARCINOGENESIS |
| 3884 |
KIDNEY DISEASE IN DIABETES |
| 3885 |
KIDNEY FIBROSIS: FROM MECHANISMS TO THERAPEUTIC MEDICINES |
| 3886 |
KLF10 MEDIATED EPIGENETIC DYSREGULATION OF EPITHELIAL CD40/CD154 PROMOTES ENDOMETRIOSIS |
| 3887 |
KLOTHO METHYLATION IS LINKED TO UREMIC TOXINS AND CHRONIC KIDNEY DISEASE |
| 3888 |
KLOTHO PATHWAYS, MYELINATION DISORDERS, NEURODEGENERATIVE DISEASES, AND EPIGENETIC DRUGS |
| 3889 |
KLOTHO RECOVERY BY GENISTEIN VIA PROMOTER HISTONE ACETYLATION AND DNA DEMETHYLATION MITIGATES RENAL FIBROSIS IN MICE |
| 3890 |
KLOTHO, PHOSPHATE AND INFLAMMATION/AGEING IN CHRONIC KIDNEY DISEASE |
| 3891 |
KSHV VIL-6 ENHANCES INFLAMMATORY RESPONSES BY EPIGENETIC REPROGRAMMING |
| 3892 |
L-ACETYLCARNITINE CAUSES RAPID ANTIDEPRESSANT EFFECTS THROUGH THE EPIGENETIC INDUCTION OF MGLU2 RECEPTORS |
| 3893 |
LACTATE INDUCES METABOLIC AND EPIGENETIC REPROGRAMMING OF PRO-INFLAMMATORY TH17 CELLS |
| 3894 |
LAMIN B1 REGULATES SOMATIC MUTATIONS AND PROGRESSION OF B-CELL MALIGNANCIES |
| 3895 |
LANDSCAPES AND MECHANISMS OF CD8(+) T CELL EXHAUSTION IN GASTROINTESTINAL CANCER |
| 3896 |
LARGE-SCALE ANALYSIS OF DNA METHYLATION IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 3897 |
LARGE-SCALE ANALYSIS OF THE GENETIC AND EPIGENETIC ALTERATIONS IN HEPATOCELLULAR CARCINOMA FROM SOUTHEAST CHINA |
| 3898 |
LARGE-SCALE TOPOLOGICAL DISRUPTION OF CHROMOSOME TERRITORIES 9 AND 22 IS ASSOCIATED WITH NONRESPONSE TO TREATMENT IN CML |
| 3899 |
LATE NEUROLOGICAL CONSEQUENCES OF ZIKA VIRUS INFECTION: RISK FACTORS AND PHARMACEUTICAL APPROACHES |
| 3900 |
LATEST INSIGHTS INTO PATHOGENESIS OF MYCOSIS FUNGOIDES AND CUTANEOUS T-CELL LYMPHOMA |
| 3901 |
LEAD (PB) AND NEURODEVELOPMENT: A REVIEW ON EXPOSURE AND BIOMARKERS OF EFFECT (BDNF, HDL) AND SUSCEPTIBILITY |
| 3902 |
LEARNING FROM THE FAILURES OF DRUG DISCOVERY IN B-CELL NON-HODGKIN LYMPHOMAS AND PERSPECTIVES FOR THE FUTURE: CHRONIC LYMPHOCYTIC LEUKEMIA AND DIFFUSE LARGE B-CELL LYMPHOMA AS TWO ENDS OF A SPECTRUM IN DRUG DEVELOPMENT |
| 3903 |
LEP, LDLR AND APOA4 GENE POLYMORPHISMS AND THEIR RELATIONSHIP WITH THE RISK OF OVERWEIGHT, OBESITY AND CHRONIC DISEASES IN ADULTS OF THE STATE OF SUCRE, VENEZUELA |
| 3904 |
LEPROSY PIRNOME: EXPLORING NEW POSSIBILITIES FOR AN OLD DISEASE |
| 3905 |
LEPTIN PROMOTER METHYLATION IN FEMALE PATIENTS WITH PAINFUL MULTISOMATOFORM DISORDER AND CHRONIC WIDESPREAD PAIN |
| 3906 |
LESSONS LEARNED--RESOLVING THE ENIGMA OF GENETIC FACTORS IN IBS |
| 3907 |
LEUCOCYTIC DNA METHYLATION OF INTERLEUKIN-6 PROMOTER REDUCTION IN PRE-HYPERTENSIVE YOUNG ADULTS |
| 3908 |
LICHEN SCLEROSUS: AN AUTOIMMUNOPATHOGENIC AND GENOMIC ENIGMA WITH EMERGING GENETIC AND IMMUNE TARGETS |
| 3909 |
LIFE AFTER PANCREAS TRANSPLANTATION: REVERSAL OF DIABETIC LESIONS |
| 3910 |
LIFE COURSE OF ASTHMA |
| 3911 |
LIFE-COURSE SOCIOECONOMIC STATUS AND DNA METHYLATION OF GENES REGULATING INFLAMMATION |
| 3912 |
LIFE-SPAN EXTENSION BY CALORIC RESTRICTION IS DETERMINED BY TYPE AND LEVEL OF FOOD REDUCTION AND BY REPRODUCTIVE MODE IN BRACHIONUS MANJAVACAS (ROTIFERA) |
| 3913 |
LIFESTYLE MODIFICATIONS AND NUTRITIONAL AND THERAPEUTIC INTERVENTIONS IN DELAYING THE PROGRESSION OF CHRONIC KIDNEY DISEASE: A REVIEW |
| 3914 |
LIFETIME STRESS ACCELERATES EPIGENETIC AGING IN AN URBAN, AFRICAN AMERICAN COHORT: RELEVANCE OF GLUCOCORTICOID SIGNALING |
| 3915 |
LINE-1 IN OBESITY AND CARDIOMETABOLIC DISEASES: A SYSTEMATIC REVIEW |
| 3916 |
LINE1 CPG-DNA HYPOMETHYLATION IN GRANULOSA CELLS AND BLOOD LEUKOCYTES IS ASSOCIATED WITH PCOS AND RELATED TRAITS |
| 3917 |
LINK BETWEEN CHRONIC INFLAMMATION AND HUMAN PAPILLOMAVIRUS-INDUCED CARCINOGENESIS (REVIEW) |
| 3918 |
LINKING ABERRANT CHROMATIN FEATURES IN CHRONIC LYMPHOCYTIC LEUKEMIA TO TRANSCRIPTION FACTOR NETWORKS |
| 3919 |
LINKING DIET TO COLORECTAL CANCER: THE EMERGING ROLE OF MICRORNA IN THE COMMUNICATION BETWEEN PLANT AND ANIMAL KINGDOMS |
| 3920 |
LINKING IMMUNITY, EPIGENETICS, AND CANCER IN INFLAMMATORY BOWEL DISEASE |
| 3921 |
LINKING INFLAMMATION TO CELL CYCLE PROGRESSION |
| 3922 |
LIPIDS AND THE HALLMARKS OF AGEING: FROM PATHOLOGY TO INTERVENTIONS |
| 3923 |
LIPOPROTEIN LIPASE IN CHRONIC LYMPHOCYTIC LEUKAEMIA - STRONG BIOMARKER WITH LACK OF FUNCTIONAL SIGNIFICANCE |
| 3924 |
LIPOSOMAL UHRF1 SIRNA SHOWS LUNG FIBROSIS TREATMENT POTENTIAL THROUGH REGULATION OF FIBROBLAST ACTIVATION |
| 3925 |
LIQUID BIOPSIES BASED ON DNA METHYLATION AS BIOMARKERS FOR THE DETECTION AND PROGNOSIS OF LUNG CANCER |
| 3926 |
LITERATURE REVIEW AND METHODOLOGICAL CONSIDERATIONS FOR UNDERSTANDING CIRCULATING RISK BIOMARKERS FOLLOWING TRAUMA EXPOSURE |
| 3927 |
LIVER ABNORMALITIES AFTER ELIMINATION OF HCV INFECTION: PERSISTENT EPIGENETIC AND IMMUNOLOGICAL PERTURBATIONS POST-CURE |
| 3928 |
LIVER CELL CIRCUITS AND THERAPEUTIC DISCOVERY FOR ADVANCED LIVER DISEASE AND CANCER |
| 3929 |
LIVER EPIGENOME CHANGES IN PATIENTS WITH HEPATOPULMONARY SYNDROME: A PILOT STUDY |
| 3930 |
LIVER FIBROGENESIS: UN UPDATE ON ESTABLISHED AND EMERGING BASIC CONCEPTS |
| 3931 |
LIVER INJURY AND THE ACTIVATION OF THE HEPATIC MYOFIBROBLASTS |
| 3932 |
LIVER REGENERATION, LIVER CANCERS AND CYCLINS |
| 3933 |
LIVER SINUSOIDAL ENDOTHELIAL CELLS ARE IMPLICATED IN MULTIPLE FIBROTIC MECHANISMS |
| 3934 |
LIVER TUMOR INDUCTION |
| 3935 |
LIVER-SPECIFIC KNOCKDOWN OF CLASS IIA HDACS HAS LIMITED EFFICACY ON GLUCOSE METABOLISM BUT ENTAILS SEVERE ORGAN SIDE EFFECTS IN MICE |
| 3936 |
LIVING IN ENDEMIC AREA FOR INFECTIOUS DISEASES ACCELERATES EPIGENETIC AGE |
| 3937 |
LKB1 SIGNALING IS ALTERED IN SKELETAL MUSCLE OF A DUCHENNE MUSCULAR DYSTROPHY MOUSE MODEL |
| 3938 |
LNC(ING)RNAS TO THE "SHOCK AND KILL" STRATEGY FOR HIV-1 CURE |
| 3939 |
LNC-IL7R ALLEVIATES PM(2 |
| 3940 |
LNCRNA DLEU2 REGULATES SIRTUINS AND MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX IV: A NOVEL PATHWAY IN OBESITY AND OFFSPRING'S HEALTH |
| 3941 |
LNCRNA DRAIR IS DOWNREGULATED IN DIABETIC MONOCYTES AND MODULATES THE INFLAMMATORY PHENOTYPE VIA EPIGENETIC MECHANISMS |
| 3942 |
LNCRNA DUXAP10 UPREGULATION AND THE HEDGEHOG PATHWAY ACTIVATION ARE CRITICALLY INVOLVED IN CHRONIC CADMIUM EXPOSURE-INDUCED CANCER STEM CELL-LIKE PROPERTY |
| 3943 |
LNCRNA ENST00000563492 PROMOTING THE OSTEOGENESIS-ANGIOGENESIS COUPLING PROCESS IN BONE MESENCHYMAL STEM CELLS (BMSCS) BY FUNCTIONS AS A CERNA FOR MIR-205-5P |
| 3944 |
LNCRNA H19-EZH2 INTERACTION PROMOTES LIVER FIBROSIS VIA REPROGRAMMING H3K27ME3 PROFILES |
| 3945 |
LNCRNA IL21-AS1 INTERACTS WITH HNRNPU PROTEIN TO PROMOTE IL21 OVEREXPRESSION AND ABERRANT DIFFERENTIATION OF TFH CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS |
| 3946 |
LNCRNA MALAT1 BINDS CHROMATIN REMODELING SUBUNIT BRG1 TO EPIGENETICALLY PROMOTE INFLAMMATION-RELATED HEPATOCELLULAR CARCINOMA PROGRESSION |
| 3947 |
LNCRNA UCA1 INDUCES AUTOPHAGIC GENE EXPRESSION VIA EPIGENETIC REGULATION MEDIATED BY ATG16L1 AND MIR-132-3P IN SH-SY5Y CELLS TREATED WITH RETINOIC ACID |
| 3948 |
LNCRNA-CD160 DECREASES THE IMMUNITY OF CD8(+) T CELLS THROUGH EPIGENETIC MECHANISMS IN HEPATITIS B VIRUS INFECTION |
| 3949 |
LNCRNAS IN T LYMPHOCYTES: RNA REGULATION AT THE HEART OF THE IMMUNE RESPONSE |
| 3950 |
LNFLAMMATION-INDUCED EPIGENETIC SWITCHES IN CANCER |
| 3951 |
LOCUS-SPECIFIC DIFFERENTIAL DNA METHYLATION AND URINARY ARSENIC: AN EPIGENOME-WIDE ASSOCIATION STUDY IN BLOOD AMONG ADULTS WITH LOW-TO-MODERATE ARSENIC EXPOSURE |
| 3952 |
LOCUS-SPECIFIC EPIGENETIC REMODELING CONTROLS ADDICTION- AND DEPRESSION-RELATED BEHAVIORS |
| 3953 |
LOCUS-SPECIFIC REVERSIBLE DNA METHYLATION REGULATES TRANSIENT IL-10 EXPRESSION IN TH1 CELLS |
| 3954 |
LONG INTERSPERSED NUCLEAR ELEMENT-1 METHYLATION STATUS IN THE CIRCULATING DNA FROM BLOOD OF PATIENTS WITH MALIGNANT AND CHRONIC INFLAMMATORY LUNG DISEASES |
| 3955 |
LONG MARCH TOWARD SAFE AND EFFECTIVE ANALGESIA BY ENHANCING GENE EXPRESSION OF KCC2: FIRST STEPS TAKEN |
| 3956 |
LONG NON-CODING RNA GENES POLYMORPHISMS H19 (RS2251375) AND MALAT1 (RS3200401) ASSOCIATION WITH RHEUMATOID ARTHRITIS AND THEIR CORRELATION WITH DISEASE ACTIVITY IN A COHORT OF EGYPTIAN PATIENTS: A PILOT STUDY |
| 3957 |
LONG NON-CODING RNAS AS EMERGING REGULATORS OF MIRNAS AND EPIGENETICS IN DIABETES-RELATED CHRONIC KIDNEY DISEASE |
| 3958 |
LONG NON-CODING RNAS IN BONE METASTASIS: PROGRESSES AND PERSPECTIVES AS POTENTIAL DIAGNOSTIC AND PROGNOSTIC BIOMARKERS |
| 3959 |
LONG NON-CODING RNAS TARGET PATHOGENETICALLY RELEVANT GENES AND PATHWAYS IN RHEUMATOID ARTHRITIS |
| 3960 |
LONG NON-CODING RNAS: A DOUBLE-EDGED SWORD IN AGING KIDNEY AND RENAL DISEASE |
| 3961 |
LONG NON-CODING RNAS: THE NEW FRONTIER INTO UNDERSTANDING THE ETIOLOGY OF ALCOHOL USE DISORDER |
| 3962 |
LONG NONCODING RNA LEENE PROMOTES ANGIOGENESIS AND ISCHEMIC RECOVERY IN DIABETES MODELS |
| 3963 |
LONG NONCODING RNA UC |
| 3964 |
LONG NONCODING RNAS IN LUNG CANCER |
| 3965 |
LONG NONCODING RNAS IN THE METABOLIC CONTROL OF INFLAMMATION AND IMMUNE DISORDERS |
| 3966 |
LONG NONCODING TRANSCRIPTOME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 3967 |
LONG TERM EXPOSURE TO POLYPHENOLS OF ARTICHOKE (CYNARA SCOLYMUS L |
| 3968 |
LONG-LASTING ANALGESIA VIA TARGETED IN SITU REPRESSION OF NA(V)1 |
| 3969 |
LONG-LASTING DEPRESSION-LIKE BEHAVIOR AND EPIGENETIC CHANGES OF BDNF GENE EXPRESSION INDUCED BY PERINATAL EXPOSURE TO METHYLMERCURY |
| 3970 |
LONG-LASTING EPIGENETIC CHANGES IN THE DOPAMINE TRANSPORTER IN ADULT ANIMALS EXPOSED TO AMPHETAMINE DURING EMBRYOGENESIS: INVESTIGATING BEHAVIORAL EFFECTS |
| 3971 |
LONG-LASTING NEUROTOXIC EFFECTS OF EXPOSURE TO METHYLMERCURY DURING DEVELOPMENT |
| 3972 |
LONG-TERM BEHAVIORAL AND CELL-TYPE-SPECIFIC MOLECULAR EFFECTS OF EARLY LIFE STRESS ARE MEDIATED BY H3K79ME2 DYNAMICS IN MEDIUM SPINY NEURONS |
| 3973 |
LONG-TERM BEHAVIORAL AND NEUROENDOCRINE ALTERATIONS FOLLOWING CHRONIC SOCIAL STRESS IN MICE: IMPLICATIONS FOR STRESS-RELATED DISORDERS |
| 3974 |
LONG-TERM CADMIUM EXPOSURE IMPAIRS COGNITIVE FUNCTION BY ACTIVATING LNC-GM10532/M6A/FIS1 AXIS-MEDIATED MITOCHONDRIAL FISSION AND DYSFUNCTION |
| 3975 |
LONG-TERM CONSEQUENCES OF PLACENTAL VASCULAR PATHOLOGY ON THE MATERNAL AND OFFSPRING CARDIOVASCULAR SYSTEMS |
| 3976 |
LONG-TERM DEFECTS OF NASAL EPITHELIUM BARRIER FUNCTIONS IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA POST CHEMO-RADIOTHERAPY |
| 3977 |
LONG-TERM EFFECT OF POST-TRAUMATIC STRESS IN ADOLESCENCE ON DENDRITE DEVELOPMENT AND H3K9ME2/BDNF EXPRESSION IN MALE RAT HIPPOCAMPUS AND PREFRONTAL CORTEX |
| 3978 |
LONG-TERM EFFECTS OF PRENATAL SEVERE HYPOXIA ON CENTRAL AND PERIPHERAL COMPONENTS OF THE GLUCOCORTICOID SYSTEM IN RATS |
| 3979 |
LONG-TERM EFFECTS OF STRESS EARLY IN LIFE ON MICRORNA-30A AND ITS NETWORK: PREVENTIVE EFFECTS OF LURASIDONE AND POTENTIAL IMPLICATIONS FOR DEPRESSION VULNERABILITY |
| 3980 |
LONG-TERM EPIGENETIC ALTERATIONS IN A RAT MODEL OF GULF WAR ILLNESS |
| 3981 |
LONG-TERM EPIGENETIC THERAPY WITH ORAL ZEBULARINE HAS MINIMAL SIDE EFFECTS AND PREVENTS INTESTINAL TUMORS IN MICE |
| 3982 |
LONG-TERM EXPOSURE OF LEUKEMIA CELLS TO MULTI-TARGETED TYROSINE KINASE INHIBITOR INDUCES ACTIVATIONS OF AKT, ERK AND STAT5 SIGNALING VIA EPIGENETIC SILENCING OF THE PTEN GENE |
| 3983 |
LONG-TERM EXPOSURE TO CIGARETTE SMOKE EXTRACT INDUCES HYPOMETHYLATION AT THE RUNX3 AND IGF2-H19 LOCI IN IMMORTALIZED HUMAN UROTHELIAL CELLS |
| 3984 |
LONG-TERM IMPACT OF MATERNAL HIGH-FAT DIET ON OFFSPRING CARDIAC HEALTH: ROLE OF MICRO-RNA BIOGENESIS |
| 3985 |
LONG-TERM MAINTENANCE OF THE MUCOSAL HEALING INDUCED BY AZACITIDINE THERAPY IN A PATIENT WITH INTESTINAL BEHCET'S-LIKE DISEASE ACCOMPANIED WITH MYELODYSPLASTIC SYNDROME INVOLVING TRISOMY 8 |
| 3986 |
LONG-TERM OVARIECTOMY INCREASES BDNF GENE METHYLATION STATUS IN MOUSE HIPPOCAMPUS |
| 3987 |
LONG-TERM PROBIOTIC INTERVENTION MITIGATES MEMORY DYSFUNCTION THROUGH A NOVEL H3K27ME3-BASED MECHANISM IN LEAD-EXPOSED RATS |
| 3988 |
LONG-TERM WINDOW OF ISCHEMIC TOLERANCE: AN EVOLUTIONARILY CONSERVED FORM OF METABOLIC PLASTICITY REGULATED BY EPIGENETIC MODIFICATIONS? IN THE ABSENCE OF EFFECTIVE NEUROPROTECTIVE AGENTS IN THE CLINIC, ISCHEMIC AND PHARMACOLOGICAL PRECONDITIONING ARE GAINING INCREASED INTEREST IN THE FIELD OF CEREBRAL ISCHEMIA |
| 3989 |
LONGITUDINAL ANALYSIS OF BLOOD DNA METHYLATION IDENTIFIES MECHANISMS OF RESPONSE TO TUMOR NECROSIS FACTOR INHIBITOR THERAPY IN RHEUMATOID ARTHRITIS |
| 3990 |
LONGITUDINAL ASSOCIATIONS BETWEEN USE OF ANTIHYPERTENSIVE, ANTIDIABETIC, AND LIPID-LOWERING MEDICATIONS AND BIOLOGICAL AGING |
| 3991 |
LONGITUDINAL EFFECTS OF DEVELOPMENTAL BISPHENOL A, VARIABLE DIET, AND PHYSICAL ACTIVITY ON AGE-RELATED METHYLATION IN BLOOD |
| 3992 |
LONGITUDINAL EPIGENOME-WIDE ANALYSIS OF KIDNEY TRANSPLANT RECIPIENTS PRETRANSPLANT AND POSTTRANSPLANT |
| 3993 |
LONGITUDINAL FOLLOW-UP OF THE ASTHMA STATUS IN A FRENCH-CANADIAN COHORT |
| 3994 |
LONGITUDINAL PROFILING IN PATIENTS UNDERGOING CARDIAC SURGERY REVEALS POSTOPERATIVE CHANGES IN DNA METHYLATION |
| 3995 |
LONGITUDINAL STUDY OF DNA METHYLATION OF INFLAMMATORY GENES AND CANCER RISK |
| 3996 |
LOOKING FORWARD: NOVEL THERAPEUTIC APPROACHES IN CHRONIC AND ADVANCED PHASES OF MYELOFIBROSIS |
| 3997 |
LOSS OF DNMT3A INDUCES CLL AND PTCL WITH DISTINCT METHYLOMES AND TRANSCRIPTOMES IN MICE |
| 3998 |
LOSS OF EPIGENETIC MODIFICATION DRIVEN BY THE FOXP3 TRANSCRIPTION FACTOR LEADS TO REGULATORY T CELL INSUFFICIENCY |
| 3999 |
LOSS OF HDAC3 RESULTS IN NONRECEPTIVE ENDOMETRIUM AND FEMALE INFERTILITY |
| 4000 |
LOSS OF HISTONE H3 K79 METHYLTRANSFERASE DOT1L FACILITATES KIDNEY FIBROSIS BY UPREGULATING ENDOTHELIN 1 THROUGH HISTONE DEACETYLASE 2 |
| 4001 |
LOSS OF MEN1 LEADS TO RENAL FIBROSIS AND DECREASES HGF-ADAMTS5 PATHWAY ACTIVITY VIA AN EPIGENETIC MECHANISM |
| 4002 |
LOSS OF P120 CATENIN AND LINKS TO MITOTIC ALTERATIONS, INFLAMMATION, AND SKIN CANCER |
| 4003 |
LOSS OF PRMT7 REPROGRAMS GLYCINE METABOLISM TO SELECTIVELY ERADICATE LEUKEMIA STEM CELLS IN CML |
| 4004 |
LOSS OF THE POLYCOMB MARK FROM BIVALENT PROMOTERS LEADS TO ACTIVATION OF CANCER-PROMOTING GENES IN COLORECTAL TUMORS |
| 4005 |
LOSS OF THE TUMOR SUPPRESSOR BAP1 CAUSES MYELOID TRANSFORMATION |
| 4006 |
LOST AMONG THE TREES? THE AUTONOMIC NERVOUS SYSTEM AND PAEDIATRICS |
| 4007 |
LOW BIRTHWEIGHT AS A RISK FACTOR FOR NON-COMMUNICABLE DISEASES IN ADULTS |
| 4008 |
LOW DOSE OF URANIUM INDUCES MULTIGENERATIONAL EPIGENETIC EFFECTS IN RAT KIDNEY |
| 4009 |
LOW LEVELS OF CD INDUCE PERSISTING EPIGENETIC MODIFICATIONS AND ACCLIMATION MECHANISMS IN THE EARTHWORM LUMBRICUS TERRESTRIS |
| 4010 |
LOW MATERNAL ADHERENCE TO A MEDITERRANEAN DIET IS ASSOCIATED WITH INCREASE IN METHYLATION AT THE MEG3-IG DIFFERENTIALLY METHYLATED REGION IN FEMALE INFANTS |
| 4011 |
LOW PATERNAL DIETARY FOLATE ALTERS THE MOUSE SPERM EPIGENOME AND IS ASSOCIATED WITH NEGATIVE PREGNANCY OUTCOMES |
| 4012 |
LOW-DENSITY GRANULOCYTES IN SYSTEMIC AUTOIMMUNITY AND AUTOINFLAMMATION |
| 4013 |
LOW-DENSITY LIPOPROTEIN-CHOLESTEROL-INDUCED ENDOTHELIAL DYSFUNCTION AND OXIDATIVE STRESS: THE ROLE OF STATINS |
| 4014 |
LOW-DOSE CD INDUCES HEPATIC GENE HYPERMETHYLATION, ALONG WITH THE PERSISTENT REDUCTION OF CELL DEATH AND INCREASE OF CELL PROLIFERATION IN RATS AND MICE |
| 4015 |
LOW-DOSE EXPOSURE TO BISPHENOLS A, F AND S OF HUMAN PRIMARY ADIPOCYTE IMPACTS CODING AND NON-CODING RNA PROFILES |
| 4016 |
LOW-DOSE HYDRALAZINE PREVENTS FIBROSIS IN A MURINE MODEL OF ACUTE KIDNEY INJURY-TO-CHRONIC KIDNEY DISEASE PROGRESSION |
| 4017 |
LOW-DOSE HYDRALAZINE REDUCES ALBUMINURIA AND GLOMERULOSCLEROSIS IN A MOUSE MODEL OF OBESITY-RELATED CHRONIC KIDNEY DISEASE |
| 4018 |
LOW-DOSE IONIZING RADIATION: INDUCTION OF DIFFERENTIAL INTRACELLULAR SIGNALLING POSSIBLY AFFECTING INTERCELLULAR COMMUNICATION |
| 4019 |
LOW-DOSE OR LOW-DOSE-RATE IONIZING RADIATION-INDUCED BIOEFFECTS IN ANIMAL MODELS |
| 4020 |
LOW-MOLECULAR-WEIGHT FIBROBLAST GROWTH FACTOR 2 ATTENUATES HEPATIC FIBROSIS BY EPIGENETIC DOWN-REGULATION OF DELTA-LIKE1 |
| 4021 |
LOWERED DNA METHYLTRANSFERASE (DNMT-3B) MRNA EXPRESSION IS ASSOCIATED WITH GENOMIC DNA HYPERMETHYLATION IN PATIENTS WITH CHRONIC ALCOHOLISM |
| 4022 |
LSD1 FOR THE TARGETED REGULATION OF ADIPOSE TISSUE |
| 4023 |
LSD1-S112A EXACERBATES THE PATHOGENESIS OF CSE/LPS-INDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MICE |
| 4024 |
LUNG ALLOGRAFT EPITHELIUM DNA METHYLATION AGE IS ASSOCIATED WITH GRAFT CHRONOLOGIC AGE AND PRIMARY GRAFT DYSFUNCTION |
| 4025 |
LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: NEEDS AND OPPORTUNITIES FOR INTEGRATED RESEARCH |
| 4026 |
LUNG CANCER AND ITS ASSOCIATION WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: UPDATE ON NEXUS OF EPIGENETICS |
| 4027 |
LUNG CANCER IN A CF PATIENT: COMBINATION OF BAD LUCK OR IS THERE MORE TO SAY? PATIENTS WITH CYSTIC FIBROSIS HAVE INCREASED RISK FOR GASTROINTESTINAL CANCER, LYMPHOID LEUKEMIA AND TESTICULAR CARCINOMAS |
| 4028 |
LUNG TUMORS, COPD AND IMMUNE RESPONSE: IS EPIGENETICS THE BOTTOM LINE? NSCLC IS A HETEROGENEOUS DISORDER CONSISTING OF DISTINCT MOLECULAR SUBTYPES WHICH CAN BE TREATED BY USING SPECIFIC DRUGS TARGETED TO DISTINCT GENETIC LESIONS |
| 4029 |
LUNGS, BONE MARROW, AND ADIPOSE TISSUE |
| 4030 |
LUPUS ERYTHEMATOSUS: A SHORT ACCOUNT |
| 4031 |
LYSINE DEACETYLASE (KDAC) REGULATORY PATHWAYS: AN ALTERNATIVE APPROACH TO SELECTIVE MODULATION |
| 4032 |
M344 PROMOTES NONAMYLOIDOGENIC AMYLOID PRECURSOR PROTEIN PROCESSING WHILE NORMALIZING ALZHEIMER'S DISEASE GENES AND IMPROVING MEMORY |
| 4033 |
M6A HYPOMETHYLATION OF DNMT3B REGULATED BY ALKBH5 PROMOTES INTERVERTEBRAL DISC DEGENERATION VIA E4F1 DEFICIENCY |
| 4034 |
M6A METHYLATION PROMOTES WHITE-TO-BEIGE FAT TRANSITION BY FACILITATING HIF1A TRANSLATION |
| 4035 |
MACHINE-LEARNED ANALYSIS OF GLOBAL AND GLIAL/OPIOID INTERSECTION-RELATED DNA METHYLATION IN PATIENTS WITH PERSISTENT PAIN AFTER BREAST CANCER SURGERY |
| 4036 |
MACROPHAGE EPIGENETIC MEMORIES OF EARLY LIFE INJURY DRIVE NEONATAL NOCICEPTIVE PRIMING |
| 4037 |
MACROPHAGE IMMUNOMETABOLISM AND INFLAMMAGING: ROLES OF MITOCHONDRIAL DYSFUNCTION, CELLULAR SENESCENCE, CD38, AND NAD |
| 4038 |
MACROPHAGE IMPLICATION IN IPF: UPDATES ON IMMUNE, EPIGENETIC, AND METABOLIC PATHWAYS |
| 4039 |
MACROPHAGE NOX2 NADPH OXIDASE MAINTAINS ALVEOLAR HOMEOSTASIS IN MICE |
| 4040 |
MACROPHAGE PLASTICITY AND POLARIZATION: IN VIVO VERITAS |
| 4041 |
MACROPHAGE PLASTICITY IN DUCHENNE MUSCULAR DYSTROPHY: A NEXUS OF PATHOLOGICAL REMODELLING WITH THERAPEUTIC IMPLICATIONS |
| 4042 |
MACROPHAGES ACQUIRE A TNF-DEPENDENT INFLAMMATORY MEMORY IN ALLERGIC ASTHMA |
| 4043 |
MACROPHAGES IN CHRONIC LIVER FAILURE: DIVERSITY, PLASTICITY AND THERAPEUTIC TARGETING |
| 4044 |
MACROPHAGES IN OXIDATIVE STRESS AND MODELS TO EVALUATE THE ANTIOXIDANT FUNCTION OF DIETARY NATURAL COMPOUNDS |
| 4045 |
MACROPHAGES IN THE AGING LIVER AND AGE-RELATED LIVER DISEASE |
| 4046 |
MADE IN THE WOMB: MATERNAL PROGRAMMING OF OFFSPRING CARDIOVASCULAR FUNCTION BY AN OBESOGENIC WOMB |
| 4047 |
MAIN PATHOGENIC MECHANISMS AND RECENT ADVANCES IN COPD PERIPHERAL SKELETAL MUSCLE WASTING |
| 4048 |
MAINTENANCE AND PHARMACOLOGIC TARGETING OF ROR1 PROTEIN LEVELS VIA UHRF1 IN T(1;19) PRE-B-ALL |
| 4049 |
MAKING MEMORIES THAT LAST A LIFETIME: HERITABLE FUNCTIONS OF SELF-RENEWING MEMORY CD8 T CELLS |
| 4050 |
MALADAPTIVE TRAINED IMMUNITY AND CLONAL HEMATOPOIESIS AS POTENTIAL MECHANISTIC LINKS BETWEEN PERIODONTITIS AND INFLAMMATORY COMORBIDITIES |
| 4051 |
MALE OBESITY: EPIGENETIC ORIGIN AND EFFECTS IN SPERM AND OFFSPRING |
| 4052 |
MALIGNANT TRANSFORMATION OF A DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR (DNET) CHARACTERIZED BY GENOME-WIDE METHYLATION ANALYSIS |
| 4053 |
MANAGING KELOID SCARS: FROM RADIATION THERAPY TO ACTUAL AND POTENTIAL DRUG DELIVERIES |
| 4054 |
MAPK IS A MUTUAL PATHWAY TARGETED BY ANXIETY-RELATED MIRNAS, AND E2F5 IS A PUTATIVE TARGET FOR ANXIOLYTIC MIRNAS |
| 4055 |
MAPPING OF HISTONE MODIFICATIONS IN EPISOMAL HBV CCCDNA UNCOVERS AN UNUSUAL CHROMATIN ORGANIZATION AMENABLE TO EPIGENETIC MANIPULATION |
| 4056 |
MAPPING THE HETEROGENEITY OF HISTONE MODIFICATIONS ON HEPATITIS B VIRUS DNA USING LIVER NEEDLE BIOPSIES OBTAINED FROM CHRONICALLY INFECTED PATIENTS |
| 4057 |
MAPPING THE LINEAGE RELATIONSHIP BETWEEN CXCR5(+) AND CXCR5(-) CD4(+) T CELLS IN HIV-INFECTED HUMAN LYMPH NODES |
| 4058 |
MARKERS OF REJECTION OF A LUNG ALLOGRAFT: STATE OF THE ART |
| 4059 |
MASSIVE ANALYSIS OF CDNA ENDS (MACE) AND MIRNA EXPRESSION PROFILING IDENTIFIES PROATHEROGENIC PATHWAYS IN CHRONIC KIDNEY DISEASE |
| 4060 |
MAST CELLS, ANGIOGENESIS AND LYMPHANGIOGENESIS IN HUMAN GASTRIC CANCER |
| 4061 |
MATERNAL ADVERSITIES DURING PREGNANCY AND CORD BLOOD OXYTOCIN RECEPTOR (OXTR) DNA METHYLATION |
| 4062 |
MATERNAL AND CHILD HEALTH SERVICES AND AN INTEGRATED, LIFE-CYCLE APPROACH TO THE PREVENTION OF NON-COMMUNICABLE DISEASES |
| 4063 |
MATERNAL AND CHILDHOOD ASTHMA: RISK FACTORS, INTERACTIONS, AND RAMIFICATIONS |
| 4064 |
MATERNAL AND EARLY-LIFE CIRCADIAN DISRUPTION HAVE LONG-LASTING NEGATIVE CONSEQUENCES ON OFFSPRING DEVELOPMENT AND ADULT BEHAVIOR IN MICE |
| 4065 |
MATERNAL AND GESTATIONAL INFLUENCES ON CHILDHOOD BLOOD PRESSURE |
| 4066 |
MATERNAL AND PATERNAL PERICONCEPTIONAL NUTRITION AS AN INDICATOR OF OFFSPRING METABOLIC SYNDROME RISK IN LATER LIFE THROUGH EPIGENETIC IMPRINTING: A SYSTEMATIC REVIEW |
| 4067 |
MATERNAL AND PEDIATRIC HEALTH AND DISEASE: INTEGRATING BIOPSYCHOSOCIAL MODELS AND EPIGENETICS |
| 4068 |
MATERNAL ANDROGEN EXCESS AND OBESITY INDUCE SEXUALLY DIMORPHIC ANXIETY-LIKE BEHAVIOR IN THE OFFSPRING |
| 4069 |
MATERNAL CHRONIC FOLATE SUPPLEMENTATION AMELIORATES BEHAVIOR DISORDERS INDUCED BY PRENATAL HIGH-FAT DIET THROUGH METHYLATION ALTERATION OF BDNF AND GRIN2B IN OFFSPRING HIPPOCAMPUS |
| 4070 |
MATERNAL DIABETES, PROGRAMMING OF BETA-CELL DISORDERS AND INTERGENERATIONAL RISK OF TYPE 2 DIABETES |
| 4071 |
MATERNAL DIETARY DEFICIENCY OF N-3 FATTY ACIDS AFFECTS METABOLIC AND EPIGENETIC PHENOTYPES OF THE DEVELOPING FETUS |
| 4072 |
MATERNAL DNA METHYLATION SIGNATURES OF ARSENIC EXPOSURE IS ASSOCIATED WITH ADULT OFFSPRING INSULIN RESISTANCE IN THE STRONG HEART STUDY |
| 4073 |
MATERNAL EATING DISORDERS AFFECT OFFSPRING CORD BLOOD DNA METHYLATION: A PROSPECTIVE STUDY |
| 4074 |
MATERNAL EXPOSURE TO THE HOLOCAUST AND HEALTH COMPLAINTS IN OFFSPRING |
| 4075 |
MATERNAL HIGH-FAT DIET IMPAIRS LEPTIN SIGNALING AND UP-REGULATES TYPE-1 CANNABINOID RECEPTOR WITH SEX-SPECIFIC EPIGENETIC CHANGES IN THE HYPOTHALAMUS OF NEWBORN RATS |
| 4076 |
MATERNAL HIGH-FAT DIET MODIFIES EPIGENETIC MARKS H3K27ME3 AND H3K27AC IN BONE TO REGULATE OFFSPRING OSTEOBLASTOGENESIS IN MICE |
| 4077 |
MATERNAL INFLAMMATION INDUCES SPATIAL LEARNING AND MEMORY IMPAIRMENT IN THE F1 AND F2 GENERATIONS OF MICE VIA SEX-SPECIFIC EPIGENETIC MECHANISMS |
| 4078 |
MATERNAL INFLAMMATION, GROWTH RETARDATION, AND PRETERM BIRTH: INSIGHTS INTO ADULT CARDIOVASCULAR DISEASE |
| 4079 |
MATERNAL L-CARNITINE SUPPLEMENTATION AMELIORATES RENAL UNDERDEVELOPMENT AND EPIGENETIC CHANGES IN MALE MICE OFFSPRING DUE TO MATERNAL SMOKING |
| 4080 |
MATERNAL LIFESTYLE INTERVENTIONS: TARGETING PRECONCEPTION HEALTH |
| 4081 |
MATERNAL MICRONUTRIENT SUPPLEMENTATION SUPPRESSES T CELL CHEMOKINE RECEPTOR EXPRESSION AND FUNCTION IN F1 MICE |
| 4082 |
MATERNAL MODIFIERS OF THE INFANT GUT MICROBIOTA: METABOLIC CONSEQUENCES |
| 4083 |
MATERNAL NUTRITION AND FETAL DEVELOPMENT |
| 4084 |
MATERNAL NUTRITION DURING PREGNANCY AND HEALTH OF THE OFFSPRING |
| 4085 |
MATERNAL OBESITY AND GESTATIONAL DIABETES REPROGRAM THE METHYLOME OF OFFSPRING BEYOND BIRTH BY INDUCING EPIGENETIC SIGNATURES IN METABOLIC AND DEVELOPMENTAL PATHWAYS |
| 4086 |
MATERNAL OBESITY DISRUPTS THE METHIONINE CYCLE IN BABOON PREGNANCY |
| 4087 |
MATERNAL OBESITY INCREASES THE RISK OF METABOLIC DISEASE AND IMPACTS RENAL HEALTH IN OFFSPRING |
| 4088 |
MATERNAL OBESITY PROGRAMS OFFSPRING NON-ALCOHOLIC FATTY LIVER DISEASE THROUGH DISRUPTION OF 24-H RHYTHMS IN MICE |
| 4089 |
MATERNAL OBESITY PROGRAMS SENESCENCE SIGNALING AND GLUCOSE METABOLISM IN OSTEO-PROGENITORS FROM RAT AND HUMAN |
| 4090 |
MATERNAL PRE-PREGNANCY BMI, OFFSPRING EPIGENOME-WIDE DNA METHYLATION, AND CHILDHOOD OBESITY: FINDINGS FROM THE BOSTON BIRTH COHORT |
| 4091 |
MATERNAL PRECONCEPTION BODY MASS INDEX AND OFFSPRING CORD BLOOD DNA METHYLATION: EXPLORATION OF EARLY LIFE ORIGINS OF DISEASE |
| 4092 |
MATERNAL REPETITIVE HYPOXIA PRIOR TO MATING CONFERS EPIGENETIC RESILIENCE TO MEMORY IMPAIRMENT IN MALE PROGENY |
| 4093 |
MATERNAL SEPARATION FOLLOWED BY CHRONIC MILD STRESS IN ADULTHOOD IS ASSOCIATED WITH CONCERTED EPIGENETIC REGULATION OF AP-1 COMPLEX GENES |
| 4094 |
MATERNAL SIGNALS FOR PROGENY PREVENTION AGAINST ALLERGY AND ASTHMA |
| 4095 |
MATERNALLY DERIVED LOW GLUCOCORTICOID MEDIATES ADRENAL DEVELOPMENTAL PROGRAMMING ALTERATION IN OFFSPRING INDUCED BY DEXAMETHASONE |
| 4096 |
MATRIX METALLOPROTEINASES, NEURAL EXTRACELLULAR MATRIX, AND CENTRAL NERVOUS SYSTEM PATHOLOGY |
| 4097 |
MATRIX STIFFNESS REGULATES MACROPHAGE POLARIZATION IN ATHEROSCLEROSIS |
| 4098 |
MBD1 CONTRIBUTES TO THE GENESIS OF ACUTE PAIN AND NEUROPATHIC PAIN BY EPIGENETIC SILENCING OF OPRM1 AND KCNA2 GENES IN PRIMARY SENSORY NEURONS |
| 4099 |
MBD2 ENABLES TUMOURIGENESIS WITHIN THE INTESTINE WHILE PREVENTING TUMOUR-PROMOTING INFLAMMATION |
| 4100 |
MCPH1 MAINTAINS LONG-TERM EPIGENETIC SILENCING OF ANGPT2 IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 4101 |
MDCT AND MR UROGRAM SPECTRUM OF CONGENITAL ANOMALIES OF THE KIDNEY AND URINARY TRACT DIAGNOSED IN ADULTHOOD |
| 4102 |
MDR1-P-GLYCOPROTEIN BEHAVES AS AN ONCOFETAL PROTEIN THAT PROMOTES CELL SURVIVAL IN GASTRIC CANCER CELLS |
| 4103 |
MECHANICAL CUES REGULATE HISTONE MODIFICATIONS AND CELL BEHAVIOR |
| 4104 |
MECHANISM AND THERAPEUTIC OPPORTUNITIES OF HISTONE MODIFICATIONS IN CHRONIC LIVER DISEASE |
| 4105 |
MECHANISM AND THERAPEUTIC TARGETS OF C-JUN-N-TERMINAL KINASES ACTIVATION IN NONALCOHOLIC FATTY LIVER DISEASE |
| 4106 |
MECHANISM OF INFLAMMATION IN AGE-RELATED MACULAR DEGENERATION |
| 4107 |
MECHANISMS AFFECTING NEUROENDOCRINE AND EPIGENETIC REGULATION OF BODY WEIGHT AND ONSET OF PUBERTY: POTENTIAL IMPLICATIONS IN THE CHILD BORN SMALL FOR GESTATIONAL AGE (SGA) |
| 4108 |
MECHANISMS AND DISEASE CONSEQUENCES OF NONALCOHOLIC FATTY LIVER DISEASE |
| 4109 |
MECHANISMS AND DRUG THERAPY OF PULMONARY HYPERTENSION AT HIGH ALTITUDE |
| 4110 |
MECHANISMS BY WHICH PLEIOTROPIC AMPHIPHILIC N-3 PUFA REDUCE COLON CANCER RISK |
| 4111 |
MECHANISMS CONTRIBUTING TO PERSISTENTLY ACTIVATED CELL PHENOTYPES IN PULMONARY HYPERTENSION |
| 4112 |
MECHANISMS CONTRIBUTING TO THE COMORBIDITY OF COPD AND LUNG CANCER |
| 4113 |
MECHANISMS CONTRIBUTING TO THE DYSREGULATION OF MIRNA-124 IN PULMONARY HYPERTENSION |
| 4114 |
MECHANISMS FOR THE INDUCTION OF GASTRIC CANCER BY HELICOBACTER PYLORI INFECTION: ABERRANT DNA METHYLATION PATHWAY |
| 4115 |
MECHANISMS OF AGING OF THE EXTRACELLULAR MATRIX: ROLE OF THE ELASTIN-LAMININ RECEPTOR |
| 4116 |
MECHANISMS OF AIRWAY EPITHELIAL INJURY AND ABNORMAL REPAIR IN ASTHMA AND COPD |
| 4117 |
MECHANISMS OF AUTOPHAGIC RESPONSES TO ALTERED NUTRITIONAL STATUS |
| 4118 |
MECHANISMS OF BRAIN GLUCOCORTICOID RESISTANCE IN STRESS-INDUCED PSYCHOPATHOLOGIES |
| 4119 |
MECHANISMS OF CADMIUM CARCINOGENICITY IN THE GASTROINTESTINAL TRACT |
| 4120 |
MECHANISMS OF CARDIOVASCULAR DISORDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A PROCESS RELATED TO ACCELERATED SENESCENCE |
| 4121 |
MECHANISMS OF CHEMICALLY INDUCED RENAL CARCINOGENESIS IN THE LABORATORY RODENT |
| 4122 |
MECHANISMS OF DEVELOPMENT OF MULTIMORBIDITY IN THE ELDERLY |
| 4123 |
MECHANISMS OF DIMETHYLBENZANTHRACENE-INDUCED IMMUNOTOXICITY |
| 4124 |
MECHANISMS OF DISEASE PROGRESSION AND RESISTANCE TO TYROSINE KINASE INHIBITOR THERAPY IN CHRONIC MYELOID LEUKEMIA: AN UPDATE |
| 4125 |
MECHANISMS OF DISEASE: IN UTERO PROGRAMMING IN THE PATHOGENESIS OF HYPERTENSION |
| 4126 |
MECHANISMS OF DISEASE: THE DEVELOPMENTAL ORIGINS OF DISEASE AND THE ROLE OF THE EPIGENOTYPE |
| 4127 |
MECHANISMS OF DNA METHYLATION IN VIRUS-HOST INTERACTION IN HEPATITIS B INFECTION: PATHOGENESIS AND ONCOGENETIC PROPERTIES |
| 4128 |
MECHANISMS OF DRUG RESISTANCE IN THE PATHOGENESIS OF EPILEPSY: ROLE OF NEUROINFLAMMATION |
| 4129 |
MECHANISMS OF ENDOMETRIAL PROGESTERONE RESISTANCE |
| 4130 |
MECHANISMS OF FERROPTOSIS AND EMERGING LINKS TO THE PATHOLOGY OF NEURODEGENERATIVE DISEASES |
| 4131 |
MECHANISMS OF HBV-INDUCED HEPATOCELLULAR CARCINOMA |
| 4132 |
MECHANISMS OF HEPATIC FIBROGENESIS |
| 4133 |
MECHANISMS OF HEPATITIS B VIRUS-INDUCED HEPATOCARCINOGENESIS |
| 4134 |
MECHANISMS OF HUMAN HEPATOCARCINOGENESIS |
| 4135 |
MECHANISMS OF LUNG DAMAGE AND DEVELOPMENT OF COPD DUE TO HOUSEHOLD BIOMASS-SMOKE EXPOSURE: INFLAMMATION, OXIDATIVE STRESS, MICRORNAS, AND GENE POLYMORPHISMS |
| 4136 |
MECHANISMS OF MANGANESE-INDUCED NEUROTOXICITY AND THE PURSUIT OF NEUROTHERAPEUTIC STRATEGIES |
| 4137 |
MECHANISMS OF METABOLIC MEMORY AND RENAL HYPOXIA AS A THERAPEUTIC TARGET IN DIABETIC KIDNEY DISEASE |
| 4138 |
MECHANISMS OF MICROGLIAL ACTIVATION IN MODELS OF INFLAMMATION AND HYPOXIA: IMPLICATIONS FOR CHRONIC INTERMITTENT HYPOXIA |
| 4139 |
MECHANISMS OF MIGRAINE AS A CHRONIC EVOLUTIVE CONDITION |
| 4140 |
MECHANISMS OF P-GLYCOPROTEIN ALTERATION DURING ANTICANCER TREATMENT: ROLE IN THE PHARMACOKINETIC AND PHARMACOLOGICAL EFFECTS OF VARIOUS SUBSTRATE DRUGS |
| 4141 |
MECHANISMS OF POST-CRITICAL ILLNESS CARDIOVASCULAR DISEASE |
| 4142 |
MECHANISMS OF RESISTANCE TO TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA AND RECENT THERAPEUTIC STRATEGIES TO OVERCOME RESISTANCE |
| 4143 |
MECHANISMS OF SCARRING IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
| 4144 |
MECHANISMS OF STRESS-INDUCED VISCERAL PAIN |
| 4145 |
MECHANISMS OF VASCULAR AGING |
| 4146 |
MECHANISMS REGULATING MUSCLE PROTEIN SYNTHESIS IN CKD |
| 4147 |
MECHANISMS UNDERLYING BIOLOGICAL EFFECTS OF CRUCIFEROUS GLUCOSINOLATE-DERIVED ISOTHIOCYANATES/INDOLES: A FOCUS ON METABOLIC SYNDROME |
| 4148 |
MECHANISTIC BASIS OF EX VIVO UMBILICAL CORD BLOOD STEM PROGENITOR CELL EXPANSION |
| 4149 |
MECHANISTIC INSIGHT INTO THE EFFECTS OF CURCUMIN ON NEUROINFLAMMATION-DRIVEN CHRONIC PAIN |
| 4150 |
MECHANISTIC INSIGHTS INTO EPIGENETIC MODULATION OF ETHANOL CONSUMPTION |
| 4151 |
MECHANISTIC INSIGHTS INTO GLUCOSE INDUCED VASCULAR EPIGENETIC REPROGRAMMING IN TYPE 2 DIABETES |
| 4152 |
MECHANISTIC INSIGHTS INTO THE PLEIOTROPIC EFFECTS OF BUTYRATE AS A POTENTIAL THERAPEUTIC AGENT ON NAFLD MANAGEMENT: A SYSTEMATIC REVIEW |
| 4153 |
MECHANISTIC INSIGHTS OF CHEMICALS AND DRUGS AS RISK FACTORS FOR SYSTEMIC LUPUS ERYTHEMATOSUS |
| 4154 |
MECHANISTIC ROLES OF EPITHELIAL AND IMMUNE CELL SIGNALING DURING THE DEVELOPMENT OF COLITIS-ASSOCIATED CANCER |
| 4155 |
MECHANISTIC UNDERSTANDING OF THE TOXIC EFFECTS OF ARSENIC AND WARFARE ARSENICALS ON HUMAN HEALTH AND ENVIRONMENT |
| 4156 |
MECHANOBIOLOGY AND ADAPTIVE PLASTICITY THEORY AS A POTENTIAL CONFOUNDING FACTOR IN PREDICTING MUSCULOSKELETAL FOOT FUNCTION |
| 4157 |
MECHANOIMMUNOLOGY: ARE INFLAMMATORY EPIGENETIC STATES OF MACROPHAGES TUNED BY BIOPHYSICAL FACTORS? MANY INFLAMMATORY DISEASES THAT ARE RESPONSIBLE FOR A MAJORITY OF DEATHS ARE STILL UNCURABLE, IN PART AS THE UNDERPINNING PATHOMECHANISMS AND HOW TO COMBAT THEM IS STILL POORLY UNDERSTOOD |
| 4158 |
MECHANOTRANSDUCTION DETERMINES THE STRUCTURE AND FUNCTION OF LUNG AND BONE: A THEORETICAL MODEL FOR THE PATHOPHYSIOLOGY OF CHRONIC DISEASE |
| 4159 |
MECP2 CONTROLS AN EPIGENETIC PATHWAY THAT PROMOTES MYOFIBROBLAST TRANSDIFFERENTIATION AND FIBROSIS |
| 4160 |
MECP2 EPIGENETIC SILENCING OF OPRM1 GENE IN PRIMARY SENSORY NEURONS UNDER NEUROPATHIC PAIN CONDITIONS |
| 4161 |
MECP2 REGULATES ETHANOL SENSITIVITY AND INTAKE |
| 4162 |
MECP2 REGULATES PTCH1 EXPRESSION THROUGH DNA METHYLATION IN RHEUMATOID ARTHRITIS |
| 4163 |
MECP2 REPRESSION OF G9A IN REGULATION OF PAIN AND MORPHINE REWARD |
| 4164 |
MEDIATORS OF CAPILLARY-TO-VENULE CONVERSION IN THE CHRONIC INFLAMMATORY SKIN DISEASE PSORIASIS |
| 4165 |
MEDICAL SCHOOL HOTLINE: IMMUNOEPIGENETIC-MICROBIOME AXIS: IMPLICATIONS FOR HEALTH DISPARITIES RESEARCH IN NATIVE HAWAIIANS AND PACIFIC ISLANDERS |
| 4166 |
MEDICAL, ETHICAL, AND LEGAL ASPECTS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CROHN'S DISEASE IN BRAZIL |
| 4167 |
MEDICINE AND PHLEBOLYMPHOLOGY: TIME TO CHANGE? BIOMEDICAL SCIENCE IS UNDERGOING A REAPPRAISAL OF ITS SCIENTIFIC ADVANCEMENT PROCESS AND OF THE RELATED HEALTHCARE MANAGEMENT |
| 4168 |
MEDITERRANEAN DIET AS A TOOL TO COMBAT INFLAMMATION AND CHRONIC DISEASES |
| 4169 |
MEETING REPORT ON THE 3RD INTERNATIONAL CONGRESS ON DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (DOHAD) |
| 4170 |
MEETING REPORT: ISN FOREFRONTS IN NEPHROLOGY ON ENDOTHELIAL BIOLOGY AND RENAL DISEASE: FROM BENCH TO PREVENTION |
| 4171 |
MEGAKARYOCYTIC LEUKEMIA 1 DIRECTS A HISTONE H3 LYSINE 4 METHYLTRANSFERASE COMPLEX TO REGULATE HYPOXIC PULMONARY HYPERTENSION |
| 4172 |
MELATONIN IMPEDES TET1-DEPENDENT MGLUR5 PROMOTER DEMETHYLATION TO RELIEVE PAIN |
| 4173 |
MELATONIN INDUCES HISTONE HYPERACETYLATION IN THE RAT BRAIN |
| 4174 |
MELATONIN MEDIATED INHIBITION OF EZH2-NOS2 CROSSTALK ATTENUATES INFLAMMATORY BOWEL DISEASE IN PRECLINICAL IN VITRO AND IN VIVO MODELS |
| 4175 |
MELATONIN PROTECTS CHOLANGIOCYTES FROM OXIDATIVE STRESS-INDUCED PROAPOPTOTIC AND PROINFLAMMATORY STIMULI VIA MIR-132 AND MIR-34 |
| 4176 |
MELATONIN RELIEVES NEUROPATHIC ALLODYNIA THROUGH SPINAL MT2-ENHANCED PP2AC AND DOWNSTREAM HDAC4 SHUTTLING-DEPENDENT EPIGENETIC MODIFICATION OF HMGB1 TRANSCRIPTION |
| 4177 |
MEMORY T CELL, EXHAUSTION, AND TUMOR IMMUNITY |
| 4178 |
MEMORY T-CELL HETEROGENEITY AND TERMINOLOGY |
| 4179 |
MEN WHO INJECT OPIOIDS EXHIBIT ALTERED TRNA-GLY-GCC ISOFORMS IN SEMEN |
| 4180 |
MERCURY EXPOSURE INDUCES CYTOSKELETON DISRUPTION AND LOSS OF RENAL FUNCTION THROUGH EPIGENETIC MODULATION OF MMP9 EXPRESSION |
| 4181 |
MESENCHYMAL STEM CELLS IN IMMUNE-MEDIATED BONE MARROW FAILURE SYNDROMES |
| 4182 |
MESOAMERICAN NEPHROPATHY (MEN): WHAT WE KNOW SO FAR |
| 4183 |
META-HALLMARKS OF AGING AND CANCER |
| 4184 |
META-PREDICTION OF MTHFR GENE POLYMORPHISM-MUTATIONS, AIR POLLUTION, AND RISKS OF LEUKEMIA AMONG WORLD POPULATIONS |
| 4185 |
METABOLIC ADAPTIONS/REPROGRAMMING IN ISLET BETA-CELLS IN RESPONSE TO PHYSIOLOGICAL STIMULATORS-WHAT ARE THE CONSEQUENCES |
| 4186 |
METABOLIC AND EPIGENETIC REGULATION OF T-CELL EXHAUSTION |
| 4187 |
METABOLIC AND VASCULAR EFFECT OF THE MEDITERRANEAN DIET |
| 4188 |
METABOLIC ASSOCIATED FATTY LIVER DISEASE IN CHILDREN AND ADOLESCENTS: MECHANISMS OF A SILENT EPIDEMIC AND THERAPEUTIC OPTIONS |
| 4189 |
METABOLIC DISEASE PROGRAMMING: FROM MITOCHONDRIA TO EPIGENETICS, GLUCOCORTICOID SIGNALLING AND BEYOND |
| 4190 |
METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE: ADVANCES IN GENETIC AND EPIGENETIC IMPLICATIONS |
| 4191 |
METABOLIC LANDSCAPE IN CARDIAC AGING: INSIGHTS INTO MOLECULAR BIOLOGY AND THERAPEUTIC IMPLICATIONS |
| 4192 |
METABOLIC MEMORY AND CHRONIC DIABETES COMPLICATIONS: POTENTIAL ROLE FOR EPIGENETIC MECHANISMS |
| 4193 |
METABOLIC MEMORY AND DIABETIC NEPHROPATHY: BENEFICIAL EFFECTS OF NATURAL EPIGENETIC MODIFIERS |
| 4194 |
METABOLIC MEMORY IN DIABETIC FOOT SYNDROME (DFS): MICRO-RNAS, SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS) FREQUENCY AND THEIR RELATIONSHIP WITH INDICES OF ENDOTHELIAL FUNCTION AND ADIPO-INFLAMMATORY DYSFUNCTION |
| 4195 |
METABOLIC MEMORY: MECHANISMS AND IMPLICATIONS FOR DIABETIC RETINOPATHY |
| 4196 |
METABOLIC PLASTICITY AND REGULATION OF T CELL EXHAUSTION |
| 4197 |
METABOLIC PROFILES IN OVINE CAROTID ARTERIES WITH DEVELOPMENTAL MATURATION AND LONG-TERM HYPOXIA |
| 4198 |
METABOLIC PROFILING DISTINGUISHES THREE SUBTYPES OF ALZHEIMER'S DISEASE |
| 4199 |
METABOLIC REPROGRAMMING AND CELL FATE REGULATION IN ALCOHOLIC LIVER DISEASE |
| 4200 |
METABOLIC REQUIREMENTS OF TH17 CELLS AND OF B CELLS: REGULATION AND DEFECTS IN HEALTH AND IN INFLAMMATORY DISEASES |
| 4201 |
METABOLIC REWIRING AND REDOX ALTERATIONS IN MALIGNANT PLEURAL MESOTHELIOMA |
| 4202 |
METABOLIC SYNDROME IN CHILDREN BORN SMALL-FOR-GESTATIONAL AGE |
| 4203 |
METABOLISM OF DOXORUBICIN TO THE CARDIOTOXIC METABOLITE DOXORUBICINOL IS INCREASED IN A MOUSE MODEL OF CHRONIC GLUTATHIONE DEFICIENCY: A POTENTIAL ROLE FOR CARBONYL REDUCTASE 3 |
| 4204 |
METABOLISM, EPIGENETICS, AND CAUSAL INFERENCE IN HEART FAILURE |
| 4205 |
METABOLO-EPIGENETIC INTERPLAY PROVIDES TARGETED NUTRITIONAL INTERVENTIONS IN CHRONIC DISEASES AND AGEING |
| 4206 |
METABOTROPIC GLUTAMATE 2/3 RECEPTORS AND EPIGENETIC MODIFICATIONS IN PSYCHOTIC DISORDERS: A REVIEW |
| 4207 |
METABOTROPIC GLUTAMATE RECEPTORS AND THE CONTROL OF CHRONIC PAIN |
| 4208 |
METAL CARCINOGEN EXPOSURE INDUCES CANCER STEM CELL-LIKE PROPERTY THROUGH EPIGENETIC REPROGRAMING: A NOVEL MECHANISM OF METAL CARCINOGENESIS |
| 4209 |
METALLOTHIONEIN 2A GENE POLYMORPHISMS IN RELATION TO DISEASES AND TRACE ELEMENT LEVELS IN HUMANS |
| 4210 |
METFORMIN AND VITAMIN D MODULATE INFLAMMATION AND AUTOPHAGY DURING ADIPOSE-DERIVED STEM CELL DIFFERENTIATION |
| 4211 |
METFORMIN FOR CARDIOVASCULAR PROTECTION, INFLAMMATORY BOWEL DISEASE, OSTEOPOROSIS, PERIODONTITIS, POLYCYSTIC OVARIAN SYNDROME, NEURODEGENERATION, CANCER, INFLAMMATION AND SENESCENCE: WHAT IS NEXT? DIABETES IS ACCOMPANIED BY SEVERAL COMPLICATIONS |
| 4212 |
METHAMPHETAMINE DOWNREGULATES STRIATAL GLUTAMATE RECEPTORS VIA DIVERSE EPIGENETIC MECHANISMS |
| 4213 |
METHIONINE MEDIATES RESILIENCE TO CHRONIC SOCIAL DEFEAT STRESS BY EPIGENETIC REGULATION OF NMDA RECEPTOR SUBUNIT EXPRESSION |
| 4214 |
METHIONINE METABOLISM IN YUCATAN MINIATURE SWINE |
| 4215 |
METHYL DEFICIENCY, ALTERATIONS IN GLOBAL HISTONE MODIFICATIONS, AND CARCINOGENESIS |
| 4216 |
METHYL DONOR MICRONUTRIENTS: A POTENTIAL DIETARY EPIGENETIC TARGET IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS |
| 4217 |
METHYL DONOR NUTRIENTS IN CHRONIC KIDNEY DISEASE: IMPACT ON THE EPIGENETIC LANDSCAPE |
| 4218 |
METHYL SUPPLEMENTATION ATTENUATES COCAINE-SEEKING BEHAVIORS AND COCAINE-INDUCED C-FOS ACTIVATION IN A DNA METHYLATION-DEPENDENT MANNER |
| 4219 |
METHYL-DONOR DEFICIENCY IN ADOLESCENCE AFFECTS MEMORY AND EPIGENETIC STATUS IN THE MOUSE HIPPOCAMPUS |
| 4220 |
METHYLATED CYSTEINE DIOXYGENASE-1 GENE PROMOTER IN THE SERUM IS A POTENTIAL BIOMARKER FOR HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA |
| 4221 |
METHYLATION AND SILENCING OF PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE O IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 4222 |
METHYLATION AT THE CPG ISLAND SHORE REGION UPREGULATES NR3C1 PROMOTER ACTIVITY AFTER EARLY-LIFE STRESS |
| 4223 |
METHYLATION CHANGES AT NR3C1 IN NEWBORNS ASSOCIATE WITH MATERNAL PRENATAL STRESS EXPOSURE AND NEWBORN BIRTH WEIGHT |
| 4224 |
METHYLATION CHANGES IN MUSCLE AND LIVER TISSUES OF MALE AND FEMALE MICE EXPOSED TO ACUTE AND CHRONIC LOW-DOSE X-RAY-IRRADIATION |
| 4225 |
METHYLATION DEGREE OF METALLOPROTEINASE INHIBITOR RECK GENE: LINKS TO RECK PROTEIN LEVEL AND HEPATOCELLULAR CARCINOMA IN CHRONIC HCV INFECTION PATIENTS |
| 4226 |
METHYLATION IN PERICYTES AFTER ACUTE INJURY PROMOTES CHRONIC KIDNEY DISEASE |
| 4227 |
METHYLATION OF FREE-FLOATING DEOXYRIBONUCLEIC ACID FRAGMENTS IN THE BRONCHOALVEOLAR LAVAGE FLUID OF DOGS WITH CHRONIC BRONCHITIS EXPOSED TO ENVIRONMENTAL TOBACCO SMOKE |
| 4228 |
METHYLATION OF INFLAMMATORY CELLS IN LUNG DISEASES |
| 4229 |
METHYLATION OF INK4 AND CIP/KIP FAMILIES OF CYCLIN-DEPENDENT KINASE INHIBITOR IN CHRONIC LYMPHOCYTIC LEUKAEMIA IN CHINESE PATIENTS |
| 4230 |
METHYLATION OF POLYCOMB TARGET GENES IN INTESTINAL CANCER IS MEDIATED BY INFLAMMATION |
| 4231 |
METHYLATION OF PROTOCADHERIN 10, A NOVEL TUMOR SUPPRESSOR, IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH GASTRIC CANCER |
| 4232 |
METHYLATION OF RUNX3 IN VARIOUS TYPES OF HUMAN CANCERS AND PREMALIGNANT STAGES OF GASTRIC CARCINOMA |
| 4233 |
METHYLATION OF SEPTIN9 MEDIATED BY DNMT3A ENHANCES HEPATIC STELLATE CELLS ACTIVATION AND LIVER FIBROGENESIS |
| 4234 |
METHYLATION OF SPECIFIC CPG SITES IN IL-1BETA AND IL1R1 GENES IS AFFECTED BY HYPERGLYCAEMIA IN TYPE 2 DIABETIC PATIENTS |
| 4235 |
METHYLATION OF THE AIM2 GENE: AN EPIGENETIC MEDIATOR OF PTSD-RELATED INFLAMMATION AND NEUROPATHOLOGY PLASMA BIOMARKERS |
| 4236 |
METHYLATION OF THE TYROSINE HYDROXYLASE GENE IS DYSREGULATED BY COCAINE DEPENDENCE IN THE HUMAN STRIATUM |
| 4237 |
METHYLATION PATTERN OF THBS1, GATA-4, AND HIC1 IN PEDIATRIC AND ADULT PATIENTS INFECTED WITH HELICOBACTER PYLORI |
| 4238 |
METHYLATION PATTERN OF URINARY DNA AS A MARKER OF KIDNEY FUNCTION DECLINE IN DIABETES |
| 4239 |
METHYLATION PROFILE OF HEPATITIS B VIRUS IS NOT INFLUENCED BY INTERFERON ALPHA IN HUMAN LIVER CANCER CELLS |
| 4240 |
METHYLATION QUANTITATIVE TRAIT LOCUS ANALYSIS OF CHRONIC POSTSURGICAL PAIN UNCOVERS EPIGENETIC MEDIATORS OF GENETIC RISK |
| 4241 |
METHYLATION REGULATION OF ANTIVIRAL HOST FACTORS, INTERFERON STIMULATED GENES (ISGS) AND T-CELL RESPONSES ASSOCIATED WITH NATURAL HIV CONTROL |
| 4242 |
METHYLATION STATUS OF ALU AND LINE-1 INTERSPERSED REPETITIVE SEQUENCES IN BEHCET'S DISEASE PATIENTS |
| 4243 |
METHYLATION STATUS OF CEBPA GENE PROMOTER IN CHRONIC MYELOID LEUKEMIA |
| 4244 |
METHYLATION STATUS OF COX-2 IN BLOOD LEUKOCYTE DNA AND RISK OF GASTRIC CANCER IN A HIGH-RISK CHINESE POPULATION |
| 4245 |
METHYLATION STATUS OF DDIT3 GENE IN CHRONIC MYELOID LEUKEMIA |
| 4246 |
METHYLATION STATUS OF THE T-CADHERIN GENE PROMOTOR IN PERIPHERAL BLOOD MONONUCLEAR CELLS IS ASSOCIATED WITH HBV-RELATED HEPATOCELLULAR CARCINOMA PROGRESSION |
| 4247 |
METHYLATION STATUS REGULATES LIPOPROTEIN LIPASE EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 4248 |
METHYLATION STATUS, MRNA AND PROTEIN EXPRESSION OF THE SMAD4 GENE IN PATIENTS WITH NON-MELANOCYTIC SKIN CANCERS |
| 4249 |
METHYLATION-BASED BIOLOGICAL AGE AND BREAST CANCER RISK |
| 4250 |
METHYLATION-DEMETHYLATION DYNAMICS: IMPLICATIONS OF CHANGES IN ACUTE KIDNEY INJURY |
| 4251 |
METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) GENE POLYMORPHISMS RESULTING IN SUBOPTIMAL OOCYTE MATURATION: A DISCUSSION OF FOLATE STATUS, NEURAL TUBE DEFECTS, SCHIZOPHRENIA, AND VASCULOPATHY |
| 4252 |
METHYLOME CHANGES ASSOCIATED WITH FUNCTIONAL MOVEMENT/CONVERSION DISORDER: INFLUENCE OF BIOLOGICAL SEX AND CHILDHOOD ABUSE EXPOSURE |
| 4253 |
METHYLOME OF HUMAN SKELETAL MUSCLE AFTER ACUTE & CHRONIC RESISTANCE EXERCISE TRAINING, DETRAINING & RETRAINING |
| 4254 |
METHYLOME-BASED CELL-OF-ORIGIN MODELING (METHYL-COOM) IDENTIFIES ABERRANT EXPRESSION OF IMMUNE REGULATORY MOLECULES IN CLL |
| 4255 |
METHYLOME-WIDE ANALYSIS OF CHRONIC HIV INFECTION REVEALS FIVE-YEAR INCREASE IN BIOLOGICAL AGE AND EPIGENETIC TARGETING OF HLA |
| 4256 |
METHYLOMIC MARKERS OF PERSISTENT CHILDHOOD ASTHMA: A LONGITUDINAL STUDY OF ASTHMA-DISCORDANT MONOZYGOTIC TWINS |
| 4257 |
METHYLOMIC PROFILING AND REPLICATION IMPLICATES DEREGULATION OF PCSK9 IN ALCOHOL USE DISORDER |
| 4258 |
METHYLOMICS OF NITROXIDATIVE STRESS ON PRECANCEROUS CELLS REVEALS DNA METHYLATION ALTERATION AT THE TRANSITION FROM IN SITU TO INVASIVE CERVICAL CANCER |
| 4259 |
METTL3 SUPPRESSES NEUROPATHIC PAIN VIA MODULATING N6-METHYLADENOSINE-DEPENDENT PRIMARY MIR-150 PROCESSING |
| 4260 |
METTL3-MEDIATED M6A MODIFICATION OF SIRT1 MRNA INHIBITS PROGRESSION OF ENDOMETRIOSIS BY CELLULAR SENESCENCE ENHANCING |
| 4261 |
MGMT-METHYLATION IN NON-NEOPLASTIC DISEASES OF THE CENTRAL NERVOUS SYSTEM |
| 4262 |
MICE EXPOSED TO COMBINED CHRONIC LOW-DOSE IRRADIATION AND MODELED MICROGRAVITY DEVELOP LONG-TERM NEUROLOGICAL SEQUELAE |
| 4263 |
MICRO(RNA) MANAGEMENT AND MISMANAGEMENT OF THE ISLET |
| 4264 |
MICRO-OPIOID RECEPTOR GENE VARIANT OPRM1 118 A>G: A SUMMARY OF ITS MOLECULAR AND CLINICAL CONSEQUENCES FOR PAIN |
| 4265 |
MICRO-RNA-125A MEDIATES THE EFFECTS OF HYPOMETHYLATING AGENTS IN CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 4266 |
MICRO-RNAS: CROSSROADS BETWEEN THE EXPOSURE TO ENVIRONMENTAL PARTICULATE POLLUTION AND THE OBSTRUCTIVE PULMONARY DISEASE |
| 4267 |
MICROARRAY DATASET OF TRANSIENT AND PERMANENT DNA METHYLATION CHANGES IN HELA CELLS UNDERGOING INORGANIC ARSENIC-MEDIATED EPITHELIAL-TO-MESENCHYMAL TRANSITION |
| 4268 |
MICROBIAL AGENTS AS PUTATIVE INDUCERS OF B CELL LYMPHOMA IN SJOGREN'S SYNDROME THROUGH AN IMPAIRED EPIGENETIC CONTROL: THE STATE-OF-THE-ART |
| 4269 |
MICROBIAL DYSBIOSIS AND LACK OF SCFA PRODUCTION IN A SPANISH COHORT OF PATIENTS WITH MULTIPLE SCLEROSIS |
| 4270 |
MICROBIAL DYSBIOSIS AND THE HOST AIRWAY EPITHELIAL RESPONSE: INSIGHTS INTO HIV-ASSOCIATED COPD USING MULTI'OMICS PROFILING |
| 4271 |
MICROBIAL DYSBIOSIS-INDUCED OBESITY: ROLE OF GUT MICROBIOTA IN HOMOEOSTASIS OF ENERGY METABOLISM |
| 4272 |
MICROBIOME AND BEHCET'S DISEASE: A SYSTEMATIC REVIEW |
| 4273 |
MICROBIOTA AND EPIGENETICS: HEALTH IMPACT |
| 4274 |
MICROBIOTA IN INFLAMMATORY BOWEL DISEASE PATHOGENESIS AND THERAPY: IS IT ALL ABOUT DIET? INFLAMMATORY BOWEL DISEASE (IBD), INCLUDING ULCERATIVE COLITIS, CROHN'S DISEASE, AND UNCLASSIFIED IBD, CONTINUES TO CAUSE SIGNIFICANT MORBIDITY |
| 4275 |
MICROGLIA ACTIVATION IN THE MIDBRAIN OF THE HUMAN NEONATE: THE EFFECT OF PERINATAL HYPOXIC-ISCHEMIC INJURY |
| 4276 |
MICROGLIA FROM OFFSPRING OF DAMS WITH ALLERGIC ASTHMA EXHIBIT EPIGENOMIC ALTERATIONS IN GENES DYSREGULATED IN AUTISM |
| 4277 |
MICROGLIA SEQUELAE: BRAIN SIGNATURE OF INNATE IMMUNITY IN SCHIZOPHRENIA |
| 4278 |
MICROGLIAL INNATE MEMORY AND EPIGENETIC REPROGRAMMING IN NEUROLOGICAL DISORDERS |
| 4279 |
MICRONUCLEI, INFLAMMATION AND AUTO-IMMUNE DISEASE |
| 4280 |
MICRONUTRIENTS IN EARLY LIFE AND OFFSPRING METABOLIC HEALTH PROGRAMMING: A PROMISING TARGET FOR PREVENTING NON-COMMUNICABLE DISEASES |
| 4281 |
MICRONUTRIENTS IN PREGNANCY IN LOW- AND MIDDLE-INCOME COUNTRIES |
| 4282 |
MICRORNA AND EXOSOME: KEY PLAYERS IN RHEUMATOID ARTHRITIS |
| 4283 |
MICRORNA BIOMARKERS IN IBD-DIFFERENTIAL DIAGNOSIS AND PREDICTION OF COLITIS-ASSOCIATED CANCER |
| 4284 |
MICRORNA CIRCUITS REGULATE THE CANCER-INFLAMMATION LINK |
| 4285 |
MICRORNA EPIGENETIC SIGNATURES IN HUMAN DISEASE |
| 4286 |
MICRORNA EXPRESSION ANALYSIS IN HIGH FAT DIET-INDUCED NAFLD-NASH-HCC PROGRESSION: STUDY ON C57BL/6J MICE |
| 4287 |
MICRORNA EXPRESSION PROFILING IN BEHCET'S DISEASE |
| 4288 |
MICRORNA IN LEUKEMIA: TUMOR SUPPRESSORS AND ONCOGENES WITH PROGNOSTIC POTENTIAL |
| 4289 |
MICRORNA IN OSTEOARTHRITIS |
| 4290 |
MICRORNA LOADED EDIBLE NANOPARTICLES: AN EMERGING PERSONALIZED THERAPEUTIC APPROACH FOR THE TREATMENT OF OBESITY AND METABOLIC DISORDERS |
| 4291 |
MICRORNA PROFILES IN INTESTINAL EPITHELIAL CELLS IN A MOUSE MODEL OF SEPSIS |
| 4292 |
MICRORNA PROFILES OF MATERNAL AND NEONATAL ENDOTHELIAL PROGENITOR CELLS IN PREECLAMPSIA |
| 4293 |
MICRORNA PROFILING IN MUC2 KNOCKOUT MICE OF COLITIS-ASSOCIATED CANCER MODEL REVEALS EPIGENETIC ALTERATIONS DURING CHRONIC COLITIS MALIGNANT TRANSFORMATION |
| 4294 |
MICRORNA REGULATORY NETWORKS IN IDIOPATHIC PULMONARY FIBROSIS |
| 4295 |
MICRORNA RESPONSE OF INHALATION EXPOSURE TO HEXANAL IN LUNG TISSUES FROM FISCHER 344 RATS |
| 4296 |
MICRORNA-1 MODULATES CHONDROCYTE PHENOTYPE BY REGULATING FZD7 OF WNT/ BETA-CATENIN SIGNALING PATHWAY |
| 4297 |
MICRORNA-1224 SPLICING CIRCULARRNA-FILIP1L IN AN AGO2-DEPENDENT MANNER REGULATES CHRONIC INFLAMMATORY PAIN VIA TARGETING UBR5 |
| 4298 |
MICRORNA-146A GOVERNS FIBROBLAST ACTIVATION AND JOINT PATHOLOGY IN ARTHRITIS |
| 4299 |
MICRORNA-15B CONTRIBUTES TO DEPRESSION-LIKE BEHAVIOR IN MICE BY AFFECTING SYNAPTIC PROTEIN LEVELS AND FUNCTION IN THE NUCLEUS ACCUMBENS |
| 4300 |
MICRORNA-19A CONTRIBUTES TO THE EPIGENETIC REGULATION OF TISSUE FACTOR IN DIABETES |
| 4301 |
MICRORNA-21-ENRICHED EXOSOMES AS EPIGENETIC REGULATORS IN MELANOMAGENESIS AND MELANOMA PROGRESSION: THE IMPACT OF WESTERN LIFESTYLE FACTORS |
| 4302 |
MICRORNA-223 CONTROLS THE EXPRESSION OF HISTONE DEACETYLASE 2: A NOVEL AXIS IN COPD |
| 4303 |
MICRORNA-223 INHIBITS TISSUE FACTOR EXPRESSION IN VASCULAR ENDOTHELIAL CELLS |
| 4304 |
MICRORNA-223 PROTECTS NEURONS FROM DEGENERATION IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS |
| 4305 |
MICRORNA-27A-3P ENHANCES THE INFLAMMATORY PHENOTYPE OF JUVENILE IDIOPATHIC ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES |
| 4306 |
MICRORNA-29A MITIGATES LAMINECTOMY-INDUCED SPINAL EPIDURAL FIBROSIS AND GAIT DYSREGULATION BY REPRESSING TGF-BETA1 AND IL-6 |
| 4307 |
MICRORNA-30 MODULATES METABOLIC INFLAMMATION BY REGULATING NOTCH SIGNALING IN ADIPOSE TISSUE MACROPHAGES |
| 4308 |
MICRORNA?155 MODULATION OF CD8(+) T?CELL ACTIVITY PERSONALIZES RESPONSE TO DISEASE?MODIFYING THERAPIES OF PATIENTS WITH RELAPSING?REMITTING MULTIPLE SCLEROSIS |
| 4309 |
MICRORNAS 29B AND 181A DOWN-REGULATE THE EXPRESSION OF THE NOREPINEPHRINE TRANSPORTER AND GLUCOCORTICOID RECEPTORS IN PC12 CELLS |
| 4310 |
MICRORNAS AND PROGESTERONE RECEPTOR SIGNALING IN ENDOMETRIOSIS PATHOPHYSIOLOGY |
| 4311 |
MICRORNAS AND XENOBIOTIC TOXICITY: AN OVERVIEW |
| 4312 |
MICRORNAS AS A SUITABLE BIOMARKER TO DETECT THE EFFECTS OF LONG-TERM EXPOSURES TO NANOMATERIALS |
| 4313 |
MICRORNAS AS CANDIDATES FOR BIPOLAR DISORDER BIOMARKERS |
| 4314 |
MICRORNAS AS CONTROLLED SYSTEMS AND CONTROLLERS IN NON-ALCOHOLIC FATTY LIVER DISEASE |
| 4315 |
MICRORNAS AS NEW TARGETS OF DIETARY POLYPHENOLS |
| 4316 |
MICRORNAS AS NON-INVASIVE DIAGNOSTIC BIOMARKERS FOR GASTRIC CANCER: CURRENT INSIGHTS AND FUTURE PERSPECTIVES |
| 4317 |
MICRORNAS AS REGULATORS OF AIRBORNE POLLUTION-INDUCED LUNG INFLAMMATION AND CARCINOGENESIS |
| 4318 |
MICRORNAS IN ANKYLOSING SPONDYLITIS: FUNCTION, POTENTIAL AND CHALLENGES |
| 4319 |
MICRORNAS IN AXIAL SPONDYLARTHRITIS: AN OVERVIEW OF THE RECENT PROGRESSES IN THE FIELD WITH A FOCUS ON ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS |
| 4320 |
MICRORNAS IN CHRONIC LYMPHOCYTIC LEUKEMIA: AN OLD DISEASE WITH NEW GENETIC INSIGHTS |
| 4321 |
MICRORNAS IN MAJOR DEPRESSIVE DISORDER |
| 4322 |
MICRORNAS IN MYELOPROLIFERATIVE NEOPLASMS |
| 4323 |
MICRORNAS IN PSYCHOLOGICAL STRESS REACTIONS AND THEIR USE AS STRESS-ASSOCIATED BIOMARKERS, ESPECIALLY IN HUMAN SALIVA |
| 4324 |
MICRORNAS IN RHEUMATOID ARTHRITIS: FROM PATHOGENESIS TO CLINICAL IMPACT |
| 4325 |
MICRORNAS IN THE EVALUATION AND POTENTIAL TREATMENT OF LIVER DISEASES |
| 4326 |
MICRORNAS IN THE PATHOGENESIS OF NONALCOHOLIC FATTY LIVER DISEASE |
| 4327 |
MICRORNAS MODULATE INTERACTIONS BETWEEN STRESS AND RISK FOR COCAINE ADDICTION |
| 4328 |
MICRORNAS, STEM CELLS IN BIPOLAR DISORDER, AND LITHIUM THERAPEUTIC APPROACH |
| 4329 |
MICRORNAS: A NEW AVENUE TO UNDERSTAND, INVESTIGATE AND TREAT IMMUNOGLOBULIN A NEPHROPATHY? IGA NEPHROPATHY (IGAN) IS THE MOST COMMON CAUSE OF PRIMARY GLOMERULONEPHRITIS WORLDWIDE |
| 4330 |
MICRORNAS: AN EPIGENETIC TOOL TO STUDY CELIAC DISEASE |
| 4331 |
MICRORNAS: EMERGING BIOMARKERS AND THERAPEUTIC TARGETS OF BONE FRAGILITY IN CHRONIC KIDNEY DISEASE |
| 4332 |
MICRORNAS: IMPORTANT MODULATORS OF OXLDL-MEDIATED SIGNALING IN ATHEROSCLEROSIS |
| 4333 |
MICRORNAS: KEY PLAYERS IN MICROGLIA AND ASTROCYTE MEDIATED INFLAMMATION IN CNS PATHOLOGIES |
| 4334 |
MICRORNAS: NOVEL DIAGNOSTIC AND THERAPEUTIC TOOLS FOR PANCREATIC DUCTAL ADENOCARCINOMA? PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IS KNOWN FOR ITS VERY POOR OVERALL PROGNOSIS, MAKING TOOLS FOR EARLY DIAGNOSIS AND NEW THERAPEUTIC MODALITIES URGENTLY NEEDED |
| 4335 |
MICRORNAS: SMALL MOLECULES WITH SIGNIFICANT FUNCTIONS, PARTICULARLY IN THE CONTEXT OF VIRAL HEPATITIS B AND C INFECTION |
| 4336 |
MICRORNAS: THE UNDERLYING MEDIATORS OF PATHOGENETIC PROCESSES IN VASCULAR COMPLICATIONS OF DIABETES |
| 4337 |
MICROTUBULES AS MAJOR REGULATORS OF ENDOTHELIAL FUNCTION: IMPLICATION FOR LUNG INJURY |
| 4338 |
MICROVASCULAR BARRIER PROTECTION BY MICRORNA-183 VIA FOXO1 REPRESSION: A PATHWAY DISTURBED IN NEUROPATHY AND COMPLEX REGIONAL PAIN SYNDROME |
| 4339 |
MIGRAINE: A GENETIC DISEASE? MIGRAINES CARRY A SUBSTANTIAL GENETIC LIABILITY, AND IN FAMILIES AFFECTED WITH THE TYPICAL MIGRAINES (MIGRAINE WITH, MA, AND WITHOUT AURA, MO) LINKAGE TO SOME CHROMOSOMAL LOCI HAS BEEN REPORTED |
| 4340 |
MIGRATION OF STEM-LIKE CD8 T CELLS BETWEEN TISSUE MICROENVIRONMENTS UNDERPINS SUCCESSFUL ANTI-TUMOUR IMMUNE RESPONSES |
| 4341 |
MIGRATION TEST OF BISPHENOL A FROM POLYCARBONATE CUPS USING EXCITATION-EMISSION FLUORESCENCE DATA WITH PARALLEL FACTOR ANALYSIS |
| 4342 |
MINIREVIEW: EPIGENETICS OF OBESITY AND DIABETES IN HUMANS |
| 4343 |
MINIREVIEW: STRESS-RELATED PSYCHIATRIC DISORDERS WITH LOW CORTISOL LEVELS: A METABOLIC HYPOTHESIS |
| 4344 |
MINIREVIEW: TRANSLATIONAL ANIMAL MODELS OF HUMAN MENOPAUSE: CHALLENGES AND EMERGING OPPORTUNITIES |
| 4345 |
MIR-103 PROMOTES ENDOTHELIAL MALADAPTATION BY TARGETING LNCWDR59 |
| 4346 |
MIR-10A, MIR-15A, LET-7A, AND LET-7G EXPRESSION AS STRESS-RELEVANT BIOMARKERS TO ASSESS ACUTE OR CHRONIC PSYCHOLOGICAL STRESS AND MENTAL HEALTH IN HUMAN CAPILLARY BLOOD |
| 4347 |
MIR-140 ATTENUATES THE PROGRESSION OF EARLY-STAGE OSTEOARTHRITIS BY RETARDING CHONDROCYTE SENESCENCE |
| 4348 |
MIR-146A DYSREGULATES ENERGY METABOLISM DURING NEUROINFLAMMATION |
| 4349 |
MIR-155 AND MIR-122 EXPRESSION OF SPERMATOZOA IN OBESE SUBJECTS |
| 4350 |
MIR-181A-5P IS A POTENTIAL CANDIDATE EPIGENETIC BIOMARKER IN MULTIPLE SCLEROSIS |
| 4351 |
MIR-199A-5P SILENCING REGULATES THE UNFOLDED PROTEIN RESPONSE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ALPHA1-ANTITRYPSIN DEFICIENCY |
| 4352 |
MIR-200A-3P MODULATES GENE EXPRESSION IN COMORBID PAIN AND DEPRESSION: MOLECULAR IMPLICATION FOR CENTRAL SENSITIZATION |
| 4353 |
MIR-20B-5P ATTENUATES HYPOXIA-INDUCED APOPTOSIS IN CARDIOMYOCYTES VIA THE HIF-1ALPHA/NF-KAPPAB PATHWAY |
| 4354 |
MIR-21-5P DIRECTLY CONTRIBUTES TO REGULATING ENOS EXPRESSION IN HUMAN ARTERY ENDOTHELIAL CELLS UNDER NORMOXIA AND HYPOXIA |
| 4355 |
MIR-30 FAMILY MIRNAS MEDIATE THE EFFECT OF CHRONIC SOCIAL DEFEAT STRESS ON HIPPOCAMPAL NEUROGENESIS IN MOUSE DEPRESSION MODEL |
| 4356 |
MIR-30A-5P PROMOTES GLOMERULAR PODOCYTE APOPTOSIS VIA DNMT1-MEDIATED HYPERMETHYLATION UNDER HYPERHOMOCYSTEINEMIA |
| 4357 |
MIR-30E* IS OVEREXPRESSED IN PROSTATE CANCER AND PROMOTES NF-KAPPAB-MEDIATED PROLIFERATION AND TUMOR GROWTH |
| 4358 |
MIR-338-3P BLOCKS TGFBETA-INDUCED MYOFIBROBLAST DIFFERENTIATION THROUGH THE INDUCTION OF PTEN |
| 4359 |
MIR-422A SUPPRESSES SMAD4 PROTEIN EXPRESSION AND PROMOTES RESISTANCE TO MUSCLE LOSS |
| 4360 |
MIR-6769B-5P TARGETS CCND-1 TO REGULATE PROLIFERATION IN CADMIUM-TREATED PLACENTAL TROPHOBLASTS: ASSOCIATION WITH THE IMPAIRMENT OF FETAL GROWTH |
| 4361 |
MIR-96 ACTS AS A TUMOR SUPPRESSOR VIA TARGETING THE BCR-ABL1 ONCOGENE IN CHRONIC MYELOID LEUKEMIA BLASTIC TRANSFORMATION |
| 4362 |
MIR?152 REGULATES TGF?BETA1?INDUCED EPITHELIAL?MESENCHYMAL TRANSITION BY TARGETING HPIP IN TUBULAR EPITHELIAL CELLS |
| 4363 |
MIRNA AS MARKERS FOR THE DIAGNOSTIC SCREENING OF COLON CANCER |
| 4364 |
MIRNA DEREGULATION BY EPIGENETIC SILENCING DISRUPTS SUPPRESSION OF THE ONCOGENE PLAG1 IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 4365 |
MIRNA MOLECULES-LATE BREAKING TREATMENT FOR INFLAMMATORY BOWEL DISEASES? MICRORNAS (MIRNAS) ARE A GROUP OF NON-CODING RNAS THAT PLAY A CRITICAL ROLE IN REGULATING EPIGENETIC MECHANISMS IN INFLAMMATION-RELATED DISEASES |
| 4366 |
MIRNA-23A/CXCR4 REGULATES NEUROPATHIC PAIN VIA DIRECTLY TARGETING TXNIP/NLRP3 INFLAMMASOME AXIS |
| 4367 |
MIRNA-BASED "FITNESS SCORE" TO ASSESS THE INDIVIDUAL RESPONSE TO DIET, METABOLISM, AND EXERCISE |
| 4368 |
MIRNA-DEPENDENT CD4(+) T CELL DIFFERENTIATION IN THE PATHOGENESIS OF MULTIPLE SCLEROSIS |
| 4369 |
MIRNAS AND NAFLD: FROM PATHOPHYSIOLOGY TO THERAPY |
| 4370 |
MIRNAS AND THEIR ROLE IN THE CORRELATION BETWEEN SCHIZOPHRENIA AND CANCER (REVIEW) |
| 4371 |
MIRNAS POTENTIALLY INVOLVED IN POST LUNG TRANSPLANT-OBLITERATIVE BRONCHIOLITIS: THE ROLE OF MIR-21-5P |
| 4372 |
MIRNAS, OXIDATIVE STRESS, AND CANCER: A COMPREHENSIVE AND UPDATED REVIEW |
| 4373 |
MIRNAS: IMPORTANT TARGETS FOR ORAL CANCER PAIN RESEARCH |
| 4374 |
MISMATCH REPAIR PROTEINS RECRUIT DNA METHYLTRANSFERASE 1 TO SITES OF OXIDATIVE DNA DAMAGE |
| 4375 |
MISREGULATED INFLAMMATION AS AN OUTCOME OF EARLY-LIFE EXPOSURE TO ENDOCRINE-DISRUPTING CHEMICALS |
| 4376 |
MITOCHONDRIAL (DYS) FUNCTION IN INFLAMMAGING: DO MITOMIRS INFLUENCE THE ENERGETIC, OXIDATIVE, AND INFLAMMATORY STATUS OF SENESCENT CELLS? A RELEVANT FEATURE OF AGING IS CHRONIC LOW-GRADE INFLAMMATION, TERMED INFLAMMAGING, A KEY PROCESS PROMOTING THE DEVELOPMENT OF ALL MAJOR AGE-RELATED DISEASES |
| 4377 |
MITOCHONDRIAL AGING: FOCUS ON MITOCHONDRIAL DNA DAMAGE IN ATHEROSCLEROSIS - A MINI-REVIEW |
| 4378 |
MITOCHONDRIAL DNA COPY NUMBER AND EXPOSURE TO POLYCYCLIC AROMATIC HYDROCARBONS |
| 4379 |
MITOCHONDRIAL DYSFUNCTION AND AGING: INSIGHTS FROM THE ANALYSIS OF EXTRACELLULAR VESICLES |
| 4380 |
MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS IN RHEUMATOID ARTHRITIS |
| 4381 |
MITOCHONDRIAL DYSFUNCTION AND THE AKI-TO-CKD TRANSITION |
| 4382 |
MITOCHONDRIAL EPIGENETICS AND ENVIRONMENTAL EXPOSURE |
| 4383 |
MITOCHONDRIAL EPIGENETICS AND ENVIRONMENTAL HEALTH: MAKING A CASE FOR ENDOCRINE DISRUPTING CHEMICALS |
| 4384 |
MITOCHONDRIAL EPIGENETICS REGULATING INFLAMMATION IN CANCER AND AGING |
| 4385 |
MITOCHONDRIAL PERMEABILITY TRANSITION IS ALTERED IN EARLY STAGES OF CARCINOGENESIS OF 2-ACETYLAMINOFLUORENE |
| 4386 |
MITOCHONDRIAL STRESS INDUCED BY CONTINUOUS STIMULATION UNDER HYPOXIA RAPIDLY DRIVES T CELL EXHAUSTION |
| 4387 |
MITOTIC DYSFUNCTION ASSOCIATED WITH AGING HALLMARKS |
| 4388 |
MLL2/KMT2D AND MLL3/KMT2C EXPRESSION CORRELATES WITH DISEASE PROGRESSION AND RESPONSE TO IMATINIB MESYLATE IN CHRONIC MYELOID LEUKEMIA |
| 4389 |
MODELING EPIGENETIC MODIFICATIONS IN RENAL DEVELOPMENT AND DISEASE WITH ORGANOIDS AND GENOME EDITING |
| 4390 |
MODELING THE MOLECULAR EPIGENETIC PROFILE OF PSYCHOSIS IN PRENATALLY STRESSED MICE |
| 4391 |
MODERATE EXERCISE INDUCES TRAINED IMMUNITY IN MACROPHAGES |
| 4392 |
MODIFIABLE RISK FACTORS IN PERIODONTAL DISEASE: EPIGENETIC REGULATION OF GENE EXPRESSION IN THE INFLAMMATORY RESPONSE |
| 4393 |
MODIFIABLE RISK FACTORS IN PERIODONTITIS: AT THE INTERSECTION OF AGING AND DISEASE |
| 4394 |
MODIFICATION OF EPIGENETIC PATTERNS IN LOW BIRTH WEIGHT CHILDREN: IMPORTANCE OF HYPOMETHYLATION OF THE ACE GENE PROMOTER |
| 4395 |
MODM DNA METHYLTRANSFERASE METHYLOME ANALYSIS REVEALS A POTENTIAL ROLE FOR MORAXELLA CATARRHALIS PHASEVARIONS IN OTITIS MEDIA |
| 4396 |
MODULATION OF CHRONIC INFLAMMATION BY QUERCETIN: THE BENEFICIAL EFFECTS ON OBESITY |
| 4397 |
MODULATION OF DNA METHYLATION AND GENE EXPRESSION IN RODENT CORTICAL NEUROPLASTICITY PATHWAYS EXERTS RAPID ANTIDEPRESSANT-LIKE EFFECTS |
| 4398 |
MODULATION OF DNA METHYLTRANSFERASE PROFILE BY METHYL DONOR STARVATION FOLLOWED BY GAMMA IRRADIATION |
| 4399 |
MODULATION OF GENOMIC AND POSTGENOMIC ALTERATIONS IN NONCANCER DISEASES AND CRITICAL PERIODS OF LIFE |
| 4400 |
MODULATION OF HEPATIC STELLATE CELLS BY MUTAFLOR((R)) PROBIOTIC IN NON-ALCOHOLIC FATTY LIVER DISEASE MANAGEMENT |
| 4401 |
MODULATION OF NEURONAL PLASTICITY FOLLOWING CHRONIC CONCOMITANT ADMINISTRATION OF THE NOVEL ANTIPSYCHOTIC LURASIDONE WITH THE MOOD STABILIZER VALPROIC ACID |
| 4402 |
MODULATION OF NOCICEPTION BY SOCIAL FACTORS IN RODENTS: CONTRIBUTION OF THE OPIOID SYSTEM |
| 4403 |
MODULATION OF THE INFLAMMATORY RESPONSE IN POLYCYSTIC OVARY SYNDROME (PCOS)-SEARCHING FOR EPIGENETIC FACTORS |
| 4404 |
MODULATION OF THE RESPONSE TO MYCOBACTERIUM LEPRAE AND PATHOGENESIS OF LEPROSY |
| 4405 |
MOLECULAR ADAPTATIONS OF THE BLOOD-BRAIN BARRIER PROMOTE STRESS RESILIENCE VS |
| 4406 |
MOLECULAR ALTERATIONS IN HEPATOCARCINOGENESIS INDUCED BY DIETARY METHYL DEFICIENCY |
| 4407 |
MOLECULAR ANALYSIS OF A MULTISTEP LUNG CANCER MODEL INDUCED BY CHRONIC INFLAMMATION REVEALS EPIGENETIC REGULATION OF P16 AND ACTIVATION OF THE DNA DAMAGE RESPONSE PATHWAY |
| 4408 |
MOLECULAR ANALYSIS OF THE FRAGILE HISTIDINE TRIAD (FHIT) TUMOR SUPPRESSOR GENE IN VESICAL TUMORS OF CATTLE WITH CHRONIC ENZOOTIC HEMATURIA (CEH) |
| 4409 |
MOLECULAR ANATOMY AND PATHOGENIC ACTIONS OF HELICOBACTER PYLORI CAGA THAT UNDERPIN GASTRIC CARCINOGENESIS |
| 4410 |
MOLECULAR AND BIOLOGICAL PATHWAYS OF SKELETAL MUSCLE DYSFUNCTION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 4411 |
MOLECULAR AND CELLULAR BASES OF IMMUNOSENESCENCE, INFLAMMATION, AND CARDIOVASCULAR COMPLICATIONS MIMICKING "INFLAMMAGING" IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 4412 |
MOLECULAR AND CELLULAR BASIS OF RHEUMATOID JOINT DESTRUCTION |
| 4413 |
MOLECULAR AND CELLULAR INSIGHTS INTO THE DEVELOPMENT OF UTERINE FIBROIDS |
| 4414 |
MOLECULAR AND CELLULAR MECHANISMS OF PROPOLIS AND ITS POLYPHENOLIC COMPOUNDS AGAINST CANCER |
| 4415 |
MOLECULAR AND CELLULAR MECHANISMS THAT INDUCE ARTERIAL CALCIFICATION BY INDOXYL SULFATE AND P-CRESYL SULFATE |
| 4416 |
MOLECULAR AND CELLULAR PATHWAYS CONTRIBUTING TO JOINT DAMAGE IN RHEUMATOID ARTHRITIS |
| 4417 |
MOLECULAR AND CLINICOPATHOLOGICAL ASPECTS OF PROSTATE CANCER IN BULGARIAN PROBANDS |
| 4418 |
MOLECULAR AND EPIGENETIC ASPECTS OF OPIOID RECEPTORS IN DRUG ADDICTION AND PAIN MANAGEMENT IN SPORT |
| 4419 |
MOLECULAR AND EPIGENETIC MARKERS AS PROMISING TOOLS TO QUANTIFY THE EFFECT OF OCCUPATIONAL EXPOSURES AND THE RISK OF DEVELOPING NON-COMMUNICABLE DISEASES |
| 4420 |
MOLECULAR AND EPIGENETIC MECHANISMS FOR THE COMPLEX EFFECTS OF STRESS ON SYNAPTIC PHYSIOLOGY AND COGNITIVE FUNCTIONS |
| 4421 |
MOLECULAR AND FUNCTIONAL GENETICS OF HEPATOCELLULAR CARCINOMA |
| 4422 |
MOLECULAR AND GENETIC INFLAMMATION NETWORKS IN MAJOR HUMAN DISEASES |
| 4423 |
MOLECULAR AND IMMUNOLOGIC MARKERS OF KIDNEY CANCER-POTENTIAL APPLICATIONS IN PREDICTIVE, PREVENTIVE AND PERSONALIZED MEDICINE |
| 4424 |
MOLECULAR AND NEUROLOGIC RESPONSES TO CHRONIC ALCOHOL USE |
| 4425 |
MOLECULAR BASIS OF AGEING IN CHRONIC METABOLIC DISEASES |
| 4426 |
MOLECULAR BASIS OF CHRONIC LYMPHOCYTIC LEUKEMIA DIAGNOSIS AND PROGNOSIS |
| 4427 |
MOLECULAR BASIS OF ELECTROPHILIC AND OXIDATIVE DEFENSE: PROMISES AND PERILS OF NRF2 |
| 4428 |
MOLECULAR BASIS OF THE IRRITABLE BOWEL SYNDROME |
| 4429 |
MOLECULAR BIOLOGY AS A TOOL FOR THE TREATMENT OF CANCER |
| 4430 |
MOLECULAR BIOLOGY OF ONCOGENIC INFLAMMATORY PROCESSES |
| 4431 |
MOLECULAR CARCINOGENESIS OF HEPATOCELLULAR CARCINOMA AND INTRAHEPATIC CHOLANGIOCARCINOMA: ONE STEP CLOSER TO PERSONALIZED MEDICINE? HEPATOCELLULAR CARCINOMA (HCC) AND INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) ARE THE TWO MAJOR FORMS OF PRIMARY LIVER CANCERS (PLC), ACCOUNTING FOR APPROXIMATELY 90% AND 5% RESPECTIVELY |
| 4432 |
MOLECULAR CHARACTERIZATION OF RICHTER SYNDROME IDENTIFIES DE NOVO DIFFUSE LARGE B-CELL LYMPHOMAS WITH POOR PROGNOSIS |
| 4433 |
MOLECULAR COMPLEXITIES UNDERLYING THE VASCULAR COMPLICATIONS OF DIABETES MELLITUS - A COMPREHENSIVE REVIEW |
| 4434 |
MOLECULAR DISSECTION OF CD8(+) T-CELL DYSFUNCTION |
| 4435 |
MOLECULAR DYSREGULATIONS UNDERLYING THE PATHOGENESIS OF ENDOMETRIOSIS |
| 4436 |
MOLECULAR EVOLUTION OF CHRONIC MYELOID LEUKAEMIA |
| 4437 |
MOLECULAR EVOLUTION OF METAPLASIA TO ADENOCARCINOMA IN THE ESOPHAGUS |
| 4438 |
MOLECULAR FINDINGS IN BARRETT'S EPITHELIUM |
| 4439 |
MOLECULAR GENETIC AND EPIGENETIC BASIS OF MULTIPLE SCLEROSIS |
| 4440 |
MOLECULAR GENETIC TESTING IN PAIN AND ADDICTION: FACTS, FICTION AND CLINICAL UTILITY |
| 4441 |
MOLECULAR GENETICS OF COCAINE USE DISORDERS IN HUMANS |
| 4442 |
MOLECULAR GENETICS OF MDS/MPN OVERLAP SYNDROMES |
| 4443 |
MOLECULAR INSIGHTS INTO SPINDLIN1-HBX INTERPLAY AND ITS IMPACT ON HBV TRANSCRIPTION FROM CCCDNA MINICHROMOSOME |
| 4444 |
MOLECULAR LINKS BETWEEN ALCOHOL AND TOBACCO INDUCED DNA DAMAGE, GENE POLYMORPHISMS AND PATHO-PHYSIOLOGICAL CONSEQUENCES: A SYSTEMATIC REVIEW OF HEPATIC CARCINOGENESIS |
| 4445 |
MOLECULAR LINKS BETWEEN COPD AND LUNG CANCER: NEW TARGETS FOR DRUG DISCOVERY? COPD AND LUNG CANCER ARE LEADING CAUSES OF MORBIDITY AND MORTALITY WORLDWIDE, AND THEY SHARE A COMMON ENVIRONMENTAL RISK FACTOR IN CIGARETTE SMOKE EXPOSURE AND A GENETIC PREDISPOSITION REPRESENTED BY THEIR INCIDENCE IN ONLY A FRACTION OF SMOKERS |
| 4446 |
MOLECULAR MAP OF CHRONIC LYMPHOCYTIC LEUKEMIA AND ITS IMPACT ON OUTCOME |
| 4447 |
MOLECULAR MARKERS OF AGING, EXERCISE CAPACITY, & PHYSICAL ACTIVITY IN COPD |
| 4448 |
MOLECULAR MECHANISM AND TREATMENT OF VIRAL HEPATITIS-RELATED LIVER FIBROSIS |
| 4449 |
MOLECULAR MECHANISM OF HEPATITIS B VIRUS-INDUCED HEPATOCARCINOGENESIS |
| 4450 |
MOLECULAR MECHANISMS AND CELLULAR CONTRIBUTION FROM LUNG FIBROSIS TO LUNG CANCER DEVELOPMENT |
| 4451 |
MOLECULAR MECHANISMS AND FUNCTIONS OF LNCRNAS IN THE INFLAMMATORY REACTION OF DIABETES MELLITUS |
| 4452 |
MOLECULAR MECHANISMS AND MANAGEMENT OF A CUTANEOUS INFLAMMATORY DISORDER: PSORIASIS |
| 4453 |
MOLECULAR MECHANISMS AND PATHWAYS AS TARGETS FOR CANCER PREVENTION AND PROGRESSION WITH DIETARY COMPOUNDS |
| 4454 |
MOLECULAR MECHANISMS DRIVING PROGRESSION OF LIVER CIRRHOSIS TOWARDS HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B AND C INFECTIONS: A REVIEW |
| 4455 |
MOLECULAR MECHANISMS FOR THE VICIOUS CYCLE BETWEEN INSULIN RESISTANCE AND THE INFLAMMATORY RESPONSE IN OBESITY |
| 4456 |
MOLECULAR MECHANISMS IN RENAL DEGENERATIVE DISEASE |
| 4457 |
MOLECULAR MECHANISMS MEDIATED BY HUMAN ENDOGENOUS RETROVIRUSES (HERVS) IN AUTOIMMUNITY |
| 4458 |
MOLECULAR MECHANISMS OF ALCOHOL-INDUCED COLORECTAL CARCINOGENESIS |
| 4459 |
MOLECULAR MECHANISMS OF DIABETIC VASCULAR COMPLICATIONS |
| 4460 |
MOLECULAR MECHANISMS OF ENVIRONMENTAL EXPOSURES AND HUMAN DISEASE |
| 4461 |
MOLECULAR MECHANISMS OF GENDER DISPARITY IN HEPATITIS B VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA |
| 4462 |
MOLECULAR MECHANISMS OF HBV-ASSOCIATED HEPATOCARCINOGENESIS |
| 4463 |
MOLECULAR MECHANISMS OF HISTONE DEACETYLASES AND INHIBITORS IN RENAL FIBROSIS PROGRESSION |
| 4464 |
MOLECULAR MECHANISMS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)/NONALCOHOLIC STEATOHEPATITIS (NASH) |
| 4465 |
MOLECULAR MECHANISMS OF POSTTRAUMATIC STRESS DISORDER (PTSD) AS A BASIS FOR INDIVIDUALIZED AND PERSONALIZED THERAPY: RATIONALE, DESIGN AND METHODS OF THE SOUTH EASTERN EUROPE (SEE)-PTSD STUDY |
| 4466 |
MOLECULAR MECHANISMS OF REPEATED SOCIAL DEFEAT-INDUCED GLUCOCORTICOID RESISTANCE: ROLE OF MICRORNA |
| 4467 |
MOLECULAR MECHANISMS OF VASCULAR HEALTH: INSIGHTS FROM VASCULAR AGING AND CALCIFICATION |
| 4468 |
MOLECULAR MECHANISMS UNDERLYING THE RELATIONSHIP BETWEEN OBESITY AND MALE INFERTILITY |
| 4469 |
MOLECULAR NEUROLOGICAL CORRELATES OF ENDORPHINERGIC/DOPAMINERGIC MECHANISMS IN REWARD CIRCUITRY LINKED TO ENDORPHINERGIC DEFICIENCY SYNDROME (EDS) |
| 4470 |
MOLECULAR NEUROPATHOLOGY OF ASTROCYTES AND OLIGODENDROCYTES IN ALCOHOL USE DISORDERS |
| 4471 |
MOLECULAR PATHOGENESIS OF ATYPICAL CML, CMML AND MDS/MPN-UNCLASSIFIABLE |
| 4472 |
MOLECULAR PATHOGENESIS OF CHOLANGIOCARCINOMA |
| 4473 |
MOLECULAR PATHOGENESIS OF CLL AND ITS EVOLUTION |
| 4474 |
MOLECULAR PATHOGENESIS OF GALLBLADDER CANCER: AN UPDATE |
| 4475 |
MOLECULAR PATHOGENESIS OF HEPATITIS C VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA |
| 4476 |
MOLECULAR PATHOGENESIS OF HEPATOCELLULAR CARCINOMA |
| 4477 |
MOLECULAR PATHOGENESIS OF HUMAN HEPATOCELLULAR CARCINOMA |
| 4478 |
MOLECULAR PATHOGENESIS OF NONALCOHOLIC STEATOHEPATITIS- (NASH-) RELATED HEPATOCELLULAR CARCINOMA |
| 4479 |
MOLECULAR PATHOGENESIS OF ORAL SQUAMOUS CELL CARCINOMA: IMPLICATIONS FOR THERAPY |
| 4480 |
MOLECULAR PATHWAYS AND ROLE OF EPIGENETICS IN THE IDIOPATHIC PULMONARY FIBROSIS |
| 4481 |
MOLECULAR PROFILING OF CHRONIC LYMPHOCYTIC LEUKAEMIA: GENETICS MEETS EPIGENETICS TO IDENTIFY PREDISPOSING GENES |
| 4482 |
MOLECULAR REGULATION AND CLINICAL SIGNIFICANCE OF CAVEOLIN-1 METHYLATION IN CHRONIC LUNG DISEASES |
| 4483 |
MOLECULAR REGULATION OF MAMMALIAN HEPATIC ARCHITECTURE |
| 4484 |
MOLECULAR SIGNATURE OF CAID SYNDROME: NONCANONICAL ROLES OF SGO1 IN REGULATION OF TGF-BETA SIGNALING AND EPIGENOMICS |
| 4485 |
MOLECULAR SIMILARITY BETWEEN MYELODYSPLASTIC FORM OF CHRONIC MYELOMONOCYTIC LEUKEMIA AND REFRACTORY ANEMIA WITH RING SIDEROBLASTS |
| 4486 |
MOLECULAR, GENETIC AND EPIGENETIC PATHWAYS OF PEROXYNITRITE-INDUCED CELLULAR TOXICITY |
| 4487 |
MOLECULARLY TARGETED DRUG COMBINATIONS DEMONSTRATE SELECTIVE EFFECTIVENESS FOR MYELOID- AND LYMPHOID-DERIVED HEMATOLOGIC MALIGNANCIES |
| 4488 |
MONOCYTE AND HAEMATOPOIETIC PROGENITOR REPROGRAMMING AS COMMON MECHANISM UNDERLYING CHRONIC INFLAMMATORY AND CARDIOVASCULAR DISEASES |
| 4489 |
MONOCYTE AND MACROPHAGE IMMUNOMETABOLISM IN ATHEROSCLEROSIS |
| 4490 |
MONOCYTE EPIGENETICS AND INNATE IMMUNITY TO MALARIA: YET ANOTHER LEVEL OF COMPLEXITY? CHILDREN UNDER THE AGE OF 5 YEARS LIVING IN AREAS OF MODERATE TO HIGH MALARIA TRANSMISSION ARE HIGHLY SUSCEPTIBLE TO CLINICAL MALARIA WITH FEVER THAT PROMPTS TREATMENT OF BLOOD STAGE INFECTION WITH ANTI-MALARIAL DRUGS |
| 4491 |
MONOSOMY 7 MYELOPROLIFERATIVE DISEASE IN CHILDREN WITH NEUROFIBROMATOSIS, TYPE 1: EPIDEMIOLOGY AND MOLECULAR ANALYSIS |
| 4492 |
MONOZYGOTIC TWINS DISCORDANT FOR ROHHAD PHENOTYPE |
| 4493 |
MORAXELLA CATARRHALIS INDUCES INFLAMMATORY RESPONSE OF BRONCHIAL EPITHELIAL CELLS VIA MAPK AND NF-KAPPAB ACTIVATION AND HISTONE DEACETYLASE ACTIVITY REDUCTION |
| 4494 |
MORAXELLA CATARRHALIS RESTRICTION-MODIFICATION SYSTEMS ARE ASSOCIATED WITH PHYLOGENETIC LINEAGE AND DISEASE |
| 4495 |
MORE GAIN, LESS PAIN: HOW RESISTANCE TRAINING AFFECTS IMMUNE SYSTEM FUNCTIONING IN MULTIPLE SCLEROSIS PATIENTS: A REVIEW |
| 4496 |
MORE THAN GENES: THE ADVANCED FETAL PROGRAMMING HYPOTHESIS |
| 4497 |
MORPHINE LEADS TO GLOBAL GENOME CHANGES IN H3K27ME3 LEVELS VIA A POLYCOMB REPRESSIVE COMPLEX 2 (PRC2) SELF-REGULATORY MECHANISM IN MESCS |
| 4498 |
MORPHINE REGULATES ARGONAUTE 2 AND TH EXPRESSION AND ACTIVITY BUT NOT MIR-133B IN MIDBRAIN DOPAMINERGIC NEURONS |
| 4499 |
MORPHINE WITHDRAWAL PRODUCES ERK-DEPENDENT AND ERK-INDEPENDENT EPIGENETIC MARKS IN NEURONS OF THE NUCLEUS ACCUMBENS AND LATERAL SEPTUM |
| 4500 |
MORPHINE-WITHDRAWAL AVERSIVE MEMORIES AND THEIR EXTINCTION MODULATE H4K5 ACETYLATION AND BRD4 ACTIVATION IN THE RAT HIPPOCAMPUS AND BASOLATERAL AMYGDALA |
| 4501 |
MORPHOGENS AND HEPATIC STELLATE CELL FATE REGULATION IN CHRONIC LIVER DISEASE |
| 4502 |
MORTALITY ASSOCIATIONS WITH DNA METHYLATION-BASED BIOLOGICAL AGING AND PHYSICAL FUNCTIONING MEASURES ACROSS A 20-YEAR FOLLOW-UP PERIOD |
| 4503 |
MOSAIC AGING |
| 4504 |
MOTHER'S PRE-PREGNANCY BMI AND PLACENTAL CANDIDATE MIRNAS: FINDINGS FROM THE ENVIRONAGE BIRTH COHORT |
| 4505 |
MOUSE MODELS AND THE GENETICS OF DIABETES: IS THERE EVIDENCE FOR GENETIC OVERLAP BETWEEN TYPE 1 AND TYPE 2 DIABETES? IN HUMANS, BOTH TYPE 1 AND TYPE 2 DIABETES EXEMPLIFY GENETICALLY HETEROGENEOUS COMPLEX DISEASES IN WHICH EPIGENETIC FACTORS CONTRIBUTE TO UNDERLYING GENETIC SUSCEPTIBILITY |
| 4506 |
MRTF-A MEDIATES LPS-INDUCED PRO-INFLAMMATORY TRANSCRIPTION BY INTERACTING WITH THE COMPASS COMPLEX |
| 4507 |
MRTF: BASIC BIOLOGY AND ROLE IN KIDNEY DISEASE |
| 4508 |
MS-11, A MIMETIC OF THE MSIN3-BINDING HELIX IN NRSF, AMELIORATES SOCIAL INTERACTION DEFICITS IN A PRENATAL VALPROIC ACID-INDUCED AUTISM MOUSE MODEL |
| 4509 |
MSELENI JOINT DISEASE: A POTENTIAL MODEL OF EPIGENETIC CHONDRODYSPLASIA |
| 4510 |
MTOR-DEPENDENT OXIDATIVE STRESS REGULATES OXLDL-INDUCED TRAINED INNATE IMMUNITY IN HUMAN MONOCYTES |
| 4511 |
MU OPIOID RECEPTOR-TRIGGERED NOTCH-1 ACTIVATION CONTRIBUTES TO MORPHINE TOLERANCE: ROLE OF NEURON-GLIA COMMUNICATION |
| 4512 |
MUC1-C IN CHRONIC INFLAMMATION AND CARCINOGENESIS; EMERGENCE AS A TARGET FOR CANCER TREATMENT |
| 4513 |
MULTI-OMIC APPROACHES TO ACUTE KIDNEY INJURY AND REPAIR |
| 4514 |
MULTI-OMICS ANALYSIS REVEALS CHANGES IN THE INTESTINAL MICROBIOME, TRANSCRIPTOME, AND METHYLOME IN A RAT MODEL OF CHRONIC NON-BACTERIAL PROSTATITIS: INDICATIONS FOR THE EXISTENCE OF THE GUT-PROSTATE AXIS |
| 4515 |
MULTI-OMICS APPROACHES FOR PRECISION OBESITY MANAGEMENT : POTENTIALS AND LIMITATIONS OF OMICS IN PRECISION PREVENTION, TREATMENT AND RISK REDUCTION OF OBESITY |
| 4516 |
MULTI-OMICS CHARACTERIZATION OF INFLAMMATORY BOWEL DISEASE-INDUCED HYPERPLASIA/DYSPLASIA IN THE RAG2(-/-)/IL10(-/-) MOUSE MODEL |
| 4517 |
MULTI-OMICS FACTOR ANALYSIS-A FRAMEWORK FOR UNSUPERVISED INTEGRATION OF MULTI-OMICS DATA SETS |
| 4518 |
MULTI-OMICS FOR BIOMARKER APPROACHES IN THE DIAGNOSTIC EVALUATION AND MANAGEMENT OF ABDOMINAL PAIN AND IRRITABLE BOWEL SYNDROME: WHAT LIES AHEAD |
| 4519 |
MULTI-OMICS IN CROHN'S DISEASE: NEW INSIGHTS FROM INSIDE |
| 4520 |
MULTI-OMICS NUTRITIONAL APPROACHES TARGETING METABOLIC-ASSOCIATED FATTY LIVER DISEASE |
| 4521 |
MULTI?LAYERED PREVENTION AND TREATMENT OF CHRONIC INFLAMMATION, ORGAN FIBROSIS AND CANCER ASSOCIATED WITH CANONICAL WNT/BETA?CATENIN SIGNALING ACTIVATION (REVIEW) |
| 4522 |
MULTIDIMENSIONAL EVALUATION OF THE PAIN PROFILE AS PROGNOSTIC FACTOR IN INDIVIDUALS WITH HIP OR KNEE OSTEOARTHRITIS RECEIVING TOTAL JOINT REPLACEMENT: PROTOCOL OF A 2-YEAR LONGITUDINAL PROGNOSTIC COHORT STUDY |
| 4523 |
MULTIDISCIPLINARY APPROACH TO PROSTATITIS |
| 4524 |
MULTIFACETED CONTROL OF DNA REPAIR PATHWAYS BY THE HYPOXIC TUMOR MICROENVIRONMENT |
| 4525 |
MULTIFACTORIAL CAUSES OF PARANOID SCHIZOPHRENIA WITH AUDITORY-VISUAL HALLUCINATIONS IN A 31-YEAR-OLD MALE WITH HISTORY OF TRAUMATIC BRAIN INJURY AND SUBSTANCE ABUSE |
| 4526 |
MULTIFUNCTIONAL TARGETS OF DIETARY POLYPHENOLS IN DISEASE: A CASE FOR THE CHEMOKINE NETWORK AND ENERGY METABOLISM |
| 4527 |
MULTIGENERATIONAL EFFECTS OF 4-METHYLBENZYLIDENE CAMPHOR (4-MBC) ON THE SURVIVAL, DEVELOPMENT AND REPRODUCTION OF THE MARINE COPEPOD TIGRIOPUS JAPONICUS |
| 4528 |
MULTIGENERATIONAL EFFECTS OF CADMIUM ON THE LIFESPAN AND FERTILITY OF DROSOPHILA MELANOGASTER |
| 4529 |
MULTIGENERATIONAL GRAPHENE OXIDE INTOXICATION RESULTS IN REPRODUCTION DISORDERS AT THE MOLECULAR LEVEL OF VITELLOGENIN PROTEIN EXPRESSION IN ACHETA DOMESTICUS |
| 4530 |
MULTILAYER INTRACLONAL HETEROGENEITY IN CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 4531 |
MULTILAYER-OMICS ANALYSES OF HUMAN CANCERS: EXPLORATION OF BIOMARKERS AND DRUG TARGETS BASED ON THE ACTIVITIES OF THE INTERNATIONAL HUMAN EPIGENOME CONSORTIUM |
| 4532 |
MULTIMODAL ANALGESIA FOR PERIOPERATIVE MANAGEMENT OF PATIENTS PRESENTING FOR SPINAL SURGERY |
| 4533 |
MULTIPLE GENE KNOCKDOWN STRATEGIES FOR INVESTIGATING THE PROPERTIES OF HUMAN LEUKEMIA STEM CELLS AND EXPLORING NEW THERAPIES |
| 4534 |
MULTIPLE REGULATIONS OF KEAP1/NRF2 SYSTEM BY DIETARY PHYTOCHEMICALS |
| 4535 |
MULTIPLE ROLES OF TOLL-LIKE RECEPTOR 4 IN COLORECTAL CANCER |
| 4536 |
MULTIPLE SCLEROSIS - RISK FACTORS |
| 4537 |
MULTIPLE SCLEROSIS SUSCEPTIBILITY AND THE X CHROMOSOME |
| 4538 |
MULTISCALE APPROACH TO DECIPHERING THE MOLECULAR MECHANISMS INVOLVED IN THE DIRECT AND INTERGENERATIONAL EFFECT OF IBUPROFEN ON MOSQUITO AEDES AEGYPTI |
| 4539 |
MULTISTAGE CARCINOGENESIS IN MOUSE SKIN |
| 4540 |
MULTISTEP PATHOGENESIS OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN PATIENTS |
| 4541 |
MULTISYSTEMIC ALTERATIONS IN HUMANS INDUCED BY BISPHENOL A AND PHTHALATES: EXPERIMENTAL, EPIDEMIOLOGICAL AND CLINICAL STUDIES REVEAL THE NEED TO CHANGE HEALTH POLICIES |
| 4542 |
MURINE MODELS OF SLEEP APNEA: FUNCTIONAL IMPLICATIONS OF ALTERED MACROPHAGE POLARITY AND EPIGENETIC MODIFICATIONS IN ADIPOSE AND VASCULAR TISSUES |
| 4543 |
MUSCLE DYSFUNCTION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: UPDATE ON CAUSES AND BIOLOGICAL FINDINGS |
| 4544 |
MUSCLE HYPERTROPHY IN HYPOXIA WITH INFLAMMATION IS CONTROLLED BY BROMODOMAIN AND EXTRA-TERMINAL DOMAIN PROTEINS |
| 4545 |
MUTANT P53 GAIN OF FUNCTION AND CHEMORESISTANCE: THE ROLE OF MUTANT P53 IN RESPONSE TO CLINICAL CHEMOTHERAPY |
| 4546 |
MUTANT P53 REGULATES ENHANCER-ASSOCIATED H3K4 MONOMETHYLATION THROUGH INTERACTIONS WITH THE METHYLTRANSFERASE MLL4 |
| 4547 |
MUTATION ALLELE BURDEN REMAINS UNCHANGED IN CHRONIC MYELOMONOCYTIC LEUKAEMIA RESPONDING TO HYPOMETHYLATING AGENTS |
| 4548 |
MUTATION ANALYSIS OF THE FAS AND TNFR APOPTOTIC CASCADE GENES IN HEMATOLOGICAL MALIGNANCIES |
| 4549 |
MUTATION ANALYSIS OF THERAPY-RELATED MYELOID NEOPLASMS |
| 4550 |
MUTATION-PROMOTING MOLECULAR NETWORKS OF UNCONTROLLED INFLAMMATION |
| 4551 |
MUTATIONAL HIERARCHIES IN MYELODYSPLASTIC SYNDROMES DYNAMICALLY ADAPT AND EVOLVE UPON THERAPY RESPONSE AND FAILURE |
| 4552 |
MUTATIONAL LANDSCAPE OF CHRONIC MYELOID LEUKEMIA: MORE THAN A SINGLE ONCOGENE LEUKEMIA |
| 4553 |
MUTATIONAL LANDSCAPE OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN CHINESE PATIENTS |
| 4554 |
MUTATIONAL PROFILING IN MYELOFIBROSIS: IMPLICATIONS FOR MANAGEMENT |
| 4555 |
MUTATIONAL SPECTRUM ANALYSIS OF CHRONIC MYELOMONOCYTIC LEUKEMIA INCLUDES GENES ASSOCIATED WITH EPIGENETIC REGULATION: UTX, EZH2, AND DNMT3A |
| 4556 |
MUTATIONAL SPECTRUM OF MYELOID MALIGNANCIES WITH INV(3)/T(3;3) REVEALS A PREDOMINANT INVOLVEMENT OF RAS/RTK SIGNALING PATHWAYS |
| 4557 |
MUTATIONS IN ASXL1 ARE ASSOCIATED WITH POOR PROGNOSIS ACROSS THE SPECTRUM OF MALIGNANT MYELOID DISEASES |
| 4558 |
MUTATIONS IN THE NF-KAPPAB SIGNALING PATHWAY: IMPLICATIONS FOR HUMAN DISEASE |
| 4559 |
MUTATIONS OF THE TRANSCRIPTIONAL COREPRESSOR ZMYM2 CAUSE SYNDROMIC URINARY TRACT MALFORMATIONS |
| 4560 |
MUTATIONS WITH EPIGENETIC EFFECTS IN MYELOPROLIFERATIVE NEOPLASMS AND RECENT PROGRESS IN TREATMENT: PROCEEDINGS FROM THE 5TH INTERNATIONAL POST-ASH SYMPOSIUM |
| 4561 |
MYD88 HYPERMETHYLATION MEDIATED BY DNMT1 IS ASSOCIATED WITH LTA-INDUCED INFLAMMATORY RESPONSE IN HUMAN ODONTOBLAST-LIKE CELLS |
| 4562 |
MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM OVERLAP SYNDROMES: A FOCUSED REVIEW |
| 4563 |
MYELOID DNA METHYLTRANSFERASE3B DEFICIENCY AGGRAVATES PULMONARY FIBROSIS BY ENHANCING PROFIBROTIC MACROPHAGE ACTIVATION |
| 4564 |
MYELOID KDM6B DEFICIENCY RESULTS IN ADVANCED ATHEROSCLEROSIS |
| 4565 |
MYELOID MALIGNANCIES: MUTATIONS, MODELS AND MANAGEMENT |
| 4566 |
MYELOID SOMATIC MUTATION PANEL TESTING IN MYELOPROLIFERATIVE NEOPLASMS |
| 4567 |
MYELOID-DERIVED SUPPRESSOR CELL FUNCTION AND EPIGENETIC EXPRESSION EVOLVES OVER TIME AFTER SURGICAL SEPSIS |
| 4568 |
MYELOID-DERIVED SUPPRESSOR CELLS (MDSC): WHEN GOOD INTENTIONS GO AWRY |
| 4569 |
MYELOID-SPECIFIC INACTIVATION OF P15INK4B RESULTS IN MONOCYTOSIS AND PREDISPOSITION TO MYELOID LEUKEMIA |
| 4570 |
MYELOMONOCYTIC CELLS IN GIANT CELL ARTERITIS ACTIVATE TRAINED IMMUNITY PROGRAMS SUSTAINING INFLAMMATION AND CYTOKINE PRODUCTION |
| 4571 |
MYELOMONOCYTIC SKEWING IN CHRONIC MYELOMONOCYTIC LEUKEMIA: PHENOTYPIC, MOLECULAR AND BIOLOGIC FEATURES AND IMPACT ON SURVIVAL |
| 4572 |
MYELOPEROXIDASE IMMUNOHISTOCHEMISTRY AS A MEASURE OF DISEASE ACTIVITY IN ULCERATIVE COLITIS: ASSOCIATION WITH ULCERATIVE COLITIS-COLORECTAL CANCER, TUMOR NECROSIS FACTOR POLYMORPHISM AND RUNX3 METHYLATION |
| 4573 |
MYOCARDIAL INFARCTION-ASSOCIATED TRANSCRIPT, A LONG NONCODING RNA, IS OVEREXPRESSED DURING DILATED CARDIOMYOPATHY DUE TO CHRONIC CHAGAS DISEASE |
| 4574 |
MYOCARDIN-RELATED TRANSCRIPTION FACTOR A EPIGENETICALLY REGULATES RENAL FIBROSIS IN DIABETIC NEPHROPATHY |
| 4575 |
MYOFIBROBLASTS |
| 4576 |
MYOGENIC POTENTIAL OF CANINE CRANIOFACIAL SATELLITE CELLS |
| 4577 |
MYOSTATIN: BASIC BIOLOGY TO CLINICAL APPLICATION |
| 4578 |
N(6) -METHYLADENOSINE MODIFICATION IN CHRONIC STRESS RESPONSE DUE TO SOCIAL HIERARCHY POSITIONING OF MICE |
| 4579 |
N(6)-METHYLADENOSINE METHYLASE METTL3 CONTRIBUTES TO NEUROPATHIC PAIN BY EPIGENETIC SILENCING OF MU OPIOID RECEPTOR |
| 4580 |
N(6)-METHYLADENOSINE MODIFICATION OF FATTY ACID AMIDE HYDROLASE MESSENGER RNA IN CIRCULAR RNA STAG1-REGULATED ASTROCYTE DYSFUNCTION AND DEPRESSIVE-LIKE BEHAVIORS |
| 4581 |
N-METHYL-D-ASPARTATE 2B RECEPTOR SUBTYPE (NR2B) PROMOTER METHYLATION IN PATIENTS DURING ALCOHOL WITHDRAWAL |
| 4582 |
N-TERMINAL BET BROMODOMAIN INHIBITORS DISRUPT A BRD4-P65 INTERACTION AND REDUCE INDUCIBLE NITRIC OXIDE SYNTHASE TRANSCRIPTION IN PANCREATIC BETA-CELLS |
| 4583 |
N6-METHYLADENINE RNA METHYLATION EPIGENETIC MODIFICATION AND KIDNEY DISEASES |
| 4584 |
N6-METHYLADENOSINE-METHYLOMIC LANDSCAPE OF LUNG TISSUES OF MICE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 4585 |
NAD(+) AND VASCULAR DYSFUNCTION: FROM MECHANISMS TO THERAPEUTIC OPPORTUNITIES |
| 4586 |
NAFLD AT THE INTERFACE OF THE MOTHER-INFANT DYAD |
| 4587 |
NANO-ENGINEERED VITAMINS AS A POTENTIAL EPIGENETIC MODIFIER AGAINST ENVIRONMENTAL AIR POLLUTANTS |
| 4588 |
NANOPARTICLE EXPOSURES FROM NANO-ENABLED TONER-BASED PRINTING EQUIPMENT AND HUMAN HEALTH: STATE OF SCIENCE AND FUTURE RESEARCH NEEDS |
| 4589 |
NANOPARTICLES IN THE DIAGNOSIS AND TREATMENT OF VASCULAR AGING AND RELATED DISEASES |
| 4590 |
NANOPORE SEQUENCING IDENTIFIES DIFFERENTIALLY METHYLATED GENES IN THE CENTRAL NERVOUS SYSTEM IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS |
| 4591 |
NARRATIVE REVIEW OF THE COMPLEX INTERACTION BETWEEN PAIN AND TRAUMA IN CHILDREN: A FOCUS ON BIOLOGICAL MEMORY, PRECLINICAL DATA, AND EPIGENETIC PROCESSES |
| 4592 |
NATURAL ENVIRONMENTS, NATURE RELATEDNESS AND THE ECOLOGICAL THEATER: CONNECTING SATELLITES AND SEQUENCING TO SHINRIN-YOKU |
| 4593 |
NATURAL GENETIC VARIATION IN A MULTIGENERATIONAL PHENOTYPE IN C |
| 4594 |
NATURAL HISTORY AND LONG-TERM CLINICAL COURSE OF CROHN'S DISEASE |
| 4595 |
NATURAL KILLER CELLS AND IMMUNE-CHECKPOINT INHIBITOR THERAPY: CURRENT KNOWLEDGE AND NEW CHALLENGES |
| 4596 |
NATURAL KILLER CELLS IN HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION: SPOTLIGHT ON THE IMPACT OF HUMAN CYTOMEGALOVIRUS |
| 4597 |
NATURAL PRODUCTS WITH ANTI-AGING POTENTIAL: AFFECTED TARGETS AND MOLECULAR MECHANISMS |
| 4598 |
NATURAL PRODUCTS: THE ROLE AND MECHANISM IN LOW-DENSITY LIPOPROTEIN OXIDATION AND ATHEROSCLEROSIS |
| 4599 |
NATURE AND NURTURE OF HUMAN PAIN |
| 4600 |
NATURE OR NURTURE: LET FOOD BE YOUR EPIGENETIC MEDICINE IN CHRONIC INFLAMMATORY DISORDERS |
| 4601 |
NDRG2 MRNA LEVELS AND MIR-28-5P AND MIR-650 ACTIVITY IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 4602 |
NECESSITY OF EPIGENETIC EPIDEMIOLOGY STUDIES ON THE CARCINOGENESIS OF LUNG CANCER IN NEVER SMOKERS |
| 4603 |
NEGATIVE ALLOSTERIC MODULATION OF MGLUR5 PARTIALLY CORRECTS PATHOPHYSIOLOGY IN A MOUSE MODEL OF RETT SYNDROME |
| 4604 |
NEGATIVE EVIDENCE FOR A FUNCTIONAL ROLE OF NEURONAL DNMT3A IN PERSISTENT PAIN |
| 4605 |
NEGATIVE REGULATORS OF TGF-BETA1 SIGNALING IN RENAL FIBROSIS; PATHOLOGICAL MECHANISMS AND NOVEL THERAPEUTIC OPPORTUNITIES |
| 4606 |
NEIGHBORHOOD CHARACTERISTICS INFLUENCE DNA METHYLATION OF GENES INVOLVED IN STRESS RESPONSE AND INFLAMMATION: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS |
| 4607 |
NEIGHBORHOOD ENVIRONMENT AND DNA METHYLATION: IMPLICATIONS FOR CARDIOVASCULAR DISEASE RISK |
| 4608 |
NEONATAL ANESTHESIA AND DYSREGULATION OF THE EPIGENOMEDAGGER |
| 4609 |
NEONATAL DNA METHYLATION AND CHILDHOOD LOW PROSOCIAL BEHAVIOR: AN EPIGENOME-WIDE ASSOCIATION META-ANALYSIS |
| 4610 |
NEONATAL DNA METHYLATION AND EARLY-ONSET CONDUCT PROBLEMS: A GENOME-WIDE, PROSPECTIVE STUDY |
| 4611 |
NEONATAL IMMUNE CHALLENGE FOLLOWED BY ADULT IMMUNE CHALLENGE INDUCES EPIGENETIC-SUSCEPTIBILITY TO AGGRAVATED VISCERAL HYPERSENSITIVITY |
| 4612 |
NEONATAL PAIN AND COMT VAL158MET GENOTYPE IN RELATION TO SEROTONIN TRANSPORTER (SLC6A4) PROMOTER METHYLATION IN VERY PRETERM CHILDREN AT SCHOOL AGE |
| 4613 |
NEOVASCULARIZATION IS A KEY FEATURE OF LIVER FIBROSIS PROGRESSION: ANTI-ANGIOGENESIS AS AN INNOVATIVE WAY OF LIVER FIBROSIS TREATMENT |
| 4614 |
NERVE EXCITABILITY AND NEUROPATHIC PAIN IS REDUCED BY BET PROTEIN INHIBITION AFTER SPARED NERVE INJURY |
| 4615 |
NERVE INJURY DIMINISHES OPIOID ANALGESIA THROUGH LYSINE METHYLTRANSFERASE-MEDIATED TRANSCRIPTIONAL REPRESSION OF MU-OPIOID RECEPTORS IN PRIMARY SENSORY NEURONS |
| 4616 |
NERVE INJURY INCREASES BRAIN-DERIVED NEUROTROPHIC FACTOR LEVELS TO SUPPRESS BK CHANNEL ACTIVITY IN PRIMARY SENSORY NEURONS |
| 4617 |
NERVE INJURY-INDUCED CHRONIC PAIN IS ASSOCIATED WITH PERSISTENT DNA METHYLATION REPROGRAMMING IN DORSAL ROOT GANGLION |
| 4618 |
NERVE INJURY-INDUCED EPIGENETIC SILENCING OF OPIOID RECEPTORS CONTROLLED BY DNMT3A IN PRIMARY AFFERENT NEURONS |
| 4619 |
NERVE TRAUMA-CAUSED DOWNREGULATION OF OPIOID RECEPTORS IN PRIMARY AFFERENT NEURONS: MOLECULAR MECHANISMS AND POTENTIAL MANAGEMENTS |
| 4620 |
NEURO-IMMUNE DYSFUNCTION DURING BRAIN AGING: NEW INSIGHTS IN MICROGLIAL CELL REGULATION |
| 4621 |
NEUROBIOLOGICAL AND SYSTEMIC EFFECTS OF CHRONIC STRESS |
| 4622 |
NEUROBIOLOGICAL DEVELOPMENT IN THE CONTEXT OF CHILDHOOD TRAUMA |
| 4623 |
NEUROBIOLOGY OF BIPOLAR DISORDERS: A REVIEW OF GENETIC COMPONENTS, SIGNALING PATHWAYS, BIOCHEMICAL CHANGES, AND NEUROIMAGING FINDINGS |
| 4624 |
NEUROBIOLOGY OF KB220Z-GLUTAMINERGIC-DOPAMINERGIC OPTIMIZATION COMPLEX [GDOC] AS A LIQUID NANO: CLINICAL ACTIVATION OF BRAIN IN A HIGHLY FUNCTIONAL CLINICIAN IMPROVING FOCUS, MOTIVATION AND OVERALL SENSORY INPUT FOLLOWING CHRONIC INTAKE |
| 4625 |
NEUROBIOLOGY OF VITAMIN C: EXPANDING THE FOCUS FROM ANTIOXIDANT TO ENDOGENOUS NEUROMODULATOR |
| 4626 |
NEURODEVELOPMENTAL DISORDERS AND ENVIRONMENTAL TOXICANTS: EPIGENETICS AS AN UNDERLYING MECHANISM |
| 4627 |
NEUROENDOCRINOLOGICAL AND EPIGENETIC MECHANISMS SUBSERVING AUTONOMIC IMBALANCE AND HPA DYSFUNCTION IN THE METABOLIC SYNDROME |
| 4628 |
NEUROEPIGENETIC ALTERATIONS IN THE PREFRONTAL CORTEX OF TYPE 2 DIABETIC MICE THROUGH DNA HYPERMETHYLATION |
| 4629 |
NEUROEPIGENETIC CHANGES IN DNA METHYLATION AFFECTING DIABETES-INDUCED COGNITIVE IMPAIRMENT |
| 4630 |
NEUROEPIGENETIC REGULATION OF PATHOGENIC MEMORIES |
| 4631 |
NEUROGENETICS OF ACUTE AND CHRONIC OPIATE/OPIOID ABSTINENCE: TREATING SYMPTOMS AND THE CAUSE |
| 4632 |
NEUROIMAGING GENETIC APPROACHES TO POSTTRAUMATIC STRESS DISORDER |
| 4633 |
NEUROIMMUNE ACTIVATION DRIVES MULTIPLE BRAIN STATES |
| 4634 |
NEUROINFLAMMATION REGULATES THE BALANCE BETWEEN HIPPOCAMPAL NEURON DEATH AND NEUROGENESIS IN AN EX VIVO MODEL OF THIAMINE DEFICIENCY |
| 4635 |
NEUROINFLAMMATORY MECHANISMS IN PARKINSON'S DISEASE: POTENTIAL ENVIRONMENTAL TRIGGERS, PATHWAYS, AND TARGETS FOR EARLY THERAPEUTIC INTERVENTION |
| 4636 |
NEUROLOGIC COMPLICATIONS OF ACUTE HIV INFECTION |
| 4637 |
NEURON-RESTRICTIVE SILENCER FACTOR CAUSES EPIGENETIC SILENCING OF KV4 |
| 4638 |
NEURON-SPECIFIC METHYLOME ANALYSIS REVEALS EPIGENETIC REGULATION AND TAU-RELATED DYSFUNCTION OF BRCA1 IN ALZHEIMER'S DISEASE |
| 4639 |
NEURONAL EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) ACTIVITY AS MARKER AND MEDIATOR OF ALCOHOL AND OPIOID DEPENDENCE |
| 4640 |
NEURONAL NUCLEAR CALCIUM SIGNALING SUPPRESSION OF MICROGLIAL REACTIVITY IS MEDIATED BY OSTEOPROTEGERIN AFTER TRAUMATIC BRAIN INJURY |
| 4641 |
NEURONAL NUCLEI ISOLATION FROM HUMAN POSTMORTEM BRAIN TISSUE |
| 4642 |
NEURONAL PLASTICITY: A LINK BETWEEN STRESS AND MOOD DISORDERS |
| 4643 |
NEUROPATHIC PAIN AS A TRIGGER FOR HISTONE MODIFICATIONS IN LIMBIC CIRCUITRY |
| 4644 |
NEUROPATHIC PAIN TREATMENT: STILL A CHALLENGE |
| 4645 |
NEUROPATHIC PAIN: FROM MECHANISMS TO TREATMENT |
| 4646 |
NEUROPATHOLOGICAL MECHANISMS ASSOCIATED WITH PESTICIDES IN ALZHEIMER'S DISEASE |
| 4647 |
NEUROPEPTIDE AND SMALL TRANSMITTER COEXISTENCE: FUNDAMENTAL STUDIES AND RELEVANCE TO MENTAL ILLNESS |
| 4648 |
NEUROPEPTIDE Y IN ALCOHOL ADDICTION AND AFFECTIVE DISORDERS |
| 4649 |
NEUROPEPTIDES AND NEUROPEPTIDE RECEPTORS: DRUG TARGETS, AND PEPTIDE AND NON-PEPTIDE LIGANDS: A TRIBUTE TO PROF |
| 4650 |
NEUROPLASTICITY IN ADDICTION: CELLULAR AND TRANSCRIPTIONAL PERSPECTIVES |
| 4651 |
NEUROPROGRESSION IN SCHIZOPHRENIA: PATHWAYS UNDERPINNING CLINICAL STAGING AND THERAPEUTIC COROLLARIES |
| 4652 |
NEUROPROTECTION WITH NATURAL ANTIOXIDANTS AND NUTRACEUTICALS IN THE CONTEXT OF BRAIN CELL DEGENERATION: THE EPIGENETIC CONNECTION |
| 4653 |
NEUROSCIENCE OF ALCOHOLISM: MOLECULAR AND CELLULAR MECHANISMS |
| 4654 |
NEUROSTEROIDS (ALLOPREGNANOLONE) AND ALCOHOL USE DISORDER: FROM MECHANISMS TO POTENTIAL PHARMACOTHERAPY |
| 4655 |
NEUROTROPHIN MEDIATED HPA AXIS DYSREGULATION IN STRESS INDUCED GENESIS OF PSYCHIATRIC DISORDERS: ORCHESTRATION BY EPIGENETIC MODIFICATIONS |
| 4656 |
NEW ADVANCES IN JUVENILE IDIOPATHIC ARTHRITIS |
| 4657 |
NEW ADVANCES OF DNA METHYLATION AND HISTONE MODIFICATIONS IN RHEUMATOID ARTHRITIS, WITH SPECIAL EMPHASIS ON MECP2 |
| 4658 |
NEW ANTI-INFLAMMATORY TARGETS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 4659 |
NEW APPROACHES FOR STUDYING ALCOHOLIC LIVER DISEASE |
| 4660 |
NEW APPROACHES TO THE TREATMENT OF MYELODYSPLASIA |
| 4661 |
NEW ASPECTS OF THE EPIGENETIC REGULATION OF EMT RELATED TO PULMONARY FIBROSIS |
| 4662 |
NEW DEVELOPMENTS IN THE PATHOGENESIS OF OBESITY-INDUCED HYPERTENSION |
| 4663 |
NEW HORIZONS: NOVEL APPROACHES TO ENHANCE HEALTHSPAN THROUGH TARGETING CELLULAR SENESCENCE AND RELATED AGING MECHANISMS |
| 4664 |
NEW IMMUNE HORIZONS IN THERAPEUTICS AND DIAGNOSTIC APPROACHES TO PREECLAMPSIA |
| 4665 |
NEW INSIGHTS AND ADVANCES IN PATHOGENESIS AND TREATMENT OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE |
| 4666 |
NEW INSIGHTS AND OPTIONS INTO THE MECHANISMS AND EFFECTS OF COMBINED TARGETED THERAPY AND IMMUNOTHERAPY IN PROSTATE CANCER |
| 4667 |
NEW INSIGHTS INTO ADULT AND PAEDIATRIC CHRONIC NON-BACTERIAL OSTEOMYELITIS CNO |
| 4668 |
NEW INSIGHTS INTO MOLECULAR MECHANISMS OF EPIGENETIC REGULATION IN KIDNEY DISEASE |
| 4669 |
NEW INSIGHTS INTO PATHOPHYSIOLOGY OF VESTIBULAR MIGRAINE |
| 4670 |
NEW INSIGHTS INTO THE EPIGENETIC REGULATION OF INFLAMMATORY BOWEL DISEASE |
| 4671 |
NEW INSIGHTS INTO THE MECHANISM OF ACTION OF ASPIRIN IN THE PREVENTION OF COLORECTAL NEOPLASIA |
| 4672 |
NEW INSIGHTS INTO THE MECHANISMS OF THE KETOGENIC DIET |
| 4673 |
NEW INSIGHTS INTO THE PATHOGENESIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME |
| 4674 |
NEW INSIGHTS INTO THE ROLE AND MECHANISM OF PARTIAL EPITHELIAL-MESENCHYMAL TRANSITION IN KIDNEY FIBROSIS |
| 4675 |
NEW INSIGHTS INTO UNDERSTANDING THE MECHANISMS, PATHOGENESIS, AND MANAGEMENT OF MALIGNANT MESOTHELIOMAS |
| 4676 |
NEW INSIGHTS TOWARD THE PATHOGENESIS OF ANKYLOSING SPONDYLITIS; GENETIC VARIATIONS AND EPIGENETIC MODIFICATIONS |
| 4677 |
NEW LNCRNAS IN CHRONIC HEPATITIS C PROGRESSION: FROM FIBROSIS TO HEPATOCELLULAR CARCINOMA |
| 4678 |
NEW MOLECULAR MARKERS IN RESISTANT B-CLL |
| 4679 |
NEW MOLECULAR TARGETS FOR THE TREATMENT OF OSTEOARTHRITIS |
| 4680 |
NEW MUTATIONS AND PATHOGENESIS OF MYELOPROLIFERATIVE NEOPLASMS |
| 4681 |
NEW OPTIONS IN THE TREATMENT OF MYELODYSPLASTIC SYNDROME |
| 4682 |
NEW PATHWAYS IDENTIFY NOVEL DRUG TARGETS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE |
| 4683 |
NEW PERSPECTIVES ON FOLATE TRANSPORT IN RELATION TO ALCOHOLISM-INDUCED FOLATE MALABSORPTION--ASSOCIATION WITH EPIGENOME STABILITY AND CANCER DEVELOPMENT |
| 4684 |
NEW POTENTIAL THERAPEUTIC APPROACHES TARGETING SYNOVIAL FIBROBLASTS IN RHEUMATOID ARTHRITIS |
| 4685 |
NEW TARGETS AND STRATEGIES FOR RHEUMATOID ARTHRITIS: FROM SIGNAL TRANSDUCTION TO EPIGENETIC ASPECT |
| 4686 |
NEW THERAPEUTIC TARGETS IN TRANSFUSION-DEPENDENT AND -INDEPENDENT THALASSEMIA |
| 4687 |
NEW TOOLS FOR MOLECULAR THERAPY OF HEPATOCELLULAR CARCINOMA |
| 4688 |
NEW UNDERSTANDING OF DIAGNOSIS, TREATMENT AND PREVENTION OF ENDOMETRIOSIS |
| 4689 |
NEW-ONSET POSTPARTUM PREECLAMPSIA: EPIGENETIC MECHANISM AND PREDICTION |
| 4690 |
NEWBORN DNA-METHYLATION, CHILDHOOD LUNG FUNCTION, AND THE RISKS OF ASTHMA AND COPD ACROSS THE LIFE COURSE |
| 4691 |
NEWBORNS OF OBESE PARENTS HAVE ALTERED DNA METHYLATION PATTERNS AT IMPRINTED GENES |
| 4692 |
NEWS FROM THE "5TH INTERNATIONAL MEETING ON INFLAMMATORY BOWEL DISEASES" CAPRI 2010 |
| 4693 |
NEXT GENERATION OF TARGETED MOLECULES FOR NON-HODGKIN LYMPHOMAS: SMALL-MOLECULE INHIBITORS OF INTRACELLULAR TARGETS AND SIGNALING PATHWAYS |
| 4694 |
NEXT-GENERATION SEQUENCING IDENTIFIES MAJOR DNA METHYLATION CHANGES DURING PROGRESSION OF PH+ CHRONIC MYELOID LEUKEMIA |
| 4695 |
NF-KAPPAB ACTIVATION IN CHRONIC LYMPHOCYTIC LEUKEMIA: A POINT OF CONVERGENCE OF EXTERNAL TRIGGERS AND INTRINSIC LESIONS |
| 4696 |
NF-KAPPAB REPRESSES RETINOIC ACID RECEPTOR-MEDIATED GPRC5A TRANSACTIVATION IN LUNG EPITHELIAL CELLS TO PROMOTE NEOPLASIA |
| 4697 |
NF-KAPPAB UPREGULATION THROUGH EPIGENETIC SILENCING OF LDOC1 DRIVES TUMOR BIOLOGY AND SPECIFIC IMMUNOPHENOTYPE IN GROUP A EPENDYMOMA |
| 4698 |
NFATC2-DEPENDENT EPIGENETIC DOWNREGULATION OF THE TSC2/BECLIN-1 PATHWAY IS INVOLVED IN NEUROPATHIC PAIN INDUCED BY OXALIPLATIN |
| 4699 |
NFATC2-DEPENDENT EPIGENETIC UPREGULATION OF CXCL14 IS INVOLVED IN THE DEVELOPMENT OF NEUROPATHIC PAIN INDUCED BY PACLITAXEL |
| 4700 |
NICKEL EXPOSURE INDUCES PERSISTENT MESENCHYMAL PHENOTYPE IN HUMAN LUNG EPITHELIAL CELLS THROUGH EPIGENETIC ACTIVATION OF ZEB1 |
| 4701 |
NICOTINE AND THE ADOLESCENT BRAIN |
| 4702 |
NICOTINE-INDUCED OXIDATIVE STRESS CONTRIBUTES TO EMT AND STEMNESS DURING NEOPLASTIC TRANSFORMATION THROUGH EPIGENETIC MODIFICATIONS IN HUMAN KIDNEY EPITHELIAL CELLS |
| 4703 |
NIK AS A DRUGGABLE MEDIATOR OF TISSUE INJURY |
| 4704 |
NITRATION OF DISTINCT TYROSINE RESIDUES CAUSES INACTIVATION OF HISTONE DEACETYLASE 2 |
| 4705 |
NLRP3: A NEW THERAPEUTIC TARGET IN ALCOHOLIC LIVER DISEASE |
| 4706 |
NMP4/CIZ CLOSES THE PARATHYROID HORMONE ANABOLIC WINDOW |
| 4707 |
NMR PLASMA METABOLOMICS STUDY OF PATIENTS OVERCOMING ACUTE MYOCARDIAL INFARCTION: IN THE FIRST 12 H AFTER ONSET OF CHEST PAIN WITH STATISTICAL DISCRIMINATION TOWARDS METABOLOMIC BIOMARKERS |
| 4708 |
NO ASSOCIATION OF POLYMORPHISMS IN NAV1 |
| 4709 |
NON-ALCOHOLIC FATTY LIVER DISEASE AND ALCOHOL-RELATED LIVER DISEASE: TWO INTERTWINED ENTITIES |
| 4710 |
NON-ALCOHOLIC FATTY LIVER DISEASE AND THE IMPACT OF GENETIC, EPIGENETIC AND ENVIRONMENTAL FACTORS IN THE OFFSPRING |
| 4711 |
NON-ALCOHOLIC FATTY LIVER DISEASE IN OBESE CHILDREN AND ADOLESCENTS: A ROLE FOR NUTRITION? NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) HAS BECOME THE MOST COMMON CAUSE OF CHRONIC LIVER DISEASE IN CHILDREN, PARALLELING THE INCREASING PREVALENCE OF OBESITY WORLDWIDE |
| 4712 |
NON-ALCOHOLIC FATTY LIVER DISEASE: METABOLIC, GENETIC, EPIGENETIC AND ENVIRONMENTAL RISK FACTORS |
| 4713 |
NON-CODING RNA AND N6-METHYLADENOSINE MODIFICATION PLAY CRUCIAL ROLES IN NEUROPATHIC PAIN |
| 4714 |
NON-CODING RNA IN ALCOHOL USE DISORDER BY AFFECTING SYNAPTIC PLASTICITY |
| 4715 |
NON-CODING RNA REGULATION OF T CELL BIOLOGY: IMPLICATIONS FOR AGE-ASSOCIATED CARDIOVASCULAR DISEASES |
| 4716 |
NON-GENETIC RATS MODELS FOR ATHEROSCLEROSIS RESEARCH: FROM PAST TO PRESENT |
| 4717 |
NON-GENOMIC TRANSGENERATIONAL INHERITANCE OF DISEASE RISK |
| 4718 |
NON-TYPEABLE HAEMOPHILUS INFLUENZAE ISOLATES FROM PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE CONTAIN NEW PHASE-VARIABLE MODA METHYLTRANSFERASE ALLELES CONTROLLING PHASEVARIONS |
| 4719 |
NONCODING RNA AND EPIGENETIC GENE REGULATION IN RENAL DISEASES |
| 4720 |
NONCODING RNAS AS ADDITIONAL MEDIATORS OF EPIGENETIC REGULATION IN NONALCOHOLIC FATTY LIVER DISEASE |
| 4721 |
NONCODING RNAS IN MULTIPLE SCLEROSIS |
| 4722 |
NONCODING RNAS IN NONALCOHOLIC FATTY LIVER DISEASE: POTENTIAL DIAGNOSIS AND PROGNOSIS BIOMARKERS |
| 4723 |
NONHUMAN PRIMATE MODELS OF POLYCYSTIC OVARY SYNDROME |
| 4724 |
NONINVASIVE MULTIMODAL METHODS TO DIFFERENTIATE INFLAMED VS FIBROTIC STRICTURES IN PATIENTS WITH CROHN'S DISEASE |
| 4725 |
NORMAL GASTRIC TISSUE HELICOBACTER PYLORI INFECTION IS ASSOCIATED WITH EPIGENETIC AGE ACCELERATION, INCREASED MITOTIC TICK RATE, TISSUE CELL COMPOSITION, AND NATURAL KILLER CELL METHYLATION ALTERATIONS |
| 4726 |
NOT-SO-OPPOSITE ENDS OF THE SPECTRUM: CD8(+) T CELL DYSFUNCTION ACROSS CHRONIC INFECTION, CANCER AND AUTOIMMUNITY |
| 4727 |
NOTABLE ROLES OF EZH2 AND DNMT1 IN EPIGENETIC DORMANCY OF THE SHP1 GENE DURING THE PROGRESSION OF CHRONIC MYELOID LEUKAEMIA |
| 4728 |
NOTCH SIGNALING PROMOTES DISEASE INITIATION AND PROGRESSION IN MURINE CHRONIC LYMPHOCYTIC LEUKEMIA |
| 4729 |
NOTCH1 MUTATIONS ASSOCIATE WITH LOW CD20 LEVEL IN CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE FOR A NOTCH1 MUTATION-DRIVEN EPIGENETIC DYSREGULATION |
| 4730 |
NOVEL AGE-ASSOCIATED DNA METHYLATION CHANGES AND EPIGENETIC AGE ACCELERATION IN MIDDLE-AGED AFRICAN AMERICANS AND WHITES |
| 4731 |
NOVEL ANTI-AGING GENE NM_026333 CONTRIBUTES TO PROTON-INDUCED AGING VIA NCX1-PATHWAY |
| 4732 |
NOVEL BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE AND COLORECTAL CANCER: AN INTERPLAY BETWEEN METABOLIC DYSREGULATION AND EXCESSIVE INFLAMMATION |
| 4733 |
NOVEL BIOMARKERS FOR THE IDENTIFICATION AND TARGETED THERAPY OF GASTRIC CANCER |
| 4734 |
NOVEL CONCEPTS IN RADIATION-INDUCED CARDIOVASCULAR DISEASE |
| 4735 |
NOVEL DETECTION OF POST-TRANSLATIONAL MODIFICATIONS IN HUMAN MONOCYTE-DERIVED DENDRITIC CELLS AFTER CHRONIC ALCOHOL EXPOSURE: ROLE OF INFLAMMATION REGULATOR H4K12AC |
| 4736 |
NOVEL EPIGENETIC BIOMARKERS MEDIATING BISPHENOL A EXPOSURE AND METABOLIC PHENOTYPES IN FEMALE MICE |
| 4737 |
NOVEL EPIGENETIC-SENSITIVE CLINICAL CHALLENGES BOTH IN TYPE 1 AND TYPE 2 DIABETES |
| 4738 |
NOVEL FIBROBLAST PHENOTYPES IN HOMEOSTASIS AND CHRONIC INFLAMMATION: FROM FUNCTIONS TO POTENTIAL REGULATORS |
| 4739 |
NOVEL GENE-SPECIFIC TRANSLATION MECHANISM OF DYSREGULATED, CHRONIC INFLAMMATION REVEALS PROMISING, MULTIFACETED COVID-19 THERAPEUTICS |
| 4740 |
NOVEL GENETIC VARIANTS ASSOCIATED WITH CHRONIC KIDNEY DISEASE PROGRESSION |
| 4741 |
NOVEL HDAC INHIBITOR MAKV-8 AND IMATINIB SYNERGISTICALLY KILL CHRONIC MYELOID LEUKEMIA CELLS VIA INHIBITION OF BCR-ABL/MYC-SIGNALING: EFFECT ON IMATINIB RESISTANCE AND STEM CELLS |
| 4742 |
NOVEL HISTONE MODIFICATIONS IN MICROGLIA DERIVED FROM A MOUSE MODEL OF CHRONIC PAIN |
| 4743 |
NOVEL INSIGHTS FROM GENETIC AND EPIGENETIC STUDIES IN UNDERSTANDING THE COMPLEX URAEMIC PHENOTYPE |
| 4744 |
NOVEL INSIGHTS INTO THE GENETICS OF SMOKING BEHAVIOUR, LUNG FUNCTION, AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (UK BILEVE): A GENETIC ASSOCIATION STUDY IN UK BIOBANK |
| 4745 |
NOVEL INSIGHTS OF EZH2-MEDIATED EPIGENETIC MODIFICATIONS IN DEGENERATIVE MUSCULOSKELETAL DISEASES |
| 4746 |
NOVEL LNC RNA REGULATED BY HIF-1 INHIBITS APOPTOTIC CELL DEATH IN THE RENAL TUBULAR EPITHELIAL CELLS UNDER HYPOXIA |
| 4747 |
NOVEL MODULATORS OF HEPATOSTEATOSIS, INFLAMMATION AND FIBROGENESIS |
| 4748 |
NOVEL MUTATIONS AND THEIR FUNCTIONAL AND CLINICAL RELEVANCE IN MYELOPROLIFERATIVE NEOPLASMS: JAK2, MPL, TET2, ASXL1, CBL, IDH AND IKZF1 |
| 4749 |
NOVEL PROSPECTS FOR SCARLESS WOUND HEALING: THE ROLES OF MYOFIBROBLASTS AND ADIPOCYTES |
| 4750 |
NOVEL REGIONAL AGE-ASSOCIATED DNA METHYLATION CHANGES WITHIN HUMAN COMMON DISEASE-ASSOCIATED LOCI |
| 4751 |
NOVEL RISK MARKERS FOR GASTRIC CANCER SCREENING: PRESENT STATUS AND FUTURE PROSPECTS |
| 4752 |
NOVEL ROLE OF GESTATIONAL HYDRALAZINE IN LIMITING MATERNAL AND DIETARY OBESITY-RELATED CHRONIC KIDNEY DISEASE |
| 4753 |
NOVEL THERAPEUTIC ADVANCES IN BETA-THALASSEMIA |
| 4754 |
NOVEL THERAPEUTIC STRATEGIES FOR CHRONIC HEPATITIS B |
| 4755 |
NOVEL THERAPEUTIC STRATEGY WITH HYPOXIA-INDUCIBLE FACTORS VIA REVERSIBLE EPIGENETIC REGULATION MECHANISMS IN PROGRESSIVE TUBULOINTERSTITIAL FIBROSIS |
| 4756 |
NOVEL THERAPEUTIC TARGET(S) FOR PSORIATIC DISEASE |
| 4757 |
NOVEL TREATMENT OPPORTUNITIES FOR SULFUR MUSTARD-RELATED CANCERS: GENETIC AND EPIGENETIC PERSPECTIVES |
| 4758 |
NOVEL TREATMENT STRATEGIES TARGETING MYELIN AND OLIGODENDROCYTE DYSFUNCTION IN SCHIZOPHRENIA |
| 4759 |
NOVEL TREATMENTS FOR MYELOFIBROSIS: BEYOND JAK INHIBITORS |
| 4760 |
NOVEL TREATMENTS OF ADULT T CELL LEUKEMIA LYMPHOMA |
| 4761 |
NRF2 SENSITIZES FERROPTOSIS THROUGH L-2-HYDROXYGLUTARATE-MEDIATED CHROMATIN MODIFICATIONS IN SICKLE CELL DISEASE |
| 4762 |
NRF2 SIGNALING AND THE SLOWED AGING PHENOTYPE: EVIDENCE FROM LONG-LIVED MODELS |
| 4763 |
NRF2-RELATED EPIGENETIC MODIFICATIONS IN CARDIAC AND VASCULAR COMPLICATIONS OF DIABETES MELLITUS |
| 4764 |
NRF2: FRIEND OR FOE FOR CHEMOPREVENTION? HEALTH REFLECTS THE ABILITY OF AN ORGANISM TO ADAPT TO STRESS |
| 4765 |
NRSF AND ITS EPIGENETIC EFFECTORS: NEW TREATMENTS FOR NEUROLOGICAL DISEASE |
| 4766 |
NT-4/5 AND LIF, BUT NOT NT-3 AND BDNF, PROMOTE NPY MRNA EXPRESSION IN CORTICAL NEURONS IN THE ABSENCE OF SPONTANEOUS BIOELECTRICAL ACTIVITY |
| 4767 |
NUCLEAR AND MITOCHONDRIAL DNA ALTERATIONS IN NEWBORNS WITH PRENATAL EXPOSURE TO CIGARETTE SMOKE |
| 4768 |
NUCLEAR EFFECTS OF ETHANOL-INDUCED PROTEASOME INHIBITION IN LIVER CELLS |
| 4769 |
NUCLEAR MORPHOMETRY, NUCLEOMICS AND PROSTATE CANCER PROGRESSION |
| 4770 |
NUCLEAR RECEPTORS AND EPIGENETIC REGULATION: OPPORTUNITIES FOR NUTRITIONAL TARGETING AND DISEASE PREVENTION |
| 4771 |
NUCLEAR SENSOR INTERFERON-INDUCIBLE PROTEIN 16 INHIBITS THE FUNCTION OF HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA BY INTEGRATING INNATE IMMUNE ACTIVATION AND EPIGENETIC SUPPRESSION |
| 4772 |
NUCLEAR SIRTUINS AND INFLAMMATORY SIGNALING PATHWAYS |
| 4773 |
NUCLEAR TRAFFICKING OF BACTERIAL EFFECTOR PROTEINS |
| 4774 |
NUCLEIC ACID APTAMERS TARGETING EPIGENETIC REGULATORS: AN INNOVATIVE THERAPEUTIC OPTION |
| 4775 |
NUCLEIC ACID-SENSING AND INTERFERON-INDUCIBLE PATHWAYS SHOW DIFFERENTIAL METHYLATION IN MZ TWINS DISCORDANT FOR LUPUS AND OVEREXPRESSION IN INDEPENDENT LUPUS SAMPLES: IMPLICATIONS FOR PATHOGENIC MECHANISM AND DRUG TARGETING |
| 4776 |
NUTRACEUTICAL ACTIVITY IN OSTEOARTHRITIS BIOLOGY: A FOCUS ON THE NUTRIGENOMIC ROLE |
| 4777 |
NUTRACEUTICALS AND NETWORK PHARMACOLOGY APPROACH FOR ACUTE KIDNEY INJURY: A REVIEW FROM THE DRUG DISCOVERY ASPECT |
| 4778 |
NUTRACEUTICALS AND THE NETWORK OF OBESITY MODULATORS |
| 4779 |
NUTRIENTS, GENETIC FACTORS, AND THEIR INTERACTION IN NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR DISEASE |
| 4780 |
NUTRIEPIGENOMICS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POTENTIAL ROLE OF DIETARY AND EPIGENETICS FACTORS IN DISEASE DEVELOPMENT AND MANAGEMENT |
| 4781 |
NUTRIEPIGENOMICS AND MALNUTRITION |
| 4782 |
NUTRIGENETICS, EPIGENETICS AND GESTATIONAL DIABETES: CONSEQUENCES IN MOTHER AND CHILD |
| 4783 |
NUTRIGENOMICS IN PARKINSON'S DISEASE: DIVERSITY OF MODULATORY ACTIONS OF POLYPHENOLS ON EPIGENETIC EFFECTS INDUCED BY TOXINS |
| 4784 |
NUTRIMIROMICS: ROLE OF MICRORNAS AND NUTRITION IN MODULATING INFLAMMATION AND CHRONIC DISEASES |
| 4785 |
NUTRITION AND DEVELOPMENTAL BIOLOGY--IMPLICATIONS FOR PUBLIC HEALTH |
| 4786 |
NUTRITION AND HEALTH DURING MID-LIFE: SEARCHING FOR SOLUTIONS AND MEETING CHALLENGES FOR THE AGING POPULATION |
| 4787 |
NUTRITION, AGING AND CANCER: LESSONS FROM DIETARY INTERVENTION STUDIES |
| 4788 |
NUTRITION, EPIGENETICS, AND METABOLIC SYNDROME |
| 4789 |
NUTRITION, IMMUNOLOGICAL MECHANISMS AND DIETARY IMMUNOMODULATION IN ADHD |
| 4790 |
NUTRITIONAL ADVERSITY, SEX AND REPRODUCTION: 30 YEARS OF DOHAD AND WHAT HAVE WE LEARNED? IT IS WELL ESTABLISHED THAT EARLY LIFE ENVIRONMENTAL SIGNALS, INCLUDING NUTRITION, SET THE STAGE FOR LONG-TERM HEALTH AND DISEASE RISK - EFFECTS THAT SPAN MULTIPLE GENERATIONS |
| 4791 |
NUTRITIONAL CATCH-UP GROWTH |
| 4792 |
NUTRITIONAL EPIGENETICS AND PHYTOCHEMICALS IN CANCER FORMATION |
| 4793 |
NUTRITIONAL FACTORS, DNA METHYLATION, AND RISK OF TYPE 2 DIABETES AND OBESITY: PERSPECTIVES AND CHALLENGES |
| 4794 |
NUTRITIONAL GENOMIC APPROACHES TO CANCER PREVENTION RESEARCH |
| 4795 |
NUTRITIONAL GENOMICS IN NONALCOHOLIC FATTY LIVER DISEASE |
| 4796 |
NUTRITIONAL INTERVENTION AS AN ESSENTIAL PART OF MULTIPLE SCLEROSIS TREATMENT? MULTIPLE SCLEROSIS (MS) IS A CHRONIC INFLAMMATORY AND DEMYELINATING DISEASE OF THE CENTRAL NERVOUS SYSTEM |
| 4797 |
NUTRITIONAL INTERVENTIONS TO IMPROVE BRAIN OUTCOMES IN PRETERM INFANTS |
| 4798 |
NUTRITIONALLY MEDIATED PROGRAMMING OF THE DEVELOPING IMMUNE SYSTEM |
| 4799 |
OBESITY AND AGEING: TWO SIDES OF THE SAME COIN |
| 4800 |
OBESITY AND INFLAMMATION: COLORECTAL CANCER ENGINES |
| 4801 |
OBESITY AND INSULIN RESISTANCE: ASSOCIATIONS WITH CHRONIC INFLAMMATION, GENETIC AND EPIGENETIC FACTORS |
| 4802 |
OBESITY AND LIFESPAN HEALTH--IMPORTANCE OF THE FETAL ENVIRONMENT |
| 4803 |
OBESITY AND MALE INFERTILITY |
| 4804 |
OBESITY AND MALE INFERTILITY: MECHANISMS AND MANAGEMENT |
| 4805 |
OBESITY AND METABOLIC COMORBIDITIES: ENVIRONMENTAL DISEASES? OBESITY AND METABOLIC COMORBIDITIES REPRESENT INCREASING HEALTH PROBLEMS |
| 4806 |
OBESITY AND METABOLIC SYNDROME ASSOCIATED WITH SYSTEMIC INFLAMMATION AND THE IMPACT ON THE MALE REPRODUCTIVE SYSTEM |
| 4807 |
OBESITY IN LOW- AND MIDDLE-INCOME COUNTRIES: BURDEN, DRIVERS, AND EMERGING CHALLENGES |
| 4808 |
OBESITY MANAGEMENT: AT THE FOREFRONT AGAINST DISEASE STIGMA AND THERAPEUTIC INERTIA |
| 4809 |
OBESITY PREVENTION |
| 4810 |
OBESITY--A CHRONIC HEALTH PROBLEM IN CLONED MICE? THE MAJORITY OF CLONED ANIMALS DERIVED BY NUCLEAR TRANSFER DIE DURING GESTATION AND DISPLAY NEONATAL ABNORMALITIES |
| 4811 |
OBESITY-ASSOCIATED ALTERATIONS IN INFLAMMATION, EPIGENETICS, AND MAMMARY TUMOR GROWTH PERSIST IN FORMERLY OBESE MICE |
| 4812 |
OBESOGEN EFFECT OF BISPHENOL S ALTERS MRNA EXPRESSION AND DNA METHYLATION PROFILING IN MALE MOUSE LIVER |
| 4813 |
OBSTRUCTIVE SLEEP APNEA AND HALLMARKS OF AGING |
| 4814 |
OBSTRUCTIVE SLEEP APNEA, CIRCADIAN CLOCK DISRUPTION, AND METABOLIC CONSEQUENCES |
| 4815 |
OCCULT HEPATITIS B INFECTION AND HEPATOCELLULAR CARCINOMA: EPIDEMIOLOGY, VIROLOGY, HEPATOCARCINOGENESIS AND CLINICAL SIGNIFICANCE |
| 4816 |
OCCULT HEPATITIS B VIRUS INFECTION: A COMPLEX ENTITY WITH RELEVANT CLINICAL IMPLICATIONS |
| 4817 |
OCCULT HEPATITIS B VIRUS INFECTION: AN UPDATE |
| 4818 |
OCCURRENCE OF ACCELERATED EPIGENETIC AGING AND METHYLATION DISRUPTIONS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION BEFORE ANTIRETROVIRAL THERAPY |
| 4819 |
OCCURRENCE OF TOXICITY AND CELL PROLIFERATION AFTER A SINGLE GAVAGE ADMINISTRATION OF CHLOROFORM TO MALE F344 RATS |
| 4820 |
OCHRATOXIN A AS A POTENTIAL ETIOLOGIC FACTOR IN ENDEMIC NEPHROPATHY: LESSONS FROM TOXICITY STUDIES IN RATS |
| 4821 |
OCHRATOXIN A: 13-WEEK ORAL TOXICITY AND CELL PROLIFERATION IN MALE F344/N RATS |
| 4822 |
OCHRATOXIN A: 50 YEARS OF RESEARCH |
| 4823 |
OCHRATOXIN A: POTENTIAL EPIGENETIC MECHANISMS OF TOXICITY AND CARCINOGENICITY |
| 4824 |
OCHRATOXIN A: THE CONTINUING ENIGMA |
| 4825 |
OCULAR FUNDUS ABNORMALITIES IN PATIENTS WITH BALKAN ENDEMIC NEPHROPATHY AND OTHER CHRONIC KIDNEY DISEASES |
| 4826 |
OF PLEIOTROPY AND TRAJECTORIES: DOES THE TGF-BETA PATHWAY LINK CHILDHOOD ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE? THE STUDY OF DEVELOPMENTAL TRAJECTORIES IS WHERE EPIGENETICS TRULY SHINES |
| 4827 |
OFF-TARGET DRUG EFFECTS RESULTING IN ALTERED GENE EXPRESSION EVENTS WITH EPIGENETIC AND "QUASI-EPIGENETIC" ORIGINS |
| 4828 |
OLANZAPINE INDUCED DNA METHYLATION CHANGES SUPPORT THE DOPAMINE HYPOTHESIS OF PSYCHOSIS |
| 4829 |
OLANZAPINE-INDUCED DNA METHYLATION IN THE HIPPOCAMPUS AND CEREBELLUM IN GENES MAPPED TO HUMAN 22Q11 AND IMPLICATED IN SCHIZOPHRENIA |
| 4830 |
OLD AND NEW BIOMARKERS ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION IN CHRONIC HYPERGLYCEMIA |
| 4831 |
OLIGOMERIC S100A4 IS ASSOCIATED WITH MONOCYTE INNATE IMMUNE MEMORY AND BYPASS OF TOLERANCE TO SUBSEQUENT STIMULATION WITH LIPOPOLYSACCHARIDES |
| 4832 |
OMICS BIOMARKERS IN OBESITY: NOVEL ETIOLOGICAL INSIGHTS AND TARGETS FOR PRECISION PREVENTION |
| 4833 |
ON THE CUTTING EDGE OF ORAL CANCER PREVENTION: FINDING RISK-PREDICTIVE MARKERS IN PRECANCEROUS LESIONS BY LONGITUDINAL STUDIES |
| 4834 |
ON THE INTERPLAY BETWEEN THE MEDICINE OF HILDEGARD OF BINGEN AND MODERN MEDICINE: THE ROLE OF ESTROGEN RECEPTOR AS AN EXAMPLE OF BIODYNAMIC INTERFACE FOR STUDYING THE CHRONIC DISEASE'S COMPLEXITY |
| 4835 |
ON THE RELATIONSHIP BETWEEN THEORETICAL PRESUMPTIONS ASBESTOS GENOTOXICITY AND THE PRACTICAL MONITORING OF EXPOSED WORKERS |
| 4836 |
ONCOGENIC FUNCTIONS OF THE TRANSCRIPTION FACTOR NRF2 |
| 4837 |
ONCOGENIC GENE EXPRESSION AND EPIGENETIC REMODELING OF CIS-REGULATORY ELEMENTS IN ASXL1-MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 4838 |
ONCOGENIC N-RAS AND TET2 HAPLOINSUFFICIENCY COLLABORATE TO DYSREGULATE HEMATOPOIETIC STEM AND PROGENITOR CELLS |
| 4839 |
ONCOGENIC ROLE AND TARGET PROPERTIES OF THE LYSINE-SPECIFIC DEMETHYLASE KDM1A IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 4840 |
ONCOGENOMIC DISRUPTIONS IN ARSENIC-INDUCED CARCINOGENESIS |
| 4841 |
ONE WEEK, BUT NOT 12 HOURS, OF CAST IMMOBILIZATION ALTERS PROMOTOR DNA METHYLATION PATTERNS IN THE NNOS GENE IN MOUSE SKELETAL MUSCLE |
| 4842 |
ONE YEAR IN REVIEW 2017: PATHOGENESIS OF RHEUMATOID ARTHRITIS |
| 4843 |
ONE YEAR IN REVIEW 2019: BEHCET'S SYNDROME |
| 4844 |
ONE YEAR IN REVIEW 2019: PATHOGENESIS OF RHEUMATOID ARTHRITIS |
| 4845 |
ONE YEAR IN REVIEW 2020: PATHOGENESIS OF RHEUMATOID ARTHRITIS |
| 4846 |
OPIATE ADDICTION AND COCAINE ADDICTION: UNDERLYING MOLECULAR NEUROBIOLOGY AND GENETICS |
| 4847 |
OPIOID DEPENDENCE AND PREGNANCY: MINIMIZING STRESS ON THE FETAL BRAIN |
| 4848 |
OPIOID-INDUCED STRUCTURAL AND FUNCTIONAL PLASTICITY OF MEDIUM-SPINY NEURONS IN THE NUCLEUS ACCUMBENS |
| 4849 |
OPIOID-MEDIATED HIV-1 IMMUNOPATHOGENESIS |
| 4850 |
OPIOIDS AND OPIOID RECEPTORS; UNDERSTANDING PHARMACOLOGICAL MECHANISMS AS A KEY TO THERAPEUTIC ADVANCES AND MITIGATION OF THE MISUSE CRISIS |
| 4851 |
OPIOIDS ENHANCE CXCL1 EXPRESSION AND FUNCTION AFTER INCISION IN MICE |
| 4852 |
OPPORTUNITIES AND CHALLENGES IN DRUG DEVELOPMENT FOR PEDIATRIC CANCERS |
| 4853 |
OPPOSING EPIGENETIC SIGNATURES IN HUMAN SPERM BY INTAKE OF FAST FOOD VERSUS HEALTHY FOOD |
| 4854 |
OPRM1 METHYLATION CONTRIBUTES TO OPIOID TOLERANCE IN CANCER PATIENTS |
| 4855 |
OPTIMIZE DIETARY INTAKE OF VITAMIN D: AN EPIGENETIC PERSPECTIVE |
| 4856 |
OPTIMIZING RETROVIRAL GENE EXPRESSION FOR EFFECTIVE THERAPIES |
| 4857 |
OPTOGENETIC STIMULATION OF THE ANTERIOR CINGULATE CORTEX AMELIORATES AUTISTIC-LIKE BEHAVIORS IN RATS INDUCED BY NEONATAL ISOLATION, CAUDATE PUTAMEN AS A SITE FOR ALTERATION |
| 4858 |
ORAL ANTIBIOTIC USE AND CHRONIC DISEASE: LONG-TERM HEALTH IMPACT BEYOND ANTIMICROBIAL RESISTANCE AND CLOSTRIDIOIDES DIFFICILE |
| 4859 |
ORAL SQUAMOUS CELL CARCINOMA: DIAGNOSTIC MARKERS AND PROGNOSTIC INDICATORS |
| 4860 |
OREXIN SIGNALING MEDIATES THE ANTIDEPRESSANT-LIKE EFFECT OF CALORIE RESTRICTION |
| 4861 |
ORGANIC ANION TRANSPORTER 1 IS AN HDAC4-REGULATED MEDIATOR OF NOCICEPTIVE HYPERSENSITIVITY IN MICE |
| 4862 |
ORGANOPHOSPHATE PESTICIDE EXPOSURE AND DIFFERENTIAL GENOME-WIDE DNA METHYLATION |
| 4863 |
ORIGINS OF LIFETIME HEALTH AROUND THE TIME OF CONCEPTION: CAUSES AND CONSEQUENCES |
| 4864 |
ORLANDO MAGIC: REPORT FROM THE 57TH MEETING OF THE AMERICAN SOCIETY OF HAEMATOLOGY, 5-7 DECEMBER 2015, ORLANDO, USA |
| 4865 |
ORO-FACIAL PAIN AND TEMPOROMANDIBULAR DISORDERS CLASSIFICATION SYSTEMS: A CRITICAL APPRAISAL AND FUTURE DIRECTIONS |
| 4866 |
ORTHOGONAL CRISPR SCREENS TO IDENTIFY TRANSCRIPTIONAL AND EPIGENETIC REGULATORS OF HUMAN CD8 T CELL FUNCTION |
| 4867 |
OSSIFYING FIBROMA TUMOR STEM CELLS ARE MAINTAINED BY EPIGENETIC REGULATION OF A TSP1/TGF-BETA/SMAD3 AUTOCRINE LOOP |
| 4868 |
OSTEOARTHRITIS RELATED EPIGENETIC VARIATIONS IN MIRNA EXPRESSION AND DNA METHYLATION |
| 4869 |
OSTEOARTHRITIS YEAR IN REVIEW: GENETICS, GENOMICS, EPIGENETICS |
| 4870 |
OSTEOPOROSIS: A LIFECOURSE APPROACH |
| 4871 |
OUR GENES ARE NOT OUR DESTINY: INCORPORATING MOLECULAR MEDICINE INTO CLINICAL PRACTICE |
| 4872 |
OUTSIDE-IN HYPOTHESIS REVISITED: THE ROLE OF MICROBIAL, EPITHELIAL, AND IMMUNE INTERACTIONS |
| 4873 |
OVER-EXPRESSION OF PROTHYMOSIN-ALPHA ANTAGONIZES TGFBETA SIGNALLING TO PROMOTE THE DEVELOPMENT OF EMPHYSEMA |
| 4874 |
OVERCOMING ACQUIRED EPIGENETIC RESISTANCE TO BTK INHIBITORS |
| 4875 |
OVEREXPRESSION OF AKT1 ENHANCES ADIPOGENESIS AND LEADS TO LIPOMA FORMATION IN ZEBRAFISH |
| 4876 |
OVEREXPRESSION OF ARGINASE 1 IS LINKED TO DNMT3A AND TET2 MUTATIONS IN LOWER-GRADE MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 4877 |
OVEREXPRESSION OF MIR-4433 BY SUBEROYLANILIDE HYDROXAMIC ACID SUPPRESSES GROWTH OF CML CELLS AND INDUCES APOPTOSIS THROUGH TARGETING BCR-ABL |
| 4878 |
OVEREXPRESSION OF THE HISTONE DIMETHYLTRANSFERASE G9A IN NUCLEUS ACCUMBENS SHELL INCREASES COCAINE SELF-ADMINISTRATION, STRESS-INDUCED REINSTATEMENT, AND ANXIETY |
| 4879 |
OVERLAPPING SIGNATURES OF CHRONIC PAIN IN THE DNA METHYLATION LANDSCAPE OF PREFRONTAL CORTEX AND PERIPHERAL T CELLS |
| 4880 |
OVERVIEW OF MMP-13 AS A PROMISING TARGET FOR THE TREATMENT OF OSTEOARTHRITIS |
| 4881 |
OVERVIEW OF THE CARDIOVASCULAR EFFECTS OF ENVIRONMENTAL METALS: NEW PRECLINICAL AND CLINICAL INSIGHTS |
| 4882 |
OVERVIEW OF THE CELLULAR AND MOLECULAR BASIS OF KIDNEY FIBROSIS |
| 4883 |
OVERVIEW OF THE MOLECULAR DETERMINANTS CONTRIBUTING TO THE EXPRESSION OF PSORIASIS AND PSORIATIC ARTHRITIS PHENOTYPES |
| 4884 |
OVERVIEW OF THE PATHOGENESIS, GENETIC, AND NON-INVASIVE CLINICAL, BIOCHEMICAL, AND SCORING METHODS IN THE ASSESSMENT OF NAFLD |
| 4885 |
OVERVIEW ON MOLECULAR BIOMARKERS FOR LARYNGEAL CANCER: LOOKING FOR NEW ANSWERS TO AN OLD PROBLEM |
| 4886 |
OVERWEIGHT AND OBESITY BEFORE, DURING AND AFTER PREGNANCY: PART 1: PATHOPHYSIOLOGY, MOLECULAR BIOLOGY AND EPIGENETIC CONSEQUENCES |
| 4887 |
OXALIPLATIN-INDUCED NEUROPATHY: GENETIC AND EPIGENETIC PROFILE TO BETTER UNDERSTAND HOW TO AMELIORATE THIS SIDE EFFECT |
| 4888 |
OXIDATIVE DAMAGE IN THE PROGRESSION OF CHRONIC LIVER DISEASE TO HEPATOCELLULAR CARCINOMA: AN INTRICATE PATHWAY |
| 4889 |
OXIDATIVE STRESS AND CHROMATIN REMODELING IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND SMOKING-RELATED DISEASES |
| 4890 |
OXIDATIVE STRESS AND HEPATIC NOX PROTEINS IN CHRONIC HEPATITIS C AND HEPATOCELLULAR CARCINOMA |
| 4891 |
OXIDATIVE STRESS AND INFLAMMATORY MARKERS IN PREDIABETES AND DIABETES |
| 4892 |
OXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: OXIDATIVE STRESS IN POLYCYSTIC OVARY SYNDROME |
| 4893 |
OXIDATIVE STRESS BIOMARKERS IN THE RELATIONSHIP BETWEEN TYPE 2 DIABETES AND AIR POLLUTION |
| 4894 |
OXIDATIVE STRESS CAUSED BY ACUTE AND CHRONIC EXPOSITION TO ALTITUDE |
| 4895 |
OXIDATIVE STRESS DRIVERS AND MODULATORS IN OBESITY AND CARDIOVASCULAR DISEASE: FROM BIOMARKERS TO THERAPEUTIC APPROACH |
| 4896 |
OXIDATIVE STRESS IN AIRWAY DISEASES |
| 4897 |
OXIDATIVE STRESS IN ALCOHOL-RELATED LIVER DISEASE |
| 4898 |
OXIDATIVE STRESS INDUCED LUNG CANCER AND COPD: OPPORTUNITIES FOR EPIGENETIC THERAPY |
| 4899 |
OXIDATIVE STRESS MEDIATES THE APOPTOSIS AND EPIGENETIC MODIFICATION OF THE BCL-2 PROMOTER VIA DNMT1 IN A CIGARETTE SMOKE-INDUCED EMPHYSEMA MODEL |
| 4900 |
OXIDATIVE STRESS-INDUCED EPIGENETIC CHANGES ASSOCIATED WITH MALIGNANT TRANSFORMATION OF HUMAN KIDNEY EPITHELIAL CELLS |
| 4901 |
OXIDATIVE, INFLAMMATORY, GENETIC, AND EPIGENETIC BIOMARKERS ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISORDER |
| 4902 |
OXIDATIVE-STRESS-INDUCED EPIGENETIC CHANGES IN CHRONIC DIABETIC COMPLICATIONS |
| 4903 |
P16 PROMOTER HYPERMETHYLATION IN HUMAN HEPATOCELLULAR CARCINOMA WITH OR WITHOUT HEPATITIS VIRUS INFECTION |
| 4904 |
P16INK4A GENE ALTERATIONS ARE NOT A PROGNOSTIC INDICATOR FOR SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING CURATIVE HEPATECTOMY |
| 4905 |
P16INK4A HYPERMETHYLATION IS ASSOCIATED WITH HEPATITIS VIRUS INFECTION, AGE, AND GENDER IN HEPATOCELLULAR CARCINOMA |
| 4906 |
P300 EXERTS AN EPIGENETIC ROLE IN CHRONIC NEUROPATHIC PAIN THROUGH ITS ACETYLTRANSFERASE ACTIVITY IN RATS FOLLOWING CHRONIC CONSTRICTION INJURY (CCI) |
| 4907 |
P53 ABERRATIONS DO NOT PREDICT INDIVIDUAL RESPONSE TO FLUDARABINE IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA IN ADVANCED STAGES RAI III/IV |
| 4908 |
P53 ACTIVATION BY NI(II) IS A HIF-1ALPHA INDEPENDENT RESPONSE CAUSING CASPASES 9/3-MEDIATED APOPTOSIS IN HUMAN LUNG CELLS |
| 4909 |
PAIN AND STRESS IN A SYSTEMS PERSPECTIVE: RECIPROCAL NEURAL, ENDOCRINE, AND IMMUNE INTERACTIONS |
| 4910 |
PAIN EXPOSURE ASSOCIATES WITH TELOMERE LENGTH EROSION IN VERY PRETERM INFANTS |
| 4911 |
PAIN IMAGING: FUTURE APPLICATIONS TO INTEGRATIVE CLINICAL AND BASIC NEUROBIOLOGY |
| 4912 |
PAIN INTERFERENCE MEDIATES THE ASSOCIATION BETWEEN EPIGENETIC AGING AND GRIP STRENGTH IN MIDDLE TO OLDER AGED MALES AND FEMALES WITH CHRONIC PAIN |
| 4913 |
PAIN MODULATION IN WAG/RIJ EPILEPTIC RATS (A GENETIC MODEL OF ABSENCE EPILEPSY): EFFECTS OF BIOLOGICAL AND PHARMACOLOGICAL HISTONE DEACETYLASE INHIBITORS |
| 4914 |
PAIN VULNERABILITY: A NEUROBIOLOGICAL PERSPECTIVE |
| 4915 |
PAIN, ANALGESIA AND GENETICS |
| 4916 |
PAIN-RELATED INCREASE IN SEROTONIN TRANSPORTER GENE METHYLATION ASSOCIATES WITH EMOTIONAL REGULATION IN 4 |
| 4917 |
PAIN-RELATED STRESS DURING THE NEONATAL INTENSIVE CARE UNIT STAY AND SLC6A4 METHYLATION IN VERY PRETERM INFANTS |
| 4918 |
PANCREATIC CANCER: FROM BENCH TO 5-YEAR SURVIVAL |
| 4919 |
PANNEXIN-1 UP-REGULATION IN THE DORSAL ROOT GANGLION CONTRIBUTES TO NEUROPATHIC PAIN DEVELOPMENT |
| 4920 |
PARALLEL EPIGENETIC AND GENETIC CHANGES IN THE PATHOGENESIS OF HEPATITIS VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA |
| 4921 |
PARENT-OF-ORIGIN EFFECTS IMPLICATE EPIGENETIC REGULATION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS AND IDENTIFY IMPRINTED DLK1 AS A NOVEL RISK GENE |
| 4922 |
PARENTAL AGE AND RISK OF LYMPHOID NEOPLASMS |
| 4923 |
PARENTAL DIURON EXPOSURE CAUSES LOWER HATCHABILITY AND ABNORMAL OVARIAN DEVELOPMENT IN OFFSPRING OF MEDAKA (ORYZIAS MELASTIGMA) |
| 4924 |
PARENTAL HYPOXIC EXPOSURE CONFERS OFFSPRING HYPOXIA RESISTANCE IN ZEBRAFISH (DANIO RERIO) |
| 4925 |
PARENTAL MICRONUTRIENT DEFICIENCY DISTORTS LIVER DNA METHYLATION AND EXPRESSION OF LIPID GENES ASSOCIATED WITH A FATTY-LIVER-LIKE PHENOTYPE IN OFFSPRING |
| 4926 |
PARKINSON'S DISEASE AND SARS-COV-2 INFECTION: PARTICULARITIES OF MOLECULAR AND CELLULAR MECHANISMS REGARDING PATHOGENESIS AND TREATMENT |
| 4927 |
PARKINSON'S DISEASE: FROM PATHOGENESIS TO PHARMACOGENOMICS |
| 4928 |
PARP-1 AND PARP-2 ACTIVITY IN CANCER-INDUCED CACHEXIA: POTENTIAL THERAPEUTIC IMPLICATIONS |
| 4929 |
PAST, PRESENT, AND FUTURE OF CHEMICALLY INDUCED HEPATOCARCINOGENESIS RODENT MODELS: PERSPECTIVES CONCERNING CLASSIC AND NEW CANCER HALLMARKS |
| 4930 |
PATERNAL ALCOHOL EXPOSURE REDUCES ACQUISITION OF OPERANT ALCOHOL SELF-ADMINISTRATION AND AFFECTS BDNF DNA METHYLATION IN MALE AND FEMALE OFFSPRING |
| 4931 |
PATERNAL ALCOHOL EXPOSURE REDUCES ALCOHOL DRINKING AND INCREASES BEHAVIORAL SENSITIVITY TO ALCOHOL SELECTIVELY IN MALE OFFSPRING |
| 4932 |
PATERNAL ALCOHOL EXPOSURES PROGRAM INTERGENERATIONAL HORMETIC EFFECTS ON OFFSPRING FETOPLACENTAL GROWTH |
| 4933 |
PATERNAL CHRONIC COLITIS CAUSES EPIGENETIC INHERITANCE OF SUSCEPTIBILITY TO COLITIS |
| 4934 |
PATERNAL CHRONIC FOLATE SUPPLEMENTATION INDUCED THE TRANSGENERATIONAL INHERITANCE OF ACQUIRED DEVELOPMENTAL AND METABOLIC CHANGES IN CHICKENS |
| 4935 |
PATERNAL COCAINE TAKING ELICITS EPIGENETIC REMODELING AND MEMORY DEFICITS IN MALE PROGENY |
| 4936 |
PATERNAL COMBINED BOTANICALS CONTRIBUTE TO THE PREVENTION OF ESTROGEN RECEPTOR-NEGATIVE MAMMARY CANCER IN TRANSGENIC MICE |
| 4937 |
PATERNAL MORPHINE EXPOSURE IN RATS REDUCES SOCIAL PLAY IN ADOLESCENT MALE PROGENY WITHOUT AFFECTING DRUG-TAKING BEHAVIOR IN JUVENILE MALES OR FEMALE OFFSPRING |
| 4938 |
PATERNAL NICOTINE ENHANCES FEAR MEMORY, REDUCES NICOTINE ADMINISTRATION, AND ALTERS HIPPOCAMPAL GENETIC AND NEURAL FUNCTION IN OFFSPRING |
| 4939 |
PATERNAL NICOTINE EXPOSURE IN RATS PRODUCES LONG-LASTING NEUROBEHAVIORAL EFFECTS IN THE OFFSPRING |
| 4940 |
PATERNAL NICOTINE EXPOSURE PROMOTES HEPATIC FIBROSIS IN OFFSPRING |
| 4941 |
PATERNAL OBESITY, INTERVENTIONS, AND MECHANISTIC PATHWAYS TO IMPAIRED HEALTH IN OFFSPRING |
| 4942 |
PATERNAL OBESITY: HOW BAD IS IT FOR SPERM QUALITY AND PROGENY HEALTH? THERE IS SUBSTANTIAL EVIDENCE THAT PATERNAL OBESITY IS ASSOCIATED NOT ONLY WITH AN INCREASED INCIDENCE OF INFERTILITY, BUT ALSO WITH AN INCREASED RISK OF METABOLIC DISTURBANCE IN ADULT OFFSPRING |
| 4943 |
PATERNAL PRECONCEPTION ALCOHOL EXPOSURE IMPARTS INTERGENERATIONAL ALCOHOL-RELATED BEHAVIORS TO MALE OFFSPRING ON A PURE C57BL/6J BACKGROUND |
| 4944 |
PATERNAL PRECONCEPTION ETHANOL EXPOSURE BLUNTS HYPOTHALAMIC-PITUITARY-ADRENAL AXIS RESPONSIVITY AND STRESS-INDUCED EXCESSIVE FLUID INTAKE IN MALE MICE |
| 4945 |
PATERNAL PRECONCEPTION EVERY-OTHER-DAY ETHANOL DRINKING ALTERS BEHAVIOR AND ETHANOL CONSUMPTION IN OFFSPRING |
| 4946 |
PATERNAL PSYCHOLOGICAL STRESS REPROGRAMS HEPATIC GLUCONEOGENESIS IN OFFSPRING |
| 4947 |
PATERNAL SEPSIS INDUCES ALTERATIONS OF THE SPERM METHYLOME AND DAMPENS OFFSPRING IMMUNE RESPONSES-AN ANIMAL STUDY |
| 4948 |
PATERNAL STRESS EXPOSURE ALTERS SPERM MICRORNA CONTENT AND REPROGRAMS OFFSPRING HPA STRESS AXIS REGULATION |
| 4949 |
PATERNAL TRANSMISSION OF STRESS-INDUCED PATHOLOGIES |
| 4950 |
PATHOGENESIS OF ADENOMYOSIS: AN UPDATE ON MOLECULAR MECHANISMS |
| 4951 |
PATHOGENESIS OF CHOLANGIOCARCINOMA: FROM GENETICS TO SIGNALLING PATHWAYS |
| 4952 |
PATHOGENESIS OF CHRONIC CHIKUNGUNYA ARTHRITIS: RESEMBLANCES AND LINKS WITH RHEUMATOID ARTHRITIS |
| 4953 |
PATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) INDUCED BY CIGARETTE SMOKE |
| 4954 |
PATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 4955 |
PATHOGENESIS OF COVID-19 DESCRIBED THROUGH THE LENS OF AN UNDERSULFATED AND DEGRADED EPITHELIAL AND ENDOTHELIAL GLYCOCALYX |
| 4956 |
PATHOGENESIS OF ENDOMETRIOSIS: FOCUS ON ADENOGENESIS-RELATED FACTORS |
| 4957 |
PATHOGENESIS OF ENDOMETRIOSIS: THE GENETIC/EPIGENETIC THEORY |
| 4958 |
PATHOGENESIS OF HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS: A CELLULAR PERSPECTIVE |
| 4959 |
PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS |
| 4960 |
PATHOGENESIS OF PRE-NEOPLASTIC LESIONS OF THE STOMACH: TARGETS FOR PREVENTION |
| 4961 |
PATHOGENESIS OF PSORIASIS IN THE "OMIC" ERA |
| 4962 |
PATHOGENESIS OF PSORIATIC ARTHRITIS |
| 4963 |
PATHOGENESIS OF THYROID NODULES: HISTOLOGICAL CLASSIFICATION? THYROID NODULE GENESIS MAY BE CONSIDERED AS AN AMPLIFICATION OF THYROID HETEROGENEITY DUE TO GENETIC AND/OR EPIGENETIC MECHANISMS |
| 4964 |
PATHOGENETIC AND CLINICAL ASPECTS OF ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODY-ASSOCIATED VASCULITIDES |
| 4965 |
PATHOGENIC KDM5B VARIANTS IN THE CONTEXT OF DEVELOPMENTAL DISORDERS |
| 4966 |
PATHOGENOMICS OF ENDOMETRIOSIS DEVELOPMENT |
| 4967 |
PATHOLOGICAL CONDITIONS RE-SHAPE PHYSIOLOGICAL TREGS INTO PATHOLOGICAL TREGS |
| 4968 |
PATHOLOGICAL MECHANISMS AND THERAPEUTIC OUTLOOKS FOR ARTHROFIBROSIS |
| 4969 |
PATHOLOGICAL NEUROINFLAMMATORY CONVERSION OF REACTIVE ASTROCYTES IS INDUCED BY MICROGLIA AND INVOLVES CHROMATIN REMODELING |
| 4970 |
PATHOMECHANISMS OF PRENATALLY PROGRAMMED ADULT DISEASES |
| 4971 |
PATHOPHYSIOLOGIC MECHANISMS IN DIABETIC KIDNEY DISEASE: A FOCUS ON CURRENT AND FUTURE THERAPEUTIC TARGETS |
| 4972 |
PATHOPHYSIOLOGICAL BASIS FOR COMPROMISED HEALTH BEYOND GENERATIONS: ROLE OF MATERNAL HIGH-FAT DIET AND LOW-GRADE CHRONIC INFLAMMATION |
| 4973 |
PATHOPHYSIOLOGICAL EFFECTS OF CONTEMPORARY LIFESTYLE ON EVOLUTIONARY-CONSERVED SURVIVAL MECHANISMS IN POLYCYSTIC OVARY SYNDROME |
| 4974 |
PATHOPHYSIOLOGICAL MECHANISMS LEADING TO MUSCLE LOSS IN CHRONIC KIDNEY DISEASE |
| 4975 |
PATHOPHYSIOLOGICAL MECHANISMS OF AUTOIMMUNITY |
| 4976 |
PATHOPHYSIOLOGICAL MECHANISMS OF HEPATIC STELLATE CELLS ACTIVATION IN LIVER FIBROSIS |
| 4977 |
PATHOPHYSIOLOGY AND EVOLUTIONARY ASPECTS OF DIETARY FATS AND LONG-CHAIN POLYUNSATURATED FATTY ACIDS ACROSS THE LIFE CYCLE |
| 4978 |
PATHOPHYSIOLOGY AND NEW ADVANCES IN PULMONARY HYPERTENSION |
| 4979 |
PATHOPHYSIOLOGY AND TREATMENT OF SICKLE CELL DISEASE |
| 4980 |
PATHOPHYSIOLOGY OF LIVER FIBROSIS |
| 4981 |
PATHOPHYSIOLOGY OF SYSTEMIC SCLEROSIS: CURRENT UNDERSTANDING AND NEW INSIGHTS |
| 4982 |
PATHOPHYSIOLOGY OF THE BLOOD-BRAIN BARRIER: ANIMAL MODELS AND METHODS |
| 4983 |
PATHOPHYSIOLOGY, CELLULAR AND MOLECULAR MECHANISMS OF FOETAL GROWTH RETARDATION |
| 4984 |
PATHWAYS OF GASTRIC CARCINOGENESIS, HELICOBACTER PYLORI VIRULENCE AND INTERACTIONS WITH ANTIOXIDANT SYSTEMS, VITAMIN C AND PHYTOCHEMICALS |
| 4985 |
PATHWAYS TO AGING: THE MITOCHONDRION AT THE INTERSECTION OF BIOLOGICAL AND PSYCHOSOCIAL SCIENCES |
| 4986 |
PATIENT-REPORTED SYMPTOM OUTCOMES AND MICROSATELLITE INSTABILITY IN PATIENTS WITH METASTATIC COLORECTAL CANCER |
| 4987 |
PATTERNS OF CALCIUM SIGNALING: A LINK BETWEEN CHRONIC EMOTIONS AND CANCER |
| 4988 |
PATTERNS OF HEMATOPOIETIC LINEAGE INVOLVEMENT IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 AND MALIGNANT MYELOID DISORDERS |
| 4989 |
PCSK9 IS INCREASED IN CEREBROSPINAL FLUID OF INDIVIDUALS WITH ALCOHOL USE DISORDER |
| 4990 |
PD-1-CIS IL-2R AGONISM YIELDS BETTER EFFECTORS FROM STEM-LIKE CD8(+) T CELLS |
| 4991 |
PEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE: NUTRITIONAL ORIGINS AND POTENTIAL MOLECULAR MECHANISMS |
| 4992 |
PEELING THE ONION: ANOTHER LAYER IN THE REGULATION OF INSULIN SECRETION |
| 4993 |
PENTOXIFYLLINE-INDUCED PROTEIN EXPRESSION CHANGE IN RAW 264 |
| 4994 |
PERFORMANCE OF DNA METHYLATION ON THE MOLECULAR PATHOGENESIS OF HELICOBACTER PYLORI IN GASTRIC CANCER; TARGETED THERAPY APPROACH |
| 4995 |
PERINATAL ENVIRONMENT AND ITS INFLUENCES ON METABOLIC PROGRAMMING OF OFFSPRING |
| 4996 |
PERINATAL EPIGENETIC DETERMINANTS OF COGNITIVE AND METABOLIC DISORDERS |
| 4997 |
PERINATAL LEAD (PB) EXPOSURE RESULTS IN SEX AND TISSUE-DEPENDENT ADULT DNA METHYLATION ALTERATIONS IN MURINE IAP TRANSPOSONS |
| 4998 |
PERINATAL ORIGINS OF ADULT DISEASE |
| 4999 |
PERINATAL PROGRAMMING OF CIRCADIAN CLOCK-STRESS CROSSTALK |
| 5000 |
PERINATAL PROGRAMMING PREVENTION MEASURES |
| 5001 |
PERINATAL RISK FACTORS IN TOURETTE'S AND CHRONIC TIC DISORDERS: A TOTAL POPULATION SIBLING COMPARISON STUDY |
| 5002 |
PERIODONTITIS AND PERIODONTOPATHIC BACTERIA AS RISK FACTORS FOR RHEUMATOID ARTHRITIS: A REVIEW OF THE LAST 10 YEARS |
| 5003 |
PERIODONTITIS IS AN INFLAMMATORY DISEASE OF OXIDATIVE STRESS: WE SHOULD TREAT IT THAT WAY |
| 5004 |
PERIPHERAL B CELLS FROM PATIENTS WITH HEPATITIS C VIRUS-ASSOCIATED LYMPHOMA EXHIBIT CLONAL EXPANSION AND AN ANERGIC-LIKE TRANSCRIPTIONAL PROFILE |
| 5005 |
PERIPHERAL BLOOD DNA METHYLATION-BASED MACHINE LEARNING MODELS FOR PREDICTION OF KNEE OSTEOARTHRITIS PROGRESSION: BIOLOGIC SPECIMENS AND DATA FROM THE OSTEOARTHRITIS INITIATIVE AND JOHNSTON COUNTY OSTEOARTHRITIS PROJECT |
| 5006 |
PERIPHERAL NERVE INJURY IS ACCOMPANIED BY CHRONIC TRANSCRIPTOME-WIDE CHANGES IN THE MOUSE PREFRONTAL CORTEX |
| 5007 |
PERIPHERAL NERVE INJURY IS ASSOCIATED WITH CHRONIC, REVERSIBLE CHANGES IN GLOBAL DNA METHYLATION IN THE MOUSE PREFRONTAL CORTEX |
| 5008 |
PERIPUBERTAL STRESS WITH SOCIAL SUPPORT PROMOTES RESILIENCE IN THE FACE OF AGING |
| 5009 |
PERK IS A CRITICAL METABOLIC HUB FOR IMMUNOSUPPRESSIVE FUNCTION IN MACROPHAGES |
| 5010 |
PEROXIDATION OF LINOLEIC, ARACHIDONIC AND OLEIC ACID IN RELATION TO THE INDUCTION OF OXIDATIVE DNA DAMAGE AND CYTOGENETIC EFFECTS |
| 5011 |
PEROXIREDOXIN6, A MULTITASK ANTIOXIDANT ENZYME INVOLVED IN THE PATHOPHYSIOLOGY OF CHRONIC NONCOMMUNICABLE DISEASES |
| 5012 |
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AS A TARGET AND REGULATOR OF EPIGENETIC MECHANISMS IN NONALCOHOLIC FATTY LIVER DISEASE |
| 5013 |
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AS A THERAPEUTIC TARGET FOR HEPATIC FIBROSIS: FROM BENCH TO BEDSIDE |
| 5014 |
PERSISTENCE OF CEREBELLAR ATAXIA DURING CHRONIC ETHANOL EXPOSURE IS ASSOCIATED WITH EPIGENETIC UP-REGULATION OF FMR1 GENE EXPRESSION IN RAT CEREBELLUM |
| 5015 |
PERSISTENCE OF SELF-REACTIVE CD8+ T CELLS IN THE CNS REQUIRES TOX-DEPENDENT CHROMATIN REMODELING |
| 5016 |
PERSISTENT BACTERIAL COINFECTION OF A COVID-19 PATIENT CAUSED BY A GENETICALLY ADAPTED PSEUDOMONAS AERUGINOSA CHRONIC COLONIZER |
| 5017 |
PERSISTENT INFECTION OF CULTURED CELLS WITH MOUSE HEPATITIS VIRUS (MHV) RESULTS FROM THE EPIGENETIC EXPRESSION OF THE MHV RECEPTOR |
| 5018 |
PERSISTENT INFLAMMATION-INDUCED UP-REGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) PROMOTES SYNAPTIC DELIVERY OF ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID RECEPTOR GLUA1 SUBUNITS IN DESCENDING PAIN MODULATORY CIRCUITS |
| 5019 |
PERSISTENT INFLAMMATORY PAIN IS LINKED WITH ANXIETY-LIKE BEHAVIORS, INCREASED BLOOD CORTICOSTERONE, AND REDUCED GLOBAL DNA METHYLATION IN THE RAT AMYGDALA |
| 5020 |
PERSISTENT OVEREXPRESSION OF DNA METHYLTRANSFERASE 1 ATTENUATING GABAERGIC INHIBITION IN BASOLATERAL AMYGDALA ACCOUNTS FOR ANXIETY IN RAT OFFSPRING EXPOSED PERINATALLY TO LOW-DOSE BISPHENOL A |
| 5021 |
PERSISTENT PAIN MAINTAINS MORPHINE-SEEKING BEHAVIOR AFTER MORPHINE WITHDRAWAL THROUGH REDUCED MECP2 REPRESSION OF GLUA1 IN RAT CENTRAL AMYGDALA |
| 5022 |
PERSISTENT SUBCLINICAL INFLAMMATION AMONG A-BOMB SURVIVORS |
| 5023 |
PERSONAL MEDICINE AND BONE METASTASES: BIOMARKERS, MICRO-RNAS AND BONE METASTASES |
| 5024 |
PERSONALIZED EPIGENETIC MANAGEMENT OF DIABETES |
| 5025 |
PERSONALIZED MANAGEMENT OF CARDIOVASCULAR DISORDERS |
| 5026 |
PERSONALIZED MEDICINE IN IDIOPATHIC PULMONARY FIBROSIS: FACTS AND PROMISES |
| 5027 |
PERSONALIZED RISK ASSESSMENT FOR DYNAMIC TRANSITION OF GASTRIC NEOPLASMS |
| 5028 |
PERSONALIZING PEDIATRIC PAIN MEDICINE: USING POPULATION-SPECIFIC PHARMACOGENETICS, GENOMICS, AND OTHER -OMICS APPROACHES TO PREDICT RESPONSE |
| 5029 |
PERSPECTIVES ON MICROBES AS ONCOGENIC INFECTIOUS AGENTS AND IMPLICATIONS FOR BREAST CANCER |
| 5030 |
PERSPECTIVES ON PRECISION MEDICINE IN CHRONIC LYMPHOCYTIC LEUKEMIA: TARGETING RECURRENT MUTATIONS-NOTCH1, SF3B1, MYD88, BIRC3 |
| 5031 |
PERSPECTIVES ON THE ETIOLOGY OF CHRONIC RHINOSINUSITIS: AN IMMUNE BARRIER HYPOTHESIS |
| 5032 |
PERTURBED TRANSCRIPTIONAL PROFILES AFTER CHRONIC LOW DOSE RATE RADIATION IN MICE |
| 5033 |
PESTICIDES AND HUMAN CHRONIC DISEASES: EVIDENCES, MECHANISMS, AND PERSPECTIVES |
| 5034 |
PHARMACOEPIGENETICS OF THE ROLE OF DNA METHYLATION IN MU-OPIOID RECEPTOR EXPRESSION IN DIFFERENT HUMAN BRAIN REGIONS |
| 5035 |
PHARMACOEPIGENOMICS OF OPIATES AND METHADONE MAINTENANCE TREATMENT: CURRENT DATA AND PERSPECTIVES |
| 5036 |
PHARMACOGENETICS AND PHARMACOGENOMICS IN MODERATE-TO-SEVERE PSORIASIS |
| 5037 |
PHARMACOGENETICS IN PAIN TREATMENT |
| 5038 |
PHARMACOGENETICS OF CHRONIC PAIN AND ITS TREATMENT |
| 5039 |
PHARMACOGENETICS OF CHRONIC PAIN MANAGEMENT |
| 5040 |
PHARMACOGENETICS OF PAIN AND ANALGESIA |
| 5041 |
PHARMACOGENETICS: CAN GENES DETERMINE TREATMENT EFFICACY AND SAFETY IN JIA? JUVENILE IDIOPATHIC ARTHRITIS (JIA) IS THE MOST COMMON CHRONIC RHEUMATIC CONDITION IN CHILDHOOD, WITH MANY CHILDREN REQUIRING IMMUNOMODULATORY THERAPIES FOR MANY YEARS FOLLOWING DIAGNOSIS |
| 5042 |
PHARMACOGENOMICS IN PAIN TREATMENT |
| 5043 |
PHARMACOKINETICS AND PHARMACODYNAMICS OF CURCUMIN IN REGULATING ANTI-INFLAMMATORY AND EPIGENETIC GENE EXPRESSION |
| 5044 |
PHARMACOKINETICS AND PHARMACODYNAMICS WITH EXTENDED DOSING OF CC-486 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES |
| 5045 |
PHARMACOLOGIC EPIGENETIC MODULATORS OF ALKALINE PHOSPHATASE IN CHRONIC KIDNEY DISEASE |
| 5046 |
PHARMACOLOGICAL AND DIETARY ANTIOXIDANT THERAPIES FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 5047 |
PHARMACOLOGICAL AND THERAPEUTIC APPROACHES IN THE TREATMENT OF EPILEPSY |
| 5048 |
PHARMACOLOGICAL APPROACHES IN EITHER INTERMITTENT OR PERMANENT HYPOXIA: A TALE OF TWO EXPOSURES |
| 5049 |
PHARMACOLOGICAL INHIBITION OF RORC2 ENHANCES HUMAN TH17-TREG STABILITY AND FUNCTION |
| 5050 |
PHARMACOLOGICAL MIMICKING OF CALORIC RESTRICTION ELICITS EPIGENETIC REPROGRAMMING OF DIFFERENTIATED CELLS TO STEM-LIKE SELF-RENEWAL STATES |
| 5051 |
PHARMACOLOGICAL RESCUE OF NOCICEPTIVE HYPERSENSITIVITY AND OXYTOCIN ANALGESIA IMPAIRMENT IN A RAT MODEL OF NEONATAL MATERNAL SEPARATION |
| 5052 |
PHARMACOLOGICAL TARGETING OF HEME OXYGENASE-1 IN OSTEOARTHRITIS |
| 5053 |
PHARMACOLOGY OF PULMONARY ARTERIAL HYPERTENSION: AN OVERVIEW OF CURRENT AND EMERGING THERAPIES |
| 5054 |
PHARMACOPROTEOMICS REVEAL NOVEL PROTECTIVE ACTIVITY OF BROMODOMAIN CONTAINING 4 INHIBITORS ON VASCULAR HOMEOSTASIS IN TLR3-MEDIATED AIRWAY REMODELING |
| 5055 |
PHASE 2 TRIAL OF THE HISTONE DEACETYLASE INHIBITOR ROMIDEPSIN FOR THE TREATMENT OF REFRACTORY MULTIPLE MYELOMA |
| 5056 |
PHASE I TRIAL OF LOW DOSE DECITABINE TARGETING DNA HYPERMETHYLATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA AND NON-HODGKIN LYMPHOMA: DOSE-LIMITING MYELOSUPPRESSION WITHOUT EVIDENCE OF DNA HYPOMETHYLATION |
| 5057 |
PHENOBARBITAL MECHANISTIC DATA AND RISK ASSESSMENT: ENZYME INDUCTION, ENHANCED CELL PROLIFERATION, AND TUMOR PROMOTION |
| 5058 |
PHENOTYPIC ALTERATION OF CD8+ T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH EPIGENETIC REPROGRAMMING |
| 5059 |
PHENOTYPIC AND IMMUNOMETABOLIC ASPECTS ON STEM CELL MEMORY AND RESIDENT MEMORY CD8(+) T CELLS |
| 5060 |
PHENYLBUTYRATE AND BETA-CELL FUNCTION: CONTRIBUTION OF HISTONE DEACETYLASES AND ER STRESS INHIBITION |
| 5061 |
PHF6 FUNCTIONS AS A TUMOR SUPPRESSOR BY RECRUITING METHYLTRANSFERASE SUV39H1 TO NUCLEOLAR REGION AND OFFERS A NOVEL THERAPEUTIC TARGET FOR PHF6-MUNTANT LEUKEMIA |
| 5062 |
PHOSPHATE NIMA-RELATED KINASE 2-DEPENDENT EPIGENETIC PATHWAYS IN DORSAL ROOT GANGLION NEURONS MEDIATES PACLITAXEL-INDUCED NEUROPATHIC PAIN |
| 5063 |
PHOSPHORYLATED HISTONE 3 AT SERINE 10 IDENTIFIES ACTIVATED SPINAL NEURONS AND CONTRIBUTES TO THE DEVELOPMENT OF TISSUE INJURY-ASSOCIATED PAIN |
| 5064 |
PHOSPHORYLATION OF RELA/P65 PROMOTES DNMT-1 RECRUITMENT TO CHROMATIN AND REPRESSES TRANSCRIPTION OF THE TUMOR METASTASIS SUPPRESSOR GENE BRMS1 |
| 5065 |
PHOTOPERIOD-INDUCED NEUROTRANSMITTER PLASTICITY DECLINES WITH AGING: AN EPIGENETIC REGULATION? NEUROPLASTICITY HAS CLASSICALLY BEEN UNDERSTOOD TO ARISE THROUGH CHANGES IN SYNAPTIC STRENGTH OR SYNAPTIC CONNECTIVITY |
| 5066 |
PHTHALATES SUPPRESS TYPE I INTERFERON IN HUMAN PLASMACYTOID DENDRITIC CELLS VIA EPIGENETIC REGULATION |
| 5067 |
PHYSICAL ACTIVITY AND DNA METHYLATION IN HUMANS |
| 5068 |
PHYSICAL ACTIVITY AND PROGENITOR CELL-MEDIATED ENDOTHELIAL REPAIR IN CHRONIC HEART FAILURE: IS THERE A ROLE FOR EPIGENETICS? CHRONIC HEART FAILURE (CHF) IS THE MOST COMMON CARDIAC DISEASE AMONG THE ELDERLY AND A LEADING CAUSE OF MORTALITY IN ELDERLY PATIENTS |
| 5069 |
PHYSICAL ACTIVITY IN THE PREVENTION OF HUMAN DISEASES: ROLE OF EPIGENETIC MODIFICATIONS |
| 5070 |
PHYSICAL ACTIVITY, TELEVISION VIEWING TIME, AND DNA METHYLATION IN PERIPHERAL BLOOD |
| 5071 |
PHYSICAL EXERCISE AND EPIGENETIC ADAPTATIONS OF THE CARDIOVASCULAR SYSTEM |
| 5072 |
PHYSICAL EXERCISE POSITIVELY INFLUENCES BREAST CANCER EVOLUTION |
| 5073 |
PHYSICAL EXERCISE PREVENTED STRESS-INDUCED ANXIETY VIA IMPROVING BRAIN RNA METHYLATION |
| 5074 |
PHYSIOLOGIC AND EPIGENETIC EFFECTS OF NUTRIENTS ON DISEASE PATHWAYS |
| 5075 |
PHYSIOLOGICAL ADAPTATION OF THE GROWTH-RESTRICTED FETUS |
| 5076 |
PHYSIOLOGICAL AND ENVIRONMENTAL FACTORS AFFECTING CANCER RISK AND PROGNOSIS IN OBESITY |
| 5077 |
PHYSIOLOGICAL PATHWAYS TO RAPID PROSOCIAL EVOLUTION |
| 5078 |
PHYSIOLOGY AND PATHOPHYSIOLOGY OF MATRIX METALLOPROTEASES |
| 5079 |
PHYSIOPATHOLOGY OF NONALCOHOLIC FATTY LIVER DISEASE: FROM DIET TO NUTRIGENOMICS |
| 5080 |
PHYTOPHARMACOLOGICAL STRATEGIES IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS |
| 5081 |
PI3KDELTA COORDINATES TRANSCRIPTIONAL, CHROMATIN, AND METABOLIC CHANGES TO PROMOTE EFFECTOR CD8(+) T CELLS AT THE EXPENSE OF CENTRAL MEMORY |
| 5082 |
PI3KDELTA/GAMMA INHIBITION PROMOTES HUMAN CART CELL EPIGENETIC AND METABOLIC REPROGRAMMING TO ENHANCE ANTITUMOR CYTOTOXICITY |
| 5083 |
PICKING A BONE WITH WISP1 (CCN4): NEW STRATEGIES AGAINST DEGENERATIVE JOINT DISEASE |
| 5084 |
PIGMENTED EPENDYMOMA, A TUMOR WITH PREDILECTION FOR THE MIDDLE-AGED ADULT: CASE REPORT WITH METHYLATION CLASSIFICATION AND REVIEW OF 16 LITERATURE CASES |
| 5085 |
PILOT STUDY OF ABSOLUTE TELOMERE LENGTHS IN PRETERM INFANTS |
| 5086 |
PILOT STUDY OF DNA METHYLATION IN THE PATHOGENESIS OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS |
| 5087 |
PIMECROLIMUS FOR THE TREATMENT OF ATOPIC DERMATITIS IN INFANTS: AN ASIAN PERSPECTIVE |
| 5088 |
PIPERLONGUMINE REGULATES EPIGENETIC MODULATION AND ALLEVIATES PSORIASIS-LIKE SKIN INFLAMMATION VIA INHIBITION OF HYPERPROLIFERATION AND INFLAMMATION |
| 5089 |
PLACENTAL ADAPTATIONS TO MICRONUTRIENT DYSREGULATION IN THE PROGRAMMING OF CHRONIC DISEASE |
| 5090 |
PLACENTAL ADIPONECTIN GENE DNA METHYLATION LEVELS ARE ASSOCIATED WITH MOTHERS' BLOOD GLUCOSE CONCENTRATION |
| 5091 |
PLACENTAL DISEASES ASSOCIATED WITH ASSISTED REPRODUCTIVE TECHNOLOGY |
| 5092 |
PLACENTAL EPIGENETIC MARKS RELATED TO GESTATIONAL WEIGHT GAIN REVEAL POTENTIAL GENES ASSOCIATED WITH OFFSPRING OBESITY PARAMETERS |
| 5093 |
PLACENTAS FROM PREGNANCIES CONCEIVED BY IVF/ICSI HAVE A REDUCED DNA METHYLATION LEVEL AT THE H19 AND MEST DIFFERENTIALLY METHYLATED REGIONS |
| 5094 |
PLASMA EXTRACELLULAR VESICLE SUBTYPES MAY BE USEFUL AS POTENTIAL BIOMARKERS OF IMMUNE ACTIVATION IN PEOPLE WITH HIV |
| 5095 |
PLASMA PROTEOMIC BIOMARKER SIGNATURE OF AGE PREDICTS HEALTH AND LIFE SPAN |
| 5096 |
PLASMODIUM FALCIPARUM SET2 DOMAIN IS ALLOSTERICALLY REGULATED BY ITS PHD-LIKE DOMAIN TO METHYLATE AT H3K36 |
| 5097 |
PLASTICS DERIVED ENDOCRINE-DISRUPTING COMPOUNDS AND THEIR EFFECTS ON EARLY DEVELOPMENT |
| 5098 |
PLEIOTROPIC EFFECTS OF METHIONINE ADENOSYLTRANSFERASES DEREGULATION AS DETERMINANTS OF LIVER CANCER PROGRESSION AND PROGNOSIS |
| 5099 |
PM2 |
| 5100 |
POLYCHLORINATED BIPHENYLS (PCBS) ALTER DNA METHYLATION AND GENOMIC INTEGRITY OF SHEEP FETAL CELLS IN A SIMPLIFIED IN VITRO MODEL OF PREGNANCY EXPOSURE |
| 5101 |
POLYCOMB FACTOR PHF19 CONTROLS CELL GROWTH AND DIFFERENTIATION TOWARD ERYTHROID PATHWAY IN CHRONIC MYELOID LEUKEMIA CELLS |
| 5102 |
POLYCOMB GENES ARE ASSOCIATED WITH RESPONSE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA |
| 5103 |
POLYCOMB YY1 IS A CRITICAL INTERFACE BETWEEN EPIGENETIC CODE AND MIRNA MACHINERY AFTER EXPOSURE TO HYPOXIA IN MALIGNANCY |
| 5104 |
POLYCYSTIC OVARIAN SYNDROME |
| 5105 |
POLYCYSTIC OVARIAN SYNDROME: A COMPLEX DISEASE WITH A GENETICS APPROACH |
| 5106 |
POLYCYSTIC OVARY SYNDROME IN ADULT WOMEN |
| 5107 |
POLYCYSTIC OVARY SYNDROME: A BRAIN DISORDER CHARACTERIZED BY EATING PROBLEMS ORIGINATING DURING PUBERTY AND ADOLESCENCE |
| 5108 |
POLYMORPHISMS OF TNF-ALPHA (- 308), IL-1BETA (+ 3954) AND IL1-RA (VNTR) ARE ASSOCIATED TO SEVERE STAGE OF ENDOMETRIOSIS IN MEXICAN WOMEN: A CASE CONTROL STUDY |
| 5109 |
POLYPHENOL-RELATED EPIGENETIC MODIFICATIONS IN OSTEOARTHRITIS: CURRENT THERAPEUTIC PERSPECTIVES |
| 5110 |
POLYPHENOLS AND THE MODULATION OF GENE EXPRESSION PATHWAYS: CAN WE EAT OUR WAY OUT OF THE DANGER OF CHRONIC DISEASE? PLANT-DERIVED DIETARY POLYPHENOLS MAY IMPROVE SOME DISEASE STATES AND PROMOTE HEALTH |
| 5111 |
POLYSOME-CAGE OF TCL1-DRIVEN CHRONIC LYMPHOCYTIC LEUKEMIA REVEALED MULTIPLE N-TERMINALLY ALTERED EPIGENETIC REGULATORS AND A TRANSLATION STRESS SIGNATURE |
| 5112 |
POLYUNSATURATED FATTY ACIDS: BIOCHEMICAL, NUTRITIONAL AND EPIGENETIC PROPERTIES |
| 5113 |
POPULATION-LEVEL IMPACTS OF PESTICIDE-INDUCED CHRONIC EFFECTS ON INDIVIDUALS DEPEND MORE ON ECOLOGY THAN TOXICOLOGY |
| 5114 |
PORPHYROMONAS GINGIVALIS LIPOPOLYSACCHARIDE STIMULATION IN HUMAN PERIODONTAL LIGAMENT STEM CELLS: ROLE OF EPIGENETIC MODIFICATIONS TO THE INFLAMMATION |
| 5115 |
PORTRAIT OF DNA METHYLATED GENES PREDICTIVE OF POOR PROGNOSIS IN HEAD AND NECK CANCER AND THE IMPLICATION FOR TARGETED THERAPY |
| 5116 |
POSITIVE REGULATION OF HUMAN TELOMERASE REVERSE TRANSCRIPTASE GENE EXPRESSION AND TELOMERASE ACTIVITY BY DNA METHYLATION IN PANCREATIC CANCER |
| 5117 |
POSSIBLE ADVERSE EFFECTS OF HIGH-DOSE NICOTINAMIDE: MECHANISMS AND SAFETY ASSESSMENT |
| 5118 |
POSSIBLE ASSOCIATION BETWEEN GERMLINE METHYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND PSORIASIS RISK IN A TURKISH POPULATION |
| 5119 |
POSSIBLE CONTRIBUTION OF CHRONIC INFLAMMATION IN THE INDUCTION OF CANCER IN RHEUMATIC DISEASES |
| 5120 |
POSSIBLE EPIGENETIC REGULATORY EFFECT OF DYSREGULATED CIRCULAR RNAS IN EPILEPSY |
| 5121 |
POSSIBLE IMPRINTING AND MICROCHIMERISM IN CHRONIC LYMPHOCYTIC LEUKEMIA AND RELATED LYMPHOPROLIFERATIVE DISORDERS |
| 5122 |
POSSIBLE ROLE OF FRUCTOSAMINE 3-KINASE GENOTYPING FOR THE MANAGEMENT OF DIABETIC PATIENTS |
| 5123 |
POSSIBLE ROLE OF TOCOPHEROLS IN THE MODULATION OF HOST MICRORNA WITH POTENTIAL ANTIVIRAL ACTIVITY IN PATIENTS WITH HEPATITIS B VIRUS-RELATED PERSISTENT INFECTION: A SYSTEMATIC REVIEW |
| 5124 |
POST-OCCLUSION ADMINISTRATION OF SODIUM BUTYRATE ATTENUATES COGNITIVE IMPAIRMENT IN A RAT MODEL OF CHRONIC CEREBRAL HYPOPERFUSION |
| 5125 |
POST-TRANSLATIONAL MODIFICATIONS OF TRYPANOSOMA CRUZI CANONICAL AND VARIANT HISTONES |
| 5126 |
POST-TRANSLATIONAL PROTEIN MODIFICATION BY O-LINKED N-ACETYL-GLUCOSAMINE: ITS ROLE IN MEDIATING THE ADVERSE EFFECTS OF DIABETES ON THE HEART |
| 5127 |
POSTMENOPAUSAL UTERINE LEIOMYOMAS AND CHRONIC LYMPHADENOPATHY: EXPLORING EPIGENETIC CHANGES AND PATHOPHYSIOLOGY |
| 5128 |
POSTNATAL INTERMITTENT HYPOXIA ENHANCES PHRENIC AND REDUCES VAGAL UPPER AIRWAY MOTOR ACTIVITIES IN RATS BY EPIGENETIC MECHANISMS |
| 5129 |
POSTOPERATIVE PAIN AND ANALGESIA: IS THERE A GENETIC BASIS TO THE OPIOID CRISIS? BACKGROUND: MULTIPLE FACTORS HAVE BEEN IMPLICATED IN DETERMINING WHY CERTAIN PATIENTS HAVE INCREASED POSTOPERATIVE PAIN, WITH THE POTENTIAL TO DEVELOP CHRONIC PAIN |
| 5130 |
POSTTRANSCRIPTIONAL GENE REGULATION: NOVEL PATHWAYS FOR GLUCOCORTICOIDS' ANTI-INFLAMMATORY ACTION |
| 5131 |
POSTWEANING DIETARY FOLATE DEFICIENCY PROVIDED THROUGH CHILDHOOD TO PUBERTY PERMANENTLY INCREASES GENOMIC DNA METHYLATION IN ADULT RAT LIVER |
| 5132 |
POTENTIAL EFFECT OF LUTEOLIN, EPIAFZELECHIN, AND ALBIGENIN ON RATS UNDER CADMIUM-INDUCED INFLAMMATORY INSULT: IN SILICO AND IN VIVO APPROACH |
| 5133 |
POTENTIAL EPIGENETIC MECHANISM(S) ASSOCIATED WITH THE PERSISTENCE OF PSYCHONEUROLOGICAL SYMPTOMS IN WOMEN RECEIVING CHEMOTHERAPY FOR BREAST CANCER: A HYPOTHESIS |
| 5134 |
POTENTIAL HEALTH RISKS OF MRNA-BASED VACCINE THERAPY: A HYPOTHESIS |
| 5135 |
POTENTIAL MECHANISMS FOR LUNG FIBROSIS ASSOCIATED WITH COVID-19 INFECTION |
| 5136 |
POTENTIAL MECHANISMS LINKING PSYCHOLOGICAL STRESS TO BONE HEALTH |
| 5137 |
POTENTIAL MECHANISMS OF NON-SUICIDAL SELF-INJURY (NSSI) IN MAJOR DEPRESSIVE DISORDER: A SYSTEMATIC REVIEW |
| 5138 |
POTENTIAL METABOLIC BIOMARKERS IN ADULT ASTHMATICS |
| 5139 |
POTENTIAL NOVEL BIOMARKERS IN CHRONIC GRAFT-VERSUS-HOST DISEASE |
| 5140 |
POTENTIAL REGULATORS OF THE SENESCENCE-ASSOCIATED SECRETORY PHENOTYPE DURING SENESCENCE AND AGING |
| 5141 |
POTENTIAL RELEVANCE OF B-CELL MATURATION PATHWAYS IN DEFINING THE CELL(S) OF ORIGIN FOR CHRONIC LYMPHOCYTIC LEUKEMIA |
| 5142 |
POTENTIAL ROLE FOR HISTONE DEACETYLATION IN CHRONIC DIAZEPAM-INDUCED DOWNREGULATION OF ALPHA1-GABA(A) RECEPTOR SUBUNIT EXPRESSION |
| 5143 |
POTENTIAL ROLE OF EPIGENETIC MECHANISM IN MANGANESE INDUCED NEUROTOXICITY |
| 5144 |
POTENTIAL ROLE OF LNCRNA-TSIX, MIR-548-A-3P, AND SOGA1 MRNA IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA |
| 5145 |
POTENTIAL ROLE OF NUTRACEUTICALS VIA TARGETING A WNT/BETA-CATENIN AND NF-KAPPAB PATHWAY IN TREATMENT OF OSTEOARTHRITIS |
| 5146 |
POTENTIAL ROLES FOR INFECTIOUS AGENTS IN THE PATHOPHYSIOLOGY OF PRIMARY BILIARY CIRRHOSIS: WHAT'S NEW? PRIMARY BILIARY CIRRHOSIS (PBC) IS A PROGRESSIVE CHOLESTATIC LIVER DISEASE SEROLOGICALLY CHARACTERIZED BY THE PRESENCE OF HIGH-TITER ANTIMITOCHONDRIAL ANTIBODIES AND, HISTOLOGICALLY BY CHRONIC NONSUPPURATIVE CHOLANGITIS AND GRANULOMATA |
| 5147 |
POTENTIAL ROLES OF LONG NONCODING RNAS AS THERAPEUTIC TARGETS IN ORGAN TRANSPLANTATION |
| 5148 |
POTENTIAL ROLES OF SUPER ENHANCERS IN INFLAMMATORY GENE TRANSCRIPTION |
| 5149 |
PPAR AND FUNCTIONAL FOODS: RATIONALE FOR NATURAL NEUROSTEROID-BASED INTERVENTIONS FOR POSTPARTUM DEPRESSION |
| 5150 |
PPARALPHA IN THE EPIGENETIC DRIVER SEAT OF NAFLD: NEW THERAPEUTIC OPPORTUNITIES FOR EPIGENETIC DRUGS? NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS A GROWING EPIDEMIC AND THE MOST COMMON CAUSE OF CHRONIC LIVER DISEASE WORLDWIDE |
| 5151 |
PPARS IN LIVER DISEASES AND CANCER: EPIGENETIC REGULATION BY MICRORNAS |
| 5152 |
PPM1F IN DENTATE GYRUS MODULATES ANXIETY-RELATED BEHAVIORS BY REGULATING BDNF EXPRESSION VIA AKT/JNK/P-H3S10 PATHWAY |
| 5153 |
PPP2R2B HYPERMETHYLATION CAUSES ACQUIRED APOPTOSIS DEFICIENCY IN SYSTEMIC AUTOIMMUNE DISEASES |
| 5154 |
PRAKRITI-BASED MEDICINE: A STEP TOWARDS PERSONALIZED MEDICINE |
| 5155 |
PRDM12 MODULATES PAIN-RELATED BEHAVIOR BY REMODELING GENE EXPRESSION IN MATURE NOCICEPTORS |
| 5156 |
PRE-BIRTH ORIGINS OF ALLERGY AND ASTHMA |
| 5157 |
PRE-NEOPLASTIC EPIGENETIC DISRUPTION OF TRANSCRIPTIONAL ENHANCERS IN CHRONIC INFLAMMATION |
| 5158 |
PRE-REPRODUCTIVE STRESS AND FLUOXETINE TREATMENT IN RATS AFFECT OFFSPRING A-TO-I RNA EDITING, GENE EXPRESSION AND SOCIAL BEHAVIOR |
| 5159 |
PRE-RHEUMATOID ARTHRITIS: PREDISPOSITION AND TRANSITION TO CLINICAL SYNOVITIS |
| 5160 |
PREADOLESCENT ADVERSITY PROGRAMS A DISRUPTED MATERNAL STRESS REACTIVITY IN HUMANS AND MICE |
| 5161 |
PRECISION AND PERSONALIZED MEDICINE: HOW GENOMIC APPROACH IMPROVES THE MANAGEMENT OF CARDIOVASCULAR AND NEURODEGENERATIVE DISEASE |
| 5162 |
PRECISION MEDICINE DRIVEN BY CANCER SYSTEMS BIOLOGY |
| 5163 |
PRECISION/PERSONALIZED MEDICINE IN ALLERGIC DISEASES AND ASTHMA |
| 5164 |
PRECLINICAL AND CLINICAL EVIDENCE OF DNA METHYLATION CHANGES IN RESPONSE TO TRAUMA AND CHRONIC STRESS |
| 5165 |
PRECLINICAL RESERPINE MODELS RECAPITULATING MOTOR AND NON-MOTOR FEATURES OF PARKINSON'S DISEASE: ROLES OF EPIGENETIC UPREGULATION OF ALPHA-SYNUCLEIN AND AUTOPHAGY IMPAIRMENT |
| 5166 |
PRECONCEPTION PATERNAL ALCOHOL EXPOSURE EXERTS SEX-SPECIFIC EFFECTS ON OFFSPRING GROWTH AND LONG-TERM METABOLIC PROGRAMMING |
| 5167 |
PRECONCEPTION PATERNAL MENTAL DISORDERS AND CHILD HEALTH: MECHANISMS AND INTERVENTIONS |
| 5168 |
PRECONCEPTIONAL PATERNAL EXPOSURE TO A SINGLE TRAUMATIC EVENT AFFECTS POSTNATAL GROWTH OF FEMALE BUT NOT MALE OFFSPRING |
| 5169 |
PRECONCEPTIONAL STRESS AND RACIAL DISPARITIES IN PRETERM BIRTH: AN OVERVIEW |
| 5170 |
PREDATION RISK DETERMINES PIGMENTATION PHENOTYPE IN NUTHATCHES BY MELANIN-RELATED GENE EXPRESSION EFFECTS |
| 5171 |
PREDATOR-BASED PSYCHOSOCIAL STRESS ANIMAL MODEL OF PTSD: PRECLINICAL ASSESSMENT OF TRAUMATIC STRESS AT COGNITIVE, HORMONAL, PHARMACOLOGICAL, CARDIOVASCULAR AND EPIGENETIC LEVELS OF ANALYSIS |
| 5172 |
PREDICTING PAIN AFTER STANDARD PAIN THERAPY FOR KNEE OSTEOARTHRITIS - THE FIRST STEPS TOWARDS PERSONALIZED MECHANISTIC-BASED PAIN MEDICINE IN OSTEOARTHRITIS |
| 5173 |
PREDICTING PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE BY CHANGES IN THE TELOMERIC EPIGENOME |
| 5174 |
PREDICTIVE AND PROGNOSTIC BIOMARKERS OF RESPIRATORY DISEASES DUE TO PARTICULATE MATTER EXPOSURE |
| 5175 |
PREDICTORS OF BIOLOGICAL AGE: THE IMPLICATIONS FOR WELLNESS AND AGING RESEARCH |
| 5176 |
PREFACE TO COAST 2016 INNOVATORS' WORKSHOP ON PERSONALIZED AND PRECISION ORTHODONTIC THERAPY |
| 5177 |
PREFRONTAL CORTEX EXPRESSION OF CHROMATIN MODIFIER GENES IN MALE WSP AND WSR MICE CHANGES ACROSS ETHANOL DEPENDENCE, WITHDRAWAL, AND ABSTINENCE |
| 5178 |
PREGNANCY AS A FUNDAMENTAL DETERMINANT OF CHILD HEALTH: A REVIEW |
| 5179 |
PREGNANCY: AN UNDERUTILIZED WINDOW OF OPPORTUNITY TO IMPROVE LONG-TERM MATERNAL AND INFANT HEALTH-AN APPEAL FOR CONTINUOUS FAMILY CARE AND INTERDISCIPLINARY COMMUNICATION |
| 5180 |
PREMALIGNANT CONDITIONS OF GASTRIC CANCER |
| 5181 |
PREMALIGNANT LESIONS IN GASTRIC CANCER |
| 5182 |
PREMALIGNANT LESIONS OF SQUAMOUS CELL CARCINOMA OF THE LUNG: THE MOLECULAR MAKE-UP AND FACTORS AFFECTING THEIR PROGRESSION |
| 5183 |
PREMATURE AGING IN CHILDHOOD CANCER SURVIVORS |
| 5184 |
PREMATURE CHROMOSOME CONDENSATION ASSAY TO STUDY INFLUENCE OF HIGH-LEVEL NATURAL RADIATION ON THE INITIAL DNA DOUBLE STRAND BREAK REPAIR IN HUMAN G(0) LYMPHOCYTES |
| 5185 |
PREMATURE PHYSIOLOGIC AGING AS A PARADIGM FOR UNDERSTANDING INCREASED RISK OF ADVERSE HEALTH ACROSS THE LIFESPAN OF SURVIVORS OF CHILDHOOD CANCER |
| 5186 |
PREMATURITY IN MICE LEADS TO REDUCTION IN NEPHRON NUMBER, HYPERTENSION, AND PROTEINURIA |
| 5187 |
PRENATAL AIRBORNE POLYCYCLIC AROMATIC HYDROCARBON EXPOSURE, ALTERED REGULATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPAR)GAMMA, AND LINKS WITH MAMMARY CANCER |
| 5188 |
PRENATAL ALCOHOL EXPOSURE ALTERS EXPRESSION OF NEUROGENESIS-RELATED GENES IN AN EX VIVO CELL CULTURE MODEL |
| 5189 |
PRENATAL ARSENIC EXPOSURE INDUCES IMMUNOMETABOLIC ALTERATION AND RENAL INJURY IN RATS |
| 5190 |
PRENATAL CAUSES OF KIDNEY DISEASE |
| 5191 |
PRENATAL DEXAMETHASONE EXPOSURE PROGRAMS THE DECREASED TESTOSTERONE SYNTHESIS IN OFFSPRING RATS BY LOW LEVEL OF ENDOGENOUS GLUCOCORTICOIDS |
| 5192 |
PRENATAL ENVIRONMENTAL STRESSORS AND DNA METHYLATION LEVELS IN PLACENTA AND PERIPHERAL TISSUES OF MOTHERS AND NEONATES EVALUATED BY APPLYING ARTIFICIAL NEURAL NETWORKS |
| 5193 |
PRENATAL EXPOSURE TO ENVIRONMENTAL PRO-OXIDANTS INDUCES MITOCHONDRIA-MEDIATED EPIGENETIC CHANGES: A CROSS-SECTIONAL PILOT STUDY |
| 5194 |
PRENATAL EXPOSURE TO POTENTIALLY TOXIC METALS AND THEIR EFFECTS ON GENETIC MATERIAL IN OFFSPRING: A SYSTEMATIC REVIEW |
| 5195 |
PRENATAL FAMINE EXPOSURE AND ADULT HEALTH OUTCOMES: AN EPIGENETIC LINK |
| 5196 |
PRENATAL FAMINE EXPOSURE AND ESTIMATED GLOMERULAR FILTRATION RATE ACROSS CONSECUTIVE GENERATIONS: ASSOCIATION AND EPIGENETIC MEDIATION IN A POPULATION-BASED COHORT STUDY IN SUIHUA CHINA |
| 5197 |
PRENATAL GLUCOCORTICOIDS EXPOSURE AND FETAL ADRENAL DEVELOPMENTAL PROGRAMMING |
| 5198 |
PRENATAL HIGH ESTRADIOL EXPOSURE INDUCES SEX-SPECIFIC AND DIETARILY REVERSIBLE INSULIN RESISTANCE THROUGH DECREASED HYPOTHALAMIC INSR |
| 5199 |
PRENATAL MATERNAL STRESS IS ASSOCIATED WITH INCREASED SENSITIVITY TO NEUROPATHIC PAIN AND SEX-SPECIFIC CHANGES IN SUPRASPINAL MRNA EXPRESSION OF EPIGENETIC- AND STRESS-RELATED GENES IN ADULTHOOD |
| 5200 |
PRENATAL MATERNAL STRESS PREDICTS METHYLATION OF GENES REGULATING THE HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL SYSTEM IN MOTHERS AND NEWBORNS IN THE DEMOCRATIC REPUBLIC OF CONGO |
| 5201 |
PRENATAL MORPHINE EXPOSURE INCREASES GAMMA OSCILLATION AND THETA COHERENCE IN THE RAT REWARD SYSTEM |
| 5202 |
PRENATAL ORIGINS OF ADULT DISEASE |
| 5203 |
PRENATAL PROGRAMMING AND EPIGENETICS IN THE GENESIS OF THE CARDIORENAL SYNDROME |
| 5204 |
PRENATAL PROGRAMMING-EFFECTS ON BLOOD PRESSURE AND RENAL FUNCTION |
| 5205 |
PRENATAL STRESS CHANGES THE GLYCOPROTEIN GPM6A GENE EXPRESSION AND INDUCES EPIGENETIC CHANGES IN RAT OFFSPRING BRAIN |
| 5206 |
PRENATAL STRESS INDUCES LONG-TERM BEHAVIORAL SEX-DEPENDENT CHANGES IN RATS OFFSPRING: THE ROLE OF THE HPA AXIS AND EPIGENETICS |
| 5207 |
PRENATAL STRESS INDUCES SPATIAL MEMORY DEFICITS AND EPIGENETIC CHANGES IN THE HIPPOCAMPUS INDICATIVE OF HETEROCHROMATIN FORMATION AND REDUCED GENE EXPRESSION |
| 5208 |
PRENATAL STRESS, PREMATURITY, AND ASTHMA |
| 5209 |
PRENATAL XENOBIOTIC EXPOSURE AND INTRAUTERINE HYPOTHALAMUS-PITUITARY-ADRENAL AXIS PROGRAMMING ALTERATION |
| 5210 |
PRENEOPLASTIC ALTERATIONS DEFINE CLL DNA METHYLOME AND PERSIST THROUGH DISEASE PROGRESSION AND THERAPY |
| 5211 |
PRENEOPLASTIC LESIONS IN HUMAN HEPATOCARCINOGENESIS |
| 5212 |
PRESERVATION OF QUIESCENT CHRONIC MYELOGENOUS LEUKEMIA STEM CELLS BY THE BONE MARROW MICROENVIRONMENT |
| 5213 |
PRESYMPTOMATIC RISK ASSESSMENT FOR CHRONIC NON-COMMUNICABLE DISEASES |
| 5214 |
PRETERM BEHAVIORAL EPIGENETICS: A SYSTEMATIC REVIEW |
| 5215 |
PRETERM BIRTH AND ITS LONG-TERM EFFECTS: METHYLATION TO MECHANISMS |
| 5216 |
PRETERM BIRTH: LONG TERM CARDIOVASCULAR AND RENAL CONSEQUENCES |
| 5217 |
PREVALENCE AND CHARACTERISTICS OF PSORIASIS IN ROMANIA-FIRST STUDY IN OVERALL POPULATION |
| 5218 |
PREVENTION OF HEPATOCELLULAR CARCINOMA |
| 5219 |
PREVIOUS HISTORY OF CHRONIC STRESS CHANGES THE TRANSCRIPTIONAL RESPONSE TO GLUCOCORTICOID CHALLENGE IN THE DENTATE GYRUS REGION OF THE MALE RAT HIPPOCAMPUS |
| 5220 |
PRIMARY BILIARY CHOLANGITIS: A TALE OF EPIGENETICALLY-INDUCED SECRETORY FAILURE? PRIMARY BILIARY CHOLANGITIS (PBC) IS A CHRONIC CHOLESTATIC LIVER DISEASE ASSOCIATED WITH AUTOIMMUNE-RELATED DESTRUCTION OF SMALL TO MEDIUM SIZE INTRAHEPATIC BILE DUCTS |
| 5221 |
PRIMARY BILIARY CHOLANGITIS: PATHOGENESIS AND THERAPEUTIC OPPORTUNITIES |
| 5222 |
PRIMARY BILIARY CIRRHOSIS: FAMILY STORIES |
| 5223 |
PRIMARY MURINE CD4+ T CELLS FAIL TO ACQUIRE THE ABILITY TO PRODUCE EFFECTOR CYTOKINES WHEN ACTIVE RAS IS PRESENT DURING TH1/TH2 DIFFERENTIATION |
| 5224 |
PRIORITIZED RESEARCH FOR THE PREVENTION, TREATMENT, AND REVERSAL OF CHRONIC DISEASE: RECOMMENDATIONS FROM THE LIFESTYLE MEDICINE RESEARCH SUMMIT |
| 5225 |
PRMT1 MODULATES PROCESSING OF ASTHMA-RELATED PRIMARY MICRORNAS (PRI-MIRNAS) INTO MATURE MIRNAS IN LUNG EPITHELIAL CELLS |
| 5226 |
PRMT5 RESTRICTS HEPATITIS B VIRUS REPLICATION THROUGH EPIGENETIC REPRESSION OF COVALENTLY CLOSED CIRCULAR DNA TRANSCRIPTION AND INTERFERENCE WITH PREGENOMIC RNA ENCAPSIDATION |
| 5227 |
PRMT6 MEDIATES INFLAMMATION VIA ACTIVATION OF THE NF-KAPPAB/P65 PATHWAY ON A CIGARETTE SMOKE EXTRACT-INDUCED MURINE EMPHYSEMA MODEL |
| 5228 |
PRMT7 TARGETS OF FOXM1 CONTROLS ALVEOLAR MYOFIBROBLAST PROLIFERATION AND DIFFERENTIATION DURING ALVEOLOGENESIS |
| 5229 |
PRO-APOPTOTIC TP53 HOMOLOG TAP63 IS REPRESSED VIA EPIGENETIC SILENCING AND B-CELL RECEPTOR SIGNALLING IN CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 5230 |
PRO-DOPAMINE REGULATOR (KB220) A FIFTY YEAR SOJOURN TO COMBAT REWARD DEFICIENCY SYNDROME (RDS): EVIDENCE BASED BIBLIOGRAPHY (ANNOTATED) |
| 5231 |
PROBIOTICS AND AMELIORATION OF RHEUMATOID ARTHRITIS: SIGNIFICANT ROLES OF LACTOBACILLUS CASEI AND LACTOBACILLUS ACIDOPHILUS |
| 5232 |
PROBLEMS IN ASSESSMENT OF RISKS FROM EXPOSURES TO MICROWAVES OF MOBILE COMMUNICATION |
| 5233 |
PROFIBROTIC SIGNALING AND HCC RISK DURING CHRONIC VIRAL HEPATITIS: BIOMARKER DEVELOPMENT |
| 5234 |
PROFILE ANALYSIS AND FUNCTIONAL MODELING IDENTIFY CIRCULAR RNAS IN NONALCOHOLIC FATTY LIVER DISEASE AS REGULATORS OF HEPATIC LIPID METABOLISM |
| 5235 |
PROFILE OF EPIGENETIC MECHANISMS IN LUNG TUMORS OF PATIENTS WITH UNDERLYING CHRONIC RESPIRATORY CONDITIONS |
| 5236 |
PROFILING NON-CODING RNA LEVELS WITH CLINICAL CLASSIFIERS IN PEDIATRIC CROHN'S DISEASE |
| 5237 |
PROFILING OF CELL-FREE DNA METHYLATION AND HISTONE SIGNATURES IN PEDIATRIC NAFLD: A PILOT STUDY |
| 5238 |
PROFILING OF H3K27AC REVEALS THE INFLUENCE OF ASTHMA ON THE EPIGENOME OF THE AIRWAY EPITHELIUM |
| 5239 |
PROGESTERONE ALLEVIATES ENDOMETRIOSIS VIA INHIBITION OF UTERINE CELL PROLIFERATION, INFLAMMATION AND ANGIOGENESIS IN AN IMMUNOCOMPETENT MOUSE MODEL |
| 5240 |
PROGESTERONE EFFECTS ON OLIGODENDROCYTE DIFFERENTIATION IN INJURED SPINAL CORD |
| 5241 |
PROGESTERONE RESISTANCE IN ENDOMETRIOSIS: CURRENT EVIDENCE AND PUTATIVE MECHANISMS |
| 5242 |
PROGESTERONE RESISTANCE IN ENDOMETRIOSIS: ORIGINS, CONSEQUENCES AND INTERVENTIONS |
| 5243 |
PROGNOSTIC IMPACT OF EPIGENETIC CLASSIFICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA: THE CASE OF SUBSET #2 |
| 5244 |
PROGNOSTIC INTERACTION BETWEEN ASXL1 AND TET2 MUTATIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 5245 |
PROGNOSTIC RELEVANCE OF INTEGRATED GENETIC PROFILING IN ADULT T-CELL LEUKEMIA/LYMPHOMA |
| 5246 |
PROGNOSTIC SCORE INCLUDING GENE MUTATIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 5247 |
PROGRAMMED ADULT KIDNEY DISEASE: IMPORTANCE OF FETAL ENVIRONMENT |
| 5248 |
PROGRAMMED CELL DEATH 1-DIRECTED IMMUNOTHERAPY FOR ENHANCING T-CELL FUNCTION |
| 5249 |
PROGRAMMED CELL DEATH-1 PATHWAY INHIBITION IN MYELOID MALIGNANCIES: IMPLICATIONS FOR MYELOPROLIFERATIVE NEOPLASMS |
| 5250 |
PROGRAMMED DISORDERS OF BETA-CELL DEVELOPMENT AND FUNCTION AS ONE CAUSE FOR TYPE 2 DIABETES? THE GK RAT PARADIGM |
| 5251 |
PROGRAMMED INCREASES IN LXRALPHA INDUCED BY PATERNAL ALCOHOL USE ENHANCE OFFSPRING METABOLIC ADAPTATION TO HIGH-FAT DIET INDUCED OBESITY |
| 5252 |
PROGRAMMING AND REGULATION OF METABOLIC HOMEOSTASIS |
| 5253 |
PROGRAMMING CHANGES OF HIPPOCAMPAL MIR-134-5P/SOX2 SIGNAL MEDIATE THE SUSCEPTIBILITY TO DEPRESSION IN PRENATAL DEXAMETHASONE-EXPOSED FEMALE OFFSPRING |
| 5254 |
PROGRAMMING OF RESPIRATORY HEALTH IN CHILDHOOD: INFLUENCE OF OUTDOOR AIR POLLUTION |
| 5255 |
PROGRESS IN UNDERSTANDING THE PATHOGENESIS OF BPD USING THE BABOON AND SHEEP MODELS |
| 5256 |
PROGRESSES IN EPIGENETIC STUDIES OF ASTHMA FROM THE PERSPECTIVE OF HIGH-THROUGHPUT ANALYSIS TECHNOLOGIES: A NARRATIVE REVIEW |
| 5257 |
PROGRESSION OF MYELOPROLIFERATIVE NEOPLASMS (MPN): DIAGNOSTIC AND THERAPEUTIC PERSPECTIVES |
| 5258 |
PROGRESSION OF TUBULOINTERSTITIAL FIBROSIS AND THE CHRONIC KIDNEY DISEASE PHENOTYPE - ROLE OF RISK FACTORS AND EPIGENETICS |
| 5259 |
PROGRESSIVE DE NOVO DNA METHYLATION AT THE BCR-ABL LOCUS IN THE COURSE OF CHRONIC MYELOGENOUS LEUKEMIA |
| 5260 |
PROGRESSIVE OSSEOUS HETEROPLASIA, AS AN ISOLATED ENTITY OR OVERLAPPING WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY |
| 5261 |
PROGRESSIVE SILENCING OF THE ZINC TRANSPORTER ZIP8 (SLC39A8) IN CHRONIC CADMIUM-EXPOSED LUNG EPITHELIAL CELLS |
| 5262 |
PROLACTIN ACTIVATES IRF1 AND LEADS TO ALTERED BALANCE OF HISTONE ACETYLATION: IMPLICATIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS |
| 5263 |
PROMISING BIOMARKERS OF HUMAN AGING: IN SEARCH OF A MULTI-OMICS PANEL TO UNDERSTAND THE AGING PROCESS FROM A MULTIDIMENSIONAL PERSPECTIVE |
| 5264 |
PROMISING DIRECTIONS IN ATHEROSCLEROSIS TREATMENT BASED ON EPIGENETIC REGULATION USING MICRORNAS AND LONG NONCODING RNAS |
| 5265 |
PROMISING THERAPEUTIC TARGETS FOR TREATMENT OF RHEUMATOID ARTHRITIS |
| 5266 |
PROMOTED INTERACTION OF C/EBPALPHA WITH DEMETHYLATED CXCR3 GENE PROMOTER CONTRIBUTES TO NEUROPATHIC PAIN IN MICE |
| 5267 |
PROMOTER ACTIVITY-BASED CASE-CONTROL ASSOCIATION STUDY ON SLC6A4 HIGHLIGHTING HYPERMETHYLATION AND ALTERED AMYGDALA VOLUME IN MALE PATIENTS WITH SCHIZOPHRENIA |
| 5268 |
PROMOTER DEMETHYLATION OF CYSTATHIONINE-BETA-SYNTHETASE GENE CONTRIBUTES TO INFLAMMATORY PAIN IN RATS |
| 5269 |
PROMOTER DNA METHYLATION CONTRIBUTES TO HUMAN BETA-DEFENSIN-1 DEFICIENCY IN ATOPIC DERMATITIS |
| 5270 |
PROMOTER DNA METHYLATION FREQUENCY AND CLINICOPATHOLOGICAL ROLE OF MIR-129-2 GENE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA |
| 5271 |
PROMOTER HYPERMETHYLATION OF PROGESTERONE RECEPTOR ISOFORM B (PR-B) IN ENDOMETRIOSIS |
| 5272 |
PROMOTER HYPERMETHYLATION OF THE AE2/SLC4A2 GENE IN PBC |
| 5273 |
PROMOTER METHYLATION AND BDNF AND DAT1 GENE EXPRESSION PROFILES IN PATIENTS WITH DRUG ADDICTION |
| 5274 |
PROMOTER METHYLATION OF P16 AND EDNRB GENE IN LEUKEMIA PATIENTS IN TAIWAN |
| 5275 |
PROMOTER METHYLATION OF THE BONE MORPHOGENETIC PROTEIN-6 GENE IN ASSOCIATION WITH ADULT T-CELL LEUKEMIA |
| 5276 |
PROMOTER METHYLATION OF TUMOR-RELATED GENES IN GASTRIC CARCINOGENESIS |
| 5277 |
PROMOTER METHYLATION PROFILE IN PRENEOPLASTIC AND NEOPLASTIC GALLBLADDER LESIONS |
| 5278 |
PROMOTER METHYLATION-MEDIATED INACTIVATION OF PCDH10 IN ACUTE LYMPHOBLASTIC LEUKEMIA CONTRIBUTES TO CHEMOTHERAPY RESISTANCE |
| 5279 |
PROMOTER-SPECIFIC RELEVANCE OF HISTONE MODIFICATIONS INDUCED BY DEXAMETHASONE DURING THE REGULATION OF PRO-INFLAMMATORY MEDIATORS |
| 5280 |
PROMOTING SYMPATHOVAGAL BALANCE IN MULTIPLE SCLEROSIS; PHARMACOLOGICAL, NON-PHARMACOLOGICAL, AND SURGICAL STRATEGIES |
| 5281 |
PROMOTION AND SELECTION BY SERUM GROWTH FACTORS DRIVE FIELD CANCERIZATION, WHICH IS ANTICIPATED IN VIVO BY TYPE 2 DIABETES AND OBESITY |
| 5282 |
PROMOTION OF HEPATOCARCINOGENESIS IN HUMANS AND ANIMAL MODELS |
| 5283 |
PROPHYLACTIC OR PREEMPTIVE LOW-DOSE AZACITIDINE AND DONOR LYMPHOCYTE INFUSION TO PREVENT DISEASE RELAPSE FOLLOWING ALLOGENEIC TRANSPLANTATION IN PATIENTS WITH HIGH-RISK ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROME |
| 5284 |
PROPOSALS FOR CLINICAL TRIALS IN CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 5285 |
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) IN THE BRAIN AND RELEVANCE FOR NEUROPSYCHIATRIC DISORDERS |
| 5286 |
PRORESOLVING LIPID MEDIATORS: POTENTIAL FOR PREVENTION AND TREATMENT OF PERIODONTITIS |
| 5287 |
PROSPECTIVE EPIGENOME AND TRANSCRIPTOME ANALYSES OF CORD AND PERIPHERAL BLOOD FROM PRETERM INFANTS AT RISK OF BRONCHOPULMONARY DYSPLASIA |
| 5288 |
PROSPECTS FOR EPIGENETIC COMPOUNDS IN THE TREATMENT OF AUTOIMMUNE DISEASE |
| 5289 |
PROSTANOID RECEPTOR GENES CONFER POOR PROGNOSIS IN HEAD AND NECK SQUAMOUS CELL CARCINOMA VIA EPIGENETIC INACTIVATION |
| 5290 |
PROSTATE CANCER PREVENTION: AGENT DEVELOPMENT STRATEGIES |
| 5291 |
PROSTATE CARCINOGENESIS: INSIGHTS IN RELATION TO EPIGENETICS AND INFLAMMATION |
| 5292 |
PROSTATIC INFLAMMATION ENHANCES BASAL-TO-LUMINAL DIFFERENTIATION AND ACCELERATES INITIATION OF PROSTATE CANCER WITH A BASAL CELL ORIGIN |
| 5293 |
PROTEASOMAL DEGRADATION OF THE HISTONE ACETYL TRANSFERASE P300 CONTRIBUTES TO BETA-CELL INJURY IN A DIABETES ENVIRONMENT |
| 5294 |
PROTECTIVE EFFECTS OF MATERNAL METHYL DONOR SUPPLEMENTATION ON ADULT OFFSPRING OF HIGH FAT DIET-FED DAMS |
| 5295 |
PROTECTIVE POTENTIAL OF THYMOQUINONE AGAINST CADMIUM, ARSENIC, AND LEAD TOXICITY: A SHORT REVIEW WITH EMPHASIS ON OXIDATIVE PATHWAYS |
| 5296 |
PROTECTIVE ROLE OF SODIUM BUTYRATE, A HDAC INHIBITOR ON BETA-CELL PROLIFERATION, FUNCTION AND GLUCOSE HOMEOSTASIS THROUGH MODULATION OF P38/ERK MAPK AND APOPTOTIC PATHWAYS: STUDY IN JUVENILE DIABETIC RAT |
| 5297 |
PROTEIN ARGININE METHYLTRANSFERASE 5 CONTRIBUTES TO PACLITAXEL-INDUCED NEUROPATHIC PAIN BY ACTIVATING TRANSIENT RECEPTOR POTENTIAL VANILLOID 1 EPIGENETIC MODIFICATION IN DORSAL ROOT GANGLION |
| 5298 |
PROTEIN ARGININE METHYLTRANSFERASE 5 SUPPRESSES THE TRANSCRIPTION OF THE RB FAMILY OF TUMOR SUPPRESSORS IN LEUKEMIA AND LYMPHOMA CELLS |
| 5299 |
PROTEIN INTERACTION NETWORKS PROVIDE INSIGHT INTO FETAL ORIGINS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 5300 |
PROTEIN METHYLATION IN DIABETIC KIDNEY DISEASE |
| 5301 |
PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT ALPHA PLAYS A MYD88-DEPENDENT, CENTRAL ROLE IN THE GENE-SPECIFIC REGULATION OF ENDOTOXIN TOLERANCE |
| 5302 |
PROTEIN-C REACTIVE AS BIOMARKER PREDICTOR OF SCHIZOPHRENIA PHASES OF ILLNESS? A SYSTEMATIC REVIEW |
| 5303 |
PROTEOME DATA OF SERUM SAMPLES FROM PATIENTS WITH SCHIZOPHRENIA |
| 5304 |
PROTEOMIC ANALYSIS OF INFLAMMATORY BIOMARKERS ASSOCIATED WITH BREAST CANCER RECURRENCE |
| 5305 |
PROTEOMICS ANALYSIS OF HUMAN OBESITY REVEALS THE EPIGENETIC FACTOR HDAC4 AS A POTENTIAL TARGET FOR OBESITY |
| 5306 |
PROTEOMICS PROFILING WITH SWATH-MS QUANTITATIVE ANALYSIS OF CHANGES IN THE HUMAN BRAIN WITH HIV INFECTION REVEALS A DIFFERENTIAL IMPACT ON THE FRONTAL AND TEMPORAL LOBES |
| 5307 |
PROXIMITY UTILIZING BIOTINYLATION OF NUCLEAR PROTEINS IN VIVO |
| 5308 |
PSORIASIS AND PHYSICAL ACTIVITY: A REVIEW |
| 5309 |
PSORIASIS PATHOGENESIS AND TREATMENT |
| 5310 |
PSYCHOBIOLOGY AND MOLECULAR GENETICS OF RESILIENCE |
| 5311 |
PSYCHOLOGICAL AND BIOLOGICAL RESILIENCE MODULATES THE EFFECTS OF STRESS ON EPIGENETIC AGING |
| 5312 |
PSYCHOLOGICAL FACTORS AND DNA METHYLATION OF GENES RELATED TO IMMUNE/INFLAMMATORY SYSTEM MARKERS: THE VA NORMATIVE AGING STUDY |
| 5313 |
PSYCHOLOGICAL STRESS AS A MODULATOR OF FUNCTIONAL RECOVERY FOLLOWING SPINAL CORD INJURY |
| 5314 |
PSYCHOLOGICAL STRESS IN ASTHMA: REPERCUSSIONS ON EPIGENETICS-GENETICS, IMMUNE RESPONSES, AND PULMONARY FUNCTION IN THE PEDIATRIC POPULATION |
| 5315 |
PSYCHOLOGICAL STRESS IN CHILDHOOD AND SUSCEPTIBILITY TO THE CHRONIC DISEASES OF AGING: MOVING TOWARD A MODEL OF BEHAVIORAL AND BIOLOGICAL MECHANISMS |
| 5316 |
PSYCHOLOGICAL STRESS IN EARLY LIFE AS A PREDISPOSING FACTOR FOR THE DEVELOPMENT OF CHRONIC PAIN: CLINICAL AND PRECLINICAL EVIDENCE AND NEUROBIOLOGICAL MECHANISMS |
| 5317 |
PSYCHOLOGICAL STRESS, INTESTINAL BARRIER DYSFUNCTIONS, AND AUTOIMMUNE DISORDERS: AN OVERVIEW |
| 5318 |
PSYCHONEUROENDOCRINE INTERVENTIONS AIMED AT ATTENUATING IMMUNOSENESCENCE: A REVIEW |
| 5319 |
PTEN IS FUNDAMENTAL FOR ELIMINATION OF LEUKEMIA STEM CELLS MEDIATED BY GSK126 TARGETING EZH2 IN CHRONIC MYELOGENOUS LEUKEMIA |
| 5320 |
PU |
| 5321 |
PULMONARY ARTERY SMOOTH MUSCLE CELL PROLIFERATION AND MIGRATION IN FETAL LAMBS ACCLIMATIZED TO HIGH-ALTITUDE LONG-TERM HYPOXIA: ROLE OF HISTONE ACETYLATION |
| 5322 |
PULMONARY DISEASES AND AGEING |
| 5323 |
PULMONARY INVOLVEMENT IN SYSTEMIC SCLEROSIS: EXPLORING CELLULAR, GENETIC AND EPIGENETIC MECHANISMS |
| 5324 |
PULMONARY MICRORNA PROFILING: IMPLICATIONS IN UPPER LOBE PREDOMINANT LUNG DISEASE |
| 5325 |
PULMONARY PATHOGEN-INDUCED EPIGENETIC MODIFICATIONS |
| 5326 |
PULP INNATE IMMUNE DEFENSE: TRANSLATIONAL OPPORTUNITIES |
| 5327 |
PULSED GLUCOCORTICOIDS ENHANCE DYSTROPHIC MUSCLE PERFORMANCE THROUGH EPIGENETIC-METABOLIC REPROGRAMMING |
| 5328 |
PULSED RADIOFREQUENCY ATTENUATES COMPLETE FREUND'S ADJUVANT-INDUCED EPIGENETIC SUPPRESSION OF POTASSIUM CHLORIDE COTRANSPORTER 2 EXPRESSION |
| 5329 |
PURINERGIC SIGNALING IN THE LUMEN OF A NORMAL NEPHRON AND IN REMODELED PKD ENCAPSULATED CYSTS |
| 5330 |
PUTATIVE EPIGENETIC BIOMARKERS OF STRESS IN RED BLOOD CELLS OF CHICKENS REARED ACROSS DIFFERENT BIOMES |
| 5331 |
PUTTING THE PIECES TOGETHER IN GILLES DE LA TOURETTE SYNDROME: EXPLORING THE LINK BETWEEN CLINICAL OBSERVATIONS AND THE BIOLOGICAL BASIS OF DYSFUNCTION |
| 5332 |
PYRUVATE DEHYDROGENASE KINASE 1 AND 2 DEFICIENCY REDUCES HIGH-FAT DIET-INDUCED HYPERTROPHIC OBESITY AND INHIBITS THE DIFFERENTIATION OF PREADIPOCYTES INTO MATURE ADIPOCYTES |
| 5333 |
PYRUVATE KINASE DEFICIENCY: THE GENOTYPE-PHENOTYPE ASSOCIATION |
| 5334 |
QUADRICEPS MUSCLE WEAKNESS AND ATROPHY ARE ASSOCIATED WITH A DIFFERENTIAL EPIGENETIC PROFILE IN ADVANCED COPD |
| 5335 |
QUANTIFICATION AND EPIGENETIC EVALUATION OF THE RESIDUAL POOL OF HEPATITIS B COVALENTLY CLOSED CIRCULAR DNA IN LONG-TERM NUCLEOSIDE ANALOGUE-TREATED PATIENTS |
| 5336 |
QUANTIFICATION OF THE PACE OF BIOLOGICAL AGING IN HUMANS THROUGH A BLOOD TEST, THE DUNEDINPOAM DNA METHYLATION ALGORITHM |
| 5337 |
QUANTITATIVE ANALYSIS OF HISTONE H3 AND H4 POST-TRANSLATIONAL MODIFICATIONS IN DOXORUBICIN-RESISTANT LEUKEMIA CELLS |
| 5338 |
QUANTITATIVE EVALUATION OF RASSF1A METHYLATION IN THE NON-LESIONAL, REGENERATIVE AND NEOPLASTIC LIVER |
| 5339 |
QUETIAPINE TREATMENT REVERSES DEPRESSIVE-LIKE BEHAVIOR AND REDUCES DNA METHYLTRANSFERASE ACTIVITY INDUCED BY MATERNAL DEPRIVATION |
| 5340 |
QUORUM SENSING AND VIRULENCE OF PSEUDOMONAS AERUGINOSA DURING LUNG INFECTION OF CYSTIC FIBROSIS PATIENTS |
| 5341 |
RADIATION-HORMESIS PHENOTYPES, THE RELATED MECHANISMS AND IMPLICATIONS FOR DISEASE PREVENTION AND THERAPY |
| 5342 |
RADIATION-INDUCED LATE EFFECTS IN TWO AFFECTED INDIVIDUALS OF THE LILO RADIATION ACCIDENT |
| 5343 |
RADIATION-STIMULATED EPIGENETIC REPROGRAMMING OF ADAPTIVE-RESPONSE GENES IN THE LUNG: AN EVOLUTIONARY GIFT FOR MOUNTING ADAPTIVE PROTECTION AGAINST LUNG CANCER |
| 5344 |
RADIOBIOLOGICAL FEATURES IN OFFSPRING OF NATURAL POPULATIONS OF DROSOPHILA MELANOGASTER AFTER CHERNOBYL ACCIDENT |
| 5345 |
RAPID CHANGES IN EXPRESSION OF CLASS I AND IV HISTONE DEACETYLASES DURING EPILEPTOGENESIS IN MOUSE MODELS OF TEMPORAL LOBE EPILEPSY |
| 5346 |
RAPID CHANGES IN HISTONE DEACETYLASES AND INFLAMMATORY GENE EXPRESSION IN EXPERT MEDITATORS |
| 5347 |
RARBETA AGONIST DRUG (C286) DEMONSTRATES EFFICACY IN A PRE-CLINICAL NEUROPATHIC PAIN MODEL RESTORING MULTIPLE PATHWAYS VIA DNA REPAIR MECHANISMS |
| 5348 |
RASGRF1, A POTENTIAL METHYLATIC MEDIATOR OF ANTI-EPILEPTOGENESIS? EPILEPTOGENESIS, INDUCED BY STATUS EPILEPTICUS (SE), IS A CHRONIC PROCESS, AND INTERVENTION IN THIS PROGRESS MAY PREVENT CHRONIC EPILEPSY |
| 5349 |
RASSF1A AND DOK1 PROMOTER METHYLATION LEVELS IN HEPATOCELLULAR CARCINOMA, CIRRHOTIC AND NON-CIRRHOTIC LIVER, AND CORRELATION WITH LIVER CANCER IN BRAZILIAN PATIENTS |
| 5350 |
RATIONAL DEVELOPMENT OF ADJUNCT IMMUNE-BASED THERAPIES FOR DRUG-RESISTANT TUBERCULOSIS: HYPOTHESES AND EXPERIMENTAL DESIGNS |
| 5351 |
RATIONALE FOR DIETARY ANTIOXIDANT TREATMENT OF ADHD |
| 5352 |
RE-ESTABLISHING THE COMPREHENSION OF PHYTOMEDICINE AND NANOMEDICINE IN INFLAMMATION-MEDIATED CANCER SIGNALING |
| 5353 |
RE-EVALUATION OF POLIHEXANIDE USE IN WOUND ANTISEPSIS IN ORDER TO CLARIFY AMBIGUITIES OF TWO ANIMAL STUDIES |
| 5354 |
RE1-SILENCING TRANSCRIPTION FACTOR CONTROLS THE ACUTE-TO-CHRONIC NEUROPATHIC PAIN TRANSITION AND CHRM2 RECEPTOR GENE EXPRESSION IN PRIMARY SENSORY NEURONS |
| 5355 |
REAC ANTALGIC NEURO MODULATION IN CHRONIC POST HERPETIC NEURALGIA |
| 5356 |
REAC-INDUCED ENDOGENOUS BIOELECTRIC CURRENTS IN THE TREATMENT OF VENOUS ULCERS: A THREE-ARM RANDOMIZED CONTROLLED PROSPECTIVE STUDY |
| 5357 |
REACTIVE OXYGEN SPECIES INDUCE EPIGENETIC INSTABILITY THROUGH THE FORMATION OF 8-HYDROXYDEOXYGUANOSINE IN HUMAN HEPATOCARCINOGENESIS |
| 5358 |
REBALANCING TGFBETA1/BMP SIGNALS IN EXHAUSTED T CELLS UNLOCKS RESPONSIVENESS TO IMMUNE CHECKPOINT BLOCKADE THERAPY |
| 5359 |
REBOOTING REGULATORY T CELL AND DENDRITIC CELL FUNCTION IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: BIOMARKER AND THERAPY DISCOVERY UNDER A MULTI-OMICS LENS |
| 5360 |
RECENT ADVANCEMENTS IN COMPREHENSIVE GENETIC ANALYSES FOR HUMAN HEPATOCELLULAR CARCINOMA |
| 5361 |
RECENT ADVANCES IN ARSENIC RESEARCH: SIGNIFICANCE OF DIFFERENTIAL SUSCEPTIBILITY AND SUSTAINABLE STRATEGIES FOR MITIGATION |
| 5362 |
RECENT ADVANCES IN CALORIE RESTRICTION RESEARCH ON AGING |
| 5363 |
RECENT ADVANCES IN DIABETIC KIDNEY DISEASES: FROM KIDNEY INJURY TO KIDNEY FIBROSIS |
| 5364 |
RECENT ADVANCES IN EPIGENETICS OF AGE-RELATED KIDNEY DISEASES |
| 5365 |
RECENT ADVANCES IN HEPATITIS B TREATMENT |
| 5366 |
RECENT ADVANCES IN LEAN NAFLD |
| 5367 |
RECENT ADVANCES IN SUNLIGHT-INDUCED CARCINOGENESIS USING THE XIPHOPHORUS MELANOMA MODEL |
| 5368 |
RECENT ADVANCES IN THE STUDY OF HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA |
| 5369 |
RECENT ADVANCES IN UNDERSTANDING NEUROPATHIC PAIN: GLIA, SEX DIFFERENCES, AND EPIGENETICS |
| 5370 |
RECENT ADVANCES IN UNDERSTANDING OF CHRONIC KIDNEY DISEASE |
| 5371 |
RECENT ADVANCES IN UNDERSTANDING THE GENETIC BASIS OF SYSTEMIC LUPUS ERYTHEMATOSUS |
| 5372 |
RECENT ADVANCES IN UNDERSTANDING THE PATHOGENESIS OF RHEUMATOID ARTHRITIS: NEW TREATMENT STRATEGIES |
| 5373 |
RECENT ADVANCES IN UNDERSTANDING THE ROLE OF DIET AND OBESITY IN THE DEVELOPMENT OF COLORECTAL CANCER |
| 5374 |
RECENT ADVANCES IN UNDERSTANDING/MANAGEMENT OF PREMENSTRUAL DYSPHORIC DISORDER/PREMENSTRUAL SYNDROME |
| 5375 |
RECENT ADVANCES ON POSSIBLE ASSOCIATION BETWEEN THE PERIODONTAL INFECTION OF PORPHYROMONAS GINGIVALIS AND CENTRAL NERVOUS SYSTEM INJURY |
| 5376 |
RECENT DEVELOPMENTS IN EPIGENETICS OF ACUTE AND CHRONIC KIDNEY DISEASES |
| 5377 |
RECENT FINDINGS IN ALZHEIMER DISEASE AND NUTRITION FOCUSING ON EPIGENETICS |
| 5378 |
RECENT INSIGHTS ON THE GENETICS AND EPIGENETICS OF ENDOMETRIOSIS |
| 5379 |
RECENT PROGRESS IN THE GENETICS AND EPIGENETICS OF PARAOXONASE: WHY IT IS RELEVANT TO CHILDREN'S ENVIRONMENTAL HEALTH |
| 5380 |
RECENT UPDATES ON BIOMARKERS OF EXPOSURE AND SYSTEMIC TOXICITY IN E-CIGARETTE USERS AND EVALI |
| 5381 |
RECONSIDERING THE ROLE OF MITOCHONDRIA IN AGING |
| 5382 |
RECURRENT CHROMOSOMAL AND EPIGENETIC ALTERATIONS IN ORAL SQUAMOUS CELL CARCINOMA AND ITS PUTATIVE PREMALIGNANT CONDITION ORAL LICHEN PLANUS |
| 5383 |
RECURRENT XPO1 MUTATIONS ALTER PATHOGENESIS OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| 5384 |
REDIFFERENTIATION OF RADIOIODINE-REFRACTORY THYROID CANCERS |
| 5385 |
REDOX BALANCE SIGNALLING IN OCCUPATIONAL STRESS: MODIFICATION BY NUTRACEUTICAL INTERVENTION |
| 5386 |
REDOX HOMEOSTASIS AND EPIGENETICS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) |
| 5387 |
REDOX MECHANISMS IN MIGRAINE: NOVEL THERAPEUTICS AND DIETARY INTERVENTIONS |
| 5388 |
REDOX REGULATION OF MICRORNAS IN ENDOMETRIOSIS-ASSOCIATED PAIN |
| 5389 |
REDOX SWITCHES IN NOISE-INDUCED CARDIOVASCULAR AND NEURONAL DYSREGULATION |
| 5390 |
REDOX-FIBROSIS: IMPACT OF TGFBETA1 ON ROS GENERATORS, MEDIATORS AND FUNCTIONAL CONSEQUENCES |
| 5391 |
REDOX-RELATED BIOMARKERS IN HUMAN CARDIOVASCULAR DISEASE - CLASSICAL FOOTPRINTS AND BEYOND |
| 5392 |
REDOXISOME AND DIABETIC RETINOPATHY: PATHOPHYSIOLOGY AND THERAPEUTIC INTERVENTIONS |
| 5393 |
REDUCED CHROMATIN ACCESSIBILITY TO CD4 T CELL SUPER-ENHANCERS ENCOMPASSING SUSCEPTIBILITY LOCI OF RHEUMATOID ARTHRITIS |
| 5394 |
REDUCED DNA METHYLATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 5 IN ALVEOLAR MACROPHAGES IN COPD: A POTENTIAL LINK TO FAILED EFFEROCYTOSIS |
| 5395 |
REDUCED EPIGENETIC AGE IN OLDER ADULTS WITH HIGH SENSE OF PURPOSE IN LIFE |
| 5396 |
REDUCED HISTONE BIOSYNTHESIS AND CHROMATIN CHANGES ARISING FROM A DAMAGE SIGNAL AT TELOMERES |
| 5397 |
REDUCED LEVELS OF MIRNAS 449 AND 34 IN SPERM OF MICE AND MEN EXPOSED TO EARLY LIFE STRESS |
| 5398 |
REDUCED MOUSE ALLERGEN IS ASSOCIATED WITH EPIGENETIC CHANGES IN REGULATORY GENES, BUT NOT MOUSE SENSITIZATION, IN ASTHMATIC CHILDREN |
| 5399 |
REDUCED TEN-ELEVEN TRANSLOCATION AND ISOCITRATE DEHYDROGENASE EXPRESSION IN INFLAMMATORY HIDRADENITIS SUPPURATIVA LESIONS |
| 5400 |
REDUCING TOBACCO-RELATED DISABILITY IN CHRONIC SMOKERS |
| 5401 |
REDUCTION OF SIRT1 EPIGENETICALLY UPREGULATES NALP1 EXPRESSION AND CONTRIBUTES TO NEUROPATHIC PAIN INDUCED BY CHEMOTHERAPEUTIC DRUG BORTEZOMIB |
| 5402 |
REDUCTION OF SIRT1-MEDIATED EPIGENETIC UPREGULATION OF NAV1 |
| 5403 |
REGENERATION AFTER ACUTE KIDNEY INJURY REQUIRES PTIP-MEDIATED EPIGENETIC MODIFICATIONS |
| 5404 |
REGENERATIVE INTESTINAL STEM CELLS INDUCED BY ACUTE AND CHRONIC INJURY: THE SAVING GRACE OF THE EPITHELIUM? THE INTESTINAL EPITHELIUM IS REPLENISHED EVERY 3-4 DAYS THROUGH AN ORDERLY PROCESS THAT MAINTAINS IMPORTANT SECRETORY AND ABSORPTIVE FUNCTIONS WHILE PRESERVING A CONTINUOUS MUCOSAL BARRIER |
| 5405 |
REGULATED EXPRESSION OF P210 BCR-ABL DURING EMBRYONIC STEM CELL DIFFERENTIATION STIMULATES MULTIPOTENTIAL PROGENITOR EXPANSION AND MYELOID CELL FATE |
| 5406 |
REGULATING THE REGULATORS: MICRORNA AND ASTHMA |
| 5407 |
REGULATION AND IMMUNOTHERAPEUTIC TARGETING OF THE EPIGENOME IN EXHAUSTED CD8 T CELL RESPONSES |
| 5408 |
REGULATION AND SIGNALING OF THE GPR17 RECEPTOR IN OLIGODENDROGLIAL CELLS |
| 5409 |
REGULATION OF ACETYLATION STATES BY NUTRIENTS IN THE INHIBITION OF VASCULAR INFLAMMATION AND ATHEROSCLEROSIS |
| 5410 |
REGULATION OF ADAPTIVE IMMUNE CELLS BY SIRTUINS |
| 5411 |
REGULATION OF AIRWAY MUCIN GENE EXPRESSION |
| 5412 |
REGULATION OF ANTITUMOR IMMUNITY BY INFLAMMATION-INDUCED EPIGENETIC ALTERATIONS |
| 5413 |
REGULATION OF CAR AND PXR EXPRESSION IN HEALTH AND DISEASE |
| 5414 |
REGULATION OF CD8(+) T MEMORY AND EXHAUSTION BY THE MTOR SIGNALS |
| 5415 |
REGULATION OF CELLULAR IMMUNE RESPONSES IN SEPSIS BY HISTONE MODIFICATIONS |
| 5416 |
REGULATION OF CELLULAR METABOLISM: PROGRAMMING AND MAINTAINING METABOLIC HOMEOSTASIS |
| 5417 |
REGULATION OF DNA METHYLATION IN RHEUMATOID ARTHRITIS SYNOVIOCYTES |
| 5418 |
REGULATION OF DNA METHYLATION SIGNATURES ON NF-KAPPAB AND STAT3 PATHWAY GENES AND TET ACTIVITY IN CIGARETTE SMOKE EXTRACT-CHALLENGED CELLS/COPD EXACERBATION MODEL IN VITRO |
| 5419 |
REGULATION OF GENE EXPRESSION AND PAIN STATES BY EPIGENETIC MECHANISMS |
| 5420 |
REGULATION OF HYPOXIA-INDUCIBLE FACTOR IN KIDNEY DISEASE |
| 5421 |
REGULATION OF INTERLEUKIN-23 EXPRESSION IN HEALTH AND DISEASE |
| 5422 |
REGULATION OF LUNG EPITHELIAL CELL SENESCENCE IN SMOKING-INDUCED COPD/EMPHYSEMA BY MICROR-125A-5P VIA SP1 MEDIATION OF SIRT1/HIF-1A |
| 5423 |
REGULATION OF MACROPHAGE ACTIVATION AND DIFFERENTIATION IN ATHEROSCLEROSIS |
| 5424 |
REGULATION OF MONOCYTE-MACROPHAGE RESPONSES IN CIRRHOSIS-ROLE OF INNATE IMMUNE PROGRAMMING AND CHECKPOINT RECEPTORS |
| 5425 |
REGULATION OF MYELOPOIESIS BY THE TRANSCRIPTION FACTOR IRF8 |
| 5426 |
REGULATION OF SIRTUIN EXPRESSION IN AUTOIMMUNE NEUROINFLAMMATION: INDUCTION OF SIRT1 IN OLIGODENDROCYTE PROGENITOR CELLS |
| 5427 |
REGULATION OF SOCIAL STRESS AND NEURAL DEGENERATION BY ACTIVITY-REGULATED GENES AND EPIGENETIC MECHANISMS IN DOPAMINERGIC NEURONS |
| 5428 |
REGULATION OF STRESS-INDUCED HEMATOPOIESIS |
| 5429 |
REGULATION OF TYPE I INTERFERON RESPONSES |
| 5430 |
REGULATORS INVOLVED IN TROPHOBLAST SYNCYTIALIZATION IN THE PLACENTA OF INTRAUTERINE GROWTH RESTRICTION |
| 5431 |
REGULATORY T CELLS: PATHOPHYSIOLOGICAL ROLES AND CLINICAL APPLICATIONS |
| 5432 |
REJUVENATION OF MESENCHYMAL STEM CELLS TO AMELIORATE SKELETAL AGING |
| 5433 |
REL/NF-KAPPA B/I KAPPA B SIGNAL TRANSDUCTION IN THE GENERATION AND TREATMENT OF HUMAN CANCER |
| 5434 |
RELATIONSHIP BETWEEN ENVIRONMENTAL EXPOSURES IN CHILDREN AND ADULT LUNG DISEASE: THE CASE FOR OUTDOOR EXPOSURES |
| 5435 |
RELATIVE ROLE OF METHYLATOR AND TUMOR SUPPRESSOR PATHWAYS IN ULCERATIVE COLITIS-ASSOCIATED COLON CANCER |
| 5436 |
REM SLEEP AND ITS LOSS-ASSOCIATED EPIGENETIC REGULATION WITH REFERENCE TO NORADRENALINE IN PARTICULAR |
| 5437 |
REMOTE HIND-LIMB ISCHEMIA MECHANISM OF PRESERVED EJECTION FRACTION DURING HEART FAILURE |
| 5438 |
REMOVAL OF EPIGENETIC REPRESSIVE MARK ON INFLAMMATORY GENES IN FAT LIVER |
| 5439 |
RENAL CONSEQUENCES OF PRETERM BIRTH |
| 5440 |
RENAL DIFFERENTIATION OF AMNIOTIC FLUID STEM CELLS: PERSPECTIVES FOR CLINICAL APPLICATION AND FOR STUDIES ON SPECIFIC HUMAN GENETIC DISEASES |
| 5441 |
RENAL ISCHEMIA ALTERS THE TRANSCRIPTOMIC AND EPIGENETIC PROFILE OF INFLAMMATORY GENES IN SWINE SCATTERED TUBULAR-LIKE CELLS |
| 5442 |
RENIN-ANGIOTENSIN BLOCKADE RESETS PODOCYTE EPIGENOME THROUGH KRUPPEL-LIKE FACTOR 4 AND ATTENUATES PROTEINURIA |
| 5443 |
REPEATED METHAMPHETAMINE AND MODAFINIL INDUCE DIFFERENTIAL COGNITIVE EFFECTS AND SPECIFIC HISTONE ACETYLATION AND DNA METHYLATION PROFILES IN THE MOUSE MEDIAL PREFRONTAL CORTEX |
| 5444 |
REPEATED TOLUENE EXPOSURE MODIFIES THE ACETYLATION PATTERN OF HISTONES H3 AND H4 IN THE RAT BRAIN |
| 5445 |
REPEATED VAPOR ETHANOL EXPOSURE INDUCES TRANSIENT HISTONE MODIFICATIONS IN THE BRAIN THAT ARE MODIFIED BY GENOTYPE AND BRAIN REGION |
| 5446 |
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION REDUCES DEPRESSIVE-LIKE BEHAVIORS, MODIFIES DENDRITIC PLASTICITY, AND GENERATES GLOBAL EPIGENETIC CHANGES IN THE FRONTAL CORTEX AND HIPPOCAMPUS IN A RODENT MODEL OF CHRONIC STRESS |
| 5447 |
REPOSITIONING LIDOCAINE AS AN ANTICANCER DRUG: THE ROLE BEYOND ANESTHESIA |
| 5448 |
REPRESSION OF HDAC5 BY ACETATE RESTORES HYPOTHALAMIC-PITUITARY-OVARIAN FUNCTION IN TYPE 2 DIABETES MELLITUS |
| 5449 |
REPRESSION OF THE ANTIOXIDANT NRF2 PATHWAY IN PREMATURE AGING |
| 5450 |
REPRODUCTIVE TOXICITY OF COMBINED EFFECTS OF ENDOCRINE DISRUPTORS ON HUMAN REPRODUCTION |
| 5451 |
REPROGRAMMING CELLS FROM GULF WAR VETERANS INTO NEURONS TO STUDY GULF WAR ILLNESS |
| 5452 |
REPROGRAMMING DNA METHYLATION IN THE PREIMPLANTATION STAGE: PEEPING WITH DOLLY'S EYES |
| 5453 |
REPROGRAMMING OF COPD LUNG FIBROBLASTS THROUGH FORMATION OF INDUCED PLURIPOTENT STEM CELLS |
| 5454 |
REPURPOSING BELINOSTAT FOR ALLEVIATION OF ATOPIC DERMATITIS |
| 5455 |
RESCUE OF A PRIMARY MYELOFIBROSIS MODEL BY RETINOID-ANTAGONIST THERAPY |
| 5456 |
RESEARCH ADVANCES ON DNA METHYLATION IN IDIOPATHIC PULMONARY FIBROSIS |
| 5457 |
RESEARCH AND THE PROMOTION OF CHILD HEALTH: A POSITION PAPER OF THE EUROPEAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY, AND NUTRITION |
| 5458 |
RESEARCH ON EPIGENETIC MECHANISM OF SFRP2 IN ADVANCED CHRONIC MYELOID LEUKEMIA |
| 5459 |
RESEARCH ON THE EPIGENETIC REGULATION MECHANISM OF THE PTPN6 GENE IN ADVANCED CHRONIC MYELOID LEUKAEMIA |
| 5460 |
RESEARCH PERSPECTIVES ON THE REGULATION AND PHYSIOLOGICAL FUNCTIONS OF FGF21 AND ITS ASSOCIATION WITH NAFLD |
| 5461 |
RESEARCH PROGRESS OF BAP1 IN STRUCTURE, FUNCTION, AND CANCER |
| 5462 |
RESEARCH PROGRESS ON EPIGENETICS OF SMALL B-CELL LYMPHOMA |
| 5463 |
RESIDENTIAL PM(2 |
| 5464 |
RESILIENCE IN LONG-TERM VIRAL INFECTION: GENETIC DETERMINANTS AND INTERACTIONS |
| 5465 |
RESILIENCE TO STRESS: LESSONS FROM RODENTS ABOUT NATURE VERSUS NURTURE |
| 5466 |
RESILIENCE: SAFETY IN THE AFTERMATH OF TRAUMATIC STRESSOR EXPERIENCES |
| 5467 |
RESILIENT PHENOTYPE IN CHRONIC MILD STRESS PARADIGM IS ASSOCIATED WITH ALTERED EXPRESSION LEVELS OF MIR-18A-5P AND SEROTONIN 5-HT(1A) RECEPTOR IN DORSAL PART OF THE HIPPOCAMPUS |
| 5468 |
RESISTANCE TRAINING AND REDOX HOMEOSTASIS: CORRELATION WITH AGE-ASSOCIATED GENOMIC CHANGES |
| 5469 |
RESOLUTION OF INFLAMMATION AS A NOVEL CHEMOPREVENTIVE STRATEGY |
| 5470 |
RESOLVING THE ENIGMA OF THE MESOAMERICAN NEPHROPATHY: A RESEARCH WORKSHOP SUMMARY |
| 5471 |
RESPIRATORY MUSCLE SENESCENCE IN AGEING AND CHRONIC LUNG DISEASES |
| 5472 |
RESPIRATORY VIRAL INFECTIONS IN EXACERBATION OF CHRONIC AIRWAY INFLAMMATORY DISEASES: NOVEL MECHANISMS AND INSIGHTS FROM THE UPPER AIRWAY EPITHELIUM |
| 5473 |
RESPONSES OF PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS TO METHOTREXATE: A GENOMIC OUTLOOK |
| 5474 |
RESTORATION OF HISTONE ACETYLATION AMELIORATES DISEASE AND METABOLIC ABNORMALITIES IN A FUS MOUSE MODEL |
| 5475 |
RESTORING MLL REACTIVATES LATENT TUMOR SUPPRESSION-MEDIATED VULNERABILITY TO PROTEASOME INHIBITORS |
| 5476 |
RESTORING T CELL TOLERANCE, EXPLORING THE POTENTIAL OF HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS |
| 5477 |
RESTORING THE FUNCTIONAL IMMUNOGENICITY OF CHRONIC LYMPHOCYTIC LEUKEMIA USING EPIGENETIC MODIFIERS |
| 5478 |
RESULTS OF A RANDOMIZED STUDY OF 3 SCHEDULES OF LOW-DOSE DECITABINE IN HIGHER-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 5479 |
RESVERATROL ATTENUATES CIGARETTE SMOKE EXTRACT INDUCED CELLULAR SENESCENCE IN HUMAN AIRWAY EPITHELIAL CELLS BY REGULATING THE MIR-34A/SIRT1/NF-KAPPAB PATHWAY |
| 5480 |
RESVERATROL REVERSES MORPHINE-INDUCED NEUROINFLAMMATION IN MORPHINE-TOLERANT RATS BY REVERSAL HDAC1 EXPRESSION |
| 5481 |
RESVERATROL-INDUCED APOPTOSIS DEPENDS ON THE LIPID KINASE ACTIVITY OF VPS34 AND ON THE FORMATION OF AUTOPHAGOLYSOSOMES |
| 5482 |
RETHINKING GENETIC MODELS OF ASTHMA: THE ROLE OF ENVIRONMENTAL MODIFIERS |
| 5483 |
RETRACTION |
| 5484 |
REVEALING THE PATHOGENIC AND AGING-RELATED MECHANISMS OF THE ENIGMATIC IDIOPATHIC PULMONARY FIBROSIS |
| 5485 |
REVERSAL OF COCAINE-CONDITIONED PLACE PREFERENCE THROUGH METHYL SUPPLEMENTATION IN MICE: ALTERING GLOBAL DNA METHYLATION IN THE PREFRONTAL CORTEX |
| 5486 |
REVERSE INFLAMMAGING: LONG-TERM EFFECTS OF HCV CURE ON BIOLOGICAL AGE |
| 5487 |
REVERSIBLE ALTERATION IN THE EXPRESSION OF THE GAP JUNCTIONAL PROTEIN CONNEXIN 32 DURING TUMOR PROMOTION IN RAT LIVER AND ITS ROLE DURING CELL PROLIFERATION |
| 5488 |
REVERSING HEPATOCELLULAR CARCINOMA PROGRESSION BY USING NETWORKED BIOLOGICAL THERAPIES |
| 5489 |
REVERSING POST-INFECTIOUS EPIGENETIC-MEDIATED IMMUNE SUPPRESSION |
| 5490 |
REVERSING T-CELL EXHAUSTION IN IMMUNOTHERAPY: A REVIEW ON CURRENT APPROACHES AND LIMITATIONS |
| 5491 |
REVIEW ARTICLE: INFLAMMATION-RELATED PROMOTION OF GASTROINTESTINAL CARCINOGENESIS--A PERIGENETIC PATHWAY |
| 5492 |
REVIEW OF ARSENIC TOXICITY, SPECIATION AND POLYADENYLATION OF CANONICAL HISTONES |
| 5493 |
REVIEW OF IN VITRO TEST SYSTEMS USING DNA DAMAGE AND REPAIR FOR SCREENING OF CHEMICAL CARCINOGENS |
| 5494 |
REVIEW OF THE MOLECULAR MECHANISMS IN WOUND HEALING: NEW THERAPEUTIC TARGETS? THE RESTORATION OF THE SKIN BARRIER IN ACUTE AND CHRONIC WOUNDS IS CONTROLLED BY SEVERAL MOLECULAR MECHANISMS THAT SYNERGISTICALLY REGULATE CELL KINETICS, ENZYMATIC FUNCTIONS, AND NEUROVASCULAR ACTIVATION |
| 5495 |
REVIEW ON CIRCULAR RNAS AND NEW INSIGHTS INTO THEIR ROLES IN CANCER |
| 5496 |
REVIEW SHOWS THAT EARLY FOETAL ALCOHOL EXPOSURE MAY CAUSE ADVERSE EFFECTS EVEN WHEN THE MOTHER CONSUMES LOW LEVELS |
| 5497 |
REVIEW: ANIMAL MODELS OF ACQUIRED EPILEPSY: INSIGHTS INTO MECHANISMS OF HUMAN EPILEPTOGENESIS |
| 5498 |
REVIEW: DNA METHYLATION AND ALCOHOL USE DISORDERS: PROGRESS AND CHALLENGES |
| 5499 |
REVIEW: RECENT CLINICAL TRIALS IN EPIGENETIC THERAPY |
| 5500 |
REVISITING MIGRAINE: THE EVOLVING PATHOPHYSIOLOGY AND THE EXPANDING MANAGEMENT ARMAMENTARIUM |
| 5501 |
REWRITING THE EPIGENETIC CODE FOR TUMOR RESENSITIZATION: A REVIEW |
| 5502 |
RGFP109, A HISTONE DEACETYLASE INHIBITOR ATTENUATES L-DOPA-INDUCED DYSKINESIA IN THE MPTP-LESIONED MARMOSET: A PROOF-OF-CONCEPT STUDY |
| 5503 |
RGS9-2--CONTROLLED ADAPTATIONS IN THE STRIATUM DETERMINE THE ONSET OF ACTION AND EFFICACY OF ANTIDEPRESSANTS IN NEUROPATHIC PAIN STATES |
| 5504 |
RHEIN REVERSAL OF DNA HYPERMETHYLATION-ASSOCIATED KLOTHO SUPPRESSION AMELIORATES RENAL FIBROSIS IN MICE |
| 5505 |
RHEUMATOID ARTHRITIS AND ALZHEIMER'S DISEASE: GENETIC AND EPIGENETIC LINKS IN INFLAMMATORY REGULATION |
| 5506 |
RHEUMATOID ARTHRITIS AND PRIMARY BILIARY CIRRHOSIS: CAUSE, CONSEQUENCE, OR COINCIDENCE? PRIMARY BILIARY CIRRHOSIS (PBC) IS A PROGRESSIVE CHOLESTATIC LIVER DISEASE CHARACTERIZED SEROLOGICALLY BY CHOLESTASIS AND THE PRESENCE OF HIGH-TITRE ANTIMITOCHONDRIAL ANTIBODIES AND HISTOLOGICALLY BY CHRONIC NONSUPPURATIVE CHOLANGITIS AND GRANULOMATA |
| 5507 |
RHEUMATOID ARTHRITIS PROGRESSION MEDIATED BY ACTIVATED SYNOVIAL FIBROBLASTS |
| 5508 |
RHOA/RHO-KINASES IN ASTHMA: FROM PATHOGENESIS TO THERAPEUTIC TARGETS |
| 5509 |
RHPLD2 INHIBITS AIRWAY INFLAMMATION IN AN ASTHMATIC MURINE MODEL THROUGH INDUCTION OF STABLE CD25(+) FOXP3(+) TREGS |
| 5510 |
RIBAVIRIN RESTORES IFNALPHA RESPONSIVENESS IN HCV-INFECTED LIVERS BY EPIGENETIC REMODELLING AT INTERFERON STIMULATED GENES |
| 5511 |
RIBONUCLEASES IN TUMOR GROWTH |
| 5512 |
RICHTER SYNDROME IN CHRONIC LYMPHOCYTIC LEUKEMIA: UPDATES ON BIOLOGY, CLINICAL FEATURES AND THERAPY |
| 5513 |
RICHTER SYNDROME: NOVEL INSIGHTS INTO THE BIOLOGY OF TRANSFORMATION |
| 5514 |
RICHTER'S SYNDROME: BIOLOGY AND THERAPY |
| 5515 |
RILUZOLE ADMINISTRATION TO RATS WITH LEVODOPA-INDUCED DYSKINESIA LEADS TO LOSS OF DNA METHYLATION IN NEURONAL GENES |
| 5516 |
RISE OF THE MUTANTS: REPORT FROM THE 19TH CONFERENCE OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, MILAN, 12-15 JUNE 2014 |
| 5517 |
RISK FACTOR ASSESSMENT OF RHEUMATOID ARTHRITIS IN NORTH KERALA |
| 5518 |
RISK FACTORS AND FUTURE DIRECTIONS FOR PREVENTING AND DIAGNOSING EXERTIONAL RHABDOMYOLYSIS |
| 5519 |
RISK FACTORS FOR ALZHEIMER'S DISEASE: ROLE OF MULTIPLE ANTIOXIDANTS, NON-STEROIDAL ANTI-INFLAMMATORY AND CHOLINERGIC AGENTS ALONE OR IN COMBINATION IN PREVENTION AND TREATMENT |
| 5520 |
RISK FACTORS OF POSTPARTUM DEPRESSION |
| 5521 |
RISK OF HEPATOCELLULAR CARCINOMA AFTER HCV CLEARANCE BY DIRECT-ACTING ANTIVIRALS TREATMENT PREDICTIVE FACTORS AND ROLE OF EPIGENETICS |
| 5522 |
RISK OF OCCUPATIONAL EXPOSURE TO ASBESTOS, SILICON AND ARSENIC ON PULMONARY DISORDERS: UNDERSTANDING THE GENETIC-EPIGENETIC INTERPLAY AND FUTURE PROSPECTS |
| 5523 |
RISKS AND MECHANISMS OF ONCOLOGICAL DISEASE FOLLOWING STEM CELL TRANSPLANTATION |
| 5524 |
RISKY FAMILY CLIMATES PRESAGE INCREASED CELLULAR AGING IN YOUNG ADULTHOOD |
| 5525 |
RNA BINDING PROTEINS IN SENESCENCE: A POTENTIAL COMMON LINKER FOR AGE-RELATED DISEASES? AGING REPRESENTS THE MAJOR RISK FACTOR FOR THE ONSET AND/OR PROGRESSION OF VARIOUS DISORDERS INCLUDING NEURODEGENERATIVE DISEASES, METABOLIC DISORDERS, AND BONE-RELATED DEFECTS |
| 5526 |
RNA EDITING IN MESOTHELIOMA: A LOOK FORWARD |
| 5527 |
RNA HELICASE DEAD BOX PROTEIN 5 REGULATES POLYCOMB REPRESSIVE COMPLEX 2/HOX TRANSCRIPT ANTISENSE INTERGENIC RNA FUNCTION IN HEPATITIS B VIRUS INFECTION AND HEPATOCARCINOGENESIS |
| 5528 |
RNA MODIFICATION IN INFLAMMATORY BOWEL DISEASES |
| 5529 |
RNA N(6) -METHYLADENOSINE MODIFICATIONS AND POTENTIAL TARGETED THERAPEUTIC STRATEGIES IN KIDNEY DISEASE |
| 5530 |
RNA-SEQ IMPLICATES DEREGULATION OF THE IMMUNE SYSTEM IN THE PATHOGENESIS OF DIVERTICULITIS |
| 5531 |
RNAI THERAPEUTICS: AN ANTIVIRAL STRATEGY FOR HUMAN INFECTIONS |
| 5532 |
RODENT MODELS OF GROUP 1 PULMONARY HYPERTENSION |
| 5533 |
ROLE AND MECHANISM OF DNA METHYLATION AND ITS INHIBITORS IN HEPATIC FIBROSIS |
| 5534 |
ROLE OF AIRWAY EPITHELIAL CELLS IN THE DEVELOPMENT OF DIFFERENT ASTHMA PHENOTYPES |
| 5535 |
ROLE OF BRD4 PHOSPHORYLATION IN THE NUCLEUS ACCUMBENS IN RELAPSE TO COCAINE-SEEKING BEHAVIOR IN MICE |
| 5536 |
ROLE OF C-MIR-21, C-MIR-126, REDOX STATUS, AND INFLAMMATORY CONDITIONS AS POTENTIAL PREDICTORS OF VASCULAR DAMAGE IN T2DM PATIENTS |
| 5537 |
ROLE OF CALCITONIN GENE-RELATED PEPTIDE IN LIGHT-AVERSIVE BEHAVIOR: IMPLICATIONS FOR MIGRAINE |
| 5538 |
ROLE OF CHRONIC ALCOHOLISM CAUSING CANCER IN OMNIVORES AND VEGETARIANS THROUGH EPIGENETIC MODIFICATIONS |
| 5539 |
ROLE OF CYSTIC FIBROSIS BRONCHIAL EPITHELIUM IN NEUTROPHIL CHEMOTAXIS |
| 5540 |
ROLE OF DIET AND GUT MICROBIOTA ON COLORECTAL CANCER IMMUNOMODULATION |
| 5541 |
ROLE OF DIETARY PHENOLS IN MITIGATING MICROGLIA-MEDIATED NEUROINFLAMMATION |
| 5542 |
ROLE OF DNA METHYLATION ON HUMAN CTSG IN DERMATOMYOSITIC MYOIDEUM |
| 5543 |
ROLE OF ENDOGENOUS GLUCOCORTICOIDS IN CANCER IN THE ELDERLY |
| 5544 |
ROLE OF EPIGENETIC ABNORMALITIES AND INTERVENTION IN OBSTRUCTIVE SLEEP APNEA TARGET ORGANS |
| 5545 |
ROLE OF EPIGENETIC MECHANISMS IN CHRONIC PAIN |
| 5546 |
ROLE OF EPIGENETIC MECHANISMS IN THE DEVELOPMENT OF CHRONIC COMPLICATIONS OF DIABETES |
| 5547 |
ROLE OF EPIGENETIC MODIFICATION IN INTERFERON TREATMENT OF HEPATITIS B VIRUS INFECTION |
| 5548 |
ROLE OF EPIGENETIC REPROGRAMMING OF HOST GENES IN BACTERIAL PATHOGENESIS |
| 5549 |
ROLE OF EPIGENETICS IN CHRONIC MYELOID LEUKEMIA |
| 5550 |
ROLE OF EPIGENETICS IN INFLAMMATION-ASSOCIATED DISEASES |
| 5551 |
ROLE OF EPIGENETICS IN MODULATION OF IMMUNE RESPONSE AT THE JUNCTION OF HOST-PATHOGEN INTERACTION AND DANGER MOLECULE SIGNALING |
| 5552 |
ROLE OF EPIGENETICS IN THE PATHOGENESIS OF ASTHMA |
| 5553 |
ROLE OF EPIGENETICS IN THE PATHOGENESIS OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS |
| 5554 |
ROLE OF EPIGENETICS IN TRANSFORMATION OF INFLAMMATION INTO COLORECTAL CANCER |
| 5555 |
ROLE OF FLUORIDE INDUCED EPIGENETIC ALTERATIONS IN THE DEVELOPMENT OF SKELETAL FLUOROSIS |
| 5556 |
ROLE OF FLUORIDE INDUCED HISTONE TRIMETHYLATION IN DEVELOPMENT OF SKELETAL FLUOROSIS |
| 5557 |
ROLE OF GENOMIC INSTABILITY IN ARSENIC-INDUCED CARCINOGENICITY |
| 5558 |
ROLE OF GUT MICROBIOTA IN THE AETIOLOGY OF OBESITY: PROPOSED MECHANISMS AND REVIEW OF THE LITERATURE |
| 5559 |
ROLE OF HIPPOCAMPAL CIRCKCNK9 IN VISCERAL HYPERSENSITIVITY AND ANXIETY COMORBIDITY OF IRRITABLE BOWEL SYNDROME |
| 5560 |
ROLE OF HISTONE DEACETYLASE 2 IN EPIGENETICS AND CELLULAR SENESCENCE: IMPLICATIONS IN LUNG INFLAMMAGING AND COPD |
| 5561 |
ROLE OF HISTONE DEACETYLASES IN MONOCYTE FUNCTION IN HEALTH AND CHRONIC INFLAMMATORY DISEASES |
| 5562 |
ROLE OF HISTONE DEACETYLASES IN PANCREAS: IMPLICATIONS FOR PATHOGENESIS AND THERAPY |
| 5563 |
ROLE OF HISTONE POST-TRANSLATIONAL MODIFICATIONS IN INFLAMMATORY DISEASES |
| 5564 |
ROLE OF HYPERMETHYLATION OF DAP-KINASE CPG ISLAND IN THE DEVELOPMENT OF THYROID LYMPHOMA |
| 5565 |
ROLE OF HYPOXIA IN PROGRESSIVE CHRONIC KIDNEY DISEASE AND IMPLICATIONS FOR THERAPY |
| 5566 |
ROLE OF INFLAMMATION IN THE DEVELOPMENT OF COLORECTAL CANCER |
| 5567 |
ROLE OF LNCRNAS IN REMODELING OF THE CORONARY ARTERY PLAQUES IN PATIENTS WITH ATHEROSCLEROSIS |
| 5568 |
ROLE OF MARIJUANA COMPONENTS ON THE REGENERATIVE ABILITY OF STEM CELLS |
| 5569 |
ROLE OF MATERNAL VITAMINS IN PROGRAMMING HEALTH AND CHRONIC DISEASE |
| 5570 |
ROLE OF MELATONIN IN METABOLIC REGULATION |
| 5571 |
ROLE OF MICRORNA 1207-5P AND ITS HOST GENE, THE LONG NON-CODING RNA PVT1, AS MEDIATORS OF EXTRACELLULAR MATRIX ACCUMULATION IN THE KIDNEY: IMPLICATIONS FOR DIABETIC NEPHROPATHY |
| 5572 |
ROLE OF MICRORNA IN DIABETIC CARDIOMYOPATHY: FROM MECHANISM TO INTERVENTION |
| 5573 |
ROLE OF MICRORNA IN SEVERE ASTHMA |
| 5574 |
ROLE OF MICRORNA-143 IN NERVE INJURY-INDUCED UPREGULATION OF DNMT3A EXPRESSION IN PRIMARY SENSORY NEURONS |
| 5575 |
ROLE OF MICRORNAS IN SIGNALING PATHWAYS ASSOCIATED WITH THE PATHOGENESIS OF IDIOPATHIC PULMONARY FIBROSIS: A FOCUS ON EPITHELIAL-MESENCHYMAL TRANSITION |
| 5576 |
ROLE OF MICRORNAS IN THE PATHOGENESIS OF DIABETIC CARDIOMYOPATHY |
| 5577 |
ROLE OF MICRORNAS IN THE PATHOPHYSIOLOGY OF ADDICTION |
| 5578 |
ROLE OF MIRNA IN THE TRANSMISSION OF METABOLIC DISEASES ASSOCIATED WITH PATERNAL DIET-INDUCED OBESITY |
| 5579 |
ROLE OF MORPHINE, MIR-212/132 AND MU OPIOID RECEPTOR IN THE REGULATION OF BDNF IN ZEBRAFISH EMBRYOS |
| 5580 |
ROLE OF NEUROTOXICANTS IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE: A MECHANISTIC INSIGHT |
| 5581 |
ROLE OF NF-KAPPAB IN AGEING AND AGE-RELATED DISEASES: LESSONS FROM GENETICALLY MODIFIED MOUSE MODELS |
| 5582 |
ROLE OF NITRATIVE AND OXIDATIVE DNA DAMAGE IN INFLAMMATION-RELATED CARCINOGENESIS |
| 5583 |
ROLE OF NON-CODING RNAS IN NON-AGING-RELATED NEUROLOGICAL DISORDERS |
| 5584 |
ROLE OF OBESITY IN FEMALE REPRODUCTION |
| 5585 |
ROLE OF OXIDATIVE STRESS AND GENETIC POLYMORPHISM OF MATRIX METALLOPROTEINASE-2 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 IN COPD |
| 5586 |
ROLE OF PERSONALIZED NUTRITION IN CHRONIC-DEGENERATIVE DISEASES |
| 5587 |
ROLE OF S-ADENOSYLHOMOCYSTEINE IN CARDIOVASCULAR DISEASE AND ITS POTENTIAL EPIGENETIC MECHANISM |
| 5588 |
ROLE OF SENESCENCE IN THE CHRONIC HEALTH CONSEQUENCES OF COVID-19 |
| 5589 |
ROLE OF SIRT1 IN THE GROWTH AND REGULATION OF NORMAL HEMATOPOIETIC AND LEUKEMIA STEM CELLS |
| 5590 |
ROLE OF THE BICARBONATE-RESPONSIVE SOLUBLE ADENYLYL CYCLASE IN CHOLANGIOCYTE APOPTOSIS IN PRIMARY BILIARY CHOLANGITIS; A NEW HYPOTHESIS |
| 5591 |
ROLE OF THE EPIGENETIC FACTOR SIRT7 IN NEUROINFLAMMATION AND NEUROGENESIS |
| 5592 |
ROLE OF TUMOR NECROSIS FACTOR-ALPHA IN THE HUMAN SYSTEMIC ENDOTOXIN-INDUCED TRANSCRIPTOME |
| 5593 |
ROLE, FUNCTION AND REGULATION OF THE THYMOCYTE SELECTION-ASSOCIATED HIGH MOBILITY GROUP BOX PROTEIN IN CD8(+) T CELL EXHAUSTION |
| 5594 |
ROLES OF AIM2 GENE AND AIM2 INFLAMMASOME IN THE PATHOGENESIS AND TREATMENT OF PSORIASIS |
| 5595 |
ROLES OF GENETIC PREDISPOSITION IN THE SEX BIAS OF PULMONARY PATHOPHYSIOLOGY, AS A FUNCTION OF ESTROGENS : SEX MATTERS IN THE PREVALENCE OF LUNG DISEASES |
| 5596 |
ROLES OF HISTONE ACETYLATION MODIFIERS AND OTHER EPIGENETIC REGULATORS IN VASCULAR CALCIFICATION |
| 5597 |
ROLES OF MIR-432 AND CIRC_0000418 IN MEDIATING THE ANTI-DEPRESSANT ACTION OF ADAR1 |
| 5598 |
ROLES OF NON-CODING RNA IN ALZHEIMER'S DISEASE PATHOPHYSIOLOGY |
| 5599 |
ROLES OF THE NEURON-RESTRICTIVE SILENCER FACTOR IN THE PATHOPHYSIOLOGICAL PROCESS OF THE CENTRAL NERVOUS SYSTEM |
| 5600 |
ROLES OF VOLTAGE-DEPENDENT SODIUM CHANNELS IN NEURONAL DEVELOPMENT, PAIN, AND NEURODEGENERATION |
| 5601 |
RORALPHA IS CRUCIAL FOR ATTENUATED INFLAMMATORY RESPONSE TO MAINTAIN INTESTINAL HOMEOSTASIS |
| 5602 |
RORGAMMAT(+) HEMATOPOIETIC CELLS ARE NECESSARY FOR TUMOR CELL PROLIFERATION DURING COLITIS-ASSOCIATED TUMORIGENESIS IN MICE |
| 5603 |
ROS PROMOTE HYPER-METHYLATION OF NDRG2 PROMOTERS IN A DNMTS-DEPENDENT MANNER: CONTRIBUTES TO THE PROGRESSION OF RENAL FIBROSIS |
| 5604 |
ROSAVIN AMELIORATES HEPATIC INFLAMMATION AND FIBROSIS IN THE NASH RAT MODEL VIA TARGETING HEPATIC CELL DEATH |
| 5605 |
ROUTINE ASSESSMENT AND PROMOTION OF PHYSICAL ACTIVITY IN HEALTHCARE SETTINGS: A SCIENTIFIC STATEMENT FROM THE AMERICAN HEART ASSOCIATION |
| 5606 |
RPPA-BASED PROTEOMICS RECOGNIZES DISTINCT EPIGENETIC SIGNATURES IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH CLINICAL CONSEQUENCES |
| 5607 |
RSV-INDUCED H3K4 DEMETHYLASE KDM5B LEADS TO REGULATION OF DENDRITIC CELL-DERIVED INNATE CYTOKINES AND EXACERBATES PATHOGENESIS IN VIVO |
| 5608 |
RUNX1-EVI1 DISRUPTS LINEAGE DETERMINATION AND THE CELL CYCLE BY INTERFERING WITH RUNX1 AND EVI1 DRIVEN GENE REGULATORY NETWORKS |
| 5609 |
S-ADENOSYLMETHIONINE DECREASES THE PEAK BLOOD ALCOHOL LEVELS 3 H AFTER AN ACUTE BOLUS OF ETHANOL BY INDUCING ALCOHOL METABOLIZING ENZYMES IN THE LIVER |
| 5610 |
S100A4/TCF COMPLEX TRANSCRIPTION REGULATION DRIVES EPITHELIAL-MESENCHYMAL TRANSITION IN CHRONIC SINUSITIS THROUGH WNT/GSK-3BETA/BETA-CATENIN SIGNALING |
| 5611 |
S100A8 AND S100A12 PROTEINS AS BIOMARKERS OF HIGH DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS THAT CAN BE REGULATED BY EPIGENETIC DRUGS |
| 5612 |
SAFETY AND ACTIVITY OF RRX-001 IN PATIENTS WITH ADVANCED CANCER: A FIRST-IN-HUMAN, OPEN-LABEL, DOSE-ESCALATION PHASE 1 STUDY |
| 5613 |
SAFETY AND EFFICACY OF ABEXINOSTAT, A PAN-HISTONE DEACETYLASE INHIBITOR, IN NON-HODGKIN LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A PHASE II STUDY |
| 5614 |
SAFETY AND EFFICACY OF EPIGENETICALLY CONVERTED HUMAN FIBROBLASTS INTO INSULIN-SECRETING CELLS: A PRECLINICAL STUDY |
| 5615 |
SAHA INHIBITS SOMATIC HYPERALGESIA INDUCED BY STRESS COMBINED WITH OROFACIAL INFLAMMATION THROUGH TARGETING DIFFERENT SPINAL 5-HT RECEPTOR SUBTYPES |
| 5616 |
SAMUL-TANG AMELIORATES OOCYTE DAMAGE DUE TO CYCLOPHOSPHAMIDE-INDUCED CHRONIC OVARIAN DYSFUNCTION IN MICE |
| 5617 |
SARCOSINE SUPPRESSES EPILEPTOGENESIS IN RATS WITH EFFECTS ON HIPPOCAMPAL DNA METHYLATION |
| 5618 |
SARS-COV-2 INTERACTION WITH HUMAN DNA METHYL TRANSFERASE 1: A POTENTIAL RISK FOR INCREASING THE INCIDENCE OF LATER CHRONIC DISEASES IN THE SURVIVED PATIENTS |
| 5619 |
SCALING UP PRENATAL NUTRITION COULD REDUCE THE GLOBAL BURDEN OF NONCOMMUNICABLE DISEASES IN THE NEXT GENERATION: A MODELING ANALYSIS |
| 5620 |
SCHRODINGER'S T CELLS: MOLECULAR INSIGHTS INTO STEMNESS AND EXHAUSTION |
| 5621 |
SCREENING METHYLATION OF DNA REPAIR GENES IN THE ORAL MUCOSA OF CHRONIC SMOKERS |
| 5622 |
SEARCH FOR USEFUL BIOMARKERS IN HEPATOCELLULAR CARCINOMA, TUMOR FACTORS AND BACKGROUND LIVER FACTORS (REVIEW) |
| 5623 |
SECOND-HAND SMOKE AND HUMAN LUNG CANCER |
| 5624 |
SELECTIVE BOOSTING OF TRANSCRIPTIONAL AND BEHAVIORAL RESPONSES TO DRUGS OF ABUSE BY HISTONE DEACETYLASE INHIBITION |
| 5625 |
SELECTIVE CLASS I HISTONE DEACETYLASE INHIBITORS SUPPRESS PERSISTENT SPONTANEOUS NOCICEPTION AND THERMAL HYPERSENSITIVITY IN A RAT MODEL OF BEE VENOM-INDUCED INFLAMMATORY PAIN |
| 5626 |
SELECTIVE REPRESSION OF GENE EXPRESSION IN NEUROPATHIC PAIN BY THE NEURON-RESTRICTIVE SILENCING FACTOR/REPRESSOR ELEMENT-1 SILENCING TRANSCRIPTION (NRSF/REST) |
| 5627 |
SELECTIVE TARGETING OF THE STRESS CHAPEROME AS A THERAPEUTIC STRATEGY |
| 5628 |
SEMEN ABNORMALITIES, SPERM DNA DAMAGE AND GLOBAL HYPERMETHYLATION IN HEALTH WORKERS OCCUPATIONALLY EXPOSED TO IONIZING RADIATION |
| 5629 |
SENESCENCE IN COPD AND ITS COMORBIDITIES |
| 5630 |
SENESCENCE IN PULMONARY FIBROSIS: BETWEEN AGING AND EXPOSURE |
| 5631 |
SENESCENCE-INFLAMMATORY REGULATION OF REPARATIVE CELLULAR REPROGRAMMING IN AGING AND CANCER |
| 5632 |
SENESCENT CELLS: SASPECTED DRIVERS OF AGE-RELATED PATHOLOGIES |
| 5633 |
SENESCENT REMODELING OF THE INNATE AND ADAPTIVE IMMUNE SYSTEM IN THE ELDERLY MEN WITH PROSTATE CANCER |
| 5634 |
SENOLYTICS AND SENOMORPHICS: NATURAL AND SYNTHETIC THERAPEUTICS IN THE TREATMENT OF AGING AND CHRONIC DISEASES |
| 5635 |
SEPTIC SHOCK AND THE AGING PROCESS: A MOLECULAR COMPARISON |
| 5636 |
SERELAXIN ALLEVIATES CARDIAC FIBROSIS THROUGH INHIBITING ENDOTHELIAL-TO-MESENCHYMAL TRANSITION VIA RXFP1 |
| 5637 |
SEROTONIN TRANSPORTER GENE POLYMORPHISMS IN SOUTHWESTERN IRANIAN PATIENTS WITH IRRITABLE BOWEL SYNDROME |
| 5638 |
SERUM METABOLOMICS REVEALS PATHWAYS AND BIOMARKERS ASSOCIATED WITH ASTHMA PATHOGENESIS |
| 5639 |
SERUM MICRORNAS IN SYSTEMIC SCLEROSIS, ASSOCIATIONS WITH DIGITAL VASCULOPATHY AND LUNG INVOLVEMENT |
| 5640 |
SERUM TUMOR MARKERS AND MOLECULAR BIOLOGICAL DIAGNOSIS IN PANCREATIC CANCER |
| 5641 |
SETBP1 INDUCES TRANSCRIPTION OF A NETWORK OF DEVELOPMENT GENES BY ACTING AS AN EPIGENETIC HUB |
| 5642 |
SETMELANOTIDE: FIRST APPROVAL |
| 5643 |
SEX AND AUTOIMMUNITY: PROPOSED MECHANISMS OF DISEASE ONSET AND SEVERITY |
| 5644 |
SEX AND THE MIGRAINE BRAIN |
| 5645 |
SEX DEPENDENT ALTERATION OF EPIGENETIC MARKS AFTER CHRONIC MORPHINE TREATMENT IN MICE ORGANS |
| 5646 |
SEX DIFFERENCES AND EMERGING NEW RISK FACTORS FOR ATHEROSCLEROSIS AND ITS THROMBOTIC COMPLICATIONS |
| 5647 |
SEX DIFFERENCES IN FETAL KIDNEY REPROGRAMMING: THE CASE IN THE RENIN-ANGIOTENSIN SYSTEM |
| 5648 |
SEX DIFFERENCES IN OPIOID RESPONSE LINKED TO OPRM1 AND COMT GENES DNA METHYLATION/GENOTYPES CHANGES IN PATIENTS WITH CHRONIC PAIN |
| 5649 |
SEX DIFFERENCES IN PSYCHOSTIMULANT ABUSE: IMPLICATIONS FOR ESTROGEN RECEPTORS AND HISTONE DEACETYLASES |
| 5650 |
SEX DIFFERENCES IN THE DEVELOPMENT OF PHYSICAL AGGRESSION: AN INTERGENERATIONAL PERSPECTIVE AND IMPLICATIONS FOR PREVENTIVE INTERVENTIONS |
| 5651 |
SEX DIFFERENCES IN THE EPIGENETIC REGULATION OF CHRONIC VISCERAL PAIN FOLLOWING UNPREDICTABLE EARLY LIFE STRESS |
| 5652 |
SEX DIMORPHIC CHANGES IN TRH GENE METHYLATION AND THYROID-AXIS RESPONSE TO ENERGY DEMANDS IN MATERNALLY SEPARATED RATS |
| 5653 |
SEX HORMONES AND INFLAMMATION ROLE IN ORAL CANCER PROGRESSION: A MOLECULAR AND BIOLOGICAL POINT OF VIEW |
| 5654 |
SEX, NUTRITION, AND NAFLD: RELEVANCE OF ENVIRONMENTAL POLLUTION |
| 5655 |
SEX-BASED MEDICINE MEETS PSORIATIC ARTHRITIS: LESSONS LEARNED AND TO LEARN |
| 5656 |
SEX-DEPENDENT ASSOCIATION OF DNA METHYLATION IN THE CODING REGION OF THE CORTICOTROPIN-RELEASING HORMONE GENE AND SCHIZOPHRENIA SPECTRUM DISORDER |
| 5657 |
SEX-DEPENDENT PRONOCICEPTIVE ROLE OF SPINAL ALPHA(5) -GABA(A) RECEPTOR AND ITS EPIGENETIC REGULATION IN NEUROPATHIC RODENTS |
| 5658 |
SEX-DIMORPHIC PATHWAYS IN THE ASSOCIATIONS BETWEEN MATERNAL TRAIT ANXIETY, INFANT BDNF METHYLATION, AND NEGATIVE EMOTIONALITY |
| 5659 |
SEX-SPECIFIC EFFECTS OF THE HISTONE VARIANT H2A |
| 5660 |
SEX-SPECIFIC EPIGENETIC PROGRAMMING IN RENAL FIBROSIS AND INFLAMMATION |
| 5661 |
SEXUAL DIMORPHISM IN EPIGENOMIC RESPONSES OF STEM CELLS TO EXTREME FETAL GROWTH |
| 5662 |
SEXUAL DIMORPHISM IN GLUCOCORTICOID STRESS RESPONSE |
| 5663 |
SEZARY SYNDROME COEXISTING WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: CASE REPORT AND REVIEW OF THE LITERATURE |
| 5664 |
SF3B1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 5665 |
SF3B1, RUNX1 AND TP53 MUTATIONS SIGNIFICANTLY IMPACT THE OUTCOME OF PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROME |
| 5666 |
SF3B1-MUTATED CHRONIC LYMPHOCYTIC LEUKEMIA SHOWS EVIDENCE OF NOTCH1 PATHWAY ACTIVATION INCLUDING CD20 DOWNREGULATION |
| 5667 |
SFRP TUMOUR SUPPRESSOR GENES ARE POTENTIAL PLASMA-BASED EPIGENETIC BIOMARKERS FOR MALIGNANT PLEURAL MESOTHELIOMA |
| 5668 |
SFRP1 EXPRESSION REGULATES WNT SIGNALING IN CHRONIC MYELOID LEUKEMIA K562 CELLS |
| 5669 |
SFRP1 PROMOTER METHYLATION IS ASSOCIATED WITH PERSISTENT PHILADELPHIA CHROMOSOME IN CHRONIC MYELOID LEUKEMIA |
| 5670 |
SHARED (EPI)GENOMIC BACKGROUND CONNECTING NEURODEGENERATIVE DISEASES AND TYPE 2 DIABETES |
| 5671 |
SHARED AND DISTINCT BIOLOGICAL CIRCUITS IN EFFECTOR, MEMORY AND EXHAUSTED CD8(+) T CELLS REVEALED BY TEMPORAL SINGLE-CELL TRANSCRIPTOMICS AND EPIGENETICS |
| 5672 |
SHARED AND DIVERGENT EPIGENETIC MECHANISMS IN CACHEXIA AND SARCOPENIA |
| 5673 |
SHARED EPIGENETIC ALTERATIONS BETWEEN ORAL CANCER AND PERIODONTITIS: A PRELIMINARY STUDY |
| 5674 |
SHARED GENETIC AND EPIGENETIC MECHANISMS BETWEEN CHRONIC PERIODONTITIS AND ORAL SQUAMOUS CELL CARCINOMA |
| 5675 |
SHIFTS IN PODOCYTE HISTONE H3K27ME3 REGULATE MOUSE AND HUMAN GLOMERULAR DISEASE |
| 5676 |
SHIFTS IN THE IMMUNOEPIGENOMIC LANDSCAPE OF MONOCYTES IN RESPONSE TO A DIABETES-SPECIFIC SOCIAL SUPPORT INTERVENTION: A PILOT STUDY AMONG NATIVE HAWAIIAN ADULTS WITH DIABETES |
| 5677 |
SHORT AIP1 (ASK1-INTERACTING PROTEIN-1) ISOFORM LOCALIZES TO THE MITOCHONDRIA AND PROMOTES VASCULAR DYSFUNCTION |
| 5678 |
SHORT HAIRPIN RNA INDUCES METHYLATION OF HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA IN HUMAN HEPATOMA CELLS |
| 5679 |
SHORT- AND LONG-TERM HINDLIMB IMMOBILIZATION AND RELOADING: PROFILE OF EPIGENETIC EVENTS IN GASTROCNEMIUS |
| 5680 |
SHORT- AND LONG-TERM OUTCOMES OF PREECLAMPSIA IN OFFSPRING: REVIEW OF THE LITERATURE |
| 5681 |
SHORT-CHAIN FATTY ACID-MEDIATED EPIGENETIC MODULATION OF INFLAMMATORY T CELLS IN VITRO |
| 5682 |
SHORT-TERM CHANGES IN GLOBAL METHYLATION AND HYDROXYMETHYLATION DURING ALCOHOL DETOXIFICATION |
| 5683 |
SHORTER TELOMERE LENGTH IN PERIPHERAL BLOOD LYMPHOCYTES OF WORKERS EXPOSED TO POLYCYCLIC AROMATIC HYDROCARBONS |
| 5684 |
SHOULD WE EMBRACE THE INCORPORATION OF GENETICALLY GUIDED "DOPAMINE HOMEOSTASIS" IN THE TREATMENT OF REWARD DEFICIENCY SYNDROME (RSD) AS A FRONTLINE THERAPEUTIC MODALITY? IN 2019, THE US CENTER FOR DISEASE CONTROL AND PREVENTION PROVIDED VITAL STATISTICS RELATED TO DRUG OVERDOSES IN THE UNITED STATE1 |
| 5685 |
SHOULD WE INVEST IN BIOLOGICAL AGE PREDICTORS TO TREAT COLORECTAL CANCER IN OLDER ADULTS? COLORECTAL CANCER (CRC) IS A CHRONIC DISEASE OF THE OLD POPULATION WITH SLOW DEVELOPMENT PROGRESSING INTO CLINICAL SIGNS AND SYMPTOMS |
| 5686 |
SICKLE CELL DISEASE: CLINICAL PRESENTATION AND MANAGEMENT OF A GLOBAL HEALTH CHALLENGE |
| 5687 |
SIGNIFICANCE OF INACTIVATED GENES IN LEUKEMIA: PATHOGENESIS AND PROGNOSIS |
| 5688 |
SILENCING EFFECTS OF MUTANT RAS SIGNALLING ON TRANSCRIPTOMES |
| 5689 |
SILENCING HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA: THE POTENTIAL OF AN EPIGENETIC THERAPY APPROACH |
| 5690 |
SILENCING OF FEM1CR3 GENE EXPRESSION IN THE DBA/2J MOUSE PRECEDES RETINAL GANGLION CELL DEATH AND IS ASSOCIATED WITH HISTONE DEACETYLASE ACTIVITY |
| 5691 |
SILENCING OF HDAC6 AS A THERAPEUTIC TARGET IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 5692 |
SILENCING OF LNCRNA PKIA-AS1 ATTENUATES SPINAL NERVE LIGATION-INDUCED NEUROPATHIC PAIN THROUGH EPIGENETIC DOWNREGULATION OF CDK6 EXPRESSION |
| 5693 |
SILENCING OF MATERNAL HEPATIC GLUCOCORTICOID RECEPTOR IS ESSENTIAL FOR NORMAL FETAL DEVELOPMENT IN MICE |
| 5694 |
SILENCING THE OCT4-PG1 PSEUDOGENE REDUCES OCT-4 PROTEIN LEVELS AND CHANGES CHARACTERISTICS OF THE MULTIDRUG RESISTANCE PHENOTYPE IN CHRONIC MYELOID LEUKEMIA |
| 5695 |
SILENCING UHRF1 ENHANCES CELL AUTOPHAGY TO PREVENT ARTICULAR CHONDROCYTES FROM APOPTOSIS IN OSTEOARTHRITIS THROUGH PI3K/AKT/MTOR SIGNALING PATHWAY |
| 5696 |
SIMILARITIES AND DIFFERENCES IN PERIPHERAL BLOOD GENE-EXPRESSION SIGNATURES OF INDIVIDUALS WITH SCHIZOPHRENIA AND THEIR FIRST-DEGREE BIOLOGICAL RELATIVES |
| 5697 |
SIMILARITIES IN PATHOGENETIC MECHANISMS UNDERLYING THE BIDIRECTIONAL RELATIONSHIP BETWEEN ENDOMETRIOSIS AND PELVIC INFLAMMATORY DISEASE |
| 5698 |
SIMULATED CLIMATE WARMING AND MITOCHONDRIAL HAPLOGROUP MODULATE TESTICULAR SMALL NON-CODING RNA EXPRESSION IN THE NEOTROPICAL PSEUDOSCORPION, CORDYLOCHERNES SCORPIOIDES |
| 5699 |
SIMULTANEOUS DETECTION OF DNA VARIATION AND METHYLATION AT HLA CLASS II LOCUS AND IMMUNE GENE PROMOTERS USING TARGETED SURESELECT METHYL-SEQUENCING |
| 5700 |
SINGLE NUCLEOTIDE POLYMORPHISM IN DNMT3B PROMOTER AND THE RISK FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHINESE POPULATION |
| 5701 |
SINGLE NUCLEOTIDE POLYMORPHISMS OF CAUDAL TYPE HOMEOBOX 1 AND 2 ARE ASSOCIATED WITH BARRETT'S ESOPHAGUS |
| 5702 |
SINGLE-CELL GENOMICS FOR INVESTIGATING PATHOGENESIS OF INFLAMMATORY DISEASES |
| 5703 |
SINGLE-CELL MULTIOMICS REVEAL THE SCALE OF MULTILAYERED ADAPTATIONS ENABLING CLL RELAPSE DURING VENETOCLAX THERAPY |
| 5704 |
SINGLE-CELL RNA-SEQ REVEALS TOX AS A KEY REGULATOR OF CD8(+) T CELL PERSISTENCE IN CHRONIC INFECTION |
| 5705 |
SINGLE-CELL TRANSCRIPTIONAL CHANGES IN HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR-EXPRESSING NEURONS AFTER EARLY-LIFE ADVERSITY INFORM ENDURING ALTERATIONS IN VULNERABILITIES TO STRESS |
| 5706 |
SINGLE-MOLECULE QUANTIFICATION OF 5-HYDROXYMETHYLCYTOSINE FOR DIAGNOSIS OF BLOOD AND COLON CANCERS |
| 5707 |
SIRT1 AS A THERAPEUTIC TARGET IN DIABETIC COMPLICATIONS |
| 5708 |
SIRT1 ATTENUATES NEUROPATHIC PAIN BY EPIGENETIC REGULATION OF MGLUR1/5 EXPRESSIONS IN TYPE 2 DIABETIC RATS |
| 5709 |
SIRT1 DECREASES EMOTIONAL PAIN VULNERABILITY WITH ASSOCIATED CAMKIIALPHA DEACETYLATION IN CENTRAL AMYGDALA |
| 5710 |
SIRT1 DEFICIENCY IN MICROGLIA CONTRIBUTES TO COGNITIVE DECLINE IN AGING AND NEURODEGENERATION VIA EPIGENETIC REGULATION OF IL-1BETA |
| 5711 |
SIRT1 IS A HIGHLY NETWORKED PROTEIN THAT MEDIATES THE ADAPTATION TO CHRONIC PHYSIOLOGICAL STRESS |
| 5712 |
SIRT1 MEDIATES DEPRESSION-LIKE BEHAVIORS IN THE NUCLEUS ACCUMBENS |
| 5713 |
SIRT2 INHIBITION REVERSES ANHEDONIA IN THE VGLUT1+/- DEPRESSION MODEL |
| 5714 |
SIRT3 OVEREXPRESSION AND EPIGENETIC SILENCING OF CATALASE REGULATE ROS ACCUMULATION IN CLL CELLS ACTIVATING AXL SIGNALING AXIS |
| 5715 |
SIRT3 RESTRICTS HEPATITIS B VIRUS TRANSCRIPTION AND REPLICATION THROUGH EPIGENETIC REGULATION OF COVALENTLY CLOSED CIRCULAR DNA INVOLVING SUPPRESSOR OF VARIEGATION 3-9 HOMOLOG 1 AND SET DOMAIN CONTAINING 1A HISTONE METHYLTRANSFERASES |
| 5716 |
SIRT6 PROTECTS VASCULAR SMOOTH MUSCLE CELLS FROM OSTEOGENIC TRANSDIFFERENTIATION VIA RUNX2 IN CHRONIC KIDNEY DISEASE |
| 5717 |
SIRTUIN-6-DEPENDENT GENETIC AND EPIGENETIC ALTERATIONS ARE ASSOCIATED WITH POOR CLINICAL OUTCOME IN HEPATOCELLULAR CARCINOMA PATIENTS |
| 5718 |
SIRTUIN1 AND CHRONIC MYELOID LEUKEMIA: A COMPREHENSIVE GLANCE AT DRUG RESISTANCE |
| 5719 |
SIRTUINS IN NEURODEGENERATIVE DISEASES: AN UPDATE ON POTENTIAL MECHANISMS |
| 5720 |
SIRTUINS LINK INFLAMMATION AND METABOLISM |
| 5721 |
SIRTUINS-NOVEL REGULATORS OF EPIGENETIC ALTERATIONS IN AIRWAY INFLAMMATION |
| 5722 |
SISTER CHROMATID EXCHANGE AND PROLIFERATIVE RATE INDEX IN THE LONGITUDINAL RISK ASSESSMENT OF OCCUPATIONAL EXPOSURE TO PESTICIDES |
| 5723 |
SJOGREN'S SYNDROME X-CHROMOSOME DOSE EFFECT: AN EPIGENETIC PERSPECTIVE |
| 5724 |
SKELETAL MUSCLE WASTING AND ITS RELATIONSHIP WITH OSTEOARTHRITIS: A MINI-REVIEW OF MECHANISMS AND CURRENT INTERVENTIONS |
| 5725 |
SKIN MANIFESTATIONS OF INSULIN RESISTANCE: FROM A BIOCHEMICAL STANCE TO A CLINICAL DIAGNOSIS AND MANAGEMENT |
| 5726 |
SKIN WELL-BEING IN DIABETES: ROLE OF MACROPHAGES |
| 5727 |
SLEEP QUALITY AND METHYLATION STATUS OF CORE CIRCADIAN RHYTHM GENES AMONG NURSES AND MIDWIVES |
| 5728 |
SLEEP QUALITY AND METHYLATION STATUS OF SELECTED TUMOR SUPPRESSOR GENES AMONG NURSES AND MIDWIVES |
| 5729 |
SLEEP, SLEEP HOMEOSTASIS AND AROUSAL DISTURBANCES IN ALCOHOLISM |
| 5730 |
SLIT2 PROMOTER HYPERMETHYLATION PREDICTS DISEASE PROGRESSION IN CHRONIC MYELOID LEUKEMIA |
| 5731 |
SMAD3 PHOSPHO-ISOFORM SIGNALING IN HEPATITIS C VIRUS-RELATED CHRONIC LIVER DISEASES |
| 5732 |
SMAD4 TGF-BETA-INDEPENDENT FUNCTION PRECONDITIONS NAIVE CD8+ T CELLS TO PREVENT SEVERE CHRONIC INTESTINAL INFLAMMATION |
| 5733 |
SMALL MOLECULES AGAINST THE ORIGIN AND ACTIVATION OF MYOFIBROBLAST FOR RENAL INTERSTITIAL FIBROSIS THERAPY |
| 5734 |
SMALL NON-CODING RNAS ARE ALTERED BY SHORT-TERM SPRINT INTERVAL TRAINING IN MEN |
| 5735 |
SMALL VESSEL DISEASE-RELATED DEMENTIA: AN INVALID NEUROVASCULAR COUPLING? THE ARTERIOSCLEROSIS-DEPENDENT ALTERATION OF BRAIN PERFUSION IS ONE OF THE MAJOR DETERMINANTS IN SMALL VESSEL DISEASE, SINCE SMALL VESSELS HAVE A PIVOTAL ROLE IN THE BRAIN'S AUTOREGULATION |
| 5736 |
SMOKE-INDUCED CHANGES TO THE EPIGENOME PROVIDE FERTILE GROUND FOR ONCOGENIC MUTATION |
| 5737 |
SMOKING AND HEALTH: ASSOCIATION BETWEEN TELOMERE LENGTH AND FACTORS IMPACTING ON HUMAN DISEASE, QUALITY OF LIFE AND LIFE SPAN IN A LARGE POPULATION-BASED COHORT UNDER THE EFFECT OF SMOKING DURATION |
| 5738 |
SMOKING AND LUNG CANCER: THE ROLE OF INFLAMMATION |
| 5739 |
SMOKING AND RHEUMATOID ARTHRITIS |
| 5740 |
SMOKING AND TETRAMER TRYPTASE ACCELERATE INTERVERTEBRAL DISC DEGENERATION BY INDUCING METTL14-MEDIATED DIXDC1 M(6) MODIFICATION |
| 5741 |
SMOKING INDUCES DNA METHYLATION CHANGES IN MULTIPLE SCLEROSIS PATIENTS WITH EXPOSURE-RESPONSE RELATIONSHIP |
| 5742 |
SMOKING MOLECULAR DAMAGE IN BRONCHIAL EPITHELIUM |
| 5743 |
SMOKING SUPPRESSES THE THERAPEUTIC POTENTIAL OF ADIPOSE STEM CELLS IN CROHN'S DISEASE PATIENTS THROUGH EPIGENETIC CHANGES |
| 5744 |
SMOKING-INDUCED EXPRESSION OF THE GPR15 GENE INDICATES ITS POTENTIAL ROLE IN CHRONIC INFLAMMATORY PATHOLOGIES |
| 5745 |
SMOKING-RELATED CHANGES IN DNA METHYLATION AND GENE EXPRESSION ARE ASSOCIATED WITH CARDIO-METABOLIC TRAITS |
| 5746 |
SMOKING-RELATED DNA METHYLATION IS ASSOCIATED WITH DNA METHYLATION PHENOTYPIC AGE ACCELERATION: THE VETERANS AFFAIRS NORMATIVE AGING STUDY |
| 5747 |
SOCIAL ADVERSITY AND EPIGENETIC AGING: A MULTI-COHORT STUDY ON SOCIOECONOMIC DIFFERENCES IN PERIPHERAL BLOOD DNA METHYLATION |
| 5748 |
SOCIAL AND PHYSICAL ENVIRONMENTS EARLY IN DEVELOPMENT PREDICT DNA METHYLATION OF INFLAMMATORY GENES IN YOUNG ADULTHOOD |
| 5749 |
SOCIAL DEFEAT INDUCES CHANGES IN HISTONE ACETYLATION AND EXPRESSION OF HISTONE MODIFYING ENZYMES IN THE VENTRAL HIPPOCAMPUS, PREFRONTAL CORTEX, AND DORSAL RAPHE NUCLEUS |
| 5750 |
SOCIAL DEFEAT STRESS IN ADULT MICE CAUSES ALTERATIONS IN GENE EXPRESSION, ALTERNATIVE SPLICING, AND THE EPIGENETIC LANDSCAPE OF H3K4ME3 IN THE PREFRONTAL CORTEX: AN IMPACT OF EARLY-LIFE STRESS |
| 5751 |
SOCIAL ENVIRONMENT AND EPIGENETICS |
| 5752 |
SOCIAL ISOLATION AND SOCIAL SUPPORT AT ADULTHOOD AFFECT EPIGENETIC MECHANISMS, BRAIN-DERIVED NEUROTROPHIC FACTOR LEVELS AND BEHAVIOR OF CHRONICALLY STRESSED RATS |
| 5753 |
SOCIAL ISOLATION REDUCES MAMMARY DEVELOPMENT, TUMOR INCIDENCE, AND EXPRESSION OF EPIGENETIC REGULATORS IN WILD-TYPE AND P53-HETEROZYGOTIC MICE |
| 5754 |
SOCIAL PSYCHOGENIC STRESS PROMOTES THE DEVELOPMENT OF ENDOMETRIOSIS IN MOUSE |
| 5755 |
SOCIALLY STRATIFIED EPIGENETIC PROFILES ARE ASSOCIATED WITH COGNITIVE FUNCTIONING IN CHILDREN AND ADOLESCENTS |
| 5756 |
SOCIOECONOMIC DEPRIVATION, ADVERSE CHILDHOOD EXPERIENCES AND MEDICAL DISORDERS IN ADULTHOOD: MECHANISMS AND ASSOCIATIONS |
| 5757 |
SOCIOECONOMIC STATUS, KNEE PAIN, AND EPIGENETIC AGING IN COMMUNITY-DWELLING MIDDLE-TO-OLDER AGE ADULTS |
| 5758 |
SOCS3 DELETION IN T LYMPHOCYTES SUPPRESSES DEVELOPMENT OF CHRONIC OCULAR INFLAMMATION VIA UPREGULATION OF CTLA-4 AND EXPANSION OF REGULATORY T CELLS |
| 5759 |
SODIUM BUTYRATE ABOLISHES LIPOPOLYSACCHARIDE-INDUCED DEPRESSION-LIKE BEHAVIORS AND HIPPOCAMPAL MICROGLIAL ACTIVATION IN MICE |
| 5760 |
SOLUBLE URIC ACID PRIMES TLR-INDUCED PROINFLAMMATORY CYTOKINE PRODUCTION BY HUMAN PRIMARY CELLS VIA INHIBITION OF IL-1RA |
| 5761 |
SOMATIC MUTATIONS, VIRAL INTEGRATION AND EPIGENETIC MODIFICATION IN THE EVOLUTION OF HEPATITIS B VIRUS-INDUCED HEPATOCELLULAR CARCINOMA |
| 5762 |
SOMATIC VARIANTS IN EPIGENETIC MODIFIERS CAN PREDICT FAILURE OF RESPONSE TO IMATINIB BUT NOT TO SECOND-GENERATION TYROSINE KINASE INHIBITORS |
| 5763 |
SOME COMMENTS ON MASOCHISM AND THE DELUSION OF OMNIPOTENCE FROM A DEVELOPMENTAL PERSPECTIVE |
| 5764 |
SORAFENIB ATTENUATES FIBROTIC HEPATIC INJURY THROUGH MEDIATING LYSINE CROTONYLATION |
| 5765 |
SOURCE OF CHRONIC INFLAMMATION IN AGING |
| 5766 |
SPECIAL ISSUE: ALZHEIMER'S DISEASE |
| 5767 |
SPECIES-SPECIFIC ROLE OF GENE-ADJACENT RETROELEMENTS IN HUMAN AND MOUSE GASTRIC CARCINOGENESIS |
| 5768 |
SPECIFIC ALTERATIONS IN THE CIRCULATING LEVELS OF THE SIRT1, TLR4, AND IL7 PROTEINS IN PATIENTS WITH DEMENTIA |
| 5769 |
SPECIFIC EPIGENETIC REGULATORS SERVE AS POTENTIAL THERAPEUTIC TARGETS IN IDIOPATHIC PULMONARY FIBROSIS |
| 5770 |
SPECIFIC MOLECULAR SIGNATURES OF NON-TUMOR LIVER TISSUE MAY PREDICT A RISK OF HEPATOCARCINOGENESIS |
| 5771 |
SPECIFIC MOLECULAR SIGNATURES PREDICT DECITABINE RESPONSE IN CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 5772 |
SPECTRUM, SCREENING, AND DIAGNOSIS OF ALCOHOL-RELATED LIVER DISEASE |
| 5773 |
SPERM MICRORNA CONTENT IS ALTERED IN A MOUSE MODEL OF MALE OBESITY, BUT THE SAME SUITE OF MICRORNAS ARE NOT ALTERED IN OFFSPRING'S SPERM |
| 5774 |
SPERM TRANSCRIPTIONAL STATE ASSOCIATED WITH PATERNAL TRANSMISSION OF STRESS PHENOTYPES |
| 5775 |
SPERMIDINE/SPERMINE N(1)-ACETYLTRANSFERASE ACTIVITY ASSOCIATES WITH WHITE BLOOD CELL COUNT IN MYELOID LEUKEMIAS |
| 5776 |
SPHN - THE SWISS AGING CITIZEN REFERENCE (SACR) |
| 5777 |
SPINAL CIRCKCNK9 REGULATES CHRONIC VISCERAL HYPERSENSITIVITY OF IRRITABLE BOWEL SYNDROME |
| 5778 |
SPINAL CORD INJURY INDUCED NEUROPATHIC PAIN: MOLECULAR TARGETS AND THERAPEUTIC APPROACHES |
| 5779 |
SPINAL MICRORNA-134-5P TARGETS GLUTAMATE RECEPTOR IONOTROPIC KAINATE 3 TO MODULATE OPIOID INDUCED HYPERALGESIA IN MICE |
| 5780 |
SPINAL RNF20-MEDIATED HISTONE H2B MONOUBIQUITYLATION REGULATES MGLUR5 TRANSCRIPTION FOR NEUROPATHIC ALLODYNIA |
| 5781 |
SPINAL SIRT1 ACTIVATION ATTENUATES NEUROPATHIC PAIN IN MICE |
| 5782 |
SPLICING ANOMALIES IN MYELOPROLIFERATIVE NEOPLASMS: PAVING THE WAY FOR NEW THERAPEUTIC VENUES |
| 5783 |
SPONTANEOUS AND TRANSGENIC RODENT MODELS OF INFLAMMATORY BOWEL DISEASE |
| 5784 |
SPONTANEOUS FIRING AS AN EPIGENETIC FACTOR IN BRAIN DEVELOPMENT--PHYSIOLOGICAL CONSEQUENCES OF CHRONIC TETRODOTOXIN AND PICROTOXIN EXPOSURE ON CULTURED RAT NEOCORTEX NEURONS |
| 5785 |
SPONTANEOUS NEOPLASTIC TRANSFORMATION OF WB-F344 RAT LIVER EPITHELIAL CELLS |
| 5786 |
SPORT AND MALE SEXUALITY |
| 5787 |
SPUTUM ANALYSIS: NON-INVASIVE EARLY LUNG CANCER DETECTION |
| 5788 |
SREBP1 DRIVES KERATIN-80-DEPENDENT CYTOSKELETAL CHANGES AND INVASIVE BEHAVIOR IN ENDOCRINE-RESISTANT ERALPHA BREAST CANCER |
| 5789 |
SRSF2(P95H/+) CO-OPERATES WITH LOSS OF TET2 TO PROMOTE MYELOID BIAS AND INITIATE A CHRONIC MYELOMONOCYTIC LEUKEMIA-LIKE DISEASE IN MICE |
| 5790 |
SRSF2-P95 HOTSPOT MUTATION IS HIGHLY ASSOCIATED WITH ADVANCED FORMS OF MASTOCYTOSIS AND MUTATIONS IN EPIGENETIC REGULATOR GENES |
| 5791 |
STABLE HISTONE METHYLATION CHANGES AT PROTEOGLYCAN NETWORK GENES FOLLOWING ETHANOL EXPOSURE |
| 5792 |
STAGING IN BIPOLAR DISORDER: FROM THEORETICAL FRAMEWORK TO CLINICAL UTILITY |
| 5793 |
STAPHYLOCOCCAL ENTEROTOXIN B INFLUENCES THE DNA METHYLATION PATTERN IN NASAL POLYP TISSUE: A PRELIMINARY STUDY |
| 5794 |
STAT1 EPIGENETICALLY REGULATES LCP2 AND TNFAIP2 BY RECRUITING EP300 TO CONTRIBUTE TO THE PATHOGENESIS OF INFLAMMATORY BOWEL DISEASE |
| 5795 |
STAT3 INDUCTION OF MIR-146B FORMS A FEEDBACK LOOP TO INHIBIT THE NF-KAPPAB TO IL-6 SIGNALING AXIS AND STAT3-DRIVEN CANCER PHENOTYPES |
| 5796 |
STAT3 PROMOTES A YOUTHFUL EPIGENETIC STATE IN ARTICULAR CHONDROCYTES |
| 5797 |
STEM CELL-BASED THERAPY FOR HIRSCHSPRUNG DISEASE, DO WE HAVE THE GUTS TO TREAT? HIRSCHSPRUNG DISEASE (HSCR) IS A CONGENITAL ANOMALY OF THE COLON THAT RESULTS FROM FAILURE OF ENTERIC NERVOUS SYSTEM FORMATION, LEADING TO A CONSTRICTED DYSFUNCTIONAL SEGMENT OF THE COLON WITH VARIABLE LENGTHS, AND NECESSITATING SURGICAL INTERVENTION |
| 5798 |
STEM CELLS AND LUNG REGENERATION |
| 5799 |
STEPPING OUT OF ANTIQUITY: AN UPDATE ON EMERGING DRUGS FOR THE TREATMENT OF POLYCYTHEMIA VERA |
| 5800 |
STEPWISE PATHOGENIC EVOLUTION OF MYCOBACTERIUM ABSCESSUS |
| 5801 |
STIFFNESS AND AGING IN CARDIOVASCULAR DISEASES: THE DANGEROUS RELATIONSHIP BETWEEN FORCE AND SENESCENCE |
| 5802 |
STIMULATION OF HUMAN PERIODONTAL LIGAMENT FIBROBLASTS USING PURIFIED DENTILISIN EXTRACTED FROM TREPONEMA DENTICOLA |
| 5803 |
STING SIGNALING ACTIVATION INHIBITS HBV REPLICATION AND ATTENUATES THE SEVERITY OF LIVER INJURY AND HBV-INDUCED FIBROSIS |
| 5804 |
STRAIN AND SEX DEPENDENT EFFECTS OF ISOLATION HOUSING RELATIVE TO ENVIRONMENTAL ENRICHMENT ON OPERANT SENSATION SEEKING IN MICE |
| 5805 |
STRATEGIES TO PREVENT AND REVERSE LIVER FIBROSIS IN HUMANS AND LABORATORY ANIMALS |
| 5806 |
STRATEGIES TO REINVIGORATE EXHAUSTED CD8(+) T CELLS IN TUMOR MICROENVIRONMENT |
| 5807 |
STRATEGIES, MODELS AND BIOMARKERS IN EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE RESEARCH |
| 5808 |
STRATIFICATION OF COMPANION ANIMAL LIFE STAGES FROM ELECTRONIC MEDICAL RECORD DIAGNOSIS DATA |
| 5809 |
STRAWBERRY AND HUMAN HEALTH: EFFECTS BEYOND ANTIOXIDANT ACTIVITY |
| 5810 |
STRESS & SLEEP: A RELATIONSHIP LASTING A LIFETIME |
| 5811 |
STRESS - (SELF) EATING: EPIGENETIC REGULATION OF AUTOPHAGY IN RESPONSE TO PSYCHOLOGICAL STRESS |
| 5812 |
STRESS AND ANXIETY: STRUCTURAL PLASTICITY AND EPIGENETIC REGULATION AS A CONSEQUENCE OF STRESS |
| 5813 |
STRESS AND ASTHMA: NOVEL INSIGHTS ON GENETIC, EPIGENETIC, AND IMMUNOLOGIC MECHANISMS |
| 5814 |
STRESS AND FELINE HEALTH |
| 5815 |
STRESS AND GLUCOCORTICOID RECEPTOR TRANSCRIPTIONAL PROGRAMMING IN TIME AND SPACE: IMPLICATIONS FOR THE BRAIN-GUT AXIS |
| 5816 |
STRESS AND STEM CELLS |
| 5817 |
STRESS AND THE EPIGENETIC LANDSCAPE: A LINK TO THE PATHOBIOLOGY OF HUMAN DISEASES? ACCUMULATING EVIDENCE POINTS TO A MAJOR ROLE FOR CHRONIC STRESS OF CELL RENEWAL SYSTEMS IN THE PATHOGENESIS OF IMPORTANT HUMAN DISEASES, INCLUDING CANCER, ATHEROSCLEROSIS AND DIABETES |
| 5818 |
STRESS AND TRAUMA: BDNF CONTROL OF DENDRITIC-SPINE FORMATION AND REGRESSION |
| 5819 |
STRESS CHANGES AMPHETAMINE RESPONSE, D2 RECEPTOR EXPRESSION AND EPIGENETIC REGULATION IN LOW-ANXIETY RATS |
| 5820 |
STRESS DYNAMICALLY REGULATES BEHAVIOR AND GLUTAMATERGIC GENE EXPRESSION IN HIPPOCAMPUS BY OPENING A WINDOW OF EPIGENETIC PLASTICITY |
| 5821 |
STRESS IN OBESITY AND ASSOCIATED METABOLIC AND CARDIOVASCULAR DISORDERS |
| 5822 |
STRESS IN THE ONSET AND AGGRAVATION OF LEARNING DISABILITIES |
| 5823 |
STRESS INCREASES DNA METHYLATION OF THE NEURONAL PAS DOMAIN 4 (NPAS4) GENE |
| 5824 |
STRESS MODIFIES THE EXPRESSION OF GLUCOCORTICOID-RESPONSIVE GENES BY ACTING AT EPIGENETIC LEVELS IN THE RAT PREFRONTAL CORTEX: MODULATORY ACTIVITY OF LURASIDONE |
| 5825 |
STRESS MODULATES AHI1-DEPENDENT NUCLEAR LOCALIZATION OF TEN-ELEVEN TRANSLOCATION PROTEIN 2 |
| 5826 |
STRESS SIGNAL NETWORK BETWEEN HYPOXIA AND ER STRESS IN CHRONIC KIDNEY DISEASE |
| 5827 |
STRESS, BURNOUT AND DEPRESSION: A SYSTEMATIC REVIEW ON DNA METHYLATION MECHANISMS |
| 5828 |
STRESS, EPIGENETICS, AND ALCOHOLISM |
| 5829 |
STRESS, PSYCHIATRIC DISORDERS, MOLECULAR TARGETS, AND MORE |
| 5830 |
STRESS, THYROID DYSREGULATION, AND THYROID CANCER IN CHILDREN AND ADOLESCENTS: PROPOSED IMPENDING MECHANISMS |
| 5831 |
STRESS-INDUCED CHRONIC VISCERAL PAIN OF GASTROINTESTINAL ORIGIN |
| 5832 |
STRESS-INDUCED EPIGENETIC CHANGES IN HIPPOCAMPAL MKP-1 PROMOTE PERSISTENT DEPRESSIVE BEHAVIORS |
| 5833 |
STRESS-INDUCED MECHANISMS IN MENTAL ILLNESS: A ROLE FOR GLUCOCORTICOID SIGNALLING |
| 5834 |
STRESS-INDUCED VISCERAL PAIN IN FEMALE RATS IS ASSOCIATED WITH EPIGENETIC REMODELING IN THE CENTRAL NUCLEUS OF THE AMYGDALA |
| 5835 |
STRESS-INDUCED VISCERAL PAIN: TOWARD ANIMAL MODELS OF IRRITABLE-BOWEL SYNDROME AND ASSOCIATED COMORBIDITIES |
| 5836 |
STRESSED AND DEPRESSED? CHECK YOUR GDNF FOR EPIGENETIC REPRESSION |
| 5837 |
STRESSED MITOCHONDRIA: A TARGET TO INTRUDE ALZHEIMER'S DISEASE |
| 5838 |
STRIATAL SHATI/NAT8L-BDNF PATHWAYS DETERMINE THE SENSITIVITY TO SOCIAL DEFEAT STRESS IN MICE THROUGH EPIGENETIC REGULATION |
| 5839 |
STROKE RECOVERY ENHANCING THERAPIES: LESSONS FROM RECENT CLINICAL TRIALS |
| 5840 |
STRUCTURAL BRAIN CORRELATES OF SERUM AND EPIGENETIC MARKERS OF INFLAMMATION IN MAJOR DEPRESSIVE DISORDER |
| 5841 |
STRUCTURAL CHROMATIN ALTERATIONS IN PERIPHERAL BLOOD LEUKOCYTES OF ALCOHOL-DEPENDENT INDIVIDUALS DURING DETOXIFICATION THERAPY |
| 5842 |
STRUCTURE OF HUMAN SP140 PHD FINGER: AN ATYPICAL FOLD INTERACTING WITH PIN1 |
| 5843 |
STUDIES ON THE CARCINOGENICITY OF POTASSIUM IODIDE IN F344 RATS |
| 5844 |
STUDY OF PROMOTER HYPOMETHYLATION PROFILES OF RAS ONCOGENES IN HEPATOCELLULAR CARCINOMA DERIVED FROM HEPATITIS C VIRUS GENOTYPE 3A IN PAKISTANI POPULATION |
| 5845 |
STUDY PROTOCOL FOR THE EPIGENETIC CHARACTERIZATION OF ANGOR PECTORIS ACCORDING TO THE AFFECTED CORONARY COMPARTMENT: GLOBAL AND COMPREHENSIVE ASSESSMENT OF THE RELATIONSHIP BETWEEN INVASIVE CORONARY PHYSIOLOGY AND MICRORNAS |
| 5846 |
STUDY PROTOCOL: RATIONALE AND DESIGN OF THE COMMUNITY-BASED PROSPECTIVE COHORT STUDY OF KIDNEY FUNCTION AND DIABETES IN RURAL NEW MEXICO, THE COMPASS STUDY |
| 5847 |
SUBCLINICAL ATHEROSCLEROSIS AND ACCELERATED EPIGENETIC AGE MEDIATED BY INFLAMMATION: A MULTI-OMICS STUDY |
| 5848 |
SUBCLONES IN B-LYMPHOMA CELL LINES: ISOGENIC MODELS FOR THE STUDY OF GENE REGULATION |
| 5849 |
SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) AND CLADRIBINE SYNERGISTICALLY INDUCE APOPTOSIS IN NK-LGL LEUKAEMIA |
| 5850 |
SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) REDUCES FIBROSIS MARKERS AND DEACTIVATES HUMAN STELLATE CELLS VIA THE EPITHELIAL-MESENCHYMAL TRANSITION (EMT) |
| 5851 |
SUBEROYLANILIDE HYDROXAMIC ACID TRIGGERS AUTOPHAGY BY INFLUENCING THE MTOR PATHWAY IN THE SPINAL DORSAL HORN IN A RAT NEUROPATHIC PAIN MODEL |
| 5852 |
SUBLIMINAL (LATENT) PROCESSING OF PAIN AND ITS EVOLUTION TO CONSCIOUS AWARENESS |
| 5853 |
SUBSETS OF EXHAUSTED CD8(+) T CELLS DIFFERENTIALLY MEDIATE TUMOR CONTROL AND RESPOND TO CHECKPOINT BLOCKADE |
| 5854 |
SUBSTANCE P AND NEPRILYSIN IN CHRONIC PANCREATITIS |
| 5855 |
SUBSTANCE USE DISORDER A BIO-DIRECTIONAL SUBSET OF REWARD DEFICIENCY SYNDROME |
| 5856 |
SUBSTRATE UTILISATION OF CULTURED SKELETAL MUSCLE CELLS IN PATIENTS WITH CFS |
| 5857 |
SUBSTRATE-SPECIFIC BINDING OF 8-OXOGUANINE DNA GLYCOSYLASE 1 (OGG1) REPROGRAMS MUCOSAL ADAPTATIONS TO CHRONIC AIRWAY INJURY |
| 5858 |
SULFORAPHANE AND EPIGALLOCATECHIN GALLATE RESTORE ESTROGEN RECEPTOR EXPRESSION BY MODULATING EPIGENETIC EVENTS IN THE BREAST CANCER CELL LINE MDA-MB-231: A SYSTEMATIC REVIEW AND META-ANALYSIS |
| 5859 |
SULFORAPHANE PREVENTS AND REVERSES ALLERGIC AIRWAYS DISEASE IN MICE VIA ANTI-INFLAMMATORY, ANTIOXIDANT, AND EPIGENETIC MECHANISMS |
| 5860 |
SULFORAPHANE PREVENTS ANGIOTENSIN II-INDUCED CARDIOMYOPATHY BY ACTIVATION OF NRF2 THROUGH EPIGENETIC MODIFICATION |
| 5861 |
SUPER-ENHANCER LANDSCAPE REVEALS LEUKEMIA STEM CELL RELIANCE ON X-BOX BINDING PROTEIN 1 AS A THERAPEUTIC VULNERABILITY |
| 5862 |
SUPERTAG METHYLATION-SPECIFIC DIGITAL KARYOTYPING REVEALS UREMIA-INDUCED EPIGENETIC DYSREGULATION OF ATHEROSCLEROSIS-RELATED GENES |
| 5863 |
SUPPRESSION OF ALLERGIC ASTHMA BY LOSS OF FUNCTION OF MIZ1-MEDIATED TH1 SKEWING |
| 5864 |
SUPPRESSION OF ELF4 IN ULCERATIVE COLITIS PREDISPOSES HOST TO COLORECTAL CANCER |
| 5865 |
SUPPRESSION OF HDAC2 IN SPINAL CORD ALLEVIATES MECHANICAL HYPERALGESIA AND RESTORES KCC2 EXPRESSION IN A RAT MODEL OF BONE CANCER PAIN |
| 5866 |
SUPPRESSION OF MICRORNA-9-5P RESCUES LEARNING AND MEMORY IN CHRONIC CEREBRAL HYPOPERFUSION RATS MODEL |
| 5867 |
SUPPRESSIVE EFFECT OF THE HISTONE DEACETYLASE INHIBITOR SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) ON HEPATITIS C VIRUS REPLICATION |
| 5868 |
SUPPRESSIVE EFFECTS OF METFORMIN ON T-HELPER 1-RELATED CHEMOKINES EXPRESSION IN THE HUMAN MONOCYTIC LEUKEMIA CELL LINE THP-1 |
| 5869 |
SUSCEPTIBILITY TO STRESS-INDUCED VISCERAL SENSITIVITY: A BAD LEGACY FOR NEXT GENERATIONS |
| 5870 |
SUSTAINED KNOCKDOWN OF A DISEASE-CAUSING GENE IN PATIENT-SPECIFIC INDUCED PLURIPOTENT STEM CELLS USING LENTIVIRAL VECTOR-BASED GENE THERAPY |
| 5871 |
SUSTAINED NF-KAPPAB ACTIVITY IN CHRONIC LYMPHOCYTIC LEUKEMIA IS INDEPENDENT OF GENETIC AND EPIGENETIC ALTERATIONS IN THE TNFAIP3 (A20) LOCUS |
| 5872 |
SUSTAINED TNF-ALPHA STIMULATION LEADS TO TRANSCRIPTIONAL MEMORY THAT GREATLY ENHANCES SIGNAL SENSITIVITY AND ROBUSTNESS |
| 5873 |
SWEET SUCCESS, BITTER DEFEAT: A TASTE PHENOTYPE PREDICTS SOCIAL STATUS IN SELECTIVELY BRED RATS |
| 5874 |
SWIMMING EXERCISE REVERSES CUMS-INDUCED CHANGES IN DEPRESSION-LIKE BEHAVIORS AND HIPPOCAMPAL PLASTICITY-RELATED PROTEINS |
| 5875 |
SYMPTOMS OF ALLERGIC RHINITIS IN WOMEN DURING EARLY PREGNANCY ARE ASSOCIATED WITH HIGHER PREVALENCE OF ALLERGIC RHINITIS IN THEIR OFFSPRING |
| 5876 |
SYNAPTIC PLASTICITY AND PAIN AVERSION |
| 5877 |
SYNERGIC ACTION OF L-ACETYLCARNITINE AND L-METHYLFOLATE IN MOUSE MODELS OF STRESS-RELATED DISORDERS AND HUMAN IPSC-DERIVED DOPAMINERGIC NEURONS |
| 5878 |
SYNERGISTIC EFFECTS OF HYPERANDROGENEMIA AND OBESOGENIC WESTERN-STYLE DIET ON TRANSCRIPTION AND DNA METHYLATION IN VISCERAL ADIPOSE TISSUE OF NONHUMAN PRIMATES |
| 5879 |
SYNTHETIC MITOCHONDRIA AS THERAPEUTICS AGAINST SYSTEMIC AGING: A HYPOTHESIS |
| 5880 |
SYNTHETIC RETINOIDS BEYOND CANCER THERAPY |
| 5881 |
SYSTEMATIC INTEGRATED ANALYSIS OF GENETIC AND EPIGENETIC VARIATION IN DIABETIC KIDNEY DISEASE |
| 5882 |
SYSTEMATIC REVIEW OF LUNG FUNCTION AND COPD WITH PERIPHERAL BLOOD DNA METHYLATION IN POPULATION BASED STUDIES |
| 5883 |
SYSTEMIC AND AIRWAY EPIGENETIC DISRUPTIONS ARE ASSOCIATED WITH HEALTH STATUS IN COPD |
| 5884 |
SYSTEMIC INFLAMMATION AND BIOLOGICAL AGING IN THE HEALTH AND RETIREMENT STUDY |
| 5885 |
SYSTEMIC LUPUS ERYTHEMATOSUS FOLLOWING HUMAN PAPILLOMAVIRUS VACCINATION: A CASE-BASED REVIEW |
| 5886 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
| 5887 |
SYSTEMIC STEROID EXPOSURE IS ASSOCIATED WITH DIFFERENTIAL METHYLATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 5888 |
SYSTEMIC TRANSCRIPTIONAL ALTERATIONS OF INNATE AND ADAPTIVE IMMUNE SIGNALING PATHWAYS IN ATHEROSCLEROSIS, ISCHEMIA STROKE, AND MYOCARDIAL INFARCTION |
| 5889 |
SYSTEMS APPROACHES TO MODELING CHRONIC MUCOSAL INFLAMMATION |
| 5890 |
SYSTEMS BIOLOGY ELUCIDATES COMMON PATHOGENIC MECHANISMS BETWEEN NONALCOHOLIC AND ALCOHOLIC-FATTY LIVER DISEASE |
| 5891 |
SYSTEMS BIOLOGY IN CHRONIC HEART FAILURE-IDENTIFICATION OF POTENTIAL MIRNA REGULATORS |
| 5892 |
SYSTEMS GENETICS VIEW OF ENDOMETRIOSIS: A COMMON COMPLEX DISORDER |
| 5893 |
SYSTEMS MEDICINE DESIGN BASED ON SYSTEMS BIOLOGY APPROACHES AND DEEP NEURAL NETWORK FOR GASTRIC CANCER |
| 5894 |
T CELL EPIGENETIC REMODELING AND ACCELERATED EPIGENETIC AGING ARE LINKED TO LONG-TERM IMMUNE ALTERATIONS IN CHILDHOOD CANCER SURVIVORS |
| 5895 |
T CELL EXHAUSTION: AN EPIGENETICALLY IMPRINTED PHENOTYPIC AND FUNCTIONAL MAKEOVER |
| 5896 |
T CELLS IN HEALTH AND DISEASE |
| 5897 |
T FOLLICULAR HELPER CELL-DEPENDENT CLEARANCE OF A PERSISTENT VIRUS INFECTION REQUIRES T CELL EXPRESSION OF THE HISTONE DEMETHYLASE UTX |
| 5898 |
T(H)2 CELL DEVELOPMENT AND FUNCTION |
| 5899 |
T-CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA FROM AN EPIGENETIC PERSPECTIVE |
| 5900 |
T-CELL EXHAUSTION IN ORGAN TRANSPLANTATION |
| 5901 |
T-CELL HETEROGENEITY, PROGENITOR-PROGENY RELATIONSHIPS, AND FUNCTION DURING LATENT AND CHRONIC VIRAL INFECTIONS |
| 5902 |
T-HELPER 17 CELL POLARIZATION IN PULMONARY ARTERIAL HYPERTENSION |
| 5903 |
T3/TRS AXIS IN HEPATOCELLULAR CARCINOMA: NEW CONCEPTS FOR AN OLD PAIR |
| 5904 |
T677T METHYLENETETRAHYDROFOLATE REDUCTASE SINGLE NUCLEOTIDE POLYMORPHISMS INCREASED PREVALENCE IN A SUBGROUP OF INFERTILE PATIENTS WITH ENDOMETRIOSIS |
| 5905 |
TACKLING THE HETEROGENEITY OF CVID |
| 5906 |
TAKAYASU ARTERITIS RISK LOCUS IN IL6 REPRESSES THE ANTI-INFLAMMATORY GENE GPNMB THROUGH CHROMATIN LOOPING AND RECRUITING MEF2-HDAC COMPLEX |
| 5907 |
TARGET-BASED SMALL MOLECULE DRUG DISCOVERY TOWARDS NOVEL THERAPEUTICS FOR INFLAMMATORY BOWEL DISEASES |
| 5908 |
TARGETED DE-METHYLATION OF THE FOXP3-TSDR IS SUFFICIENT TO INDUCE PHYSIOLOGICAL FOXP3 EXPRESSION BUT NOT A FUNCTIONAL TREG PHENOTYPE |
| 5909 |
TARGETED DEEP SEQUENCING OF PLASMA CIRCULATING CELL-FREE DNA REVEALS VIMENTIN AND FIBULIN 1 AS POTENTIAL EPIGENETIC BIOMARKERS FOR HEPATOCELLULAR CARCINOMA |
| 5910 |
TARGETED EPIGENETIC EDITING OF SPDEF REDUCES MUCUS PRODUCTION IN LUNG EPITHELIAL CELLS |
| 5911 |
TARGETED NEXT-GENERATION SEQUENCING IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA AIDS DIAGNOSIS IN CHALLENGING CASES AND IDENTIFIES FREQUENT SPLICEOSOME MUTATIONS IN TRANSFORMED ACUTE MYELOID LEUKEMIA |
| 5912 |
TARGETED THERAPIES IN SYSTEMIC LUPUS ERYTHEMATOSUS |
| 5913 |
TARGETED THERAPY IN LEUKEMIA |
| 5914 |
TARGETED-BISULFITE SEQUENCE ANALYSIS OF THE METHYLATION OF CPG ISLANDS IN GENES ENCODING PNPLA3, SAMM50, AND PARVB OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE |
| 5915 |
TARGETING A PHOSPHO-STAT3-MIRNAS PATHWAY IMPROVES VESICULAR HEPATIC STEATOSIS IN AN IN VITRO AND IN VIVO MODEL |
| 5916 |
TARGETING AGING PATHWAYS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 5917 |
TARGETING BCL-2 IN B-CELL MALIGNANCIES AND OVERCOMING THERAPEUTIC RESISTANCE |
| 5918 |
TARGETING BMI-1 IN B CELLS RESTORES EFFECTIVE HUMORAL IMMUNE RESPONSES AND CONTROLS CHRONIC VIRAL INFECTION |
| 5919 |
TARGETING CELLULAR SENESCENCE FOR AGE-RELATED DISEASES: PATH TO CLINICAL TRANSLATION |
| 5920 |
TARGETING CHROMATIN REMODELING IN INFLAMMATION AND FIBROSIS |
| 5921 |
TARGETING CLINICAL EPIGENETIC REPROGRAMMING FOR CHEMOPREVENTION OF METABOLIC AND VIRAL HEPATOCELLULAR CARCINOMA |
| 5922 |
TARGETING DNA METHYLATION AND DEMETHYLATION IN DIABETIC FOOT ULCERS |
| 5923 |
TARGETING DNA METHYLATION IN PODOCYTES TO OVERCOME CHRONIC KIDNEY DISEASE |
| 5924 |
TARGETING DNMT1 BY DEMETHYLATING AGENT OR-2100 INCREASES TYROSINE KINASE INHIBITORS-SENSITIVITY AND DEPLETES LEUKEMIC STEM CELLS IN CHRONIC MYELOID LEUKEMIA |
| 5925 |
TARGETING EPIGENETIC DNA AND HISTONE MODIFICATIONS TO TREAT KIDNEY DISEASE |
| 5926 |
TARGETING EPIGENETIC MECHANISMS FOR CHRONIC PAIN: A VALID APPROACH FOR THE DEVELOPMENT OF NOVEL THERAPEUTICS |
| 5927 |
TARGETING EPIGENETIC MECHANISMS FOR CHRONIC VISCERAL PAIN: A VALID APPROACH FOR THE DEVELOPMENT OF NOVEL THERAPEUTICS |
| 5928 |
TARGETING EPIGENETIC MECHANISMS FOR PAIN RELIEF |
| 5929 |
TARGETING EPIGENETIC MECHANISMS IN PERIODONTAL DISEASES |
| 5930 |
TARGETING EPIGENETIC MECHANISMS TO TREAT ALCOHOL USE DISORDERS (AUD) |
| 5931 |
TARGETING EPIGENETIC MODIFIERS TO REPROGRAMME MACROPHAGES IN NON-RESOLVING INFLAMMATION-DRIVEN ATHEROSCLEROSIS |
| 5932 |
TARGETING EPIGENETIC REGULATORS FOR INFLAMMATION: MECHANISMS AND INTERVENTION THERAPY |
| 5933 |
TARGETING EPIGENETICS AND NON-CODING RNAS IN ATHEROSCLEROSIS: FROM MECHANISMS TO THERAPEUTICS |
| 5934 |
TARGETING FEATURES OF CURAXIN CBL0137 ON HEMATOLOGICAL MALIGNANCIES IN VITRO AND IN VIVO |
| 5935 |
TARGETING GATA1 AND P2X7R LOCUS BINDING IN SPINAL ASTROCYTES SUPPRESSES CHRONIC VISCERAL PAIN BY PROMOTING DNA DEMETHYLATION |
| 5936 |
TARGETING HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA AND HEPATITIS B VIRUS X PROTEIN: RECENT ADVANCES AND NEW APPROACHES |
| 5937 |
TARGETING HISTONE DEACETYLASE ACTIVITY IN RHEUMATOID ARTHRITIS AND ASTHMA AS PROTOTYPES OF INFLAMMATORY DISEASE: SHOULD WE KEEP OUR HATS ON? CELLULAR ACTIVATION, PROLIFERATION AND SURVIVAL IN CHRONIC INFLAMMATORY DISEASES IS REGULATED NOT ONLY BY ENGAGEMENT OF SIGNAL TRANS-DUCTION PATHWAYS THAT MODULATE TRANSCRIPTION FACTORS REQUIRED FOR THESE PROCESSES, BUT ALSO BY EPIGENETIC REGULATION OF TRANSCRIPTION FACTOR ACCESS TO GENE PROMOTER REGIONS |
| 5938 |
TARGETING INDUCIBLE EPIGENETIC REPROGRAMMING PATHWAYS IN CHRONIC AIRWAY REMODELING |
| 5939 |
TARGETING MECHANOTRANSDUCTION AT THE TRANSCRIPTIONAL LEVEL: YAP AND BRD4 ARE NOVEL THERAPEUTIC TARGETS FOR THE REVERSAL OF LIVER FIBROSIS |
| 5940 |
TARGETING METHYLTRANSFERASE PRMT5 ELIMINATES LEUKEMIA STEM CELLS IN CHRONIC MYELOGENOUS LEUKEMIA |
| 5941 |
TARGETING MICRORNAS WITH THYMOQUINONE: A NEW APPROACH FOR CANCER THERAPY |
| 5942 |
TARGETING OF CELLULAR REDOX METABOLISM FOR MITIGATION OF RADIATION INJURY |
| 5943 |
TARGETING OXIDATIVE STRESS IN CANCER |
| 5944 |
TARGETING SMALL MOLECULE TYROSINE KINASES BY POLYPHENOLS: NEW MOVE TOWARDS ANTI-TUMOR DRUG DISCOVERY |
| 5945 |
TARGETING THE "HALLMARKS OF AGING" TO SLOW AGING AND TREAT AGE-RELATED DISEASE: FACT OR FICTION? AGING IS A MAJOR RISK FACTOR FOR A NUMBER OF CHRONIC DISEASES, INCLUDING NEURODEGENERATIVE AND CEREBROVASCULAR DISORDERS |
| 5946 |
TARGETING THE EPIGENOME IN THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 5947 |
TARGETING THE EPIGENOME: SCREENING BIOACTIVE COMPOUNDS THAT REGULATE HISTONE DEACETYLASE ACTIVITY |
| 5948 |
TARGETING THE MOLECULAR & CELLULAR PILLARS OF HUMAN AGING WITH EXERCISE |
| 5949 |
TARGETING THE PRC2-DEPENDENT EPIGENETIC PROGRAM ALLEVIATES URINARY TRACT INFECTIONS |
| 5950 |
TARGETING THE PROGRESSION OF CHRONIC KIDNEY DISEASE |
| 5951 |
TARGETING THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM TO PREVENT HYPERTENSION AND KIDNEY DISEASE OF DEVELOPMENTAL ORIGINS |
| 5952 |
TARGETING VIRAL CCCDNA FOR CURE OF CHRONIC HEPATITIS B |
| 5953 |
TARGETS IN MPNS AND POTENTIAL THERAPEUTICS |
| 5954 |
TBI-INDUCED NOCICEPTIVE SENSITIZATION IS REGULATED BY HISTONE ACETYLATION |
| 5955 |
TELBIVUDINE TREATMENT CORRECTS HBV-INDUCED EPIGENETIC ALTERATIONS IN LIVER CELLS OF PATIENTS WITH CHRONIC HEPATITIS B |
| 5956 |
TELOMERE AND TELOMERASE: BIOLOGICAL MARKERS OF ORGANIC VITAL FORCE STATE AND HOMEOPATHIC TREATMENT EFFECTIVENESS |
| 5957 |
TELOMERE LENGTH AND EPIGENETIC AGE ACCELERATION IN ADOLESCENTS WITH ANXIETY DISORDERS |
| 5958 |
TELOMERE LENGTH AND SALIVARY CORTISOL STRESS REACTIVITY IN VERY PRETERM INFANTS |
| 5959 |
TELOMERE LENGTH AS A MARKER OF BIOLOGICAL AGE: STATE-OF-THE-ART, OPEN ISSUES, AND FUTURE PERSPECTIVES |
| 5960 |
TELOMERE LENGTH IN HEPATOCELLULAR CARCINOMA AND PAIRED ADJACENT NON-TUMOR TISSUES BY QUANTITATIVE PCR |
| 5961 |
TELOMERE LENGTH IN PRETERM INFANTS: A PROMISING BIOMARKER OF EARLY ADVERSITY AND CARE IN THE NEONATAL INTENSIVE CARE UNIT? PRETERM INFANTS PRESENT AN IMMATURE NEUROBEHAVIORAL PROFILE AT BIRTH, EVEN IN ABSENCE OF SEVERE BRAIN INJURIES AND PERINATAL COMPLICATIONS |
| 5962 |
TELOMERES, OXIDATIVE STRESS, AND TIMING FOR SPONTANEOUS TERM AND PRETERM LABOR |
| 5963 |
TEM STUDY OF CHRONIC ALCOHOLISM EFFECTS ON EARLY CARCINOGENESIS BY PROBING THE NANOSCALE STRUCTURAL ALTERATIONS OF CELL NUCLEI |
| 5964 |
TEMPORAL VARIABILITY OF GLOBAL DNA METHYLATION AND HYDROXYMETHYLATION IN BUCCAL CELLS OF HEALTHY ADULTS: ASSOCIATION WITH AIR POLLUTION |
| 5965 |
TEN-ELEVEN-TRANSLOCATION 2 (TET2) NEGATIVELY REGULATES HOMEOSTASIS AND DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS IN MICE |
| 5966 |
TERMINAL ADDITION IN A CELLULAR WORLD |
| 5967 |
TERMINATION OF ACUTE STRESS RESPONSE BY THE ENDOCANNABINOID SYSTEM IS REGULATED THROUGH LYSINE-SPECIFIC DEMETHYLASE 1-MEDIATED TRANSCRIPTIONAL REPRESSION OF 2-AG HYDROLASES ABHD6 AND MAGL |
| 5968 |
TERPENOID TREATMENT IN OSTEOPOROSIS: THIS IS WHERE WE HAVE COME IN RESEARCH |
| 5969 |
TERT PROMOTER MUTATIONS IN PRIMARY LIVER TUMORS |
| 5970 |
TESTOSTERONE ACTS WITHIN THE MEDIAL AMYGDALA OF RATS TO REDUCE INNATE FEAR TO PREDATOR ODOR AKIN TO THE EFFECTS OF TOXOPLASMA GONDII INFECTION |
| 5971 |
TET PROTEINS AND 5-METHYLCYTOSINE OXIDATION IN HEMATOLOGICAL CANCERS |
| 5972 |
TET REPRESSION AND INCREASED DNMT ACTIVITY SYNERGISTICALLY INDUCE ABERRANT DNA METHYLATION |
| 5973 |
TET-CATALYZED 5-HYDROXYMETHYLATION PRECEDES HNF4A PROMOTER CHOICE DURING DIFFERENTIATION OF BIPOTENT LIVER PROGENITORS |
| 5974 |
TET1 IN NUCLEUS ACCUMBENS OPPOSES DEPRESSION- AND ANXIETY-LIKE BEHAVIORS |
| 5975 |
TET1 IS AN IMPORTANT TRANSCRIPTIONAL ACTIVATOR OF TNFALPHA EXPRESSION IN MACROPHAGES |
| 5976 |
TET1-DEPENDENT EPIGENETIC MODIFICATION OF BDNF EXPRESSION IN DORSAL HORN NEURONS MEDIATES NEUROPATHIC PAIN IN RATS |
| 5977 |
TET1-TRPV4 SIGNALING CONTRIBUTES TO BONE CANCER PAIN IN RATS |
| 5978 |
TET2 AND TET3 IN B CELLS ARE REQUIRED TO REPRESS CD86 AND PREVENT AUTOIMMUNITY |
| 5979 |
TET2 MUTATIONS ARE ASSOCIATED WITH SPECIFIC 5-METHYLCYTOSINE AND 5-HYDROXYMETHYLCYTOSINE PROFILES IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 5980 |
TET2 MUTATIONS WERE PREDICTIVE OF INFERIOR PROGNOSIS IN THE PRESENCE OF ASXL1 MUTATIONS IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 5981 |
TET2 PROMOTES PATHOGEN INFECTION-INDUCED MYELOPOIESIS THROUGH MRNA OXIDATION |
| 5982 |
TET2 REGULATES IMMUNE TOLERANCE IN CHRONICALLY ACTIVATED MAST CELLS |
| 5983 |
TET2 RESTRAINS INFLAMMATORY GENE EXPRESSION IN MACROPHAGES |
| 5984 |
TET2, DNMT3A, IDH1, AND JAK2 MUTATION IN MYELOPROLIFERATIVE NEOPLASMS IN SOUTHERN IRAN |
| 5985 |
TET2-MEDIATED CLONAL HEMATOPOIESIS ACCELERATES HEART FAILURE THROUGH A MECHANISM INVOLVING THE IL-1BETA/NLRP3 INFLAMMASOME |
| 5986 |
TFEB IS A CENTRAL REGULATOR OF THE AGING PROCESS AND AGE-RELATED DISEASES |
| 5987 |
TGF-BETA SIGNAL SHIFTING BETWEEN TUMOR SUPPRESSION AND FIBRO-CARCINOGENESIS IN HUMAN CHRONIC LIVER DISEASES |
| 5988 |
TGF-BETA/SMAD AND RENAL FIBROSIS |
| 5989 |
TGF-BETA/SMAD PATHWAY IS MODULATED BY MIR-26B-5P: ANOTHER PIECE IN THE PUZZLE OF CHRONIC LYMPHOCYTIC LEUKEMIA PROGRESSION |
| 5990 |
TGF-BETA1 PROMOTES EXPRESSION OF FIBROSIS-RELATED GENES THROUGH THE INDUCTION OF HISTONE VARIANT H3 |
| 5991 |
TGF-BETA1/SMAD SIGNALLING IN PROLIFERATIVE GLOMERULONEPHRITIS ASSOCIATED WITH AUTOIMMUNE DISEASES |
| 5992 |
TGF-BETA: THE MASTER REGULATOR OF FIBROSIS |
| 5993 |
TGFBETA PROMOTES FIBROSIS BY MYST1-DEPENDENT EPIGENETIC REGULATION OF AUTOPHAGY |
| 5994 |
TGFBETA-INCURRED EPIGENETIC ABERRATIONS OF MIRNA AND DNA METHYLTRANSFERASE SUPPRESS KLOTHO AND POTENTIATE RENAL FIBROSIS |
| 5995 |
TGFBETA-INDUCED FIBROBLAST ACTIVATION REQUIRES PERSISTENT AND TARGETED HDAC-MEDIATED GENE REPRESSION |
| 5996 |
TH2 CELLS IN HEALTH AND DISEASE |
| 5997 |
THE "METABOLIC MEMORY" THEORY AND THE EARLY TREATMENT OF HYPERGLYCEMIA IN PREVENTION OF DIABETIC COMPLICATIONS |
| 5998 |
THE ABERRANT EPIGENETIC MODIFICATIONS IN THE PATHOGENESIS OF PSORIASIS |
| 5999 |
THE ACETYLOME REGULATORS HDAC1 AND HDAC2 DIFFERENTLY MODULATE INTESTINAL EPITHELIAL CELL DEPENDENT HOMEOSTATIC RESPONSES IN EXPERIMENTAL COLITIS |
| 6000 |
THE ACTIVATION OF HISTONE DEACETYLASES 4 PREVENTED ENDOTHELIAL DYSFUNCTION: A CRUCIAL MECHANISM OF HUANGQIGUIZHIWUWU DECOCTION IN IMPROVING MICROCIRCULATION DYSFUNCTION IN DIABETES |
| 6001 |
THE ACUTE KIDNEY INJURY TO CHRONIC KIDNEY DISEASE TRANSITION: A POTENTIAL OPPORTUNITY TO IMPROVE CARE IN ACUTE KIDNEY INJURY |
| 6002 |
THE ADAPTIVE BACTERIAL IMMUNE SYSTEM CRISPR-CAS AND ITS THERAPEUTIC POTENTIAL |
| 6003 |
THE ADAPTIVE IMMUNE SYSTEM IN MULTIPLE SCLEROSIS: AN ESTROGEN-MEDIATED POINT OF VIEW |
| 6004 |
THE AID DILEMMA: INFECTION, OR CANCER? ACTIVATION-INDUCED CYTIDINE DEAMINASE (AID), WHICH IS BOTH ESSENTIAL AND SUFFICIENT FOR FORMING ANTIBODY MEMORY, IS ALSO LINKED TO TUMORIGENESIS |
| 6005 |
THE AIRWAY EPITHELIUM-A CENTRAL PLAYER IN ASTHMA PATHOGENESIS |
| 6006 |
THE ALTERATIONS IN AND THE ROLE OF THE TH17/TREG BALANCE IN METABOLIC DISEASES |
| 6007 |
THE ANATOMY OF PAIN AND SUFFERING IN THE BRAIN AND ITS CLINICAL IMPLICATIONS |
| 6008 |
THE ANTI-INFLAMMATORY AGENT 5-ASA REDUCES THE LEVEL OF SPECIFIC TSRNAS IN SPERM CELLS OF HIGH-FAT FED C57BL/6J MOUSE SIRES AND IMPROVES GLUCOSE TOLERANCE IN FEMALE OFFSPRING |
| 6009 |
THE ANTI-INFLAMMATORY MEDIATOR, VASOACTIVE INTESTINAL PEPTIDE, MODULATES THE DIFFERENTIATION AND FUNCTION OF TH SUBSETS IN RHEUMATOID ARTHRITIS |
| 6010 |
THE ANTIMICROBIAL PEPTIDE GAMMA-THIONIN FROM HABANERO CHILE (CAPSICUM CHINENSE) INDUCES CASPASE-INDEPENDENT APOPTOSIS ON HUMAN K562 CHRONIC MYELOID LEUKEMIA CELLS AND REGULATES EPIGENETIC MARKS |
| 6011 |
THE ANTIRESECTION ACTIVITY OF THE X PROTEIN ENCODED BY HEPATITIS VIRUS B |
| 6012 |
THE APKC-CBP PATHWAY REGULATES POST-STROKE NEUROVASCULAR REMODELING AND FUNCTIONAL RECOVERY |
| 6013 |
THE APPLICATIONS OF DNA METHYLATION AS A BIOMARKER IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW |
| 6014 |
THE ARCHITECTURAL DESIGN OF CD8+ T CELL RESPONSES IN ACUTE AND CHRONIC INFECTION: PARALLEL STRUCTURES WITH DIVERGENT FATES |
| 6015 |
THE ARGININE METHYLTRANSFERASE PRMT7 PROMOTES EXTRAVASATION OF MONOCYTES RESULTING IN TISSUE INJURY IN COPD |
| 6016 |
THE ASSOCIATION BETWEEN HEPATOCARCINOGENESIS AND INTRACELLULAR ALTERATIONS DUE TO HEPATITIS B VIRUS INFECTION |
| 6017 |
THE ASSOCIATION OF ACCELERATED EPIGENETIC AGE WITH ALL-CAUSE MORTALITY IN CARDIAC CATHETERIZATION PATIENTS AS MEDIATED BY VASCULAR AND CARDIOMETABOLIC OUTCOMES |
| 6018 |
THE ASSOCIATION OF EPIGENETIC AGE ACCELERATION AND MULTIMORBIDITY AT AGE 90 IN THE WOMEN'S HEALTH INITIATIVE |
| 6019 |
THE ASSOCIATION OF HTR3A MRNA EXPRESSION AND CRAVING IN HAN CHINESE ALCOHOL-DEPENDENT PATIENTS: A PRELIMINARY STUDY |
| 6020 |
THE ATTENUATION OF RENAL FIBROSIS BY HISTONE DEACETYLASE INHIBITORS IS ASSOCIATED WITH THE PLASTICITY OF FOXP3(+)IL-17(+) T CELLS |
| 6021 |
THE BENEFICIAL AND DEBILITATING EFFECTS OF ENVIRONMENTAL AND MICROBIAL TOXINS, DRUGS, ORGANIC SOLVENTS AND HEAVY METALS ON THE ONSET AND PROGRESSION OF MULTIPLE SCLEROSIS |
| 6022 |
THE BENEFICIAL EFFECTS OF ZN ON AKT-MEDIATED INSULIN AND CELL SURVIVAL SIGNALING PATHWAYS IN DIABETES |
| 6023 |
THE BET PROTAC INHIBITOR DBET6 PROTECTS AGAINST RETINAL DEGENERATION AND INHIBITS THE CGAS-STING IN RESPONSE TO LIGHT DAMAGE |
| 6024 |
THE BIOCHEMISTRY AND EPIGENETICS OF EPILEPSY: FOCUS ON ADENOSINE AND GLYCINE |
| 6025 |
THE BIOLOGY OF CHRONIC PAIN AND ITS IMPLICATIONS FOR PAIN NEUROSCIENCE EDUCATION: STATE OF THE ART |
| 6026 |
THE BIOLOGY OF STRESS INTOLERANCE IN PATIENTS WITH CHRONIC PAIN-STATE OF THE ART AND FUTURE DIRECTIONS |
| 6027 |
THE BLOOD DNA METHYLATION CLOCK GRIMAGE IS A ROBUST SURROGATE FOR AIRWAY EPITHELIA AGING |
| 6028 |
THE BMI1 POLYCOMB PROTEIN REPRESSES CYCLIN G2-INDUCED AUTOPHAGY TO SUPPORT PROLIFERATION IN CHRONIC MYELOID LEUKEMIA CELLS |
| 6029 |
THE BURDEN OF DIABETES: EMERGING DATA |
| 6030 |
THE BURGEONING CARDIOVASCULAR DISEASE EPIDEMIC IN INDIANS - PERSPECTIVES ON CONTEXTUAL FACTORS AND POTENTIAL SOLUTIONS |
| 6031 |
THE CANCER EPIGENOME: ITS ORIGINS, CONTRIBUTIONS TO TUMORIGENESIS, AND TRANSLATIONAL IMPLICATIONS |
| 6032 |
THE CARCINOGENIC INITIATING AND PROMOTING PROPERTIES OF A LIGHTLY REFINED PARAFFINIC OIL |
| 6033 |
THE CELLULAR AND MOLECULAR BASES OF LEPTIN AND GHRELIN RESISTANCE IN OBESITY |
| 6034 |
THE CHALLENGE BY MULTIPLE ENVIRONMENTAL AND BIOLOGICAL FACTORS INDUCE INFLAMMATION IN AGING: THEIR ROLE IN THE PROMOTION OF CHRONIC DISEASE |
| 6035 |
THE CHALLENGES OF LONG-TERM TRANSCRIPTIONAL GENE SILENCING BY RNA VIRUSES |
| 6036 |
THE CHARACTERISTICS OF EXTRACHROMOSOMAL CIRCULAR DNA IN PATIENTS WITH END-STAGE RENAL DISEASE |
| 6037 |
THE CHD6 CHROMATIN REMODELER IS AN OXIDATIVE DNA DAMAGE RESPONSE FACTOR |
| 6038 |
THE CHEMICAL DEFENSIVE SYSTEM IN THE PATHOBIOLOGY OF IDIOPATHIC ENVIRONMENT-ASSOCIATED DISEASES |
| 6039 |
THE CHEMOKINE RECEPTOR CXCR2 SUPPORTS NOCICEPTIVE SENSITIZATION AFTER TRAUMATIC BRAIN INJURY |
| 6040 |
THE CHRONIC MYELOPROLIFERATIVE DISORDERS: CLONALITY AND CLINICAL HETEROGENEITY |
| 6041 |
THE CLASS III HISTONE DEACETYLASE SIRTUIN 1 IN IMMUNE SUPPRESSION AND ITS THERAPEUTIC POTENTIAL IN RHEUMATOID ARTHRITIS |
| 6042 |
THE COLON REVISITED OR THE KEY TO WELLNESS, HEALTH AND DISEASE |
| 6043 |
THE COMBINED PROGNOSTIC SIGNIFICANCE OF ALKALINE PHOSPHATASE AND INTRACRANIAL ARTERIAL CALCIFICATIONS IN HEMODIALYSIS PATIENTS |
| 6044 |
THE COMPLEX BIOLOGY OF HUMAN CYTOMEGALOVIRUS LATENCY |
| 6045 |
THE COMPLEXITY OF THE NRF2 PATHWAY: BEYOND THE ANTIOXIDANT RESPONSE |
| 6046 |
THE COMPOSITE ALLIANCE OF FTO LOCUS WITH OBESITY-RELATED GENETIC VARIANTS |
| 6047 |
THE COMPUTATIONAL ANALYSIS CONDUCTED ON MIRNA TARGET SITES IN ASSOCIATION WITH SNPS AT 3'UTR OF ADHD-IMPLICATED GENES |
| 6048 |
THE CONCEPTS OF ASTHMA ENDOTYPES AND PHENOTYPES TO GUIDE CURRENT AND NOVEL TREATMENT STRATEGIES |
| 6049 |
THE CONCURRENT DECLINE OF SOIL LEAD AND CHILDREN'S BLOOD LEAD IN NEW ORLEANS |
| 6050 |
THE CONTRIBUTION OF EPIGENETICS IN SJOGREN'S SYNDROME |
| 6051 |
THE CONTRIBUTION OF HISTONE CROTONYLATION TO TISSUE HEALTH AND DISEASE: FOCUS ON KIDNEY HEALTH |
| 6052 |
THE CROHN'S DISEASE ASSOCIATED SNP RS6651252 IMPACTS MYC GENE EXPRESSION IN HUMAN COLONIC EPITHELIAL CELLS |
| 6053 |
THE CRUCIAL ROLE OF NLRP3 INFLAMMASOME IN VIRAL INFECTION-ASSOCIATED FIBROSING INTERSTITIAL LUNG DISEASES |
| 6054 |
THE CURRENT STATE AND FUTURE OF T-CELL EXHAUSTION RESEARCH |
| 6055 |
THE CXXC1 SUBUNIT OF THE TRITHORAX COMPLEX DIRECTS EPIGENETIC LICENSING OF CD4+ T CELL DIFFERENTIATION |
| 6056 |
THE CYTIDINE N-ACETYLTRANSFERASE NAT10 PARTICIPATES IN PERIPHERAL NERVE INJURY-INDUCED NEUROPATHIC PAIN BY STABILIZING SYT9 EXPRESSION IN PRIMARY SENSORY NEURONS |
| 6057 |
THE DARK SIDE OF REGULATORY T CELLS IN PSORIASIS |
| 6058 |
THE DEFICIENCY OF N6-METHYLADENOSINE DEMETHYLASE ALKBH5 ENHANCES THE NEURODEGENERATIVE DAMAGE INDUCED BY COBALT |
| 6059 |
THE DEVELOPMENT OF A SENSITIVE FLUORESCENT PROTEIN-BASED TRANSCRIPT REPORTER FOR HIGH THROUGHPUT SCREENING OF NEGATIVE MODULATORS OF LNCRNAS |
| 6060 |
THE DEVELOPMENT OF CD8 T-CELL EXHAUSTION HETEROGENEITY AND THE THERAPEUTIC POTENTIALS IN CANCER |
| 6061 |
THE DEVELOPMENT PROSPECTION OF HDAC INHIBITORS AS A POTENTIAL THERAPEUTIC DIRECTION IN ALZHEIMER'S DISEASE |
| 6062 |
THE DEVELOPMENTAL BASIS OF EPIGENETIC REGULATION OF HTR2A AND PSYCHIATRIC OUTCOMES |
| 6063 |
THE DEVELOPMENTAL ENVIRONMENT, EPIGENETIC BIOMARKERS AND LONG-TERM HEALTH |
| 6064 |
THE DEVELOPMENTAL ORIGINS OF ADULT DISEASE |
| 6065 |
THE DEVELOPMENTAL ORIGINS OF CHRONIC PHYSICAL AGGRESSION: BIOLOGICAL PATHWAYS TRIGGERED BY EARLY LIFE ADVERSITY |
| 6066 |
THE DEVELOPMENTAL ORIGINS OF HEALTH AND CHRONIC KIDNEY DISEASE: CURRENT STATUS AND PRACTICES IN JAPAN |
| 6067 |
THE DIABETES MELLITUS-ATHEROSCLEROSIS CONNECTION: THE ROLE OF LIPID AND GLUCOSE METABOLISM AND CHRONIC INFLAMMATION |
| 6068 |
THE DIET AS A CAUSE OF HUMAN PROSTATE CANCER |
| 6069 |
THE DIOXIN RECEPTOR IS SILENCED BY PROMOTER HYPERMETHYLATION IN HUMAN ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH INHIBITION OF SP1 BINDING |
| 6070 |
THE DISCOVAIR PROJECT: A ROADMAP TOWARDS THE HUMAN LUNG CELL ATLAS |
| 6071 |
THE DNA METHYLATION INHIBITOR 5-AZACYTIDINE INCREASES REGULATORY T CELLS AND ALLEVIATES AIRWAY INFLAMMATION IN OVALBUMIN-SENSITIZED MICE |
| 6072 |
THE DNA METHYLOME OF HUMAN VASCULAR ENDOTHELIUM AND ITS USE IN LIQUID BIOPSIES |
| 6073 |
THE DRESDEN BURNOUT STUDY: PROTOCOL OF A PROSPECTIVE COHORT STUDY FOR THE BIO-PSYCHOLOGICAL INVESTIGATION OF BURNOUT |
| 6074 |
THE DYNAMIC CHROMATIN ARCHITECTURE OF THE REGENERATING LIVER |
| 6075 |
THE DYNAMICS AND PLASTICITY OF EPIGENETICS IN DIABETIC KIDNEY DISEASE: THERAPEUTIC APPLICATIONS VIS-A-VIS |
| 6076 |
THE DYNAMICS OF NUCLEAR RECEPTORS AND NUCLEAR RECEPTOR COREGULATORS IN THE PATHOGENESIS OF ENDOMETRIOSIS |
| 6077 |
THE EFFECT OF CD4 RECEPTOR DOWNREGULATION AND ITS DOWNSTREAM SIGNALING MOLECULES ON HIV-1 LATENCY |
| 6078 |
THE EFFECT OF CHRONIC ARSENIC EXPOSURE IN ZEBRAFISH |
| 6079 |
THE EFFECT OF CXCL12 PROCESSING ON CD34+ CELL MIGRATION IN MYELOPROLIFERATIVE NEOPLASMS |
| 6080 |
THE EFFECT OF DNA METHYLATION IN THE DEVELOPMENT AND PROGRESSION OF CHRONIC KIDNEY DISEASE IN THE GENERAL POPULATION: AN EPIGENOME-WIDE ASSOCIATION STUDY USING THE KOREAN GENOME AND EPIDEMIOLOGY STUDY DATABASE |
| 6081 |
THE EFFECT OF FOXO GENE FAMILY VARIANTS AND GLOBAL DNA METYLATION ON RRMS DISEASE |
| 6082 |
THE EFFECT OF MORPHINE UPON DNA METHYLATION IN TEN REGIONS OF THE RAT BRAIN |
| 6083 |
THE EFFECT OF SMOKING ON DNA METHYLATION OF PERIPHERAL BLOOD MONONUCLEAR CELLS FROM AFRICAN AMERICAN WOMEN |
| 6084 |
THE EFFECT OF TRAINING ABOUT ENVIRONMENTAL TOXICANT BISPHENOL-A EXPOSURE IN PREGNANCY ON MATERNAL URINE BISPHENOL-A LEVEL |
| 6085 |
THE EFFECTS OF ACARBOSE ON CHEMOKINE AND CYTOKINE PRODUCTION IN HUMAN MONOCYTIC THP-1 CELLS |
| 6086 |
THE EFFECTS OF ACETALDEHYDE EXPOSURE ON HISTONE MODIFICATIONS AND CHROMATIN STRUCTURE IN HUMAN LUNG BRONCHIAL EPITHELIAL CELLS |
| 6087 |
THE EFFECTS OF AEROBIC AND ANAEROBIC EXERCISES ON CIRCULATING SOLUBLE-KLOTHO AND IGF-I IN YOUNG AND ELDERLY ADULTS AND IN CAD PATIENTS |
| 6088 |
THE EFFECTS OF ASSISTED REPRODUCTION TECHNOLOGIES ON METABOLIC HEALTH AND DISEASEDAGGER |
| 6089 |
THE EFFECTS OF DEPRESSION AND USE OF ANTIDEPRESSIVE MEDICINES DURING PREGNANCY ON THE METHYLATION STATUS OF THE IGF2 IMPRINTED CONTROL REGIONS IN THE OFFSPRING |
| 6090 |
THE EFFECTS OF EARLY LIFE ADVERSITY ON THE IMMUNE SYSTEM |
| 6091 |
THE EFFECTS OF ENDOCRINE DISRUPTORS ON ADIPOGENESIS AND OSTEOGENESIS IN MESENCHYMAL STEM CELLS: A REVIEW |
| 6092 |
THE EFFECTS OF EPIGENETIC MODIFICATION ON THE OCCURRENCE AND PROGRESSION OF LIVER DISEASES AND THE INVOLVED MECHANISM |
| 6093 |
THE EFFECTS OF HIGH GLUCOSE EXPOSURE ON GLOBAL GENE EXPRESSION AND DNA METHYLATION IN HUMAN PANCREATIC ISLETS |
| 6094 |
THE EFFECTS OF MATERNAL AND POSTNATAL DIETARY METHYL NUTRIENTS ON EPIGENETIC CHANGES THAT LEAD TO NON-COMMUNICABLE DISEASES IN ADULTHOOD |
| 6095 |
THE EFFECTS OF SINGLE-DOSE INJECTIONS OF MODAFINIL AND METHAMPHETAMINE ON EPIGENETIC AND FUNCTIONAL MARKERS IN THE MOUSE MEDIAL PREFRONTAL CORTEX: POTENTIAL ROLE OF DOPAMINE RECEPTORS |
| 6096 |
THE EFFECTS OF STRESS AND MEDITATION ON THE IMMUNE SYSTEM, HUMAN MICROBIOTA, AND EPIGENETICS |
| 6097 |
THE EFFECTS OF STRESS ON GLUTAMATERGIC TRANSMISSION IN THE BRAIN |
| 6098 |
THE EFFECTS OF VALPROIC ACID ON SKIN HEALING: EXPERIMENTAL STUDY IN RATS |
| 6099 |
THE EMERGING ROLE OF BIOMARKERS IN THE DIAGNOSIS OF GESTATIONAL DIABETES MELLITUS |
| 6100 |
THE EMERGING ROLE OF EPIGENETIC MODIFIERS IN REPAIR OF DNA DAMAGE ASSOCIATED WITH CHRONIC INFLAMMATORY DISEASES |
| 6101 |
THE EMERGING ROLE OF EPIGENETICS IN THE IMMUNE RESPONSE TO VACCINATION AND INFECTION: A SYSTEMATIC REVIEW |
| 6102 |
THE EMERGING ROLE OF FIBROBLAST-LIKE SYNOVIOCYTES-MEDIATED SYNOVITIS IN OSTEOARTHRITIS: AN UPDATE |
| 6103 |
THE EMERGING ROLE OF HDACS: PATHOLOGY AND THERAPEUTIC TARGETS IN DIABETES MELLITUS |
| 6104 |
THE EMERGING ROLE OF HISTONE DEACETYLASE 1 IN ALLERGIC DISEASES |
| 6105 |
THE EMERGING ROLE OF LNCRNA FENDRR IN MULTIPLE CANCERS: A REVIEW |
| 6106 |
THE EMERGING ROLE OF MICRORNAS IN NAFLD: HIGHLIGHT OF MICRORNA-29A IN MODULATING OXIDATIVE STRESS, INFLAMMATION, AND BEYOND |
| 6107 |
THE EMERGING ROLE OF NONCODING RNAS IN SYSTEMIC LUPUS ERYTHEMATOSUS: NEW INSIGHTS INTO THE MASTER REGULATORS OF DISEASE PATHOGENESIS |
| 6108 |
THE ENRICHED ENVIRONMENT AMELIORATES CHRONIC UNPREDICTABLE MILD STRESS-INDUCED DEPRESSIVE-LIKE BEHAVIORS AND COGNITIVE IMPAIRMENT BY ACTIVATING THE SIRT1/MIR-134 SIGNALING PATHWAY IN HIPPOCAMPUS |
| 6109 |
THE EPIGENETIC AGING, OBESITY, AND LIFESTYLE |
| 6110 |
THE EPIGENETIC ALTERATION OF SYNOVIAL CELL GENE EXPRESSION IN RHEUMATOID ARTHRITIS AND THE ROLES OF NUCLEAR FACTOR KAPPAB AND NOTCH SIGNALING PATHWAYS |
| 6111 |
THE EPIGENETIC ARCHITECTURE AT GENE PROMOTERS DETERMINES CELL TYPE-SPECIFIC LPS TOLERANCE |
| 6112 |
THE EPIGENETIC CLOCK AS A PREDICTOR OF DISEASE AND MORTALITY RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS |
| 6113 |
THE EPIGENETIC CONDUCTOR: A GENOMIC ORCHESTRATOR IN CHRONIC KIDNEY DISEASE COMPLICATIONS? EPIGENETICS DEFINES THE CELLULARLY HERITABLE PROPERTIES OF GENOME FUNCTION, WHICH ARE NOT DIRECTLY ENCODED IN THE DNA PRIMARY SEQUENCE |
| 6114 |
THE EPIGENETIC CONTRIBUTION TO THE PATHOGENESIS OF PSORIASIS: RECENT ADVANCES |
| 6115 |
THE EPIGENETIC CONTROL OF HEPATITIS B VIRUS MODULATES THE OUTCOME OF INFECTION |
| 6116 |
THE EPIGENETIC CORRELATION AMONG OVARIAN CANCER, ENDOMETRIOSIS AND PCOS: A REVIEW |
| 6117 |
THE EPIGENETIC DRUG TRICHOSTATIN A AMELIORATES EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS VIA T CELL TOLERANCE INDUCTION AND IMPAIRED INFLUX OF T CELLS INTO THE SPINAL CORD |
| 6118 |
THE EPIGENETIC EFFECTS OF ASPIRIN: THE MODIFICATION OF HISTONE H3 LYSINE 27 ACETYLATION IN THE PREVENTION OF COLON CARCINOGENESIS IN AZOXYMETHANE- AND DEXTRAN SULFATE SODIUM-TREATED CF-1 MICE |
| 6119 |
THE EPIGENETIC IMPACTS OF SOCIAL STRESS: HOW DOES SOCIAL ADVERSITY BECOME BIOLOGICALLY EMBEDDED? EPIGENETIC MECHANISMS ARE IMPLICATED IN THE PROCESSES THROUGH WHICH SOCIAL STRESSORS ERODE HEALTH IN HUMANS AND OTHER ANIMALS |
| 6120 |
THE EPIGENETIC IMPLICATION IN CORONAVIRUS INFECTION AND THERAPY |
| 6121 |
THE EPIGENETIC LANDSCAPE OF T CELL EXHAUSTION |
| 6122 |
THE EPIGENETIC LANDSCAPE OF VASCULAR CALCIFICATION: AN INTEGRATIVE PERSPECTIVE |
| 6123 |
THE EPIGENETIC MACHINERY IN VASCULAR DYSFUNCTION AND HYPERTENSION |
| 6124 |
THE EPIGENETIC MECHANISMS INVOLVED IN CHRONIC PAIN IN RODENTS: A MINI- REVIEW |
| 6125 |
THE EPIGENETIC MECHANISMS OF AMPHETAMINE |
| 6126 |
THE EPIGENETIC MODIFIER PBRM1 RESTRICTS THE BASAL ACTIVITY OF THE INNATE IMMUNE SYSTEM BY REPRESSING RETINOIC ACID-INDUCIBLE GENE-I-LIKE RECEPTOR SIGNALLING AND IS A POTENTIAL PROGNOSTIC BIOMARKER FOR COLON CANCER |
| 6127 |
THE EPIGENETIC OVERLAP BETWEEN OBESITY AND MOOD DISORDERS: A SYSTEMATIC REVIEW |
| 6128 |
THE EPIGENETIC PARADIGM IN PERIODONTITIS PATHOGENESIS |
| 6129 |
THE EPIGENETIC REGULATION OF PODOCYTE FUNCTION IN DIABETES |
| 6130 |
THE EPIGENETIC REGULATION OF THE OPIOID SYSTEM: NEW INDIVIDUALIZED PROMPT PREVENTION AND TREATMENT STRATEGIES |
| 6131 |
THE EPIGENETIC REGULATION OF WOUND HEALING |
| 6132 |
THE EPIGENETIC REGULATORS BMI1 AND RING1B ARE DIFFERENTIALLY REGULATED IN PANCREATITIS AND PANCREATIC DUCTAL ADENOCARCINOMA |
| 6133 |
THE EPIGENETIC ROLE OF VITAMIN C IN NEURODEVELOPMENT |
| 6134 |
THE EPIGENETICALLY-REGULATED MIR-34A TARGETING C-SRC SUPPRESSES RAF/MEK/ERK SIGNALING PATHWAY IN K-562 CELLS |
| 6135 |
THE EPIGENETICS OF INFLAMMAGING: THE CONTRIBUTION OF AGE-RELATED HETEROCHROMATIN LOSS AND LOCUS-SPECIFIC REMODELLING AND THE MODULATION BY ENVIRONMENTAL STIMULI |
| 6136 |
THE EPIGENETICS OF MULTIPLE SCLEROSIS AND OTHER RELATED DISORDERS |
| 6137 |
THE EPIGENETICS OF PSYCHOSIS: A STRUCTURED REVIEW WITH REPRESENTATIVE LOCI |
| 6138 |
THE ETIOLOGICAL CHANGES OF ACETYLATION IN PERIPHERAL NERVE INJURY-INDUCED NEUROPATHIC HYPERSENSITIVITY |
| 6139 |
THE ETIOLOGICAL CONTRIBUTION OF GABAERGIC PLASTICITY TO THE PATHOGENESIS OF NEUROPATHIC PAIN |
| 6140 |
THE ETIOLOGY OF AUTOIMMUNE DISEASES: THE CASE OF MYASTHENIA GRAVIS |
| 6141 |
THE ETIOLOGY OF PEYRONIE'S DISEASE: PATHOGENESIS AND GENETIC CONTRIBUTIONS |
| 6142 |
THE EVALUATION OF CYTOKINES TO HELP ESTABLISH DIAGNOSIS AND GUIDE TREATMENT OF AUTOINFLAMMATORY AND AUTOIMMUNE DISEASES |
| 6143 |
THE EVOLVING LANDSCAPE OF CANCER STEM CELLS AND WAYS TO OVERCOME CANCER HETEROGENEITY |
| 6144 |
THE EVOLVING LANDSCAPE OF N(6)-METHYLADENOSINE MODIFICATION IN THE TUMOR MICROENVIRONMENT |
| 6145 |
THE EXPANDING PHENOTYPES OF COHESINOPATHIES: ONE RING TO RULE THEM ALL! PRESERVATION AND DEVELOPMENT OF LIFE DEPEND ON THE ADEQUATE SEGREGATION OF SISTER CHROMATIDS DURING MITOSIS AND MEIOSIS |
| 6146 |
THE EXPRESSION OF ENDOTHELIN-1 IN CHRONIC LYMPHOCYTIC LEUKEMIA IS CONTROLLED BY EPIGENETIC MECHANISMS AND EXTRACELLULAR STIMULI |
| 6147 |
THE EXPRESSION OF NON-CODING RNAS AND THEIR TARGET MOLECULES IN RHEUMATOID ARTHRITIS: A MOLECULAR BASIS FOR RHEUMATOID PATHOGENESIS AND ITS POTENTIAL CLINICAL APPLICATIONS |
| 6148 |
THE EXPRESSION OF TRANSCRIPTION FACTORS MECP2 AND CREB IS MODULATED IN INFLAMMATORY PELVIC PAIN |
| 6149 |
THE EXPRESSION PROFILE OF MIR-23B IS NOT ALTERED IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES |
| 6150 |
THE FETAL CEREBRAL CIRCULATION: THREE DECADES OF EXPLORATION BY THE LLU CENTER FOR PERINATAL BIOLOGY |
| 6151 |
THE FIRE WITHIN: CELL-AUTONOMOUS MECHANISMS IN INFLAMMATION-DRIVEN CANCER |
| 6152 |
THE FUNCTION OF NCRNAS IN RHEUMATIC DISEASES |
| 6153 |
THE FUNCTION OF THE METALS IN REGULATING EPIGENETICS DURING PARKINSON'S DISEASE |
| 6154 |
THE GENE EXPRESSION PROGRAM OF PROSTATE FIBROBLAST SENESCENCE MODULATES NEOPLASTIC EPITHELIAL CELL PROLIFERATION THROUGH PARACRINE MECHANISMS |
| 6155 |
THE GENETIC EPIDEMIOLOGY OF SUBSTANCE USE DISORDER: A REVIEW |
| 6156 |
THE GENETIC INFLUENCE ON THE CORTICAL PROCESSING OF EXPERIMENTAL PAIN AND THE MODERATING EFFECT OF PAIN STATUS |
| 6157 |
THE GENETICS AND EPIGENETICS OF ALTERED PROLIFERATIVE HOMEOSTASIS IN AGEING AND CANCER |
| 6158 |
THE GENETICS AND EPIGENETICS OF ATOPIC DERMATITIS-FILAGGRIN AND OTHER POLYMORPHISMS |
| 6159 |
THE GENETICS AND EPIGENETICS OF FATIGUE |
| 6160 |
THE GENETICS AND PATHOGENESIS OF CAKUT |
| 6161 |
THE GENETICS OF ASTHMA: ADAM33 AS AN EXAMPLE OF A SUSCEPTIBILITY GENE |
| 6162 |
THE GENETICS OF DIABETIC NEPHROPATHY |
| 6163 |
THE GK RAT BETA-CELL: A PROTOTYPE FOR THE DISEASED HUMAN BETA-CELL IN TYPE 2 DIABETES? INCREASING EVIDENCE INDICATES THAT DECREASED FUNCTIONAL BETA-CELL MASS IS THE HALLMARK OF TYPE 2 DIABETES (T2D) MELLITUS |
| 6164 |
THE GK RAT: A PROTOTYPE FOR THE STUDY OF NON-OVERWEIGHT TYPE 2 DIABETES |
| 6165 |
THE GLOBAL DIABETES EPIDEMIC AS A CONSEQUENCE OF LIFESTYLE-INDUCED LOW-GRADE INFLAMMATION |
| 6166 |
THE GLUTATHIONE SYSTEM: A NEW DRUG TARGET IN NEUROIMMUNE DISORDERS |
| 6167 |
THE GODDESS WHO SPINS THE THREAD OF LIFE: KLOTHO, PSYCHIATRIC STRESS, AND ACCELERATED AGING |
| 6168 |
THE GOOD AND BAD OF BETA-CATENIN IN KIDNEY DEVELOPMENT AND RENAL DYSPLASIA |
| 6169 |
THE GUT MICROBIOTA AND HEALTHY AGING: A MINI-REVIEW |
| 6170 |
THE HDAC INHIBITOR SAHA IMPROVES DEPRESSIVE-LIKE BEHAVIOR OF CRTC1-DEFICIENT MICE: POSSIBLE RELEVANCE FOR TREATMENT-RESISTANT DEPRESSION |
| 6171 |
THE HDAC INHIBITOR VALPROATE INDUCES A BIVALENT STATUS OF THE CD20 PROMOTER IN CLL PATIENTS SUGGESTING DISTINCT EPIGENETIC REGULATION OF CD20 EXPRESSION IN CLL IN VIVO |
| 6172 |
THE HDAC1/C-JUN COMPLEX IS ESSENTIAL IN THE PROMOTION OF NERVE INJURY-INDUCED NEUROPATHIC PAIN THROUGH JNK SIGNALING |
| 6173 |
THE HEALTH OUTCOMES OF HUMAN OFFSPRING CONCEIVED BY ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) |
| 6174 |
THE HIPPOCAMPUS, NEUROTROPHIC FACTORS AND DEPRESSION: POSSIBLE IMPLICATIONS FOR THE PHARMACOTHERAPY OF DEPRESSION |
| 6175 |
THE HISTONE DEACETYLASE INHIBITOR SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) ALLEVIATES DEPRESSION-LIKE BEHAVIOR AND NORMALIZES EPIGENETIC CHANGES IN THE HIPPOCAMPUS DURING ETHANOL WITHDRAWAL |
| 6176 |
THE HISTONE H3 LYSINE-27 DEMETHYLASE JMJD3 LINKS INFLAMMATION TO INHIBITION OF POLYCOMB-MEDIATED GENE SILENCING |
| 6177 |
THE HISTONE METHYLTRANSFERASE G9A MEDIATES STRESS-REGULATED ALCOHOL DRINKING |
| 6178 |
THE HISTONE MODIFICATION CODE IN THE PATHOGENESIS OF AUTOIMMUNE DISEASES |
| 6179 |
THE HUMAN MALARIA PARASITE PLASMODIUM FALCIPARUM CAN SENSE ENVIRONMENTAL CHANGES AND RESPOND BY ANTIGENIC SWITCHING |
| 6180 |
THE HYGIENE HYPOTHESIS AND NEW PERSPECTIVES-CURRENT CHALLENGES MEETING AN OLD POSTULATE |
| 6181 |
THE IMMUNE FUNCTIONS OF KERATINOCYTES IN SKIN WOUND HEALING |
| 6182 |
THE IMPACT OF ADIPOSE TISSUE-DERIVED MIRNAS IN METABOLIC SYNDROME, OBESITY, AND CANCER |
| 6183 |
THE IMPACT OF ENVIRONMENTAL FACTORS IN INFLUENCING EPIGENETICS RELATED TO OXIDATIVE STATES IN THE CARDIOVASCULAR SYSTEM |
| 6184 |
THE IMPACT OF ENVIRONMENTAL FACTORS IN SEVERE PSYCHIATRIC DISORDERS |
| 6185 |
THE IMPACT OF GENERAL ANESTHESIA ON REDOX STABILITY AND EPIGENETIC INFLAMMATION PATHWAYS: CROSSTALK ON PERIOPERATIVE ANTIOXIDANT THERAPY |
| 6186 |
THE IMPACT OF HIV INFECTION ON THE FREQUENCIES, FUNCTION, SPATIAL LOCALIZATION AND HETEROGENEITY OF T FOLLICULAR REGULATORY CELLS (TFRS) WITHIN HUMAN LYMPH NODES |
| 6187 |
THE IMPACT OF IMMUNOSENESCENCE ON PULMONARY DISEASE |
| 6188 |
THE IMPACT OF INSOMNIA ON FRAILTY AND THE HALLMARKS OF AGING |
| 6189 |
THE IMPACT OF LIFE STRESS ON HALLMARKS OF AGING AND ACCELERATED SENESCENCE: CONNECTIONS IN SICKNESS AND IN HEALTH |
| 6190 |
THE IMPACT OF METHYLATION QUANTITATIVE TRAIT LOCI (MQTLS) ON ACTIVE SMOKING-RELATED DNA METHYLATION CHANGES |
| 6191 |
THE IMPACT OF MILK AND ITS COMPONENTS ON EPIGENETIC PROGRAMMING OF IMMUNE FUNCTION IN EARLY LIFE AND BEYOND: IMPLICATIONS FOR ALLERGY AND ASTHMA |
| 6192 |
THE IMPACT OF NUTRITIONAL INSULTS DURING FETAL LIFE ON BLOOD PRESSURE |
| 6193 |
THE IMPACT OF PERCEIVED STRESS ON SKIN AGEING |
| 6194 |
THE IMPACT OF PROTEIN ACETYLATION/DEACETYLATION ON SYSTEMIC LUPUS ERYTHEMATOSUS |
| 6195 |
THE IMPACT OF RECENT ALCOHOL USE ON GENOME WIDE DNA METHYLATION SIGNATURES |
| 6196 |
THE IMPACT OF THE TH17:TREG AXIS ON THE IGA-BIOME ACROSS THE GLYCEMIC SPECTRUM |
| 6197 |
THE IMPACT OF TRADITIONAL FOOD AND LIFESTYLE BEHAVIOR ON EPIGENETIC BURDEN OF CHRONIC DISEASE |
| 6198 |
THE IMPLICATION OF CANCER PROGENITOR CELLS AND THE ROLE OF EPIGENETICS IN THE DEVELOPMENT OF NOVEL THERAPEUTIC STRATEGIES FOR CHRONIC MYELOID LEUKEMIA |
| 6199 |
THE IMPORTANCE OF EPIGENETICS IN THE DEVELOPMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| 6200 |
THE INFLAMMATORY EFFECT OF EPIGENETIC FACTORS AND MODIFICATIONS IN TYPE 2 DIABETES |
| 6201 |
THE INFLAMMATORY MICROENVIRONMENT AND MICROBIOME IN PROSTATE CANCER DEVELOPMENT |
| 6202 |
THE INFLAMMATORY RESPONSE IN PSORIASIS: A COMPREHENSIVE REVIEW |
| 6203 |
THE INFLUENCE OF EPIGENETIC MODIFICATIONS ON METABOLIC CHANGES IN WHITE ADIPOSE TISSUE AND LIVER AND THEIR POTENTIAL IMPACT IN EXERCISE |
| 6204 |
THE INFLUENCE OF EPIGENETICS AND INFLAMMATION ON CARDIOMETABOLIC RISKS |
| 6205 |
THE INFLUENCE OF PLANT EXTRACTS AND PHYTOCONSTITUENTS ON ANTIOXIDANT ENZYMES ACTIVITY AND GENE EXPRESSION IN THE PREVENTION AND TREATMENT OF IMPAIRED GLUCOSE HOMEOSTASIS AND DIABETES COMPLICATIONS |
| 6206 |
THE INFLUENCE OF TISSUE SPATIAL GEOMETRY AND FUNCTIONAL ORGANISATION ON LIVER REGENERATION |
| 6207 |
THE INHIBITION OF HISTONE DEACETYLASES REDUCES THE REINSTATEMENT OF COCAINE-SEEKING BEHAVIOR IN RATS |
| 6208 |
THE INTERACTION BETWEEN MICRORNA-152 AND DNA METHYLTRANSFERASE-1 AS AN EPIGENETIC PROGNOSTIC BIOMARKER IN HCV-INDUCED LIVER CIRRHOSIS AND HCC PATIENTS |
| 6209 |
THE INTERFERON-STIMULATED GENE TRIM22: A DOUBLE-EDGED SWORD IN HIV-1 INFECTION |
| 6210 |
THE INTERPLAY BETWEEN KERATINOCYTES AND IMMUNE CELLS IN THE PATHOGENESIS OF PSORIASIS |
| 6211 |
THE INTERPLAY BETWEEN OXIDATIVE STRESS, EXERCISE, AND PAIN IN HEALTH AND DISEASE: POTENTIAL ROLE OF AUTONOMIC REGULATION AND EPIGENETIC MECHANISMS |
| 6212 |
THE INTERPLAY OF THE GENETIC ARCHITECTURE, AGING, AND ENVIRONMENTAL FACTORS IN THE PATHOGENESIS OF IDIOPATHIC PULMONARY FIBROSIS |
| 6213 |
THE INTESTINAL EPITHELIAL CELL CYCLE: UNCOVERING ITS 'CRYPTIC' NATURE |
| 6214 |
THE INTRACELLULAR SIGNALING PATHWAYS GOVERNING MACROPHAGE ACTIVATION AND FUNCTION IN HUMAN ATHEROSCLEROSIS |
| 6215 |
THE INVOLVEMENT OF ADAR1 IN ANTIDEPRESSANT ACTION BY REGULATING BDNF VIA MIR-432 |
| 6216 |
THE INVOLVEMENT OF COPPER, CIRCULAR RNAS, AND INFLAMMATORY CYTOKINES IN CHRONIC RESPIRATORY DISEASE |
| 6217 |
THE JAK INHIBITOR TOFACITINIB INHIBITS STRUCTURAL DAMAGE IN OSTEOARTHRITIS BY MODULATING JAK1/TNF-ALPHA/IL-6 SIGNALING THROUGH MIR-149-5P |
| 6218 |
THE JOINT SYNOVIUM: A CRITICAL DETERMINANT OF ARTICULAR CARTILAGE FATE IN INFLAMMATORY JOINT DISEASES |
| 6219 |
THE KEY ROLE OF DNA METHYLATION AND HISTONE ACETYLATION IN EPIGENETICS OF ATHEROSCLEROSIS |
| 6220 |
THE KIDNEY IS THE MAJOR SITE OF S-ADENOSYLHOMOCYSTEINE DISPOSAL IN HUMANS |
| 6221 |
THE LANDSCAPE OF HISTONE MODIFICATIONS IN A HIGH-FAT DIET-INDUCED OBESE (DIO) MOUSE MODEL |
| 6222 |
THE LANDSCAPE OF SOMATIC MUTATIONS IN LYMPHOBLASTOID CELL LINES |
| 6223 |
THE LEADING ROLE OF EPITHELIAL CELLS IN THE PATHOGENESIS OF IDIOPATHIC PULMONARY FIBROSIS |
| 6224 |
THE LEUCINE CATABOLITE AND DIETARY SUPPLEMENT BETA-HYDROXY-BETA-METHYL BUTYRATE (HMB) AS AN EPIGENETIC REGULATOR IN MUSCLE PROGENITOR CELLS |
| 6225 |
THE LINK AMONG MICROBIOTA, EPIGENETICS, AND DISEASE DEVELOPMENT |
| 6226 |
THE LINK BETWEEN EPIGENETICS, PAIN SENSITIVITY AND CHRONIC PAIN |
| 6227 |
THE LINK OF ORGANOPHOSPHORUS PESTICIDES WITH NEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES BASED ON EVIDENCE AND MECHANISMS |
| 6228 |
THE LINKS BETWEEN STRESS AND DEPRESSION: PSYCHONEUROENDOCRINOLOGICAL, GENETIC, AND ENVIRONMENTAL INTERACTIONS |
| 6229 |
THE LNCRNAS IN HBV-RELATED HCCS: TARGETING CHROMATIN DYNAMICS AND BEYOND |
| 6230 |
THE LONG NONCODING RNA LANDSCAPE IN HYPOXIC AND INFLAMMATORY RENAL EPITHELIAL INJURY |
| 6231 |
THE LONG NONCODING RNA MEG3 AND ITS TARGET MIR-147 REGULATE JAK/STAT PATHWAY IN ADVANCED CHRONIC MYELOID LEUKEMIA |
| 6232 |
THE LONG NONCODING RNA MEG3 REGULATES MYOBLAST PLASTICITY AND MUSCLE REGENERATION THROUGH EPITHELIAL-MESENCHYMAL TRANSITION |
| 6233 |
THE LONG NONCODING RNA TUG1 CONNECTS METABOLIC CHANGES WITH KIDNEY DISEASE IN PODOCYTES |
| 6234 |
THE LONG-TERM EFFECTS OF PRENATAL DEVELOPMENT ON GROWTH AND METABOLISM |
| 6235 |
THE M(6)A DEMETHYLASE FTO PROMOTES RENAL EPITHELIAL-MESENCHYMAL TRANSITION BY REDUCING THE M(6)A MODIFICATION OF LNCRNA GAS5 |
| 6236 |
THE MACROPHAGE IRF8/IRF1 REGULOME IS REQUIRED FOR PROTECTION AGAINST INFECTIONS AND IS ASSOCIATED WITH CHRONIC INFLAMMATION |
| 6237 |
THE MAIN THEORIES ON THE PATHOGENESIS OF ENDOMETRIOSIS |
| 6238 |
THE MALIGNANCY SUPPRESSION ROLE OF MIR-23A BY TARGETING THE BCR/ABL ONCOGENE IN CHROMIC MYELOID LEUKEMIA |
| 6239 |
THE MANAGEMENT OF POLYPS IN FEMALE REPRODUCTIVE ORGANS |
| 6240 |
THE MANUAL STIMULATION OF ACUPUNCTURE POINTS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER: A REVIEW OF CLINICAL EMOTIONAL FREEDOM TECHNIQUES |
| 6241 |
THE MANY TALENTS OF TRANSFORMING GROWTH FACTOR-BETA IN THE KIDNEY |
| 6242 |
THE MATRICELLULAR PROTEIN SPARC DECREASES IN THE LACRIMAL GLAND AT ADULTHOOD AND DURING INFLAMMATION |
| 6243 |
THE MECHANISM OF APOLIPROTEIN A1 DOWN-REGULATED BY HEPATITIS B VIRUS |
| 6244 |
THE MECHANISMS OF HSC ACTIVATION AND EPIGENETIC REGULATION OF HSCS PHENOTYPES |
| 6245 |
THE MECHANISMS UNDERLYING CHRONIC INFLAMMATION IN RHEUMATOID ARTHRITIS FROM THE PERSPECTIVE OF THE EPIGENETIC LANDSCAPE |
| 6246 |
THE METHYL DONOR S-ADENOSYL METHIONINE REVERSES THE DNA METHYLATION SIGNATURE OF CHRONIC NEUROPATHIC PAIN IN MOUSE FRONTAL CORTEX |
| 6247 |
THE METHYLATION PATTERNS OF A DISINTEGRIN AND METALLOPROTEINASE 33 GENE (ADAM33) IN ADULT ASTHMA |
| 6248 |
THE METHYLATION STATUS OF THE DDX43 PROMOTER IN CHINESE PATIENTS WITH CHRONIC MYELOID LEUKEMIA |
| 6249 |
THE METHYLATION STATUS OF THE MAJOR BREAKPOINT CLUSTER REGION IN HUMAN LEUKEMIA CELLS, INCLUDING PHILADELPHIA CHROMOSOME-POSITIVE CELLS, IS LINKED TO THE LINEAGE OF HEMATOPOIETIC CELLS |
| 6250 |
THE METHYLENETETRAHYDROFOLATE REDUCTASE 677C>T GENE POLYMORPHISM IS NOT ASSOCIATED WITH CHRONIC PLAQUE PSORIASIS |
| 6251 |
THE MICROBIOLOGICAL MEMORY, AN EPIGENETIC REGULATOR GOVERNING THE BALANCE BETWEEN GOOD HEALTH AND METABOLIC DISORDERS |
| 6252 |
THE MICROBIOME AND CANCER: IMPLICATIONS FOR ONCOLOGY NURSING SCIENCE |
| 6253 |
THE MICROBIOME AND HEPATOCELLULAR CARCINOMA |
| 6254 |
THE MICROBIOME AND IRRITABLE BOWEL SYNDROME - A REVIEW ON THE PATHOPHYSIOLOGY, CURRENT RESEARCH AND FUTURE THERAPY |
| 6255 |
THE MICROBIOTA AND EPIGENETIC REGULATION OF T HELPER 17/REGULATORY T CELLS: IN SEARCH OF A BALANCED IMMUNE SYSTEM |
| 6256 |
THE MITOGEN AND STRESS-ACTIVATED PROTEIN KINASE 1 REGULATES THE RAPID EPIGENETIC TAGGING OF DORSAL HORN NEURONS AND NOCIFENSIVE BEHAVIOUR |
| 6257 |
THE MOLECULAR BASIS OF TOLERANCE |
| 6258 |
THE MOLECULAR MECHANISM OF POLYPHENOLS IN THE REGULATION OF AGEING HALLMARKS |
| 6259 |
THE MOLECULAR MECHANISMS BY WHICH VITAMIN D PREVENTS INSULIN RESISTANCE AND ASSOCIATED DISORDERS |
| 6260 |
THE MOLECULAR NEUROBIOLOGY OF CHRONIC PAIN-INDUCED DEPRESSION |
| 6261 |
THE MORAXELLA CATARRHALIS PHASE-VARIABLE DNA METHYLTRANSFERASE MODM3 IS AN EPIGENETIC REGULATOR THAT AFFECTS BACTERIAL SURVIVAL IN AN IN VIVO MODEL OF OTITIS MEDIA |
| 6262 |
THE MULTIFACETED FUNCTIONAL ROLE OF DNA METHYLATION IN IMMUNE-MEDIATED RHEUMATIC DISEASES |
| 6263 |
THE MULTIPLE WAYS WNT SIGNALING CONTRIBUTES TO ACUTE LEUKEMIA PATHOGENESIS |
| 6264 |
THE MULTIPLE-HIT PATHOGENESIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) |
| 6265 |
THE NEUROBIOLOGICAL BASIS OF HUMAN AGGRESSION: A REVIEW ON GENETIC AND EPIGENETIC MECHANISMS |
| 6266 |
THE NEUROBIOLOGY OF SUICIDE |
| 6267 |
THE NEUROENDOCRINOLOGY OF STRESS: A NEVER ENDING STORY |
| 6268 |
THE NEUROEPIGENOME: IMPLICATIONS OF CHEMICAL AND PHYSICAL MODIFICATIONS OF GENOMIC DNA IN SCHIZOPHRENIA |
| 6269 |
THE NEXT CHALLENGE IN PEDIATRIC CHOLESTASIS: DECIPHERING THE PATHOGENESIS OF BILIARY ATRESIA |
| 6270 |
THE OBESOGENIC ENVIRONMENT: EPIGENETIC MODIFICATIONS IN PLACENTAL MELANOCORTIN 4 RECEPTOR GENE CONNECTED TO GESTATIONAL DIABETES AND SMOKING |
| 6271 |
THE ONCOGENIC ROLE OF HEPATITIS B VIRUS |
| 6272 |
THE ORIGIN AND PATHOGENESIS OF ENDOMETRIOSIS |
| 6273 |
THE ORIGINS OF GASTRIC CANCER FROM GASTRIC STEM CELLS: LESSONS FROM MOUSE MODELS |
| 6274 |
THE P300/CBP INHIBITOR A485 NORMALIZES PSORIATIC FIBROBLAST GENE EXPRESSION IN VITRO AND REDUCES PSORIASIS-LIKE SKIN INFLAMMATION IN VIVO |
| 6275 |
THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS: HARNESSING BIG DATA TO UNDERSTAND THE MOLECULAR BASIS OF LUPUS |
| 6276 |
THE PATHOGENIC ROLE OF DYSREGULATED EPIGENETIC MODIFICATIONS IN AUTOIMMUNE DISEASES |
| 6277 |
THE PATHOGENIC ROLE OF PERSISTENT MILK SIGNALING IN MTORC1- AND MILK-MICRORNA-DRIVEN TYPE 2 DIABETES MELLITUS |
| 6278 |
THE PATHWAYS BETWEEN CORTISOL-RELATED REGULATION GENES AND PTSD PSYCHOTHERAPY |
| 6279 |
THE PLACENTA AS A TARGET OF EPIGENETIC ALTERATIONS IN WOMEN WITH GESTATIONAL DIABETES MELLITUS AND POTENTIAL IMPLICATIONS FOR THE OFFSPRING |
| 6280 |
THE PLASTICIZER BISPHENOL A PERTURBS THE HEPATIC EPIGENOME: A SYSTEMS LEVEL ANALYSIS OF THE MIRNOME |
| 6281 |
THE POTENTIAL FOR TARGETED REWRITING OF EPIGENETIC MARKS IN COPD AS A NEW THERAPEUTIC APPROACH |
| 6282 |
THE POTENTIAL IMPACT OF SOCIAL GENOMICS ON WOUND HEALING |
| 6283 |
THE POTENTIAL OF A KETOGENIC DIET TO MINIMIZE EFFECTS OF THE METABOLIC FAULT IN GLYCOGEN STORAGE DISEASE V AND VII |
| 6284 |
THE POTENTIAL OF HUMAN INDUCED PLURIPOTENT STEM CELLS FOR MODELLING DIABETIC WOUND HEALING IN VITRO |
| 6285 |
THE POTENTIAL OF LIPID-POLYMER NANOPARTICLES AS EPIGENETIC AND ROS CONTROL APPROACHES FOR COPD |
| 6286 |
THE POTENTIAL ROLE OF DNA METHYLATION IN THE PATHOGENESIS OF ABDOMINAL AORTIC ANEURYSM |
| 6287 |
THE POTENTIAL ROLE OF ENVIRONMENTAL FACTORS IN MODULATING MITOCHONDRIAL DNA EPIGENETIC MARKS |
| 6288 |
THE POTENTIAL ROLE OF EPIGENETIC MODIFICATIONS ON DIFFERENT FACETS IN THE PERIODONTAL PATHOGENESIS |
| 6289 |
THE POTENTIAL ROLE OF GENETICS, ENVIRONMENTAL FACTORS, AND GUT DYSBIOSIS IN THE ABERRANT NON-CODING RNA EXPRESSION TO MEDIATE INFLAMMATION AND OSTEOCLASTOGENIC/OSTEOGENIC DIFFERENTIATION IN ANKYLOSING SPONDYLITIS |
| 6290 |
THE POTENTIAL ROLE OF NUTRITIONAL GENOMICS TOOLS IN VALIDATING HIGH HEALTH FOODS FOR CANCER CONTROL: BROCCOLI AS EXAMPLE |
| 6291 |
THE POTENTIAL TO FIGHT OBESITY WITH ADIPOGENESIS MODULATING COMPOUNDS |
| 6292 |
THE PRIMACY OF PSYCHOANALYTIC INTERVENTION IN RECOVERY FROM THE PSYCHOSES AND SCHIZOPHRENIAS |
| 6293 |
THE PRO- AND ANTI-INFLAMMATORY POTENTIAL OF IL-12: THE DUAL ROLE OF TH1 CELLS |
| 6294 |
THE PROINFLAMMATORY CYTOKINE TNFALPHA INDUCES DNA DEMETHYLATION-DEPENDENT AND -INDEPENDENT ACTIVATION OF INTERLEUKIN-32 EXPRESSION |
| 6295 |
THE PROMISES AND CHALLENGES OF TOXICO-EPIGENOMICS: ENVIRONMENTAL CHEMICALS AND THEIR IMPACTS ON THE EPIGENOME |
| 6296 |
THE PROSPECTS FOR A SIMPLIFIED AND INTERNATIONALLY HARMONIZED APPROACH TO THE DETECTION OF POSSIBLE HUMAN CARCINOGENS AND MUTAGENS |
| 6297 |
THE PROTECTIVE EFFECT OF HBO1 ON CIGARETTE SMOKE EXTRACT-INDUCED APOPTOSIS IN AIRWAY EPITHELIAL CELLS |
| 6298 |
THE PROTECTIVE EFFECT OF ZEBULARINE, AN INHIBITOR OF DNA METHYLTRANSFERASE, ON RENAL TUBULOINTERSTITIAL INFLAMMATION AND FIBROSIS |
| 6299 |
THE PROXIMAL TUBULE IS THE PRIMARY TARGET OF INJURY AND PROGRESSION OF KIDNEY DISEASE: ROLE OF THE GLOMERULOTUBULAR JUNCTION |
| 6300 |
THE PUTATIVE ROLE OF ENVIRONMENTAL ALUMINIUM IN THE DEVELOPMENT OF CHRONIC NEUROPATHOLOGY IN ADULTS AND CHILDREN |
| 6301 |
THE PUTATIVE ROLE OF ENVIRONMENTAL MERCURY IN THE PATHOGENESIS AND PATHOPHYSIOLOGY OF AUTISM SPECTRUM DISORDERS AND SUBTYPES |
| 6302 |
THE PUTATIVE ROLE OF VIRUSES, BACTERIA, AND CHRONIC FUNGAL BIOTOXIN EXPOSURE IN THE GENESIS OF INTRACTABLE FATIGUE ACCOMPANIED BY COGNITIVE AND PHYSICAL DISABILITY |
| 6303 |
THE PUZZLE OF IMMUNE PHENOTYPES OF CHILDHOOD ASTHMA |
| 6304 |
THE QUEBEC LOW BACK PAIN STUDY: A PROTOCOL FOR AN INNOVATIVE 2-TIER PROVINCIAL COHORT |
| 6305 |
THE QUESTION IS WHETHER INTAKE OF FOLIC ACID FROM DIET ALONE DURING PREGNANCY IS SUFFICIENT |
| 6306 |
THE RECOGNITION AND TREATMENT OF GROWTH DISORDERS - A 50-YEAR RETROSPECTIVE |
| 6307 |
THE REFERENCE EPIGENOME AND REGULATORY CHROMATIN LANDSCAPE OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| 6308 |
THE REGULATION OF APOPTOSIS IN KIDNEY DEVELOPMENT: IMPLICATIONS FOR NEPHRON NUMBER AND PATTERN? APOPTOSIS IS ESSENTIAL TO REMODEL DEVELOPING STRUCTURES AND ELIMINATE SUPERFLUOUS CELLS IN A CONTROLLED MANNER DURING NORMAL DEVELOPMENT, AND CONTINUES TO BE AN IMPORTANT COMPONENT OF TISSUE REMODELING AND REGENERATION DURING AN ORGANISM'S LIFESPAN, OR AS A RESPONSE TO INJURY |
| 6309 |
THE REGULATION OF MIRNAS IN INFLAMMATION-RELATED CARCINOGENESIS |
| 6310 |
THE REGULATION OF NON-CODING RNA EXPRESSION IN THE LIVER OF MICE FED DDC |
| 6311 |
THE RELATION BETWEEN DNA METHYLATION PATTERNS AND SERUM CYTOKINE LEVELS IN COMMUNITY-DWELLING ADULTS: A PRELIMINARY STUDY |
| 6312 |
THE RELATIONSHIP BETWEEN CEREBRAL SMALL VESSEL DISEASE, HIPPOCAMPAL VOLUME AND COGNITIVE FUNCTIONING IN PATIENTS WITH COPD: AN MRI STUDY |
| 6313 |
THE RELATIONSHIP BETWEEN MERCURY EXPOSURE AND EPIGENETIC ALTERATIONS REGARDING HUMAN HEALTH, RISK ASSESSMENT AND DIAGNOSTIC STRATEGIES |
| 6314 |
THE RELATIONSHIP BETWEEN THE EPIGENETIC AGING BIOMARKER "GRIMAGE" AND LUNG FUNCTION IN BOTH THE AIRWAY AND BLOOD OF PEOPLE LIVING WITH HIV: AN OBSERVATIONAL COHORT STUDY |
| 6315 |
THE RELATIONSHIP OF MATERNAL AND CHILD METHYLATION OF THE GLUCOCORTICOID RECEPTOR NR3C1 DURING EARLY CHILDHOOD AND SUBSEQUENT CHILD PSYCHOPATHOLOGY AT SCHOOL-AGE IN THE CONTEXT OF MATERNAL INTERPERSONAL VIOLENCE-RELATED POST-TRAUMATIC STRESS DISORDER |
| 6316 |
THE RELEVANCE OF DNA METHYLATION AND HISTONE MODIFICATION IN PERIODONTITIS: A SCOPING REVIEW |
| 6317 |
THE RELEVANCE OF INTER- AND INTRASTRAIN DIFFERENCES IN MICE AND RATS AND THEIR IMPLICATIONS FOR MODELS OF SEIZURES AND EPILEPSY |
| 6318 |
THE RENIN-ANGIOTENSIN SYSTEM AND REACTIVE OXYGEN SPECIES: IMPLICATIONS IN PANCREATITIS |
| 6319 |
THE ROAD LESS TAKEN: LESS APPRECIATED PATHWAYS FOR MANIPULATING CD8(+) T CELL EXHAUSTION |
| 6320 |
THE ROCKY ROAD TO PERSONALIZED MEDICINE IN ACUTE MYELOID LEUKAEMIA |
| 6321 |
THE ROLE AND MECHANISM OF LYSINE METHYLTRANSFERASE AND ARGININE METHYLTRANSFERASE IN KIDNEY DISEASES |
| 6322 |
THE ROLE FOR EPIGENETIC MODIFICATIONS IN PAIN AND ANALGESIA RESPONSE |
| 6323 |
THE ROLE OF A POTENTIAL BIOMARKER IN PATIENTS WITH MIGRAINE: REVIEW AND NEW INSIGHTS |
| 6324 |
THE ROLE OF ALPHA-SYNUCLEIN IN THE PATHOPHYSIOLOGY OF ALCOHOLISM |
| 6325 |
THE ROLE OF ANTI-INFLAMMATORY DRUGS IN COLORECTAL CANCER |
| 6326 |
THE ROLE OF BCL-2 FAMILY PROTEINS IN CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 6327 |
THE ROLE OF CD4(+) RESIDENT MEMORY T CELLS IN LOCAL IMMUNITY IN THE MUCOSAL TISSUE - PROTECTION VERSUS PATHOLOGY |
| 6328 |
THE ROLE OF CELL ORGANELLES IN RHEUMATOID ARTHRITIS WITH FOCUS ON EXOSOMES |
| 6329 |
THE ROLE OF CHILDHOOD TRAUMA IN BIPOLAR DISORDERS |
| 6330 |
THE ROLE OF CIGARETTE SMOKE-INDUCED PULMONARY VASCULAR ENDOTHELIAL CELL APOPTOSIS IN COPD |
| 6331 |
THE ROLE OF COX-2 IN INTESTINAL INFLAMMATION AND COLORECTAL CANCER |
| 6332 |
THE ROLE OF CYTOMEGALOVIRUS INFECTION IN THE PATHOGENESIS OF PERIODONTAL DISEASES |
| 6333 |
THE ROLE OF DIETARY PHENOLIC COMPOUNDS IN EPIGENETIC MODULATION INVOLVED IN INFLAMMATORY PROCESSES |
| 6334 |
THE ROLE OF DNA METHYLATION AND HYDROXYMETHYLATION IN IMMUNOSENESCENCE |
| 6335 |
THE ROLE OF DNA METHYLATION IN THE PATHOGENESIS OF TYPE 2 DIABETES MELLITUS |
| 6336 |
THE ROLE OF DNA METHYLATION IN TRANSCRIPTIONAL REGULATION OF PRO-NOCICEPTIVE GENES IN RAT TRIGEMINAL GANGLIA |
| 6337 |
THE ROLE OF DNA-METHYLTRANSFERASES IN THE LIFE CYCLE OF HEPATITIS B VIRUS AND PATHOGENESIS OF CHRONIC HEPATITIS B |
| 6338 |
THE ROLE OF ENDOCRINE-DISRUPTING CHEMICALS IN UTERINE FIBROID PATHOGENESIS |
| 6339 |
THE ROLE OF EPIGENETIC CHANGES IN THE PROGRESSION OF ALCOHOLIC STEATOHEPATITIS |
| 6340 |
THE ROLE OF EPIGENETIC FACTORS IN PSORIASIS |
| 6341 |
THE ROLE OF EPIGENETIC MODIFICATIONS IN LATE COMPLICATIONS IN TYPE 1 DIABETES |
| 6342 |
THE ROLE OF EPIGENETIC REGULATOR SIRT1 IN BALANCING THE HOMEOSTASIS AND PREVENTING THE FORMATION OF SPECIFIC "SOIL" OF METABOLIC DISORDERS AND RELATED CANCERS |
| 6343 |
THE ROLE OF EPIGENETICS AND IMMUNOLOGICAL IMBALANCE IN THE ETIOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS |
| 6344 |
THE ROLE OF EPIGENETICS IN AGING AND AUTOIMMUNITY |
| 6345 |
THE ROLE OF EPIGENETICS IN AUTOIMMUNE/INFLAMMATORY DISEASE |
| 6346 |
THE ROLE OF EPIGENETICS IN CARDIOVASCULAR HEALTH AND AGEING: A FOCUS ON PHYSICAL ACTIVITY AND NUTRITION |
| 6347 |
THE ROLE OF EPIGENETICS IN NEUROINFLAMMATORY-DRIVEN DISEASES |
| 6348 |
THE ROLE OF EPIGENETICS IN RESPIRATORY HEALTH IN URBAN POPULATIONS IN LOW AND MIDDLE-INCOME COUNTRIES |
| 6349 |
THE ROLE OF EPIGENETICS IN THE CHRONIC SINUSITIS WITH NASAL POLYP |
| 6350 |
THE ROLE OF EPIGENOMICS IN AQUATIC TOXICOLOGY |
| 6351 |
THE ROLE OF EPIGENOMICS IN MAPPING POTENTIAL PRECURSORS FOR FOOT AND ANKLE TENDINOPATHY: A SYSTEMATIC REVIEW |
| 6352 |
THE ROLE OF GABA(A) RECEPTORS IN THE DEVELOPMENT OF ALCOHOLISM |
| 6353 |
THE ROLE OF GENETIC AND EPIGENETIC REGULATION IN INTESTINAL FIBROSIS IN INFLAMMATORY BOWEL DISEASE: A DESCENDING PROCESS OR A PROGRAMMED CONSEQUENCE? INFLAMMATORY BOWEL DISEASES (IBDS) ARE A GROUP OF CHRONIC DISEASES CHARACTERIZED BY RECURRING PERIODS OF EXACERBATION AND REMISSION |
| 6354 |
THE ROLE OF GENETICS AND EPIGENETICS IN THE PATHOGENESIS OF GESTATIONAL DIABETES MELLITUS |
| 6355 |
THE ROLE OF HERPESVIRUS 6A AND 6B IN MULTIPLE SCLEROSIS AND EPILEPSY |
| 6356 |
THE ROLE OF HOST IN THE SPECTRUM OF OUTCOMES IN FAMILY CLUSTERS OF HEPATITIS INFECTION: FROM ASYMPTOMATIC TO HEPATOCELLULAR CARCINOMA |
| 6357 |
THE ROLE OF HYPERGLYCAEMIA IN THE DEVELOPMENT OF DIABETIC CARDIOMYOPATHY |
| 6358 |
THE ROLE OF IL?16 GENE POLYMORPHISMS IN ENDOMETRIOSIS |
| 6359 |
THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF LUNG CANCER |
| 6360 |
THE ROLE OF INFLAMMATORY PATHWAYS IN CANCER-ASSOCIATED CACHEXIA AND RADIATION RESISTANCE |
| 6361 |
THE ROLE OF INNATE IMMUNITY IN THE PATHOGENESIS OF PRENEOPLASIA IN DRUG-INDUCED CHRONIC HEPATITIS BASED ON A MOUSE MODEL |
| 6362 |
THE ROLE OF ISOTHIOCYANATES AS CANCER CHEMO-PREVENTIVE, CHEMO-THERAPEUTIC AND ANTI-MELANOMA AGENTS |
| 6363 |
THE ROLE OF LNCRNA TUG1 IN OBESITY-RELATED DISEASES |
| 6364 |
THE ROLE OF LONG NONCODING RNAS IN NEURODEGENERATIVE DISEASES |
| 6365 |
THE ROLE OF METABOLIC DYSFUNCTION IN T-CELL EXHAUSTION DURING CHRONIC VIRAL INFECTION |
| 6366 |
THE ROLE OF METHYLATION IN CML |
| 6367 |
THE ROLE OF MICROGLIA IN THE ETIOLOGY AND EVOLUTION OF CHRONIC TRAUMATIC ENCEPHALOPATHY |
| 6368 |
THE ROLE OF MICRORNAS IN CHRONIC PSEUDOMONAS LUNG INFECTION IN CYSTIC FIBROSIS |
| 6369 |
THE ROLE OF MICRORNAS IN HELICOBACTER PYLORI PATHOGENESIS AND GASTRIC CARCINOGENESIS |
| 6370 |
THE ROLE OF MICRORNAS IN METAL CARCINOGEN-INDUCED CELL MALIGNANT TRANSFORMATION AND TUMORIGENESIS |
| 6371 |
THE ROLE OF MICRORNAS IN THE PATHOGENESIS AND TREATMENT OF HEMATOPOIETIC MALIGNANCIES |
| 6372 |
THE ROLE OF MIR-29A IN THE REGULATION, FUNCTION, AND SIGNALING OF LIVER FIBROSIS |
| 6373 |
THE ROLE OF MIRNAS AND EPIGENETIC MECHANISMS IN PRIMARY GASTRIC MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA |
| 6374 |
THE ROLE OF MITOCHONDRIA IN MYOCARDIAL DAMAGE CAUSED BY ENERGY METABOLISM DISORDERS: FROM MECHANISMS TO THERAPEUTICS |
| 6375 |
THE ROLE OF NEURO-IMMUNE INTERACTION IN CHRONIC PAIN CONDITIONS; FUNCTIONAL SOMATIC SYNDROME, NEUROGENIC INFLAMMATION, AND PERIPHERAL NEUROPATHY |
| 6376 |
THE ROLE OF NEUTROPHILS IN TRAINED IMMUNITY |
| 6377 |
THE ROLE OF NON-CODING RNAS IN DIABETIC NEPHROPATHY: POTENTIAL APPLICATIONS AS BIOMARKERS FOR DISEASE DEVELOPMENT AND PROGRESSION |
| 6378 |
THE ROLE OF NUTRITION ON EPIGENETIC MODIFICATIONS AND THEIR IMPLICATIONS ON HEALTH |
| 6379 |
THE ROLE OF NUTRITION ON META-INFLAMMATION: INSIGHTS AND POTENTIAL TARGETS IN COMMUNICABLE AND CHRONIC DISEASE MANAGEMENT |
| 6380 |
THE ROLE OF OBESITY AND DIABETES IN DEMENTIA |
| 6381 |
THE ROLE OF ONCOGENIC DNA VIRUSES IN PENILE CANCER DEVELOPMENT |
| 6382 |
THE ROLE OF PARTICULATE MATTERS ON METHYLATION OF IFN-GAMMA AND IL-4 PROMOTER GENES IN PEDIATRIC ALLERGIC RHINITIS |
| 6383 |
THE ROLE OF PHF6 IN HEMATOPOIESIS AND HEMATOLOGIC MALIGNANCIES |
| 6384 |
THE ROLE OF POLYCARBONATE MONOMER BISPHENOL-A IN INSULIN RESISTANCE |
| 6385 |
THE ROLE OF PROMYELOCYTIC LEUKEMIA PROTEIN IN STEATOSIS-ASSOCIATED HEPATIC TUMORS RELATED TO CHRONIC HEPATITIS B VIRUS INFECTION |
| 6386 |
THE ROLE OF QUANTITATIVE NPTX2 HYPERMETHYLATION AS A NOVEL SERUM DIAGNOSTIC MARKER IN PANCREATIC CANCER |
| 6387 |
THE ROLE OF REACTIVE OXYGEN SPECIES IN ARSENIC TOXICITY |
| 6388 |
THE ROLE OF SIRT1 IN THE BASOLATERAL AMYGDALA IN DEPRESSION-LIKE BEHAVIORS IN MICE |
| 6389 |
THE ROLE OF THE ENDOCANNABINOID SYSTEM IN THE BRAIN-GUT AXIS |
| 6390 |
THE ROLE OF THE GENETIC ABNORMALITIES, EPIGENETIC AND MICRORNA IN THE PROGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| 6391 |
THE ROLE OF THE GUT MICROBIOME AND MICROBIAL METABOLISM IN MEDIATING OPIOID-INDUCED CHANGES IN THE EPIGENOME |
| 6392 |
THE ROLE OF THE GUT MICROBIOTA IN SCHIZOPHRENIA: CURRENT AND FUTURE PERSPECTIVES |
| 6393 |
THE ROLE OF THE HISTONE METHYLTRANSFERASE EZH2 IN LIVER INFLAMMATION AND FIBROSIS IN STAM NASH MICE |
| 6394 |
THE ROLE OF THE HOST-NEUTROPHIL BIOLOGY |
| 6395 |
THE ROLE OF THE MEDIATORS OF INFLAMMATION IN CANCER DEVELOPMENT |
| 6396 |
THE ROLE OF THE MIR-148/-152 FAMILY IN PHYSIOLOGY AND DISEASE |
| 6397 |
THE ROLE OF TRANSPOSABLE ELEMENTS IN AGING AND CANCER |
| 6398 |
THE ROLE OF VITAMIN D AND VDR IN CARCINOGENESIS: THROUGH EPIDEMIOLOGY AND BASIC SCIENCES |
| 6399 |
THE ROLES AND MECHANISMS OF ACTIONS OF VITAMIN C IN BONE: NEW DEVELOPMENTS |
| 6400 |
THE ROLES OF CLASS I HISTONE DEACETYLASES (HDACS) IN MEMORY, LEARNING, AND EXECUTIVE COGNITIVE FUNCTIONS: A REVIEW |
| 6401 |
THE ROLES OF DNA EPIGENETICS AND CLINICAL SIGNIFICANCE IN CHRONIC MYELOID LEUKEMIA: A REVIEW |
| 6402 |
THE ROLES OF EPIGENETIC MODIFICATIONS OF PROAPOPTOTIC BID AND BIM GENES IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA CELLS |
| 6403 |
THE ROLES OF INDUCIBLE CHROMATIN AND TRANSCRIPTIONAL MEMORY IN CELLULAR DEFENSE SYSTEM RESPONSES TO REDOX-ACTIVE POLLUTANTS |
| 6404 |
THE RS1001179 SNP AND CPG METHYLATION REGULATE CATALASE EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 6405 |
THE SARS-COV-2 RECEPTOR ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) IN MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: ANALYSIS OF HIGH-THROUGHPUT EPIGENETIC AND GENE EXPRESSION STUDIES |
| 6406 |
THE SEARCH FOR RELIABLE BIOMARKERS OF DISEASE IN MULTIPLE CHEMICAL SENSITIVITY AND OTHER ENVIRONMENTAL INTOLERANCES |
| 6407 |
THE SEVERITY OF SARS-COV-2 INFECTION IS DICTATED BY HOST FACTORS? EPIGENETIC PERSPECTIVES |
| 6408 |
THE SEX-DEPENDENT RESPONSE TO PSYCHOSOCIAL STRESS AND ISCHAEMIC HEART DISEASE |
| 6409 |
THE SIGNALING OF CELLULAR SENESCENCE IN DIABETIC NEPHROPATHY |
| 6410 |
THE SIGNATURE OF HBV-RELATED LIVER DISEASE IN PERIPHERAL BLOOD MONONUCLEAR CELL DNA METHYLATION |
| 6411 |
THE SITE SPECIFIC DEMETHYLATION IN THE 5'-REGULATORY AREA OF NMDA RECEPTOR 2B SUBUNIT GENE ASSOCIATED WITH CIE-INDUCED UP-REGULATION OF TRANSCRIPTION |
| 6412 |
THE SPECTRUM OF FUNDAMENTAL BASIC SCIENCE DISCOVERIES CONTRIBUTING TO ORGANISMAL AGING |
| 6413 |
THE STATE OF ART OF REGENERATIVE THERAPY IN CARDIOVASCULAR ISCHEMIC DISEASE: BIOLOGY, SIGNALING PATHWAYS, AND EPIGENETICS OF ENDOTHELIAL PROGENITOR CELLS |
| 6414 |
THE STRESSED SYNAPSE 2 |
| 6415 |
THE STUDY OF P16 AND P15 GENE METHYLATION IN HEAD AND NECK SQUAMOUS CELL CARCINOMA AND THEIR QUANTITATIVE EVALUATION IN PLASMA BY REAL-TIME PCR |
| 6416 |
THE SURVEY OF THE HEALTH OF WISCONSIN (SHOW) PROGRAM: AN INFRASTRUCTURE FOR ADVANCING POPULATION HEALTH SCIENCES |
| 6417 |
THE SWI/SNF CHROMATIN REMODELING COMPLEXES BAF AND PBAF DIFFERENTIALLY REGULATE EPIGENETIC TRANSITIONS IN EXHAUSTED CD8(+) T CELLS |
| 6418 |
THE TEMPORAL EXPRESSION OF CIRCULATING MICRORNAS AFTER ACUTE EXPERIMENTAL PAIN IN HUMANS |
| 6419 |
THE TET2-UPF1 COMPLEX MODULATES MRNA STABILITY UNDER STRESS CONDITIONS |
| 6420 |
THE THERANOSTIC VALUE OF ACETYLATION GENE SIGNATURES IN OBSTRUCTIVE SLEEP APNEA DERIVED BY MACHINE LEARNING |
| 6421 |
THE THERAPEUTIC PROPERTIES OF RESMINOSTAT FOR HEPATOCELLULAR CARCINOMA |
| 6422 |
THE THIN-FAT PHENOTYPE AND GLOBAL METABOLIC DISEASE RISK |
| 6423 |
THE TOXIC EFFECTS OF CHLOROPHENOLS AND ASSOCIATED MECHANISMS IN FISH |
| 6424 |
THE TRANSCRIPTION FACTOR C/EBPBETA IN THE DORSAL ROOT GANGLION CONTRIBUTES TO PERIPHERAL NERVE TRAUMA-INDUCED NOCICEPTIVE HYPERSENSITIVITY |
| 6425 |
THE TRANSCRIPTION FACTOR REST UP-REGULATES TYROSINE HYDROXYLASE AND ANTIAPOPTOTIC GENES AND PROTECTS DOPAMINERGIC NEURONS AGAINST MANGANESE TOXICITY |
| 6426 |
THE TRANSGENERATIONAL TRANSMISSION OF THE PATERNAL TYPE 2 DIABETES-INDUCED SUBFERTILITY PHENOTYPE |
| 6427 |
THE TRANSITION FROM ACUTE TO CHRONIC PAIN: DYNAMIC EPIGENETIC REPROGRAMMING OF THE MOUSE PREFRONTAL CORTEX UP TO 1 YEAR AFTER NERVE INJURY |
| 6428 |
THE TUMOR MICROENVIRONMENT AND METASTATIC DISEASE |
| 6429 |
THE UPREGULATION OF NLRP3 INFLAMMASOME IN DORSAL ROOT GANGLION BY TEN-ELEVEN TRANSLOCATION METHYLCYTOSINE DIOXYGENASE 2 (TET2) CONTRIBUTED TO DIABETIC NEUROPATHIC PAIN IN MICE |
| 6430 |
THE USE OF MEDICAL OZONE IN CHRONIC INTERVERTEBRAL DISC DEGENERATION CAN BE AN ETIOLOGICAL AND CONSERVATIVE TREATMENT |
| 6431 |
THE USE OF TARGETED NEXT GENERATION SEQUENCING TO EXPLORE CANDIDATE REGULATORS OF TGF-BETA1'S IMPACT ON KIDNEY CELLS |
| 6432 |
THE VICIOUS CIRCLE BETWEEN HOMOCYSTEINE, METHYL GROUP-DONATING VITAMINS AND CHRONIC LEVODOPA INTAKE IN PARKINSON'S DISEASE |
| 6433 |
THE VINDICATION OF LAMARCK? EPIGENETICS AT THE INTERSECTION OF LAW AND MENTAL HEALTH |
| 6434 |
THE VON HIPPEL LINDAU TUMOUR SUPPRESSOR GENE IS A NOVEL TARGET OF E2F4-MEDIATED TRANSCRIPTIONAL REPRESSION IN PREECLAMPSIA |
| 6435 |
THE XPB SUBUNIT OF THE TFIIH COMPLEX PLAYS A CRITICAL ROLE IN HIV-1 TRANSCRIPTION AND XPB INHIBITION BY SPIRONOLACTONE PREVENTS HIV-1 REACTIVATION FROM LATENCY |
| 6436 |
THERAPEUTIC ACTIONS OF TEA PHENOLIC COMPOUNDS AGAINST OXIDATIVE STRESS AND INFLAMMATION AS CENTRAL MEDIATORS IN THE DEVELOPMENT AND PROGRESSION OF HEALTH PROBLEMS: A REVIEW FOCUSING ON MICRORNA REGULATION |
| 6437 |
THERAPEUTIC ADVANCES IN LEUKEMIA AND MYELODYSPLASTIC SYNDROME OVER THE PAST 40 YEARS |
| 6438 |
THERAPEUTIC AND PREVENTIVE INTERVENTIONS FOR POSTULATED VASOACTIVE NEUROPEPTIDE AUTOIMMUNE FATIGUE-RELATED DISORDERS |
| 6439 |
THERAPEUTIC ANTIBODIES: CURRENT STATE AND FUTURE TRENDS--IS A PARADIGM CHANGE COMING SOON? ANTIBODY-BASED THERAPEUTICS CURRENTLY ENJOY UNPRECEDENTED SUCCESS, GROWTH IN RESEARCH AND REVENUES, AND RECOGNITION OF THEIR POTENTIAL |
| 6440 |
THERAPEUTIC APPROACHES FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) EXACERBATIONS |
| 6441 |
THERAPEUTIC APPROACHES FOR NONALCOHOLIC FATTY LIVER DISEASE: ESTABLISHED TARGETS AND DRUGS |
| 6442 |
THERAPEUTIC APPROACHES IN MYELOFIBROSIS AND MYELODYSPLASTIC/MYELOPROLIFERATIVE OVERLAP SYNDROMES |
| 6443 |
THERAPEUTIC APPROACHES TO HISTONE REPROGRAMMING IN RETINAL DEGENERATION |
| 6444 |
THERAPEUTIC ASPECTS OF C-MYC SIGNALING IN INFLAMMATORY AND CANCEROUS COLONIC DISEASES |
| 6445 |
THERAPEUTIC BENEFITS OF THE METHYL DONOR S-ADENOSYLMETHIONINE ON NERVE INJURY-INDUCED MECHANICAL HYPERSENSITIVITY AND COGNITIVE IMPAIRMENT IN MICE |
| 6446 |
THERAPEUTIC INSIGHTS IN CHRONIC KIDNEY DISEASE PROGRESSION |
| 6447 |
THERAPEUTIC PROSPECTS FOR EPIGENETIC MODULATION |
| 6448 |
THERAPEUTIC SHUTDOWN OF HBV TRANSCRIPTS PROMOTES REAPPEARANCE OF THE SMC5/6 COMPLEX AND SILENCING OF THE VIRAL GENOME IN VIVO |
| 6449 |
THERAPEUTIC TARGETING OF TELOMERASE |
| 6450 |
THERAPEUTIC TARGETS FOR INFLAMMATION-MEDIATED AIRWAY REMODELING IN CHRONIC LUNG DISEASE |
| 6451 |
THERAPIES TARGETING EPIGENETIC ALTERATIONS IN ACUTE KIDNEY INJURY-TO-CHRONIC KIDNEY DISEASE TRANSITION |
| 6452 |
THERAPIES TARGETING TRAINED IMMUNE CELLS IN INFLAMMATORY AND AUTOIMMUNE DISEASES |
| 6453 |
THIOREDOXIN INTERACTING PROTEIN (TXNIP) INDUCES INFLAMMATION THROUGH CHROMATIN MODIFICATION IN RETINAL CAPILLARY ENDOTHELIAL CELLS UNDER DIABETIC CONDITIONS |
| 6454 |
THIRD JESUS CULEBRAS LECTURE - MOLECULAR BIOLOGY AND CLINICAL NUTRITION; WHERE DO WE STAND AND WHERE DO WE GO? NUTRITION PLAYS A FUNDAMENTAL ROLE IN THE MAINTENANCE OF HEALTH AND THE TREATMENT OF DISEASE, AND SERVES AS THE CROSSROADS FOR MANY DISCIPLINES |
| 6455 |
THYMOQUINONE ENHANCES APOPTOSIS OF K562 CHRONIC MYELOID LEUKEMIA CELLS THROUGH HYPOMETHYLATION OF SHP-1 AND INHIBITION OF JAK/STAT SIGNALING PATHWAY |
| 6456 |
THYMOSIN BETA4 PREVENTS OXIDATIVE STRESS, INFLAMMATION, AND FIBROSIS IN ETHANOL- AND LPS-INDUCED LIVER INJURY IN MICE |
| 6457 |
TIC DISORDERS: WHEN HABIT FORMING NEURAL SYSTEMS FORM HABITS OF THEIR OWN? TOURETTE SYNDROME (TS), OBSESSIVE-COMPULSIVE DISORDER (OCD) AND RELATED CONDITIONS ARE PREVALENT DISORDERS AFFECTING AS MANY AS 0 |
| 6458 |
TIME COURSE OF DNA METHYLATION IN PAIN CONDITIONS: FROM EXPERIMENTAL MODELS TO HUMANS |
| 6459 |
TIME TO CHANGE FROM A SIMPLE LINEAR MODEL TO A COMPLEX SYSTEMS MODEL |
| 6460 |
TIME TO RELAPSE IN CHRONIC LYMPHOCYTIC LEUKEMIA AND DNA-METHYLATION-BASED BIOLOGICAL AGE |
| 6461 |
TIME-COURSE PROGRESSION OF WHOLE TRANSCRIPTOME EXPRESSION CHANGES OF TRIGEMINAL GANGLIA COMPARED TO DORSAL ROOT GANGLIA IN RATS EXPOSED TO NERVE INJURY |
| 6462 |
TISSUE AND CIRCULATING MICRORNAS AS BIOMARKERS OF RESPONSE TO OBESITY TREATMENT STRATEGIES |
| 6463 |
TISSUE METHYLATION AND DEMETHYLATION INFLUENCE TRANSLESION SYNTHESIS DNA POLYMERASES (TLS) CONTRIBUTING TO THE GENESIS OF CHROMOSOMAL ABNORMALITIES IN MYELODYSPLASTIC SYNDROME |
| 6464 |
TISSUE MISREPAIR HYPOTHESIS FOR RADIATION CARCINOGENESIS |
| 6465 |
TISSUE REMODELING IN ADULT VERNAL KERATOCONJUNCTIVITIS |
| 6466 |
TISSUE STEM CELLS AND CANCER STEM CELLS: POTENTIAL IMPLICATIONS FOR GASTRIC CANCER |
| 6467 |
TISSUE-SPECIFIC EFFECTS OF EXERCISE AS NAD(+) -BOOSTING STRATEGY: CURRENT KNOWLEDGE AND FUTURE PERSPECTIVES |
| 6468 |
TISSUE-SPECIFIC ENRICHMENT OF LYMPHOMA RISK LOCI IN REGULATORY ELEMENTS |
| 6469 |
TISSUE-SPECIFIC METHYLATION PROFILE IN OBESE PATIENTS WITH TYPE 2 DIABETES BEFORE AND AFTER ROUX-EN-Y GASTRIC BYPASS |
| 6470 |
TLR7 AND TLR8 EXPRESSION INCREASES TUMOR CELL PROLIFERATION AND PROMOTES CHEMORESISTANCE IN HUMAN PANCREATIC CANCER |
| 6471 |
TNF-ALPHA REGULATES DIABETIC MACROPHAGE FUNCTION THROUGH THE HISTONE ACETYLTRANSFERASE MOF |
| 6472 |
TNFALPHA IN THE TRIGEMINAL NOCICEPTIVE SYSTEM IS CRITICAL FOR TEMPOROMANDIBULAR JOINT PAIN |
| 6473 |
TO DO ONE AND TO GET MORE: PART II |
| 6474 |
TOBACCO HEATING SYSTEM 2 |
| 6475 |
TOBACCO, INFLAMMATION, AND RESPIRATORY TRACT CANCER |
| 6476 |
TOLL-LIKE RECEPTORS, INFECTIONS, AND RHEUMATOID ARTHRITIS |
| 6477 |
TOLUENE IMPAIRS LEARNING AND MEMORY, HAS ANTINOCICEPTIVE EFFECTS, AND MODIFIES HISTONE ACETYLATION IN THE DENTATE GYRUS OF ADOLESCENT AND ADULT RATS |
| 6478 |
TOPICAL REVIEW: THE EMERGING FIELD OF EPIGENETICS: INFORMING MODELS OF PEDIATRIC TRAUMA AND PHYSICAL HEALTH |
| 6479 |
TOWARD A NEW ERA OF HEPATITIS B VIRUS THERAPEUTICS: THE PURSUIT OF A FUNCTIONAL CURE |
| 6480 |
TOWARDS PRECISION MEDICINE IN GENERALIZED ANXIETY DISORDER: REVIEW OF GENETICS AND PHARMACO(EPI)GENETICS |
| 6481 |
TOX IS EXPRESSED BY EXHAUSTED AND POLYFUNCTIONAL HUMAN EFFECTOR MEMORY CD8(+) T CELLS |
| 6482 |
TOX TRANSCRIPTIONALLY AND EPIGENETICALLY PROGRAMS CD8(+) T CELL EXHAUSTION |
| 6483 |
TOXIC STRESS, EPIGENETICS AND CHILD DEVELOPMENT |
| 6484 |
TOXICOLOGIC PROFILE OF ACRYLONITRILE |
| 6485 |
TOXICOLOGICAL MECHANISM OF INDIVIDUAL SUSCEPTIBILITY TO FORMALDEHYDE-INDUCED RESPIRATORY EFFECTS |
| 6486 |
TP53 AND LIVER CARCINOGENESIS |
| 6487 |
TP53 MUTATIONS AND HEPATOCELLULAR CARCINOMA: INSIGHTS INTO THE ETIOLOGY AND PATHOGENESIS OF LIVER CANCER |
| 6488 |
TP53 R72P POLYMORPHISM MODULATES DNA METHYLATION IN HEPATOCELLULAR CARCINOMA |
| 6489 |
TRACHOMA AND OCULAR CHLAMYDIAL INFECTION IN THE ERA OF GENOMICS |
| 6490 |
TRACING SLOW PHENOPTOSIS TO THE PRENATAL STAGE IN SOCIAL VERTEBRATES |
| 6491 |
TRAFFIC-DERIVED PARTICULATE MATTER EXPOSURE AND HISTONE H3 MODIFICATION: A REPEATED MEASURES STUDY |
| 6492 |
TRAFFIC-RELATED AIR POLLUTION AND GROUND-LEVEL OZONE ASSOCIATED GLOBAL DNA HYPOMETHYLATION AND BULKY DNA ADDUCT FORMATION |
| 6493 |
TRAINED IMMUNITY AND REACTIVITY OF MACROPHAGES AND ENDOTHELIAL CELLS |
| 6494 |
TRAINED IMMUNITY AS A NOVEL THERAPEUTIC STRATEGY |
| 6495 |
TRAINED IMMUNITY AS A POTENTIAL TARGET FOR THERAPEUTIC IMMUNOMODULATION IN DUCHENNE MUSCULAR DYSTROPHY |
| 6496 |
TRAINED IMMUNITY CONTRIBUTION TO AUTOIMMUNE AND INFLAMMATORY DISORDERS |
| 6497 |
TRAINED IMMUNITY IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE |
| 6498 |
TRAINED IMMUNITY IN MONOCYTE/MACROPHAGE: NOVEL MECHANISM OF PHYTOCHEMICALS IN THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE |
| 6499 |
TRAINED IMMUNITY IN PERIVASCULAR ADIPOSE TISSUE OF ABDOMINAL AORTIC ANEURYSM-A NOVEL CONCEPT FOR A STILL ELUSIVE DISEASE |
| 6500 |
TRAINED IMMUNITY IN TYPE 2 IMMUNE RESPONSES |
| 6501 |
TRAINED IMMUNITY: LINKING OBESITY AND CARDIOVASCULAR DISEASE ACROSS THE LIFE-COURSE? OBESITY, A CHRONIC INFLAMMATORY DISEASE, IS THE MOST PREVALENT MODIFIABLE RISK FACTOR FOR CARDIOVASCULAR DISEASE |
| 6502 |
TRAINED IMMUNITY: LONG-TERM ADAPTATION IN INNATE IMMUNE RESPONSES |
| 6503 |
TRAINED IMMUNITY: REPROGRAMMING INNATE IMMUNITY IN HEALTH AND DISEASE |
| 6504 |
TRAINED INNATE IMMUNITY AND ITS IMPLICATIONS FOR MUCOSAL IMMUNITY AND INFLAMMATION |
| 6505 |
TRAINED INNATE IMMUNITY AS A NOVEL MECHANISM LINKING INFECTION AND THE DEVELOPMENT OF ATHEROSCLEROSIS |
| 6506 |
TRAINED INNATE IMMUNITY NOT ALWAYS AMICABLE |
| 6507 |
TRAINING VOCATIONAL REHABILITATION COUNSELORS WHO WORK WITH CHRONIC MENTAL PATIENTS |
| 6508 |
TRAJECTORIES OF INFLAMMATORY BIOMARKERS OVER THE EIGHTH DECADE AND THEIR ASSOCIATIONS WITH IMMUNE CELL PROFILES AND EPIGENETIC AGEING |
| 6509 |
TRANSCRIPTION FACTOR RFX1 IS UBIQUITINATED BY E3 LIGASE STUB1 IN SYSTEMIC LUPUS ERYTHEMATOSUS |
| 6510 |
TRANSCRIPTION FACTORS AND EPIGENETIC MODULATION: ITS THERAPEUTIC IMPLICATION IN CHRONIC KIDNEY DISEASE |
| 6511 |
TRANSCRIPTION FACTORS AS THERAPEUTIC TARGETS IN CHRONIC KIDNEY DISEASE |
| 6512 |
TRANSCRIPTION INTERMEDIARY FACTOR 1GAMMA IS A TUMOR SUPPRESSOR IN MOUSE AND HUMAN CHRONIC MYELOMONOCYTIC LEUKEMIA |
| 6513 |
TRANSCRIPTION-ASSOCIATED EVENTS AFFECTING GENOMIC INTEGRITY |
| 6514 |
TRANSCRIPTIONAL ACTIVATION OF THE GP91PHOX NADPH OXIDASE SUBUNIT BY TPA IN HL-60 CELLS |
| 6515 |
TRANSCRIPTIONAL AND EPIGENETIC BASIS FOR RESTORATION OF G6PD ENZYMATIC ACTIVITY IN HUMAN G6PD-DEFICIENT CELLS |
| 6516 |
TRANSCRIPTIONAL AND EPIGENETIC FACTORS ASSOCIATED WITH EARLY THROMBOSIS OF FEMORAL ARTERY INVOLVED IN ARTERIOVENOUS FISTULA |
| 6517 |
TRANSCRIPTIONAL AND EPIGENETIC MECHANISMS OF ADDICTION |
| 6518 |
TRANSCRIPTIONAL AND EPIGENETIC MODULATION OF HUMAN RHINOVIRUS-INDUCED CXCL10 PRODUCTION BY CIGARETTE SMOKE |
| 6519 |
TRANSCRIPTIONAL AND EPIGENETIC REGULATION OF INTERLEUKIN-2 GENE IN ACTIVATED T CELLS BY MORPHINE |
| 6520 |
TRANSCRIPTIONAL AND EPIGENETIC REGULATION OF MONOCYTE AND MACROPHAGE DYSFUNCTION BY CHRONIC ALCOHOL CONSUMPTION |
| 6521 |
TRANSCRIPTIONAL AND EPIGENETIC REGULATION OF PD-1 EXPRESSION |
| 6522 |
TRANSCRIPTIONAL AND EPIGENETIC REGULATION OF T CELL HYPORESPONSIVENESS |
| 6523 |
TRANSCRIPTIONAL AND EPIGENETIC REGULATORY MECHANISMS AFFECTING HTLV-1 PROVIRUS |
| 6524 |
TRANSCRIPTIONAL AND EPIGENETIC RESPONSE TO SEDENTARY BEHAVIOR AND PHYSICAL ACTIVITY IN CHILDREN AND ADOLESCENTS: A SYSTEMATIC REVIEW |
| 6525 |
TRANSCRIPTIONAL AND EPIGENETIC SUBSTRATES OF METHAMPHETAMINE ADDICTION AND WITHDRAWAL: EVIDENCE FROM A LONG-ACCESS SELF-ADMINISTRATION MODEL IN THE RAT |
| 6526 |
TRANSCRIPTIONAL CHANGES IN THE OVARIES OF PERCH FROM CHERNOBYL |
| 6527 |
TRANSCRIPTIONAL CONTROL OF MALADAPTIVE AND PROTECTIVE RESPONSES IN ALCOHOLICS: A ROLE OF THE NF-KAPPAB SYSTEM |
| 6528 |
TRANSCRIPTIONAL CORRELATES OF CHRONIC ALCOHOL NEUROADAPTATION IN DROSOPHILA LARVAE |
| 6529 |
TRANSCRIPTIONAL DOWN-REGULATION OF THE WNT ANTAGONIST SFRP1 IN HAEMATOPOIETIC CELLS OF PATIENTS WITH DIFFERENT RISK TYPES OF MDS |
| 6530 |
TRANSCRIPTIONAL REGULATION AND T CELL EXHAUSTION |
| 6531 |
TRANSCRIPTIONAL REGULATION OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) BY METHYL CPG BINDING PROTEIN 2 (MECP2): A NOVEL MECHANISM FOR RE-MYELINATION AND/OR MYELIN REPAIR INVOLVED IN THE TREATMENT OF MULTIPLE SCLEROSIS (MS) |
| 6532 |
TRANSCRIPTIONAL REGULATION OF INFLAMMASOMES |
| 6533 |
TRANSCRIPTIONAL REGULATION OF INFLAMMATORY GENES ASSOCIATED WITH SEVERE ASTHMA |
| 6534 |
TRANSCRIPTIONAL REGULATION OF NMDA RECEPTOR EXPRESSION |
| 6535 |
TRANSCRIPTIONAL REGULATION OF THE ANTI-INFLAMMATORY CYTOKINE IL-10 IN ACQUIRED IMMUNE CELLS |
| 6536 |
TRANSCRIPTIONAL REGULATION OF TYPE-2 METABOTROPIC GLUTAMATE RECEPTORS: AN EPIGENETIC PATH TO NOVEL TREATMENTS FOR CHRONIC PAIN |
| 6537 |
TRANSCRIPTIONAL REGULATOR PRDM12 IS ESSENTIAL FOR HUMAN PAIN PERCEPTION |
| 6538 |
TRANSCRIPTIONAL REGULATORS AS TARGETS FOR ALCOHOL PHARMACOTHERAPIES |
| 6539 |
TRANSCRIPTIONAL VARIATIONS IN THE WIDER PERITUMORAL TISSUE ENVIRONMENT OF PANCREATIC CANCER |
| 6540 |
TRANSCRIPTIONAL, EPIGENETIC, AND FUNCTIONAL REPROGRAMMING OF MONOCYTES FROM NON-HUMAN PRIMATES FOLLOWING CHRONIC ALCOHOL DRINKING |
| 6541 |
TRANSCRIPTOME ANALYSIS OF HUMAN PRIMARY ENDOTHELIAL CELLS (HUVEC) FROM UMBILICAL CORDS OF GESTATIONAL DIABETIC MOTHERS REVEALS CANDIDATE SITES FOR AN EPIGENETIC MODULATION OF SPECIFIC GENE EXPRESSION |
| 6542 |
TRANSCRIPTOME ARCHITECTURE OF OSTEOBLASTIC CELLS INFECTED WITH STAPHYLOCOCCUS AUREUS REVEALS STRONG INFLAMMATORY RESPONSES AND SIGNATURES OF METABOLIC AND EPIGENETIC DYSREGULATION |
| 6543 |
TRANSCRIPTOME REMODELING IN HYPOXIC INFLAMMATION |
| 6544 |
TRANSCRIPTOMIC AND EPIGENETIC ALTERATIONS IN DENDRITIC CELLS CORRESPOND WITH CHRONIC KIDNEY DISEASE IN LUPUS NEPHRITIS |
| 6545 |
TRANSCRIPTOMIC AND EPIGENETIC CHANGES IN THE HYPOTHALAMUS ARE INVOLVED IN AN INCREASED SUSCEPTIBILITY TO A HIGH-FAT-SUCROSE DIET IN PRENATALLY STRESSED FEMALE RATS |
| 6546 |
TRANSCRIPTOMIC AND EPIGENETIC PROFILING OF FIBROBLASTS IN IDIOPATHIC PULMONARY FIBROSIS |
| 6547 |
TRANSCRIPTOMICS OF LONG-TERM MEDITATION PRACTICE: EVIDENCE FOR PREVENTION OR REVERSAL OF STRESS EFFECTS HARMFUL TO HEALTH |
| 6548 |
TRANSCULTURAL DIABETES CARE IN THE UNITED STATES - A POSITION STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS |
| 6549 |
TRANSFORMING GROWTH FACTOR BETA INHIBITS MUC5AC EXPRESSION BY SMAD3/HDAC2 COMPLEX FORMATION AND NF-KAPPAB DEACETYLATION AT K310 IN NCI-H292 CELLS |
| 6550 |
TRANSGENERATIONAL ACCUMULATION OF RADIATION DAMAGE IN SMALL MAMMALS CHRONICALLY EXPOSED TO CHERNOBYL FALLOUT |
| 6551 |
TRANSGENERATIONAL BLUNTING OF MORPHINE-INDUCED CORTICOSTERONE SECRETION IS ASSOCIATED WITH DYSREGULATED GENE EXPRESSION IN MALE OFFSPRING |
| 6552 |
TRANSGENERATIONAL DNA METHYLATION CHANGES IN DAPHNIA MAGNA EXPOSED TO CHRONIC GAMMA IRRADIATION |
| 6553 |
TRANSGENERATIONAL EFFECTS IN DNA METHYLATION, GENOTOXICITY AND REPRODUCTIVE PHENOTYPE BY CHRONIC ARSENIC EXPOSURE |
| 6554 |
TRANSGENERATIONAL EFFECTS OF EARLY ENVIRONMENTAL INSULTS ON AGING AND DISEASE INCIDENCE |
| 6555 |
TRANSGENERATIONAL EFFECTS OF GAMMA RADIATION DOSE AND DOSE RATE ON DROSOPHILA FLIES IRRADIATED AT AN EARLY EMBRYONAL STAGE |
| 6556 |
TRANSGENERATIONAL EFFECTS OF POLYETHYLENE MICROPLASTIC FRAGMENTS CONTAINING BENZOPHENONE-3 ADDITIVE IN DAPHNIA MAGNA |
| 6557 |
TRANSGENERATIONAL EPIGENETIC INHERITANCE OF DIABETES RISK AS A CONSEQUENCE OF EARLY NUTRITIONAL IMBALANCES |
| 6558 |
TRANSGENERATIONAL EPIGENETIC PROGRAMMING VIA SPERM MICRORNA RECAPITULATES EFFECTS OF PATERNAL STRESS |
| 6559 |
TRANSGENERATIONAL INFLUENCE OF PARENTAL MORPHINE EXPOSURE ON PAIN PERCEPTION, ANXIETY-LIKE BEHAVIOR AND PASSIVE AVOIDANCE MEMORY AMONG MALE AND FEMALE OFFSPRING OF WISTAR RATS |
| 6560 |
TRANSGENERATIONAL PROGRAMMING OF NEPHRON DEFICITS AND HYPERTENSION |
| 6561 |
TRANSGLUTAMINASE IS A THERAPEUTIC TARGET FOR OXIDATIVE STRESS, EXCITOTOXICITY AND STROKE: A NEW EPIGENETIC KID ON THE CNS BLOCK |
| 6562 |
TRANSIENT AND PERMANENT CHANGES IN DNA METHYLATION PATTERNS IN INORGANIC ARSENIC-MEDIATED EPITHELIAL-TO-MESENCHYMAL TRANSITION |
| 6563 |
TRANSIENT AND STABLE VECTOR TRANSFECTION: PITFALLS, OFF-TARGET EFFECTS, ARTIFACTS |
| 6564 |
TRANSIENT EXPOSURE TO ELEVATED GLUCOSE LEVELS CAUSES PERSISTENT CHANGES IN DERMAL MICROVASCULAR ENDOTHELIAL CELL RESPONSES TO INJURY |
| 6565 |
TRANSLATING EPIGENETICS INTO CLINIC: FOCUS ON LUPUS |
| 6566 |
TRANSLATIONAL PERSPECTIVES TO TREAT EPIDERMOLYSIS BULLOSA-WHERE DO WE STAND? EPIDERMOLYSIS BULLOSA (EB) IS THE PROTOTYPICAL EXAMPLE OF GENETIC SKIN FRAGILITY DISORDERS |
| 6567 |
TRANSLATOMIC RESPONSE OF RETINAL MULLER GLIA TO ACUTE AND CHRONIC STRESS |
| 6568 |
TRANSMATERNAL HELICOBACTER PYLORI EXPOSURE REDUCES ALLERGIC AIRWAY INFLAMMATION IN OFFSPRING THROUGH REGULATORY T CELLS |
| 6569 |
TRANSPLANTATION OF EPIGENETICALLY MODIFIED ADULT CARDIAC C-KIT+ CELLS RETARDS REMODELING AND IMPROVES CARDIAC FUNCTION IN ISCHEMIC HEART FAILURE MODEL |
| 6570 |
TRANSPOSABLE ELEMENTS AND THEIR POTENTIAL ROLE IN COMPLEX LUNG DISORDER |
| 6571 |
TRANSPOSABLE ELEMENTS CROSS KINGDOM BOUNDARIES AND CONTRIBUTE TO INFLAMMATION AND AGEING: SOMATIC ACQUISITION OF FOREIGN TRANSPOSABLE ELEMENTS AS A CATALYST OF GENOME INSTABILITY, EPIGENETIC DYSREGULATION, INFLAMMATION, SENESCENCE, AND AGEING |
| 6572 |
TRAUMATIC STRESS-INDUCED PERSISTENT CHANGES IN DNA METHYLATION REGULATE NEUROPEPTIDE Y EXPRESSION IN RAT JEJUNUM |
| 6573 |
TREATMENT OF ACUTE MYELOID LEUKEMIA IN THE ERA OF GENOMICS-ACHIEVEMENTS AND PERSISTING CHALLENGES |
| 6574 |
TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA WITH 5-AZACYTIDINE: CASE REPORTS |
| 6575 |
TREATMENT OF DIABETIC KIDNEY DISEASE: CURRENT AND FUTURE |
| 6576 |
TREATMENT OF PRIMARY SJOGREN SYNDROME |
| 6577 |
TREATMENT STRATEGIES FOR COMPLEX BEHAVIORAL INSOMNIA IN CHILDREN WITH NEURODEVELOPMENTAL DISORDERS |
| 6578 |
TREATMENT WITH TRICHURIS SUIS SOLUBLE PRODUCTS DURING MONOCYTE-TO-MACROPHAGE DIFFERENTIATION REDUCES INFLAMMATORY RESPONSES THROUGH EPIGENETIC REMODELING |
| 6579 |
TREFOIL FACTORS AND HUMAN GASTRIC CANCER (REVIEW) |
| 6580 |
TREPONEMA DENTICOLA INCREASES MMP-2 EXPRESSION AND ACTIVATION IN THE PERIODONTIUM VIA REVERSIBLE DNA AND HISTONE MODIFICATIONS |
| 6581 |
TREPONEMA DENTICOLA UPREGULATES MMP-2 ACTIVATION IN PERIODONTAL LIGAMENT CELLS: INTERPLAY BETWEEN EPIGENETICS AND PERIODONTAL INFECTION |
| 6582 |
TRICHOSTATIN A, A HISTONE DEACETYLASE INHIBITOR, ALLEVIATES THE EMOTIONAL ABNORMALITY INDUCED BY MALADAPTATION TO STRESS IN MICE |
| 6583 |
TRICLOSAN INDUCES ZEBRAFISH NEUROTOXICITY BY ABNORMAL EXPRESSION OF MIR-219 TARGETING OLIGODENDROCYTE DIFFERENTIATION OF CENTRAL NERVOUS SYSTEM |
| 6584 |
TRIGGERING RECEPTORS EXPRESSED ON MYELOID CELLS 1 : OUR NEW PARTNER IN HUMAN ONCOLOGY? INFLAMMATION IS RECOGNIZED AS ONE OF THE HALLMARKS OF CANCER |
| 6585 |
TRPV4-MEDIATED ANTI-NOCICEPTIVE EFFECT OF SUBERANILOHYDROXAMIC ACID ON MECHANICAL PAIN |
| 6586 |
TUBASTATIN, A SELECTIVE HISTONE DEACETYLASE 6 INHIBITOR SHOWS ANTI-INFLAMMATORY AND ANTI-RHEUMATIC EFFECTS |
| 6587 |
TUMOR DORMANCY AND RELAPSE: FROM A NATURAL BYPRODUCT OF EVOLUTION TO A DISEASE STATE |
| 6588 |
TUMOR HETEROGENEITY IN LYMPHOMAS: A DIFFERENT BREED |
| 6589 |
TUMOR NECROSIS FACTOR-ALPHA GENE PROMOTER METHYLATION IN JAPANESE ADULTS WITH CHRONIC PERIODONTITIS AND RHEUMATOID ARTHRITIS |
| 6590 |
TUMOR SUPPRESSOR INACTIVATION IN THE PATHOGENESIS OF ADULT T-CELL LEUKEMIA |
| 6591 |
TUMOR-ASSOCIATED MACROPHAGES AS A PARADIGM OF MACROPHAGE PLASTICITY, DIVERSITY, AND POLARIZATION: LESSONS AND OPEN QUESTIONS |
| 6592 |
TUMOR-ASSOCIATED MACROPHAGES IN HEPATOCELLULAR CARCINOMA PATHOGENESIS, PROGNOSIS AND THERAPY |
| 6593 |
TUMOR-ASSOCIATED MACROPHAGES PROMOTE EPIGENETIC SILENCING OF GELSOLIN THROUGH DNA METHYLTRANSFERASE 1 IN GASTRIC CANCER CELLS |
| 6594 |
TUMOR-AUGMENTING EFFECTS OF GESTATIONAL ARSENIC EXPOSURE ON F1 AND F2 IN MICE |
| 6595 |
TUMOR-SPECIFIC GROWTH FACTOR (TSGF): A FUTURISTIC TUMOR BIOMARKER IN EARLY DIAGNOSIS OF CANCER |
| 6596 |
TUMOR-SUPPRESSIVE MIR-192-5P HAS PROGNOSTIC VALUE IN PANCREATIC DUCTAL ADENOCARCINOMA |
| 6597 |
TUNING MONOCYTES AND MACROPHAGES FOR PERSONALIZED THERAPY AND DIAGNOSTIC CHALLENGE IN RHEUMATOID ARTHRITIS |
| 6598 |
TWINSUK: THE UK ADULT TWIN REGISTRY UPDATE |
| 6599 |
TWIST1 AND TWIST2 INDUCE HUMAN MACROPHAGE MEMORY UPON CHRONIC INNATE RECEPTOR TREATMENT BY HDAC-MEDIATED DEACETYLATION OF CYTOKINE PROMOTERS |
| 6600 |
TWIST2 DEMONSTRATES DIFFERENTIAL METHYLATION IN IMMUNOGLOBULIN VARIABLE HEAVY CHAIN MUTATED AND UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA |
| 6601 |
TWO INTRAUTERINE PROGRAMMING MECHANISMS OF ADULT HYPERCHOLESTEROLEMIA INDUCED BY PRENATAL NICOTINE EXPOSURE IN MALE OFFSPRING RATS |
| 6602 |
TWO KINDS OF TRANSCRIPTION FACTORS MEDIATE CHRONIC MORPHINE-INDUCED DECREASE IN MIR-105 IN MEDIAL PREFRONTAL CORTEX OF RATS |
| 6603 |
TWO SISTERS WITH FAMILIAL MEDITERRANEAN FEVER: LACK OF CORRELATION BETWEEN GENOTYPE AND PHENOTYPE? FAMILIAL MEDITERRANEAN FEVER (FMF) IS AN AUTOSOMAL RECESSIVE DISORDER CHARACTERIZED BY ATTACKS OF FEVER AND SEROSITIS |
| 6604 |
TYPE 1 DIABETES AND VIRAL INFECTIONS: WHAT IS THE RELATIONSHIP? TYPE 1 DIABETES (T1D) IS THE MOST COMMON CHRONIC METABOLIC DISORDER IN CHILDREN |
| 6605 |
TYPE 1 DIABETES: INTERFERONS AND THE AFTERMATH OF PANCREATIC BETA-CELL ENTEROVIRAL INFECTION |
| 6606 |
TYPE 2 DIABETES ACROSS GENERATIONS: FROM PATHOPHYSIOLOGY TO PREVENTION AND MANAGEMENT |
| 6607 |
TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR DISEASE: GENETIC AND EPIGENETIC LINKS |
| 6608 |
TYPE I INTERFERONS AS KEY PLAYERS IN PANCREATIC BETA-CELL DYSFUNCTION IN TYPE 1 DIABETES |
| 6609 |
TYROSINE KINASE INHIBITORS IN PH+ CHRONIC MYELOID LEUKEMIA THERAPY: A REVIEW |
| 6610 |
UBIQUITIN-SPECIFIC PROTEASE 2-69 IN MACROPHAGES POTENTIALLY MODULATES METAINFLAMMATION |
| 6611 |
UHRF1 REGULATES GERMINAL CENTER B CELL EXPANSION AND AFFINITY MATURATION TO CONTROL VIRAL INFECTION |
| 6612 |
ULTRA-LOW-DOSE NALOXONE ENHANCES THE ANTINOCICEPTIVE EFFECT OF MORPHINE IN PTX-TREATED RATS: REGULATION ON GLOBAL HISTONE METHYLATION |
| 6613 |
ULTRADEEP BISULFITE SEQUENCING ANALYSIS OF DNA METHYLATION PATTERNS IN MULTIPLE GENE PROMOTERS BY 454 SEQUENCING |
| 6614 |
ULTRAVIOLET IRRADIATION INDUCES KERATINOCYTE PROLIFERATION AND EPIDERMAL HYPERPLASIA THROUGH THE ACTIVATION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR |
| 6615 |
ULTRAVIOLET-A1 IRRADIATION THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS |
| 6616 |
UNCOVERING THE DNA METHYLOME IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 6617 |
UNDERPINNING THE NEUROBIOLOGICAL INTRICACIES ASSOCIATED WITH OPIOID TOLERANCE |
| 6618 |
UNDERSTANDING AND MONITORING CHRONIC MYELOID LEUKEMIA BLAST CRISIS: HOW TO BETTER MANAGE PATIENTS |
| 6619 |
UNDERSTANDING CHRONIC VENOUS DISEASE: A CRITICAL OVERVIEW OF ITS PATHOPHYSIOLOGY AND MEDICAL MANAGEMENT |
| 6620 |
UNDERSTANDING DEVELOPMENT AND PREVENTION OF CHRONIC PHYSICAL AGGRESSION: TOWARDS EXPERIMENTAL EPIGENETIC STUDIES |
| 6621 |
UNDERSTANDING FIBROSIS IN SYSTEMIC SCLEROSIS: SHIFTING PARADIGMS, EMERGING OPPORTUNITIES |
| 6622 |
UNDERSTANDING HAT1: A COMPREHENSIVE REVIEW OF NONCANONICAL ROLES AND CONNECTION WITH DISEASE |
| 6623 |
UNDERSTANDING KELOID PATHOBIOLOGY FROM A QUASI-NEOPLASTIC PERSPECTIVE: LESS OF A SCAR AND MORE OF A CHRONIC INFLAMMATORY DISEASE WITH CANCER-LIKE TENDENCIES |
| 6624 |
UNDERSTANDING PSORIASIS: ROLE OF MIRNAS |
| 6625 |
UNDERSTANDING RACIAL DISPARITIES OF PRETERM BIRTH THROUGH THE PLACENTA |
| 6626 |
UNDERSTANDING RESILIENCE |
| 6627 |
UNDERSTANDING RESILIENCE: NEW APPROACHES FOR PREVENTING AND TREATING PTSD |
| 6628 |
UNDERSTANDING THE GENETICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ALPHA1-ANTITRYPSIN DEFICIENCY, AND IMPLICATIONS FOR CLINICAL PRACTICE |
| 6629 |
UNDERSTANDING THE HUMAN AGING PROTEOME USING EPIDEMIOLOGICAL MODELS |
| 6630 |
UNDERSTANDING THE INTERPLAY BETWEEN HEALTH DISPARITIES AND EPIGENOMICS |
| 6631 |
UNDERSTANDING THE MANIFESTATION OF DIABETES IN SUB SAHARAN AFRICA TO INFORM THERAPEUTIC APPROACHES AND PREVENTIVE STRATEGIES: A NARRATIVE REVIEW |
| 6632 |
UNDERSTANDING THE ROLE OF THE CHROMOSOME 15Q25 |
| 6633 |
UNHEALTHY SMOKERS: SCOPES FOR PROPHYLACTIC INTERVENTION AND CLINICAL TREATMENT |
| 6634 |
UNINTEGRATED TWO-LONG TERMINAL REPEAT CIRCULAR HUMAN T LYMPHOTROPIC VIRUS DNA ACCUMULATION DURING CHRONIC HTLV INFECTION |
| 6635 |
UNIQUE MICRORNA ALTERATIONS IN HEPATOCELLULAR CARCINOMAS ARISING EITHER SPONTANEOUSLY OR DUE TO CHRONIC EXPOSURE TO GINKGO BILOBA EXTRACT (GBE) IN B6C3F1/N MICE |
| 6636 |
UNRAVELING A NEW PLAYER IN MULTIPLE SCLEROSIS PATHOGENESIS: THE RNA-BINDING PROTEIN HUR |
| 6637 |
UNRAVELING THE COMPLEXITY OF HEPATITIS B VIRUS: FROM MOLECULAR UNDERSTANDING TO THERAPEUTIC STRATEGY IN 50 YEARS |
| 6638 |
UNRAVELING THE EPIGENETIC LANDSCAPE OF GLOMERULAR CELLS IN KIDNEY DISEASE |
| 6639 |
UNRAVELING THE EPIGENOMIC AND TRANSCRIPTOMIC INTERPLAY DURING ALCOHOL-INDUCED ANXIOLYSIS |
| 6640 |
UNRAVELING THE MOLECULAR MECHANISMS INVOLVED IN HCV-INDUCED CARCINOGENESIS |
| 6641 |
UNRAVELING THE MULTIFACETED NATURE OF CD8 T CELL EXHAUSTION PROVIDES THE MOLECULAR BASIS FOR THERAPEUTIC T CELL RECONSTITUTION IN CHRONIC HEPATITIS B AND C |
| 6642 |
UNRAVELING THE PATHOGENESIS OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP: FOCUSING ON EPIGENETIC MECHANISMS |
| 6643 |
UNRAVELLING THE COMPLEX GENETIC BACKGROUND OF ATOPIC DERMATITIS: FROM GENETIC ASSOCIATION RESULTS TOWARDS NOVEL THERAPEUTIC STRATEGIES |
| 6644 |
UNRAVELLING THE MOLECULAR MECHANISMS OF NICKEL IN WOODLICE |
| 6645 |
UP-REGULATION OF DBPA MRNA IN HEPATOCELLULAR CARCINOMA ASSOCIATED WITH METABOLIC SYNDROME |
| 6646 |
UP-REGULATION OF HDACS, A HARBINGER OF URAEMIC ENDOTHELIAL DYSFUNCTION, IS PREVENTED BY DEFIBROTIDE |
| 6647 |
UPDATE OF PERICYTES FUNCTION AND THEIR ROLES IN KIDNEY DISEASES |
| 6648 |
UPDATE ON DIAGNOSIS, PATHOPHYSIOLOGY, AND MANAGEMENT OF DIABETIC KIDNEY DISEASE |
| 6649 |
UPDATE ON ENDOMETRIOSIS PATHOGENESIS |
| 6650 |
UPDATE ON ETIOLOGY AND PATHOGENESIS OF BILIARY ATRESIA |
| 6651 |
UPDATE ON GENETICS AND EPIGENETICS IN METABOLIC ASSOCIATED FATTY LIVER DISEASE |
| 6652 |
UPDATE ON INFLAMMATION IN CHRONIC KIDNEY DISEASE |
| 6653 |
UPDATE ON PANCREATIC CANCER AND ALCOHOL-ASSOCIATED RISK |
| 6654 |
UPDATE ON PSEUDOEXFOLIATION SYNDROME PATHOGENESIS AND ASSOCIATIONS WITH INTRAOCULAR PRESSURE, GLAUCOMA AND SYSTEMIC DISEASES |
| 6655 |
UPDATE ON THE MOLECULAR PATHOLOGY OF CUTANEOUS SQUAMOUS CELL CARCINOMA |
| 6656 |
UPDATED UNDERSTANDING OF CANCER AS A METABOLIC AND TELOMERE-DRIVEN DISEASE, AND PROPOSAL FOR COMPLEX PERSONALIZED TREATMENT, A HYPOTHESIS |
| 6657 |
UPREGULATED KAT7 IN SYNOVIAL FIBROBLASTS PROMOTES TH17 CELL DIFFERENTIATION AND INFILTRATION IN RHEUMATOID ARTHRITIS |
| 6658 |
UPREGULATED LNCRNA H19 SPONGES MIR-106A-5P AND CONTRIBUTES TO ALDOSTERONE-INDUCED VASCULAR CALCIFICATION VIA ACTIVATING THE RUNX2-DEPENDENT PATHWAY |
| 6659 |
UPREGULATION OF AKT3 CONFERS RESISTANCE TO THE AKT INHIBITOR MK2206 IN BREAST CANCER |
| 6660 |
UPREGULATION OF CXCR4 THROUGH PROMOTER DEMETHYLATION CONTRIBUTES TO INFLAMMATORY HYPERALGESIA IN RATS |
| 6661 |
UPREGULATION OF DNA METHYLTRANSFERASE-MEDIATED GENE SILENCING, ANCHORAGE-INDEPENDENT GROWTH, AND MIGRATION OF COLON CANCER CELLS BY INTERLEUKIN-6 |
| 6662 |
UPREGULATION OF FZD5 IN EOSINOPHILIC CHRONIC RHINOSINUSITIS WITH NASAL POLYPS BY EPIGENETIC MODIFICATION |
| 6663 |
UPREGULATION OF HISTONE-LYSINE METHYLTRANSFERASES PLAYS A CAUSAL ROLE IN HEXAVALENT CHROMIUM-INDUCED CANCER STEM CELL-LIKE PROPERTY AND CELL TRANSFORMATION |
| 6664 |
UPREGULATION OF LNCRNA71132 IN THE SPINAL CORD REGULATES HYPERSENSITIVITY IN A RAT MODEL OF BONE CANCER PAIN |
| 6665 |
UPSTREAM AND DOWNSTREAM REGULATORS OF KLOTHO EXPRESSION IN CHRONIC KIDNEY DISEASE |
| 6666 |
UPTAKE OF ASCORBIC ACID BY PANCREATIC ACINAR CELLS IS NEGATIVELY IMPACTED BY CHRONIC ALCOHOL EXPOSURE |
| 6667 |
URATE-INDUCED IMMUNE PROGRAMMING: CONSEQUENCES FOR GOUTY ARTHRITIS AND HYPERURICEMIA |
| 6668 |
URGENT NEEDS OF CAREGIVING IN AGEING POPULATIONS WITH ALZHEIMER'S DISEASE AND OTHER CHRONIC CONDITIONS: SUPPORT OUR LOVED ONES |
| 6669 |
URIC ACID IN METABOLIC SYNDROME: DOES URIC ACID HAVE A DEFINITIVE ROLE? INCREASED SERUM URIC ACID (SUA) LEVELS ARE COMMONLY SEEN IN PATIENTS WITH METABOLIC SYNDROME AND ARE WIDELY ACCEPTED AS RISK FACTORS FOR HYPERTENSION, GOUT, NON-ALCOHOLIC FATTY LIVER DISEASE, CHRONIC KIDNEY DISEASE (CKD), AND CARDIOVASCULAR DISEASES |
| 6670 |
URINARY MICRORNA ANALYSIS INDICATES AN EPIGENETIC REGULATION OF CHRONIC KIDNEY DISEASE OF UNKNOWN ETIOLOGY IN SRI LANKA |
| 6671 |
UROPATHOGENIC ESCHERICHIA COLI INFECTION-INDUCED EPITHELIAL TRAINED IMMUNITY IMPACTS URINARY TRACT DISEASE OUTCOME |
| 6672 |
USE OF A MOUSE IN VITRO FERTILIZATION MODEL TO UNDERSTAND THE DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE HYPOTHESIS |
| 6673 |
USE OF COMPUTER TV MORPHODENSITOMETRY TO STUDY EPIGENETIC CHANGES IN BLOOD LYMPHOCYTES FROM CHILDREN AFFECTED BY LOW-DOSE IRRADIATION |
| 6674 |
USE OF METHYLATION PROFILING TO IDENTIFY SIGNIFICANT DIFFERENTIALLY METHYLATED GENES IN BONE MARROW MESENCHYMAL STROMAL CELLS FROM ACUTE MYELOID LEUKEMIA |
| 6675 |
USING EPIGENETIC THERAPY TO OVERCOME CHEMOTHERAPY RESISTANCE |
| 6676 |
USING EPIGENETIC TOOLS TO INVESTIGATE ANTIDEPRESSANT RESPONSE |
| 6677 |
USING EPIGENETICS TO DEFINE VACCINE-INDUCED MEMORY T CELLS |
| 6678 |
USING GENETIC BURDEN SCORES FOR GENE-BY-METHYLATION INTERACTION ANALYSIS ON METABOLIC SYNDROME IN AFRICAN AMERICANS |
| 6679 |
USING MACHINE LEARNING TO PREDICT OBESITY BASED ON GENOME-WIDE AND EPIGENOME-WIDE GENE-GENE AND GENE-DIET INTERACTIONS |
| 6680 |
USING PERIPHERAL BLOOD CIRCULATING DNAS TO DETECT CPG GLOBAL METHYLATION STATUS AND GENETIC MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME |
| 6681 |
USING ZEBRAFISH EMBRYO BIOASSAYS TO IDENTIFY CHEMICALS MODULATING THE REGULATION OF THE EPIGENOME: A CASE STUDY WITH SIMVASTATIN |
| 6682 |
UTERINE LEIOMYOMA: AVAILABLE MEDICAL TREATMENTS AND NEW POSSIBLE THERAPEUTIC OPTIONS |
| 6683 |
UV RADIATION AND AIR POLLUTION AS DRIVERS OF MAJOR AUTOIMMUNE CONDITIONS |
| 6684 |
VALIDATION OF AN LC-MS BASED APPROACH FOR PROFILING HISTONES IN CHRONIC LYMPHOCYTIC LEUKEMIA |
| 6685 |
VALIDATION OF DIFFERENTIAL GDAP1 DNA METHYLATION IN ALCOHOL DEPENDENCE AND ITS POTENTIAL FUNCTION AS A BIOMARKER FOR DISEASE SEVERITY AND THERAPY OUTCOME |
| 6686 |
VALIDATION OF EPIGENETIC MARKERS TO IDENTIFY COLITIS ASSOCIATED CANCER: RESULTS OF MODULE 1 OF THE ENDCAP-C STUDY |
| 6687 |
VALIDATION OF THE EPIGENETIC READER BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4) AS A THERAPEUTIC TARGET FOR TREATMENT OF AIRWAY REMODELING |
| 6688 |
VALPROATE SYNERGIZES WITH PURINE NUCLEOSIDE ANALOGUES TO INDUCE APOPTOSIS OF B-CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS |
| 6689 |
VALPROIC ACID AT THERAPEUTIC PLASMA LEVELS MAY INCREASE 5-AZACYTIDINE EFFICACY IN HIGHER RISK MYELODYSPLASTIC SYNDROMES |
| 6690 |
VALPROIC ACID SILENCING OF ASCL1B/ASCL1 RESULTS IN THE FAILURE OF SEROTONERGIC DIFFERENTIATION IN A ZEBRAFISH MODEL OF FETAL VALPROATE SYNDROME |
| 6691 |
VARIABLE DNA METHYLATION IS ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND LUNG FUNCTION |
| 6692 |
VARIABLE DNA METHYLATION PATTERNS ASSOCIATED WITH PROGRESSION OF DISEASE IN HEPATOCELLULAR CARCINOMAS |
| 6693 |
VARIABLE INDUCTION OF PRDM1 AND DIFFERENTIATION IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH ANERGY |
| 6694 |
VARIABLE TRANSCRIPTIONAL RESPONSIVENESS OF THE P2X3 RECEPTOR GENE DURING CFA-INDUCED INFLAMMATORY HYPERALGESIA |
| 6695 |
VARIANT GENE EXPRESSION AND ANTIGENIC VARIATION BY MALARIA PARASITES |
| 6696 |
VARIATION IN GENOTYPE AND DNA METHYLATION PATTERNS BASED ON ALCOHOL USE AND CVD IN THE KOREAN GENOME AND EPIDEMIOLOGY STUDY (KOGES) |
| 6697 |
VARICELLA-ZOSTER VIRUS HUMAN GANGLIONIC LATENCY: A CURRENT SUMMARY |
| 6698 |
VARICOCOELE AND OXIDATIVE STRESS: NEW PERSPECTIVES FROM ANIMAL AND HUMAN STUDIES |
| 6699 |
VASCULAR CALCIFICATION IN CKD: NEW INSIGHTS INTO ITS MECHANISMS |
| 6700 |
VASCULAR CALCIFICATION MECHANISMS: UPDATES AND RENEWED INSIGHT INTO SIGNALING PATHWAYS INVOLVED IN HIGH PHOSPHATE-MEDIATED VASCULAR SMOOTH MUSCLE CELL CALCIFICATION |
| 6701 |
VASCULAR FACTORS AND EPIGENETIC MODIFICATIONS IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE |
| 6702 |
VEGFA PROMOTER GENE HYPERMETHYLATION AT HIF1ALPHA BINDING SITE IS AN EARLY CONTRIBUTOR TO CKD PROGRESSION AFTER RENAL ISCHEMIA |
| 6703 |
VERSATILE WORKFLOW FOR CELL TYPE-RESOLVED TRANSCRIPTIONAL AND EPIGENETIC PROFILES FROM CRYOPRESERVED HUMAN LUNG |
| 6704 |
VHL GENE METHYLATION CONTRIBUTES TO EXCESSIVE ERYTHROCYTOSIS IN CHRONIC MOUNTAIN SICKNESS RAT MODEL BY UPREGULATING THE HIF-2ALPHA/EPO PATHWAY |
| 6705 |
VHL INACTIVATION IN PRECANCEROUS KIDNEY CELLS INDUCES AN INFLAMMATORY RESPONSE VIA ER STRESS-ACTIVATED IRE1ALPHA SIGNALING |
| 6706 |
VIRAL GENE PRODUCTS ACTIVELY PROMOTE LATENT INFECTION BY EPIGENETIC SILENCING MECHANISMS |
| 6707 |
VIRAL HEPATITIS AND HEPATOCELLULAR CARCINOMA: STATE OF THE ART |
| 6708 |
VIRAL INDUCED EFFECTS ON A VULNERABLE EPITHELIUM; LESSONS LEARNED FROM PAEDIATRIC ASTHMA AND EOSINOPHILIC OESOPHAGITIS |
| 6709 |
VIRAL TRANSDUCTION OF PRIMARY HUMAN LYMPHOMA B CELLS REVEALS MECHANISMS OF NOTCH-MEDIATED IMMUNE ESCAPE |
| 6710 |
VIRAL-INDUCED HUMAN CARCINOGENESIS: AN OXIDATIVE STRESS PERSPECTIVE |
| 6711 |
VIRTUES AND WEAKNESSES OF DNA METHYLATION AS A TEST FOR CERVICAL CANCER PREVENTION |
| 6712 |
VIRUS-HOST INTERPLAY IN HEPATITIS B VIRUS INFECTION AND EPIGENETIC TREATMENT STRATEGIES |
| 6713 |
VISCERAL ADIPOSITY SYNDROME |
| 6714 |
VISION OF RESEARCH ON HUMAN LINEAR GROWTH |
| 6715 |
VITAMIN A AND THE EPIGENOME |
| 6716 |
VITAMIN A: TOO GOOD TO BE BAD? VITAMIN A IS A MICRONUTRIENT IMPORTANT FOR VISION, CELL GROWTH, REPRODUCTION AND IMMUNITY |
| 6717 |
VITAMIN B SUPPLEMENTATION AND NUTRITIONAL INTAKE OF METHYL DONORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A CRITICAL REVIEW OF THE IMPACT ON EPIGENETIC MACHINERY |
| 6718 |
VITAMIN D AND CARDIOVASCULAR DISEASES: CAUSALITY |
| 6719 |
VITAMIN D AND SUSCEPTIBILITY OF CHRONIC LUNG DISEASES: ROLE OF EPIGENETICS |
| 6720 |
VITAMIN D METABOLISM GENES ARE DIFFERENTIALLY METHYLATED IN INDIVIDUALS WITH CHRONIC KNEE PAIN |
| 6721 |
VITAMIN D RECEPTOR AGONISTS' ANTI-INFLAMMATORY PROPERTIES |
| 6722 |
VITAMIN D RECEPTOR AND EPIGENETICS IN HIV INFECTION AND DRUG ABUSE |
| 6723 |
VITAMIN D RECEPTOR GENE METHYLATION IN HEPATOCELLULAR CARCINOMA |
| 6724 |
VITAMIN D: EFFECTS ON PREGNANCY, MATERNAL, FETAL AND POSTNATAL OUTCOMES |
| 6725 |
VITAMIN D: NOT JUST BONE METABOLISM BUT A KEY PLAYER IN CARDIOVASCULAR DISEASES |
| 6726 |
VITAMIN-DEPENDENT METHIONINE METABOLISM AND ALCOHOLIC LIVER DISEASE |
| 6727 |
VITILIGO AND CHRONIC AUTOIMMUNE THYROIDITIS |
| 6728 |
VOLTAGE-GATED CALCIUM CHANNELS AND PARKINSON'S DISEASE |
| 6729 |
VULNERABILITY TO STROKE: IMPLICATIONS OF PERINATAL PROGRAMMING OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS |
| 6730 |
WALK MORE, EAT LESS, DON'T STRESS |
| 6731 |
WATERPIPE SMOKING INDUCES EPIGENETIC CHANGES IN THE SMALL AIRWAY EPITHELIUM |
| 6732 |
WESTERN DIET AND THE IMMUNE SYSTEM: AN INFLAMMATORY CONNECTION |
| 6733 |
WHAT CAN CHEMICAL CARCINOGENESIS SHED LIGHT ON THE LNT HYPOTHESIS IN RADIATION CARCINOGENESIS? TO PROTECT THE PUBLIC'S HEALTH FROM EXPOSURE TO PHYSICAL, CHEMICAL, AND MICROBIOLOGICAL AGENTS, IT IS IMPORTANT THAT ANY POLICY BE BASED ON RIGOROUS SCIENTIFICALLY BASED RESEARCH |
| 6734 |
WHAT DO WE KNOW ABOUT THE ROLE OF LNCRNAS IN MULTIPLE SCLEROSIS? MULTIPLE SCLEROSIS IS A CHRONIC, INFLAMMATORY AND DEGENERATIVE DISEASE OF THE CENTRAL NERVOUS SYSTEM OF UNKNOWN AETIOLOGY ALTHOUGH WELL-DEFINED EVIDENCE SUPPORTS AN AUTOIMMUNE PATHOGENESIS |
| 6735 |
WHAT HAVE MECHANISTIC STUDIES TAUGHT US ABOUT CHILDHOOD ASTHMA? CHILDHOOD ASTHMA IS A CHRONIC HETEROGENEOUS SYNDROME CONSISTING OF DIFFERENT DISEASE ENTITIES OR PHENOTYPES |
| 6736 |
WHAT IS A PSYCHOSIS AND WHERE IS IT LOCATED? KRAEPELIN'S DICHOTOMY, MANIC-DEPRESSIVE INSANITY AND DEMENTIA PRAECOX, ARE CONTRASTING AND TRUE ENDOGENOUS DISEASE ENTITIES WHICH AFFECT EXCITABILITY, THE FUNDAMENTAL PROPERTY OF THE CNS |
| 6737 |
WHAT MAKES GOUTY INFLAMMATION SO VARIABLE? ACUTE GOUT ARTHRITIS FLARES CONTRIBUTE DOMINANTLY TO GOUT-SPECIFIC IMPAIRED HEALTH-RELATED QUALITY OF LIFE, REPRESENTING A PROGRESSIVELY INCREASING PUBLIC HEALTH PROBLEM |
| 6738 |
WHAT'S YOUR CUP OF TEA? THE ROLE OF HERBAL COMPOUNDS IN THE MANAGEMENT OF MULTIPLE SCLEROSIS |
| 6739 |
WHEN ENVIRONMENT MEETS GENETICS: A CLINICAL REVIEW OF THE EPIGENETICS OF PAIN, PSYCHOLOGICAL FACTORS, AND PHYSICAL ACTIVITY |
| 6740 |
WHEN GETOMICS MEETS AGING AND EXERCISE IN COPD |
| 6741 |
WHERE TO STAND WITH STROMAL CELLS AND CHRONIC SYNOVITIS IN RHEUMATOID ARTHRITIS? THE SYNOVIUM EXERCISES ITS MAIN FUNCTION IN JOINT HOMEOSTASIS THROUGH THE SECRETION OF FACTORS (SUCH AS LUBRICIN AND HYALURONIC ACID) THAT ARE CRITICAL FOR THE JOINT LUBRICATION AND FUNCTION |
| 6742 |
WHITHER THE ETIOPATHOGENESIS (AND SCOLIOGENY) OF ADOLESCENT IDIOPATHIC SCOLIOSIS? ALTHOUGH CONSIDERABLE PROGRESS HAD BEEN MADE IN THE PAST TWO DECADES IN UNDERSTANDING THE ETIOPATHOGENESIS OF ADOLESCENT IDIOPATHIC SCOLIOSIS (AIS), IT STILL LACKS AN AGREED THEORY OF ETIOPATHOGENESIS |
| 6743 |
WHITHER THE ETIOPATHOGENESIS (AND SCOLIOGENY) OF ADOLESCENT IDIOPATHIC SCOLIOSIS? INCORPORATING PRESENTATIONS ON SCOLIOGENY AT THE 2012 IRSSD AND SRS MEETINGS |
| 6744 |
WHO CARES ABOUT OLIGOZOOSPERMIA WHEN WE HAVE ICSI |
| 6745 |
WHO'S YOUR DADDY?: PATERNAL INHERITANCE OF METABOLIC DISEASE RISK |
| 6746 |
WHOLE EXOME SEQUENCING OF ULCERATIVE COLITIS-ASSOCIATED COLORECTAL CANCER BASED ON NOVEL SOMATIC MUTATIONS IDENTIFIED IN CHINESE PATIENTS |
| 6747 |
WHOLE GENOME 5'-METHYLCYTOSINE LEVEL QUANTIFICATION IN CIRRHOTIC HCV-INFECTED EGYPTIAN PATIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMA |
| 6748 |
WHOLE GENOME METHYLATION ARRAY ANALYSIS REVEALS NEW ASPECTS IN BALKAN ENDEMIC NEPHROPATHY ETIOLOGY |
| 6749 |
WHOLE-GENOME CARDIAC DNA METHYLATION FINGERPRINT AND GENE EXPRESSION ANALYSIS PROVIDE NEW INSIGHTS IN THE PATHOGENESIS OF CHRONIC CHAGAS DISEASE CARDIOMYOPATHY |
| 6750 |
WHOLE-GENOME METHYLATION PROFILING FROM PBMCS IN ACUTE-EXACERBATION COPD PATIENTS WITH GOOD AND POOR RESPONSES TO CORTICOSTEROID TREATMENT |
| 6751 |
WHY ARE PEOPLE WITH HIV CONSIDERED "OLDER ADULTS" IN THEIR FIFTIES? ONE IN SIX NEW HIV DIAGNOSES IN EUROPE OCCUR AMONG PEOPLE OVER 50 YEARS OF AGE |
| 6752 |
WIDESPREAD EXONIZATION OF TRANSPOSABLE ELEMENTS IN HUMAN CODING SEQUENCES IS ASSOCIATED WITH EPIGENETIC REGULATION OF TRANSCRIPTION |
| 6753 |
WILD TYPE HBX AND TRUNCATED HBX: PLEIOTROPIC REGULATORS DRIVING SEQUENTIAL GENETIC AND EPIGENETIC STEPS OF HEPATOCARCINOGENESIS AND PROGRESSION OF HBV-ASSOCIATED NEOPLASMS |
| 6754 |
WILL WE NEED NOVEL COMBINATIONS TO CURE HBV INFECTION? CHRONIC HEPATITIS B IS A NUMERICALLY IMPORTANT CAUSE OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA |
| 6755 |
WILL WIDESPREAD SYNTHETIC OPIOID CONSUMPTION INDUCE EPIGENETIC CONSEQUENCES IN FUTURE GENERATIONS? A GROWING NUMBER OF EVIDENCE DEMONSTRATES THAT ANCESTRAL EXPOSURE TO XENOBIOTICS (POLLUTANTS, DRUGS OF ABUSE, ETC |
| 6756 |
WNT ANTAGONIST, SFRP1, IS HEDGEHOG SIGNALING TARGET |
| 6757 |
WNT SIGNALING IN LIVER FIBROSIS: PROGRESS, CHALLENGES AND POTENTIAL DIRECTIONS |
| 6758 |
WNT SIGNALING IN STEM CELL BIOLOGY AND REGENERATIVE MEDICINE |
| 6759 |
WNT SIGNALLING PATHWAY IN ORAL LESIONS |
| 6760 |
WORKGROUP ON NAPA'S SCIENTIFIC AGENDA FOR A NATIONAL INITIATIVE ON ALZHEIMER'S DISEASE |
| 6761 |
X CHROMOSOME-WIDE ANALYSIS IDENTIFIES DNA METHYLATION SITES INFLUENCED BY CIGARETTE SMOKING |
| 6762 |
ZAP70 IN CHRONIC LYMPHOCYTIC LEUKAEMIA |
| 6763 |
ZINC AND ITS ROLE IN AGE-RELATED INFLAMMATION AND IMMUNE DYSFUNCTION |
| 6764 |
ZINC DEFICIENCY ENHANCED INFLAMMATORY RESPONSE BY INCREASING IMMUNE CELL ACTIVATION AND INDUCING IL6 PROMOTER DEMETHYLATION |
| 6765 |
ZINC DEFICIENCY LEADS TO REDUCED INTERLEUKIN-2 PRODUCTION BY ACTIVE GENE SILENCING DUE TO ENHANCED CREMALPHA EXPRESSION IN T CELLS |
| 6766 |
ZINC METALLOPROTEINS IN EPIGENETICS AND THEIR CROSSTALK |
| 6767 |
ZNF382 CONTROLS MOUSE NEUROPATHIC PAIN VIA SILENCER-BASED EPIGENETIC INHIBITION OF CXCL13 IN DRG NEURONS |
| 6768 |
ZOLEDRONIC ACID EPIGENETICALLY ALLEVIATES HIGH-GLUCOSE-SUPPRESSED OSTEOGENIC DIFFERENTIATION OF MC3T3-E1 CELLS |
| 6769 |
["EDUCATION" IN AN AGE OF INCREASING EQUALITY--A PATH TOWARDS 'OCHLOCRACY"?] |
| 6770 |
[ABERRANT METHYLATION OF MULTIPLE GENES AND ITS CLINICAL IMPLICATION IN HEPATOCELLULAR CARCINOMA] |
| 6771 |
[ACQUIRED DISORDERS AND EPIGENETICS] |
| 6772 |
[ADVANCES IN EPIGENETIC MARKERS OF DERMATOMYOSITIS/POLYMYOSITIS] |
| 6773 |
[ADVANCES OF RESEARCH ON DEMETHYLATION THERAPY FOR HEMATOLOGIC MALIGNANCIES] |
| 6774 |
[AGE-RELATED VASCULAR CHANGES EXEMPLIFIED BY THE CAROTID ARTERY] |
| 6775 |
[ALCOHOL DEPENDENCE MEDIATED BY MONOAMINE NEUROTRANSMITTERS IN THE CENTRAL NERVOUS SYSTEM] |
| 6776 |
[APPROACHING NEW PHARMACOTHERAPY OPTIONS IN PAIN TREATMENT] |
| 6777 |
[ASSOCIATION OF P-MOBILE ELEMENT ACTIVITY AND DNA METHYLATION PATTERN CHANGES IN THE CONDITIONS OF DROSOPHILA MELANOGASTER PROLONGED IRRADIATION] |
| 6778 |
[BILIARY TRACT CANCERS : MOLECULAR CHARACTERIZATION AND IDENTIFICATION OF NOVEL PROGNOSTIC MARKERS] |
| 6779 |
[BIO-PSYCHO-SOCIAL THERAPY FOR STRESS-INDUCED CHRONIC PAIN] |
| 6780 |
[BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM ACCOMPANIED BY CHRONIC MYELOMONOCYTIC LEUKEMIA SUCCESSFULLY TREATED WITH AZACITIDINE] |
| 6781 |
[BREATHING: AMBIENT AIR POLLUTION AND HEALTH - PART III] |
| 6782 |
[CHRONIC DISEASES, PRECANCER, AND CANCER OF THE LUNG, WHICH ARE ASSOCIATED WITH PATHOLOGY OF THE CLUB CELLS OF RESPIRATORY AND TERMINAL BRONCHIOLES] |
| 6783 |
[CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN WOMEN] |
| 6784 |
[CHRONIC STRESS AND EPIGENETICS |
| 6785 |
[CONFLICT MEDIATION: AN ADDITIONAL OPTION FOR THE MEDICAL PRACTITIONER] |
| 6786 |
[CONSENSUS AND CONTROVERSY ON RESEARCH PROGRESS AND CLINICAL PRACTICE OF VASCULAR CALCIFICATION] |
| 6787 |
[CONTRIBUTION OF NON-HLA GENES TO JUVENILE IDIOPATHIC ARTHRITIS SUSCEPTIBILITY] |
| 6788 |
[COPD AND LUNG CANCER: EPIDEMIOLOGICAL AND BIOLOGICAL LINKS] |
| 6789 |
[CURRENT STATUS OF ATL RESEARCH: EFFORTS FOR PREVENTION AND PRECISION MEDICINE FOR ATL] |
| 6790 |
[DNA METHYLATION ANALYSIS IN ENVIRONMENTAL AND OCCUPATIONAL CANCER RESEARCH] |
| 6791 |
[DOES THE NUMBER OF PATIENTS WITH AUTOIMMUNE DISORDERS AND THE FREQUENCY OF AUTOIMMUNE DISEASES INCREASE?] |
| 6792 |
[DOHAD AND EPIGENETIC INFORMATION: SOCIETAL CHALLENGES] |
| 6793 |
[DOWN-REGULATION OF TRANSCRIPTION FACTOR PU |
| 6794 |
[EFFECT OF BENZO(A)PYRENE ON THE EXPRESSION OF AHR-REGULATED MICRORNA IN FEMALE AND MALE RAT LUNGS] |
| 6795 |
[EFFECT OF HISTONE ACETYLATION ON OSTEOGENIC DIFFERENTIATION OF PERIODONTAL LIGAMENT STEM CELLS DERIVED FROM PERIODONTITIS TISSUE] |
| 6796 |
[ENDOMETRIOSIS: A NEW APPROACH TO ETIOLOGY AND PATHOGENESIS (REVIEW)] |
| 6797 |
[EPIDEMIOLOGY, NATURAL HISTORY AND PATHOGENESIS OF HEPATOCELLULAR CARCINOMA] |
| 6798 |
[EPIDEMIOLOGY, RISK FACTORS AND MOLECULAR PATHOGENESIS OF PRIMARY LIVER CANCER] |
| 6799 |
[EPIGENETIC AND CURRENT TREATMENT APPROACHES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE] |
| 6800 |
[EPIGENETIC DISTURBANCES IN SYSTEMIC LUPUS ERYTHEMATOSUS] |
| 6801 |
[EPIGENETIC MECHANISMS AND ALCOHOL USE DISORDERS: A POTENTIAL THERAPEUTIC TARGET] |
| 6802 |
[EPIGENETIC MECHANISMS IN MODELS OF CHRONIC PAIN - A TARGET FOR NOVEL THERAPY?] |
| 6803 |
[EPIGENETIC MECHANISMS IN PHYSIOLOGIC AND PATHOLOGIC PREGNANCIES] |
| 6804 |
[EPIGENETIC REGULATION IN DEPRESSION] |
| 6805 |
[EPIGENETICS : IMPORTANT ASPECTS FOR ANESTHESIOLOGISTS, PAIN AND INTENSIVE CARE PHYSICIANS] |
| 6806 |
[EPIGENETICS AND DRUG ADDICTION: A FOCUS ON MECP2 AND ON HISTONE ACETYLATION] |
| 6807 |
[EPIGENETICS AND PAIN] |
| 6808 |
[EPIGENETICS IN ALLERGIC DISEASES AND ASTHMA] |
| 6809 |
[EPIGENETICS IN INFLAMMATORY SYSTEMIC DISEASES] |
| 6810 |
[EPIGENETICS IN KIDNEY DISEASES] |
| 6811 |
[EPIGENETICS, ENVIRONMENT AND ASTHMA] |
| 6812 |
[EPIGENETICS, INTERFACE BETWEEN ENVIRONMENT AND GENES: ROLE IN COMPLEX DISEASES] |
| 6813 |
[EPILEPSY-ASSOCIATED TUMORS OF THE CENTRAL NERVOUS SYSTEM: EPILEPSY SURGERY AND ONCOLOGICAL ASPECTS] |
| 6814 |
[EVIDENCE AND MECHANISMS OF FETAL ORIGINS OF ADULT DISEASES] |
| 6815 |
[EVOLUTIONARY ONTOGENETIC ASPECTS OF PATHOGENETICS OF CHRONIC HUMAN DISEASES] |
| 6816 |
[EXPRESSION, GENETIC AND EPIGENETIC ALTERATIONS OF LTF GENE IN NASOPHARYNGEAL CARCINOMA CELL LINES] |
| 6817 |
[FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: REPORT OF SEVEN PATIENTS] |
| 6818 |
[FETAL PROGRAMMING AS A CAUSE OF CHRONIC DISEASES IN ADULT LIFE] |
| 6819 |
[FETAL PROGRAMMING OF METABOLIC DISORDERS] |
| 6820 |
[GASTRIC CARCINOMA AND CHRONIC GASTRITIS: EPIGENETIC REGULATION OF CDH1 (E-CADHERIN), CDKN2A (P16INK4A), PTGS2 (COX-2) AND EGFR GENES THROUGH METHYLATION] |
| 6821 |
[GASTROINTESTINAL MANIFESTATIONS IN IMMUNODEFICIENCIES WITH MONOGENIC ORIGIN] |
| 6822 |
[GENDER MEDICINE |
| 6823 |
[GENERAL CONCEPTS OF EPIGENETICS: PROJECTIONS IN PAEDIATRICS] |
| 6824 |
[GENETIC ALTERATIONS IN PRENEOPLASTIC AND NEOPLASTIC INJURIES OF THE GALLBLADDER] |
| 6825 |
[GENETIC AND EPIGENETIC FACTORS OF POLYCYSTIC OVARY SYNDROME] |
| 6826 |
[GENOME-WIDE ANALYSIS OF DNA METHYLATION IN CD4+ T LYMPHOCYTES OF PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS INDICATES INVOLVEMENT OF THIS EPIGENETIC PROCESS IN THE DISEASE IMMUNOPATHOGENESIS] |
| 6827 |
[GILLES DE LA TOURETTE'S DISEASE |
| 6828 |
[GLOBAL UNDERSTANDING OF PAIN] |
| 6829 |
[HEPATITIS C VIRUS INFECTION AND HEPATOCARCINOGENESIS] |
| 6830 |
[HOW HISTONE DEACETYLASE 3 CONTROLS HEPCIDIN EXPRESSION AND HEPATITIS C VIRUS REPLICATION] |
| 6831 |
[HYPERMETHYLATION OF DAP-KINASE GENE CPG ISLAND IN MALIGNANT LYMPHOMA WITH B-CELL PHENOTYPE] |
| 6832 |
[HYPOMETHYLATION OF TNF-ALPHA GENE PROMOTER IN THE PATIENTS WITH ACUTE-ON-CHRONIC HEPATITIS B LIVER FAILURE] |
| 6833 |
[HYPOTHETICAL LINK BETWEEN ENDOMETRIOSIS AND XENOBIOTICS-ASSOCIATED GENETICALLY MODIFIED FOOD] |
| 6834 |
[IMMUNOPATHOLOGY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE] |
| 6835 |
[INFLUENCE OF AGE OF PATIENTS WITH BRONCHOPULMONARY PATHOLOGY ON LOW-MOLECULAR DNA CONCENTRATION IN BLOOD PLASMA |
| 6836 |
[INFLUENCE OF METFORMIN ON THE DIAMETER AND NUMBER OF DNA BREAKS IN BLOOD LYMPHOCYTES IN OBESITY] |
| 6837 |
[INTERSTITIAL CYSTITIS: THE LATEST FINDINGS ON ITS AETIOPATHOGENESIS] |
| 6838 |
[INTRODUCTION OF TRANSLATIONAL RESEARCH IN OMICS SCIENCE TO CLINICAL ANESTHESIA] |
| 6839 |
[LUNG CANCER AND ITS EPIGENETICS ASSOCIATION WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE] |
| 6840 |
[MALE INFERTILITY AND UROLOGIC CANCERS: ADVANCES IN STUDIES] |
| 6841 |
[MECHANISMS OF H |
| 6842 |
[MECHANISTIC ISSUES AND PREVENTION STRATEGIES TARGETING OCCUPATIONAL CARCINOGENESIS] |
| 6843 |
[MEDICAL APPLICATIONS OF GENOME DISCOVERY] |
| 6844 |
[METABOLIC PROGRAMMING: THEORETICAL CONCEPTS AND EXPERIMENTAL EVIDENCE] |
| 6845 |
[METHYLATION STATUS OF APOPTOSIS GENES AND INTENSITY OF APOPTOTIC DEATH OF PERIPHERAL BLOOD LYMPHOCYTES IN PERSONS CHRONICALLY EXPOSED TO RADIATION] |
| 6846 |
[MIGRAINE: IGNITION OF THE BRAIN] |
| 6847 |
[MOLECULAR DIAGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISEASES AND MYELODYSPLASTIC SYNDROMES] |
| 6848 |
[MOLECULAR GENETIC AND EPIGENETIC MECHANISMS OF HEPATOCARCINOGENESIS] |
| 6849 |
[MOLECULAR MECHANISM OF HEPATOCARCINOGENESIS] |
| 6850 |
[MOLECULAR PATHOGENESIS OF HEPATOCELLULAR CARCINOMA] |
| 6851 |
[MOLECULAR PROFILES OF EXHAUSTED T CELLS AND THEIR IMPACT ON RESPONSE TO IMMUNE CHECKPOINT BLOCKADE] |
| 6852 |
[MYELOPROLIFERATIVE NEOPLASMS: UPDATES ON MOLECULAR PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT STRATEGIES] |
| 6853 |
[NEUROBIOLOGY OF EARLY LIFE TRAUMATIC STRESS AND TRAUMA: PROLONGED NEUROENDOCRINE DYSREGULATION AS A NEURODEVELOPMENTAL RISK FACTOR] |
| 6854 |
[NEW ADVANCES OF EPIGENETIC STUDY IN TUMORS OF LYMPHATIC SYSTEM---REVIEW] |
| 6855 |
[NEW APPROACH TO THE INVESTIGATION OF DOHAD USING X-INACTIVATION GENE EXPRESSION SYSTEM] |
| 6856 |
[NOT AVAILABLE] |
| 6857 |
[NOVEL CONVENTIONAL THERAPIES IN ONCO-HEMATHOLOGY] |
| 6858 |
[NUTRIGENOMICS, OBESITY AND PUBLIC HEALTH] |
| 6859 |
[NUTRITIONAL FACTORS ASSOCIATED WITH MIGRAINE] |
| 6860 |
[OBESITY EPIDEMIC: CURRENT EVIDENCE, CHALLENGES AND FUTURE DIRECTIONS] |
| 6861 |
[OBESITY: A MODEL OF COMPLEX INTERACTIONS BETWEEN GENETICS AND ENVIRONMENT] |
| 6862 |
[OCCULT HEPATITIS B VIRUS INFECTION] |
| 6863 |
[ONE AUTISM, SEVERAL AUTISMS |
| 6864 |
[ORIGINS OF HEALTH AND DISEASE] |
| 6865 |
[OXIDATIVE STRESS IN PROSTATE HYPERTROPHY AND CARCINOGENESIS] |
| 6866 |
[PAIN AND EMOTIONAL DYSREGULATION: CELLULAR MEMORY DUE TO PAIN] |
| 6867 |
[PARENTAL AGEING AND ASSISTED REPRODUCTION TECHNOLOGIES: ANALYSIS OF RISK OF CHRONIC DISEASES IN THE PROGENY] |
| 6868 |
[PATHOGENESIS OF HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA] |
| 6869 |
[PATHOGENESIS OF RHEUMATOID ARTHRITIS] |
| 6870 |
[PATHOGENESIS OF THE METABOLIC SYNDROME] |
| 6871 |
[PATHOGENETIC IMPORTANCE OF HELICOBACTER PYLORI INFECTION] |
| 6872 |
[POLYPHENOLS AS PROMISING BIOACTIVE COMPOUNDS] |
| 6873 |
[PREVENTION OF OBESITY FROM PERINATAL STAGE] |
| 6874 |
[PROGRESS IN THE REGULATION OF ENERGY METABOLIC HOMEOSTASIS BY THE SWI/SNF COMPLEX SUBUNIT BAF60A] |
| 6875 |
[PROGRESS OF RESEARCHES ON ANTI-INFLAMMATORY MECHANISM OF ACUPUNCTURE UNDERLYING AMELIORATION OF CHRONIC RESPIRATORY DISEASES] |
| 6876 |
[PROLONGED EXPOSURE TO ATMOSPHERIC AIR POLLUTION AND MORTALITY FROM RESPIRATORY CAUSES] |
| 6877 |
[REASONS FOR THE DEVELOPMENT OF ALLERGIES IN CHILDREN] |
| 6878 |
[REGIONAL EXPERIENCE OF A COMPREHENSIVE DYNAMIC ASSESSMENT OF THE ADOLESCENTS' HEALTH STATUS WITH POST-COVID-19 SYNDROME DURING AFTERCARE IN A SANATORIUM] |
| 6879 |
[RELATIONSHIP BETWEEN INTESTINAL HYPERPERMEABILITY AND OBESITY] |
| 6880 |
[RESEARCH PROGRESS OF LUNG AGING IN CHRONIC RESPIRATORY DISEASES] |
| 6881 |
[RESEARCH PROGRESS OF M6A METHYLATION MODIFICATION IN HEMATOLOGICAL TUMORS--REVIEW] |
| 6882 |
[RESEARCH PROGRESS ON NON-CODING RNAS IN THE MOLECULAR PATHOGENESIS OF HEPATOCELLULAR CARCINOMA] |
| 6883 |
[RESOLUTION OF INFLAMMATION--PHARMACOLOGICAL ASPECTS] |
| 6884 |
[RHEUMATOID ARTHRITIS] |
| 6885 |
[RNA SPLICING DYSREGULATION IN HEMATOLOGICAL MALIGNANCIES] |
| 6886 |
[ROLE OF EPIGENETIC MODIFICATION IN HIGHER BRAIN DYSFUNCTION AND AGING] |
| 6887 |
[ROLE OF METAFLAMMATION AS A SYSTEMIC MANIFESTATION OF METABOLIC DISEASES] |
| 6888 |
[ROLE OF VASCULAR AGING IN THE PATHOGENESIS OF ABDOMINAL AORTIC ANEURYSM AND POTENTIAL THERAPEUTIC TARGETS] |
| 6889 |
[S-ADENOSYL L-METHIONINE IN CNS DISEASES] |
| 6890 |
[SCREENING, FUNCTIONAL ANALYSIS AND CLINICAL VALIDATION OF DIFFERENTIALLY EXPRESSED GENES IN DIABETIC FOOT ULCERS] |
| 6891 |
[SIGNAL RECEPTORS OF CONGENITAL IMMUNITY: A NEW MOLECULAR TARGET FOR DIAGNOSTICS AND TREATMENT OF INFLAMMATORY DISEASES] |
| 6892 |
[SIGNIFICANCE OF PREVENTING DEVELOPMENTAL ORIGINS OF DISEASES IN IMPROVING POPULATION QUALITY] |
| 6893 |
[SLEEP AND DEMENTIA] |
| 6894 |
[SOCIAL INEQUALITY AND MENTAL HEALTH] |
| 6895 |
[SYSTEMIC CONTROL OF THE MOLECULAR, CELL, AND EPIGENETIC MECHANISMS OF LONG-LASTING CONSEQUENCES OF STRESS] |
| 6896 |
[TARGETED EPIGENETIC THERAPY OF CANCER |
| 6897 |
[TELOMERE-TELOMERASE SYSTEM IN AGING, NORM AND PATHOLOGY (LITERATURE REVIEW)] |
| 6898 |
[THE ADVANCE OF MODEL OF ACTION IN LOW-DOSE CHRONIC BENZENE EXPOSURE INDUCED HEMATOTOXICITY] |
| 6899 |
[THE DEVELOPMENT HISTORY AND FUTURE PERSPECTIVE OF MOLECULARLY TARGETED THERAPY] |
| 6900 |
[THE DIAGNOSTIC IMPORTANCE OF CIRCULATING MICRORNA FOR NON-ALCOHOLIC FATTY LIVER DISEASE (REVIEW OF LITERATURE) |
| 6901 |
[THE EXPERIMENTAL MODEL OF AUTOIMMUNE PROCESS: THE ROLE OF EPIGENETIC VARIATION IN THE POPULATION OF MICE HYBRIDS] |
| 6902 |
[THE IMPACT OF CHROMATIN MODIFICATION ON THE DEVELOPMENT OF CHRONIC COMPLICATIONS IN PATIENTS WITH DIABETES] |
| 6903 |
[THE NEED OF PRENATAL PUBLIC HEALTH INITIATIVES IN POLAND] |
| 6904 |
[THE ROLE OF ALUMINUM AND LEAD IN THE DEVELOPMENT OF ALZHEIMER'S AND PARKINSON'S DISEASES] |
| 6905 |
[THE ROLE OF EPIGENETIC REGULATIONS IN EARLY CHILDHOOD DISEASES] |
| 6906 |
[THE ROLE OF GLYCANS IN CANCER DEVELOPMENT AND PROGRESSION |
| 6907 |
[THE ROLE OF THE CIRCULAR RNAS IN MULTIPLE SCLEROSIS AND OTHER NEUROIMMUNE DISORDERS] |
| 6908 |
[THYROID AND HEPATITIS C] |
| 6909 |
[TOXIC COMPONENTS OF PM(2 |
| 6910 |
[TRANSFORMING GROWTH FACTOR-BETA AND RENAL FIBROSIS] |
| 6911 |
[TWO GERMAN BIRTH COHORTS: GINIPLUS AND LISAPLUS] |
| 6912 |
[UNDERSTANDING OF THE PSYCHIATRY IN PALLIATIVE CARE: DYSFUNCTION OF THE REWARDING SYSTEM UNDER THE PAIN STATE ASSOCIATED WITH EXACERBATING PAIN] |
| 6913 |
[VARIOUS PATHWAYS LEADING TO THE PROGRESSION OF CHRONIC LIVER DISEASES] |
| 6914 |
[VITAMIN D DEFICIENCY IN PREGNANCY AND ITS IMPACT ON THE FETUS, THE NEWBORN AND IN CHILDHOOD] |
| 6915 |
[VULNERABILITY OF WOMEN TO TOBACCO: THE BRONCHO-PULMONARY CONSEQUENCES (ASTHMA, COPD)] |
| 6916 |
[WHAT IS MIGRAINE?] |
| 6917 |
[WHOSE BORDERLINE IS IT? HYPOTHESIZED ETIOLOGIES OF BORDERLINE PERSONALITY] |
| 6918 |
[WNT3A SIGNALING PATHWAY PLAYS A ROLE IN NEUROPATHIC PAIN THROUGH EPIGENETIC MODIFICATION OF JMJD6] |